data_2hj8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hj8 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo . . . . . 0 N--CA 1.452 -0.949 0 CA-C-O 121.01 0.337 . . . . 0.0 111.644 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.6 HD21 HD13 ' A' ' 107' ' ' LEU . 0.2 OUTLIER -96.19 123.27 39.75 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.316 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -95.33 101.87 13.63 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.431 HG23 HD13 ' A' ' 89' ' ' LEU . 46.7 pt -108.33 164.08 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.105 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 154' ' ' THR . 32.2 tp -108.87 120.96 44.05 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.273 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 90.4 t -116.95 117.39 55.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.003 0.43 . . . . 0.0 110.173 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.549 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 23.2 ttt180 -96.61 133.14 41.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.632 -177.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.705 178.371 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 . . . . . 0 C--O 1.234 0.239 0 CA-C-O 121.254 0.55 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 15.0 m -95.02 102.06 13.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.414 173.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.8 m -95.45 136.41 35.86 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.042 0.448 . . . . 0.0 110.691 -176.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.3 m -85.97 124.78 32.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.073 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.51 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 43.5 m-85 -111.07 145.71 38.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.974 0.416 . . . . 0.0 111.376 -176.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -95.15 95.86 8.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.45 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.4 m -109.37 -179.79 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.842 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.1 mtm180 -138.78 166.11 25.25 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.6 HD13 HD21 ' A' ' 89' ' ' LEU . 6.9 mp -80.44 -23.4 40.32 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.7 p -76.31 -16.91 59.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.107 174.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -85.07 138.29 32.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.091 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.655 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 38.7 p -88.1 163.71 16.09 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 175.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.584 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 3.4 t -64.14 -27.31 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.274 0.559 . . . . 0.0 109.788 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.15 -37.83 88.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.742 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -70.86 -33.99 71.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.574 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.408 HD22 HD13 ' A' ' 144' ' ' LEU . 65.7 tp -61.3 -46.07 91.85 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 173.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -59.36 -39.97 84.96 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.186 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -66.96 -32.19 73.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.306 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -62.03 -51.22 68.89 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.97 0.89 . . . . 0.0 109.134 174.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.4 t -62.3 -32.03 53.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.848 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.621 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 49.9 m -65.12 -27.58 68.84 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.807 0.337 . . . . 0.0 111.082 177.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.01 -35.02 54.64 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.679 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 75.4 mt -93.46 -67.53 0.85 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.408 0.623 . . . . 0.0 112.001 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 124' ' ' VAL . 8.1 tp10 -100.47 9.9 41.94 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.788 0.835 . . . . 0.0 110.847 -172.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -44.57 7.68 0.01 OUTLIER Glycine 0 CA--C 1.532 1.139 0 N-CA-C 118.555 2.182 . . . . 0.0 118.555 -174.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 122' ' ' GLU . 59.1 t -48.26 91.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 118.428 1.114 . . . . 0.0 111.678 173.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.405 ' C ' ' H ' ' A' ' 127' ' ' ASP . 53.9 mt-30 53.51 104.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.836 0.71 . . . . 0.0 111.698 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.651 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 4.5 p-10 -69.29 11.05 0.25 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.241 -173.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 125' ' ' GLN . 8.0 p-10 -117.62 -5.48 11.16 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 174.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.26 -31.06 14.86 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 171.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.651 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 25.0 p90 -110.14 135.05 51.54 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 172.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.404 ' HE1' ' HB3' ' A' ' 137' ' ' PRO . 4.2 t-105 -155.79 135.78 12.84 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.957 0.408 . . . . 0.0 109.937 -176.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.604 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 6.4 mp -104.67 131.79 51.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.06 0.457 . . . . 0.0 110.703 -174.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.513 HG22 ' HA ' ' A' ' 137' ' ' PRO . 19.9 p -135.22 140.59 45.4 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.681 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.684 ' CD2' ' HG3' ' A' ' 134' ' ' GLU . 6.1 t80 -106.04 -82.89 0.53 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.831 -175.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.684 ' HG3' ' CD2' ' A' ' 133' ' ' PHE . 98.6 mt-10 -77.97 25.73 0.21 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.755 0.312 . . . . 0.0 111.798 -173.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 133' ' ' PHE . . . 92.25 -7.35 78.33 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -112.79 154.89 44.7 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.513 ' HA ' HG22 ' A' ' 132' ' ' THR . 85.9 Cg_endo -76.2 -5.78 16.58 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.851 2.367 . . . . 0.0 111.972 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 86.9 mt 62.1 176.29 0.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.053 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -104.19 101.79 11.52 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.584 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 9.9 p-10 -71.84 -9.28 58.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.938 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -68.79 -29.77 68.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.227 170.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 87.2 mt -97.28 160.83 27.99 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.876 -175.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.655 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 8.7 Cg_exo -72.09 153.71 57.36 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.76 2.306 . . . . 0.0 112.059 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.408 HD13 HD22 ' A' ' 114' ' ' LEU . 7.4 mt -70.92 -18.5 62.66 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.762 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -53.19 -44.02 63.85 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.675 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -63.96 -37.49 87.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -101.21 -37.1 8.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.037 0.446 . . . . 0.0 111.963 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.87 6.4 58.56 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.475 -170.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.566 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.0 pt? -47.18 -26.33 1.12 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.648 0.379 . . . . 0.0 112.014 175.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -81.32 118.66 73.2 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.551 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.1 -10.47 27.32 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.81 2.34 . . . . 0.0 111.412 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 82.9 mt -99.76 1.74 43.5 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.166 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.0 t -66.33 101.98 0.8 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.316 0.579 . . . . 0.0 109.85 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 18.0 m -90.84 92.18 8.68 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.873 -177.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 44.9 t -77.85 125.32 37.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.367 178.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -92.85 116.54 29.13 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.976 0.417 . . . . 0.0 110.604 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.604 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 1.1 tmt? -72.8 104.98 4.16 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -103.17 154.25 19.5 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.296 -173.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.5 mt -116.66 134.54 54.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.112 173.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 . . . . . 0 C--N 1.321 -0.671 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.72 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 C--O 1.236 0.384 0 CA-C-O 121.397 0.499 . . . . 0.0 111.794 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.466 HD21 ' O ' ' A' ' 148' ' ' GLY . 66.4 tp -106.71 109.09 20.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.983 -176.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.5 m -80.63 102.26 9.72 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.958 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.5 pt -101.83 146.11 10.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.132 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 44.2 tp -98.85 110.99 23.51 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.621 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.533 HG23 ' HB ' ' A' ' 155' ' ' VAL . 96.7 t -107.22 117.59 53.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.008 0.432 . . . . 0.0 110.359 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 26.3 ttt180 -85.64 101.25 12.56 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 176.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.454 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 0.7 OUTLIER . . . . . 0 CA--C 1.507 -0.678 0 CA-C-O 121.992 0.901 . . . . 0.0 112.638 -173.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.765 0.317 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 45.7 m -101.25 103.38 14.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.889 0.376 . . . . 0.0 110.135 177.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 m -99.22 138.36 36.43 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.647 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.4 m -90.04 115.65 27.47 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -101.0 136.27 41.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.917 0.389 . . . . 0.0 110.844 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -93.0 106.39 18.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.348 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.53 -179.54 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.225 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 58.5 mtm-85 -124.86 158.14 34.2 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.5 mp -67.1 -35.71 80.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.029 -176.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -89.87 14.65 11.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.276 0.56 . . . . 0.0 110.882 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -92.96 131.07 38.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.972 0.415 . . . . 0.0 110.004 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.625 ' HB ' ' OD1' ' A' ' 140' ' ' ASP . 3.2 p -74.03 159.21 33.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.646 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 83.3 t -63.87 -32.18 56.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.407 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.42 -41.85 73.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.79 176.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -65.18 -28.34 69.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.039 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.576 ' HB2' HD11 ' A' ' 144' ' ' LEU . 63.3 tp -82.25 -46.97 12.99 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 175.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -58.28 -46.55 85.85 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.571 -176.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -65.28 -30.81 71.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -70.21 -43.62 70.3 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.546 0.689 . . . . 0.0 109.466 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.35 -35.19 60.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.298 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.789 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 41.1 m -69.25 -18.64 63.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.942 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.68 -39.12 41.37 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.53 174.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.7 mp -95.04 -64.98 1.01 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.981 0.42 . . . . 0.0 111.852 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.483 ' HB3' ' HE3' ' A' ' 157' ' ' MET . 21.9 mm-40 -95.12 8.86 41.65 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 123.724 0.81 . . . . 0.0 111.035 -173.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.789 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -45.7 8.91 0.01 OUTLIER Glycine 0 N--CA 1.471 1.031 0 N-CA-C 119.028 2.371 . . . . 0.0 119.028 -173.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.442 ' H ' ' C ' ' A' ' 122' ' ' GLU . 31.8 t -51.78 81.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 118.758 1.279 . . . . 0.0 112.575 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.41 ' HB2' HD13 ' A' ' 128' ' ' LEU . 23.7 mp0 60.8 118.03 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.226 1.011 . . . . 0.0 113.455 172.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -53.32 -28.78 30.2 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.293 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -76.07 -24.67 55.11 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.469 -176.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.435 HD13 HG13 ' A' ' 124' ' ' VAL . 92.2 mt -89.26 -36.41 15.62 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -174.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -113.35 140.88 47.67 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.861 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -153.47 154.68 34.85 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 172.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.549 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 6.4 mp -114.65 149.56 36.5 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.838 -175.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 66.6 p -126.0 144.65 50.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.826 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.525 ' C ' ' H ' ' A' ' 135' ' ' GLY . 73.0 t80 -129.23 140.12 51.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 168.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 69.78 -43.93 0.54 Allowed 'General case' 0 CA--C 1.536 0.416 0 O-C-N 123.833 0.708 . . . . 0.0 110.426 -176.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 133' ' ' PHE . . . 156.01 -18.8 0.48 Allowed Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -176.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -91.61 146.99 34.24 Favored Pre-proline 0 C--O 1.236 0.356 0 CA-C-N 115.315 -0.443 . . . . 0.0 109.94 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.27 147.61 66.37 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.541 2.16 . . . . 0.0 111.345 175.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 70.8 mt -70.59 108.15 4.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.789 0.328 . . . . 0.0 111.006 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -92.44 130.08 38.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.601 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.625 ' OD1' ' HB ' ' A' ' 110' ' ' THR . 36.5 t70 -72.45 -6.67 45.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.534 -175.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -74.12 -14.11 60.92 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.487 0.66 . . . . 0.0 109.904 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 88.5 mt -120.16 131.71 24.33 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.95 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.46 148.94 92.52 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.673 2.249 . . . . 0.0 112.004 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.576 HD11 ' HB2' ' A' ' 114' ' ' LEU . 83.2 mt -59.88 -25.39 65.05 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -176.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -61.16 -27.35 67.26 Favored Glycine 0 C--O 1.226 -0.396 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.505 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -72.32 -21.09 61.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.875 0.369 . . . . 0.0 111.184 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -100.3 -45.14 5.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.312 0.577 . . . . 0.0 110.606 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.466 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -100.16 6.67 58.21 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-O 119.227 -0.763 . . . . 0.0 113.973 -171.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.47 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.3 pt? -34.38 -41.32 0.11 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -91.23 119.88 68.61 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.529 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 17.4 Cg_exo -66.13 81.38 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.117 2.544 . . . . 0.0 112.199 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 151' ' ' PRO . 7.3 tt 167.75 -26.56 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.787 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.3 m -45.55 125.45 5.83 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.376 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 23.9 m -97.72 120.6 38.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.303 -175.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.533 ' HB ' HG23 ' A' ' 93' ' ' VAL . 61.7 t -99.96 133.04 44.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.338 176.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -103.82 124.81 49.6 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.079 0.466 . . . . 0.0 111.045 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.549 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 25.2 ttt -81.75 131.06 35.25 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 175.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -120.51 145.21 47.52 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.109 -175.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.537 HD22 ' HE2' ' A' ' 157' ' ' MET . 50.9 mt -125.16 137.73 54.15 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.607 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo . . . . . 0 N--CA 1.461 -0.415 0 CA-C-O 121.085 0.369 . . . . 0.0 111.659 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.46 ' HG ' HG21 ' A' ' 91' ' ' ILE . 58.0 tp -85.3 107.51 17.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.233 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.441 ' HB3' HG23 ' A' ' 102' ' ' THR . 24.3 m -87.33 102.68 14.75 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.624 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.46 HG21 ' HG ' ' A' ' 89' ' ' LEU . 36.8 pt -102.84 157.79 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.023 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.5 ' O ' ' HA ' ' A' ' 154' ' ' THR . 37.4 tp -103.51 102.99 12.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.131 0.491 . . . . 0.0 110.922 -176.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.518 HG21 ' HB ' ' A' ' 155' ' ' VAL . 58.8 t -107.46 123.78 62.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.987 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -89.55 135.04 33.83 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.125 0.488 . . . . 0.0 110.2 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.1 p30 . . . . . 0 C--N 1.313 -1.0 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.915 -176.937 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 . . . . . 0 N--CA 1.454 -0.255 0 CA-C-O 121.131 0.491 . . . . 0.0 111.417 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.1 m -113.54 106.97 15.18 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.15 176.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.8 m -106.16 130.62 54.01 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.213 0.53 . . . . 0.0 111.004 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.441 HG23 ' HB3' ' A' ' 90' ' ' SER . 23.5 m -86.54 105.04 16.55 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.451 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.476 ' CD2' ' HB ' ' A' ' 93' ' ' VAL . 87.4 m-85 -91.27 134.23 34.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.744 -177.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -89.48 95.63 10.36 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.416 HG11 HD13 ' A' ' 114' ' ' LEU . 31.6 m -109.44 163.67 6.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.595 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.577 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 0.7 OUTLIER -110.98 146.97 35.72 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.154 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.5 HD21 ' HA3' ' A' ' 145' ' ' GLY . 6.7 mp -60.74 -35.41 76.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.719 -172.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.8 p -98.73 9.48 43.27 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -172.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.577 ' HG2' ' O ' ' A' ' 106' ' ' ARG . 10.0 pt20 -81.07 -8.93 59.87 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.653 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.6 p 64.19 159.11 0.09 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.066 1.346 . . . . 0.0 111.346 -175.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.555 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 48.4 t -63.85 -21.02 27.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.052 0.454 . . . . 0.0 109.979 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.537 ' HB3' ' HB2' ' A' ' 140' ' ' ASP . . . -58.21 -41.53 84.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.869 176.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -69.74 -36.51 75.9 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 120.745 0.307 . . . . 0.0 110.325 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.416 HD13 HG11 ' A' ' 105' ' ' VAL . 62.3 tp -66.92 -43.61 82.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.891 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -65.82 -28.18 68.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.349 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.502 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 35.0 tt0 -76.01 -34.77 59.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.588 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -60.21 -48.71 80.6 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.797 0.808 . . . . 0.0 108.909 171.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.46 -40.66 84.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.032 174.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.821 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 25.2 p -66.07 -14.75 62.27 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.843 0.354 . . . . 0.0 111.08 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.17 -44.03 8.34 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.656 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.3 mt -91.15 -59.9 2.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.044 0.45 . . . . 0.0 112.197 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.481 ' O ' ' N ' ' A' ' 124' ' ' VAL . 4.4 tp10 -100.38 9.42 42.67 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 123.524 0.73 . . . . 0.0 110.396 -174.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.821 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -45.71 7.95 0.01 OUTLIER Glycine 0 N--CA 1.473 1.108 0 N-CA-C 118.69 2.236 . . . . 0.0 118.69 -172.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.481 ' N ' ' O ' ' A' ' 122' ' ' GLU . 40.6 t -49.46 85.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 118.167 0.984 . . . . 0.0 112.276 174.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.425 ' HB2' HD13 ' A' ' 128' ' ' LEU . 2.3 mp0 56.29 106.81 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.586 0.754 . . . . 0.0 112.241 176.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -51.26 -24.17 4.21 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.746 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -81.51 -20.71 39.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.01 -175.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.44 HD13 HG13 ' A' ' 124' ' ' VAL . 96.7 mt -81.46 -14.84 56.58 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -175.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -133.82 151.11 51.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.451 0.643 . . . . 0.0 111.816 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -149.25 157.07 43.04 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 172.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.621 HD12 HG12 ' A' ' 155' ' ' VAL . 1.3 pt? -123.57 135.85 54.21 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.727 -172.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 41.3 p -116.19 131.7 56.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.845 -178.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.539 ' CE2' ' HB2' ' A' ' 134' ' ' GLU . 8.4 t80 -94.16 -89.67 0.22 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.523 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.539 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 10.8 tt0 -98.42 25.44 6.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.561 0.696 . . . . 0.0 110.385 -170.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 133.25 -37.43 2.0 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.75 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 54.3 mmtt -117.18 156.21 48.85 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 120.54 0.209 . . . . 0.0 110.917 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 132' ' ' THR . 48.2 Cg_endo -69.25 152.99 71.94 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.121 2.547 . . . . 0.0 112.79 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.449 ' HB3' HG22 ' A' ' 111' ' ' VAL . 85.9 mt -94.6 121.72 36.45 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.767 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -84.81 146.09 27.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.589 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.555 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 6.7 p-10 -61.22 -22.05 64.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.54 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -73.42 -15.78 61.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.176 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 77.1 mt -102.14 140.17 20.93 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 121.121 0.486 . . . . 0.0 111.516 -172.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 142' ' ' LEU . 12.7 Cg_exo -71.23 144.1 45.53 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.983 2.456 . . . . 0.0 111.08 173.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.563 HD11 ' H ' ' A' ' 144' ' ' LEU . 4.1 mp -71.54 -33.9 69.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.998 -174.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.5 ' HA3' HD21 ' A' ' 107' ' ' LEU . . . -59.63 -30.29 68.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.286 -0.483 . . . . 0.0 113.686 -172.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.65 -41.26 94.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.049 0.452 . . . . 0.0 111.029 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -101.55 -30.2 11.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.529 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.454 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -98.97 6.73 60.24 Favored Glycine 0 C--O 1.227 -0.299 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.625 -172.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -41.09 -31.22 0.18 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -92.71 126.54 51.47 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.295 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -68.15 6.38 0.88 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.958 2.439 . . . . 0.0 112.922 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 97.7 mt -112.24 7.41 19.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.05 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.4 p -62.39 117.94 6.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.943 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 15.0 m -101.51 106.66 17.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.408 -175.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.621 HG12 HD12 ' A' ' 131' ' ' LEU . 25.6 t -99.33 140.09 19.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.427 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -109.81 118.3 36.13 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.434 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 2.1 ttm -81.37 106.49 13.37 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -98.82 135.03 40.87 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.741 -172.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 49.1 mt -102.88 -167.68 1.42 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.638 173.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 . . . . . 0 N--CA 1.466 0.369 0 CA-C-O 121.85 0.833 . . . . 0.0 111.754 174.482 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.454 -0.798 0 N-CA-C 110.863 -0.476 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.9 tp -84.21 110.66 18.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.333 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.7 m -88.64 112.91 23.64 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.061 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.5 pt -107.08 134.75 47.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' A' ' 100' ' ' SER . 30.2 tp -93.1 101.37 13.67 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.593 -174.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.9 t -84.7 99.8 7.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -97.39 93.93 6.77 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.703 -174.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.57 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 6.1 p30 . . . . . 0 C--O 1.237 0.422 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.408 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 . . . . . 0 CA--C 1.521 -0.135 0 CA-C-O 120.986 0.422 . . . . 0.0 111.651 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.506 ' HB3' HD11 ' A' ' 92' ' ' LEU . 18.6 m -96.5 109.04 21.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.867 174.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.2 m -111.89 112.69 24.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.108 0.48 . . . . 0.0 110.638 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.4 m -76.66 121.92 23.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.515 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -111.81 132.13 54.88 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.96 0.41 . . . . 0.0 110.553 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -81.98 130.4 35.06 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.734 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.2 m -146.36 -179.96 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.765 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 39.7 mtm-85 -138.35 169.96 16.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.175 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.9 mp -73.03 -10.47 59.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.779 0.323 . . . . 0.0 111.43 -175.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 m -85.73 0.46 52.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.221 0.534 . . . . 0.0 110.669 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.464 ' HB3' HD13 ' A' ' 144' ' ' LEU . 13.3 mm100 -86.58 136.46 33.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.089 0.471 . . . . 0.0 111.521 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.5 p -94.7 166.83 11.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.231 175.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 64.2 t -60.39 -40.61 84.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.088 0.471 . . . . 0.0 109.731 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 116' ' ' GLN . . . -53.74 -48.35 69.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.898 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.443 ' HB3' ' NE2' ' A' ' 109' ' ' GLN . 3.6 m170 -63.71 -25.77 68.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.835 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.754 ' HB2' HD11 ' A' ' 144' ' ' LEU . 63.7 tp -83.48 -43.18 16.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.915 0.388 . . . . 0.0 110.181 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -60.15 -37.98 81.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.545 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 112' ' ' ALA . 55.5 mt-30 -64.93 -38.19 90.14 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 122.955 0.159 . . . . 0.0 111.41 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -63.37 -50.09 71.3 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.12 0.486 . . . . 0.0 109.786 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.4 t -57.34 -44.29 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.753 174.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.703 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 66.6 m -62.25 -22.2 65.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.086 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.61 -39.53 21.22 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.28 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -94.74 -64.9 1.02 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.1 0.476 . . . . 0.0 111.828 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.439 ' C ' ' H ' ' A' ' 124' ' ' VAL . 4.0 tp10 -100.41 8.55 43.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.135 -174.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.703 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -55.81 7.26 0.01 OUTLIER Glycine 0 CA--C 1.521 0.466 0 N-CA-C 116.481 1.353 . . . . 0.0 116.481 -172.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.439 ' H ' ' C ' ' A' ' 122' ' ' GLU . 64.4 t -41.82 92.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 123.552 0.741 . . . . 0.0 111.777 173.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.788 HE21 ' HA ' ' A' ' 125' ' ' GLN . 0.0 OUTLIER 52.97 106.23 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 O-C-N 123.858 0.724 . . . . 0.0 111.744 -178.176 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.622 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 9.2 p-10 -69.11 1.9 3.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.439 0.638 . . . . 0.0 110.403 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -75.53 -33.63 60.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.676 169.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 93.5 mt -79.34 -33.37 43.12 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.323 -173.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.622 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 52.2 p90 -105.78 121.4 43.97 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.658 -0.817 . . . . 0.0 112.045 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.554 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 37.2 t90 -132.29 104.22 6.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.369 176.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.54 ' CB ' ' HA ' ' A' ' 157' ' ' MET . 2.4 pt? -96.77 140.69 30.97 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.496 0.665 . . . . 0.0 112.046 -170.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 76.8 p -128.05 144.97 51.13 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.067 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -109.02 -72.0 0.74 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.645 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.596 ' HB3' ' HG2' ' A' ' 136' ' ' LYS . 24.2 tt0 -92.29 32.61 1.16 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.535 -171.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.9 11.53 85.12 Favored Glycine 0 CA--C 1.509 -0.343 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -169.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.596 ' HG2' ' HB3' ' A' ' 134' ' ' GLU . 0.5 OUTLIER -134.2 149.56 71.72 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 114.474 -0.863 . . . . 0.0 109.328 -178.379 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.78 150.59 78.98 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.175 1.917 . . . . 0.0 111.115 173.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 76.1 mt -74.21 109.28 7.58 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.82 122.17 26.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.741 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.4 53.06 1.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.191 0.995 . . . . 0.0 110.569 -176.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.748 ' HG3' ' HG ' ' A' ' 142' ' ' LEU . 3.6 pt20 -129.97 -7.95 4.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.823 175.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.748 ' HG ' ' HG3' ' A' ' 141' ' ' GLN . 81.2 mt -127.22 157.01 73.76 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.781 -175.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.68 145.5 25.96 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.1 1.866 . . . . 0.0 111.789 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.754 HD11 ' HB2' ' A' ' 114' ' ' LEU . 79.6 mt -62.2 -23.01 66.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.468 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -57.67 -34.87 71.41 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.326 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -77.47 -24.09 50.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.233 0.517 . . . . 0.0 110.988 -176.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -91.11 -39.0 12.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.302 0.573 . . . . 0.0 110.629 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.05 6.37 59.9 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.655 -172.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -41.41 -32.18 0.3 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.489 ' C ' ' H ' ' A' ' 152' ' ' LEU . 24.7 ttmm -83.18 114.98 56.62 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 173.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 16.8 Cg_exo -68.52 20.58 0.14 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.566 2.844 . . . . 0.0 113.427 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.489 ' H ' ' C ' ' A' ' 150' ' ' LYS . 54.3 mt -146.93 19.73 1.27 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.588 177.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.8 p -64.97 127.27 30.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.752 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.3 m -94.59 100.72 12.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.904 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.4 t -92.6 111.49 24.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -79.13 102.35 8.41 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.042 -175.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.57 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 22.8 ttt -76.44 90.91 3.28 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.554 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 11.2 m120 -74.5 131.03 40.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.391 -173.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 76.6 mt -96.92 114.66 26.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.144 0.497 . . . . 0.0 110.164 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.785 -176.879 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo . . . . . 0 N--CA 1.454 -0.808 0 N-CA-C 111.047 -0.405 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.637 HD21 ' O ' ' A' ' 148' ' ' GLY . 55.1 tp -92.22 155.82 17.73 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.5 t -131.61 130.7 42.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.885 0.374 . . . . 0.0 110.013 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.46 HD13 HG21 ' A' ' 155' ' ' VAL . 35.4 pt -127.88 150.71 33.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.847 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.435 HD13 ' HB2' ' A' ' 100' ' ' SER . 50.6 tp -93.24 113.7 25.97 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.0 0.428 . . . . 0.0 110.762 -177.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 63.6 t -98.62 113.47 33.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.742 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -110.73 114.98 28.76 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.763 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.408 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 29.3 p30 . . . . . 0 C--N 1.325 -0.476 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.287 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 121.261 0.553 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.435 ' HB2' HD13 ' A' ' 92' ' ' LEU . 12.7 p -115.86 106.51 13.91 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 167.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.0 t -118.24 133.01 56.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.993 0.425 . . . . 0.0 110.74 -175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.72 100.69 13.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.119 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -90.66 166.04 13.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.834 0.349 . . . . 0.0 111.093 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -103.97 128.98 51.52 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.374 0.606 . . . . 0.0 110.906 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.2 m -139.56 -179.44 2.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.713 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.446 ' HB2' ' HG2' ' A' ' 109' ' ' GLN . 67.8 mtp85 -132.13 164.42 26.33 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 174.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 107' ' ' LEU . 6.7 mp -82.23 -39.14 23.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.016 0.436 . . . . 0.0 110.135 176.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.1 m -92.12 66.15 4.85 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.292 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.449 ' OE1' ' HB2' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -156.43 157.99 36.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.789 174.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 140' ' ' ASP . 14.8 p -88.58 144.92 26.01 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.609 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 47.2 t -56.73 -19.25 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 120.925 0.393 . . . . 0.0 111.224 -177.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 140' ' ' ASP . . . -55.81 -34.64 65.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.947 0.403 . . . . 0.0 110.713 173.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -74.23 -15.62 60.99 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.204 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.736 HD23 HD11 ' A' ' 144' ' ' LEU . 65.3 tp -92.46 -53.24 4.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.033 0.444 . . . . 0.0 110.028 174.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -61.44 -40.02 92.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.53 -173.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -69.1 -31.8 70.77 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.478 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -68.27 -44.81 74.72 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.87 -35.67 61.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.548 173.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.752 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 62.3 m -72.49 -14.96 61.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.451 178.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.76 -39.36 21.16 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.438 175.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.1 mp -94.85 -64.39 1.07 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.132 0.491 . . . . 0.0 111.8 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.402 ' C ' ' H ' ' A' ' 124' ' ' VAL . 19.1 mm-40 -96.81 8.3 44.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.62 -173.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.752 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -54.35 7.66 0.01 OUTLIER Glycine 0 CA--C 1.522 0.531 0 N-CA-C 118.02 1.968 . . . . 0.0 118.02 -169.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.429 HG11 HD12 ' A' ' 128' ' ' LEU . 57.7 t -43.23 93.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 118.122 0.961 . . . . 0.0 112.316 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 57.37 109.11 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.605 0.762 . . . . 0.0 111.753 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.461 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 39.1 t70 -60.22 -6.67 1.54 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.639 -176.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -96.48 -19.29 19.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.666 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.429 HD12 HG11 ' A' ' 124' ' ' VAL . 64.9 mt -79.04 -39.78 33.07 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.716 -176.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.461 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 29.6 p90 -96.59 94.71 7.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.948 0.88 . . . . 0.0 111.447 -177.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.657 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 34.1 t90 -90.12 87.6 6.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.29 176.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -88.0 139.7 30.24 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.212 0.53 . . . . 0.0 110.652 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.475 ' HG1' ' C ' ' A' ' 136' ' ' LYS . 0.8 OUTLIER -151.02 159.69 44.39 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.15 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.465 ' CD2' ' HB2' ' A' ' 134' ' ' GLU . 13.5 t80 -102.71 -74.51 0.63 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.934 -175.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.465 ' HB2' ' CD2' ' A' ' 133' ' ' PHE . 7.8 tp10 -98.49 21.26 11.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.176 0.512 . . . . 0.0 110.702 -171.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.36 9.17 62.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.512 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.478 ' HD3' ' O ' ' A' ' 137' ' ' PRO . 14.4 tmtt? -122.56 122.37 27.31 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.478 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 27.2 Cg_exo -58.91 152.75 55.66 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.785 2.324 . . . . 0.0 112.296 -176.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 44.8 mt -103.29 97.08 7.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.242 -174.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.406 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 2.6 mp0 -63.73 134.4 55.26 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 173.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.609 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 5.6 p-10 -65.54 -22.41 66.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.085 -174.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -81.89 -10.39 59.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.838 0.351 . . . . 0.0 111.202 -177.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.406 ' HG ' ' HB2' ' A' ' 139' ' ' GLU . 79.6 mt -90.55 157.06 44.88 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.977 -176.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 109' ' ' GLN . 3.0 Cg_exo -75.23 128.73 11.53 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.978 2.452 . . . . 0.0 111.686 177.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.736 HD11 HD23 ' A' ' 114' ' ' LEU . 5.1 tt -62.53 -36.72 83.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.33 -177.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -52.11 -28.91 27.24 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 114.392 0.517 . . . . 0.0 114.392 -176.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -61.63 -38.07 86.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.159 0.504 . . . . 0.0 110.481 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -100.71 -33.11 10.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.157 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.637 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -96.86 6.18 64.34 Favored Glycine 0 C--O 1.223 -0.593 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.761 -172.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.432 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.7 pt? -46.79 -25.98 0.86 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.448 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 66.6 mttm -96.84 133.89 23.79 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 17.1 Cg_exo -67.87 2.57 2.46 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.93 2.42 . . . . 0.0 111.878 176.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 150' ' ' LYS . 1.4 pt? -124.58 11.34 8.54 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.046 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 46.7 m -60.52 110.22 1.22 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.926 0.393 . . . . 0.0 110.276 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 19.8 m -84.32 101.33 11.87 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.453 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.46 HG21 HD13 ' A' ' 91' ' ' ILE . 56.4 t -87.63 115.08 27.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.62 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -87.95 103.18 15.44 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.321 0.582 . . . . 0.0 110.745 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.408 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 26.4 ttt -77.17 87.19 3.63 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.842 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.657 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 23.3 m-80 -77.71 88.09 3.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.417 -174.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.63 94.1 3.16 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 172.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.889 -171.679 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 N--CA 1.447 -1.25 0 CA-C-O 121.379 0.491 . . . . 0.0 112.783 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 148' ' ' GLY . 0.2 OUTLIER -97.98 125.75 43.07 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.031 177.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -89.11 99.18 12.22 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.008 0.433 . . . . 0.0 110.193 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 45.8 pt -101.6 163.72 3.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.218 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.499 HD13 ' HB3' ' A' ' 100' ' ' SER . 23.8 tp -119.2 111.27 18.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.778 0.323 . . . . 0.0 110.587 -178.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.409 HG22 ' HB ' ' A' ' 155' ' ' VAL . 61.7 t -110.38 112.55 41.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -90.24 125.2 35.4 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.929 0.395 . . . . 0.0 110.861 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.477 ' HA ' ' SD ' ' A' ' 157' ' ' MET . 12.2 m-20 . . . . . 0 C--N 1.325 -0.459 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 . . . . . 0 C--O 1.234 0.275 0 CA-C-O 121.144 0.497 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.499 ' HB3' HD13 ' A' ' 92' ' ' LEU . 12.4 m -81.95 106.87 14.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.851 175.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.0 m -85.66 103.74 14.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.153 0.501 . . . . 0.0 110.488 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.5 m -77.39 115.51 17.22 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.991 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -107.09 131.76 53.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.059 0.457 . . . . 0.0 111.79 -175.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -95.24 103.11 14.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.488 -0.778 . . . . 0.0 108.915 173.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.492 HG13 HD12 ' A' ' 114' ' ' LEU . 33.1 m -129.3 137.61 56.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.896 0.379 . . . . 0.0 111.151 -175.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 106' ' ' ARG . 22.1 mtm180 -83.06 149.83 26.69 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.864 0.364 . . . . 0.0 110.44 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 107' ' ' LEU . 6.6 mp -69.09 -18.47 63.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.957 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.3 m -80.59 1.03 31.39 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.367 0.604 . . . . 0.0 110.763 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -92.97 152.57 19.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.483 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 p -90.36 157.46 17.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.888 172.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.585 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 59.2 t -58.94 -30.88 44.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.034 0.445 . . . . 0.0 110.865 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.525 ' HB3' ' HB2' ' A' ' 140' ' ' ASP . . . -55.21 -39.51 69.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.397 177.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.579 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 5.9 t60 -65.65 -37.19 85.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.134 -178.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.503 HD21 HD13 ' A' ' 144' ' ' LEU . 50.8 tp -67.69 -50.49 57.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.666 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -63.09 -38.75 92.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.093 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.891 HE21 ' HA ' ' A' ' 116' ' ' GLN . 0.0 OUTLIER -66.7 -29.17 69.09 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.089 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.579 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 26.5 mt-30 -63.47 -49.66 72.76 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 172.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.1 t -59.58 -49.2 84.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.811 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.844 ' HA ' ' HA3' ' A' ' 123' ' ' GLY . 67.4 m -59.51 -20.26 54.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.762 178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -79.31 -36.49 26.97 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.105 176.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 82.7 mt -96.74 -69.15 0.77 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.03 0.443 . . . . 0.0 112.098 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -97.13 7.11 47.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.358 0.599 . . . . 0.0 110.014 -176.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.844 ' HA3' ' HA ' ' A' ' 119' ' ' SER . . . -62.25 7.18 0.22 Allowed Glycine 0 C--O 1.226 -0.374 0 N-CA-C 116.334 1.294 . . . . 0.0 116.334 -170.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.3 t -31.08 93.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.911 0.884 . . . . 0.0 112.648 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.401 ' C ' ' H ' ' A' ' 127' ' ' ASP . 21.6 mt-30 53.31 111.78 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 O-C-N 123.913 0.758 . . . . 0.0 112.545 -176.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -63.32 -4.31 2.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.716 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 125' ' ' GLN . 13.3 m-20 -88.05 -24.68 23.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.041 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.58 -42.35 14.44 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.542 0.21 . . . . 0.0 111.32 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.582 ' CE1' ' HA2' ' A' ' 123' ' ' GLY . 11.5 p90 -114.83 152.57 31.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.017 0.437 . . . . 0.0 110.477 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.716 ' CD1' ' HG3' ' A' ' 137' ' ' PRO . 1.0 OUTLIER -162.13 135.68 6.32 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 169.082 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.581 HD11 HG12 ' A' ' 155' ' ' VAL . 2.1 pp -98.22 144.79 27.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.309 0.576 . . . . 0.0 111.691 -173.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 25.7 p -120.09 152.05 38.15 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.721 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.491 ' HB3' HD23 ' A' ' 138' ' ' LEU . 14.7 t80 -137.11 -60.43 0.68 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.995 0.426 . . . . 0.0 110.796 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 136' ' ' LYS . 1.8 tm-20 -81.79 35.62 0.42 Allowed 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 133' ' ' PHE . . . 81.69 -29.58 2.96 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -170.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.474 ' H ' ' C ' ' A' ' 134' ' ' GLU . 22.7 pttp -118.05 173.68 3.12 Favored Pre-proline 0 N--CA 1.446 -0.66 0 CA-C-N 115.026 -0.587 . . . . 0.0 109.838 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.716 ' HG3' ' CD1' ' A' ' 130' ' ' TRP . 24.7 Cg_exo -62.38 171.73 5.08 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.376 2.051 . . . . 0.0 111.899 175.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.514 ' HB2' HG12 ' A' ' 111' ' ' VAL . 93.5 mt -101.92 146.06 28.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.44 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -74.3 112.3 10.33 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.585 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.9 p-10 -60.97 -26.79 67.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.819 -174.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -77.72 -19.67 54.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.382 -175.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 61.5 mt -93.2 156.25 40.34 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.732 0.301 . . . . 0.0 110.966 -174.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.05 136.14 54.91 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.896 2.397 . . . . 0.0 112.236 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.503 HD13 HD21 ' A' ' 114' ' ' LEU . 3.0 tt -63.74 -35.78 81.71 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.831 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -59.04 -23.9 57.74 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.835 -0.62 . . . . 0.0 113.162 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -69.07 -30.74 69.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.002 0.401 . . . . 0.0 110.597 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -100.17 -29.24 12.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.147 0.499 . . . . 0.0 110.922 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' A' ' 89' ' ' LEU . . . -100.27 5.58 57.52 Favored Glycine 0 C--O 1.219 -0.809 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.591 -174.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.426 ' N ' HD23 ' A' ' 149' ' ' LEU . 2.3 pt? -46.03 -32.61 2.91 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 22.7 tptm -97.41 116.68 65.92 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 17.4 Cg_exo -66.02 79.69 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.169 2.579 . . . . 0.0 111.806 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 49.2 tp 172.87 -25.06 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.105 -173.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.6 t -46.05 117.45 1.53 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.721 175.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 24.0 m -110.32 120.41 42.35 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.113 -175.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.581 HG12 HD11 ' A' ' 131' ' ' LEU . 42.7 t -98.19 135.9 31.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.614 177.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -111.98 124.82 53.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.811 0.339 . . . . 0.0 110.815 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.477 ' SD ' ' HA ' ' A' ' 95' ' ' ASN . 63.1 mtt -75.42 126.59 31.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.729 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -105.26 152.17 23.21 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.137 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 79.5 mt -115.77 144.91 43.31 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.413 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 160' ' ' ARG . 26.2 ttt180 . . . . . 0 C--N 1.321 -0.65 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.351 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo . . . . . 0 N--CA 1.454 -0.824 0 CA-C-O 121.187 0.411 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.536 HD22 ' O ' ' A' ' 148' ' ' GLY . 45.5 tp -110.67 123.63 50.38 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.873 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.6 m -90.55 99.66 12.65 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.008 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.4 pt -100.61 145.54 10.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' A' ' 100' ' ' SER . 23.9 tp -106.21 106.0 16.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.044 0.45 . . . . 0.0 110.256 -176.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 61.0 t -99.86 128.56 51.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.036 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.584 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 81.6 mtt180 -100.4 123.12 44.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.18 0.514 . . . . 0.0 110.875 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.963 178.682 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 94' ' ' ARG . 11.6 ttm180 . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.459 ' HB3' HD11 ' A' ' 92' ' ' LEU . 43.8 m -89.49 94.21 9.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.947 0.403 . . . . 0.0 110.155 177.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.8 m -98.95 127.93 44.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.625 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.8 m -88.42 109.39 19.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.554 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -93.86 121.24 35.1 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -86.43 101.84 13.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.815 0.817 . . . . 0.0 109.854 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.453 HG23 HD13 ' A' ' 144' ' ' LEU . 26.2 m -111.9 -177.94 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.623 -177.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.498 ' O ' ' HG3' ' A' ' 109' ' ' GLN . 41.8 ttm180 -133.35 153.68 51.38 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.51 ' CD2' HD21 ' A' ' 89' ' ' LEU . 14.3 mt -75.68 -9.11 58.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.023 0.44 . . . . 0.0 110.571 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.48 ' H ' ' HG2' ' A' ' 106' ' ' ARG . 0.2 OUTLIER -91.44 5.2 50.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.313 -177.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.498 ' HG3' ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -122.69 161.73 23.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.824 0.345 . . . . 0.0 110.464 177.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 32.6 p -89.93 167.56 12.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.821 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.605 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 60.4 t -59.82 -31.38 47.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.057 174.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.494 ' HB2' ' HB3' ' A' ' 140' ' ' ASP . . . -57.47 -35.18 69.83 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.028 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -68.49 -17.71 64.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.153 0.502 . . . . 0.0 110.591 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.568 HD22 HD12 ' A' ' 144' ' ' LEU . 48.1 tp -100.12 -48.18 4.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.197 0.523 . . . . 0.0 110.468 176.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.2 tttm -63.19 -41.52 99.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.181 -177.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.792 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 63.5 tt0 -79.69 -17.97 52.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.062 0.458 . . . . 0.0 110.438 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -67.7 -52.79 33.61 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 51.7 t -64.59 -42.35 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.314 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 1.065 ' HA ' ' HA3' ' A' ' 123' ' ' GLY . 93.9 p -62.98 -32.13 73.41 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.965 0.412 . . . . 0.0 110.62 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.92 -29.3 70.96 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.862 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 78.7 mt -91.61 -77.02 0.43 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.688 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -103.26 -15.84 15.86 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 1.065 ' HA3' ' HA ' ' A' ' 119' ' ' SER . . . -42.35 -54.92 4.57 Favored Glycine 0 C--O 1.229 -0.201 0 N-CA-C 115.426 0.93 . . . . 0.0 115.426 -165.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 84.1 t 60.07 82.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.962 0.411 . . . . 0.0 110.443 -172.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.498 ' C ' ' H ' ' A' ' 127' ' ' ASP . 27.6 mt-30 58.56 112.08 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.135 -175.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.6 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 8.0 p-10 -72.69 19.34 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.059 0.457 . . . . 0.0 111.496 -176.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.498 ' H ' ' C ' ' A' ' 125' ' ' GLN . 29.5 t70 -108.11 -25.08 11.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.278 175.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.9 mt -75.96 -11.54 59.98 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.091 0.472 . . . . 0.0 110.742 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.6 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 31.2 p90 -142.85 148.48 37.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.131 178.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.465 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 1.3 p90 -150.08 156.34 41.47 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.834 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 7.1 mp -112.64 149.53 32.7 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.567 -176.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.531 HG22 ' HA ' ' A' ' 137' ' ' PRO . 47.4 p -131.75 154.4 49.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.961 -178.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -139.23 130.62 26.97 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.301 171.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 70.66 -0.94 2.75 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 123.725 0.641 . . . . 0.0 111.037 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 111.59 -4.32 27.83 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.808 -174.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 137' ' ' PRO . 35.5 mtmm -106.6 134.85 19.64 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.627 0.251 . . . . 0.0 110.616 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.531 ' HA ' HG22 ' A' ' 132' ' ' THR . 7.6 Cg_exo -72.5 147.62 46.55 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.651 2.234 . . . . 0.0 111.266 174.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 37.7 mt -86.49 111.32 20.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.335 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -80.33 126.17 30.83 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.605 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 0.0 OUTLIER -61.18 -25.17 66.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.038 0.447 . . . . 0.0 111.036 -177.583 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -78.54 -0.43 29.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.3 -175.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.2 mt -120.76 151.69 54.87 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.666 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 41.1 Cg_endo -67.47 143.79 64.59 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.736 2.291 . . . . 0.0 111.568 176.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.568 HD12 HD22 ' A' ' 114' ' ' LEU . 0.5 OUTLIER -65.9 -27.3 68.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.746 -174.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.64 -28.15 56.04 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.127 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -58.32 -39.29 79.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.996 0.426 . . . . 0.0 110.954 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -100.07 -38.56 8.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.166 0.507 . . . . 0.0 111.081 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.536 ' O ' HD22 ' A' ' 89' ' ' LEU . . . -96.06 6.54 66.62 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-O 119.223 -0.765 . . . . 0.0 114.255 -170.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -39.59 -31.73 0.11 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 152' ' ' LEU . 34.6 ttpt -96.5 124.8 49.65 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 122.286 -0.259 . . . . 0.0 110.359 175.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 20.0 Cg_exo -67.92 24.3 0.13 Allowed 'Trans proline' 0 N--CA 1.477 0.547 0 C-N-CA 123.69 2.927 . . . . 0.0 113.301 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.496 ' H ' ' C ' ' A' ' 150' ' ' LYS . 34.8 tp -133.64 6.19 3.74 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.4 p -60.47 119.67 8.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.654 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.3 m -92.52 99.49 12.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.78 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 49.1 t -92.34 132.61 36.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.715 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -103.3 130.16 50.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.674 0.273 . . . . 0.0 110.746 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.834 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 26.2 ttt -85.01 97.97 10.13 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 176.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 39.2 m-80 -82.37 90.59 6.7 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.168 -173.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.49 HD22 ' HB3' ' A' ' 129' ' ' PHE . 43.6 mt -84.13 84.88 7.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.162 174.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 160' ' ' ARG . 5.1 mpt_? . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.215 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 N--CA 1.449 -1.142 0 CA-C-O 120.956 0.315 . . . . 0.0 111.657 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.477 ' HG ' HG22 ' A' ' 91' ' ' ILE . 52.9 tp -70.72 102.65 2.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.192 0.52 . . . . 0.0 110.527 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.8 m -95.58 95.49 8.41 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.832 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.477 HG22 ' HG ' ' A' ' 89' ' ' LEU . 28.8 pt -102.92 156.83 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.412 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.7 tp -96.38 108.01 20.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.063 0.458 . . . . 0.0 110.599 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.508 ' HB ' ' CD1' ' A' ' 103' ' ' TYR . 57.8 t -100.34 118.06 46.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.925 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 22.6 ttt85 -104.85 108.62 20.21 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.476 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.54 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 3.9 p-10 . . . . . 0 C--N 1.323 -0.584 0 CA-C-O 121.96 0.886 . . . . 0.0 111.687 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 . . . . . 0 N--CA 1.451 -0.379 0 CA-C-O 121.288 0.565 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.544 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 2.7 p -107.53 107.81 18.82 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.798 172.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.8 t -116.63 138.16 51.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.351 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.9 m -76.39 116.75 17.37 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.508 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 43.6 m-85 -104.37 148.46 26.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.978 0.418 . . . . 0.0 111.168 -177.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -102.31 110.3 22.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.016 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.4 -179.91 3.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.999 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.608 ' HB2' ' HG3' ' A' ' 109' ' ' GLN . 83.8 mtm180 -128.39 159.87 34.02 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.733 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 mp -81.27 -27.45 35.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.054 0.454 . . . . 0.0 110.13 -176.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.6 m -84.81 10.17 12.22 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.538 0.685 . . . . 0.0 110.861 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.608 ' HG3' ' HB2' ' A' ' 106' ' ' ARG . 28.3 mt-30 -95.05 143.24 26.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.641 172.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 24.9 p -79.64 156.65 27.53 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 170.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.584 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 99.3 t -59.39 -26.83 35.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.842 0.353 . . . . 0.0 110.391 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' A' ' 140' ' ' ASP . . . -58.1 -33.49 69.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.634 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -70.75 -43.11 69.53 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.473 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.56 ' HB2' HD12 ' A' ' 144' ' ' LEU . 64.6 tp -69.72 -37.27 76.47 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 112' ' ' ALA . 21.8 tptp -49.73 -51.43 38.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.82 176.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -65.19 -33.61 76.41 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.093 0.245 . . . . 0.0 111.642 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.47 -43.43 85.48 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.056 0.455 . . . . 0.0 110.177 174.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 114' ' ' LEU . 99.4 t -61.42 -42.6 94.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.627 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 53.8 m -60.69 -21.05 62.44 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.401 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -85.47 -27.21 33.43 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.669 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.7 mt -99.97 -66.49 0.9 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.133 0.492 . . . . 0.0 112.065 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.429 ' C ' ' H ' ' A' ' 124' ' ' VAL . 3.8 tp10 -100.48 8.06 43.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.655 -177.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.627 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -54.45 7.7 0.01 OUTLIER Glycine 0 CA--C 1.523 0.567 0 N-CA-C 117.186 1.634 . . . . 0.0 117.186 -172.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.429 ' H ' ' C ' ' A' ' 122' ' ' GLU . 94.1 t -31.02 95.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.852 0.861 . . . . 0.0 112.3 173.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 52.03 103.7 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 O-C-N 123.939 0.775 . . . . 0.0 110.855 -174.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.487 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 32.0 t70 -56.91 -13.05 2.31 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.74 -170.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -99.85 -16.21 18.13 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 60.6 mt -80.71 -13.79 58.69 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 121.964 -0.46 . . . . 0.0 112.026 -175.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.554 ' HB3' HD21 ' A' ' 159' ' ' LEU . 44.5 p90 -123.58 151.18 43.21 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.306 0.574 . . . . 0.0 111.934 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 4.0 p90 -149.38 158.13 43.91 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 172.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.729 ' HG ' ' HG2' ' A' ' 157' ' ' MET . 5.5 mp -105.64 135.54 46.86 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.165 -173.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 21.0 p -123.66 123.63 40.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.121 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -97.11 -69.65 0.75 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.914 0.387 . . . . 0.0 110.293 172.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -69.86 -31.63 69.57 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.724 0.773 . . . . 0.0 110.312 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 139.4 -24.57 2.78 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -169.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -84.99 151.68 57.78 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 114.478 -0.861 . . . . 0.0 109.911 172.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.86 133.32 31.01 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.825 2.35 . . . . 0.0 111.914 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 37.8 mt -67.35 120.79 14.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.052 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -73.95 120.98 20.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.385 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.584 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.1 p-10 -68.19 -16.14 63.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.283 0.563 . . . . 0.0 110.428 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -84.03 -4.08 58.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.459 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 70.0 mt -112.52 158.29 37.77 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.194 178.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 57.6 Cg_endo -72.45 148.15 47.84 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.605 2.203 . . . . 0.0 112.864 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 114' ' ' LEU . 20.5 mt -66.09 -37.17 85.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.196 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -59.66 -23.91 59.15 Favored Glycine 0 C--O 1.226 -0.396 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.788 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.482 ' HB2' ' HG2' ' A' ' 143' ' ' PRO . 2.5 tt0 -69.74 -29.58 66.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.885 0.374 . . . . 0.0 110.478 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -100.92 -38.97 7.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.292 0.568 . . . . 0.0 110.831 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.42 ' O ' HD22 ' A' ' 89' ' ' LEU . . . -98.13 7.33 62.29 Favored Glycine 0 C--O 1.227 -0.342 0 CA-C-N 115.497 -0.774 . . . . 0.0 113.859 -169.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.458 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.5 pt? -38.9 -36.09 0.25 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -103.62 133.79 20.09 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.65 -7.42 9.04 Favored 'Trans proline' 0 N--CA 1.474 0.354 0 C-N-CA 122.889 2.393 . . . . 0.0 112.422 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 92.5 mt -94.57 -0.64 54.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.984 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 62.6 m -65.14 105.08 1.0 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.037 0.446 . . . . 0.0 110.09 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.1 m -82.25 101.32 10.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.142 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.434 ' HB ' HG21 ' A' ' 93' ' ' VAL . 49.1 t -81.91 106.24 12.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.074 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -83.12 103.06 12.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.164 0.506 . . . . 0.0 110.087 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.729 ' HG2' ' HG ' ' A' ' 131' ' ' LEU . 7.6 tmm? -78.79 112.37 15.86 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.04 113.26 24.93 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -168.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.724 ' HG ' ' HE3' ' A' ' 157' ' ' MET . 54.8 mt -92.84 81.38 4.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.318 174.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 110.897 -178.098 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 N--CA 1.449 -1.094 0 N-CA-C 110.102 -0.768 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.446 ' CD1' ' HA ' ' A' ' 151' ' ' PRO . 0.1 OUTLIER -75.63 114.65 14.45 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.314 -173.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.6 t -82.37 95.44 7.64 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.9 pt -95.35 154.43 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.429 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 154' ' ' THR . 37.3 tp -106.72 114.39 28.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.941 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.3 t -109.37 118.83 57.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.039 0.447 . . . . 0.0 109.896 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 -90.29 132.74 35.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.241 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.465 0.32 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.966 -175.224 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 36.4 ttt-85 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.89 0.376 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.406 ' HB3' HD13 ' A' ' 92' ' ' LEU . 14.8 m -118.64 121.94 41.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.873 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.7 t -114.73 126.0 54.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.136 0.493 . . . . 0.0 109.903 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.8 m -90.14 134.48 34.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.981 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -132.64 139.2 47.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.516 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -99.58 107.38 19.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.957 0.408 . . . . 0.0 110.769 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.483 HG13 HD11 ' A' ' 114' ' ' LEU . 21.0 m -125.82 147.55 30.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.105 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -93.75 156.77 16.5 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.52 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.646 ' HG ' ' HA3' ' A' ' 145' ' ' GLY . 8.7 mp -65.44 -13.52 58.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.007 -175.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.2 t -88.58 3.72 49.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.831 0.348 . . . . 0.0 111.36 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -93.26 148.32 22.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.134 0.493 . . . . 0.0 111.02 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.1 p -85.14 159.96 20.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.977 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.533 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 55.8 t -62.17 -33.2 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.209 0.528 . . . . 0.0 109.87 175.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.474 ' HB1' ' HB2' ' A' ' 140' ' ' ASP . . . -64.43 -34.11 77.42 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.832 178.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.463 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 1.5 t60 -67.8 -41.85 82.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.962 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.727 HD21 HD13 ' A' ' 144' ' ' LEU . 62.2 tp -62.17 -45.75 92.02 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.111 173.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -55.13 -37.82 67.41 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.014 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -68.64 -35.39 77.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.758 0.314 . . . . 0.0 110.968 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 18.5 mt-30 -66.76 -45.45 78.49 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.485 0.66 . . . . 0.0 109.336 175.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.3 t -61.06 -36.76 74.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.613 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.816 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 72.5 m -66.82 -16.64 64.42 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.032 176.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.7 -35.75 35.15 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.654 174.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.7 mp -96.18 -71.55 0.67 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.439 ' C ' ' H ' ' A' ' 124' ' ' VAL . 28.4 mm-40 -93.92 8.85 39.77 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.125 0.57 . . . . 0.0 111.109 -173.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.816 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -51.07 7.9 0.01 OUTLIER Glycine 0 N--CA 1.471 1.016 0 N-CA-C 118.09 1.996 . . . . 0.0 118.09 -170.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.439 ' H ' ' C ' ' A' ' 122' ' ' GLU . 28.1 t -54.73 82.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 118.154 0.977 . . . . 0.0 112.267 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.16 113.18 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.228 1.011 . . . . 0.0 112.348 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.521 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 1.8 p-10 -58.42 -12.89 4.31 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -173.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -72.75 -29.36 63.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.8 0.333 . . . . 0.0 110.414 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.9 mt -80.19 -39.5 29.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.903 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.521 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 25.8 p90 -109.67 105.04 14.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.946 0.879 . . . . 0.0 110.889 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -119.7 110.97 17.45 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.587 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.4 pp -92.41 152.19 19.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.075 0.464 . . . . 0.0 111.751 -172.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 13.8 p -140.71 154.82 46.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.121 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.419 ' CD2' ' HG3' ' A' ' 134' ' ' GLU . 10.3 t80 -125.0 -67.21 0.92 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.746 0.308 . . . . 0.0 110.863 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.419 ' HG3' ' CD2' ' A' ' 133' ' ' PHE . 46.3 mt-10 -77.85 3.54 14.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.08 0.467 . . . . 0.0 110.557 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.56 -24.19 27.95 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -168.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -92.99 158.21 37.88 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 114.873 -0.664 . . . . 0.0 109.551 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -76.63 -2.42 12.64 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.075 2.517 . . . . 0.0 112.051 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 58.8 mt 70.67 -171.14 0.16 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.416 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -139.82 132.97 29.68 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.533 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.0 p-10 -70.47 -21.31 62.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.765 -174.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -65.15 -30.5 71.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.033 0.444 . . . . 0.0 110.871 177.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 72.5 mt -87.4 143.61 34.52 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.643 -176.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.05 131.8 32.0 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.642 2.228 . . . . 0.0 111.772 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.727 HD13 HD21 ' A' ' 114' ' ' LEU . 4.1 tt -55.27 -35.47 65.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.336 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.646 ' HA3' ' HG ' ' A' ' 107' ' ' LEU . . . -58.83 -23.37 56.06 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.638 -177.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -66.01 -31.24 72.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.221 0.51 . . . . 0.0 110.49 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -100.06 -29.11 12.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.151 0.5 . . . . 0.0 110.809 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.401 ' O ' ' HG ' ' A' ' 89' ' ' LEU . . . -100.09 5.73 57.89 Favored Glycine 0 C--O 1.222 -0.646 0 CA-C-N 115.652 -0.704 . . . . 0.0 113.937 -172.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.45 HD21 ' N ' ' A' ' 149' ' ' LEU . 2.5 pt? -46.28 -30.47 2.05 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -176.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.839 ' HD3' ' HD2' ' A' ' 151' ' ' PRO . 17.3 tppt? -89.21 119.73 69.75 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.839 ' HD2' ' HD3' ' A' ' 150' ' ' LYS . 48.6 Cg_endo -71.06 61.52 2.46 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.527 2.818 . . . . 0.0 112.165 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.4 tp -179.9 -26.79 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.307 -172.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.6 t -45.9 130.46 9.63 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.439 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 33.6 m -110.97 128.32 55.8 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.864 -173.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.8 t -99.1 138.57 23.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.027 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -110.1 117.0 32.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.964 0.411 . . . . 0.0 111.304 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 73.5 mtp -80.2 99.03 7.6 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.864 174.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -79.36 96.04 5.89 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.396 0.617 . . . . 0.0 110.442 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.35 106.1 4.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.707 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 70.9 ttp85 . . . . . 0 C--N 1.322 -0.595 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.125 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo . . . . . 0 N--CA 1.458 -0.597 0 CA-C-O 120.87 0.279 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.48 HD22 ' O ' ' A' ' 148' ' ' GLY . 65.7 tp -174.07 104.0 0.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.924 -175.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.8 m -85.33 105.96 16.37 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.005 0.431 . . . . 0.0 110.855 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 28.2 pt -106.8 145.47 14.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.162 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 14.5 tp -99.86 112.75 24.99 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 64.4 t -94.23 121.04 44.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.307 0.575 . . . . 0.0 111.44 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -85.17 118.55 24.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 175.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.533 ' ND2' ' HA ' ' A' ' 99' ' ' ARG . 4.1 p30 . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.348 -167.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.65 ' H ' ' HD3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.184 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.9 p -169.16 59.58 0.05 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.52 0.676 . . . . 0.0 109.349 172.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.2 m -80.39 104.64 11.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.098 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 m -75.49 90.57 2.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.002 0.429 . . . . 0.0 110.094 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -82.87 117.35 22.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.907 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -86.28 101.14 12.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 173.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.4 m -121.04 -179.66 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.416 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -125.36 145.44 50.04 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.01 -12.11 52.77 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.981 -173.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.3 t -85.05 7.61 20.86 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.083 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -94.97 148.48 22.27 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.264 0.554 . . . . 0.0 111.806 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.636 ' HB ' ' OD1' ' A' ' 140' ' ' ASP . 9.4 p -82.02 166.86 19.43 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.188 170.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.09 -34.67 70.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.359 0.6 . . . . 0.0 109.688 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.53 -41.34 89.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.029 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -66.95 -15.49 63.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.937 0.399 . . . . 0.0 110.559 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.626 ' HB2' HD12 ' A' ' 144' ' ' LEU . 61.4 tp -91.89 -54.87 3.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.488 176.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -75.67 -10.01 59.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -172.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.865 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 10.4 tt0 -81.63 -31.86 32.19 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.048 0.451 . . . . 0.0 110.154 173.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -65.34 -35.78 82.04 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 172.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.23 -43.45 88.25 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.247 173.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.865 ' OG ' ' HA ' ' A' ' 116' ' ' GLN . 2.3 p -74.18 2.33 9.29 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.947 0.403 . . . . 0.0 111.69 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -92.42 -47.62 3.22 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.874 168.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.8 mt -86.71 -44.31 11.91 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.553 0.692 . . . . 0.0 111.267 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 124' ' ' VAL . 4.9 tp10 -98.29 10.55 40.42 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.227 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -29.35 6.62 0.0 OUTLIER Glycine 0 N--CA 1.486 2.003 0 N-CA-C 121.141 3.217 . . . . 0.0 121.141 -174.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' A' ' 122' ' ' GLU . 8.3 t -50.3 161.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 119.548 1.674 . . . . 0.0 109.407 169.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -42.54 136.99 2.27 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.339 0.59 . . . . 0.0 112.485 -175.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.629 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 28.2 t70 -61.01 -23.94 65.78 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.339 -172.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -89.42 -1.69 58.14 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.843 0.354 . . . . 0.0 110.873 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.492 HD11 HG11 ' A' ' 124' ' ' VAL . 74.6 mt -97.28 -28.02 14.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.64 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.629 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 42.5 p90 -103.55 113.84 27.65 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.076 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 9.7 t90 -112.07 155.47 23.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.618 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 5.5 mp -137.81 154.11 49.58 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.5 p -150.56 144.68 25.46 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.828 0.346 . . . . 0.0 111.2 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.536 ' CD2' ' HG2' ' A' ' 134' ' ' GLU . 14.8 t80 -135.31 -66.73 0.56 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.337 171.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.536 ' HG2' ' CD2' ' A' ' 133' ' ' PHE . 8.5 mm-40 -80.5 26.08 0.39 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.678 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.33 -9.35 67.47 Favored Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -173.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -124.38 162.81 40.04 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.545 ' HA ' ' O ' ' A' ' 131' ' ' LEU . 5.4 Cg_exo -74.92 4.07 5.02 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.179 2.586 . . . . 0.0 113.072 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 74.6 mt 73.8 142.22 0.07 Allowed 'General case' 0 N--CA 1.464 0.229 0 O-C-N 124.045 0.84 . . . . 0.0 110.996 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -85.52 124.18 31.79 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.35 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.636 ' OD1' ' HB ' ' A' ' 110' ' ' THR . 29.8 t70 -65.61 -22.14 66.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.343 0.592 . . . . 0.0 110.365 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -60.04 -26.91 66.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.504 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 87.8 mt -103.56 144.91 29.62 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.589 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.47 147.23 64.28 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.64 2.226 . . . . 0.0 112.027 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' A' ' 114' ' ' LEU . 76.6 mt -57.32 -33.19 67.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.659 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -56.23 -27.7 53.06 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.255 -0.498 . . . . 0.0 113.302 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.17 -43.92 83.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.097 0.475 . . . . 0.0 110.304 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -100.73 -28.53 12.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.811 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.48 ' O ' HD22 ' A' ' 89' ' ' LEU . . . -96.41 5.76 65.24 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.517 -174.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.44 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.5 pt? -47.83 -27.7 2.21 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -91.13 110.23 40.88 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.442 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 16.9 Cg_exo -67.2 81.02 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.854 2.37 . . . . 0.0 111.913 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 151' ' ' PRO . 6.3 mt 162.86 -19.62 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.801 1.24 . . . . 0.0 109.683 -175.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.8 t -52.72 127.11 22.09 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.182 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.8 m -96.46 118.27 32.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.323 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.9 t -86.22 118.48 32.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.419 176.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -88.79 99.25 12.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.045 0.45 . . . . 0.0 110.751 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.435 ' HE3' ' HG2' ' A' ' 122' ' ' GLU . 24.6 ttt -80.08 98.66 7.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.303 0.573 . . . . 0.0 109.52 177.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.87 91.44 8.61 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.885 -177.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.4 tt -67.46 118.66 11.09 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 . . . . . 0 C--N 1.322 -0.595 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.653 -176.914 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo . . . . . 0 N--CA 1.454 -0.813 0 CA-C-O 121.423 0.509 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.495 HD11 ' HA ' ' A' ' 151' ' ' PRO . 29.1 tp -106.25 111.4 23.98 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.148 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.0 t -91.19 86.68 6.25 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.92 0.39 . . . . 0.0 110.301 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.5 pt -91.23 169.19 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.861 -176.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.512 HD11 ' HB2' ' A' ' 100' ' ' SER . 42.7 tp -108.54 106.12 16.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.042 0.448 . . . . 0.0 110.585 -177.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.0 t -97.69 116.0 39.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.5 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 71.6 mtp180 -96.99 157.86 15.7 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.013 0.435 . . . . 0.0 111.099 -177.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 C--N 1.321 -0.658 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.121 174.566 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 42.4 mtp-105 . . . . . 0 C--O 1.235 0.295 0 CA-C-O 121.343 0.592 . . . . 0.0 111.796 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 20.5 p -144.79 120.67 10.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.249 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.2 t -115.37 128.58 56.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.173 0.511 . . . . 0.0 110.196 -177.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.1 m -87.54 107.86 18.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.475 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -101.05 141.62 33.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.059 0.457 . . . . 0.0 111.901 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -83.85 102.37 12.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.243 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.6 m -114.66 -179.86 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 176.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.598 ' HB2' ' HG3' ' A' ' 109' ' ' GLN . 77.0 mtt85 -140.84 146.61 37.79 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.424 ' N ' HD12 ' A' ' 107' ' ' LEU . 7.0 mp -64.83 -31.16 72.26 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.267 0.354 . . . . 0.0 111.404 -173.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 m -75.97 -19.23 58.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.151 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.598 ' HG3' ' HB2' ' A' ' 106' ' ' ARG . 25.2 mt-30 -74.22 133.06 42.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.652 0.263 . . . . 0.0 110.39 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.738 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 23.2 p -71.3 159.26 34.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.302 174.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.602 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 59.2 t -60.59 -28.7 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.0 0.429 . . . . 0.0 110.462 177.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.94 -35.43 74.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.104 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.436 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 31.1 m80 -66.61 -42.89 86.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.446 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.838 ' HB2' HD13 ' A' ' 144' ' ' LEU . 60.6 tp -62.26 -44.98 95.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.46 175.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -62.01 -32.26 72.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.722 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 47.1 mt-30 -81.03 -21.09 40.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 0.0 111.59 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 46.5 mt-30 -73.58 -47.78 37.88 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 170.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 81.1 t -61.07 -40.65 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.085 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.929 ' HA ' ' HA3' ' A' ' 123' ' ' GLY . 91.6 p -65.5 -34.18 77.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.916 0.388 . . . . 0.0 110.406 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.29 -27.49 72.49 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.207 175.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 37.3 mt -98.72 -76.29 0.54 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 111.77 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.456 ' C ' ' H ' ' A' ' 124' ' ' VAL . 6.1 tp10 -102.21 8.18 40.63 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.228 0.611 . . . . 0.0 111.621 -174.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.929 ' HA3' ' HA ' ' A' ' 119' ' ' SER . . . -53.36 7.37 0.01 OUTLIER Glycine 0 CA--C 1.525 0.715 0 N-CA-C 117.213 1.645 . . . . 0.0 117.213 -172.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.456 ' H ' ' C ' ' A' ' 122' ' ' GLU . 87.1 t -38.02 97.39 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 123.623 0.769 . . . . 0.0 112.414 175.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.431 ' C ' ' H ' ' A' ' 127' ' ' ASP . 13.0 mt-30 48.08 102.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 O-C-N 124.087 0.867 . . . . 0.0 112.263 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.516 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 12.1 p-10 -71.67 17.87 0.08 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -174.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 125' ' ' GLN . 16.3 t70 -100.24 -21.54 15.45 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 171.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.0 mt -82.2 -16.41 49.77 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.914 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.516 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 25.8 p90 -143.32 159.9 41.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.666 0.269 . . . . 0.0 111.015 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -163.44 155.51 17.67 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.495 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 6.9 mp -106.81 146.95 30.29 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.44 -174.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 13.3 p -138.75 143.17 38.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.145 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.431 ' CD2' ' HB2' ' A' ' 134' ' ' GLU . 20.9 t80 -111.49 -74.62 0.63 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.131 0.491 . . . . 0.0 110.962 176.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.431 ' HB2' ' CD2' ' A' ' 133' ' ' PHE . 28.7 tt0 -93.51 14.55 18.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.41 0.624 . . . . 0.0 110.091 -173.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 102.51 -19.02 49.39 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 -169.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 137' ' ' PRO . 59.7 mttp -73.89 134.95 77.73 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 115.036 -0.582 . . . . 0.0 109.681 174.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 3.3 Cg_exo -77.31 4.66 5.69 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.994 2.463 . . . . 0.0 111.454 175.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 39.8 mt 69.98 -176.39 0.2 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.725 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.479 ' OE2' ' HG ' ' A' ' 142' ' ' LEU . 36.4 tt0 -145.33 121.1 10.55 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 174.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.602 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 1.2 p-10 -63.8 -22.08 66.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.35 0.595 . . . . 0.0 110.674 -175.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -74.69 -27.29 60.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.351 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.479 ' HG ' ' OE2' ' A' ' 139' ' ' GLU . 68.1 mt -94.15 157.05 38.31 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.837 0.351 . . . . 0.0 111.324 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.738 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 10.1 Cg_exo -72.67 151.42 52.11 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.071 2.514 . . . . 0.0 112.566 177.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.838 HD13 ' HB2' ' A' ' 114' ' ' LEU . 43.3 mt -66.67 -32.78 74.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.58 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.537 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -53.83 -34.88 51.88 Favored Glycine 0 C--N 1.332 0.326 0 O-C-N 123.314 0.384 . . . . 0.0 113.133 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -61.0 -33.11 72.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.871 0.367 . . . . 0.0 111.544 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -101.09 -42.07 6.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.723 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -100.13 6.95 58.39 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-O 119.358 -0.69 . . . . 0.0 114.349 -168.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.537 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.6 pt? -43.45 -29.0 0.4 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -175.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 153' ' ' SER . 40.6 tptt -67.82 125.09 90.89 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.495 ' HA ' HD11 ' A' ' 89' ' ' LEU . 52.9 Cg_exo -56.13 -19.24 26.19 Favored 'Trans proline' 0 N--CA 1.478 0.604 0 C-N-CA 123.45 2.767 . . . . 0.0 114.09 -173.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 152' ' ' LEU . 1.5 pt? -132.8 34.21 3.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.228 0.537 . . . . 0.0 109.815 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.617 ' HB3' ' HB3' ' A' ' 150' ' ' LYS . 34.7 p -60.69 139.42 57.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.48 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.7 m -100.86 101.88 12.81 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.013 0.435 . . . . 0.0 111.11 -176.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.3 t -94.56 132.26 39.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -103.1 120.54 40.86 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.0 0.428 . . . . 0.0 111.027 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.495 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 1.7 tmt? -83.5 103.27 12.71 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -98.19 145.16 26.89 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.293 -172.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 95.3 mt -102.39 156.9 17.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.644 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 . . . . . 0 C--N 1.326 -0.42 0 O-C-N 123.94 0.775 . . . . 0.0 112.371 -174.421 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo . . . . . 0 N--CA 1.456 -0.693 0 CA-C-O 120.782 0.243 . . . . 0.0 111.485 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.3 tp -114.11 100.51 8.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.087 0.47 . . . . 0.0 110.003 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.5 t -92.84 107.31 19.12 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.617 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.7 pt -105.03 151.8 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.279 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.522 HD13 ' HB2' ' A' ' 100' ' ' SER . 19.8 tp -95.84 112.29 24.06 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.203 0.525 . . . . 0.0 111.751 -172.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.7 124.09 62.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.684 175.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -99.44 121.61 41.37 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 . . . . . 0 N--CA 1.469 0.48 0 O-C-N 123.522 0.514 . . . . 0.0 112.238 -172.283 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 . . . . . 0 CA--C 1.516 -0.357 0 CA-C-O 121.211 0.529 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.522 ' HB2' HD13 ' A' ' 92' ' ' LEU . 15.4 p -103.98 84.02 2.19 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.712 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.1 m -94.96 118.12 31.27 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.58 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.9 t -88.49 113.29 23.93 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.59 0.71 . . . . 0.0 109.643 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -90.15 132.02 35.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.622 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -80.59 99.93 8.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.263 0.554 . . . . 0.0 109.937 177.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 29.7 m -113.3 179.24 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.53 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -139.13 146.62 40.86 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -177.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.4 mp -69.83 -31.85 69.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.36 -172.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 33.8 m -63.43 -28.07 69.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.337 0.589 . . . . 0.0 110.246 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.545 ' NE2' HD12 ' A' ' 144' ' ' LEU . 4.1 tt0 -79.2 141.01 37.54 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.518 -177.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.815 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 39.0 p -82.8 167.37 18.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.563 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.58 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 54.1 t -64.85 -23.59 33.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.1 176.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.24 -37.44 67.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.946 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.591 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 7.4 t-160 -66.07 -41.54 90.61 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.79 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.691 ' HB2' HD13 ' A' ' 144' ' ' LEU . 46.7 tp -65.4 -42.84 92.14 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -51.46 -50.36 59.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.403 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.762 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 77.9 mt-30 -75.85 -26.92 57.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.183 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.591 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 48.7 mt-30 -64.24 -50.2 68.94 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 174.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.2 t -63.49 -43.42 98.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.065 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.912 ' HA ' ' HA3' ' A' ' 123' ' ' GLY . 60.6 p -66.15 -23.66 66.52 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.89 0.376 . . . . 0.0 111.153 -176.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.34 -43.0 32.87 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.926 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.9 mt -85.66 -72.66 0.48 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.132 0.492 . . . . 0.0 111.55 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.401 ' C ' ' H ' ' A' ' 124' ' ' VAL . 4.2 tp10 -100.36 6.8 44.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.503 -174.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.912 ' HA3' ' HA ' ' A' ' 119' ' ' SER . . . -63.74 6.92 0.51 Allowed Glycine 0 C--O 1.227 -0.29 0 CA-C-O 118.996 -0.891 . . . . 0.0 115.314 -172.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.492 HG12 HD13 ' A' ' 128' ' ' LEU . 63.6 t -35.24 92.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 123.934 0.894 . . . . 0.0 112.124 175.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 47.51 106.08 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 O-C-N 124.003 0.814 . . . . 0.0 111.046 -171.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.613 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 6.8 p-10 -61.9 -0.94 0.54 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -170.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -100.89 -7.12 23.79 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 176.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.492 HD13 HG12 ' A' ' 124' ' ' VAL . 85.9 mt -83.77 -12.44 55.7 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-O 120.88 0.371 . . . . 0.0 110.684 177.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.613 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 51.9 p90 -128.76 147.24 50.76 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 173.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.649 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 36.9 t90 -133.96 90.12 2.66 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.54 0.686 . . . . 0.0 110.029 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.512 ' CB ' ' HA ' ' A' ' 157' ' ' MET . 2.6 pt? -90.16 149.54 22.39 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.6 t -160.9 163.53 31.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.353 0.597 . . . . 0.0 111.15 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.417 ' HB3' HD21 ' A' ' 138' ' ' LEU . 6.9 t80 -142.3 -54.56 0.43 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.95 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -88.0 6.65 34.95 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.117 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.62 -22.56 39.94 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 -171.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 138' ' ' LEU . 61.9 mttp -101.48 152.47 38.02 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 131' ' ' LEU . 62.3 Cg_endo -73.32 22.44 0.33 Allowed 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.653 2.235 . . . . 0.0 112.759 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.503 ' HB3' HG12 ' A' ' 111' ' ' VAL . 42.5 mt 68.36 117.13 0.03 OUTLIER 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.899 0.88 . . . . 0.0 110.981 -178.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -83.23 121.92 27.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.094 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.58 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 2.5 p-10 -69.78 -18.07 63.46 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.179 -174.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -70.0 -24.71 63.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.508 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.4 mt -95.19 156.93 37.23 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.708 -176.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.815 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 71.7 Cg_endo -77.17 153.77 32.13 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.631 2.22 . . . . 0.0 111.764 176.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.691 HD13 ' HB2' ' A' ' 114' ' ' LEU . 10.7 mt -71.25 -22.62 61.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.534 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -58.22 -30.99 64.98 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.55 177.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -66.53 -35.61 80.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.19 0.519 . . . . 0.0 110.856 -177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -95.53 -40.73 9.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.318 0.58 . . . . 0.0 111.081 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -97.54 6.76 63.2 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.232 -0.895 . . . . 0.0 114.156 -168.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -42.06 -32.49 0.46 Allowed 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 117.494 0.647 . . . . 0.0 112.55 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -90.93 123.7 64.04 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 173.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.62 -9.46 18.42 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.752 2.301 . . . . 0.0 112.31 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.8 pp -105.26 8.55 33.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.076 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 33.6 p -63.49 118.17 7.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.092 0.473 . . . . 0.0 109.976 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 9.9 m -98.93 106.11 18.34 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.966 -177.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 53.9 t -86.71 120.83 36.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.35 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.21 108.41 20.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.122 0.487 . . . . 0.0 110.752 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.512 ' HA ' ' CB ' ' A' ' 131' ' ' LEU . 27.5 ttt -85.37 100.89 12.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.564 176.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.649 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 43.1 m-80 -86.27 135.49 33.53 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.683 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 67.1 mt -97.78 20.58 11.79 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.176 0.512 . . . . 0.0 110.731 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.229 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.457 -0.675 0 N-CA-C 111.184 -0.352 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.448 HD22 HD22 ' A' ' 107' ' ' LEU . 46.5 tp -78.08 114.97 17.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.271 0.558 . . . . 0.0 111.121 -174.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.8 p -94.35 98.63 11.03 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.591 176.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.2 pt -91.02 174.04 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.449 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.505 HD11 ' HB3' ' A' ' 100' ' ' SER . 1.3 tm? -118.6 112.93 20.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.878 0.371 . . . . 0.0 110.357 -176.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.8 t -103.16 127.35 57.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.887 175.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -98.58 108.53 21.25 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.552 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 36.0 p30 . . . . . 0 C--N 1.323 -0.569 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.535 -175.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 . . . . . 0 C--O 1.236 0.358 0 CA-C-O 120.967 0.413 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.505 ' HB3' HD11 ' A' ' 92' ' ' LEU . 17.6 m -90.2 94.36 9.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.426 175.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.2 p -90.1 111.16 22.2 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.995 0.426 . . . . 0.0 110.612 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.7 m -78.66 114.26 17.43 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.283 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -99.99 120.36 39.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.011 0.434 . . . . 0.0 111.348 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -85.01 103.2 13.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.501 176.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.41 176.36 9.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.205 0.526 . . . . 0.0 111.579 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -115.24 156.61 25.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.785 174.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.474 HD21 ' HA2' ' A' ' 145' ' ' GLY . 80.4 mt -65.88 -29.37 69.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.978 0.418 . . . . 0.0 111.112 -177.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 p -97.53 21.94 9.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.359 -175.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.511 ' HB3' ' HB3' ' A' ' 113' ' ' HIS . 13.4 mt-30 -77.47 -30.2 53.05 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.108 176.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 m 72.91 157.78 0.19 Allowed 'General case' 0 C--O 1.236 0.388 0 O-C-N 123.899 0.75 . . . . 0.0 109.965 -175.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.2 t -54.71 -38.81 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 0.0 110.578 -178.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -47.63 -48.06 28.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.657 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 109' ' ' GLN . 13.2 t-80 -77.69 -7.92 57.17 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.42 -172.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 54.1 tp -100.44 -51.04 3.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.068 0.461 . . . . 0.0 110.347 175.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.412 ' HE2' ' CZ ' ' A' ' 129' ' ' PHE . 3.3 tmtp? -59.02 -48.1 82.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.411 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.569 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 19.7 mm-40 -69.36 -18.28 63.77 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -174.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -70.67 -48.93 52.29 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.2 t -62.52 -36.74 76.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.224 175.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.723 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 55.3 m -62.05 -25.84 67.91 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.17 175.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.07 -35.46 53.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.843 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.7 mt -92.39 -71.89 0.62 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.909 0.385 . . . . 0.0 111.984 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 124' ' ' VAL . 48.0 mt-10 -99.98 9.3 43.13 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.855 0.462 . . . . 0.0 110.797 -174.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.723 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -46.93 7.79 0.01 OUTLIER Glycine 0 N--CA 1.47 0.901 0 N-CA-C 118.719 2.248 . . . . 0.0 118.719 -172.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 122' ' ' GLU . 80.7 t -37.75 100.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 118.446 1.123 . . . . 0.0 112.024 173.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.501 ' HB3' ' HG ' ' A' ' 128' ' ' LEU . 4.0 mm-40 55.81 106.18 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.122 0 O-C-N 123.916 0.76 . . . . 0.0 112.653 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -52.84 -24.54 9.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.023 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.27 -5.83 39.32 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -173.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.501 ' HG ' ' HB3' ' A' ' 125' ' ' GLN . 74.3 mt -89.37 -52.42 5.05 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.984 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.492 ' CE1' ' HA2' ' A' ' 123' ' ' GLY . 13.7 p90 -94.98 126.61 40.43 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.405 0.621 . . . . 0.0 110.155 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.617 ' HZ2' ' H ' ' A' ' 138' ' ' LEU . 9.4 t-105 -144.79 133.58 22.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.278 -178.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.799 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 4.9 mp -105.43 139.34 40.2 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.102 -174.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.528 HG23 ' HA ' ' A' ' 137' ' ' PRO . 45.8 p -132.91 140.7 48.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.31 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.493 ' CD2' ' HG3' ' A' ' 134' ' ' GLU . 11.1 t80 -87.83 -69.94 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.598 0.237 . . . . 0.0 111.462 -178.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.493 ' HG3' ' CD2' ' A' ' 133' ' ' PHE . 37.5 mt-10 -74.7 12.58 0.79 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.01 -177.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 133' ' ' PHE . . . 80.41 2.94 89.86 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -166.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -112.87 147.93 38.26 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 114.867 -0.666 . . . . 0.0 109.574 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.528 ' HA ' HG23 ' A' ' 132' ' ' THR . 59.3 Cg_endo -69.71 146.03 59.27 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.468 2.112 . . . . 0.0 111.916 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.617 ' H ' ' HZ2' ' A' ' 130' ' ' TRP . 70.5 mt -105.05 149.15 26.05 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.78 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.85 144.19 43.91 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -65.49 -25.0 67.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.079 0.466 . . . . 0.0 110.625 -177.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -64.57 -21.85 66.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.856 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 69.4 mt -96.18 131.54 28.54 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.268 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.567 ' HG2' ' HB2' ' A' ' 146' ' ' GLU . 29.2 Cg_endo -63.09 131.27 31.84 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.356 2.037 . . . . 0.0 111.592 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.425 ' HA ' ' CE1' ' A' ' 147' ' ' TYR . 6.9 tt -57.51 -35.94 70.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.577 -175.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -66.38 -24.84 72.39 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.04 -0.6 . . . . 0.0 113.723 -178.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.567 ' HB2' ' HG2' ' A' ' 143' ' ' PRO . 35.7 tt0 -61.59 -41.86 98.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.122 0.461 . . . . 0.0 111.231 -175.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.425 ' CE1' ' HA ' ' A' ' 144' ' ' LEU . 0.9 OUTLIER -100.62 -32.59 10.68 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.682 178.526 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -92.22 5.62 78.23 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 121.127 -0.559 . . . . 0.0 114.13 -172.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.506 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.4 pt? -53.33 -24.29 11.54 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -76.34 132.02 73.84 Favored Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.248 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.28 -14.77 44.06 Favored 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.407 2.071 . . . . 0.0 111.962 -178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.1 pp -112.05 14.66 20.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.739 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 77.8 p -62.87 104.78 0.58 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 5.7 m -88.3 104.31 16.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.239 -172.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.47 HG13 ' HB3' ' A' ' 131' ' ' LEU . 43.4 t -88.59 115.3 28.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.405 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -88.07 120.98 29.94 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.435 0.636 . . . . 0.0 111.198 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.799 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 26.9 ttt -76.61 103.7 6.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.55 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 0.9 OUTLIER -92.9 142.56 27.17 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.512 -178.052 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.1 tt -114.59 110.64 20.11 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 . . . . . 0 C--N 1.32 -0.716 0 CA-C-O 121.103 0.477 . . . . 0.0 111.196 -175.786 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo . . . . . 0 N--CA 1.448 -1.187 0 CA-C-O 120.876 0.282 . . . . 0.0 111.742 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 148' ' ' GLY . 23.2 tp -124.81 113.59 18.11 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.456 0.646 . . . . 0.0 110.019 176.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.2 t -93.63 111.7 23.43 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.808 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.4 pt -115.25 162.21 13.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.9 0.381 . . . . 0.0 110.716 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.434 HD12 ' HB3' ' A' ' 100' ' ' SER . 47.3 tp -110.79 104.03 12.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.116 0.484 . . . . 0.0 110.511 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.514 HG23 ' HB ' ' A' ' 155' ' ' VAL . 96.1 t -100.69 115.8 42.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.789 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -104.39 154.45 19.84 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.953 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.3 p30 . . . . . 0 C--N 1.316 -0.873 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 175.564 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.161 0.505 . . . . 0.0 111.803 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.434 ' HB3' HD12 ' A' ' 92' ' ' LEU . 3.4 m -112.28 131.11 55.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.971 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.0 t -124.93 130.31 52.12 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.961 0.41 . . . . 0.0 110.131 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.5 m -92.11 107.19 19.03 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.282 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.464 ' CE1' ' HB ' ' A' ' 93' ' ' VAL . 32.8 m-85 -94.65 132.59 39.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.273 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -104.19 99.9 9.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.343 0.592 . . . . 0.0 109.621 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.402 HG11 HD13 ' A' ' 114' ' ' LEU . 34.8 m -115.33 -179.78 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.819 -174.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -119.15 151.39 38.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.952 175.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.64 -13.42 62.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.234 -175.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.9 m -74.86 -13.89 60.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.203 0.525 . . . . 0.0 110.844 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -85.12 144.3 28.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.734 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.4 p -94.23 175.6 6.64 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.6 t -55.23 -41.31 60.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.9 -42.91 90.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.903 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -69.67 -24.61 63.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.857 -172.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.569 HD22 HD12 ' A' ' 144' ' ' LEU . 57.3 tp -88.23 -43.41 11.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.981 0.42 . . . . 0.0 110.054 172.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -60.67 -42.44 97.04 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.662 -177.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -58.6 -35.21 72.07 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.274 0.359 . . . . 0.0 111.107 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -63.59 -48.3 77.93 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.446 0.641 . . . . 0.0 109.541 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.486 HG11 ' SD ' ' A' ' 157' ' ' MET . 45.0 t -61.81 -41.17 89.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.596 176.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.625 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 50.9 m -59.82 -21.43 60.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.431 177.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.99 -37.15 16.54 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.419 -0.895 . . . . 0.0 112.256 175.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 80.8 mt -92.11 -66.26 0.94 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.214 0.531 . . . . 0.0 112.068 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.432 ' C ' ' H ' ' A' ' 124' ' ' VAL . 2.7 tp10 -100.49 8.27 43.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.945 -175.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.625 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -53.83 7.5 0.01 OUTLIER Glycine 0 CA--C 1.522 0.492 0 N-CA-C 117.547 1.779 . . . . 0.0 117.547 -170.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.432 ' H ' ' C ' ' A' ' 122' ' ' GLU . 58.4 t -29.87 94.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.07 0.948 . . . . 0.0 112.376 176.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.492 ' HB3' ' HG ' ' A' ' 128' ' ' LEU . 8.9 tt0 48.63 109.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 O-C-N 124.063 0.852 . . . . 0.0 111.314 -171.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -54.59 -19.07 5.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.02 -175.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.449 ' O ' ' HD3' ' A' ' 160' ' ' ARG . 0.7 OUTLIER -95.53 -6.53 40.29 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -177.753 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.492 ' HG ' ' HB3' ' A' ' 125' ' ' GLN . 66.4 mt -82.11 -26.65 33.39 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.174 0.443 . . . . 0.0 111.066 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.413 ' CE1' ' HA2' ' A' ' 123' ' ' GLY . 16.1 p90 -120.1 125.44 48.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.352 0.596 . . . . 0.0 111.046 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -132.62 130.11 39.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.844 175.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.404 ' CB ' ' HA ' ' A' ' 157' ' ' MET . 2.6 pt? -106.08 138.16 42.76 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.966 0.412 . . . . 0.0 110.399 -173.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.545 HG23 ' HA ' ' A' ' 137' ' ' PRO . 49.6 p -134.76 146.25 49.2 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.865 -175.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.518 ' HB3' HD23 ' A' ' 138' ' ' LEU . 32.7 t80 -108.18 139.28 43.09 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.458 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 29.2 tt0 72.19 -29.4 0.2 Allowed 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.727 0.642 . . . . 0.0 111.766 174.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 133' ' ' PHE . . . 130.13 6.19 4.03 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -173.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -117.12 147.69 40.81 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-O 120.509 0.195 . . . . 0.0 110.538 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.545 ' HA ' HG23 ' A' ' 132' ' ' THR . 93.0 Cg_endo -74.87 142.78 28.71 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.187 1.925 . . . . 0.0 110.661 172.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.518 HD23 ' HB3' ' A' ' 133' ' ' PHE . 33.0 mt -95.51 141.1 29.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.623 -170.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.515 ' OE2' ' HB3' ' A' ' 141' ' ' GLN . 33.0 tt0 -86.31 132.3 34.01 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.51 -28.27 61.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.736 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.515 ' HB3' ' OE2' ' A' ' 139' ' ' GLU . 1.1 tm0? -59.29 -44.17 92.52 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.1 mt -74.59 139.84 74.73 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.089 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.76 154.18 73.95 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.505 2.137 . . . . 0.0 112.32 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.569 HD12 HD22 ' A' ' 114' ' ' LEU . 5.7 tt -58.92 -37.05 75.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.234 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.55 -20.46 56.0 Favored Glycine 0 C--O 1.227 -0.282 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.845 -178.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -67.42 -31.15 71.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.268 0.556 . . . . 0.0 110.108 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.459 ' CD1' HD22 ' A' ' 138' ' ' LEU . 16.2 m-85 -100.21 -29.67 12.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.068 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.52 ' O ' HD22 ' A' ' 89' ' ' LEU . . . -94.62 5.78 70.24 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.489 -175.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -49.9 -21.59 1.22 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.525 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 55.8 mttp -86.91 120.7 71.75 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 172.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -59.12 -0.79 0.67 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.959 2.439 . . . . 0.0 112.746 174.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.449 ' H ' ' C ' ' A' ' 150' ' ' LYS . 1.9 pp -128.61 17.51 6.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.712 176.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.525 ' OG ' ' HB2' ' A' ' 150' ' ' LYS . 14.2 m -52.02 108.12 0.26 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.883 0.373 . . . . 0.0 110.69 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.6 m -80.99 90.71 5.98 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.278 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.514 ' HB ' HG23 ' A' ' 93' ' ' VAL . 45.3 t -91.23 114.47 28.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.347 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -90.25 109.6 20.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.366 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.486 ' SD ' HG11 ' A' ' 118' ' ' VAL . 59.4 ttp -77.17 92.89 3.85 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -87.37 114.53 24.06 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.088 -170.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.85 125.24 26.15 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 165.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.449 ' HD3' ' O ' ' A' ' 127' ' ' ASP . 84.0 mtp180 . . . . . 0 C--N 1.32 -0.714 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -170.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 N--CA 1.452 -0.97 0 CA-C-O 121.163 0.401 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.535 HD22 ' O ' ' A' ' 148' ' ' GLY . 63.3 tp -91.28 100.73 13.48 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.486 ' HB3' HG22 ' A' ' 102' ' ' THR . 47.3 m -83.87 111.88 19.62 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.557 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 39.2 pt -102.03 151.81 5.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.982 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.507 HD13 ' HB2' ' A' ' 100' ' ' SER . 18.0 tp -101.02 105.18 16.36 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.107 0.479 . . . . 0.0 110.874 -174.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.471 HG22 ' HB ' ' A' ' 155' ' ' VAL . 58.9 t -104.72 126.8 59.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.056 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 100' ' ' SER . 20.0 mtp180 -109.67 128.63 55.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.649 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.548 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 6.0 p30 . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.12 177.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.984 0.421 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.511 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 3.0 p -87.9 100.35 12.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.387 176.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 m -101.61 119.99 39.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.432 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.486 HG22 ' HB3' ' A' ' 90' ' ' SER . 0.2 OUTLIER -82.13 103.78 11.99 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.478 -179.145 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -94.38 127.88 40.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.194 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -88.0 131.14 34.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.634 0.73 . . . . 0.0 110.963 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 29.7 m -147.85 -178.42 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.257 -177.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -140.51 166.71 23.97 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 174.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.1 mp -78.14 -5.6 52.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.026 0.441 . . . . 0.0 110.155 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.73 -3.23 56.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.775 -176.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.61 178.32 4.33 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.804 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 p -110.22 167.92 9.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.981 0.42 . . . . 0.0 112.091 -174.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.9 t -58.69 -30.92 43.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.64 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.0 -43.21 60.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.917 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.442 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 24.7 t60 -74.44 -14.56 60.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.723 0.297 . . . . 0.0 111.321 -174.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.768 ' HB2' HD11 ' A' ' 144' ' ' LEU . 59.0 tp -87.63 -48.02 8.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.449 0.642 . . . . 0.0 109.274 174.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.408 ' HZ1' ' CG ' ' A' ' 126' ' ' ASP . 62.2 tttp -59.34 -43.07 92.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.68 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.415 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 63.6 tt0 -63.41 -31.52 72.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.321 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 47.7 mt-30 -63.78 -44.28 93.85 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.106 0.479 . . . . 0.0 109.865 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.5 t -66.16 -45.19 90.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.93 175.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.415 ' HB2' ' HA ' ' A' ' 116' ' ' GLN . 67.5 m -66.63 -8.0 24.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.775 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -100.3 -36.44 4.11 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.94 177.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.7 mt -94.84 -44.32 7.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.513 0.673 . . . . 0.0 110.942 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 124' ' ' VAL . 10.0 tp10 -100.12 11.11 40.14 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.234 -178.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -29.18 7.31 0.0 OUTLIER Glycine 0 N--CA 1.488 2.118 0 N-CA-C 121.104 3.202 . . . . 0.0 121.104 -172.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 122' ' ' GLU . 17.6 t -46.65 164.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 119.758 1.779 . . . . 0.0 109.798 167.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.433 ' HB2' ' CD1' ' A' ' 128' ' ' LEU . 76.1 mt-30 -35.24 118.58 0.46 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.542 0.687 . . . . 0.0 111.95 -176.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.408 ' CG ' ' HZ1' ' A' ' 115' ' ' LYS . 12.9 t70 -58.11 -29.56 65.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.828 -167.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -100.47 14.43 31.25 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.433 ' CD1' ' HB2' ' A' ' 125' ' ' GLN . 59.9 mt -91.14 -16.63 27.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.903 0.382 . . . . 0.0 110.788 174.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -121.75 145.76 47.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.537 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.43 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 7.2 t-105 -147.68 129.6 15.32 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 173.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.526 ' HB3' ' HA ' ' A' ' 157' ' ' MET . 1.1 pt? -111.48 134.5 53.02 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.065 0.46 . . . . 0.0 110.698 -173.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.549 HG23 ' HA ' ' A' ' 137' ' ' PRO . 46.2 p -135.29 131.52 36.61 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.823 -177.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . 14.8 t80 -70.89 -65.38 0.74 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.306 0.574 . . . . 0.0 111.078 179.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -92.77 1.43 57.28 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.232 -173.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.21 -10.13 69.7 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -164.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.48 ' HD2' ' HE1' ' A' ' 147' ' ' TYR . 17.3 ttmm -81.59 127.62 72.39 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 113.908 -1.146 . . . . 0.0 108.446 175.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.549 ' HA ' HG23 ' A' ' 132' ' ' THR . 82.1 Cg_endo -73.63 131.76 16.45 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.123 1.882 . . . . 0.0 111.862 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.4 mt -77.29 119.34 20.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.604 -174.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -97.74 134.43 40.92 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.486 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.15 -17.22 64.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.384 0.612 . . . . 0.0 111.03 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -58.14 -27.32 63.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.308 172.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.41 HD13 ' HH ' ' A' ' 147' ' ' TYR . 56.6 mt -109.72 145.24 31.57 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.661 -176.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.26 155.69 51.37 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.583 2.189 . . . . 0.0 110.866 173.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.768 HD11 ' HB2' ' A' ' 114' ' ' LEU . 22.6 mt -64.7 -20.34 66.27 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -176.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -54.56 -31.63 52.54 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.79 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -58.77 -38.7 79.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.97 0.414 . . . . 0.0 110.989 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.48 ' HE1' ' HD2' ' A' ' 136' ' ' LYS . 13.8 m-85 -100.66 -32.31 10.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.272 0.558 . . . . 0.0 111.024 -177.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.535 ' O ' HD22 ' A' ' 89' ' ' LEU . . . -97.7 7.05 63.05 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.39 -0.823 . . . . 0.0 113.986 -171.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -44.86 -23.62 0.15 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -104.47 134.46 19.67 Favored Pre-proline 0 C--N 1.329 -0.325 0 O-C-N 122.217 -0.302 . . . . 0.0 110.608 175.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -67.16 4.89 1.0 Allowed 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.967 2.445 . . . . 0.0 112.586 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -127.6 11.63 6.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.441 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 55.9 m -57.61 107.77 0.48 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.944 0.402 . . . . 0.0 110.15 177.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.5 m -85.64 102.72 13.82 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.973 -176.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 133' ' ' PHE . 40.7 t -92.75 121.85 43.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.541 177.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -92.8 118.55 31.22 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.217 0.532 . . . . 0.0 110.856 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.548 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 40.4 ttm -79.81 93.13 5.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.181 176.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 51.5 m-80 -79.91 123.2 27.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.331 0.586 . . . . 0.0 111.519 -172.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 70.2 mt -105.39 95.56 5.91 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.368 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 . . . . . 0 C--N 1.325 -0.499 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.984 -177.026 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo . . . . . 0 N--CA 1.455 -0.788 0 N-CA-C 109.316 -1.071 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.52 ' HB3' HG23 ' A' ' 105' ' ' VAL . 14.0 tp -150.83 138.63 19.86 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.514 173.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.6 t -125.67 109.72 12.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.535 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 32.2 pt -116.12 134.72 58.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.945 0.402 . . . . 0.0 110.765 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.429 HD13 ' HB3' ' A' ' 100' ' ' SER . 58.4 tp -94.46 105.84 17.81 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.038 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 69.1 t -88.53 104.56 14.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.469 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -93.16 114.46 26.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.673 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.561 HD21 ' N ' ' A' ' 95' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--N 1.318 -0.767 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.224 176.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? . . . . . 0 N--CA 1.454 -0.266 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.429 ' HB3' HD13 ' A' ' 92' ' ' LEU . 8.8 m -93.38 96.53 9.99 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.801 0.334 . . . . 0.0 110.109 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.2 p -108.31 119.33 39.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.952 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.1 m -82.11 120.17 24.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.344 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -110.72 136.03 50.41 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -91.01 123.83 34.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.656 0.741 . . . . 0.0 109.679 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.52 HG23 ' HB3' ' A' ' 89' ' ' LEU . 16.0 m -135.78 -178.97 2.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.257 -175.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -127.1 157.0 40.83 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.16 -30.38 64.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 110.324 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -78.83 50.33 0.99 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.835 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -139.88 155.82 47.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.659 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.1 p -86.28 152.29 22.89 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.594 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 59.4 t -63.09 -23.79 34.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.004 0.431 . . . . 0.0 109.848 176.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.512 ' CA ' ' HB2' ' A' ' 140' ' ' ASP . . . -57.07 -44.09 82.74 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.81 174.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.508 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 13.0 m-70 -65.32 -32.96 74.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.269 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.414 HD22 HD11 ' A' ' 144' ' ' LEU . 56.4 tp -71.13 -48.0 54.67 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 174.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -54.94 -47.36 74.55 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.897 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.454 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 29.0 mt-30 -63.8 -34.31 77.63 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -176.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.508 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 25.3 mt-30 -66.43 -47.06 74.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.336 0.589 . . . . 0.0 109.729 176.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.99 -34.89 65.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.633 174.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.879 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 60.8 m -79.26 -1.33 36.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.399 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -88.81 -37.0 7.52 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.788 168.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.0 mt -86.5 -64.39 1.16 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.02 0.438 . . . . 0.0 111.508 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 124' ' ' VAL . 17.1 mm-40 -99.63 8.93 43.98 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.649 0.78 . . . . 0.0 110.069 -175.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.879 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -44.48 9.12 0.0 OUTLIER Glycine 0 CA--C 1.526 0.723 0 N-CA-C 120.032 2.773 . . . . 0.0 120.032 -170.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 122' ' ' GLU . 13.0 t -58.45 75.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 119.517 1.658 . . . . 0.0 112.222 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 123' ' ' GLY . 24.5 mt-30 63.7 121.28 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.504 1.121 . . . . 0.0 113.399 175.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -73.53 54.81 0.47 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 122.412 1.101 . . . . 0.0 109.406 173.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.493 ' O ' ' HD2' ' A' ' 160' ' ' ARG . 19.0 t70 -146.4 -37.69 0.24 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.48 -1.237 . . . . 0.0 108.711 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.7 mt -80.87 -20.02 43.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.604 175.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -135.74 148.28 48.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.652 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.909 ' HZ3' ' HA ' ' A' ' 160' ' ' ARG . 1.2 p90 -155.32 152.52 29.28 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 170.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.757 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 6.7 mp -109.01 141.78 40.65 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.549 -173.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.8 p -122.41 131.37 53.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.83 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.514 ' HB3' HD21 ' A' ' 138' ' ' LEU . 10.9 t80 -100.79 -62.22 1.27 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.166 0.508 . . . . 0.0 110.768 174.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -95.87 27.85 3.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.914 -174.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.4 4.02 90.32 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.596 -174.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -127.05 149.54 69.62 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -62.46 148.52 93.18 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.803 2.335 . . . . 0.0 112.182 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.514 HD21 ' HB3' ' A' ' 133' ' ' PHE . 43.3 mt -96.92 112.94 24.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.443 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -61.76 130.65 46.8 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 173.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.594 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.7 p-10 -77.46 -18.52 57.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.49 -176.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.65 -36.73 73.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.867 0.365 . . . . 0.0 110.602 177.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.427 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 93.2 mt -78.54 158.17 76.44 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.402 -174.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.636 ' HG2' ' HG2' ' A' ' 146' ' ' GLU . 44.4 Cg_endo -69.23 146.71 64.34 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.648 2.232 . . . . 0.0 112.58 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.45 HD13 HG22 ' A' ' 111' ' ' VAL . 22.7 tp -72.12 -37.34 69.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.604 -174.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -57.4 -25.23 54.47 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.396 -0.431 . . . . 0.0 113.716 -176.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.636 ' HG2' ' HG2' ' A' ' 143' ' ' PRO . 24.4 mm-40 -65.78 -29.69 70.22 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.468 -0.43 . . . . 0.0 111.483 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -100.53 -38.47 8.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.171 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.434 ' O ' HD11 ' A' ' 89' ' ' LEU . . . -98.59 6.21 60.73 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-O 119.412 -0.66 . . . . 0.0 113.912 -172.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.412 ' N ' HD21 ' A' ' 149' ' ' LEU . 2.5 pt? -37.21 -38.2 0.2 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -175.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.483 ' C ' ' H ' ' A' ' 152' ' ' LEU . 38.7 ttpt -90.76 125.95 57.49 Favored Pre-proline 0 C--N 1.322 -0.605 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.349 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.09 27.35 0.22 Allowed 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.356 2.704 . . . . 0.0 112.653 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.483 ' H ' ' C ' ' A' ' 150' ' ' LYS . 0.2 OUTLIER -140.83 14.83 2.3 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.718 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 31.9 p -75.92 131.74 39.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.443 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 23.6 m -95.09 110.43 22.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.737 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 41.0 t -92.7 109.52 21.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -85.26 120.32 26.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.843 0.354 . . . . 0.0 111.065 -176.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.757 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 27.4 ttt -85.19 103.87 14.55 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.65 123.44 46.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.513 -172.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.9 147.1 45.65 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.909 ' HA ' ' HZ3' ' A' ' 130' ' ' TRP . 60.6 ttt180 . . . . . 0 C--N 1.324 -0.513 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -170.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo . . . . . 0 N--CA 1.459 -0.541 0 CA-C-O 120.783 0.243 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.477 HD23 ' CD2' ' A' ' 107' ' ' LEU . 52.3 tp -109.34 103.44 12.37 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.455 ' OG ' HG21 ' A' ' 102' ' ' THR . 7.3 t -96.16 98.48 10.36 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.105 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.45 HG23 ' HG ' ' A' ' 89' ' ' LEU . 33.3 pt -95.5 159.99 2.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.41 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 33.8 tp -99.99 119.09 37.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.839 0.352 . . . . 0.0 110.877 -177.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 68.9 t -110.13 114.2 46.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.86 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.436 ' HG3' ' OG ' ' A' ' 100' ' ' SER . 34.0 ttt-85 -110.08 137.98 47.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.703 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.541 ' ND2' ' HB2' ' A' ' 99' ' ' ARG . 56.7 p30 . . . . . 0 C--N 1.329 -0.292 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.871 175.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.541 ' HB2' ' ND2' ' A' ' 95' ' ' ASN . 4.6 mmp_? . . . . . 0 CA--C 1.518 -0.261 0 CA-C-O 121.115 0.483 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.436 ' OG ' ' HG3' ' A' ' 94' ' ' ARG . 5.2 m -118.71 100.09 7.19 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.503 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.9 t -101.27 136.62 40.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.86 0.362 . . . . 0.0 110.382 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.455 HG21 ' OG ' ' A' ' 90' ' ' SER . 0.6 OUTLIER -91.68 109.33 20.64 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.603 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -95.86 120.15 35.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.021 0.439 . . . . 0.0 111.71 -174.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -79.69 100.39 7.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.663 176.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.416 ' C ' ' HD2' ' A' ' 106' ' ' ARG . 35.1 m -123.81 -179.86 2.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.023 0.439 . . . . 0.0 110.975 -177.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.496 ' N ' ' HD2' ' A' ' 106' ' ' ARG . 4.6 mpt_? -123.33 157.2 33.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.477 ' CD2' HD23 ' A' ' 89' ' ' LEU . 23.8 mt -62.03 -29.18 70.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.723 0.297 . . . . 0.0 111.364 -176.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.0 m -74.93 -7.89 54.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.695 -175.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -80.29 125.27 29.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.795 0.331 . . . . 0.0 110.912 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 21.2 p -73.96 157.86 35.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.759 172.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.585 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 60.3 t -59.03 -29.37 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.08 0.467 . . . . 0.0 109.963 177.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' A' ' 140' ' ' ASP . . . -58.71 -38.33 78.06 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.35 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -64.92 -46.33 82.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.708 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.445 HD21 HD13 ' A' ' 131' ' ' LEU . 34.0 tp -64.11 -40.68 96.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.319 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -52.85 -48.84 66.75 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.849 175.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.529 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 11.6 mm-40 -69.03 -28.94 67.02 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -66.98 -48.68 67.74 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.504 0.668 . . . . 0.0 109.452 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.8 t -64.11 -33.6 63.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.495 175.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.712 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 67.9 m -67.68 -17.4 64.57 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.196 175.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.76 -37.09 27.25 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.559 175.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.9 mt -93.36 -64.98 1.03 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.958 0.409 . . . . 0.0 112.04 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 124' ' ' VAL . 64.6 mm-40 -98.06 9.61 42.42 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.349 0.659 . . . . 0.0 111.367 -174.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.712 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -45.11 7.3 0.01 OUTLIER Glycine 0 N--CA 1.473 1.131 0 N-CA-C 118.583 2.193 . . . . 0.0 118.583 -173.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.464 ' N ' ' O ' ' A' ' 122' ' ' GLU . 57.9 t -50.57 88.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 118.532 1.166 . . . . 0.0 111.019 171.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.405 ' C ' ' H ' ' A' ' 127' ' ' ASP . 20.1 mt-30 49.04 105.8 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.824 0.703 . . . . 0.0 111.794 -175.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.554 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 3.4 p-10 -69.65 5.93 1.28 Allowed 'General case' 0 C--N 1.328 -0.364 0 O-C-N 121.92 -0.488 . . . . 0.0 110.618 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 125' ' ' GLN . 8.8 m-20 -77.54 -35.61 53.09 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.719 169.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.2 mt -73.78 -21.05 60.3 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.275 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.554 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 52.6 p90 -132.13 120.39 22.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.632 0.73 . . . . 0.0 111.403 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -134.12 131.97 39.35 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 170.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.445 HD13 HD21 ' A' ' 114' ' ' LEU . 2.2 pt? -104.19 130.62 51.95 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.265 0.555 . . . . 0.0 111.273 -171.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.535 HG21 ' HA ' ' A' ' 137' ' ' PRO . 68.3 p -118.09 138.2 52.41 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.707 -174.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -84.23 132.14 34.68 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.179 175.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 63.87 8.08 3.64 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.959 175.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.04 -2.18 63.6 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.037 -177.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.469 ' O ' ' HB ' ' A' ' 132' ' ' THR . 78.4 mttt -102.02 132.83 21.12 Favored Pre-proline 0 C--N 1.327 -0.396 0 C-N-CA 122.321 0.248 . . . . 0.0 110.479 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.535 ' HA ' HG21 ' A' ' 132' ' ' THR . 19.5 Cg_exo -65.26 127.99 19.47 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.883 2.388 . . . . 0.0 112.936 -175.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 75.6 mt -98.45 164.58 12.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.427 178.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.447 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 32.8 mt-10 -105.99 141.13 37.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.75 175.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.585 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.8 p-10 -64.33 -18.53 64.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.216 0.532 . . . . 0.0 110.263 176.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -72.28 -16.87 61.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.285 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.447 ' HG ' ' HB2' ' A' ' 139' ' ' GLU . 87.4 mt -100.84 148.57 35.23 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.625 -173.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 2.8 Cg_exo -76.94 149.57 29.19 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.102 2.535 . . . . 0.0 112.159 175.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.417 HD13 ' HB2' ' A' ' 114' ' ' LEU . 60.8 mt -73.65 -29.24 62.22 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.401 -176.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.419 ' CA ' HD21 ' A' ' 107' ' ' LEU . . . -54.3 -37.97 60.91 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.308 -0.472 . . . . 0.0 114.131 -173.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -64.55 -32.04 73.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.904 0.383 . . . . 0.0 111.334 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -100.63 -24.31 14.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.21 0.529 . . . . 0.0 111.238 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.424 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -100.4 6.24 57.62 Favored Glycine 0 C--O 1.224 -0.511 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.108 -175.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.411 HD21 ' N ' ' A' ' 149' ' ' LEU . 2.6 pt? -39.58 -35.92 0.35 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -177.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -100.31 129.65 27.59 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.42 -24.93 63.49 Favored 'Trans proline' 0 N--CA 1.473 0.314 0 C-N-CA 122.834 2.356 . . . . 0.0 112.54 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.3 pp -87.71 -1.28 57.86 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.496 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.3 t -68.89 120.68 15.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.5 m -98.01 119.05 35.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.323 0.582 . . . . 0.0 111.978 -172.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 29.2 t -96.11 119.16 43.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -88.95 117.78 28.21 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.803 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.536 ' HE3' HD23 ' A' ' 159' ' ' LEU . 20.7 ttt -77.56 91.47 3.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.19 176.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -75.46 109.88 9.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.0 -173.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.536 HD23 ' HE3' ' A' ' 157' ' ' MET . 99.6 mt -88.2 113.69 24.07 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.712 176.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 . . . . . 0 C--N 1.325 -0.495 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.603 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo . . . . . 0 N--CA 1.454 -0.844 0 N-CA-C 110.531 -0.603 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.568 HD22 ' O ' ' A' ' 148' ' ' GLY . 45.7 tp -78.9 89.26 4.7 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.939 -174.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.493 ' HB3' HG23 ' A' ' 102' ' ' THR . 19.7 m -84.91 93.63 8.58 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.617 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.2 pt -90.21 165.07 2.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.504 HD12 ' HB2' ' A' ' 100' ' ' SER . 21.5 tp -108.69 107.02 17.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.196 0.522 . . . . 0.0 110.916 -175.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.74 107.41 19.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.365 176.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.536 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 16.5 ttm180 -84.33 105.0 14.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -175.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.524 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 50.8 t-20 . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 115.493 -0.776 . . . . 0.0 108.973 175.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.418 ' CB ' ' HB3' ' A' ' 95' ' ' ASN . 13.3 mmt180 . . . . . 0 C--O 1.229 -0.012 0 CA-C-O 121.176 0.513 . . . . 0.0 111.478 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 32.6 p -79.65 92.05 5.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.116 0.484 . . . . 0.0 109.862 176.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.4 m -86.38 123.42 31.6 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.894 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.493 HG23 ' HB3' ' A' ' 90' ' ' SER . 8.7 m -90.2 102.54 15.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.124 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -95.89 136.32 36.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.51 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -79.49 103.65 9.55 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 173.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.464 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 21.9 m -107.97 166.28 4.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -138.33 154.17 48.98 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 16.3 mt -60.31 -33.46 72.4 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -169.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.6 m -80.56 -7.78 59.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.371 0.605 . . . . 0.0 111.187 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -86.96 122.26 30.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.1 p -79.18 165.99 22.69 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.82 0.343 . . . . 0.0 111.322 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.626 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 46.6 t -64.37 -27.84 43.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.21 177.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.491 ' HB3' ' HB2' ' A' ' 140' ' ' ASP . . . -59.62 -45.02 93.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.15 0.5 . . . . 0.0 110.252 174.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.442 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 50.9 m80 -63.42 -37.04 85.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.382 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.617 ' HB2' HD11 ' A' ' 144' ' ' LEU . 55.5 tp -65.25 -47.14 77.79 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.648 ' HD2' ' HB2' ' A' ' 126' ' ' ASP . 5.2 tppp? -54.1 -49.26 69.5 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.966 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.794 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 34.9 tt0 -70.26 -32.56 70.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.796 -174.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 27.6 mt-30 -63.67 -39.6 94.74 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 67.2 t -71.63 -38.06 65.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.895 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.794 ' OG ' ' HA ' ' A' ' 116' ' ' GLN . 92.0 p -72.71 -5.0 34.68 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.005 0.431 . . . . 0.0 110.555 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -94.76 -59.46 1.13 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.372 173.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.4 mp -77.33 -45.24 26.77 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.328 0.585 . . . . 0.0 111.405 -177.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 124' ' ' VAL . 8.7 mm-40 -96.8 9.6 41.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.431 -176.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -28.82 6.54 0.0 OUTLIER Glycine 0 N--CA 1.485 1.911 0 N-CA-C 121.956 3.542 . . . . 0.0 121.956 -165.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.559 ' N ' ' O ' ' A' ' 122' ' ' GLU . 48.1 t -52.15 144.95 2.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 119.852 1.826 . . . . 0.0 108.53 168.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -49.03 135.93 15.26 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.097 0.475 . . . . 0.0 112.03 -170.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.648 ' HB2' ' HD2' ' A' ' 115' ' ' LYS . 7.2 p-10 -74.4 9.55 1.66 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.514 -171.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.67 -21.86 40.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.169 0.509 . . . . 0.0 110.125 173.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.45 HD12 HG12 ' A' ' 124' ' ' VAL . 83.0 mt -91.49 -45.93 8.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.007 -171.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.569 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 34.5 p90 -83.49 102.23 11.96 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.161 0.982 . . . . 0.0 110.848 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.59 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 25.4 t90 -100.81 93.22 5.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.493 -1.231 . . . . 0.0 109.414 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.486 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 8.6 mp -79.45 115.52 19.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.199 0.523 . . . . 0.0 111.762 -173.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 25.6 p -121.33 119.23 31.57 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.75 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.52 ' HB2' HG22 ' A' ' 155' ' ' VAL . 6.7 t80 -82.06 -74.39 0.34 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.886 0.374 . . . . 0.0 110.614 177.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.66 36.45 1.38 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.377 0.608 . . . . 0.0 109.64 -175.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.95 -36.42 3.85 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.869 -177.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -91.81 144.47 29.41 Favored Pre-proline 0 C--O 1.237 0.447 0 CA-C-O 120.581 0.229 . . . . 0.0 111.037 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -76.83 137.11 17.48 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.873 2.382 . . . . 0.0 111.541 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 71.2 mt -77.81 133.92 38.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.732 -177.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.496 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 44.2 mt-10 -76.12 139.46 41.33 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.626 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 6.6 p-10 -66.92 -24.77 66.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 0.0 111.894 -173.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -76.09 -14.63 60.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.108 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.496 ' HG ' ' HB2' ' A' ' 139' ' ' GLU . 87.5 mt -86.17 146.13 42.01 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.03 -175.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 142' ' ' LEU . 2.7 Cg_exo -76.74 140.37 20.81 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.142 2.562 . . . . 0.0 111.656 175.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.617 HD11 ' HB2' ' A' ' 114' ' ' LEU . 74.8 mt -67.73 -26.38 66.11 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -175.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.05 -35.02 62.95 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.85 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -50.35 -56.53 10.96 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -101.25 -13.14 18.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.455 -173.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.568 ' O ' HD22 ' A' ' 89' ' ' LEU . . . -100.2 3.46 56.82 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.932 -177.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -46.73 -31.4 2.93 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.107 0.479 . . . . 0.0 111.744 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -92.63 117.35 67.56 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 174.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -58.01 -18.59 36.48 Favored 'Trans proline' 0 N--CA 1.476 0.443 0 C-N-CA 122.66 2.24 . . . . 0.0 112.911 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 84.9 mt -94.18 7.02 46.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.788 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 29.5 t -59.78 107.39 0.6 Allowed 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 23.6 m -94.97 100.23 12.11 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.28 -174.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.52 HG22 ' HB2' ' A' ' 133' ' ' PHE . 42.3 t -87.1 115.5 27.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.5 176.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.536 ' CE2' ' HD2' ' A' ' 94' ' ' ARG . 74.0 m-85 -79.28 117.97 20.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.904 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.524 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 52.6 ttm -80.47 83.4 6.29 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 174.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.59 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 1.9 m-20 -73.0 98.88 2.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.797 -174.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 91.6 mt -75.24 103.78 5.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.03 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.457 179.791 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 N--CA 1.451 -0.998 0 CA-C-O 121.052 0.355 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.573 HD22 ' O ' ' A' ' 148' ' ' GLY . 61.9 tp -112.4 111.45 22.31 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.585 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.4 t -85.72 114.61 22.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.666 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.4 pt -109.19 163.09 6.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.93 176.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.482 HD12 ' HB2' ' A' ' 100' ' ' SER . 27.0 tp -115.33 110.71 19.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.025 0.44 . . . . 0.0 110.724 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.8 t -104.68 109.21 26.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.284 0.564 . . . . 0.0 110.583 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 94' ' ' ARG . 16.3 ttt180 -92.61 116.93 29.44 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.385 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.497 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 30.4 p-10 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 121.777 0.799 . . . . 0.0 111.517 -174.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 . . . . . 0 N--CA 1.456 -0.174 0 CA-C-O 121.222 0.534 . . . . 0.0 111.743 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.482 ' HB2' HD12 ' A' ' 92' ' ' LEU . 12.6 p -88.31 92.07 9.03 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 171.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.2 m -83.32 124.66 30.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.697 -173.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.2 m -91.58 113.43 25.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.93 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -115.05 132.82 56.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.885 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -107.15 97.5 7.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.259 0.552 . . . . 0.0 111.1 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.9 m -104.15 -179.5 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.54 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.585 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 33.2 ttm180 -110.46 125.06 52.88 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 174.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.521 ' HB3' HD21 ' A' ' 89' ' ' LEU . 1.4 pp -62.88 -6.59 3.92 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -173.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 m -86.76 0.72 54.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.726 0.298 . . . . 0.0 110.926 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.585 ' HG2' ' O ' ' A' ' 106' ' ' ARG . 2.5 pt20 -92.66 158.86 15.72 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.0 m -87.43 154.29 20.77 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.547 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 30.3 t -58.18 -25.68 27.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.094 0.474 . . . . 0.0 110.844 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 140' ' ' ASP . . . -60.84 -34.32 74.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.215 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.562 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 17.1 t-80 -72.34 -46.77 54.08 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.461 ' HA ' ' NE2' ' A' ' 117' ' ' GLN . 59.5 tp -47.83 -45.97 30.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.063 173.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.524 ' HE2' ' HB2' ' A' ' 126' ' ' ASP . 48.5 tttt -61.13 -41.9 97.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.627 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 18.1 tm0? -67.02 -39.72 87.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.985 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.562 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 18.6 mt-30 -57.15 -46.23 82.92 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.35 0.595 . . . . 0.0 109.867 176.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 63.8 t -65.49 -36.36 77.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.899 175.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.435 ' C ' ' HA2' ' A' ' 123' ' ' GLY . 62.4 m -67.88 -8.2 34.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.259 177.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -98.69 -61.93 0.87 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.63 173.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 88.7 mt -71.09 -41.4 70.69 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.494 0.664 . . . . 0.0 111.335 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 124' ' ' VAL . 6.0 mm-40 -100.06 11.07 40.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.814 -177.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.435 ' HA2' ' C ' ' A' ' 119' ' ' SER . . . -27.87 7.3 0.0 OUTLIER Glycine 0 N--CA 1.488 2.117 0 N-CA-C 122.334 3.694 . . . . 0.0 122.334 -157.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' A' ' 122' ' ' GLU . 44.3 t -51.57 141.71 4.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 119.928 1.864 . . . . 0.0 108.576 165.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -45.6 137.99 4.81 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -173.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.742 ' HA ' ' CE2' ' A' ' 129' ' ' PHE . 4.1 p-10 -63.77 -22.95 67.16 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.363 -172.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -73.82 -21.79 60.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.296 0.57 . . . . 0.0 110.657 178.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.494 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 93.4 mt -83.24 -17.25 43.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.837 -174.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.742 ' CE2' ' HA ' ' A' ' 126' ' ' ASP . 38.7 p90 -112.36 124.26 52.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.974 0.892 . . . . 0.0 111.45 175.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.706 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 49.9 t90 -112.68 92.55 4.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.688 177.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 2.6 pt? -97.2 144.01 27.44 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.004 -177.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.36 150.23 36.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.249 0.547 . . . . 0.0 111.393 -178.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.514 ' HB2' HG23 ' A' ' 155' ' ' VAL . 5.1 t80 -112.69 -58.52 2.14 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.911 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.34 -20.26 23.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.501 -175.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 136.87 -19.69 3.48 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -171.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -102.25 149.41 36.6 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 114.334 -0.933 . . . . 0.0 109.202 174.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 131' ' ' LEU . 59.0 Cg_endo -72.02 0.35 7.34 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.699 2.266 . . . . 0.0 112.312 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.4 mt 69.61 115.83 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 O-C-N 123.931 0.769 . . . . 0.0 110.03 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.681 ' HB2' ' CD2' ' A' ' 142' ' ' LEU . 7.3 mm-40 -72.04 137.9 47.5 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.457 -177.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.547 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 5.7 p-10 -77.46 33.49 0.16 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.392 -176.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.428 ' H ' ' C ' ' A' ' 139' ' ' GLU . 26.3 tt0 -118.63 -21.89 7.72 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.228 0.537 . . . . 0.0 109.789 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.681 ' CD2' ' HB2' ' A' ' 139' ' ' GLU . 0.6 OUTLIER -95.95 153.97 39.08 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.261 -173.253 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.01 136.6 53.28 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.402 2.068 . . . . 0.0 110.999 173.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.416 ' O ' HD21 ' A' ' 144' ' ' LEU . 6.9 tt -60.78 -32.39 71.71 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.258 -176.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.496 ' HA3' ' HB2' ' A' ' 107' ' ' LEU . . . -60.42 -28.21 66.93 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 116.094 -0.503 . . . . 0.0 113.33 -178.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -61.67 -37.3 83.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.937 0.399 . . . . 0.0 110.814 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -100.77 -32.74 10.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.756 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.573 ' O ' HD22 ' A' ' 89' ' ' LEU . . . -98.99 5.83 59.71 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.742 -172.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.469 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.5 pt? -45.2 -29.93 1.07 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.465 ' C ' ' H ' ' A' ' 152' ' ' LEU . 48.7 tttp -79.73 121.16 82.09 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 21.4 Cg_exo -67.25 12.86 0.17 Allowed 'Trans proline' 0 N--CA 1.476 0.457 0 C-N-CA 123.088 2.525 . . . . 0.0 112.789 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.465 ' H ' ' C ' ' A' ' 150' ' ' LYS . 26.5 tp -137.5 20.28 2.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.409 0.624 . . . . 0.0 109.417 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.0 p -67.37 118.77 11.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.142 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.7 m -97.19 111.06 23.46 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.999 -175.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.514 HG23 ' HB2' ' A' ' 133' ' ' PHE . 39.9 t -100.86 129.29 52.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.609 177.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 131' ' ' LEU . 94.7 m-85 -95.07 110.21 22.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.822 0.344 . . . . 0.0 110.818 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.497 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 23.6 ttt -82.18 97.38 8.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.854 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.706 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 50.7 m-80 -90.6 136.2 33.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.323 -178.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.452 HD22 ' HE2' ' A' ' 157' ' ' MET . 90.3 mt -104.54 81.6 1.81 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.488 -0.189 . . . . 0.0 110.488 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 128' ' ' LEU . 1.9 mmp_? . . . . . 0 N--CA 1.466 0.369 0 O-C-N 123.792 0.682 . . . . 0.0 111.306 -176.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo . . . . . 0 C--O 1.237 0.464 0 CA-C-O 121.166 0.403 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.56 HD21 ' O ' ' A' ' 148' ' ' GLY . 31.7 tp -105.69 116.36 31.82 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.246 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.402 ' HB3' ' OG1' ' A' ' 102' ' ' THR . 16.0 m -94.57 107.23 19.22 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.469 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 102' ' ' THR . 35.4 pt -99.06 160.93 3.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 154' ' ' THR . 36.7 tp -106.19 116.07 31.3 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.762 -176.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.1 t -104.37 121.49 56.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.461 ' HD2' ' CE1' ' A' ' 156' ' ' PHE . 18.4 ttm180 -106.54 107.01 17.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.188 -177.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.555 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 40.4 m-20 . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.52 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.504 ' NE ' ' HA ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 120.425 0.155 . . . . 0.0 111.132 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.3 m -94.15 86.15 4.88 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.4 t -104.8 129.96 52.99 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.109 -176.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 10.8 t -76.92 143.58 39.45 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 173.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -121.37 133.03 55.09 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.293 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -83.19 108.07 16.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.931 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.88 -179.18 3.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.491 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -121.47 178.84 4.65 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 173.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.61 -32.18 19.43 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.2 m -89.51 64.67 6.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.308 0.575 . . . . 0.0 110.74 -178.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.504 ' O ' ' HA ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -163.72 163.54 24.12 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.181 173.374 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 140' ' ' ASP . 32.6 p -96.94 162.18 13.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.803 0.335 . . . . 0.0 111.332 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.525 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 45.3 t -57.51 -21.39 15.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.843 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.528 ' HB1' ' HB2' ' A' ' 140' ' ' ASP . . . -50.49 -46.33 56.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.557 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -81.57 -0.83 44.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.513 -175.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.58 ' HB2' HD12 ' A' ' 144' ' ' LEU . 43.7 tp -100.34 -47.33 4.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.437 0.637 . . . . 0.0 109.721 172.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -63.2 -27.33 69.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.628 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.88 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 0.9 OUTLIER -78.11 -23.26 47.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.521 177.357 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -68.56 -43.87 75.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.3 -43.73 98.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.872 174.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.88 ' OG ' ' HA ' ' A' ' 116' ' ' GLN . 7.9 p -76.38 -1.74 28.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.776 0.322 . . . . 0.0 111.435 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -88.35 -36.31 8.21 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.779 172.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 mp -99.94 -58.46 1.91 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.446 0.641 . . . . 0.0 111.197 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' A' ' 124' ' ' VAL . 4.0 mm-40 -91.28 9.22 32.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.919 -177.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.822 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -49.26 7.72 0.01 OUTLIER Glycine 0 N--CA 1.469 0.851 0 N-CA-C 117.788 1.875 . . . . 0.0 117.788 -173.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.445 ' O ' HD23 ' A' ' 128' ' ' LEU . 94.6 t -47.26 86.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 CA-C-N 117.965 0.883 . . . . 0.0 111.742 172.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.404 ' O ' HD23 ' A' ' 128' ' ' LEU . 93.9 mt-30 59.29 119.26 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.61 0.719 . . . . 0.0 112.59 -178.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -78.85 57.01 2.02 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -147.63 -43.47 0.17 Allowed 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.435 -175.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.571 HD22 ' N ' ' A' ' 129' ' ' PHE . 0.9 OUTLIER -72.15 -22.58 61.29 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -169.642 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.571 ' N ' HD22 ' A' ' 128' ' ' LEU . 37.9 p90 -105.1 147.77 27.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.221 0.534 . . . . 0.0 111.313 -176.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.531 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 39.2 t90 -141.1 98.07 3.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.969 -175.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.511 ' HB3' ' HA ' ' A' ' 157' ' ' MET . 2.5 pp -99.13 138.55 36.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.152 0.501 . . . . 0.0 111.322 -174.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 137' ' ' PRO . 38.8 p -136.2 150.98 49.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.098 -174.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.4 ' CD2' ' HB3' ' A' ' 147' ' ' TYR . 30.4 t80 -116.43 -70.37 0.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.026 0.441 . . . . 0.0 110.8 175.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -87.43 30.95 0.76 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.444 0.64 . . . . 0.0 110.469 -173.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.17 -3.53 71.24 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -172.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -115.54 143.67 30.98 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 115.036 -0.582 . . . . 0.0 109.476 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.414 ' HA ' HG22 ' A' ' 132' ' ' THR . 32.4 Cg_endo -65.55 137.79 51.92 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.267 1.978 . . . . 0.0 111.06 173.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.423 ' HB3' HG23 ' A' ' 111' ' ' VAL . 87.2 mt -81.7 106.77 13.9 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.059 0.457 . . . . 0.0 110.483 -178.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.535 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 42.7 mt-10 -71.96 141.76 49.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.935 177.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.528 ' HB2' ' HB1' ' A' ' 112' ' ' ALA . 4.1 p-10 -73.03 -5.78 41.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.97 0.414 . . . . 0.0 111.15 -177.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -83.49 -15.72 48.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.485 173.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.535 ' HG ' ' HB2' ' A' ' 139' ' ' GLU . 82.8 mt -91.32 144.29 29.54 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.037 -176.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 109' ' ' GLN . 6.3 Cg_exo -79.88 138.98 13.52 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.154 2.569 . . . . 0.0 111.612 174.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.58 HD12 ' HB2' ' A' ' 114' ' ' LEU . 33.6 mt -68.83 -40.2 79.57 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -177.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.26 -30.2 31.67 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.166 -0.54 . . . . 0.0 113.923 -175.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -66.25 -32.94 74.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.927 0.394 . . . . 0.0 110.899 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.4 ' HB3' ' CD2' ' A' ' 133' ' ' PHE . 89.0 m-85 -101.06 -32.23 10.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.36 0.6 . . . . 0.0 110.899 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.56 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -97.06 6.54 64.06 Favored Glycine 0 C--O 1.223 -0.531 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.809 -170.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -44.82 -24.54 0.22 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.478 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 67.7 mttt -102.23 131.0 23.08 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.497 177.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 12.8 Cg_exo -69.93 9.63 0.6 Allowed 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.197 2.598 . . . . 0.0 112.449 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' A' ' 150' ' ' LYS . 2.9 pp -119.93 0.0 10.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.586 178.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.6 m -61.83 110.87 1.66 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.895 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 29.3 m -95.6 114.38 26.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.03 -176.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.51 118.63 37.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.13 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.461 ' CE1' ' HD2' ' A' ' 94' ' ' ARG . 80.5 m-85 -90.57 113.96 26.08 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.942 0.401 . . . . 0.0 110.869 -177.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.555 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 2.0 tmt? -88.19 97.7 11.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.3 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.531 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 92.2 m-20 -97.49 176.93 5.69 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.646 -173.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.481 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 96.0 mt -120.33 133.27 55.48 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.918 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 159' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.943 0 O-C-N 124.132 0.895 . . . . 0.0 112.389 -174.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.427 ' C ' ' HD3' ' A' ' 88' ' ' PRO . 4.6 p-10 . . . . . 0 N--CA 1.461 0.124 0 CA-C-O 120.635 0.255 . . . . 0.0 111.585 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.664 ' HB2' HD11 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -118.55 75.62 12.68 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.427 ' HD3' ' C ' ' A' ' 86' ' ' ASP . 8.7 Cg_endo -88.16 110.75 0.66 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.006 2.471 . . . . 0.0 111.644 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.6 HD21 HD13 ' A' ' 107' ' ' LEU . 0.2 OUTLIER -96.19 123.27 39.75 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.316 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -95.33 101.87 13.63 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.431 HG23 HD13 ' A' ' 89' ' ' LEU . 46.7 pt -108.33 164.08 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.105 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 154' ' ' THR . 32.2 tp -108.87 120.96 44.05 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.273 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 90.4 t -116.95 117.39 55.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.003 0.43 . . . . 0.0 110.173 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.549 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 23.2 ttt180 -96.61 133.14 41.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.632 -177.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -76.44 91.85 3.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.705 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.2 p30 42.27 -76.39 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.244 1.418 . . . . 0.0 114.301 -174.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -123.39 -15.29 7.2 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 122.039 -0.413 . . . . 0.0 110.775 -176.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -84.55 -124.66 1.23 Allowed Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.989 -0.55 . . . . 0.0 113.761 -170.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -79.93 143.64 34.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.254 0.55 . . . . 0.0 111.501 -173.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 15.0 m -95.02 102.06 13.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.414 173.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.8 m -95.45 136.41 35.86 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.042 0.448 . . . . 0.0 110.691 -176.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.3 m -85.97 124.78 32.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.073 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.51 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 43.5 m-85 -111.07 145.71 38.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.974 0.416 . . . . 0.0 111.376 -176.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -95.15 95.86 8.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.45 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.4 m -109.37 -179.79 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.842 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.42 ' HB3' ' OE1' ' A' ' 87' ' ' GLU . 20.1 mtm180 -138.78 166.11 25.25 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.664 HD11 ' HB2' ' A' ' 87' ' ' GLU . 6.9 mp -80.44 -23.4 40.32 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.7 p -76.31 -16.91 59.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.107 174.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -85.07 138.29 32.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.091 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.655 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 38.7 p -88.1 163.71 16.09 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 175.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.584 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 3.4 t -64.14 -27.31 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.274 0.559 . . . . 0.0 109.788 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.15 -37.83 88.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.742 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -70.86 -33.99 71.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.574 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.408 HD22 HD13 ' A' ' 144' ' ' LEU . 65.7 tp -61.3 -46.07 91.85 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 173.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -59.36 -39.97 84.96 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.186 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -66.96 -32.19 73.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.306 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -62.03 -51.22 68.89 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.97 0.89 . . . . 0.0 109.134 174.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.4 t -62.3 -32.03 53.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.848 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.621 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 49.9 m -65.12 -27.58 68.84 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.807 0.337 . . . . 0.0 111.082 177.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.01 -35.02 54.64 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.679 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 75.4 mt -93.46 -67.53 0.85 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.408 0.623 . . . . 0.0 112.001 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 124' ' ' VAL . 8.1 tp10 -100.47 9.9 41.94 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.788 0.835 . . . . 0.0 110.847 -172.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -44.57 7.68 0.01 OUTLIER Glycine 0 CA--C 1.532 1.139 0 N-CA-C 118.555 2.182 . . . . 0.0 118.555 -174.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 122' ' ' GLU . 59.1 t -48.26 91.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 118.428 1.114 . . . . 0.0 111.678 173.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.405 ' C ' ' H ' ' A' ' 127' ' ' ASP . 53.9 mt-30 53.51 104.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.836 0.71 . . . . 0.0 111.698 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.651 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 4.5 p-10 -69.29 11.05 0.25 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.241 -173.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 125' ' ' GLN . 8.0 p-10 -117.62 -5.48 11.16 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 174.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 44.6 mt -93.26 -31.06 14.86 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 171.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.651 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 25.0 p90 -110.14 135.05 51.54 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 172.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.404 ' HE1' ' HB3' ' A' ' 137' ' ' PRO . 4.2 t-105 -155.79 135.78 12.84 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.957 0.408 . . . . 0.0 109.937 -176.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.604 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 6.4 mp -104.67 131.79 51.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.06 0.457 . . . . 0.0 110.703 -174.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.513 HG22 ' HA ' ' A' ' 137' ' ' PRO . 19.9 p -135.22 140.59 45.4 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.681 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.684 ' CD2' ' HG3' ' A' ' 134' ' ' GLU . 6.1 t80 -106.04 -82.89 0.53 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.831 -175.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.684 ' HG3' ' CD2' ' A' ' 133' ' ' PHE . 98.6 mt-10 -77.97 25.73 0.21 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.755 0.312 . . . . 0.0 111.798 -173.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 133' ' ' PHE . . . 92.25 -7.35 78.33 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -112.79 154.89 44.7 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.513 ' HA ' HG22 ' A' ' 132' ' ' THR . 85.9 Cg_endo -76.2 -5.78 16.58 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.851 2.367 . . . . 0.0 111.972 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 86.9 mt 62.1 176.29 0.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.053 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -104.19 101.79 11.52 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.584 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 9.9 p-10 -71.84 -9.28 58.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.938 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -68.79 -29.77 68.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.227 170.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 87.2 mt -97.28 160.83 27.99 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.876 -175.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.655 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 8.7 Cg_exo -72.09 153.71 57.36 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.76 2.306 . . . . 0.0 112.059 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.408 HD13 HD22 ' A' ' 114' ' ' LEU . 7.4 mt -70.92 -18.5 62.66 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.762 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -53.19 -44.02 63.85 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.675 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -63.96 -37.49 87.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -101.21 -37.1 8.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.037 0.446 . . . . 0.0 111.963 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.87 6.4 58.56 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.475 -170.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.566 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.0 pt? -47.18 -26.33 1.12 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.648 0.379 . . . . 0.0 112.014 175.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -81.32 118.66 73.2 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.551 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.1 -10.47 27.32 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.81 2.34 . . . . 0.0 111.412 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 82.9 mt -99.76 1.74 43.5 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.166 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.0 t -66.33 101.98 0.8 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.316 0.579 . . . . 0.0 109.85 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 18.0 m -90.84 92.18 8.68 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.873 -177.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 44.9 t -77.85 125.32 37.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.367 178.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -92.85 116.54 29.13 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.976 0.417 . . . . 0.0 110.604 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.604 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 1.1 tmt? -72.8 104.98 4.16 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -103.17 154.25 19.5 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.296 -173.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.5 mt -116.66 134.54 54.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.112 173.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 . . . . . 0 C--N 1.321 -0.671 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.72 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.6 t70 . . . . . 0 CA--C 1.518 -0.277 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -126.47 162.74 44.82 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.103 -174.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.75 111.01 0.61 Allowed 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.641 2.227 . . . . 0.0 111.794 176.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.466 HD21 ' O ' ' A' ' 148' ' ' GLY . 66.4 tp -106.71 109.09 20.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.983 -176.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.5 m -80.63 102.26 9.72 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.958 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.5 pt -101.83 146.11 10.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.132 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 44.2 tp -98.85 110.99 23.51 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.621 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.533 HG23 ' HB ' ' A' ' 155' ' ' VAL . 96.7 t -107.22 117.59 53.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.008 0.432 . . . . 0.0 110.359 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 26.3 ttt180 -85.64 101.25 12.56 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 176.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.454 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 0.7 OUTLIER -87.95 -176.71 5.56 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.992 0.901 . . . . 0.0 112.638 -173.684 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -70.68 175.7 4.73 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 113.728 -1.578 . . . . 0.0 108.534 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.4 mttp 64.07 15.66 9.42 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 123.633 0.773 . . . . 0.0 111.486 -172.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 59.33 67.47 2.16 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.616 -0.72 . . . . 0.0 114.086 174.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -157.55 141.39 15.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.107 0.454 . . . . 0.0 110.614 176.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 45.7 m -101.25 103.38 14.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.889 0.376 . . . . 0.0 110.135 177.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 m -99.22 138.36 36.43 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.647 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.4 m -90.04 115.65 27.47 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -101.0 136.27 41.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.917 0.389 . . . . 0.0 110.844 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -93.0 106.39 18.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.348 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.53 -179.54 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.225 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 58.5 mtm-85 -124.86 158.14 34.2 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.5 mp -67.1 -35.71 80.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.029 -176.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -89.87 14.65 11.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.276 0.56 . . . . 0.0 110.882 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -92.96 131.07 38.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.972 0.415 . . . . 0.0 110.004 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.625 ' HB ' ' OD1' ' A' ' 140' ' ' ASP . 3.2 p -74.03 159.21 33.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.646 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 83.3 t -63.87 -32.18 56.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.407 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.42 -41.85 73.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.79 176.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -65.18 -28.34 69.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.039 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.576 ' HB2' HD11 ' A' ' 144' ' ' LEU . 63.3 tp -82.25 -46.97 12.99 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 175.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -58.28 -46.55 85.85 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.571 -176.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -65.28 -30.81 71.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -70.21 -43.62 70.3 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.546 0.689 . . . . 0.0 109.466 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.35 -35.19 60.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.298 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.789 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 41.1 m -69.25 -18.64 63.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.942 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.68 -39.12 41.37 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.53 174.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.7 mp -95.04 -64.98 1.01 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.981 0.42 . . . . 0.0 111.852 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.483 ' HB3' ' HE3' ' A' ' 157' ' ' MET . 21.9 mm-40 -95.12 8.86 41.65 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 123.724 0.81 . . . . 0.0 111.035 -173.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.789 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -45.7 8.91 0.01 OUTLIER Glycine 0 N--CA 1.471 1.031 0 N-CA-C 119.028 2.371 . . . . 0.0 119.028 -173.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.442 ' H ' ' C ' ' A' ' 122' ' ' GLU . 31.8 t -51.78 81.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 118.758 1.279 . . . . 0.0 112.575 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.41 ' HB2' HD13 ' A' ' 128' ' ' LEU . 23.7 mp0 60.8 118.03 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.226 1.011 . . . . 0.0 113.455 172.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -53.32 -28.78 30.2 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.293 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -76.07 -24.67 55.11 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.469 -176.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.435 HD13 HG13 ' A' ' 124' ' ' VAL . 92.2 mt -89.26 -36.41 15.62 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -174.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -113.35 140.88 47.67 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.861 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -153.47 154.68 34.85 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 172.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.549 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 6.4 mp -114.65 149.56 36.5 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.838 -175.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 66.6 p -126.0 144.65 50.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.826 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.525 ' C ' ' H ' ' A' ' 135' ' ' GLY . 73.0 t80 -129.23 140.12 51.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 168.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 69.78 -43.93 0.54 Allowed 'General case' 0 CA--C 1.536 0.416 0 O-C-N 123.833 0.708 . . . . 0.0 110.426 -176.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 133' ' ' PHE . . . 156.01 -18.8 0.48 Allowed Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -176.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -91.61 146.99 34.24 Favored Pre-proline 0 C--O 1.236 0.356 0 CA-C-N 115.315 -0.443 . . . . 0.0 109.94 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.27 147.61 66.37 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.541 2.16 . . . . 0.0 111.345 175.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 70.8 mt -70.59 108.15 4.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.789 0.328 . . . . 0.0 111.006 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -92.44 130.08 38.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.601 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.625 ' OD1' ' HB ' ' A' ' 110' ' ' THR . 36.5 t70 -72.45 -6.67 45.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.534 -175.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -74.12 -14.11 60.92 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.487 0.66 . . . . 0.0 109.904 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 88.5 mt -120.16 131.71 24.33 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.95 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.46 148.94 92.52 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.673 2.249 . . . . 0.0 112.004 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.576 HD11 ' HB2' ' A' ' 114' ' ' LEU . 83.2 mt -59.88 -25.39 65.05 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -176.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -61.16 -27.35 67.26 Favored Glycine 0 C--O 1.226 -0.396 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.505 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -72.32 -21.09 61.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.875 0.369 . . . . 0.0 111.184 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -100.3 -45.14 5.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.312 0.577 . . . . 0.0 110.606 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.466 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -100.16 6.67 58.21 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-O 119.227 -0.763 . . . . 0.0 113.973 -171.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.47 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.3 pt? -34.38 -41.32 0.11 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -91.23 119.88 68.61 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.529 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 17.4 Cg_exo -66.13 81.38 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.117 2.544 . . . . 0.0 112.199 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 151' ' ' PRO . 7.3 tt 167.75 -26.56 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.787 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.3 m -45.55 125.45 5.83 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.376 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 23.9 m -97.72 120.6 38.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.303 -175.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.533 ' HB ' HG23 ' A' ' 93' ' ' VAL . 61.7 t -99.96 133.04 44.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.338 176.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -103.82 124.81 49.6 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.079 0.466 . . . . 0.0 111.045 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.549 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 25.2 ttt -81.75 131.06 35.25 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 175.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -120.51 145.21 47.52 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.109 -175.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.537 HD22 ' HE2' ' A' ' 157' ' ' MET . 50.9 mt -125.16 137.73 54.15 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.607 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 . . . . . 0 CA--C 1.517 -0.316 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 27.8 mm-40 -88.08 137.4 31.3 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.756 -172.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 24.0 Cg_exo -64.95 95.47 0.24 Allowed 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.71 2.273 . . . . 0.0 111.659 175.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.46 ' HG ' HG21 ' A' ' 91' ' ' ILE . 58.0 tp -85.3 107.51 17.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.233 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.441 ' HB3' HG23 ' A' ' 102' ' ' THR . 24.3 m -87.33 102.68 14.75 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.624 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.46 HG21 ' HG ' ' A' ' 89' ' ' LEU . 36.8 pt -102.84 157.79 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.023 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.5 ' O ' ' HA ' ' A' ' 154' ' ' THR . 37.4 tp -103.51 102.99 12.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.131 0.491 . . . . 0.0 110.922 -176.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.518 HG21 ' HB ' ' A' ' 155' ' ' VAL . 58.8 t -107.46 123.78 62.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.987 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -89.55 135.04 33.83 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.125 0.488 . . . . 0.0 110.2 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -99.28 170.18 8.84 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.915 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -69.03 -19.21 64.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.713 -175.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -79.17 2.4 21.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.914 0.388 . . . . 0.0 111.16 177.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.38 -9.65 69.39 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.145 -0.55 . . . . 0.0 113.272 171.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 33.5 mtp180 -83.93 160.61 21.04 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.131 0.491 . . . . 0.0 111.417 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.1 m -113.54 106.97 15.18 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.15 176.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.8 m -106.16 130.62 54.01 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.213 0.53 . . . . 0.0 111.004 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.441 HG23 ' HB3' ' A' ' 90' ' ' SER . 23.5 m -86.54 105.04 16.55 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.451 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.476 ' CD2' ' HB ' ' A' ' 93' ' ' VAL . 87.4 m-85 -91.27 134.23 34.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.744 -177.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -89.48 95.63 10.36 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.416 HG11 HD13 ' A' ' 114' ' ' LEU . 31.6 m -109.44 163.67 6.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.595 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.577 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 0.7 OUTLIER -110.98 146.97 35.72 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.154 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.5 HD21 ' HA3' ' A' ' 145' ' ' GLY . 6.7 mp -60.74 -35.41 76.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.719 -172.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.8 p -98.73 9.48 43.27 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -172.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.577 ' HG2' ' O ' ' A' ' 106' ' ' ARG . 10.0 pt20 -81.07 -8.93 59.87 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.653 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.6 p 64.19 159.11 0.09 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.066 1.346 . . . . 0.0 111.346 -175.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.555 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 48.4 t -63.85 -21.02 27.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.052 0.454 . . . . 0.0 109.979 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.537 ' HB3' ' HB2' ' A' ' 140' ' ' ASP . . . -58.21 -41.53 84.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.869 176.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -69.74 -36.51 75.9 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 120.745 0.307 . . . . 0.0 110.325 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.416 HD13 HG11 ' A' ' 105' ' ' VAL . 62.3 tp -66.92 -43.61 82.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.891 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -65.82 -28.18 68.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.349 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.502 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 35.0 tt0 -76.01 -34.77 59.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.588 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -60.21 -48.71 80.6 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.797 0.808 . . . . 0.0 108.909 171.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.46 -40.66 84.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.032 174.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.821 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 25.2 p -66.07 -14.75 62.27 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.843 0.354 . . . . 0.0 111.08 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.17 -44.03 8.34 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.656 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.3 mt -91.15 -59.9 2.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.044 0.45 . . . . 0.0 112.197 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.481 ' O ' ' N ' ' A' ' 124' ' ' VAL . 4.4 tp10 -100.38 9.42 42.67 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 123.524 0.73 . . . . 0.0 110.396 -174.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.821 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -45.71 7.95 0.01 OUTLIER Glycine 0 N--CA 1.473 1.108 0 N-CA-C 118.69 2.236 . . . . 0.0 118.69 -172.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.481 ' N ' ' O ' ' A' ' 122' ' ' GLU . 40.6 t -49.46 85.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 118.167 0.984 . . . . 0.0 112.276 174.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.425 ' HB2' HD13 ' A' ' 128' ' ' LEU . 2.3 mp0 56.29 106.81 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.586 0.754 . . . . 0.0 112.241 176.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -51.26 -24.17 4.21 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.746 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -81.51 -20.71 39.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.01 -175.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.44 HD13 HG13 ' A' ' 124' ' ' VAL . 96.7 mt -81.46 -14.84 56.58 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -175.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -133.82 151.11 51.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.451 0.643 . . . . 0.0 111.816 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -149.25 157.07 43.04 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 172.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.621 HD12 HG12 ' A' ' 155' ' ' VAL . 1.3 pt? -123.57 135.85 54.21 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.727 -172.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 41.3 p -116.19 131.7 56.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.845 -178.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.539 ' CE2' ' HB2' ' A' ' 134' ' ' GLU . 8.4 t80 -94.16 -89.67 0.22 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.523 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.539 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 10.8 tt0 -98.42 25.44 6.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.561 0.696 . . . . 0.0 110.385 -170.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 133.25 -37.43 2.0 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.75 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 54.3 mmtt -117.18 156.21 48.85 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 120.54 0.209 . . . . 0.0 110.917 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 132' ' ' THR . 48.2 Cg_endo -69.25 152.99 71.94 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.121 2.547 . . . . 0.0 112.79 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.449 ' HB3' HG22 ' A' ' 111' ' ' VAL . 85.9 mt -94.6 121.72 36.45 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.767 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -84.81 146.09 27.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.589 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.555 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 6.7 p-10 -61.22 -22.05 64.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.54 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -73.42 -15.78 61.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.176 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 77.1 mt -102.14 140.17 20.93 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 121.121 0.486 . . . . 0.0 111.516 -172.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 142' ' ' LEU . 12.7 Cg_exo -71.23 144.1 45.53 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.983 2.456 . . . . 0.0 111.08 173.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.563 HD11 ' H ' ' A' ' 144' ' ' LEU . 4.1 mp -71.54 -33.9 69.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.998 -174.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.5 ' HA3' HD21 ' A' ' 107' ' ' LEU . . . -59.63 -30.29 68.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.286 -0.483 . . . . 0.0 113.686 -172.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.65 -41.26 94.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.049 0.452 . . . . 0.0 111.029 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -101.55 -30.2 11.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.529 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.454 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -98.97 6.73 60.24 Favored Glycine 0 C--O 1.227 -0.299 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.625 -172.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -41.09 -31.22 0.18 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -92.71 126.54 51.47 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.295 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -68.15 6.38 0.88 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.958 2.439 . . . . 0.0 112.922 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 97.7 mt -112.24 7.41 19.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.05 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.4 p -62.39 117.94 6.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.943 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 15.0 m -101.51 106.66 17.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.408 -175.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.621 HG12 HD12 ' A' ' 131' ' ' LEU . 25.6 t -99.33 140.09 19.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.427 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -109.81 118.3 36.13 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.434 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 2.1 ttm -81.37 106.49 13.37 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -98.82 135.03 40.87 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.741 -172.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 49.1 mt -102.88 -167.68 1.42 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.638 173.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 . . . . . 0 N--CA 1.466 0.369 0 CA-C-O 121.85 0.833 . . . . 0.0 111.754 174.482 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 . . . . . 0 N--CA 1.467 0.4 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -75.47 116.48 55.23 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -82.49 84.53 1.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.309 2.006 . . . . 0.0 110.863 174.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.9 tp -84.21 110.66 18.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.333 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.7 m -88.64 112.91 23.64 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.061 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.5 pt -107.08 134.75 47.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' A' ' 100' ' ' SER . 30.2 tp -93.1 101.37 13.67 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.593 -174.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.9 t -84.7 99.8 7.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -97.39 93.93 6.77 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.703 -174.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.57 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 6.1 p30 -79.16 136.37 37.09 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.408 -177.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 27.2 t-20 67.98 -77.32 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.24 -171.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.42 ' HB3' ' O ' ' A' ' 96' ' ' ASN . 17.2 ptpt 168.68 -23.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.98 0.912 . . . . 0.0 109.771 174.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -81.21 -38.6 14.64 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.0 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -93.67 106.76 18.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.986 0.422 . . . . 0.0 111.651 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.506 ' HB3' HD11 ' A' ' 92' ' ' LEU . 18.6 m -96.5 109.04 21.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.867 174.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.2 m -111.89 112.69 24.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.108 0.48 . . . . 0.0 110.638 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.4 m -76.66 121.92 23.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.515 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -111.81 132.13 54.88 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.96 0.41 . . . . 0.0 110.553 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -81.98 130.4 35.06 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.734 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.2 m -146.36 -179.96 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.765 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 39.7 mtm-85 -138.35 169.96 16.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.175 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.9 mp -73.03 -10.47 59.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.779 0.323 . . . . 0.0 111.43 -175.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 m -85.73 0.46 52.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.221 0.534 . . . . 0.0 110.669 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.464 ' HB3' HD13 ' A' ' 144' ' ' LEU . 13.3 mm100 -86.58 136.46 33.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.089 0.471 . . . . 0.0 111.521 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.5 p -94.7 166.83 11.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.231 175.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 64.2 t -60.39 -40.61 84.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.088 0.471 . . . . 0.0 109.731 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 116' ' ' GLN . . . -53.74 -48.35 69.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.898 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.443 ' HB3' ' NE2' ' A' ' 109' ' ' GLN . 3.6 m170 -63.71 -25.77 68.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.835 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.754 ' HB2' HD11 ' A' ' 144' ' ' LEU . 63.7 tp -83.48 -43.18 16.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.915 0.388 . . . . 0.0 110.181 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -60.15 -37.98 81.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.545 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 112' ' ' ALA . 55.5 mt-30 -64.93 -38.19 90.14 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 122.955 0.159 . . . . 0.0 111.41 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -63.37 -50.09 71.3 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.12 0.486 . . . . 0.0 109.786 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.4 t -57.34 -44.29 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.753 174.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.703 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 66.6 m -62.25 -22.2 65.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.086 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.61 -39.53 21.22 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.28 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -94.74 -64.9 1.02 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.1 0.476 . . . . 0.0 111.828 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.439 ' C ' ' H ' ' A' ' 124' ' ' VAL . 4.0 tp10 -100.41 8.55 43.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.135 -174.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.703 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -55.81 7.26 0.01 OUTLIER Glycine 0 CA--C 1.521 0.466 0 N-CA-C 116.481 1.353 . . . . 0.0 116.481 -172.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.439 ' H ' ' C ' ' A' ' 122' ' ' GLU . 64.4 t -41.82 92.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 123.552 0.741 . . . . 0.0 111.777 173.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.788 HE21 ' HA ' ' A' ' 125' ' ' GLN . 0.0 OUTLIER 52.97 106.23 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 O-C-N 123.858 0.724 . . . . 0.0 111.744 -178.176 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.622 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 9.2 p-10 -69.11 1.9 3.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.439 0.638 . . . . 0.0 110.403 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -75.53 -33.63 60.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.676 169.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 93.5 mt -79.34 -33.37 43.12 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.323 -173.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.622 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 52.2 p90 -105.78 121.4 43.97 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.658 -0.817 . . . . 0.0 112.045 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.554 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 37.2 t90 -132.29 104.22 6.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.369 176.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.54 ' CB ' ' HA ' ' A' ' 157' ' ' MET . 2.4 pt? -96.77 140.69 30.97 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.496 0.665 . . . . 0.0 112.046 -170.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 76.8 p -128.05 144.97 51.13 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.067 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -109.02 -72.0 0.74 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.645 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.596 ' HB3' ' HG2' ' A' ' 136' ' ' LYS . 24.2 tt0 -92.29 32.61 1.16 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.535 -171.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.9 11.53 85.12 Favored Glycine 0 CA--C 1.509 -0.343 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -169.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.596 ' HG2' ' HB3' ' A' ' 134' ' ' GLU . 0.5 OUTLIER -134.2 149.56 71.72 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 114.474 -0.863 . . . . 0.0 109.328 -178.379 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.78 150.59 78.98 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.175 1.917 . . . . 0.0 111.115 173.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 76.1 mt -74.21 109.28 7.58 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.82 122.17 26.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.741 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.4 53.06 1.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.191 0.995 . . . . 0.0 110.569 -176.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.748 ' HG3' ' HG ' ' A' ' 142' ' ' LEU . 3.6 pt20 -129.97 -7.95 4.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.823 175.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.748 ' HG ' ' HG3' ' A' ' 141' ' ' GLN . 81.2 mt -127.22 157.01 73.76 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.781 -175.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.68 145.5 25.96 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.1 1.866 . . . . 0.0 111.789 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.754 HD11 ' HB2' ' A' ' 114' ' ' LEU . 79.6 mt -62.2 -23.01 66.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.468 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -57.67 -34.87 71.41 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.326 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -77.47 -24.09 50.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.233 0.517 . . . . 0.0 110.988 -176.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -91.11 -39.0 12.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.302 0.573 . . . . 0.0 110.629 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.05 6.37 59.9 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.655 -172.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -41.41 -32.18 0.3 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.489 ' C ' ' H ' ' A' ' 152' ' ' LEU . 24.7 ttmm -83.18 114.98 56.62 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 173.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 16.8 Cg_exo -68.52 20.58 0.14 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.566 2.844 . . . . 0.0 113.427 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.489 ' H ' ' C ' ' A' ' 150' ' ' LYS . 54.3 mt -146.93 19.73 1.27 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.588 177.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.8 p -64.97 127.27 30.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.752 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.3 m -94.59 100.72 12.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.904 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.4 t -92.6 111.49 24.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -79.13 102.35 8.41 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.042 -175.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.57 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 22.8 ttt -76.44 90.91 3.28 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.554 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 11.2 m120 -74.5 131.03 40.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.391 -173.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 76.6 mt -96.92 114.66 26.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.144 0.497 . . . . 0.0 110.164 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.785 -176.879 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.5 t70 . . . . . 0 CA--C 1.515 -0.377 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 64.75 81.18 0.22 Allowed Pre-proline 0 N--CA 1.455 -0.21 0 CA-C-N 113.191 -1.822 . . . . 0.0 112.836 169.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.92 132.52 15.63 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.682 2.254 . . . . 0.0 111.047 169.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.637 HD21 ' O ' ' A' ' 148' ' ' GLY . 55.1 tp -92.22 155.82 17.73 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.5 t -131.61 130.7 42.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.885 0.374 . . . . 0.0 110.013 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.46 HD13 HG21 ' A' ' 155' ' ' VAL . 35.4 pt -127.88 150.71 33.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.847 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.435 HD13 ' HB2' ' A' ' 100' ' ' SER . 50.6 tp -93.24 113.7 25.97 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.0 0.428 . . . . 0.0 110.762 -177.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 63.6 t -98.62 113.47 33.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.742 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -110.73 114.98 28.76 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.763 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.408 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 29.3 p30 -94.68 136.43 35.0 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.287 -178.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 17.52 -80.83 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.591 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.7 OUTLIER -139.13 8.92 2.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.928 0.394 . . . . 0.0 111.134 -165.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -122.03 -78.49 0.47 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.366 -1.397 . . . . 0.0 114.772 -170.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -111.29 136.65 50.08 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.261 0.553 . . . . 0.0 112.455 -164.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.435 ' HB2' HD13 ' A' ' 92' ' ' LEU . 12.7 p -115.86 106.51 13.91 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 167.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.0 t -118.24 133.01 56.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.993 0.425 . . . . 0.0 110.74 -175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.72 100.69 13.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.119 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -90.66 166.04 13.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.834 0.349 . . . . 0.0 111.093 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -103.97 128.98 51.52 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.374 0.606 . . . . 0.0 110.906 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.2 m -139.56 -179.44 2.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.713 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.446 ' HB2' ' HG2' ' A' ' 109' ' ' GLN . 67.8 mtp85 -132.13 164.42 26.33 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 174.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 107' ' ' LEU . 6.7 mp -82.23 -39.14 23.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.016 0.436 . . . . 0.0 110.135 176.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.1 m -92.12 66.15 4.85 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.292 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.449 ' OE1' ' HB2' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -156.43 157.99 36.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.789 174.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 140' ' ' ASP . 14.8 p -88.58 144.92 26.01 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.609 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 47.2 t -56.73 -19.25 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 120.925 0.393 . . . . 0.0 111.224 -177.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 140' ' ' ASP . . . -55.81 -34.64 65.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.947 0.403 . . . . 0.0 110.713 173.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -74.23 -15.62 60.99 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.204 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.736 HD23 HD11 ' A' ' 144' ' ' LEU . 65.3 tp -92.46 -53.24 4.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.033 0.444 . . . . 0.0 110.028 174.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -61.44 -40.02 92.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.53 -173.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -69.1 -31.8 70.77 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.478 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -68.27 -44.81 74.72 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.87 -35.67 61.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.548 173.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.752 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 62.3 m -72.49 -14.96 61.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.451 178.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.76 -39.36 21.16 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.438 175.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.1 mp -94.85 -64.39 1.07 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.132 0.491 . . . . 0.0 111.8 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.402 ' C ' ' H ' ' A' ' 124' ' ' VAL . 19.1 mm-40 -96.81 8.3 44.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.62 -173.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.752 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -54.35 7.66 0.01 OUTLIER Glycine 0 CA--C 1.522 0.531 0 N-CA-C 118.02 1.968 . . . . 0.0 118.02 -169.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.429 HG11 HD12 ' A' ' 128' ' ' LEU . 57.7 t -43.23 93.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 118.122 0.961 . . . . 0.0 112.316 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 57.37 109.11 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.605 0.762 . . . . 0.0 111.753 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.461 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 39.1 t70 -60.22 -6.67 1.54 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.639 -176.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -96.48 -19.29 19.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.666 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.429 HD12 HG11 ' A' ' 124' ' ' VAL . 64.9 mt -79.04 -39.78 33.07 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.716 -176.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.461 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 29.6 p90 -96.59 94.71 7.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.948 0.88 . . . . 0.0 111.447 -177.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.657 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 34.1 t90 -90.12 87.6 6.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.29 176.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -88.0 139.7 30.24 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.212 0.53 . . . . 0.0 110.652 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.475 ' HG1' ' C ' ' A' ' 136' ' ' LYS . 0.8 OUTLIER -151.02 159.69 44.39 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.15 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.465 ' CD2' ' HB2' ' A' ' 134' ' ' GLU . 13.5 t80 -102.71 -74.51 0.63 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.934 -175.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.465 ' HB2' ' CD2' ' A' ' 133' ' ' PHE . 7.8 tp10 -98.49 21.26 11.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.176 0.512 . . . . 0.0 110.702 -171.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.36 9.17 62.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.512 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.478 ' HD3' ' O ' ' A' ' 137' ' ' PRO . 14.4 tmtt? -122.56 122.37 27.31 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.478 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 27.2 Cg_exo -58.91 152.75 55.66 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.785 2.324 . . . . 0.0 112.296 -176.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 44.8 mt -103.29 97.08 7.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.242 -174.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.406 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 2.6 mp0 -63.73 134.4 55.26 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 173.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.609 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 5.6 p-10 -65.54 -22.41 66.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.085 -174.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -81.89 -10.39 59.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.838 0.351 . . . . 0.0 111.202 -177.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.406 ' HG ' ' HB2' ' A' ' 139' ' ' GLU . 79.6 mt -90.55 157.06 44.88 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.977 -176.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 109' ' ' GLN . 3.0 Cg_exo -75.23 128.73 11.53 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.978 2.452 . . . . 0.0 111.686 177.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.736 HD11 HD23 ' A' ' 114' ' ' LEU . 5.1 tt -62.53 -36.72 83.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.33 -177.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -52.11 -28.91 27.24 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 114.392 0.517 . . . . 0.0 114.392 -176.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -61.63 -38.07 86.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.159 0.504 . . . . 0.0 110.481 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -100.71 -33.11 10.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.157 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.637 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -96.86 6.18 64.34 Favored Glycine 0 C--O 1.223 -0.593 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.761 -172.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.432 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.7 pt? -46.79 -25.98 0.86 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.448 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 66.6 mttm -96.84 133.89 23.79 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 17.1 Cg_exo -67.87 2.57 2.46 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.93 2.42 . . . . 0.0 111.878 176.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 150' ' ' LYS . 1.4 pt? -124.58 11.34 8.54 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.046 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 46.7 m -60.52 110.22 1.22 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.926 0.393 . . . . 0.0 110.276 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 19.8 m -84.32 101.33 11.87 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.453 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.46 HG21 HD13 ' A' ' 91' ' ' ILE . 56.4 t -87.63 115.08 27.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.62 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -87.95 103.18 15.44 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.321 0.582 . . . . 0.0 110.745 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.408 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 26.4 ttt -77.17 87.19 3.63 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.842 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.657 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 23.3 m-80 -77.71 88.09 3.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.417 -174.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.63 94.1 3.16 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 172.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.889 -171.679 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.514 ' OD1' ' HD3' ' A' ' 106' ' ' ARG . 31.0 t70 . . . . . 0 CA--C 1.518 -0.258 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 53.67 73.84 0.86 Allowed Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.865 174.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -93.43 137.02 1.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 123.049 2.499 . . . . 0.0 112.783 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 148' ' ' GLY . 0.2 OUTLIER -97.98 125.75 43.07 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.031 177.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -89.11 99.18 12.22 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.008 0.433 . . . . 0.0 110.193 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 45.8 pt -101.6 163.72 3.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.218 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.499 HD13 ' HB3' ' A' ' 100' ' ' SER . 23.8 tp -119.2 111.27 18.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.778 0.323 . . . . 0.0 110.587 -178.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.409 HG22 ' HB ' ' A' ' 155' ' ' VAL . 61.7 t -110.38 112.55 41.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -90.24 125.2 35.4 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.929 0.395 . . . . 0.0 110.861 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.477 ' HA ' ' SD ' ' A' ' 157' ' ' MET . 12.2 m-20 -67.0 150.5 49.17 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -61.16 106.01 0.56 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.665 0.269 . . . . 0.0 110.592 -176.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt 61.32 21.0 11.58 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.28 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.74 -145.62 9.58 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.081 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -89.72 160.62 16.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.144 0.497 . . . . 0.0 111.226 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.499 ' HB3' HD13 ' A' ' 92' ' ' LEU . 12.4 m -81.95 106.87 14.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.851 175.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.0 m -85.66 103.74 14.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.153 0.501 . . . . 0.0 110.488 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.5 m -77.39 115.51 17.22 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.991 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -107.09 131.76 53.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.059 0.457 . . . . 0.0 111.79 -175.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -95.24 103.11 14.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.488 -0.778 . . . . 0.0 108.915 173.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.492 HG13 HD12 ' A' ' 114' ' ' LEU . 33.1 m -129.3 137.61 56.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.896 0.379 . . . . 0.0 111.151 -175.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.514 ' HD3' ' OD1' ' A' ' 86' ' ' ASP . 22.1 mtm180 -83.06 149.83 26.69 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.864 0.364 . . . . 0.0 110.44 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 107' ' ' LEU . 6.6 mp -69.09 -18.47 63.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.957 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.3 m -80.59 1.03 31.39 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.367 0.604 . . . . 0.0 110.763 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -92.97 152.57 19.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.483 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 p -90.36 157.46 17.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.888 172.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.585 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 59.2 t -58.94 -30.88 44.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.034 0.445 . . . . 0.0 110.865 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.525 ' HB3' ' HB2' ' A' ' 140' ' ' ASP . . . -55.21 -39.51 69.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.397 177.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.579 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 5.9 t60 -65.65 -37.19 85.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.134 -178.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.503 HD21 HD13 ' A' ' 144' ' ' LEU . 50.8 tp -67.69 -50.49 57.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.666 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -63.09 -38.75 92.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.093 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.891 HE21 ' HA ' ' A' ' 116' ' ' GLN . 0.0 OUTLIER -66.7 -29.17 69.09 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.089 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.579 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 26.5 mt-30 -63.47 -49.66 72.76 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 172.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.1 t -59.58 -49.2 84.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.811 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.844 ' HA ' ' HA3' ' A' ' 123' ' ' GLY . 67.4 m -59.51 -20.26 54.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.762 178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -79.31 -36.49 26.97 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.105 176.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 82.7 mt -96.74 -69.15 0.77 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.03 0.443 . . . . 0.0 112.098 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -97.13 7.11 47.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.358 0.599 . . . . 0.0 110.014 -176.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.844 ' HA3' ' HA ' ' A' ' 119' ' ' SER . . . -62.25 7.18 0.22 Allowed Glycine 0 C--O 1.226 -0.374 0 N-CA-C 116.334 1.294 . . . . 0.0 116.334 -170.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.3 t -31.08 93.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.911 0.884 . . . . 0.0 112.648 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.401 ' C ' ' H ' ' A' ' 127' ' ' ASP . 21.6 mt-30 53.31 111.78 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 O-C-N 123.913 0.758 . . . . 0.0 112.545 -176.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -63.32 -4.31 2.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.716 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 125' ' ' GLN . 13.3 m-20 -88.05 -24.68 23.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.041 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 93.7 mt -85.58 -42.35 14.44 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.542 0.21 . . . . 0.0 111.32 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.582 ' CE1' ' HA2' ' A' ' 123' ' ' GLY . 11.5 p90 -114.83 152.57 31.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.017 0.437 . . . . 0.0 110.477 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.716 ' CD1' ' HG3' ' A' ' 137' ' ' PRO . 1.0 OUTLIER -162.13 135.68 6.32 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 169.082 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.581 HD11 HG12 ' A' ' 155' ' ' VAL . 2.1 pp -98.22 144.79 27.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.309 0.576 . . . . 0.0 111.691 -173.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 25.7 p -120.09 152.05 38.15 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.721 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.491 ' HB3' HD23 ' A' ' 138' ' ' LEU . 14.7 t80 -137.11 -60.43 0.68 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.995 0.426 . . . . 0.0 110.796 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 136' ' ' LYS . 1.8 tm-20 -81.79 35.62 0.42 Allowed 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 133' ' ' PHE . . . 81.69 -29.58 2.96 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -170.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.474 ' H ' ' C ' ' A' ' 134' ' ' GLU . 22.7 pttp -118.05 173.68 3.12 Favored Pre-proline 0 N--CA 1.446 -0.66 0 CA-C-N 115.026 -0.587 . . . . 0.0 109.838 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.716 ' HG3' ' CD1' ' A' ' 130' ' ' TRP . 24.7 Cg_exo -62.38 171.73 5.08 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.376 2.051 . . . . 0.0 111.899 175.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.514 ' HB2' HG12 ' A' ' 111' ' ' VAL . 93.5 mt -101.92 146.06 28.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.44 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -74.3 112.3 10.33 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.585 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.9 p-10 -60.97 -26.79 67.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.819 -174.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -77.72 -19.67 54.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.382 -175.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 61.5 mt -93.2 156.25 40.34 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.732 0.301 . . . . 0.0 110.966 -174.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.05 136.14 54.91 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.896 2.397 . . . . 0.0 112.236 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.503 HD13 HD21 ' A' ' 114' ' ' LEU . 3.0 tt -63.74 -35.78 81.71 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.831 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -59.04 -23.9 57.74 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.835 -0.62 . . . . 0.0 113.162 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -69.07 -30.74 69.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.002 0.401 . . . . 0.0 110.597 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -100.17 -29.24 12.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.147 0.499 . . . . 0.0 110.922 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' A' ' 89' ' ' LEU . . . -100.27 5.58 57.52 Favored Glycine 0 C--O 1.219 -0.809 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.591 -174.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.426 ' N ' HD23 ' A' ' 149' ' ' LEU . 2.3 pt? -46.03 -32.61 2.91 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 22.7 tptm -97.41 116.68 65.92 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 17.4 Cg_exo -66.02 79.69 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.169 2.579 . . . . 0.0 111.806 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 49.2 tp 172.87 -25.06 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.105 -173.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.6 t -46.05 117.45 1.53 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.721 175.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 24.0 m -110.32 120.41 42.35 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.113 -175.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.581 HG12 HD11 ' A' ' 131' ' ' LEU . 42.7 t -98.19 135.9 31.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.614 177.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -111.98 124.82 53.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.811 0.339 . . . . 0.0 110.815 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.477 ' SD ' ' HA ' ' A' ' 95' ' ' ASN . 63.1 mtt -75.42 126.59 31.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.729 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -105.26 152.17 23.21 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.137 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 79.5 mt -115.77 144.91 43.31 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.413 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 160' ' ' ARG . 26.2 ttt180 . . . . . 0 C--N 1.321 -0.65 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.351 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 . . . . . 0 CA--C 1.521 -0.165 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 33.94 66.5 1.32 Allowed Pre-proline 0 N--CA 1.472 0.673 0 C-N-CA 124.446 1.098 . . . . 0.0 113.816 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.52 149.12 11.44 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.899 1.732 . . . . 0.0 111.915 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.536 HD22 ' O ' ' A' ' 148' ' ' GLY . 45.5 tp -110.67 123.63 50.38 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.873 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.6 m -90.55 99.66 12.65 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.008 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.4 pt -100.61 145.54 10.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' A' ' 100' ' ' SER . 23.9 tp -106.21 106.0 16.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.044 0.45 . . . . 0.0 110.256 -176.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 61.0 t -99.86 128.56 51.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.036 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.584 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 81.6 mtt180 -100.4 123.12 44.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.18 0.514 . . . . 0.0 110.875 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -67.73 169.66 9.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.963 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.535 ' HB3' HD11 ' A' ' 159' ' ' LEU . 19.8 p-10 -52.05 -44.38 64.24 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.618 -177.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -75.97 -38.01 57.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.751 0.31 . . . . 0.0 111.411 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 133.13 44.86 0.13 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.747 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 94' ' ' ARG . 11.6 ttm180 -104.02 123.87 48.0 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 175.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.459 ' HB3' HD11 ' A' ' 92' ' ' LEU . 43.8 m -89.49 94.21 9.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.947 0.403 . . . . 0.0 110.155 177.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.8 m -98.95 127.93 44.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.625 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.8 m -88.42 109.39 19.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.554 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -93.86 121.24 35.1 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -86.43 101.84 13.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.815 0.817 . . . . 0.0 109.854 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.453 HG23 HD13 ' A' ' 144' ' ' LEU . 26.2 m -111.9 -177.94 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.623 -177.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.498 ' O ' ' HG3' ' A' ' 109' ' ' GLN . 41.8 ttm180 -133.35 153.68 51.38 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.51 ' CD2' HD21 ' A' ' 89' ' ' LEU . 14.3 mt -75.68 -9.11 58.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.023 0.44 . . . . 0.0 110.571 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.48 ' H ' ' HG2' ' A' ' 106' ' ' ARG . 0.2 OUTLIER -91.44 5.2 50.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.313 -177.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.498 ' HG3' ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -122.69 161.73 23.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.824 0.345 . . . . 0.0 110.464 177.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 32.6 p -89.93 167.56 12.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.821 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.605 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 60.4 t -59.82 -31.38 47.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.057 174.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.494 ' HB2' ' HB3' ' A' ' 140' ' ' ASP . . . -57.47 -35.18 69.83 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.028 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -68.49 -17.71 64.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.153 0.502 . . . . 0.0 110.591 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.568 HD22 HD12 ' A' ' 144' ' ' LEU . 48.1 tp -100.12 -48.18 4.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.197 0.523 . . . . 0.0 110.468 176.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.2 tttm -63.19 -41.52 99.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.181 -177.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.792 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 63.5 tt0 -79.69 -17.97 52.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.062 0.458 . . . . 0.0 110.438 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -67.7 -52.79 33.61 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 51.7 t -64.59 -42.35 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.314 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 1.065 ' HA ' ' HA3' ' A' ' 123' ' ' GLY . 93.9 p -62.98 -32.13 73.41 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.965 0.412 . . . . 0.0 110.62 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.92 -29.3 70.96 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.862 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 78.7 mt -91.61 -77.02 0.43 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.688 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -103.26 -15.84 15.86 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 1.065 ' HA3' ' HA ' ' A' ' 119' ' ' SER . . . -42.35 -54.92 4.57 Favored Glycine 0 C--O 1.229 -0.201 0 N-CA-C 115.426 0.93 . . . . 0.0 115.426 -165.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 84.1 t 60.07 82.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.962 0.411 . . . . 0.0 110.443 -172.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.498 ' C ' ' H ' ' A' ' 127' ' ' ASP . 27.6 mt-30 58.56 112.08 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.135 -175.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.6 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 8.0 p-10 -72.69 19.34 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.059 0.457 . . . . 0.0 111.496 -176.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.498 ' H ' ' C ' ' A' ' 125' ' ' GLN . 29.5 t70 -108.11 -25.08 11.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.278 175.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.9 mt -75.96 -11.54 59.98 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.091 0.472 . . . . 0.0 110.742 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.6 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 31.2 p90 -142.85 148.48 37.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.131 178.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.465 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 1.3 p90 -150.08 156.34 41.47 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.834 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 7.1 mp -112.64 149.53 32.7 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.567 -176.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.531 HG22 ' HA ' ' A' ' 137' ' ' PRO . 47.4 p -131.75 154.4 49.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.961 -178.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -139.23 130.62 26.97 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.301 171.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 70.66 -0.94 2.75 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 123.725 0.641 . . . . 0.0 111.037 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 111.59 -4.32 27.83 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.808 -174.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 137' ' ' PRO . 35.5 mtmm -106.6 134.85 19.64 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.627 0.251 . . . . 0.0 110.616 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.531 ' HA ' HG22 ' A' ' 132' ' ' THR . 7.6 Cg_exo -72.5 147.62 46.55 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.651 2.234 . . . . 0.0 111.266 174.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 37.7 mt -86.49 111.32 20.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.335 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -80.33 126.17 30.83 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.605 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 0.0 OUTLIER -61.18 -25.17 66.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.038 0.447 . . . . 0.0 111.036 -177.583 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -78.54 -0.43 29.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.3 -175.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.2 mt -120.76 151.69 54.87 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.666 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 41.1 Cg_endo -67.47 143.79 64.59 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.736 2.291 . . . . 0.0 111.568 176.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.568 HD12 HD22 ' A' ' 114' ' ' LEU . 0.5 OUTLIER -65.9 -27.3 68.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.746 -174.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.64 -28.15 56.04 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.127 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -58.32 -39.29 79.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.996 0.426 . . . . 0.0 110.954 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -100.07 -38.56 8.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.166 0.507 . . . . 0.0 111.081 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.536 ' O ' HD22 ' A' ' 89' ' ' LEU . . . -96.06 6.54 66.62 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-O 119.223 -0.765 . . . . 0.0 114.255 -170.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -39.59 -31.73 0.11 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 152' ' ' LEU . 34.6 ttpt -96.5 124.8 49.65 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 122.286 -0.259 . . . . 0.0 110.359 175.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 20.0 Cg_exo -67.92 24.3 0.13 Allowed 'Trans proline' 0 N--CA 1.477 0.547 0 C-N-CA 123.69 2.927 . . . . 0.0 113.301 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.496 ' H ' ' C ' ' A' ' 150' ' ' LYS . 34.8 tp -133.64 6.19 3.74 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.4 p -60.47 119.67 8.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.654 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.3 m -92.52 99.49 12.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.78 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 49.1 t -92.34 132.61 36.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.715 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -103.3 130.16 50.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.674 0.273 . . . . 0.0 110.746 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.834 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 26.2 ttt -85.01 97.97 10.13 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 176.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 39.2 m-80 -82.37 90.59 6.7 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.168 -173.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.535 HD11 ' HB3' ' A' ' 96' ' ' ASN . 43.6 mt -84.13 84.88 7.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.162 174.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 160' ' ' ARG . 5.1 mpt_? . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.215 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.604 ' O ' ' HD3' ' A' ' 88' ' ' PRO . 8.0 m-20 . . . . . 0 CA--C 1.519 -0.219 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -94.05 103.91 11.87 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.987 0.423 . . . . 0.0 111.638 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.604 ' HD3' ' O ' ' A' ' 86' ' ' ASP . 57.9 Cg_endo -99.54 74.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.464 2.776 . . . . 0.0 111.657 176.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.477 ' HG ' HG22 ' A' ' 91' ' ' ILE . 52.9 tp -70.72 102.65 2.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.192 0.52 . . . . 0.0 110.527 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.8 m -95.58 95.49 8.41 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.832 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.477 HG22 ' HG ' ' A' ' 89' ' ' LEU . 28.8 pt -102.92 156.83 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.412 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.7 tp -96.38 108.01 20.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.063 0.458 . . . . 0.0 110.599 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.508 ' HB ' ' CD1' ' A' ' 103' ' ' TYR . 57.8 t -100.34 118.06 46.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.925 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 22.6 ttt85 -104.85 108.62 20.21 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.476 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.54 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 3.9 p-10 -90.43 111.33 22.54 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.96 0.886 . . . . 0.0 111.687 -176.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.511 ' HB2' HD13 ' A' ' 159' ' ' LEU . 53.4 t30 69.62 -86.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 113.824 -1.535 . . . . 0.0 112.692 177.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -129.6 -72.25 0.59 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -172.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -106.48 25.72 22.2 Favored Glycine 0 N--CA 1.455 -0.095 0 C-N-CA 120.205 -0.998 . . . . 0.0 113.872 -166.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -132.85 95.74 3.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.288 0.565 . . . . 0.0 111.555 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.544 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 2.7 p -107.53 107.81 18.82 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.798 172.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.8 t -116.63 138.16 51.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.351 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.9 m -76.39 116.75 17.37 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.508 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 43.6 m-85 -104.37 148.46 26.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.978 0.418 . . . . 0.0 111.168 -177.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -102.31 110.3 22.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.016 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.4 -179.91 3.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.999 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.608 ' HB2' ' HG3' ' A' ' 109' ' ' GLN . 83.8 mtm180 -128.39 159.87 34.02 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.733 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 mp -81.27 -27.45 35.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.054 0.454 . . . . 0.0 110.13 -176.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.6 m -84.81 10.17 12.22 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.538 0.685 . . . . 0.0 110.861 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.608 ' HG3' ' HB2' ' A' ' 106' ' ' ARG . 28.3 mt-30 -95.05 143.24 26.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.641 172.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 24.9 p -79.64 156.65 27.53 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 170.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.584 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 99.3 t -59.39 -26.83 35.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.842 0.353 . . . . 0.0 110.391 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' A' ' 140' ' ' ASP . . . -58.1 -33.49 69.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.634 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -70.75 -43.11 69.53 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.473 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.56 ' HB2' HD12 ' A' ' 144' ' ' LEU . 64.6 tp -69.72 -37.27 76.47 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 112' ' ' ALA . 21.8 tptp -49.73 -51.43 38.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.82 176.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -65.19 -33.61 76.41 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.093 0.245 . . . . 0.0 111.642 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.47 -43.43 85.48 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.056 0.455 . . . . 0.0 110.177 174.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 114' ' ' LEU . 99.4 t -61.42 -42.6 94.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.627 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 53.8 m -60.69 -21.05 62.44 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.401 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -85.47 -27.21 33.43 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.669 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.7 mt -99.97 -66.49 0.9 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.133 0.492 . . . . 0.0 112.065 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.429 ' C ' ' H ' ' A' ' 124' ' ' VAL . 3.8 tp10 -100.48 8.06 43.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.655 -177.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.627 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -54.45 7.7 0.01 OUTLIER Glycine 0 CA--C 1.523 0.567 0 N-CA-C 117.186 1.634 . . . . 0.0 117.186 -172.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.429 ' H ' ' C ' ' A' ' 122' ' ' GLU . 94.1 t -31.02 95.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.852 0.861 . . . . 0.0 112.3 173.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 52.03 103.7 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 O-C-N 123.939 0.775 . . . . 0.0 110.855 -174.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.487 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 32.0 t70 -56.91 -13.05 2.31 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.74 -170.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -99.85 -16.21 18.13 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 60.6 mt -80.71 -13.79 58.69 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 121.964 -0.46 . . . . 0.0 112.026 -175.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.554 ' HB3' HD21 ' A' ' 159' ' ' LEU . 44.5 p90 -123.58 151.18 43.21 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.306 0.574 . . . . 0.0 111.934 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 4.0 p90 -149.38 158.13 43.91 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 172.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.729 ' HG ' ' HG2' ' A' ' 157' ' ' MET . 5.5 mp -105.64 135.54 46.86 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.165 -173.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 21.0 p -123.66 123.63 40.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.121 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -97.11 -69.65 0.75 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.914 0.387 . . . . 0.0 110.293 172.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -69.86 -31.63 69.57 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.724 0.773 . . . . 0.0 110.312 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 139.4 -24.57 2.78 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -169.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -84.99 151.68 57.78 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 114.478 -0.861 . . . . 0.0 109.911 172.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.86 133.32 31.01 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.825 2.35 . . . . 0.0 111.914 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 37.8 mt -67.35 120.79 14.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.052 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -73.95 120.98 20.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.385 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.584 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.1 p-10 -68.19 -16.14 63.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.283 0.563 . . . . 0.0 110.428 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -84.03 -4.08 58.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.459 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.404 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 70.0 mt -112.52 158.29 37.77 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.194 178.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 57.6 Cg_endo -72.45 148.15 47.84 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.605 2.203 . . . . 0.0 112.864 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 114' ' ' LEU . 20.5 mt -66.09 -37.17 85.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.196 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -59.66 -23.91 59.15 Favored Glycine 0 C--O 1.226 -0.396 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.788 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.482 ' HB2' ' HG2' ' A' ' 143' ' ' PRO . 2.5 tt0 -69.74 -29.58 66.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.885 0.374 . . . . 0.0 110.478 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -100.92 -38.97 7.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.292 0.568 . . . . 0.0 110.831 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.42 ' O ' HD22 ' A' ' 89' ' ' LEU . . . -98.13 7.33 62.29 Favored Glycine 0 C--O 1.227 -0.342 0 CA-C-N 115.497 -0.774 . . . . 0.0 113.859 -169.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.458 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.5 pt? -38.9 -36.09 0.25 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -103.62 133.79 20.09 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.65 -7.42 9.04 Favored 'Trans proline' 0 N--CA 1.474 0.354 0 C-N-CA 122.889 2.393 . . . . 0.0 112.422 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 92.5 mt -94.57 -0.64 54.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.984 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 62.6 m -65.14 105.08 1.0 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.037 0.446 . . . . 0.0 110.09 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.1 m -82.25 101.32 10.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.142 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.434 ' HB ' HG21 ' A' ' 93' ' ' VAL . 49.1 t -81.91 106.24 12.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.074 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -83.12 103.06 12.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.164 0.506 . . . . 0.0 110.087 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.729 ' HG2' ' HG ' ' A' ' 131' ' ' LEU . 7.6 tmm? -78.79 112.37 15.86 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.04 113.26 24.93 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -168.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.724 ' HG ' ' HE3' ' A' ' 157' ' ' MET . 54.8 mt -92.84 81.38 4.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.318 174.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 110.897 -178.098 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 CA--C 1.513 -0.451 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 62.91 78.63 0.28 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 114.151 -1.386 . . . . 0.0 112.269 175.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -81.64 91.77 1.06 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.403 2.069 . . . . 0.0 110.102 170.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.446 ' CD1' ' HA ' ' A' ' 151' ' ' PRO . 0.1 OUTLIER -75.63 114.65 14.45 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.314 -173.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.6 t -82.37 95.44 7.64 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.9 pt -95.35 154.43 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.429 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 154' ' ' THR . 37.3 tp -106.72 114.39 28.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.941 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.3 t -109.37 118.83 57.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.039 0.447 . . . . 0.0 109.896 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 -90.29 132.74 35.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.241 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -62.96 -17.49 62.05 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.966 -175.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 157' ' ' MET . 3.2 p30 -169.44 -59.61 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -169.08 -33.25 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.911 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -78.09 -76.42 0.9 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.753 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 36.4 ttt-85 -69.67 134.3 48.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.89 0.376 . . . . 0.0 110.769 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.406 ' HB3' HD13 ' A' ' 92' ' ' LEU . 14.8 m -118.64 121.94 41.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.873 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.7 t -114.73 126.0 54.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.136 0.493 . . . . 0.0 109.903 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.8 m -90.14 134.48 34.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.981 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -132.64 139.2 47.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.516 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -99.58 107.38 19.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.957 0.408 . . . . 0.0 110.769 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.483 HG13 HD11 ' A' ' 114' ' ' LEU . 21.0 m -125.82 147.55 30.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.105 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -93.75 156.77 16.5 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.52 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.646 ' HG ' ' HA3' ' A' ' 145' ' ' GLY . 8.7 mp -65.44 -13.52 58.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.007 -175.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.2 t -88.58 3.72 49.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.831 0.348 . . . . 0.0 111.36 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -93.26 148.32 22.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.134 0.493 . . . . 0.0 111.02 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.1 p -85.14 159.96 20.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.977 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.533 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 55.8 t -62.17 -33.2 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.209 0.528 . . . . 0.0 109.87 175.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.474 ' HB1' ' HB2' ' A' ' 140' ' ' ASP . . . -64.43 -34.11 77.42 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.832 178.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.463 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 1.5 t60 -67.8 -41.85 82.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.962 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.727 HD21 HD13 ' A' ' 144' ' ' LEU . 62.2 tp -62.17 -45.75 92.02 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.111 173.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -55.13 -37.82 67.41 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.014 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -68.64 -35.39 77.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.758 0.314 . . . . 0.0 110.968 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 18.5 mt-30 -66.76 -45.45 78.49 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.485 0.66 . . . . 0.0 109.336 175.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.3 t -61.06 -36.76 74.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.613 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.816 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 72.5 m -66.82 -16.64 64.42 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.032 176.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.7 -35.75 35.15 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.654 174.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.7 mp -96.18 -71.55 0.67 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.439 ' C ' ' H ' ' A' ' 124' ' ' VAL . 28.4 mm-40 -93.92 8.85 39.77 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.125 0.57 . . . . 0.0 111.109 -173.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.816 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -51.07 7.9 0.01 OUTLIER Glycine 0 N--CA 1.471 1.016 0 N-CA-C 118.09 1.996 . . . . 0.0 118.09 -170.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.439 ' H ' ' C ' ' A' ' 122' ' ' GLU . 28.1 t -54.73 82.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 118.154 0.977 . . . . 0.0 112.267 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.16 113.18 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.228 1.011 . . . . 0.0 112.348 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.521 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 1.8 p-10 -58.42 -12.89 4.31 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -173.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -72.75 -29.36 63.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.8 0.333 . . . . 0.0 110.414 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.9 mt -80.19 -39.5 29.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.903 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.521 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 25.8 p90 -109.67 105.04 14.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.946 0.879 . . . . 0.0 110.889 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -119.7 110.97 17.45 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.587 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.4 pp -92.41 152.19 19.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.075 0.464 . . . . 0.0 111.751 -172.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 13.8 p -140.71 154.82 46.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.121 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.419 ' CD2' ' HG3' ' A' ' 134' ' ' GLU . 10.3 t80 -125.0 -67.21 0.92 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.746 0.308 . . . . 0.0 110.863 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.419 ' HG3' ' CD2' ' A' ' 133' ' ' PHE . 46.3 mt-10 -77.85 3.54 14.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.08 0.467 . . . . 0.0 110.557 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.56 -24.19 27.95 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -168.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -92.99 158.21 37.88 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 114.873 -0.664 . . . . 0.0 109.551 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -76.63 -2.42 12.64 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.075 2.517 . . . . 0.0 112.051 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 58.8 mt 70.67 -171.14 0.16 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.416 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -139.82 132.97 29.68 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.533 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.0 p-10 -70.47 -21.31 62.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.765 -174.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -65.15 -30.5 71.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.033 0.444 . . . . 0.0 110.871 177.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 72.5 mt -87.4 143.61 34.52 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.643 -176.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.05 131.8 32.0 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.642 2.228 . . . . 0.0 111.772 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.727 HD13 HD21 ' A' ' 114' ' ' LEU . 4.1 tt -55.27 -35.47 65.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.336 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.646 ' HA3' ' HG ' ' A' ' 107' ' ' LEU . . . -58.83 -23.37 56.06 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.638 -177.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -66.01 -31.24 72.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.221 0.51 . . . . 0.0 110.49 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -100.06 -29.11 12.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.151 0.5 . . . . 0.0 110.809 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.401 ' O ' ' HG ' ' A' ' 89' ' ' LEU . . . -100.09 5.73 57.89 Favored Glycine 0 C--O 1.222 -0.646 0 CA-C-N 115.652 -0.704 . . . . 0.0 113.937 -172.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.45 HD21 ' N ' ' A' ' 149' ' ' LEU . 2.5 pt? -46.28 -30.47 2.05 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -176.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.839 ' HD3' ' HD2' ' A' ' 151' ' ' PRO . 17.3 tppt? -89.21 119.73 69.75 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.839 ' HD2' ' HD3' ' A' ' 150' ' ' LYS . 48.6 Cg_endo -71.06 61.52 2.46 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.527 2.818 . . . . 0.0 112.165 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.4 tp -179.9 -26.79 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.307 -172.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.6 t -45.9 130.46 9.63 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.439 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 33.6 m -110.97 128.32 55.8 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.864 -173.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.8 t -99.1 138.57 23.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.027 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -110.1 117.0 32.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.964 0.411 . . . . 0.0 111.304 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.466 ' O ' ' HA ' ' A' ' 96' ' ' ASN . 73.5 mtp -80.2 99.03 7.6 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.864 174.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -79.36 96.04 5.89 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.396 0.617 . . . . 0.0 110.442 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.35 106.1 4.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.707 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 70.9 ttp85 . . . . . 0 C--N 1.322 -0.595 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.125 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.9 t70 . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 8.0 mt-10 -95.12 110.2 48.86 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.414 -170.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 4.4 Cg_exo -80.94 -172.61 1.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.69 2.927 . . . . 0.0 112.225 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.48 HD22 ' O ' ' A' ' 148' ' ' GLY . 65.7 tp -174.07 104.0 0.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.924 -175.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.8 m -85.33 105.96 16.37 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.005 0.431 . . . . 0.0 110.855 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 28.2 pt -106.8 145.47 14.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.162 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 14.5 tp -99.86 112.75 24.99 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 64.4 t -94.23 121.04 44.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.307 0.575 . . . . 0.0 111.44 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -85.17 118.55 24.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 175.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.533 ' ND2' ' HA ' ' A' ' 99' ' ' ARG . 4.1 p30 -135.63 -156.19 0.7 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.348 -167.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -93.33 -51.01 5.19 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -68.38 -76.01 0.1 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.781 0.324 . . . . 0.0 110.962 -171.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -123.26 106.05 0.97 Allowed Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 174.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.65 ' H ' ' HD3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -78.25 59.65 2.33 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -162.563 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.9 p -169.16 59.58 0.05 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.52 0.676 . . . . 0.0 109.349 172.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.2 m -80.39 104.64 11.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.098 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 m -75.49 90.57 2.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.002 0.429 . . . . 0.0 110.094 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -82.87 117.35 22.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.907 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -86.28 101.14 12.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 173.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.4 m -121.04 -179.66 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.416 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -125.36 145.44 50.04 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.01 -12.11 52.77 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.981 -173.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.3 t -85.05 7.61 20.86 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.083 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -94.97 148.48 22.27 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.264 0.554 . . . . 0.0 111.806 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.636 ' HB ' ' OD1' ' A' ' 140' ' ' ASP . 9.4 p -82.02 166.86 19.43 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.188 170.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.09 -34.67 70.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.359 0.6 . . . . 0.0 109.688 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.53 -41.34 89.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.029 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -66.95 -15.49 63.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.937 0.399 . . . . 0.0 110.559 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.626 ' HB2' HD12 ' A' ' 144' ' ' LEU . 61.4 tp -91.89 -54.87 3.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.488 176.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -75.67 -10.01 59.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -172.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.865 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 10.4 tt0 -81.63 -31.86 32.19 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.048 0.451 . . . . 0.0 110.154 173.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -65.34 -35.78 82.04 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 172.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.23 -43.45 88.25 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.247 173.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.865 ' OG ' ' HA ' ' A' ' 116' ' ' GLN . 2.3 p -74.18 2.33 9.29 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.947 0.403 . . . . 0.0 111.69 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -92.42 -47.62 3.22 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.874 168.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.8 mt -86.71 -44.31 11.91 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.553 0.692 . . . . 0.0 111.267 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 124' ' ' VAL . 4.9 tp10 -98.29 10.55 40.42 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.227 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -29.35 6.62 0.0 OUTLIER Glycine 0 N--CA 1.486 2.003 0 N-CA-C 121.141 3.217 . . . . 0.0 121.141 -174.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' A' ' 122' ' ' GLU . 8.3 t -50.3 161.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 119.548 1.674 . . . . 0.0 109.407 169.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -42.54 136.99 2.27 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.339 0.59 . . . . 0.0 112.485 -175.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.629 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 28.2 t70 -61.01 -23.94 65.78 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.339 -172.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -89.42 -1.69 58.14 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.843 0.354 . . . . 0.0 110.873 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.492 HD11 HG11 ' A' ' 124' ' ' VAL . 74.6 mt -97.28 -28.02 14.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.64 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.629 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 42.5 p90 -103.55 113.84 27.65 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.076 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 9.7 t90 -112.07 155.47 23.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.618 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 5.5 mp -137.81 154.11 49.58 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.5 p -150.56 144.68 25.46 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.828 0.346 . . . . 0.0 111.2 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.536 ' CD2' ' HG2' ' A' ' 134' ' ' GLU . 14.8 t80 -135.31 -66.73 0.56 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.337 171.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.536 ' HG2' ' CD2' ' A' ' 133' ' ' PHE . 8.5 mm-40 -80.5 26.08 0.39 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.678 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.33 -9.35 67.47 Favored Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -173.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -124.38 162.81 40.04 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.545 ' HA ' ' O ' ' A' ' 131' ' ' LEU . 5.4 Cg_exo -74.92 4.07 5.02 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.179 2.586 . . . . 0.0 113.072 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 74.6 mt 73.8 142.22 0.07 Allowed 'General case' 0 N--CA 1.464 0.229 0 O-C-N 124.045 0.84 . . . . 0.0 110.996 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -85.52 124.18 31.79 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.35 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.636 ' OD1' ' HB ' ' A' ' 110' ' ' THR . 29.8 t70 -65.61 -22.14 66.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.343 0.592 . . . . 0.0 110.365 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -60.04 -26.91 66.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.504 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 87.8 mt -103.56 144.91 29.62 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.589 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.47 147.23 64.28 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.64 2.226 . . . . 0.0 112.027 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' A' ' 114' ' ' LEU . 76.6 mt -57.32 -33.19 67.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.659 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -56.23 -27.7 53.06 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.255 -0.498 . . . . 0.0 113.302 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.17 -43.92 83.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.097 0.475 . . . . 0.0 110.304 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -100.73 -28.53 12.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.811 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.48 ' O ' HD22 ' A' ' 89' ' ' LEU . . . -96.41 5.76 65.24 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.517 -174.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.44 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.5 pt? -47.83 -27.7 2.21 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -91.13 110.23 40.88 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.442 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 16.9 Cg_exo -67.2 81.02 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.854 2.37 . . . . 0.0 111.913 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 151' ' ' PRO . 6.3 mt 162.86 -19.62 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.801 1.24 . . . . 0.0 109.683 -175.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.8 t -52.72 127.11 22.09 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.182 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.8 m -96.46 118.27 32.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.323 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.9 t -86.22 118.48 32.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.419 176.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -88.79 99.25 12.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.045 0.45 . . . . 0.0 110.751 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.435 ' HE3' ' HG2' ' A' ' 122' ' ' GLU . 24.6 ttt -80.08 98.66 7.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.303 0.573 . . . . 0.0 109.52 177.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.87 91.44 8.61 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.885 -177.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.4 tt -67.46 118.66 11.09 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 . . . . . 0 C--N 1.322 -0.595 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.653 -176.914 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 N--CA 1.463 0.184 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 59.29 70.69 1.06 Allowed Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.857 174.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -79.22 118.13 3.94 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.425 2.083 . . . . 0.0 112.23 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.495 HD11 ' HA ' ' A' ' 151' ' ' PRO . 29.1 tp -106.25 111.4 23.98 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.148 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.0 t -91.19 86.68 6.25 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.92 0.39 . . . . 0.0 110.301 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.5 pt -91.23 169.19 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.861 -176.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.512 HD11 ' HB2' ' A' ' 100' ' ' SER . 42.7 tp -108.54 106.12 16.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.042 0.448 . . . . 0.0 110.585 -177.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.0 t -97.69 116.0 39.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.5 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 71.6 mtp180 -96.99 157.86 15.7 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.013 0.435 . . . . 0.0 111.099 -177.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -77.18 -175.23 3.54 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.121 174.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -71.77 84.79 0.92 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.187 0.518 . . . . 0.0 109.852 177.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.442 ' HE2' ' HB3' ' A' ' 97' ' ' LYS . 32.0 mtpt 61.01 22.87 13.08 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.611 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -116.42 -118.57 3.06 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.512 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 42.4 mtp-105 -70.26 -179.84 2.14 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.343 0.592 . . . . 0.0 111.796 -177.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 20.5 p -144.79 120.67 10.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.249 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.2 t -115.37 128.58 56.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.173 0.511 . . . . 0.0 110.196 -177.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.1 m -87.54 107.86 18.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.475 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -101.05 141.62 33.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.059 0.457 . . . . 0.0 111.901 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -83.85 102.37 12.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.243 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.6 m -114.66 -179.86 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 176.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.598 ' HB2' ' HG3' ' A' ' 109' ' ' GLN . 77.0 mtt85 -140.84 146.61 37.79 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.424 ' N ' HD12 ' A' ' 107' ' ' LEU . 7.0 mp -64.83 -31.16 72.26 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.267 0.354 . . . . 0.0 111.404 -173.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 m -75.97 -19.23 58.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.151 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.598 ' HG3' ' HB2' ' A' ' 106' ' ' ARG . 25.2 mt-30 -74.22 133.06 42.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.652 0.263 . . . . 0.0 110.39 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.738 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 23.2 p -71.3 159.26 34.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.302 174.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.602 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 59.2 t -60.59 -28.7 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.0 0.429 . . . . 0.0 110.462 177.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.94 -35.43 74.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.104 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.436 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 31.1 m80 -66.61 -42.89 86.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.446 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.838 ' HB2' HD13 ' A' ' 144' ' ' LEU . 60.6 tp -62.26 -44.98 95.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.46 175.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -62.01 -32.26 72.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.722 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 47.1 mt-30 -81.03 -21.09 40.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 0.0 111.59 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 46.5 mt-30 -73.58 -47.78 37.88 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 170.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 81.1 t -61.07 -40.65 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.085 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.929 ' HA ' ' HA3' ' A' ' 123' ' ' GLY . 91.6 p -65.5 -34.18 77.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.916 0.388 . . . . 0.0 110.406 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.29 -27.49 72.49 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.207 175.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 37.3 mt -98.72 -76.29 0.54 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 111.77 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.456 ' C ' ' H ' ' A' ' 124' ' ' VAL . 6.1 tp10 -102.21 8.18 40.63 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.228 0.611 . . . . 0.0 111.621 -174.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.929 ' HA3' ' HA ' ' A' ' 119' ' ' SER . . . -53.36 7.37 0.01 OUTLIER Glycine 0 CA--C 1.525 0.715 0 N-CA-C 117.213 1.645 . . . . 0.0 117.213 -172.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.456 ' H ' ' C ' ' A' ' 122' ' ' GLU . 87.1 t -38.02 97.39 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 123.623 0.769 . . . . 0.0 112.414 175.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.431 ' C ' ' H ' ' A' ' 127' ' ' ASP . 13.0 mt-30 48.08 102.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 O-C-N 124.087 0.867 . . . . 0.0 112.263 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.516 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 12.1 p-10 -71.67 17.87 0.08 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -174.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 125' ' ' GLN . 16.3 t70 -100.24 -21.54 15.45 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 171.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.0 mt -82.2 -16.41 49.77 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.914 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.516 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 25.8 p90 -143.32 159.9 41.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.666 0.269 . . . . 0.0 111.015 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -163.44 155.51 17.67 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.495 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 6.9 mp -106.81 146.95 30.29 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.44 -174.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 13.3 p -138.75 143.17 38.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.145 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.431 ' CD2' ' HB2' ' A' ' 134' ' ' GLU . 20.9 t80 -111.49 -74.62 0.63 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.131 0.491 . . . . 0.0 110.962 176.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.431 ' HB2' ' CD2' ' A' ' 133' ' ' PHE . 28.7 tt0 -93.51 14.55 18.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.41 0.624 . . . . 0.0 110.091 -173.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 102.51 -19.02 49.39 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 -169.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 137' ' ' PRO . 59.7 mttp -73.89 134.95 77.73 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 115.036 -0.582 . . . . 0.0 109.681 174.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 3.3 Cg_exo -77.31 4.66 5.69 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.994 2.463 . . . . 0.0 111.454 175.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 39.8 mt 69.98 -176.39 0.2 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.725 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.479 ' OE2' ' HG ' ' A' ' 142' ' ' LEU . 36.4 tt0 -145.33 121.1 10.55 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 174.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.602 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 1.2 p-10 -63.8 -22.08 66.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.35 0.595 . . . . 0.0 110.674 -175.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -74.69 -27.29 60.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.351 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.479 ' HG ' ' OE2' ' A' ' 139' ' ' GLU . 68.1 mt -94.15 157.05 38.31 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.837 0.351 . . . . 0.0 111.324 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.738 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 10.1 Cg_exo -72.67 151.42 52.11 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.071 2.514 . . . . 0.0 112.566 177.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.838 HD13 ' HB2' ' A' ' 114' ' ' LEU . 43.3 mt -66.67 -32.78 74.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.58 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.537 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -53.83 -34.88 51.88 Favored Glycine 0 C--N 1.332 0.326 0 O-C-N 123.314 0.384 . . . . 0.0 113.133 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -61.0 -33.11 72.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.871 0.367 . . . . 0.0 111.544 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -101.09 -42.07 6.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.723 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -100.13 6.95 58.39 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-O 119.358 -0.69 . . . . 0.0 114.349 -168.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.537 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.6 pt? -43.45 -29.0 0.4 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -175.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 153' ' ' SER . 40.6 tptt -67.82 125.09 90.89 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.495 ' HA ' HD11 ' A' ' 89' ' ' LEU . 52.9 Cg_exo -56.13 -19.24 26.19 Favored 'Trans proline' 0 N--CA 1.478 0.604 0 C-N-CA 123.45 2.767 . . . . 0.0 114.09 -173.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 152' ' ' LEU . 1.5 pt? -132.8 34.21 3.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.228 0.537 . . . . 0.0 109.815 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.617 ' HB3' ' HB3' ' A' ' 150' ' ' LYS . 34.7 p -60.69 139.42 57.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.48 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.7 m -100.86 101.88 12.81 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.013 0.435 . . . . 0.0 111.11 -176.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.3 t -94.56 132.26 39.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -103.1 120.54 40.86 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.0 0.428 . . . . 0.0 111.027 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.495 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 1.7 tmt? -83.5 103.27 12.71 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -98.19 145.16 26.89 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.293 -172.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 95.3 mt -102.39 156.9 17.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.644 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 . . . . . 0 C--N 1.326 -0.42 0 O-C-N 123.94 0.775 . . . . 0.0 112.371 -174.421 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.616 ' O ' ' HD3' ' A' ' 88' ' ' PRO . 6.7 p-10 . . . . . 0 CA--C 1.523 -0.09 0 CA-C-O 120.792 0.329 . . . . 0.0 110.493 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.617 ' O ' ' HG2' ' A' ' 106' ' ' ARG . 1.8 pm0 -107.52 90.57 6.13 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 121.202 0.525 . . . . 0.0 111.262 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.616 ' HD3' ' O ' ' A' ' 86' ' ' ASP . 4.7 Cg_exo -79.38 100.84 1.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.509 2.139 . . . . 0.0 111.485 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.3 tp -114.11 100.51 8.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.087 0.47 . . . . 0.0 110.003 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.5 t -92.84 107.31 19.12 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.617 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.7 pt -105.03 151.8 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.279 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.522 HD13 ' HB2' ' A' ' 100' ' ' SER . 19.8 tp -95.84 112.29 24.06 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.203 0.525 . . . . 0.0 111.751 -172.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.7 124.09 62.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.684 175.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -99.44 121.61 41.37 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -62.43 -21.59 65.53 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.522 0.514 . . . . 0.0 112.238 -172.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -173.76 -66.58 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -163.32 11.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.992 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -129.8 -68.14 0.11 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.041 -1.076 . . . . 0.0 111.956 -177.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -69.39 116.79 10.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.211 0.529 . . . . 0.0 111.159 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.522 ' HB2' HD13 ' A' ' 92' ' ' LEU . 15.4 p -103.98 84.02 2.19 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.712 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.1 m -94.96 118.12 31.27 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.58 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.9 t -88.49 113.29 23.93 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.59 0.71 . . . . 0.0 109.643 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -90.15 132.02 35.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.622 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -80.59 99.93 8.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.263 0.554 . . . . 0.0 109.937 177.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 29.7 m -113.3 179.24 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.53 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.617 ' HG2' ' O ' ' A' ' 87' ' ' GLU . 80.9 mtt85 -139.13 146.62 40.86 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -177.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.4 mp -69.83 -31.85 69.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.36 -172.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 33.8 m -63.43 -28.07 69.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.337 0.589 . . . . 0.0 110.246 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.545 ' NE2' HD12 ' A' ' 144' ' ' LEU . 4.1 tt0 -79.2 141.01 37.54 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.518 -177.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.815 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 39.0 p -82.8 167.37 18.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.563 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.58 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 54.1 t -64.85 -23.59 33.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.1 176.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.24 -37.44 67.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.946 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.591 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 7.4 t-160 -66.07 -41.54 90.61 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.79 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.691 ' HB2' HD13 ' A' ' 144' ' ' LEU . 46.7 tp -65.4 -42.84 92.14 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -51.46 -50.36 59.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.403 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.762 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 77.9 mt-30 -75.85 -26.92 57.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.183 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.591 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 48.7 mt-30 -64.24 -50.2 68.94 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 174.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.2 t -63.49 -43.42 98.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.065 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.912 ' HA ' ' HA3' ' A' ' 123' ' ' GLY . 60.6 p -66.15 -23.66 66.52 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.89 0.376 . . . . 0.0 111.153 -176.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.34 -43.0 32.87 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.926 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.9 mt -85.66 -72.66 0.48 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.132 0.492 . . . . 0.0 111.55 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.401 ' C ' ' H ' ' A' ' 124' ' ' VAL . 4.2 tp10 -100.36 6.8 44.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.503 -174.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.912 ' HA3' ' HA ' ' A' ' 119' ' ' SER . . . -63.74 6.92 0.51 Allowed Glycine 0 C--O 1.227 -0.29 0 CA-C-O 118.996 -0.891 . . . . 0.0 115.314 -172.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.492 HG12 HD13 ' A' ' 128' ' ' LEU . 63.6 t -35.24 92.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 123.934 0.894 . . . . 0.0 112.124 175.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 47.51 106.08 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 O-C-N 124.003 0.814 . . . . 0.0 111.046 -171.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.613 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 6.8 p-10 -61.9 -0.94 0.54 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -170.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -100.89 -7.12 23.79 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 176.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.492 HD13 HG12 ' A' ' 124' ' ' VAL . 85.9 mt -83.77 -12.44 55.7 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-O 120.88 0.371 . . . . 0.0 110.684 177.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.613 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 51.9 p90 -128.76 147.24 50.76 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 173.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.649 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 36.9 t90 -133.96 90.12 2.66 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.54 0.686 . . . . 0.0 110.029 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.512 ' CB ' ' HA ' ' A' ' 157' ' ' MET . 2.6 pt? -90.16 149.54 22.39 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.6 t -160.9 163.53 31.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.353 0.597 . . . . 0.0 111.15 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.417 ' HB3' HD21 ' A' ' 138' ' ' LEU . 6.9 t80 -142.3 -54.56 0.43 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.95 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -88.0 6.65 34.95 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.117 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.62 -22.56 39.94 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 -171.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 138' ' ' LEU . 61.9 mttp -101.48 152.47 38.02 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 131' ' ' LEU . 62.3 Cg_endo -73.32 22.44 0.33 Allowed 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.653 2.235 . . . . 0.0 112.759 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.503 ' HB3' HG12 ' A' ' 111' ' ' VAL . 42.5 mt 68.36 117.13 0.03 OUTLIER 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.899 0.88 . . . . 0.0 110.981 -178.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -83.23 121.92 27.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.094 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.58 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 2.5 p-10 -69.78 -18.07 63.46 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.179 -174.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -70.0 -24.71 63.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.508 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.4 mt -95.19 156.93 37.23 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.708 -176.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.815 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 71.7 Cg_endo -77.17 153.77 32.13 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.631 2.22 . . . . 0.0 111.764 176.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.691 HD13 ' HB2' ' A' ' 114' ' ' LEU . 10.7 mt -71.25 -22.62 61.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.534 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -58.22 -30.99 64.98 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.55 177.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -66.53 -35.61 80.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.19 0.519 . . . . 0.0 110.856 -177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -95.53 -40.73 9.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.318 0.58 . . . . 0.0 111.081 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -97.54 6.76 63.2 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.232 -0.895 . . . . 0.0 114.156 -168.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -42.06 -32.49 0.46 Allowed 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 117.494 0.647 . . . . 0.0 112.55 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -90.93 123.7 64.04 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 173.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.62 -9.46 18.42 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.752 2.301 . . . . 0.0 112.31 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.8 pp -105.26 8.55 33.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.076 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 33.6 p -63.49 118.17 7.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.092 0.473 . . . . 0.0 109.976 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 9.9 m -98.93 106.11 18.34 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.966 -177.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 53.9 t -86.71 120.83 36.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.35 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.21 108.41 20.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.122 0.487 . . . . 0.0 110.752 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.512 ' HA ' ' CB ' ' A' ' 131' ' ' LEU . 27.5 ttt -85.37 100.89 12.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.564 176.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.649 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 43.1 m-80 -86.27 135.49 33.53 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.683 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 67.1 mt -97.78 20.58 11.79 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.176 0.512 . . . . 0.0 110.731 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.229 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.5 t70 . . . . . 0 N--CA 1.469 0.492 0 CA-C-O 121.397 0.618 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 11.6 tp10 -116.84 107.97 45.33 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.652 -177.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 1.7 Cg_endo -82.48 114.14 2.38 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.207 2.605 . . . . 0.0 111.184 175.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.448 HD22 HD22 ' A' ' 107' ' ' LEU . 46.5 tp -78.08 114.97 17.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.271 0.558 . . . . 0.0 111.121 -174.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.8 p -94.35 98.63 11.03 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.591 176.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.2 pt -91.02 174.04 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.449 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.505 HD11 ' HB3' ' A' ' 100' ' ' SER . 1.3 tm? -118.6 112.93 20.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.878 0.371 . . . . 0.0 110.357 -176.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.8 t -103.16 127.35 57.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.887 175.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -98.58 108.53 21.25 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.552 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 36.0 p30 -84.79 174.34 9.95 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.535 -175.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.467 ' OD1' ' HB2' ' A' ' 159' ' ' LEU . 9.8 m-80 -62.02 -24.19 66.91 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.155 0.503 . . . . 0.0 111.226 -175.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -90.39 8.19 34.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.922 -171.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.98 9.62 86.03 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 116.014 -0.539 . . . . 0.0 113.139 174.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -92.3 138.72 31.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.967 0.413 . . . . 0.0 111.034 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.505 ' HB3' HD11 ' A' ' 92' ' ' LEU . 17.6 m -90.2 94.36 9.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.426 175.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.2 p -90.1 111.16 22.2 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.995 0.426 . . . . 0.0 110.612 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.7 m -78.66 114.26 17.43 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.283 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -99.99 120.36 39.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.011 0.434 . . . . 0.0 111.348 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -85.01 103.2 13.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.501 176.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.41 176.36 9.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.205 0.526 . . . . 0.0 111.579 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -115.24 156.61 25.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.785 174.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.474 HD21 ' HA2' ' A' ' 145' ' ' GLY . 80.4 mt -65.88 -29.37 69.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.978 0.418 . . . . 0.0 111.112 -177.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 p -97.53 21.94 9.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.359 -175.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.511 ' HB3' ' HB3' ' A' ' 113' ' ' HIS . 13.4 mt-30 -77.47 -30.2 53.05 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.108 176.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 m 72.91 157.78 0.19 Allowed 'General case' 0 C--O 1.236 0.388 0 O-C-N 123.899 0.75 . . . . 0.0 109.965 -175.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.2 t -54.71 -38.81 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 0.0 110.578 -178.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -47.63 -48.06 28.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.657 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 109' ' ' GLN . 13.2 t-80 -77.69 -7.92 57.17 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.42 -172.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 54.1 tp -100.44 -51.04 3.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.068 0.461 . . . . 0.0 110.347 175.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.412 ' HE2' ' CZ ' ' A' ' 129' ' ' PHE . 3.3 tmtp? -59.02 -48.1 82.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.411 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.569 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 19.7 mm-40 -69.36 -18.28 63.77 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -174.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -70.67 -48.93 52.29 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.2 t -62.52 -36.74 76.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.224 175.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.723 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 55.3 m -62.05 -25.84 67.91 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.17 175.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.07 -35.46 53.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.843 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.7 mt -92.39 -71.89 0.62 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.909 0.385 . . . . 0.0 111.984 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 124' ' ' VAL . 48.0 mt-10 -99.98 9.3 43.13 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.855 0.462 . . . . 0.0 110.797 -174.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.723 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -46.93 7.79 0.01 OUTLIER Glycine 0 N--CA 1.47 0.901 0 N-CA-C 118.719 2.248 . . . . 0.0 118.719 -172.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 122' ' ' GLU . 80.7 t -37.75 100.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 118.446 1.123 . . . . 0.0 112.024 173.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.501 ' HB3' ' HG ' ' A' ' 128' ' ' LEU . 4.0 mm-40 55.81 106.18 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.122 0 O-C-N 123.916 0.76 . . . . 0.0 112.653 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -52.84 -24.54 9.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.023 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.27 -5.83 39.32 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -173.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.501 ' HG ' ' HB3' ' A' ' 125' ' ' GLN . 74.3 mt -89.37 -52.42 5.05 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.984 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.492 ' CE1' ' HA2' ' A' ' 123' ' ' GLY . 13.7 p90 -94.98 126.61 40.43 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.405 0.621 . . . . 0.0 110.155 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.617 ' HZ2' ' H ' ' A' ' 138' ' ' LEU . 9.4 t-105 -144.79 133.58 22.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.278 -178.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.799 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 4.9 mp -105.43 139.34 40.2 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.102 -174.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.528 HG23 ' HA ' ' A' ' 137' ' ' PRO . 45.8 p -132.91 140.7 48.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.31 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.493 ' CD2' ' HG3' ' A' ' 134' ' ' GLU . 11.1 t80 -87.83 -69.94 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.598 0.237 . . . . 0.0 111.462 -178.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.493 ' HG3' ' CD2' ' A' ' 133' ' ' PHE . 37.5 mt-10 -74.7 12.58 0.79 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.01 -177.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 133' ' ' PHE . . . 80.41 2.94 89.86 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -166.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -112.87 147.93 38.26 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 114.867 -0.666 . . . . 0.0 109.574 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.528 ' HA ' HG23 ' A' ' 132' ' ' THR . 59.3 Cg_endo -69.71 146.03 59.27 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.468 2.112 . . . . 0.0 111.916 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.617 ' H ' ' HZ2' ' A' ' 130' ' ' TRP . 70.5 mt -105.05 149.15 26.05 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.78 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.85 144.19 43.91 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -65.49 -25.0 67.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.079 0.466 . . . . 0.0 110.625 -177.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -64.57 -21.85 66.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.856 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 69.4 mt -96.18 131.54 28.54 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.268 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.567 ' HG2' ' HB2' ' A' ' 146' ' ' GLU . 29.2 Cg_endo -63.09 131.27 31.84 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.356 2.037 . . . . 0.0 111.592 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.425 ' HA ' ' CE1' ' A' ' 147' ' ' TYR . 6.9 tt -57.51 -35.94 70.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.577 -175.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -66.38 -24.84 72.39 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.04 -0.6 . . . . 0.0 113.723 -178.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.567 ' HB2' ' HG2' ' A' ' 143' ' ' PRO . 35.7 tt0 -61.59 -41.86 98.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.122 0.461 . . . . 0.0 111.231 -175.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.425 ' CE1' ' HA ' ' A' ' 144' ' ' LEU . 0.9 OUTLIER -100.62 -32.59 10.68 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.682 178.526 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -92.22 5.62 78.23 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 121.127 -0.559 . . . . 0.0 114.13 -172.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.506 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.4 pt? -53.33 -24.29 11.54 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -76.34 132.02 73.84 Favored Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.248 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.28 -14.77 44.06 Favored 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.407 2.071 . . . . 0.0 111.962 -178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.1 pp -112.05 14.66 20.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.739 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 77.8 p -62.87 104.78 0.58 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 5.7 m -88.3 104.31 16.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.239 -172.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.47 HG13 ' HB3' ' A' ' 131' ' ' LEU . 43.4 t -88.59 115.3 28.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.405 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -88.07 120.98 29.94 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.435 0.636 . . . . 0.0 111.198 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.799 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 26.9 ttt -76.61 103.7 6.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.55 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 0.9 OUTLIER -92.9 142.56 27.17 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.512 -178.052 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.467 ' HB2' ' OD1' ' A' ' 96' ' ' ASN . 2.1 tt -114.59 110.64 20.11 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 . . . . . 0 C--N 1.32 -0.716 0 CA-C-O 121.103 0.477 . . . . 0.0 111.196 -175.786 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.535 ' O ' ' HD3' ' A' ' 88' ' ' PRO . 11.6 p-10 . . . . . 0 N--CA 1.46 0.059 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -111.84 84.83 5.76 Favored Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.44 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 86' ' ' ASP . 74.7 Cg_endo -99.09 168.98 0.54 Allowed 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 123.273 2.649 . . . . 0.0 111.742 173.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 148' ' ' GLY . 23.2 tp -124.81 113.59 18.11 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.456 0.646 . . . . 0.0 110.019 176.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.2 t -93.63 111.7 23.43 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.808 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.4 pt -115.25 162.21 13.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.9 0.381 . . . . 0.0 110.716 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.434 HD12 ' HB3' ' A' ' 100' ' ' SER . 47.3 tp -110.79 104.03 12.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.116 0.484 . . . . 0.0 110.511 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.514 HG23 ' HB ' ' A' ' 155' ' ' VAL . 96.1 t -100.69 115.8 42.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.789 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -104.39 154.45 19.84 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.953 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -104.52 165.8 10.82 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 175.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -70.1 -5.18 25.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.791 -175.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.631 ' HB3' ' HZ3' ' A' ' 97' ' ' LYS . 4.9 mtpm? -89.69 -14.53 34.56 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.823 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.99 -28.09 6.23 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.398 175.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -69.73 142.27 53.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.161 0.505 . . . . 0.0 111.803 -175.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.434 ' HB3' HD12 ' A' ' 92' ' ' LEU . 3.4 m -112.28 131.11 55.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.971 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.0 t -124.93 130.31 52.12 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.961 0.41 . . . . 0.0 110.131 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.5 m -92.11 107.19 19.03 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.282 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.464 ' CE1' ' HB ' ' A' ' 93' ' ' VAL . 32.8 m-85 -94.65 132.59 39.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.273 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -104.19 99.9 9.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.343 0.592 . . . . 0.0 109.621 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.402 HG11 HD13 ' A' ' 114' ' ' LEU . 34.8 m -115.33 -179.78 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.819 -174.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -119.15 151.39 38.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.952 175.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.64 -13.42 62.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.234 -175.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.9 m -74.86 -13.89 60.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.203 0.525 . . . . 0.0 110.844 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -85.12 144.3 28.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.734 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.4 p -94.23 175.6 6.64 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.6 t -55.23 -41.31 60.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.9 -42.91 90.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.903 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -69.67 -24.61 63.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.857 -172.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.569 HD22 HD12 ' A' ' 144' ' ' LEU . 57.3 tp -88.23 -43.41 11.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.981 0.42 . . . . 0.0 110.054 172.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -60.67 -42.44 97.04 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.662 -177.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -58.6 -35.21 72.07 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.274 0.359 . . . . 0.0 111.107 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -63.59 -48.3 77.93 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.446 0.641 . . . . 0.0 109.541 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.486 HG11 ' SD ' ' A' ' 157' ' ' MET . 45.0 t -61.81 -41.17 89.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.596 176.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.625 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 50.9 m -59.82 -21.43 60.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.431 177.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.99 -37.15 16.54 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.419 -0.895 . . . . 0.0 112.256 175.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 80.8 mt -92.11 -66.26 0.94 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.214 0.531 . . . . 0.0 112.068 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.432 ' C ' ' H ' ' A' ' 124' ' ' VAL . 2.7 tp10 -100.49 8.27 43.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.945 -175.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.625 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -53.83 7.5 0.01 OUTLIER Glycine 0 CA--C 1.522 0.492 0 N-CA-C 117.547 1.779 . . . . 0.0 117.547 -170.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.432 ' H ' ' C ' ' A' ' 122' ' ' GLU . 58.4 t -29.87 94.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.07 0.948 . . . . 0.0 112.376 176.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.492 ' HB3' ' HG ' ' A' ' 128' ' ' LEU . 8.9 tt0 48.63 109.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 O-C-N 124.063 0.852 . . . . 0.0 111.314 -171.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -54.59 -19.07 5.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.02 -175.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.449 ' O ' ' HD3' ' A' ' 160' ' ' ARG . 0.7 OUTLIER -95.53 -6.53 40.29 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -177.753 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.492 ' HG ' ' HB3' ' A' ' 125' ' ' GLN . 66.4 mt -82.11 -26.65 33.39 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.174 0.443 . . . . 0.0 111.066 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.413 ' CE1' ' HA2' ' A' ' 123' ' ' GLY . 16.1 p90 -120.1 125.44 48.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.352 0.596 . . . . 0.0 111.046 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 21.6 t-105 -132.62 130.11 39.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.844 175.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.404 ' CB ' ' HA ' ' A' ' 157' ' ' MET . 2.6 pt? -106.08 138.16 42.76 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.966 0.412 . . . . 0.0 110.399 -173.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.545 HG23 ' HA ' ' A' ' 137' ' ' PRO . 49.6 p -134.76 146.25 49.2 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.865 -175.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.518 ' HB3' HD23 ' A' ' 138' ' ' LEU . 32.7 t80 -108.18 139.28 43.09 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.458 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 29.2 tt0 72.19 -29.4 0.2 Allowed 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.727 0.642 . . . . 0.0 111.766 174.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 133' ' ' PHE . . . 130.13 6.19 4.03 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -173.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -117.12 147.69 40.81 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-O 120.509 0.195 . . . . 0.0 110.538 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.545 ' HA ' HG23 ' A' ' 132' ' ' THR . 93.0 Cg_endo -74.87 142.78 28.71 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.187 1.925 . . . . 0.0 110.661 172.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.518 HD23 ' HB3' ' A' ' 133' ' ' PHE . 33.0 mt -95.51 141.1 29.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.623 -170.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.515 ' OE2' ' HB3' ' A' ' 141' ' ' GLN . 33.0 tt0 -86.31 132.3 34.01 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.51 -28.27 61.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.736 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.515 ' HB3' ' OE2' ' A' ' 139' ' ' GLU . 1.1 tm0? -59.29 -44.17 92.52 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.1 mt -74.59 139.84 74.73 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.089 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.76 154.18 73.95 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.505 2.137 . . . . 0.0 112.32 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.569 HD12 HD22 ' A' ' 114' ' ' LEU . 5.7 tt -58.92 -37.05 75.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.234 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.55 -20.46 56.0 Favored Glycine 0 C--O 1.227 -0.282 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.845 -178.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -67.42 -31.15 71.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.268 0.556 . . . . 0.0 110.108 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.459 ' CD1' HD22 ' A' ' 138' ' ' LEU . 16.2 m-85 -100.21 -29.67 12.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.068 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.52 ' O ' HD22 ' A' ' 89' ' ' LEU . . . -94.62 5.78 70.24 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.489 -175.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -49.9 -21.59 1.22 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.525 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 55.8 mttp -86.91 120.7 71.75 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 172.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -59.12 -0.79 0.67 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.959 2.439 . . . . 0.0 112.746 174.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.449 ' H ' ' C ' ' A' ' 150' ' ' LYS . 1.9 pp -128.61 17.51 6.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.712 176.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.525 ' OG ' ' HB2' ' A' ' 150' ' ' LYS . 14.2 m -52.02 108.12 0.26 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.883 0.373 . . . . 0.0 110.69 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.6 m -80.99 90.71 5.98 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.278 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.514 ' HB ' HG23 ' A' ' 93' ' ' VAL . 45.3 t -91.23 114.47 28.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.347 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -90.25 109.6 20.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.366 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.486 ' SD ' HG11 ' A' ' 118' ' ' VAL . 59.4 ttp -77.17 92.89 3.85 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -87.37 114.53 24.06 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.088 -170.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.85 125.24 26.15 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 165.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.449 ' HD3' ' O ' ' A' ' 127' ' ' ASP . 84.0 mtp180 . . . . . 0 C--N 1.32 -0.714 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -170.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 C--O 1.233 0.201 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 65.3 81.04 0.22 Allowed Pre-proline 0 C--O 1.234 0.274 0 CA-C-O 121.105 0.479 . . . . 0.0 110.274 -176.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.28 158.28 12.98 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.069 2.513 . . . . 0.0 112.491 -178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.535 HD22 ' O ' ' A' ' 148' ' ' GLY . 63.3 tp -91.28 100.73 13.48 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.486 ' HB3' HG22 ' A' ' 102' ' ' THR . 47.3 m -83.87 111.88 19.62 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.557 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 39.2 pt -102.03 151.81 5.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.982 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.507 HD13 ' HB2' ' A' ' 100' ' ' SER . 18.0 tp -101.02 105.18 16.36 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.107 0.479 . . . . 0.0 110.874 -174.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.471 HG22 ' HB ' ' A' ' 155' ' ' VAL . 58.9 t -104.72 126.8 59.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.056 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 100' ' ' SER . 20.0 mtp180 -109.67 128.63 55.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.649 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.548 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 6.0 p30 -72.99 105.88 4.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.12 177.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 64.52 -77.16 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.396 -174.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -158.8 5.23 0.1 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.105 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -91.0 -83.04 1.42 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.304 -0.951 . . . . 0.0 113.776 -167.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -93.3 129.23 39.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.984 0.421 . . . . 0.0 111.064 -172.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.511 ' HA ' ' HG2' ' A' ' 94' ' ' ARG . 3.0 p -87.9 100.35 12.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.387 176.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 m -101.61 119.99 39.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.432 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.486 HG22 ' HB3' ' A' ' 90' ' ' SER . 0.2 OUTLIER -82.13 103.78 11.99 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.478 -179.145 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -94.38 127.88 40.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.194 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -88.0 131.14 34.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.634 0.73 . . . . 0.0 110.963 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 29.7 m -147.85 -178.42 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.257 -177.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -140.51 166.71 23.97 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 174.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.1 mp -78.14 -5.6 52.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.026 0.441 . . . . 0.0 110.155 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.73 -3.23 56.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.775 -176.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.61 178.32 4.33 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.804 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 p -110.22 167.92 9.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.981 0.42 . . . . 0.0 112.091 -174.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.9 t -58.69 -30.92 43.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.64 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.0 -43.21 60.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.917 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.442 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 24.7 t60 -74.44 -14.56 60.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.723 0.297 . . . . 0.0 111.321 -174.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.768 ' HB2' HD11 ' A' ' 144' ' ' LEU . 59.0 tp -87.63 -48.02 8.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.449 0.642 . . . . 0.0 109.274 174.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.408 ' HZ1' ' CG ' ' A' ' 126' ' ' ASP . 62.2 tttp -59.34 -43.07 92.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.68 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.415 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 63.6 tt0 -63.41 -31.52 72.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.321 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 47.7 mt-30 -63.78 -44.28 93.85 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.106 0.479 . . . . 0.0 109.865 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.5 t -66.16 -45.19 90.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.93 175.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.415 ' HB2' ' HA ' ' A' ' 116' ' ' GLN . 67.5 m -66.63 -8.0 24.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.775 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -100.3 -36.44 4.11 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.94 177.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.7 mt -94.84 -44.32 7.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.513 0.673 . . . . 0.0 110.942 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 124' ' ' VAL . 10.0 tp10 -100.12 11.11 40.14 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.234 -178.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -29.18 7.31 0.0 OUTLIER Glycine 0 N--CA 1.488 2.118 0 N-CA-C 121.104 3.202 . . . . 0.0 121.104 -172.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 122' ' ' GLU . 17.6 t -46.65 164.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 119.758 1.779 . . . . 0.0 109.798 167.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.433 ' HB2' ' CD1' ' A' ' 128' ' ' LEU . 76.1 mt-30 -35.24 118.58 0.46 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.542 0.687 . . . . 0.0 111.95 -176.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.408 ' CG ' ' HZ1' ' A' ' 115' ' ' LYS . 12.9 t70 -58.11 -29.56 65.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.828 -167.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -100.47 14.43 31.25 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.433 ' CD1' ' HB2' ' A' ' 125' ' ' GLN . 59.9 mt -91.14 -16.63 27.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.903 0.382 . . . . 0.0 110.788 174.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -121.75 145.76 47.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.537 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.43 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 7.2 t-105 -147.68 129.6 15.32 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 173.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.526 ' HB3' ' HA ' ' A' ' 157' ' ' MET . 1.1 pt? -111.48 134.5 53.02 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.065 0.46 . . . . 0.0 110.698 -173.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.549 HG23 ' HA ' ' A' ' 137' ' ' PRO . 46.2 p -135.29 131.52 36.61 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.823 -177.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . 14.8 t80 -70.89 -65.38 0.74 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.306 0.574 . . . . 0.0 111.078 179.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -92.77 1.43 57.28 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.232 -173.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.21 -10.13 69.7 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -164.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.48 ' HD2' ' HE1' ' A' ' 147' ' ' TYR . 17.3 ttmm -81.59 127.62 72.39 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 113.908 -1.146 . . . . 0.0 108.446 175.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.549 ' HA ' HG23 ' A' ' 132' ' ' THR . 82.1 Cg_endo -73.63 131.76 16.45 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.123 1.882 . . . . 0.0 111.862 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.4 mt -77.29 119.34 20.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.604 -174.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -97.74 134.43 40.92 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.486 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.15 -17.22 64.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.384 0.612 . . . . 0.0 111.03 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -58.14 -27.32 63.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.308 172.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.41 HD13 ' HH ' ' A' ' 147' ' ' TYR . 56.6 mt -109.72 145.24 31.57 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.661 -176.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.26 155.69 51.37 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.583 2.189 . . . . 0.0 110.866 173.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.768 HD11 ' HB2' ' A' ' 114' ' ' LEU . 22.6 mt -64.7 -20.34 66.27 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -176.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -54.56 -31.63 52.54 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.79 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -58.77 -38.7 79.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.97 0.414 . . . . 0.0 110.989 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.48 ' HE1' ' HD2' ' A' ' 136' ' ' LYS . 13.8 m-85 -100.66 -32.31 10.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.272 0.558 . . . . 0.0 111.024 -177.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.535 ' O ' HD22 ' A' ' 89' ' ' LEU . . . -97.7 7.05 63.05 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.39 -0.823 . . . . 0.0 113.986 -171.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -44.86 -23.62 0.15 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -104.47 134.46 19.67 Favored Pre-proline 0 C--N 1.329 -0.325 0 O-C-N 122.217 -0.302 . . . . 0.0 110.608 175.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -67.16 4.89 1.0 Allowed 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.967 2.445 . . . . 0.0 112.586 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -127.6 11.63 6.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.441 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 55.9 m -57.61 107.77 0.48 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.944 0.402 . . . . 0.0 110.15 177.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.5 m -85.64 102.72 13.82 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.973 -176.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 133' ' ' PHE . 40.7 t -92.75 121.85 43.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.541 177.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -92.8 118.55 31.22 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.217 0.532 . . . . 0.0 110.856 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.548 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 40.4 ttm -79.81 93.13 5.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.181 176.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 51.5 m-80 -79.91 123.2 27.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.331 0.586 . . . . 0.0 111.519 -172.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 70.2 mt -105.39 95.56 5.91 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.368 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 . . . . . 0 C--N 1.325 -0.499 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.984 -177.026 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 C--O 1.234 0.267 0 CA-C-O 120.887 0.375 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -156.78 108.94 1.97 Allowed Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.853 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -82.37 -147.6 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.478 2.118 . . . . 0.0 109.316 166.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.52 ' HB3' HG23 ' A' ' 105' ' ' VAL . 14.0 tp -150.83 138.63 19.86 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.514 173.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.6 t -125.67 109.72 12.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.535 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 32.2 pt -116.12 134.72 58.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.945 0.402 . . . . 0.0 110.765 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.429 HD13 ' HB3' ' A' ' 100' ' ' SER . 58.4 tp -94.46 105.84 17.81 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.038 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 69.1 t -88.53 104.56 14.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.469 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -93.16 114.46 26.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.673 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.561 HD21 ' N ' ' A' ' 95' ' ' ASN . 0.7 OUTLIER -78.54 142.15 37.58 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.224 176.226 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.45 ' OD1' ' HG ' ' A' ' 159' ' ' LEU . 3.8 p-10 -62.56 -23.01 66.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.981 0.42 . . . . 0.0 110.491 178.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -84.92 15.25 4.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.112 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.75 55.91 3.25 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.991 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -141.67 96.51 2.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.997 0.399 . . . . 0.0 110.13 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.429 ' HB3' HD13 ' A' ' 92' ' ' LEU . 8.8 m -93.38 96.53 9.99 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.801 0.334 . . . . 0.0 110.109 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.2 p -108.31 119.33 39.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.952 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.1 m -82.11 120.17 24.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.344 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -110.72 136.03 50.41 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -91.01 123.83 34.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.656 0.741 . . . . 0.0 109.679 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.52 HG23 ' HB3' ' A' ' 89' ' ' LEU . 16.0 m -135.78 -178.97 2.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.257 -175.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -127.1 157.0 40.83 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.16 -30.38 64.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 110.324 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -78.83 50.33 0.99 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.835 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -139.88 155.82 47.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.659 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.1 p -86.28 152.29 22.89 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.594 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 59.4 t -63.09 -23.79 34.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.004 0.431 . . . . 0.0 109.848 176.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.512 ' CA ' ' HB2' ' A' ' 140' ' ' ASP . . . -57.07 -44.09 82.74 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.81 174.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.508 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 13.0 m-70 -65.32 -32.96 74.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.269 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.414 HD22 HD11 ' A' ' 144' ' ' LEU . 56.4 tp -71.13 -48.0 54.67 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 174.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -54.94 -47.36 74.55 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.897 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.454 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 29.0 mt-30 -63.8 -34.31 77.63 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -176.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.508 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 25.3 mt-30 -66.43 -47.06 74.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.336 0.589 . . . . 0.0 109.729 176.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.99 -34.89 65.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.633 174.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.879 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 60.8 m -79.26 -1.33 36.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.399 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -88.81 -37.0 7.52 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.788 168.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.0 mt -86.5 -64.39 1.16 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.02 0.438 . . . . 0.0 111.508 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 124' ' ' VAL . 17.1 mm-40 -99.63 8.93 43.98 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.649 0.78 . . . . 0.0 110.069 -175.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.879 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -44.48 9.12 0.0 OUTLIER Glycine 0 CA--C 1.526 0.723 0 N-CA-C 120.032 2.773 . . . . 0.0 120.032 -170.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 122' ' ' GLU . 13.0 t -58.45 75.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 119.517 1.658 . . . . 0.0 112.222 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 123' ' ' GLY . 24.5 mt-30 63.7 121.28 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.504 1.121 . . . . 0.0 113.399 175.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -73.53 54.81 0.47 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 122.412 1.101 . . . . 0.0 109.406 173.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.493 ' O ' ' HD2' ' A' ' 160' ' ' ARG . 19.0 t70 -146.4 -37.69 0.24 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.48 -1.237 . . . . 0.0 108.711 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.7 mt -80.87 -20.02 43.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.604 175.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -135.74 148.28 48.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.652 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.909 ' HZ3' ' HA ' ' A' ' 160' ' ' ARG . 1.2 p90 -155.32 152.52 29.28 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 170.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.757 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 6.7 mp -109.01 141.78 40.65 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.549 -173.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.8 p -122.41 131.37 53.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.83 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.514 ' HB3' HD21 ' A' ' 138' ' ' LEU . 10.9 t80 -100.79 -62.22 1.27 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.166 0.508 . . . . 0.0 110.768 174.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -95.87 27.85 3.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.914 -174.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.4 4.02 90.32 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.596 -174.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -127.05 149.54 69.62 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -62.46 148.52 93.18 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.803 2.335 . . . . 0.0 112.182 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.514 HD21 ' HB3' ' A' ' 133' ' ' PHE . 43.3 mt -96.92 112.94 24.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.443 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -61.76 130.65 46.8 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 173.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.594 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.7 p-10 -77.46 -18.52 57.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.49 -176.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.65 -36.73 73.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.867 0.365 . . . . 0.0 110.602 177.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.427 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 93.2 mt -78.54 158.17 76.44 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.402 -174.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.636 ' HG2' ' HG2' ' A' ' 146' ' ' GLU . 44.4 Cg_endo -69.23 146.71 64.34 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.648 2.232 . . . . 0.0 112.58 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.45 HD13 HG22 ' A' ' 111' ' ' VAL . 22.7 tp -72.12 -37.34 69.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.604 -174.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -57.4 -25.23 54.47 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.396 -0.431 . . . . 0.0 113.716 -176.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.636 ' HG2' ' HG2' ' A' ' 143' ' ' PRO . 24.4 mm-40 -65.78 -29.69 70.22 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.468 -0.43 . . . . 0.0 111.483 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -100.53 -38.47 8.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.171 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.434 ' O ' HD11 ' A' ' 89' ' ' LEU . . . -98.59 6.21 60.73 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-O 119.412 -0.66 . . . . 0.0 113.912 -172.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.412 ' N ' HD21 ' A' ' 149' ' ' LEU . 2.5 pt? -37.21 -38.2 0.2 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -175.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.483 ' C ' ' H ' ' A' ' 152' ' ' LEU . 38.7 ttpt -90.76 125.95 57.49 Favored Pre-proline 0 C--N 1.322 -0.605 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.349 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.09 27.35 0.22 Allowed 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.356 2.704 . . . . 0.0 112.653 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.483 ' H ' ' C ' ' A' ' 150' ' ' LYS . 0.2 OUTLIER -140.83 14.83 2.3 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.718 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 31.9 p -75.92 131.74 39.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.443 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 23.6 m -95.09 110.43 22.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.737 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 41.0 t -92.7 109.52 21.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -85.26 120.32 26.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.843 0.354 . . . . 0.0 111.065 -176.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.757 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 27.4 ttt -85.19 103.87 14.55 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.65 123.44 46.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.513 -172.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.45 ' HG ' ' OD1' ' A' ' 96' ' ' ASN . 88.5 mt -72.9 147.1 45.65 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.909 ' HA ' ' HZ3' ' A' ' 130' ' ' TRP . 60.6 ttt180 . . . . . 0 C--N 1.324 -0.513 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -170.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.7 p30 . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -103.93 107.65 57.47 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 178.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.03 131.83 10.16 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.197 2.598 . . . . 0.0 111.9 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.477 HD23 ' CD2' ' A' ' 107' ' ' LEU . 52.3 tp -109.34 103.44 12.37 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.455 ' OG ' HG21 ' A' ' 102' ' ' THR . 7.3 t -96.16 98.48 10.36 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.105 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.45 HG23 ' HG ' ' A' ' 89' ' ' LEU . 33.3 pt -95.5 159.99 2.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.41 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 33.8 tp -99.99 119.09 37.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.839 0.352 . . . . 0.0 110.877 -177.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 68.9 t -110.13 114.2 46.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.86 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.436 ' HG3' ' OG ' ' A' ' 100' ' ' SER . 34.0 ttt-85 -110.08 137.98 47.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.703 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.541 ' ND2' ' HB2' ' A' ' 99' ' ' ARG . 56.7 p30 -79.84 -160.08 0.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.871 175.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -64.25 -32.27 73.79 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -174.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -160.08 105.13 1.53 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.96 0.41 . . . . 0.0 111.482 -176.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.21 -62.09 0.33 Allowed Glycine 0 C--N 1.318 -0.437 0 C-N-CA 120.67 -0.776 . . . . 0.0 114.443 164.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.541 ' HB2' ' ND2' ' A' ' 95' ' ' ASN . 4.6 mmp_? -69.56 105.8 2.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.115 0.483 . . . . 0.0 110.884 -172.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.436 ' OG ' ' HG3' ' A' ' 94' ' ' ARG . 5.2 m -118.71 100.09 7.19 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.503 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.9 t -101.27 136.62 40.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.86 0.362 . . . . 0.0 110.382 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.455 HG21 ' OG ' ' A' ' 90' ' ' SER . 0.6 OUTLIER -91.68 109.33 20.64 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.603 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -95.86 120.15 35.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.021 0.439 . . . . 0.0 111.71 -174.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -79.69 100.39 7.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.663 176.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.416 ' C ' ' HD2' ' A' ' 106' ' ' ARG . 35.1 m -123.81 -179.86 2.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.023 0.439 . . . . 0.0 110.975 -177.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.496 ' N ' ' HD2' ' A' ' 106' ' ' ARG . 4.6 mpt_? -123.33 157.2 33.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.477 ' CD2' HD23 ' A' ' 89' ' ' LEU . 23.8 mt -62.03 -29.18 70.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.723 0.297 . . . . 0.0 111.364 -176.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.0 m -74.93 -7.89 54.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.695 -175.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -80.29 125.27 29.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.795 0.331 . . . . 0.0 110.912 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 21.2 p -73.96 157.86 35.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.759 172.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.585 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 60.3 t -59.03 -29.37 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.08 0.467 . . . . 0.0 109.963 177.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' A' ' 140' ' ' ASP . . . -58.71 -38.33 78.06 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.35 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -64.92 -46.33 82.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.708 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.445 HD21 HD13 ' A' ' 131' ' ' LEU . 34.0 tp -64.11 -40.68 96.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.319 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -52.85 -48.84 66.75 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.849 175.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.529 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 11.6 mm-40 -69.03 -28.94 67.02 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -66.98 -48.68 67.74 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.504 0.668 . . . . 0.0 109.452 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.8 t -64.11 -33.6 63.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.495 175.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.712 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 67.9 m -67.68 -17.4 64.57 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.196 175.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.76 -37.09 27.25 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.559 175.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.9 mt -93.36 -64.98 1.03 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.958 0.409 . . . . 0.0 112.04 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 124' ' ' VAL . 64.6 mm-40 -98.06 9.61 42.42 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.349 0.659 . . . . 0.0 111.367 -174.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.712 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -45.11 7.3 0.01 OUTLIER Glycine 0 N--CA 1.473 1.131 0 N-CA-C 118.583 2.193 . . . . 0.0 118.583 -173.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.464 ' N ' ' O ' ' A' ' 122' ' ' GLU . 57.9 t -50.57 88.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 118.532 1.166 . . . . 0.0 111.019 171.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.405 ' C ' ' H ' ' A' ' 127' ' ' ASP . 20.1 mt-30 49.04 105.8 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.824 0.703 . . . . 0.0 111.794 -175.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.554 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 3.4 p-10 -69.65 5.93 1.28 Allowed 'General case' 0 C--N 1.328 -0.364 0 O-C-N 121.92 -0.488 . . . . 0.0 110.618 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 125' ' ' GLN . 8.8 m-20 -77.54 -35.61 53.09 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.719 169.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.2 mt -73.78 -21.05 60.3 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.275 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.554 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 52.6 p90 -132.13 120.39 22.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.632 0.73 . . . . 0.0 111.403 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -134.12 131.97 39.35 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 170.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.445 HD13 HD21 ' A' ' 114' ' ' LEU . 2.2 pt? -104.19 130.62 51.95 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.265 0.555 . . . . 0.0 111.273 -171.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.535 HG21 ' HA ' ' A' ' 137' ' ' PRO . 68.3 p -118.09 138.2 52.41 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.707 -174.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -84.23 132.14 34.68 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.179 175.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 63.87 8.08 3.64 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.959 175.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.04 -2.18 63.6 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.037 -177.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.469 ' O ' ' HB ' ' A' ' 132' ' ' THR . 78.4 mttt -102.02 132.83 21.12 Favored Pre-proline 0 C--N 1.327 -0.396 0 C-N-CA 122.321 0.248 . . . . 0.0 110.479 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.535 ' HA ' HG21 ' A' ' 132' ' ' THR . 19.5 Cg_exo -65.26 127.99 19.47 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.883 2.388 . . . . 0.0 112.936 -175.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 75.6 mt -98.45 164.58 12.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.427 178.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.447 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 32.8 mt-10 -105.99 141.13 37.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.75 175.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.585 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.8 p-10 -64.33 -18.53 64.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.216 0.532 . . . . 0.0 110.263 176.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -72.28 -16.87 61.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.285 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.447 ' HG ' ' HB2' ' A' ' 139' ' ' GLU . 87.4 mt -100.84 148.57 35.23 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.625 -173.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 2.8 Cg_exo -76.94 149.57 29.19 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.102 2.535 . . . . 0.0 112.159 175.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.417 HD13 ' HB2' ' A' ' 114' ' ' LEU . 60.8 mt -73.65 -29.24 62.22 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.401 -176.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.419 ' CA ' HD21 ' A' ' 107' ' ' LEU . . . -54.3 -37.97 60.91 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.308 -0.472 . . . . 0.0 114.131 -173.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -64.55 -32.04 73.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.904 0.383 . . . . 0.0 111.334 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -100.63 -24.31 14.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.21 0.529 . . . . 0.0 111.238 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.424 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -100.4 6.24 57.62 Favored Glycine 0 C--O 1.224 -0.511 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.108 -175.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.411 HD21 ' N ' ' A' ' 149' ' ' LEU . 2.6 pt? -39.58 -35.92 0.35 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -177.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -100.31 129.65 27.59 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.42 -24.93 63.49 Favored 'Trans proline' 0 N--CA 1.473 0.314 0 C-N-CA 122.834 2.356 . . . . 0.0 112.54 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.3 pp -87.71 -1.28 57.86 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.496 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.3 t -68.89 120.68 15.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.5 m -98.01 119.05 35.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.323 0.582 . . . . 0.0 111.978 -172.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 29.2 t -96.11 119.16 43.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -88.95 117.78 28.21 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.803 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.536 ' HE3' HD23 ' A' ' 159' ' ' LEU . 20.7 ttt -77.56 91.47 3.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.19 176.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -75.46 109.88 9.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.0 -173.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.536 HD23 ' HE3' ' A' ' 157' ' ' MET . 99.6 mt -88.2 113.69 24.07 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.712 176.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 . . . . . 0 C--N 1.325 -0.495 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.603 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 CA--C 1.52 -0.19 0 CA-C-O 121.096 0.474 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 106' ' ' ARG . 50.4 mm-40 -119.4 91.88 44.94 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.898 176.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -77.67 70.56 6.87 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.675 2.25 . . . . 0.0 110.531 175.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.568 HD22 ' O ' ' A' ' 148' ' ' GLY . 45.7 tp -78.9 89.26 4.7 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.939 -174.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.493 ' HB3' HG23 ' A' ' 102' ' ' THR . 19.7 m -84.91 93.63 8.58 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.617 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.2 pt -90.21 165.07 2.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.504 HD12 ' HB2' ' A' ' 100' ' ' SER . 21.5 tp -108.69 107.02 17.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.196 0.522 . . . . 0.0 110.916 -175.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.74 107.41 19.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.365 176.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.536 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 16.5 ttm180 -84.33 105.0 14.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -175.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.524 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 50.8 t-20 -78.92 106.46 10.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.493 -0.776 . . . . 0.0 108.973 175.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 68.06 -84.07 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.086 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -146.8 -65.98 0.28 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.642 0.258 . . . . 0.0 111.606 -177.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -84.48 -25.17 44.0 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.986 -174.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.418 ' CB ' ' HB3' ' A' ' 95' ' ' ASN . 13.3 mmt180 -80.44 64.44 5.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.176 0.513 . . . . 0.0 111.478 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 32.6 p -79.65 92.05 5.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.116 0.484 . . . . 0.0 109.862 176.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.4 m -86.38 123.42 31.6 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.894 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.493 HG23 ' HB3' ' A' ' 90' ' ' SER . 8.7 m -90.2 102.54 15.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.124 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -95.89 136.32 36.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.51 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -79.49 103.65 9.55 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 173.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.464 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 21.9 m -107.97 166.28 4.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 87' ' ' GLU . 56.0 mtt180 -138.33 154.17 48.98 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 16.3 mt -60.31 -33.46 72.4 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -169.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.6 m -80.56 -7.78 59.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.371 0.605 . . . . 0.0 111.187 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -86.96 122.26 30.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.1 p -79.18 165.99 22.69 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.82 0.343 . . . . 0.0 111.322 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.626 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 46.6 t -64.37 -27.84 43.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.21 177.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.491 ' HB3' ' HB2' ' A' ' 140' ' ' ASP . . . -59.62 -45.02 93.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.15 0.5 . . . . 0.0 110.252 174.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.442 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 50.9 m80 -63.42 -37.04 85.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.382 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.617 ' HB2' HD11 ' A' ' 144' ' ' LEU . 55.5 tp -65.25 -47.14 77.79 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.648 ' HD2' ' HB2' ' A' ' 126' ' ' ASP . 5.2 tppp? -54.1 -49.26 69.5 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.966 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.794 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 34.9 tt0 -70.26 -32.56 70.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.796 -174.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 27.6 mt-30 -63.67 -39.6 94.74 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 67.2 t -71.63 -38.06 65.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.895 176.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.794 ' OG ' ' HA ' ' A' ' 116' ' ' GLN . 92.0 p -72.71 -5.0 34.68 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.005 0.431 . . . . 0.0 110.555 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -94.76 -59.46 1.13 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.372 173.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.4 mp -77.33 -45.24 26.77 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.328 0.585 . . . . 0.0 111.405 -177.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 124' ' ' VAL . 8.7 mm-40 -96.8 9.6 41.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.431 -176.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -28.82 6.54 0.0 OUTLIER Glycine 0 N--CA 1.485 1.911 0 N-CA-C 121.956 3.542 . . . . 0.0 121.956 -165.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.559 ' N ' ' O ' ' A' ' 122' ' ' GLU . 48.1 t -52.15 144.95 2.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 119.852 1.826 . . . . 0.0 108.53 168.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -49.03 135.93 15.26 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.097 0.475 . . . . 0.0 112.03 -170.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.648 ' HB2' ' HD2' ' A' ' 115' ' ' LYS . 7.2 p-10 -74.4 9.55 1.66 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.514 -171.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.67 -21.86 40.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.169 0.509 . . . . 0.0 110.125 173.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.45 HD12 HG12 ' A' ' 124' ' ' VAL . 83.0 mt -91.49 -45.93 8.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.007 -171.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.569 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 34.5 p90 -83.49 102.23 11.96 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.161 0.982 . . . . 0.0 110.848 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.59 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 25.4 t90 -100.81 93.22 5.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.493 -1.231 . . . . 0.0 109.414 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.486 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 8.6 mp -79.45 115.52 19.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.199 0.523 . . . . 0.0 111.762 -173.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 25.6 p -121.33 119.23 31.57 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.75 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.52 ' HB2' HG22 ' A' ' 155' ' ' VAL . 6.7 t80 -82.06 -74.39 0.34 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.886 0.374 . . . . 0.0 110.614 177.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.66 36.45 1.38 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.377 0.608 . . . . 0.0 109.64 -175.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.95 -36.42 3.85 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.869 -177.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -91.81 144.47 29.41 Favored Pre-proline 0 C--O 1.237 0.447 0 CA-C-O 120.581 0.229 . . . . 0.0 111.037 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -76.83 137.11 17.48 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.873 2.382 . . . . 0.0 111.541 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 71.2 mt -77.81 133.92 38.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.732 -177.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.496 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 44.2 mt-10 -76.12 139.46 41.33 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.626 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 6.6 p-10 -66.92 -24.77 66.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 0.0 111.894 -173.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -76.09 -14.63 60.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.108 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.496 ' HG ' ' HB2' ' A' ' 139' ' ' GLU . 87.5 mt -86.17 146.13 42.01 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.03 -175.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 142' ' ' LEU . 2.7 Cg_exo -76.74 140.37 20.81 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.142 2.562 . . . . 0.0 111.656 175.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.617 HD11 ' HB2' ' A' ' 114' ' ' LEU . 74.8 mt -67.73 -26.38 66.11 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -175.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.05 -35.02 62.95 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.85 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -50.35 -56.53 10.96 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -101.25 -13.14 18.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.455 -173.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.568 ' O ' HD22 ' A' ' 89' ' ' LEU . . . -100.2 3.46 56.82 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.932 -177.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -46.73 -31.4 2.93 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.107 0.479 . . . . 0.0 111.744 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -92.63 117.35 67.56 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 174.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -58.01 -18.59 36.48 Favored 'Trans proline' 0 N--CA 1.476 0.443 0 C-N-CA 122.66 2.24 . . . . 0.0 112.911 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 84.9 mt -94.18 7.02 46.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.788 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 29.5 t -59.78 107.39 0.6 Allowed 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 23.6 m -94.97 100.23 12.11 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.28 -174.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.52 HG22 ' HB2' ' A' ' 133' ' ' PHE . 42.3 t -87.1 115.5 27.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.5 176.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.536 ' CE2' ' HD2' ' A' ' 94' ' ' ARG . 74.0 m-85 -79.28 117.97 20.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.904 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.524 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 52.6 ttm -80.47 83.4 6.29 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 174.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.59 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 1.9 m-20 -73.0 98.88 2.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.797 -174.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 91.6 mt -75.24 103.78 5.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.03 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.457 179.791 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.7 t70 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 121.618 0.723 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -65.38 120.75 70.42 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.303 -176.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -86.7 161.24 9.23 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.584 2.189 . . . . 0.0 111.983 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.573 HD22 ' O ' ' A' ' 148' ' ' GLY . 61.9 tp -112.4 111.45 22.31 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.585 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.4 t -85.72 114.61 22.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.666 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.4 pt -109.19 163.09 6.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.93 176.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.482 HD12 ' HB2' ' A' ' 100' ' ' SER . 27.0 tp -115.33 110.71 19.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.025 0.44 . . . . 0.0 110.724 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.8 t -104.68 109.21 26.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.284 0.564 . . . . 0.0 110.583 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 94' ' ' ARG . 16.3 ttt180 -92.61 116.93 29.44 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.385 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.497 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 30.4 p-10 -82.07 100.73 9.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.777 0.799 . . . . 0.0 111.517 -174.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.443 ' OD1' ' HG2' ' A' ' 97' ' ' LYS . 10.7 t-20 65.11 -75.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.547 176.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.443 ' HG2' ' OD1' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -154.37 21.81 0.48 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -175.073 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -128.81 -93.96 0.76 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.638 -1.268 . . . . 0.0 114.109 -174.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -84.53 131.98 34.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.222 0.534 . . . . 0.0 111.743 -167.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.482 ' HB2' HD12 ' A' ' 92' ' ' LEU . 12.6 p -88.31 92.07 9.03 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 171.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.2 m -83.32 124.66 30.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.697 -173.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.2 m -91.58 113.43 25.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.93 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -115.05 132.82 56.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.885 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -107.15 97.5 7.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.259 0.552 . . . . 0.0 111.1 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.9 m -104.15 -179.5 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.54 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.585 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 33.2 ttm180 -110.46 125.06 52.88 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 174.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.521 ' HB3' HD21 ' A' ' 89' ' ' LEU . 1.4 pp -62.88 -6.59 3.92 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -173.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 m -86.76 0.72 54.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.726 0.298 . . . . 0.0 110.926 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.585 ' HG2' ' O ' ' A' ' 106' ' ' ARG . 2.5 pt20 -92.66 158.86 15.72 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.0 m -87.43 154.29 20.77 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.547 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 30.3 t -58.18 -25.68 27.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.094 0.474 . . . . 0.0 110.844 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 140' ' ' ASP . . . -60.84 -34.32 74.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.215 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.562 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 17.1 t-80 -72.34 -46.77 54.08 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.461 ' HA ' ' NE2' ' A' ' 117' ' ' GLN . 59.5 tp -47.83 -45.97 30.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.063 173.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.524 ' HE2' ' HB2' ' A' ' 126' ' ' ASP . 48.5 tttt -61.13 -41.9 97.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.627 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 18.1 tm0? -67.02 -39.72 87.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.985 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.562 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 18.6 mt-30 -57.15 -46.23 82.92 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.35 0.595 . . . . 0.0 109.867 176.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 63.8 t -65.49 -36.36 77.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.899 175.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.435 ' C ' ' HA2' ' A' ' 123' ' ' GLY . 62.4 m -67.88 -8.2 34.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.259 177.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -98.69 -61.93 0.87 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.63 173.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 88.7 mt -71.09 -41.4 70.69 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.494 0.664 . . . . 0.0 111.335 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 124' ' ' VAL . 6.0 mm-40 -100.06 11.07 40.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.814 -177.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.435 ' HA2' ' C ' ' A' ' 119' ' ' SER . . . -27.87 7.3 0.0 OUTLIER Glycine 0 N--CA 1.488 2.117 0 N-CA-C 122.334 3.694 . . . . 0.0 122.334 -157.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' A' ' 122' ' ' GLU . 44.3 t -51.57 141.71 4.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 119.928 1.864 . . . . 0.0 108.576 165.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -45.6 137.99 4.81 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -173.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.742 ' HA ' ' CE2' ' A' ' 129' ' ' PHE . 4.1 p-10 -63.77 -22.95 67.16 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.363 -172.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -73.82 -21.79 60.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.296 0.57 . . . . 0.0 110.657 178.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.494 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 93.4 mt -83.24 -17.25 43.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.837 -174.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.742 ' CE2' ' HA ' ' A' ' 126' ' ' ASP . 38.7 p90 -112.36 124.26 52.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.974 0.892 . . . . 0.0 111.45 175.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.706 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 49.9 t90 -112.68 92.55 4.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.688 177.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 2.6 pt? -97.2 144.01 27.44 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.004 -177.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.36 150.23 36.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.249 0.547 . . . . 0.0 111.393 -178.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.514 ' HB2' HG23 ' A' ' 155' ' ' VAL . 5.1 t80 -112.69 -58.52 2.14 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.911 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.34 -20.26 23.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.501 -175.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 136.87 -19.69 3.48 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -171.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -102.25 149.41 36.6 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 114.334 -0.933 . . . . 0.0 109.202 174.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 131' ' ' LEU . 59.0 Cg_endo -72.02 0.35 7.34 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.699 2.266 . . . . 0.0 112.312 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.4 mt 69.61 115.83 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 O-C-N 123.931 0.769 . . . . 0.0 110.03 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.681 ' HB2' ' CD2' ' A' ' 142' ' ' LEU . 7.3 mm-40 -72.04 137.9 47.5 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.457 -177.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.547 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 5.7 p-10 -77.46 33.49 0.16 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.392 -176.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.428 ' H ' ' C ' ' A' ' 139' ' ' GLU . 26.3 tt0 -118.63 -21.89 7.72 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.228 0.537 . . . . 0.0 109.789 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.681 ' CD2' ' HB2' ' A' ' 139' ' ' GLU . 0.6 OUTLIER -95.95 153.97 39.08 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.261 -173.253 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.01 136.6 53.28 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.402 2.068 . . . . 0.0 110.999 173.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.416 ' O ' HD21 ' A' ' 144' ' ' LEU . 6.9 tt -60.78 -32.39 71.71 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.258 -176.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.496 ' HA3' ' HB2' ' A' ' 107' ' ' LEU . . . -60.42 -28.21 66.93 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 116.094 -0.503 . . . . 0.0 113.33 -178.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -61.67 -37.3 83.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.937 0.399 . . . . 0.0 110.814 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -100.77 -32.74 10.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.756 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.573 ' O ' HD22 ' A' ' 89' ' ' LEU . . . -98.99 5.83 59.71 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.742 -172.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.469 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.5 pt? -45.2 -29.93 1.07 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.465 ' C ' ' H ' ' A' ' 152' ' ' LEU . 48.7 tttp -79.73 121.16 82.09 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 21.4 Cg_exo -67.25 12.86 0.17 Allowed 'Trans proline' 0 N--CA 1.476 0.457 0 C-N-CA 123.088 2.525 . . . . 0.0 112.789 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.465 ' H ' ' C ' ' A' ' 150' ' ' LYS . 26.5 tp -137.5 20.28 2.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.409 0.624 . . . . 0.0 109.417 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.0 p -67.37 118.77 11.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.142 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.7 m -97.19 111.06 23.46 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.999 -175.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.514 HG23 ' HB2' ' A' ' 133' ' ' PHE . 39.9 t -100.86 129.29 52.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.609 177.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 131' ' ' LEU . 94.7 m-85 -95.07 110.21 22.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.822 0.344 . . . . 0.0 110.818 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.497 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 23.6 ttt -82.18 97.38 8.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.854 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.706 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 50.7 m-80 -90.6 136.2 33.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.323 -178.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.452 HD22 ' HE2' ' A' ' 157' ' ' MET . 90.3 mt -104.54 81.6 1.81 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.488 -0.189 . . . . 0.0 110.488 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 128' ' ' LEU . 1.9 mmp_? . . . . . 0 N--CA 1.466 0.369 0 O-C-N 123.792 0.682 . . . . 0.0 111.306 -176.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 CA--C 1.516 -0.332 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -92.24 134.69 27.97 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.189 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.03 124.74 13.99 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 122.487 2.125 . . . . 0.0 111.713 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.56 HD21 ' O ' ' A' ' 148' ' ' GLY . 31.7 tp -105.69 116.36 31.82 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.246 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.402 ' HB3' ' OG1' ' A' ' 102' ' ' THR . 16.0 m -94.57 107.23 19.22 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.469 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 102' ' ' THR . 35.4 pt -99.06 160.93 3.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 154' ' ' THR . 36.7 tp -106.19 116.07 31.3 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.762 -176.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.1 t -104.37 121.49 56.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.461 ' HD2' ' CE1' ' A' ' 156' ' ' PHE . 18.4 ttm180 -106.54 107.01 17.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.188 -177.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.555 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 40.4 m-20 -81.67 148.85 28.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.52 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -56.64 -23.97 45.11 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.482 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -73.51 5.33 3.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.475 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.98 51.31 4.8 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.453 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.504 ' NE ' ' HA ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -137.95 103.34 4.95 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.132 -176.848 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.3 m -94.15 86.15 4.88 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.4 t -104.8 129.96 52.99 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.109 -176.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 10.8 t -76.92 143.58 39.45 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 173.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -121.37 133.03 55.09 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.293 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -83.19 108.07 16.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.931 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.88 -179.18 3.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.491 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -121.47 178.84 4.65 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 173.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.61 -32.18 19.43 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.2 m -89.51 64.67 6.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.308 0.575 . . . . 0.0 110.74 -178.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.504 ' O ' ' HA ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -163.72 163.54 24.12 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.181 173.374 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 140' ' ' ASP . 32.6 p -96.94 162.18 13.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.803 0.335 . . . . 0.0 111.332 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.525 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 45.3 t -57.51 -21.39 15.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.843 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.528 ' HB1' ' HB2' ' A' ' 140' ' ' ASP . . . -50.49 -46.33 56.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.557 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -81.57 -0.83 44.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.513 -175.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.58 ' HB2' HD12 ' A' ' 144' ' ' LEU . 43.7 tp -100.34 -47.33 4.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.437 0.637 . . . . 0.0 109.721 172.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -63.2 -27.33 69.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.628 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.88 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 0.9 OUTLIER -78.11 -23.26 47.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.521 177.357 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -68.56 -43.87 75.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.3 -43.73 98.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.872 174.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.88 ' OG ' ' HA ' ' A' ' 116' ' ' GLN . 7.9 p -76.38 -1.74 28.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.776 0.322 . . . . 0.0 111.435 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -88.35 -36.31 8.21 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.779 172.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 mp -99.94 -58.46 1.91 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.446 0.641 . . . . 0.0 111.197 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' A' ' 124' ' ' VAL . 4.0 mm-40 -91.28 9.22 32.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.919 -177.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.822 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -49.26 7.72 0.01 OUTLIER Glycine 0 N--CA 1.469 0.851 0 N-CA-C 117.788 1.875 . . . . 0.0 117.788 -173.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.445 ' O ' HD23 ' A' ' 128' ' ' LEU . 94.6 t -47.26 86.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 CA-C-N 117.965 0.883 . . . . 0.0 111.742 172.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.404 ' O ' HD23 ' A' ' 128' ' ' LEU . 93.9 mt-30 59.29 119.26 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.61 0.719 . . . . 0.0 112.59 -178.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -78.85 57.01 2.02 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -147.63 -43.47 0.17 Allowed 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.435 -175.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.571 HD22 ' N ' ' A' ' 129' ' ' PHE . 0.9 OUTLIER -72.15 -22.58 61.29 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -169.642 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.571 ' N ' HD22 ' A' ' 128' ' ' LEU . 37.9 p90 -105.1 147.77 27.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.221 0.534 . . . . 0.0 111.313 -176.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.531 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 39.2 t90 -141.1 98.07 3.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.969 -175.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.511 ' HB3' ' HA ' ' A' ' 157' ' ' MET . 2.5 pp -99.13 138.55 36.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.152 0.501 . . . . 0.0 111.322 -174.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 137' ' ' PRO . 38.8 p -136.2 150.98 49.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.098 -174.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.4 ' CD2' ' HB3' ' A' ' 147' ' ' TYR . 30.4 t80 -116.43 -70.37 0.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.026 0.441 . . . . 0.0 110.8 175.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -87.43 30.95 0.76 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.444 0.64 . . . . 0.0 110.469 -173.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.17 -3.53 71.24 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -172.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -115.54 143.67 30.98 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 115.036 -0.582 . . . . 0.0 109.476 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.414 ' HA ' HG22 ' A' ' 132' ' ' THR . 32.4 Cg_endo -65.55 137.79 51.92 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.267 1.978 . . . . 0.0 111.06 173.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.423 ' HB3' HG23 ' A' ' 111' ' ' VAL . 87.2 mt -81.7 106.77 13.9 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.059 0.457 . . . . 0.0 110.483 -178.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.535 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 42.7 mt-10 -71.96 141.76 49.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.935 177.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.528 ' HB2' ' HB1' ' A' ' 112' ' ' ALA . 4.1 p-10 -73.03 -5.78 41.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.97 0.414 . . . . 0.0 111.15 -177.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -83.49 -15.72 48.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.485 173.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.535 ' HG ' ' HB2' ' A' ' 139' ' ' GLU . 82.8 mt -91.32 144.29 29.54 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.037 -176.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 109' ' ' GLN . 6.3 Cg_exo -79.88 138.98 13.52 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.154 2.569 . . . . 0.0 111.612 174.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.58 HD12 ' HB2' ' A' ' 114' ' ' LEU . 33.6 mt -68.83 -40.2 79.57 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -177.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.26 -30.2 31.67 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.166 -0.54 . . . . 0.0 113.923 -175.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -66.25 -32.94 74.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.927 0.394 . . . . 0.0 110.899 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.4 ' HB3' ' CD2' ' A' ' 133' ' ' PHE . 89.0 m-85 -101.06 -32.23 10.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.36 0.6 . . . . 0.0 110.899 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.56 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -97.06 6.54 64.06 Favored Glycine 0 C--O 1.223 -0.531 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.809 -170.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -44.82 -24.54 0.22 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.478 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 67.7 mttt -102.23 131.0 23.08 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.497 177.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 12.8 Cg_exo -69.93 9.63 0.6 Allowed 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.197 2.598 . . . . 0.0 112.449 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.408 ' H ' ' C ' ' A' ' 150' ' ' LYS . 2.9 pp -119.93 0.0 10.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.586 178.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.6 m -61.83 110.87 1.66 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.895 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 29.3 m -95.6 114.38 26.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.03 -176.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.51 118.63 37.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.13 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.461 ' CE1' ' HD2' ' A' ' 94' ' ' ARG . 80.5 m-85 -90.57 113.96 26.08 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.942 0.401 . . . . 0.0 110.869 -177.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.555 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 2.0 tmt? -88.19 97.7 11.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.3 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.531 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 92.2 m-20 -97.49 176.93 5.69 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.646 -173.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.481 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 96.0 mt -120.33 133.27 55.48 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.918 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 159' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.943 0 O-C-N 124.132 0.895 . . . . 0.0 112.389 -174.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo . . . . . 0 N--CA 1.452 -0.949 0 CA-C-O 121.01 0.337 . . . . 0.0 111.644 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.613 HD23 HD11 ' A' ' 107' ' ' LEU . 0.2 OUTLIER -96.19 123.27 39.75 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.316 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -95.33 101.87 13.63 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.438 HG23 HD12 ' A' ' 89' ' ' LEU . 46.7 pt -108.33 164.08 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.105 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 154' ' ' THR . 32.2 tp -108.87 120.96 44.05 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.273 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 90.4 t -116.95 117.39 55.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.003 0.43 . . . . 0.0 110.173 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.563 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 23.2 ttt180 -96.61 133.14 41.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.632 -177.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 8.4 m120 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.705 178.371 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 . . . . . 0 C--O 1.234 0.239 0 CA-C-O 121.254 0.55 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 15.0 m -95.02 102.06 13.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.414 173.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.8 m -95.45 136.41 35.86 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.042 0.448 . . . . 0.0 110.691 -176.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.3 m -85.97 124.78 32.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.073 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.516 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 43.5 m-85 -111.07 145.71 38.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.974 0.416 . . . . 0.0 111.376 -176.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -95.15 95.86 8.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.45 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.4 m -109.37 -179.79 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.842 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.1 mtm180 -138.78 166.11 25.25 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.613 HD11 HD23 ' A' ' 89' ' ' LEU . 6.9 mp -80.44 -23.4 40.32 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.7 p -76.31 -16.91 59.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.107 174.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -85.07 138.29 32.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.091 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.717 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 38.7 p -88.1 163.71 16.09 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 175.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.615 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 3.4 t -64.14 -27.31 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.274 0.559 . . . . 0.0 109.788 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.15 -37.83 88.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.742 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -70.86 -33.99 71.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.574 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.423 HD22 HD11 ' A' ' 144' ' ' LEU . 65.7 tp -61.3 -46.07 91.85 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 173.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -59.36 -39.97 84.96 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.186 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -66.96 -32.19 73.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.306 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -62.03 -51.22 68.89 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.97 0.89 . . . . 0.0 109.134 174.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.4 t -62.3 -32.03 53.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.848 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.648 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 49.9 m -65.12 -27.58 68.84 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.807 0.337 . . . . 0.0 111.082 177.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.01 -35.02 54.64 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.679 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 75.4 mt -93.46 -67.53 0.85 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.408 0.623 . . . . 0.0 112.001 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 124' ' ' VAL . 8.1 tp10 -100.47 9.9 41.94 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.788 0.835 . . . . 0.0 110.847 -172.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.648 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -44.57 7.68 0.01 OUTLIER Glycine 0 CA--C 1.532 1.139 0 N-CA-C 118.555 2.182 . . . . 0.0 118.555 -174.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 122' ' ' GLU . 59.1 t -48.26 91.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 118.428 1.114 . . . . 0.0 111.678 173.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 53.51 104.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.836 0.71 . . . . 0.0 111.698 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.653 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 4.5 p-10 -69.29 11.05 0.25 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.241 -173.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -117.62 -5.48 11.16 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 174.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 128' ' ' LEU . 44.6 mt -93.26 -31.06 14.86 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 171.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.653 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 25.0 p90 -110.14 135.05 51.54 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 172.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.471 ' HE1' ' HB3' ' A' ' 137' ' ' PRO . 4.2 t-105 -155.79 135.78 12.84 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.957 0.408 . . . . 0.0 109.937 -176.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.639 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 6.4 mp -104.67 131.79 51.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.06 0.457 . . . . 0.0 110.703 -174.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.828 HG22 ' HA ' ' A' ' 137' ' ' PRO . 19.9 p -135.22 140.59 45.4 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.681 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.697 ' CD2' ' HG3' ' A' ' 134' ' ' GLU . 6.1 t80 -106.04 -82.89 0.53 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.831 -175.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.697 ' HG3' ' CD2' ' A' ' 133' ' ' PHE . 98.6 mt-10 -77.97 25.73 0.21 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.755 0.312 . . . . 0.0 111.798 -173.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.25 -7.35 78.33 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -175.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -112.79 154.89 44.7 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.828 ' HA ' HG22 ' A' ' 132' ' ' THR . 85.9 Cg_endo -76.2 -5.78 16.58 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.851 2.367 . . . . 0.0 111.972 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 86.9 mt 62.1 176.29 0.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.053 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -104.19 101.79 11.52 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.615 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 9.9 p-10 -71.84 -9.28 58.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.938 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -68.79 -29.77 68.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.227 170.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 87.2 mt -97.28 160.83 27.99 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.876 -175.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.717 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 8.7 Cg_exo -72.09 153.71 57.36 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.76 2.306 . . . . 0.0 112.059 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.423 HD11 HD22 ' A' ' 114' ' ' LEU . 7.4 mt -70.92 -18.5 62.66 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.762 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.572 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -53.19 -44.02 63.85 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.675 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -63.96 -37.49 87.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -101.21 -37.1 8.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.037 0.446 . . . . 0.0 111.963 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.87 6.4 58.56 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.475 -170.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.572 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.0 pt? -47.18 -26.33 1.12 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.648 0.379 . . . . 0.0 112.014 175.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 53.6 mtmt -81.32 118.66 73.2 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.551 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 21.0 Cg_exo -66.1 -10.47 27.32 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.81 2.34 . . . . 0.0 111.412 177.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 82.9 mt -99.76 1.74 43.5 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.166 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.0 t -66.33 101.98 0.8 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.316 0.579 . . . . 0.0 109.85 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 18.0 m -90.84 92.18 8.68 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.873 -177.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 44.9 t -77.85 125.32 37.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.367 178.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -92.85 116.54 29.13 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.976 0.417 . . . . 0.0 110.604 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.639 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 1.1 tmt? -72.8 104.98 4.16 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -103.17 154.25 19.5 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.296 -173.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.5 mt -116.66 134.54 54.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.112 173.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 . . . . . 0 C--N 1.321 -0.671 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.72 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 C--O 1.236 0.384 0 CA-C-O 121.397 0.499 . . . . 0.0 111.794 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.479 HD21 ' O ' ' A' ' 148' ' ' GLY . 66.4 tp -106.71 109.09 20.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.983 -176.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.5 m -80.63 102.26 9.72 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.958 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.5 pt -101.83 146.11 10.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.132 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 44.2 tp -98.85 110.99 23.51 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.621 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.55 HG22 ' HB ' ' A' ' 155' ' ' VAL . 96.7 t -107.22 117.59 53.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.008 0.432 . . . . 0.0 110.359 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 26.3 ttt180 -85.64 101.25 12.56 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 176.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.486 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 0.5 OUTLIER . . . . . 0 CA--C 1.507 -0.678 0 CA-C-O 121.992 0.901 . . . . 0.0 112.638 -173.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.765 0.317 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 45.7 m -101.25 103.38 14.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.889 0.376 . . . . 0.0 110.135 177.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 m -99.22 138.36 36.43 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.647 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.4 m -90.04 115.65 27.47 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -101.0 136.27 41.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.917 0.389 . . . . 0.0 110.844 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -93.0 106.39 18.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.348 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.53 -179.54 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.225 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 58.5 mtm-85 -124.86 158.14 34.2 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.5 mp -67.1 -35.71 80.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.029 -176.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -89.87 14.65 11.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.276 0.56 . . . . 0.0 110.882 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -92.96 131.07 38.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.972 0.415 . . . . 0.0 110.004 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.634 ' HB ' ' OD1' ' A' ' 140' ' ' ASP . 3.2 p -74.03 159.21 33.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.646 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 83.3 t -63.87 -32.18 56.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.407 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.42 -41.85 73.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.79 176.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -65.18 -28.34 69.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.039 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.597 ' HB2' HD11 ' A' ' 144' ' ' LEU . 63.3 tp -82.25 -46.97 12.99 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 175.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -58.28 -46.55 85.85 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.571 -176.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -65.28 -30.81 71.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -70.21 -43.62 70.3 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.546 0.689 . . . . 0.0 109.466 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.35 -35.19 60.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.298 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.813 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 41.1 m -69.25 -18.64 63.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.942 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.68 -39.12 41.37 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.53 174.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.7 mp -95.04 -64.98 1.01 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.981 0.42 . . . . 0.0 111.852 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 124' ' ' VAL . 21.9 mm-40 -95.12 8.86 41.65 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 123.724 0.81 . . . . 0.0 111.035 -173.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.813 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -45.7 8.91 0.01 OUTLIER Glycine 0 N--CA 1.471 1.031 0 N-CA-C 119.028 2.371 . . . . 0.0 119.028 -173.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 122' ' ' GLU . 31.8 t -51.78 81.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 118.758 1.279 . . . . 0.0 112.575 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.432 ' HB2' HD12 ' A' ' 128' ' ' LEU . 23.7 mp0 60.8 118.03 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.226 1.011 . . . . 0.0 113.455 172.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -53.32 -28.78 30.2 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.293 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -76.07 -24.67 55.11 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.469 -176.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.441 HD12 HG12 ' A' ' 124' ' ' VAL . 92.2 mt -89.26 -36.41 15.62 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -174.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -113.35 140.88 47.67 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.861 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -153.47 154.68 34.85 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 172.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.593 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 6.4 mp -114.65 149.56 36.5 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.838 -175.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 66.6 p -126.0 144.65 50.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.826 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.486 ' C ' ' H ' ' A' ' 135' ' ' GLY . 73.0 t80 -129.23 140.12 51.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 168.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 69.78 -43.93 0.54 Allowed 'General case' 0 CA--C 1.536 0.416 0 O-C-N 123.833 0.708 . . . . 0.0 110.426 -176.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 133' ' ' PHE . . . 156.01 -18.8 0.48 Allowed Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -176.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -91.61 146.99 34.24 Favored Pre-proline 0 C--O 1.236 0.356 0 CA-C-N 115.315 -0.443 . . . . 0.0 109.94 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.27 147.61 66.37 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.541 2.16 . . . . 0.0 111.345 175.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 70.8 mt -70.59 108.15 4.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.789 0.328 . . . . 0.0 111.006 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -92.44 130.08 38.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.601 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.634 ' OD1' ' HB ' ' A' ' 110' ' ' THR . 36.5 t70 -72.45 -6.67 45.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.534 -175.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -74.12 -14.11 60.92 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.487 0.66 . . . . 0.0 109.904 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.469 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 88.5 mt -120.16 131.71 24.33 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.95 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 142' ' ' LEU . 28.0 Cg_exo -62.46 148.94 92.52 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.673 2.249 . . . . 0.0 112.004 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.597 HD11 ' HB2' ' A' ' 114' ' ' LEU . 83.2 mt -59.88 -25.39 65.05 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -176.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -61.16 -27.35 67.26 Favored Glycine 0 C--O 1.226 -0.396 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.505 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -72.32 -21.09 61.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.875 0.369 . . . . 0.0 111.184 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -100.3 -45.14 5.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.312 0.577 . . . . 0.0 110.606 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.479 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -100.16 6.67 58.21 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-O 119.227 -0.763 . . . . 0.0 113.973 -171.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.474 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.3 pt? -34.38 -41.32 0.11 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 88.4 tttt -91.23 119.88 68.61 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.533 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 17.4 Cg_exo -66.13 81.38 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.117 2.544 . . . . 0.0 112.199 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 151' ' ' PRO . 7.3 tt 167.75 -26.56 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.787 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.3 m -45.55 125.45 5.83 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.376 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 23.9 m -97.72 120.6 38.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.303 -175.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.55 ' HB ' HG22 ' A' ' 93' ' ' VAL . 61.7 t -99.96 133.04 44.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.338 176.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -103.82 124.81 49.6 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.079 0.466 . . . . 0.0 111.045 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.593 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 25.2 ttt -81.75 131.06 35.25 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 175.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -120.51 145.21 47.52 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.109 -175.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 50.9 mt -125.16 137.73 54.15 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 160' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.607 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 177.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo . . . . . 0 N--CA 1.461 -0.415 0 CA-C-O 121.085 0.369 . . . . 0.0 111.659 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.464 ' HG ' HG23 ' A' ' 91' ' ' ILE . 58.0 tp -85.3 107.51 17.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.233 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.447 ' HB3' HG22 ' A' ' 102' ' ' THR . 24.3 m -87.33 102.68 14.75 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.624 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.464 HG23 ' HG ' ' A' ' 89' ' ' LEU . 36.8 pt -102.84 157.79 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.023 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 154' ' ' THR . 37.4 tp -103.51 102.99 12.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.131 0.491 . . . . 0.0 110.922 -176.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.537 HG22 ' HB ' ' A' ' 155' ' ' VAL . 58.8 t -107.46 123.78 62.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.987 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -89.55 135.04 33.83 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.125 0.488 . . . . 0.0 110.2 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.407 HD21 ' HB2' ' A' ' 99' ' ' ARG . 4.1 p30 . . . . . 0 C--N 1.313 -1.0 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.915 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.407 ' HB2' HD21 ' A' ' 95' ' ' ASN . 33.5 mtp180 . . . . . 0 N--CA 1.454 -0.255 0 CA-C-O 121.131 0.491 . . . . 0.0 111.417 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.1 m -113.54 106.97 15.18 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.15 176.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.8 m -106.16 130.62 54.01 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.213 0.53 . . . . 0.0 111.004 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.447 HG22 ' HB3' ' A' ' 90' ' ' SER . 23.5 m -86.54 105.04 16.55 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.451 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.484 ' CD2' ' HB ' ' A' ' 93' ' ' VAL . 87.4 m-85 -91.27 134.23 34.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.744 -177.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -89.48 95.63 10.36 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.42 HG11 HD13 ' A' ' 114' ' ' LEU . 31.6 m -109.44 163.67 6.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.595 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.579 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 0.7 OUTLIER -110.98 146.97 35.72 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.154 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.511 HD23 ' HA3' ' A' ' 145' ' ' GLY . 6.7 mp -60.74 -35.41 76.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.719 -172.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.8 p -98.73 9.48 43.27 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -172.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.579 ' HG2' ' O ' ' A' ' 106' ' ' ARG . 10.0 pt20 -81.07 -8.93 59.87 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.653 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.6 p 64.19 159.11 0.09 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.066 1.346 . . . . 0.0 111.346 -175.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.581 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 48.4 t -63.85 -21.02 27.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.052 0.454 . . . . 0.0 109.979 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.57 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -58.21 -41.53 84.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.869 176.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -69.74 -36.51 75.9 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 120.745 0.307 . . . . 0.0 110.325 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.42 HD13 HG11 ' A' ' 105' ' ' VAL . 62.3 tp -66.92 -43.61 82.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.891 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -65.82 -28.18 68.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.349 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.513 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 35.0 tt0 -76.01 -34.77 59.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.588 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -60.21 -48.71 80.6 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.797 0.808 . . . . 0.0 108.909 171.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.46 -40.66 84.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.032 174.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.846 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 25.2 p -66.07 -14.75 62.27 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.843 0.354 . . . . 0.0 111.08 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.17 -44.03 8.34 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.656 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.3 mt -91.15 -59.9 2.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.044 0.45 . . . . 0.0 112.197 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 124' ' ' VAL . 4.4 tp10 -100.38 9.42 42.67 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 123.524 0.73 . . . . 0.0 110.396 -174.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.846 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -45.71 7.95 0.01 OUTLIER Glycine 0 N--CA 1.473 1.108 0 N-CA-C 118.69 2.236 . . . . 0.0 118.69 -172.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 122' ' ' GLU . 40.6 t -49.46 85.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 118.167 0.984 . . . . 0.0 112.276 174.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.409 ' HB2' HD12 ' A' ' 128' ' ' LEU . 2.3 mp0 56.29 106.81 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.586 0.754 . . . . 0.0 112.241 176.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -51.26 -24.17 4.21 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.746 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -81.51 -20.71 39.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.01 -175.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.461 HD12 HG12 ' A' ' 124' ' ' VAL . 96.7 mt -81.46 -14.84 56.58 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -175.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.417 ' HB3' HD23 ' A' ' 159' ' ' LEU . 54.4 p90 -133.82 151.11 51.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.451 0.643 . . . . 0.0 111.816 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.414 ' HD1' ' HB3' ' A' ' 137' ' ' PRO . 0.8 OUTLIER -149.25 157.07 43.04 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 172.936 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.651 HD12 HG11 ' A' ' 155' ' ' VAL . 1.3 pt? -123.57 135.85 54.21 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.727 -172.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 41.3 p -116.19 131.7 56.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.845 -178.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.553 ' CE2' ' HB2' ' A' ' 134' ' ' GLU . 8.4 t80 -94.16 -89.67 0.22 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.523 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.553 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 10.8 tt0 -98.42 25.44 6.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.561 0.696 . . . . 0.0 110.385 -170.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 133.25 -37.43 2.0 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.75 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 54.3 mmtt -117.18 156.21 48.85 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 120.54 0.209 . . . . 0.0 110.917 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 132' ' ' THR . 48.2 Cg_endo -69.25 152.99 71.94 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.121 2.547 . . . . 0.0 112.79 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.463 ' HB3' HG21 ' A' ' 111' ' ' VAL . 85.9 mt -94.6 121.72 36.45 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.767 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -84.81 146.09 27.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.589 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.581 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 6.7 p-10 -61.22 -22.05 64.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.54 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -73.42 -15.78 61.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.176 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 77.1 mt -102.14 140.17 20.93 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 121.121 0.486 . . . . 0.0 111.516 -172.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 142' ' ' LEU . 12.7 Cg_exo -71.23 144.1 45.53 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.983 2.456 . . . . 0.0 111.08 173.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.643 HD12 ' H ' ' A' ' 144' ' ' LEU . 4.1 mp -71.54 -33.9 69.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.998 -174.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.511 ' HA3' HD23 ' A' ' 107' ' ' LEU . . . -59.63 -30.29 68.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.286 -0.483 . . . . 0.0 113.686 -172.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.65 -41.26 94.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.049 0.452 . . . . 0.0 111.029 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -101.55 -30.2 11.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.529 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.445 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -98.97 6.73 60.24 Favored Glycine 0 C--O 1.227 -0.299 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.625 -172.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -41.09 -31.22 0.18 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -92.71 126.54 51.47 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.295 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -68.15 6.38 0.88 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.958 2.439 . . . . 0.0 112.922 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 97.7 mt -112.24 7.41 19.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.05 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.4 p -62.39 117.94 6.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.943 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 15.0 m -101.51 106.66 17.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.408 -175.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.651 HG11 HD12 ' A' ' 131' ' ' LEU . 25.6 t -99.33 140.09 19.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.427 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -109.81 118.3 36.13 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.434 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 2.1 ttm -81.37 106.49 13.37 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -98.82 135.03 40.87 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.741 -172.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.417 HD23 ' HB3' ' A' ' 129' ' ' PHE . 49.1 mt -102.88 -167.68 1.42 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.638 173.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 . . . . . 0 N--CA 1.466 0.369 0 CA-C-O 121.85 0.833 . . . . 0.0 111.754 174.482 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.454 -0.798 0 N-CA-C 110.863 -0.476 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.9 tp -84.21 110.66 18.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.333 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.7 m -88.64 112.91 23.64 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.061 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.5 pt -107.08 134.75 47.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.529 HD11 ' HB3' ' A' ' 100' ' ' SER . 30.2 tp -93.1 101.37 13.67 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.593 -174.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.9 t -84.7 99.8 7.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -97.39 93.93 6.77 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.703 -174.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.593 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 6.1 p30 . . . . . 0 C--O 1.237 0.422 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.408 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 . . . . . 0 CA--C 1.521 -0.135 0 CA-C-O 120.986 0.422 . . . . 0.0 111.651 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.529 ' HB3' HD11 ' A' ' 92' ' ' LEU . 18.6 m -96.5 109.04 21.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.867 174.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.2 m -111.89 112.69 24.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.108 0.48 . . . . 0.0 110.638 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.4 m -76.66 121.92 23.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.515 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -111.81 132.13 54.88 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.96 0.41 . . . . 0.0 110.553 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -81.98 130.4 35.06 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.734 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.2 m -146.36 -179.96 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.765 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 39.7 mtm-85 -138.35 169.96 16.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.175 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.9 mp -73.03 -10.47 59.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.779 0.323 . . . . 0.0 111.43 -175.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 m -85.73 0.46 52.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.221 0.534 . . . . 0.0 110.669 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.489 ' HB3' HD12 ' A' ' 144' ' ' LEU . 13.3 mm100 -86.58 136.46 33.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.089 0.471 . . . . 0.0 111.521 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.5 p -94.7 166.83 11.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.231 175.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 64.2 t -60.39 -40.61 84.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.088 0.471 . . . . 0.0 109.731 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.418 ' O ' ' HG3' ' A' ' 116' ' ' GLN . . . -53.74 -48.35 69.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.898 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.457 ' HB3' ' NE2' ' A' ' 109' ' ' GLN . 3.6 m170 -63.71 -25.77 68.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.835 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.769 ' HB2' HD11 ' A' ' 144' ' ' LEU . 63.7 tp -83.48 -43.18 16.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.915 0.388 . . . . 0.0 110.181 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -60.15 -37.98 81.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.545 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 112' ' ' ALA . 55.5 mt-30 -64.93 -38.19 90.14 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 122.955 0.159 . . . . 0.0 111.41 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -63.37 -50.09 71.3 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.12 0.486 . . . . 0.0 109.786 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.4 t -57.34 -44.29 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.753 174.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.727 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 66.6 m -62.25 -22.2 65.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.086 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.61 -39.53 21.22 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.28 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -94.74 -64.9 1.02 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.1 0.476 . . . . 0.0 111.828 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -100.41 8.55 43.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.135 -174.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.727 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -55.81 7.26 0.01 OUTLIER Glycine 0 CA--C 1.521 0.466 0 N-CA-C 116.481 1.353 . . . . 0.0 116.481 -172.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 64.4 t -41.82 92.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 123.552 0.741 . . . . 0.0 111.777 173.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 52.97 106.23 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 O-C-N 123.858 0.724 . . . . 0.0 111.744 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.629 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 9.2 p-10 -69.11 1.9 3.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.439 0.638 . . . . 0.0 110.403 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -75.53 -33.63 60.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.676 169.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 93.5 mt -79.34 -33.37 43.12 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.323 -173.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.629 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 52.2 p90 -105.78 121.4 43.97 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.658 -0.817 . . . . 0.0 112.045 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.552 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 37.2 t90 -132.29 104.22 6.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.369 176.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.721 HD23 ' H ' ' A' ' 131' ' ' LEU . 2.4 pt? -96.77 140.69 30.97 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.496 0.665 . . . . 0.0 112.046 -170.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 76.8 p -128.05 144.97 51.13 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.067 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -109.02 -72.0 0.74 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.645 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.615 ' HB3' ' HG2' ' A' ' 136' ' ' LYS . 24.2 tt0 -92.29 32.61 1.16 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.535 -171.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.9 11.53 85.12 Favored Glycine 0 CA--C 1.509 -0.343 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -169.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.615 ' HG2' ' HB3' ' A' ' 134' ' ' GLU . 0.5 OUTLIER -134.2 149.56 71.72 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 114.474 -0.863 . . . . 0.0 109.328 -178.379 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.78 150.59 78.98 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.175 1.917 . . . . 0.0 111.115 173.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 76.1 mt -74.21 109.28 7.58 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.82 122.17 26.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.741 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.4 53.06 1.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.191 0.995 . . . . 0.0 110.569 -176.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.77 ' HG3' ' HG ' ' A' ' 142' ' ' LEU . 8.5 pt20 -129.97 -7.95 4.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.823 175.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.77 ' HG ' ' HG3' ' A' ' 141' ' ' GLN . 81.2 mt -127.22 157.01 73.76 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.781 -175.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.68 145.5 25.96 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.1 1.866 . . . . 0.0 111.789 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.769 HD11 ' HB2' ' A' ' 114' ' ' LEU . 79.6 mt -62.2 -23.01 66.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.468 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -57.67 -34.87 71.41 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.326 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -77.47 -24.09 50.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.233 0.517 . . . . 0.0 110.988 -176.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -91.11 -39.0 12.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.302 0.573 . . . . 0.0 110.629 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.05 6.37 59.9 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.655 -172.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -41.41 -32.18 0.3 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.462 ' HG2' ' H ' ' A' ' 152' ' ' LEU . 24.7 ttmm -83.18 114.98 56.62 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 173.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 16.8 Cg_exo -68.52 20.58 0.14 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.566 2.844 . . . . 0.0 113.427 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.462 ' H ' ' HG2' ' A' ' 150' ' ' LYS . 54.3 mt -146.93 19.73 1.27 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.588 177.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.8 p -64.97 127.27 30.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.752 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.3 m -94.59 100.72 12.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.904 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.4 t -92.6 111.49 24.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -79.13 102.35 8.41 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.042 -175.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.593 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 22.8 ttt -76.44 90.91 3.28 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.552 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 11.2 m120 -74.5 131.03 40.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.391 -173.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 76.6 mt -96.92 114.66 26.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.144 0.497 . . . . 0.0 110.164 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.785 -176.879 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo . . . . . 0 N--CA 1.454 -0.808 0 N-CA-C 111.047 -0.405 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.643 HD21 ' O ' ' A' ' 148' ' ' GLY . 55.1 tp -92.22 155.82 17.73 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 6.5 t -131.61 130.7 42.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.885 0.374 . . . . 0.0 110.013 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.465 HD12 HG21 ' A' ' 155' ' ' VAL . 35.4 pt -127.88 150.71 33.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.847 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.45 HD11 ' HB2' ' A' ' 100' ' ' SER . 50.6 tp -93.24 113.7 25.97 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.0 0.428 . . . . 0.0 110.762 -177.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 63.6 t -98.62 113.47 33.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.742 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -110.73 114.98 28.76 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.763 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.614 HD22 ' N ' ' A' ' 99' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.476 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.287 -178.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.614 ' N ' HD22 ' A' ' 95' ' ' ASN . 23.0 tpp180 . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 121.261 0.553 . . . . 0.0 112.455 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.45 ' HB2' HD11 ' A' ' 92' ' ' LEU . 12.7 p -115.86 106.51 13.91 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 167.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.0 t -118.24 133.01 56.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.993 0.425 . . . . 0.0 110.74 -175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.72 100.69 13.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.119 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 90' ' ' SER . 84.5 m-85 -90.66 166.04 13.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.834 0.349 . . . . 0.0 111.093 -176.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -103.97 128.98 51.52 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.374 0.606 . . . . 0.0 110.906 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.2 m -139.56 -179.44 2.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.713 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.47 ' HB2' ' HG2' ' A' ' 109' ' ' GLN . 67.8 mtp85 -132.13 164.42 26.33 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 174.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 107' ' ' LEU . 6.7 mp -82.23 -39.14 23.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.016 0.436 . . . . 0.0 110.135 176.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.1 m -92.12 66.15 4.85 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.292 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.47 ' HG2' ' HB2' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -156.43 157.99 36.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.789 174.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.523 ' HB ' ' O ' ' A' ' 140' ' ' ASP . 14.8 p -88.58 144.92 26.01 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.651 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 47.2 t -56.73 -19.25 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 120.925 0.393 . . . . 0.0 111.224 -177.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -55.81 -34.64 65.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.947 0.403 . . . . 0.0 110.713 173.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -74.23 -15.62 60.99 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.204 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.714 HD22 HD11 ' A' ' 144' ' ' LEU . 65.3 tp -92.46 -53.24 4.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.033 0.444 . . . . 0.0 110.028 174.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -61.44 -40.02 92.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.53 -173.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -69.1 -31.8 70.77 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.478 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -68.27 -44.81 74.72 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.87 -35.67 61.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.548 173.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.769 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 62.3 m -72.49 -14.96 61.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.451 178.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.76 -39.36 21.16 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.438 175.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.1 mp -94.85 -64.39 1.07 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.132 0.491 . . . . 0.0 111.8 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -96.81 8.3 44.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.62 -173.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.769 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -54.35 7.66 0.01 OUTLIER Glycine 0 CA--C 1.522 0.531 0 N-CA-C 118.02 1.968 . . . . 0.0 118.02 -169.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.471 HG12 HD12 ' A' ' 128' ' ' LEU . 57.7 t -43.23 93.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 118.122 0.961 . . . . 0.0 112.316 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 57.37 109.11 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.605 0.762 . . . . 0.0 111.753 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.466 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 39.1 t70 -60.22 -6.67 1.54 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.639 -176.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -96.48 -19.29 19.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.666 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.471 HD12 HG12 ' A' ' 124' ' ' VAL . 64.9 mt -79.04 -39.78 33.07 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.716 -176.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.466 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 29.6 p90 -96.59 94.71 7.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.948 0.88 . . . . 0.0 111.447 -177.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.665 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 34.1 t90 -90.12 87.6 6.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.29 176.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.604 HD23 ' H ' ' A' ' 131' ' ' LEU . 2.7 pt? -88.0 139.7 30.24 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.212 0.53 . . . . 0.0 110.652 -176.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.02 159.69 44.39 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.15 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.478 ' CD2' ' HB2' ' A' ' 134' ' ' GLU . 13.5 t80 -102.71 -74.51 0.63 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.934 -175.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.478 ' HB2' ' CD2' ' A' ' 133' ' ' PHE . 7.8 tp10 -98.49 21.26 11.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.176 0.512 . . . . 0.0 110.702 -171.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.36 9.17 62.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.512 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.495 ' HD3' ' O ' ' A' ' 137' ' ' PRO . 14.4 tmtt? -122.56 122.37 27.31 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.495 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 27.2 Cg_exo -58.91 152.75 55.66 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.785 2.324 . . . . 0.0 112.296 -176.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 44.8 mt -103.29 97.08 7.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.242 -174.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.42 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 2.6 mp0 -63.73 134.4 55.26 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 173.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.651 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 5.6 p-10 -65.54 -22.41 66.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.085 -174.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -81.89 -10.39 59.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.838 0.351 . . . . 0.0 111.202 -177.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.42 ' HG ' ' HB2' ' A' ' 139' ' ' GLU . 79.6 mt -90.55 157.06 44.88 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.977 -176.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 109' ' ' GLN . 3.0 Cg_exo -75.23 128.73 11.53 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.978 2.452 . . . . 0.0 111.686 177.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.714 HD11 HD22 ' A' ' 114' ' ' LEU . 5.1 tt -62.53 -36.72 83.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.33 -177.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -52.11 -28.91 27.24 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 114.392 0.517 . . . . 0.0 114.392 -176.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -61.63 -38.07 86.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.159 0.504 . . . . 0.0 110.481 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -100.71 -33.11 10.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.157 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.643 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -96.86 6.18 64.34 Favored Glycine 0 C--O 1.223 -0.593 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.761 -172.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.7 pt? -46.79 -25.98 0.86 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.463 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 66.6 mttm -96.84 133.89 23.79 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 17.1 Cg_exo -67.87 2.57 2.46 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.93 2.42 . . . . 0.0 111.878 176.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -124.58 11.34 8.54 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.046 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 46.7 m -60.52 110.22 1.22 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.926 0.393 . . . . 0.0 110.276 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 19.8 m -84.32 101.33 11.87 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.453 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.465 HG21 HD12 ' A' ' 91' ' ' ILE . 56.4 t -87.63 115.08 27.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.62 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -87.95 103.18 15.44 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.321 0.582 . . . . 0.0 110.745 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.421 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 26.4 ttt -77.17 87.19 3.63 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.842 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.665 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 23.3 m-80 -77.71 88.09 3.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.417 -174.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.63 94.1 3.16 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 172.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.889 -171.679 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 N--CA 1.447 -1.25 0 CA-C-O 121.379 0.491 . . . . 0.0 112.783 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 148' ' ' GLY . 0.2 OUTLIER -97.98 125.75 43.07 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.031 177.617 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -89.11 99.18 12.22 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.008 0.433 . . . . 0.0 110.193 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 45.8 pt -101.6 163.72 3.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.218 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.541 HD11 ' HB3' ' A' ' 100' ' ' SER . 23.8 tp -119.2 111.27 18.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.778 0.323 . . . . 0.0 110.587 -178.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.421 HG22 ' HB ' ' A' ' 155' ' ' VAL . 61.7 t -110.38 112.55 41.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -90.24 125.2 35.4 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.929 0.395 . . . . 0.0 110.861 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.496 ' HA ' ' SD ' ' A' ' 157' ' ' MET . 12.2 m-20 . . . . . 0 C--N 1.325 -0.459 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 99' ' ' ARG . 14.8 ptt180 . . . . . 0 C--O 1.234 0.275 0 CA-C-O 121.144 0.497 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.541 ' HB3' HD11 ' A' ' 92' ' ' LEU . 12.4 m -81.95 106.87 14.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.851 175.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.0 m -85.66 103.74 14.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.153 0.501 . . . . 0.0 110.488 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.5 m -77.39 115.51 17.22 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.991 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -107.09 131.76 53.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.059 0.457 . . . . 0.0 111.79 -175.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -95.24 103.11 14.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.488 -0.778 . . . . 0.0 108.915 173.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.526 HG11 HD13 ' A' ' 114' ' ' LEU . 33.1 m -129.3 137.61 56.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.896 0.379 . . . . 0.0 111.151 -175.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.451 HH11 ' HD3' ' A' ' 106' ' ' ARG . 22.1 mtm180 -83.06 149.83 26.69 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.864 0.364 . . . . 0.0 110.44 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 107' ' ' LEU . 6.6 mp -69.09 -18.47 63.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.957 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.3 m -80.59 1.03 31.39 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.367 0.604 . . . . 0.0 110.763 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -92.97 152.57 19.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.483 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 p -90.36 157.46 17.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.888 172.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.618 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 59.2 t -58.94 -30.88 44.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.034 0.445 . . . . 0.0 110.865 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.551 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -55.21 -39.51 69.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.397 177.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.583 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 5.9 t60 -65.65 -37.19 85.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.134 -178.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.526 HD13 HG11 ' A' ' 105' ' ' VAL . 50.8 tp -67.69 -50.49 57.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.666 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -63.09 -38.75 92.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.093 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 7.2 tp60 -66.7 -29.17 69.09 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.089 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.583 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 93.8 mt-30 -63.47 -49.66 72.76 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 172.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.1 t -59.58 -49.2 84.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.811 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.878 ' HA ' ' HA3' ' A' ' 123' ' ' GLY . 67.4 m -59.51 -20.26 54.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.762 178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -79.31 -36.49 26.97 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.105 176.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 82.7 mt -96.74 -69.15 0.77 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.03 0.443 . . . . 0.0 112.098 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -97.13 7.11 47.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.358 0.599 . . . . 0.0 110.014 -176.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.878 ' HA3' ' HA ' ' A' ' 119' ' ' SER . . . -62.25 7.18 0.22 Allowed Glycine 0 C--O 1.226 -0.374 0 N-CA-C 116.334 1.294 . . . . 0.0 116.334 -170.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.414 HG12 HD12 ' A' ' 128' ' ' LEU . 59.3 t -31.08 93.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.911 0.884 . . . . 0.0 112.648 177.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 53.31 111.78 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 O-C-N 123.913 0.758 . . . . 0.0 112.545 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -63.32 -4.31 2.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.716 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -88.05 -24.68 23.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.041 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.414 HD12 HG12 ' A' ' 124' ' ' VAL . 93.7 mt -85.58 -42.35 14.44 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.542 0.21 . . . . 0.0 111.32 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.587 ' CE1' ' HA2' ' A' ' 123' ' ' GLY . 11.5 p90 -114.83 152.57 31.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.017 0.437 . . . . 0.0 110.477 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.727 ' CD1' ' HG3' ' A' ' 137' ' ' PRO . 1.0 OUTLIER -162.13 135.68 6.32 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 169.082 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.601 HD13 HG11 ' A' ' 155' ' ' VAL . 2.1 pp -98.22 144.79 27.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.309 0.576 . . . . 0.0 111.691 -173.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 25.7 p -120.09 152.05 38.15 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.721 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.517 ' HB3' HD21 ' A' ' 138' ' ' LEU . 14.7 t80 -137.11 -60.43 0.68 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.995 0.426 . . . . 0.0 110.796 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.439 ' C ' ' H ' ' A' ' 136' ' ' LYS . 1.8 tm-20 -81.79 35.62 0.42 Allowed 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.69 -29.58 2.96 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -170.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.492 ' HB2' ' HD2' ' A' ' 137' ' ' PRO . 22.7 pttp -118.05 173.68 3.12 Favored Pre-proline 0 N--CA 1.446 -0.66 0 CA-C-N 115.026 -0.587 . . . . 0.0 109.838 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.727 ' HG3' ' CD1' ' A' ' 130' ' ' TRP . 24.7 Cg_exo -62.38 171.73 5.08 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.376 2.051 . . . . 0.0 111.899 175.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.527 ' HB2' HG11 ' A' ' 111' ' ' VAL . 93.5 mt -101.92 146.06 28.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.44 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -74.3 112.3 10.33 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.618 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.9 p-10 -60.97 -26.79 67.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.819 -174.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -77.72 -19.67 54.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.382 -175.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 61.5 mt -93.2 156.25 40.34 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.732 0.301 . . . . 0.0 110.966 -174.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.05 136.14 54.91 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.896 2.397 . . . . 0.0 112.236 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.507 HD11 HD22 ' A' ' 114' ' ' LEU . 3.0 tt -63.74 -35.78 81.71 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.831 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -59.04 -23.9 57.74 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.835 -0.62 . . . . 0.0 113.162 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -69.07 -30.74 69.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.002 0.401 . . . . 0.0 110.597 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -100.17 -29.24 12.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.147 0.499 . . . . 0.0 110.922 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.448 ' O ' ' HG ' ' A' ' 89' ' ' LEU . . . -100.27 5.58 57.52 Favored Glycine 0 C--O 1.219 -0.809 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.591 -174.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.405 HD23 ' N ' ' A' ' 149' ' ' LEU . 2.3 pt? -46.03 -32.61 2.91 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 22.7 tptm -97.41 116.68 65.92 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 17.4 Cg_exo -66.02 79.69 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.169 2.579 . . . . 0.0 111.806 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 49.2 tp 172.87 -25.06 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.105 -173.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.6 t -46.05 117.45 1.53 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.721 175.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 24.0 m -110.32 120.41 42.35 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.113 -175.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.601 HG11 HD13 ' A' ' 131' ' ' LEU . 42.7 t -98.19 135.9 31.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.614 177.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -111.98 124.82 53.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.811 0.339 . . . . 0.0 110.815 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.496 ' SD ' ' HA ' ' A' ' 95' ' ' ASN . 63.1 mtt -75.42 126.59 31.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.729 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -105.26 152.17 23.21 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.137 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 79.5 mt -115.77 144.91 43.31 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.413 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 160' ' ' ARG . 26.2 ttt180 . . . . . 0 C--N 1.321 -0.65 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.351 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo . . . . . 0 N--CA 1.454 -0.824 0 CA-C-O 121.187 0.411 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.537 HD21 ' O ' ' A' ' 148' ' ' GLY . 45.5 tp -110.67 123.63 50.38 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.873 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.6 m -90.55 99.66 12.65 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.008 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.4 pt -100.61 145.54 10.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' A' ' 100' ' ' SER . 23.9 tp -106.21 106.0 16.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.044 0.45 . . . . 0.0 110.256 -176.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 61.0 t -99.86 128.56 51.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.036 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.59 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 81.6 mtt180 -100.4 123.12 44.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.18 0.514 . . . . 0.0 110.875 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.963 178.682 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 94' ' ' ARG . 11.6 ttm180 . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.484 ' HB3' HD11 ' A' ' 92' ' ' LEU . 43.8 m -89.49 94.21 9.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.947 0.403 . . . . 0.0 110.155 177.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.8 m -98.95 127.93 44.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.625 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.8 m -88.42 109.39 19.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.554 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -93.86 121.24 35.1 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -86.43 101.84 13.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.815 0.817 . . . . 0.0 109.854 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.469 HG21 HD13 ' A' ' 144' ' ' LEU . 26.2 m -111.9 -177.94 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.623 -177.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.525 ' HG2' ' H ' ' A' ' 108' ' ' THR . 41.8 ttm180 -133.35 153.68 51.38 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.516 ' CD2' HD22 ' A' ' 89' ' ' LEU . 14.3 mt -75.68 -9.11 58.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.023 0.44 . . . . 0.0 110.571 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.525 ' H ' ' HG2' ' A' ' 106' ' ' ARG . 0.2 OUTLIER -91.44 5.2 50.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.313 -177.393 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -122.69 161.73 23.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.824 0.345 . . . . 0.0 110.464 177.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 32.6 p -89.93 167.56 12.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.821 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.637 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 60.4 t -59.82 -31.38 47.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.057 174.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.54 ' HB2' ' HB3' ' A' ' 140' ' ' ASP . . . -57.47 -35.18 69.83 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.028 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -68.49 -17.71 64.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.153 0.502 . . . . 0.0 110.591 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.563 HD22 HD11 ' A' ' 144' ' ' LEU . 48.1 tp -100.12 -48.18 4.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.197 0.523 . . . . 0.0 110.468 176.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.2 tttm -63.19 -41.52 99.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.181 -177.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.791 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 63.5 tt0 -79.69 -17.97 52.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.062 0.458 . . . . 0.0 110.438 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -67.7 -52.79 33.61 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 51.7 t -64.59 -42.35 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.314 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . 1.049 ' HA ' ' HA3' ' A' ' 123' ' ' GLY . 93.9 p -62.98 -32.13 73.41 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.965 0.412 . . . . 0.0 110.62 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.92 -29.3 70.96 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.862 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 78.7 mt -91.61 -77.02 0.43 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.688 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -103.26 -15.84 15.86 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 1.049 ' HA3' ' HA ' ' A' ' 119' ' ' SER . . . -42.35 -54.92 4.57 Favored Glycine 0 C--O 1.229 -0.201 0 N-CA-C 115.426 0.93 . . . . 0.0 115.426 -165.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.401 HG12 HD12 ' A' ' 128' ' ' LEU . 84.1 t 60.07 82.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.962 0.411 . . . . 0.0 110.443 -172.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.468 ' C ' ' H ' ' A' ' 127' ' ' ASP . 93.5 mt-30 58.56 112.08 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.135 -175.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.608 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 8.0 p-10 -72.69 19.34 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.059 0.457 . . . . 0.0 111.496 -176.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 125' ' ' GLN . 29.5 t70 -108.11 -25.08 11.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.278 175.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.401 HD12 HG12 ' A' ' 124' ' ' VAL . 97.9 mt -75.96 -11.54 59.98 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.091 0.472 . . . . 0.0 110.742 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.608 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 31.2 p90 -142.85 148.48 37.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.131 178.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.453 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 1.3 p90 -150.08 156.34 41.47 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.867 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 7.1 mp -112.64 149.53 32.7 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.567 -176.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.491 HG22 ' HA ' ' A' ' 137' ' ' PRO . 47.4 p -131.75 154.4 49.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.961 -178.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -139.23 130.62 26.97 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.301 171.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 70.66 -0.94 2.75 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 123.725 0.641 . . . . 0.0 111.037 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 111.59 -4.32 27.83 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.808 -174.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 137' ' ' PRO . 35.5 mtmm -106.6 134.85 19.64 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.627 0.251 . . . . 0.0 110.616 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.491 ' HA ' HG22 ' A' ' 132' ' ' THR . 7.6 Cg_exo -72.5 147.62 46.55 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.651 2.234 . . . . 0.0 111.266 174.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 37.7 mt -86.49 111.32 20.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.335 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -80.33 126.17 30.83 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.637 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 0.0 OUTLIER -61.18 -25.17 66.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.038 0.447 . . . . 0.0 111.036 -177.583 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 141' ' ' GLN . 11.6 pt20 -78.54 -0.43 29.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.3 -175.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.2 mt -120.76 151.69 54.87 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.666 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 41.1 Cg_endo -67.47 143.79 64.59 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.736 2.291 . . . . 0.0 111.568 176.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.563 HD11 HD22 ' A' ' 114' ' ' LEU . 0.5 OUTLIER -65.9 -27.3 68.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.746 -174.413 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.64 -28.15 56.04 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.127 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -58.32 -39.29 79.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.996 0.426 . . . . 0.0 110.954 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -100.07 -38.56 8.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.166 0.507 . . . . 0.0 111.081 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.537 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -96.06 6.54 66.62 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-O 119.223 -0.765 . . . . 0.0 114.255 -170.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -39.59 -31.73 0.11 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.469 ' C ' ' H ' ' A' ' 152' ' ' LEU . 34.6 ttpt -96.5 124.8 49.65 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 122.286 -0.259 . . . . 0.0 110.359 175.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 20.0 Cg_exo -67.92 24.3 0.13 Allowed 'Trans proline' 0 N--CA 1.477 0.547 0 C-N-CA 123.69 2.927 . . . . 0.0 113.301 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.469 ' H ' ' C ' ' A' ' 150' ' ' LYS . 34.8 tp -133.64 6.19 3.74 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.4 p -60.47 119.67 8.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.654 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.3 m -92.52 99.49 12.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.78 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 49.1 t -92.34 132.61 36.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.715 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -103.3 130.16 50.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.674 0.273 . . . . 0.0 110.746 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.867 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 26.2 ttt -85.01 97.97 10.13 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 176.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 39.2 m-80 -82.37 90.59 6.7 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.168 -173.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' A' ' 129' ' ' PHE . 43.6 mt -84.13 84.88 7.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.162 174.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 160' ' ' ARG . 5.1 mpt_? . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.215 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 N--CA 1.449 -1.142 0 CA-C-O 120.956 0.315 . . . . 0.0 111.657 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.471 ' HG ' HG23 ' A' ' 91' ' ' ILE . 52.9 tp -70.72 102.65 2.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.192 0.52 . . . . 0.0 110.527 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.8 m -95.58 95.49 8.41 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.832 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.471 HG23 ' HG ' ' A' ' 89' ' ' LEU . 28.8 pt -102.92 156.83 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.412 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.7 tp -96.38 108.01 20.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.063 0.458 . . . . 0.0 110.599 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.511 ' HB ' ' CD1' ' A' ' 103' ' ' TYR . 57.8 t -100.34 118.06 46.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.925 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.551 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 22.6 ttt85 -104.85 108.62 20.21 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.476 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.573 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 3.9 p-10 . . . . . 0 C--N 1.323 -0.584 0 CA-C-O 121.96 0.886 . . . . 0.0 111.687 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 . . . . . 0 N--CA 1.451 -0.379 0 CA-C-O 121.288 0.565 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 2.7 p -107.53 107.81 18.82 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.798 172.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.8 t -116.63 138.16 51.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.351 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.9 m -76.39 116.75 17.37 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.511 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 43.6 m-85 -104.37 148.46 26.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.978 0.418 . . . . 0.0 111.168 -177.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -102.31 110.3 22.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.016 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.4 -179.91 3.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.999 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.621 ' HB2' ' HG3' ' A' ' 109' ' ' GLN . 83.8 mtm180 -128.39 159.87 34.02 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.733 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 mp -81.27 -27.45 35.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.054 0.454 . . . . 0.0 110.13 -176.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.6 m -84.81 10.17 12.22 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.538 0.685 . . . . 0.0 110.861 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.621 ' HG3' ' HB2' ' A' ' 106' ' ' ARG . 28.3 mt-30 -95.05 143.24 26.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.641 172.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 24.9 p -79.64 156.65 27.53 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 170.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.614 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 99.3 t -59.39 -26.83 35.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.842 0.353 . . . . 0.0 110.391 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -58.1 -33.49 69.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.634 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -70.75 -43.11 69.53 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.473 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.605 ' HB2' HD11 ' A' ' 144' ' ' LEU . 64.6 tp -69.72 -37.27 76.47 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 112' ' ' ALA . 21.8 tptp -49.73 -51.43 38.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.82 176.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -65.19 -33.61 76.41 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.093 0.245 . . . . 0.0 111.642 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.47 -43.43 85.48 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.056 0.455 . . . . 0.0 110.177 174.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 114' ' ' LEU . 99.4 t -61.42 -42.6 94.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.648 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 53.8 m -60.69 -21.05 62.44 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.401 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -85.47 -27.21 33.43 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.669 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.7 mt -99.97 -66.49 0.9 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.133 0.492 . . . . 0.0 112.065 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -100.48 8.06 43.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.655 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.648 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -54.45 7.7 0.01 OUTLIER Glycine 0 CA--C 1.523 0.567 0 N-CA-C 117.186 1.634 . . . . 0.0 117.186 -172.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.1 t -31.02 95.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.852 0.861 . . . . 0.0 112.3 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 52.03 103.7 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 O-C-N 123.939 0.775 . . . . 0.0 110.855 -174.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.513 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 32.0 t70 -56.91 -13.05 2.31 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.74 -170.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -99.85 -16.21 18.13 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 60.6 mt -80.71 -13.79 58.69 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 121.964 -0.46 . . . . 0.0 112.026 -175.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.651 ' HB3' HD23 ' A' ' 159' ' ' LEU . 44.5 p90 -123.58 151.18 43.21 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.306 0.574 . . . . 0.0 111.934 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 4.0 p90 -149.38 158.13 43.91 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 172.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.74 ' HG ' ' HG2' ' A' ' 157' ' ' MET . 5.5 mp -105.64 135.54 46.86 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.165 -173.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 21.0 p -123.66 123.63 40.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.121 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -97.11 -69.65 0.75 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.914 0.387 . . . . 0.0 110.293 172.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -69.86 -31.63 69.57 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.724 0.773 . . . . 0.0 110.312 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 139.4 -24.57 2.78 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -169.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 137' ' ' PRO . 52.8 mtpt -84.99 151.68 57.78 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 114.478 -0.861 . . . . 0.0 109.911 172.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 21.3 Cg_exo -66.86 133.32 31.01 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.825 2.35 . . . . 0.0 111.914 176.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 37.8 mt -67.35 120.79 14.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.052 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -73.95 120.98 20.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.385 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.614 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.1 p-10 -68.19 -16.14 63.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.283 0.563 . . . . 0.0 110.428 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -84.03 -4.08 58.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.459 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 70.0 mt -112.52 158.29 37.77 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.194 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.61 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 57.6 Cg_endo -72.45 148.15 47.84 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.605 2.203 . . . . 0.0 112.864 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.605 HD11 ' HB2' ' A' ' 114' ' ' LEU . 20.5 mt -66.09 -37.17 85.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.196 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -59.66 -23.91 59.15 Favored Glycine 0 C--O 1.226 -0.396 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.788 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.507 ' HB2' ' HG2' ' A' ' 143' ' ' PRO . 2.5 tt0 -69.74 -29.58 66.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.885 0.374 . . . . 0.0 110.478 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -100.92 -38.97 7.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.292 0.568 . . . . 0.0 110.831 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.445 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -98.13 7.33 62.29 Favored Glycine 0 C--O 1.227 -0.342 0 CA-C-N 115.497 -0.774 . . . . 0.0 113.859 -169.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.5 pt? -38.9 -36.09 0.25 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -103.62 133.79 20.09 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.65 -7.42 9.04 Favored 'Trans proline' 0 N--CA 1.474 0.354 0 C-N-CA 122.889 2.393 . . . . 0.0 112.422 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 92.5 mt -94.57 -0.64 54.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.984 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 62.6 m -65.14 105.08 1.0 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.037 0.446 . . . . 0.0 110.09 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.1 m -82.25 101.32 10.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.142 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.442 ' HB ' HG22 ' A' ' 93' ' ' VAL . 49.1 t -81.91 106.24 12.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.074 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -83.12 103.06 12.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.164 0.506 . . . . 0.0 110.087 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.74 ' HG2' ' HG ' ' A' ' 131' ' ' LEU . 7.6 tmm? -78.79 112.37 15.86 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.04 113.26 24.93 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -168.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.651 HD23 ' HB3' ' A' ' 129' ' ' PHE . 54.8 mt -92.84 81.38 4.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.318 174.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 110.897 -178.098 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 N--CA 1.449 -1.094 0 N-CA-C 110.102 -0.768 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.41 ' CD1' ' HA ' ' A' ' 151' ' ' PRO . 0.1 OUTLIER -75.63 114.65 14.45 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.314 -173.382 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.6 t -82.37 95.44 7.64 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.9 pt -95.35 154.43 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.429 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 154' ' ' THR . 37.3 tp -106.72 114.39 28.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.941 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.3 t -109.37 118.83 57.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.039 0.447 . . . . 0.0 109.896 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 -90.29 132.74 35.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.241 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.465 0.32 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.966 -175.224 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 36.4 ttt-85 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.89 0.376 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.447 ' HB3' HD11 ' A' ' 92' ' ' LEU . 14.8 m -118.64 121.94 41.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.873 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.7 t -114.73 126.0 54.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.136 0.493 . . . . 0.0 109.903 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.8 m -90.14 134.48 34.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.981 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -132.64 139.2 47.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.516 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -99.58 107.38 19.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.957 0.408 . . . . 0.0 110.769 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.503 HG11 HD13 ' A' ' 114' ' ' LEU . 21.0 m -125.82 147.55 30.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.105 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -93.75 156.77 16.5 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.52 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.677 ' HG ' ' HA3' ' A' ' 145' ' ' GLY . 8.7 mp -65.44 -13.52 58.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.007 -175.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.2 t -88.58 3.72 49.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.831 0.348 . . . . 0.0 111.36 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -93.26 148.32 22.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.134 0.493 . . . . 0.0 111.02 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.1 p -85.14 159.96 20.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.977 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.545 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 55.8 t -62.17 -33.2 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.209 0.528 . . . . 0.0 109.87 175.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.524 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -64.43 -34.11 77.42 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.832 178.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.47 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 1.5 t60 -67.8 -41.85 82.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.962 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.738 HD22 HD11 ' A' ' 144' ' ' LEU . 62.2 tp -62.17 -45.75 92.02 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.111 173.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -55.13 -37.82 67.41 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.014 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -68.64 -35.39 77.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.758 0.314 . . . . 0.0 110.968 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 18.5 mt-30 -66.76 -45.45 78.49 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.485 0.66 . . . . 0.0 109.336 175.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.3 t -61.06 -36.76 74.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.613 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.829 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 72.5 m -66.82 -16.64 64.42 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.032 176.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.7 -35.75 35.15 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.654 174.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.7 mp -96.18 -71.55 0.67 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 124' ' ' VAL . 28.4 mm-40 -93.92 8.85 39.77 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.125 0.57 . . . . 0.0 111.109 -173.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.829 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -51.07 7.9 0.01 OUTLIER Glycine 0 N--CA 1.471 1.016 0 N-CA-C 118.09 1.996 . . . . 0.0 118.09 -170.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.417 ' N ' ' O ' ' A' ' 122' ' ' GLU . 28.1 t -54.73 82.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 118.154 0.977 . . . . 0.0 112.267 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.16 113.18 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.228 1.011 . . . . 0.0 112.348 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.537 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 1.8 p-10 -58.42 -12.89 4.31 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -173.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -72.75 -29.36 63.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.8 0.333 . . . . 0.0 110.414 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.9 mt -80.19 -39.5 29.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.903 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.537 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 25.8 p90 -109.67 105.04 14.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.946 0.879 . . . . 0.0 110.889 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.405 ' HE1' ' HG3' ' A' ' 137' ' ' PRO . 1.6 t90 -119.7 110.97 17.45 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.587 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.4 pp -92.41 152.19 19.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.075 0.464 . . . . 0.0 111.751 -172.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 13.8 p -140.71 154.82 46.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.121 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.444 ' CD2' ' HG3' ' A' ' 134' ' ' GLU . 10.3 t80 -125.0 -67.21 0.92 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.746 0.308 . . . . 0.0 110.863 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.444 ' HG3' ' CD2' ' A' ' 133' ' ' PHE . 46.3 mt-10 -77.85 3.54 14.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.08 0.467 . . . . 0.0 110.557 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.56 -24.19 27.95 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -168.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -92.99 158.21 37.88 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 114.873 -0.664 . . . . 0.0 109.551 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.405 ' HG3' ' HE1' ' A' ' 130' ' ' TRP . 3.5 Cg_exo -76.63 -2.42 12.64 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.075 2.517 . . . . 0.0 112.051 178.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 58.8 mt 70.67 -171.14 0.16 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.416 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -139.82 132.97 29.68 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.545 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.0 p-10 -70.47 -21.31 62.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.765 -174.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -65.15 -30.5 71.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.033 0.444 . . . . 0.0 110.871 177.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 72.5 mt -87.4 143.61 34.52 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.643 -176.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 142' ' ' LEU . 20.5 Cg_exo -64.05 131.8 32.0 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.642 2.228 . . . . 0.0 111.772 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.738 HD11 HD22 ' A' ' 114' ' ' LEU . 4.1 tt -55.27 -35.47 65.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.336 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.677 ' HA3' ' HG ' ' A' ' 107' ' ' LEU . . . -58.83 -23.37 56.06 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.638 -177.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -66.01 -31.24 72.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.221 0.51 . . . . 0.0 110.49 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -100.06 -29.11 12.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.151 0.5 . . . . 0.0 110.809 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.401 ' O ' ' HG ' ' A' ' 89' ' ' LEU . . . -100.09 5.73 57.89 Favored Glycine 0 C--O 1.222 -0.646 0 CA-C-N 115.652 -0.704 . . . . 0.0 113.937 -172.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.402 ' N ' HD23 ' A' ' 149' ' ' LEU . 2.5 pt? -46.28 -30.47 2.05 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -176.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.843 ' HD3' ' HD2' ' A' ' 151' ' ' PRO . 17.3 tppt? -89.21 119.73 69.75 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.843 ' HD2' ' HD3' ' A' ' 150' ' ' LYS . 48.6 Cg_endo -71.06 61.52 2.46 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.527 2.818 . . . . 0.0 112.165 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.4 tp -179.9 -26.79 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.307 -172.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.6 t -45.9 130.46 9.63 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.439 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 33.6 m -110.97 128.32 55.8 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.864 -173.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.8 t -99.1 138.57 23.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.027 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -110.1 117.0 32.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.964 0.411 . . . . 0.0 111.304 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 73.5 mtp -80.2 99.03 7.6 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.864 174.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -79.36 96.04 5.89 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.396 0.617 . . . . 0.0 110.442 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.35 106.1 4.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.707 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 70.9 ttp85 . . . . . 0 C--N 1.322 -0.595 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.125 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo . . . . . 0 N--CA 1.458 -0.597 0 CA-C-O 120.87 0.279 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.48 HD21 ' O ' ' A' ' 148' ' ' GLY . 65.7 tp -174.07 104.0 0.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.924 -175.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.8 m -85.33 105.96 16.37 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.005 0.431 . . . . 0.0 110.855 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 28.2 pt -106.8 145.47 14.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.162 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 14.5 tp -99.86 112.75 24.99 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 64.4 t -94.23 121.04 44.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.307 0.575 . . . . 0.0 111.44 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.405 ' HD3' ' HD1' ' A' ' 156' ' ' PHE . 21.4 ttt180 -85.17 118.55 24.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 175.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.406 ' OD1' ' HA ' ' A' ' 99' ' ' ARG . 9.1 p-10 . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.348 -167.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.406 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.184 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.9 p -169.16 59.58 0.05 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.52 0.676 . . . . 0.0 109.349 172.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.2 m -80.39 104.64 11.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.098 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 m -75.49 90.57 2.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.002 0.429 . . . . 0.0 110.094 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -82.87 117.35 22.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.907 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -86.28 101.14 12.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 173.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.4 m -121.04 -179.66 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.416 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -125.36 145.44 50.04 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.01 -12.11 52.77 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.981 -173.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.3 t -85.05 7.61 20.86 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.083 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -94.97 148.48 22.27 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.264 0.554 . . . . 0.0 111.806 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.64 ' HB ' ' OD1' ' A' ' 140' ' ' ASP . 9.4 p -82.02 166.86 19.43 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.188 170.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.09 -34.67 70.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.359 0.6 . . . . 0.0 109.688 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.53 -41.34 89.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.029 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -66.95 -15.49 63.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.937 0.399 . . . . 0.0 110.559 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.644 ' HB2' HD11 ' A' ' 144' ' ' LEU . 61.4 tp -91.89 -54.87 3.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.488 176.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -75.67 -10.01 59.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -172.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.859 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 63.7 tt0 -81.63 -31.86 32.19 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.048 0.451 . . . . 0.0 110.154 173.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -65.34 -35.78 82.04 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 172.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.23 -43.45 88.25 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.247 173.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.859 ' OG ' ' HA ' ' A' ' 116' ' ' GLN . 2.3 p -74.18 2.33 9.29 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.947 0.403 . . . . 0.0 111.69 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -92.42 -47.62 3.22 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.874 168.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.8 mt -86.71 -44.31 11.91 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.553 0.692 . . . . 0.0 111.267 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 124' ' ' VAL . 4.9 tp10 -98.29 10.55 40.42 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.227 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -29.35 6.62 0.0 OUTLIER Glycine 0 N--CA 1.486 2.003 0 N-CA-C 121.141 3.217 . . . . 0.0 121.141 -174.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' A' ' 122' ' ' GLU . 8.3 t -50.3 161.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 119.548 1.674 . . . . 0.0 109.407 169.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -42.54 136.99 2.27 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.339 0.59 . . . . 0.0 112.485 -175.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.643 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 28.2 t70 -61.01 -23.94 65.78 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.339 -172.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -89.42 -1.69 58.14 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.843 0.354 . . . . 0.0 110.873 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.499 HD12 HG12 ' A' ' 124' ' ' VAL . 74.6 mt -97.28 -28.02 14.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.64 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.643 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 42.5 p90 -103.55 113.84 27.65 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.076 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.403 ' HB3' ' O ' ' A' ' 158' ' ' ASN . 9.7 t90 -112.07 155.47 23.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.618 -176.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 5.5 mp -137.81 154.11 49.58 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.5 p -150.56 144.68 25.46 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.828 0.346 . . . . 0.0 111.2 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.543 ' CD2' ' HG2' ' A' ' 134' ' ' GLU . 14.8 t80 -135.31 -66.73 0.56 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.337 171.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.543 ' HG2' ' CD2' ' A' ' 133' ' ' PHE . 8.5 mm-40 -80.5 26.08 0.39 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.678 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.33 -9.35 67.47 Favored Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -173.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -124.38 162.81 40.04 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 131' ' ' LEU . 5.4 Cg_exo -74.92 4.07 5.02 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.179 2.586 . . . . 0.0 113.072 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 74.6 mt 73.8 142.22 0.07 Allowed 'General case' 0 N--CA 1.464 0.229 0 O-C-N 124.045 0.84 . . . . 0.0 110.996 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -85.52 124.18 31.79 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.35 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.64 ' OD1' ' HB ' ' A' ' 110' ' ' THR . 29.8 t70 -65.61 -22.14 66.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.343 0.592 . . . . 0.0 110.365 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -60.04 -26.91 66.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.504 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 87.8 mt -103.56 144.91 29.62 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.589 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 142' ' ' LEU . 14.4 Cg_exo -69.47 147.23 64.28 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.64 2.226 . . . . 0.0 112.027 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.644 HD11 ' HB2' ' A' ' 114' ' ' LEU . 76.6 mt -57.32 -33.19 67.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.659 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -56.23 -27.7 53.06 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.255 -0.498 . . . . 0.0 113.302 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.17 -43.92 83.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.097 0.475 . . . . 0.0 110.304 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -100.73 -28.53 12.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.811 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.48 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -96.41 5.76 65.24 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.517 -174.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.5 pt? -47.83 -27.7 2.21 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -91.13 110.23 40.88 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.462 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 16.9 Cg_exo -67.2 81.02 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.854 2.37 . . . . 0.0 111.913 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 151' ' ' PRO . 6.3 mt 162.86 -19.62 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.801 1.24 . . . . 0.0 109.683 -175.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.8 t -52.72 127.11 22.09 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.182 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.8 m -96.46 118.27 32.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.323 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.9 t -86.22 118.48 32.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.419 176.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.405 ' HD1' ' HD3' ' A' ' 94' ' ' ARG . 96.1 m-85 -88.79 99.25 12.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.045 0.45 . . . . 0.0 110.751 -177.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 24.6 ttt -80.08 98.66 7.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.303 0.573 . . . . 0.0 109.52 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 130' ' ' TRP . 4.6 m-20 -89.87 91.44 8.61 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.885 -177.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.4 tt -67.46 118.66 11.09 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 . . . . . 0 C--N 1.322 -0.595 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.653 -176.914 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo . . . . . 0 N--CA 1.454 -0.813 0 CA-C-O 121.423 0.509 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.554 HD11 ' HA ' ' A' ' 151' ' ' PRO . 29.1 tp -106.25 111.4 23.98 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.148 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.0 t -91.19 86.68 6.25 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.92 0.39 . . . . 0.0 110.301 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.5 pt -91.23 169.19 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.861 -176.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.517 HD11 ' HB2' ' A' ' 100' ' ' SER . 42.7 tp -108.54 106.12 16.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.042 0.448 . . . . 0.0 110.585 -177.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.0 t -97.69 116.0 39.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.5 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.56 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 71.6 mtp180 -96.99 157.86 15.7 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.013 0.435 . . . . 0.0 111.099 -177.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 C--N 1.321 -0.658 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.121 174.566 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 42.4 mtp-105 . . . . . 0 C--O 1.235 0.295 0 CA-C-O 121.343 0.592 . . . . 0.0 111.796 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 20.5 p -144.79 120.67 10.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.249 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.2 t -115.37 128.58 56.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.173 0.511 . . . . 0.0 110.196 -177.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.1 m -87.54 107.86 18.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.475 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -101.05 141.62 33.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.059 0.457 . . . . 0.0 111.901 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -83.85 102.37 12.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.243 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.6 m -114.66 -179.86 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 176.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.61 ' HB2' ' HG3' ' A' ' 109' ' ' GLN . 77.0 mtt85 -140.84 146.61 37.79 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.83 -31.16 72.26 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.267 0.354 . . . . 0.0 111.404 -173.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 m -75.97 -19.23 58.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.151 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.61 ' HG3' ' HB2' ' A' ' 106' ' ' ARG . 25.2 mt-30 -74.22 133.06 42.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.652 0.263 . . . . 0.0 110.39 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.799 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 23.2 p -71.3 159.26 34.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.302 174.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.634 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 59.2 t -60.59 -28.7 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.0 0.429 . . . . 0.0 110.462 177.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.94 -35.43 74.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.104 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.442 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 31.1 m80 -66.61 -42.89 86.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.446 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.852 ' HB2' HD11 ' A' ' 144' ' ' LEU . 60.6 tp -62.26 -44.98 95.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.46 175.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -62.01 -32.26 72.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.728 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 47.1 mt-30 -81.03 -21.09 40.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 0.0 111.59 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 51.8 mt-30 -73.58 -47.78 37.88 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 170.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 81.1 t -61.07 -40.65 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.085 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.946 ' HA ' ' HA3' ' A' ' 123' ' ' GLY . 91.6 p -65.5 -34.18 77.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.916 0.388 . . . . 0.0 110.406 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.29 -27.49 72.49 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.207 175.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 37.3 mt -98.72 -76.29 0.54 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 111.77 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.414 ' C ' ' H ' ' A' ' 124' ' ' VAL . 6.1 tp10 -102.21 8.18 40.63 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.228 0.611 . . . . 0.0 111.621 -174.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.946 ' HA3' ' HA ' ' A' ' 119' ' ' SER . . . -53.36 7.37 0.01 OUTLIER Glycine 0 CA--C 1.525 0.715 0 N-CA-C 117.213 1.645 . . . . 0.0 117.213 -172.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.414 ' H ' ' C ' ' A' ' 122' ' ' GLU . 87.1 t -38.02 97.39 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 123.623 0.769 . . . . 0.0 112.414 175.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.414 ' C ' ' H ' ' A' ' 127' ' ' ASP . 57.3 mt-30 48.08 102.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 O-C-N 124.087 0.867 . . . . 0.0 112.263 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.518 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 12.1 p-10 -71.67 17.87 0.08 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -174.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 125' ' ' GLN . 16.3 t70 -100.24 -21.54 15.45 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 171.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.0 mt -82.2 -16.41 49.77 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.914 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.518 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 25.8 p90 -143.32 159.9 41.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.666 0.269 . . . . 0.0 111.015 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -163.44 155.51 17.67 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.523 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 6.9 mp -106.81 146.95 30.29 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.44 -174.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 13.3 p -138.75 143.17 38.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.145 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.44 ' CD2' ' HB2' ' A' ' 134' ' ' GLU . 20.9 t80 -111.49 -74.62 0.63 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.131 0.491 . . . . 0.0 110.962 176.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.44 ' HB2' ' CD2' ' A' ' 133' ' ' PHE . 28.7 tt0 -93.51 14.55 18.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.41 0.624 . . . . 0.0 110.091 -173.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 102.51 -19.02 49.39 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 -169.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 137' ' ' PRO . 59.7 mttp -73.89 134.95 77.73 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 115.036 -0.582 . . . . 0.0 109.681 174.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 3.3 Cg_exo -77.31 4.66 5.69 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.994 2.463 . . . . 0.0 111.454 175.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 39.8 mt 69.98 -176.39 0.2 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.725 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.483 ' OE2' ' HG ' ' A' ' 142' ' ' LEU . 36.4 tt0 -145.33 121.1 10.55 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 174.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.634 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 1.2 p-10 -63.8 -22.08 66.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.35 0.595 . . . . 0.0 110.674 -175.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -74.69 -27.29 60.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.351 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.483 ' HG ' ' OE2' ' A' ' 139' ' ' GLU . 68.1 mt -94.15 157.05 38.31 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.837 0.351 . . . . 0.0 111.324 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.799 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 10.1 Cg_exo -72.67 151.42 52.11 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.071 2.514 . . . . 0.0 112.566 177.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.852 HD11 ' HB2' ' A' ' 114' ' ' LEU . 43.3 mt -66.67 -32.78 74.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.58 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.541 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -53.83 -34.88 51.88 Favored Glycine 0 C--N 1.332 0.326 0 O-C-N 123.314 0.384 . . . . 0.0 113.133 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -61.0 -33.11 72.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.871 0.367 . . . . 0.0 111.544 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -101.09 -42.07 6.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.723 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -100.13 6.95 58.39 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-O 119.358 -0.69 . . . . 0.0 114.349 -168.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.541 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.6 pt? -43.45 -29.0 0.4 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -175.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.635 ' HB3' ' HB3' ' A' ' 153' ' ' SER . 40.6 tptt -67.82 125.09 90.89 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.554 ' HA ' HD11 ' A' ' 89' ' ' LEU . 52.9 Cg_exo -56.13 -19.24 26.19 Favored 'Trans proline' 0 N--CA 1.478 0.604 0 C-N-CA 123.45 2.767 . . . . 0.0 114.09 -173.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.447 HD23 ' N ' ' A' ' 152' ' ' LEU . 1.5 pt? -132.8 34.21 3.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.228 0.537 . . . . 0.0 109.815 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.635 ' HB3' ' HB3' ' A' ' 150' ' ' LYS . 34.7 p -60.69 139.42 57.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.48 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.7 m -100.86 101.88 12.81 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.013 0.435 . . . . 0.0 111.11 -176.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.3 t -94.56 132.26 39.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -103.1 120.54 40.86 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.0 0.428 . . . . 0.0 111.027 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.523 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 1.7 tmt? -83.5 103.27 12.71 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -98.19 145.16 26.89 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.293 -172.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 95.3 mt -102.39 156.9 17.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.644 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 160' ' ' ARG . 7.4 tpt180 . . . . . 0 C--N 1.326 -0.42 0 O-C-N 123.94 0.775 . . . . 0.0 112.371 -174.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo . . . . . 0 N--CA 1.456 -0.693 0 CA-C-O 120.782 0.243 . . . . 0.0 111.485 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.3 tp -114.11 100.51 8.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.087 0.47 . . . . 0.0 110.003 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.5 t -92.84 107.31 19.12 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.617 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 102' ' ' THR . 43.7 pt -105.03 151.8 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.279 -178.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 100' ' ' SER . 19.8 tp -95.84 112.29 24.06 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.203 0.525 . . . . 0.0 111.751 -172.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.7 124.09 62.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.684 175.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -99.44 121.61 41.37 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 . . . . . 0 N--CA 1.469 0.48 0 O-C-N 123.522 0.514 . . . . 0.0 112.238 -172.283 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 . . . . . 0 CA--C 1.516 -0.357 0 CA-C-O 121.211 0.529 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.528 ' HB2' HD11 ' A' ' 92' ' ' LEU . 15.4 p -103.98 84.02 2.19 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.712 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.1 m -94.96 118.12 31.27 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.58 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 14.9 t -88.49 113.29 23.93 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.59 0.71 . . . . 0.0 109.643 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -90.15 132.02 35.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.622 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -80.59 99.93 8.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.263 0.554 . . . . 0.0 109.937 177.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 29.7 m -113.3 179.24 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.53 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -139.13 146.62 40.86 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -177.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.449 HD12 ' H ' ' A' ' 107' ' ' LEU . 5.4 mp -69.83 -31.85 69.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.36 -172.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 33.8 m -63.43 -28.07 69.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.337 0.589 . . . . 0.0 110.246 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.547 ' NE2' HD12 ' A' ' 144' ' ' LEU . 4.1 tt0 -79.2 141.01 37.54 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.518 -177.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.855 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 39.0 p -82.8 167.37 18.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.563 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.61 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 54.1 t -64.85 -23.59 33.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.1 176.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.24 -37.44 67.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.946 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.587 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 7.4 t-160 -66.07 -41.54 90.61 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.79 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.719 ' HB2' HD11 ' A' ' 144' ' ' LEU . 46.7 tp -65.4 -42.84 92.14 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -51.46 -50.36 59.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.403 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.763 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 77.9 mt-30 -75.85 -26.92 57.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.183 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.587 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 54.8 mt-30 -64.24 -50.2 68.94 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 174.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.2 t -63.49 -43.42 98.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.065 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.927 ' HA ' ' HA3' ' A' ' 123' ' ' GLY . 60.6 p -66.15 -23.66 66.52 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.89 0.376 . . . . 0.0 111.153 -176.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.34 -43.0 32.87 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.926 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.9 mt -85.66 -72.66 0.48 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.132 0.492 . . . . 0.0 111.55 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -100.36 6.8 44.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.503 -174.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.927 ' HA3' ' HA ' ' A' ' 119' ' ' SER . . . -63.74 6.92 0.51 Allowed Glycine 0 C--O 1.227 -0.29 0 CA-C-O 118.996 -0.891 . . . . 0.0 115.314 -172.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.504 HG12 HD12 ' A' ' 128' ' ' LEU . 63.6 t -35.24 92.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 123.934 0.894 . . . . 0.0 112.124 175.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 47.51 106.08 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 O-C-N 124.003 0.814 . . . . 0.0 111.046 -171.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.625 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 6.8 p-10 -61.9 -0.94 0.54 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -170.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -100.89 -7.12 23.79 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 176.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.504 HD12 HG12 ' A' ' 124' ' ' VAL . 85.9 mt -83.77 -12.44 55.7 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-O 120.88 0.371 . . . . 0.0 110.684 177.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.625 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 51.9 p90 -128.76 147.24 50.76 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 173.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.645 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 36.9 t90 -133.96 90.12 2.66 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.54 0.686 . . . . 0.0 110.029 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 131' ' ' LEU . 2.6 pt? -90.16 149.54 22.39 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.6 t -160.9 163.53 31.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.353 0.597 . . . . 0.0 111.15 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.433 ' HB3' HD21 ' A' ' 138' ' ' LEU . 6.9 t80 -142.3 -54.56 0.43 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.95 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -88.0 6.65 34.95 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.117 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.62 -22.56 39.94 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 -171.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.443 ' C ' ' H ' ' A' ' 138' ' ' LEU . 61.9 mttp -101.48 152.47 38.02 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 131' ' ' LEU . 62.3 Cg_endo -73.32 22.44 0.33 Allowed 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.653 2.235 . . . . 0.0 112.759 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.572 ' HB3' HG11 ' A' ' 111' ' ' VAL . 42.5 mt 68.36 117.13 0.03 OUTLIER 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.899 0.88 . . . . 0.0 110.981 -178.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -83.23 121.92 27.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.094 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.61 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 2.5 p-10 -69.78 -18.07 63.46 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.179 -174.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -70.0 -24.71 63.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.508 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.4 mt -95.19 156.93 37.23 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.708 -176.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.855 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 71.7 Cg_endo -77.17 153.77 32.13 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.631 2.22 . . . . 0.0 111.764 176.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.719 HD11 ' HB2' ' A' ' 114' ' ' LEU . 10.7 mt -71.25 -22.62 61.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.534 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -58.22 -30.99 64.98 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.55 177.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -66.53 -35.61 80.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.19 0.519 . . . . 0.0 110.856 -177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -95.53 -40.73 9.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.318 0.58 . . . . 0.0 111.081 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -97.54 6.76 63.2 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.232 -0.895 . . . . 0.0 114.156 -168.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -42.06 -32.49 0.46 Allowed 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 117.494 0.647 . . . . 0.0 112.55 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -90.93 123.7 64.04 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 173.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.62 -9.46 18.42 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.752 2.301 . . . . 0.0 112.31 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.8 pp -105.26 8.55 33.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.076 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 33.6 p -63.49 118.17 7.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.092 0.473 . . . . 0.0 109.976 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 9.9 m -98.93 106.11 18.34 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.966 -177.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 53.9 t -86.71 120.83 36.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.35 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.21 108.41 20.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.122 0.487 . . . . 0.0 110.752 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.53 ' HA ' ' CB ' ' A' ' 131' ' ' LEU . 27.5 ttt -85.37 100.89 12.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.564 176.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.645 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 43.1 m-80 -86.27 135.49 33.53 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.683 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 67.1 mt -97.78 20.58 11.79 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.176 0.512 . . . . 0.0 110.731 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 160' ' ' ARG . 8.1 tpt180 . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.457 -0.675 0 N-CA-C 111.184 -0.352 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.447 HD22 HD21 ' A' ' 107' ' ' LEU . 46.5 tp -78.08 114.97 17.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.271 0.558 . . . . 0.0 111.121 -174.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.8 p -94.35 98.63 11.03 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.591 176.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.2 pt -91.02 174.04 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.449 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' A' ' 100' ' ' SER . 1.3 tm? -118.6 112.93 20.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.878 0.371 . . . . 0.0 110.357 -176.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.8 t -103.16 127.35 57.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.887 175.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -98.58 108.53 21.25 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.586 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 36.0 p30 . . . . . 0 C--N 1.323 -0.569 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.535 -175.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 . . . . . 0 C--O 1.236 0.358 0 CA-C-O 120.967 0.413 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.491 ' HB3' HD11 ' A' ' 92' ' ' LEU . 17.6 m -90.2 94.36 9.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.426 175.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.2 p -90.1 111.16 22.2 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.995 0.426 . . . . 0.0 110.612 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.7 m -78.66 114.26 17.43 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.283 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -99.99 120.36 39.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.011 0.434 . . . . 0.0 111.348 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -85.01 103.2 13.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.501 176.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.41 176.36 9.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.205 0.526 . . . . 0.0 111.579 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -115.24 156.61 25.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.785 174.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.509 HD22 ' HA2' ' A' ' 145' ' ' GLY . 80.4 mt -65.88 -29.37 69.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.978 0.418 . . . . 0.0 111.112 -177.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 p -97.53 21.94 9.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.359 -175.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.533 ' HB3' ' HB3' ' A' ' 113' ' ' HIS . 13.4 mt-30 -77.47 -30.2 53.05 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.108 176.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 m 72.91 157.78 0.19 Allowed 'General case' 0 C--O 1.236 0.388 0 O-C-N 123.899 0.75 . . . . 0.0 109.965 -175.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.2 t -54.71 -38.81 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 0.0 110.578 -178.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -47.63 -48.06 28.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.657 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.533 ' HB3' ' HB3' ' A' ' 109' ' ' GLN . 13.2 t-80 -77.69 -7.92 57.17 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.42 -172.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 54.1 tp -100.44 -51.04 3.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.068 0.461 . . . . 0.0 110.347 175.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.424 ' HE2' ' CZ ' ' A' ' 129' ' ' PHE . 3.3 tmtp? -59.02 -48.1 82.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.411 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.587 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 19.7 mm-40 -69.36 -18.28 63.77 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -174.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -70.67 -48.93 52.29 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.2 t -62.52 -36.74 76.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.224 175.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.737 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 55.3 m -62.05 -25.84 67.91 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.17 175.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.07 -35.46 53.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.843 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.7 mt -92.39 -71.89 0.62 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.909 0.385 . . . . 0.0 111.984 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 124' ' ' VAL . 48.0 mt-10 -99.98 9.3 43.13 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.855 0.462 . . . . 0.0 110.797 -174.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.737 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -46.93 7.79 0.01 OUTLIER Glycine 0 N--CA 1.47 0.901 0 N-CA-C 118.719 2.248 . . . . 0.0 118.719 -172.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 122' ' ' GLU . 80.7 t -37.75 100.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 118.446 1.123 . . . . 0.0 112.024 173.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.517 ' HB3' ' HG ' ' A' ' 128' ' ' LEU . 4.0 mm-40 55.81 106.18 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.122 0 O-C-N 123.916 0.76 . . . . 0.0 112.653 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -52.84 -24.54 9.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.023 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.27 -5.83 39.32 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -173.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.517 ' HG ' ' HB3' ' A' ' 125' ' ' GLN . 74.3 mt -89.37 -52.42 5.05 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.984 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.5 ' CE1' ' HA2' ' A' ' 123' ' ' GLY . 13.7 p90 -94.98 126.61 40.43 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.405 0.621 . . . . 0.0 110.155 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.638 ' HZ2' ' H ' ' A' ' 138' ' ' LEU . 9.4 t-105 -144.79 133.58 22.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.278 -178.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.829 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 4.9 mp -105.43 139.34 40.2 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.102 -174.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.581 HG22 ' HA ' ' A' ' 137' ' ' PRO . 45.8 p -132.91 140.7 48.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.31 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.519 ' CD2' ' HG3' ' A' ' 134' ' ' GLU . 11.1 t80 -87.83 -69.94 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.598 0.237 . . . . 0.0 111.462 -178.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.519 ' HG3' ' CD2' ' A' ' 133' ' ' PHE . 37.5 mt-10 -74.7 12.58 0.79 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.01 -177.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.41 2.94 89.86 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -166.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -112.87 147.93 38.26 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 114.867 -0.666 . . . . 0.0 109.574 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.581 ' HA ' HG22 ' A' ' 132' ' ' THR . 59.3 Cg_endo -69.71 146.03 59.27 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.468 2.112 . . . . 0.0 111.916 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.638 ' H ' ' HZ2' ' A' ' 130' ' ' TRP . 70.5 mt -105.05 149.15 26.05 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.78 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.85 144.19 43.91 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -65.49 -25.0 67.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.079 0.466 . . . . 0.0 110.625 -177.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -64.57 -21.85 66.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.856 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 69.4 mt -96.18 131.54 28.54 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.268 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.593 ' HG2' ' HB2' ' A' ' 146' ' ' GLU . 29.2 Cg_endo -63.09 131.27 31.84 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.356 2.037 . . . . 0.0 111.592 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.444 ' HA ' ' CE1' ' A' ' 147' ' ' TYR . 6.9 tt -57.51 -35.94 70.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.577 -175.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.509 ' HA2' HD22 ' A' ' 107' ' ' LEU . . . -66.38 -24.84 72.39 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.04 -0.6 . . . . 0.0 113.723 -178.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.593 ' HB2' ' HG2' ' A' ' 143' ' ' PRO . 35.7 tt0 -61.59 -41.86 98.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.122 0.461 . . . . 0.0 111.231 -175.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.444 ' CE1' ' HA ' ' A' ' 144' ' ' LEU . 0.9 OUTLIER -100.62 -32.59 10.68 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.682 178.526 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -92.22 5.62 78.23 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 121.127 -0.559 . . . . 0.0 114.13 -172.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.509 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.4 pt? -53.33 -24.29 11.54 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -76.34 132.02 73.84 Favored Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.248 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.28 -14.77 44.06 Favored 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.407 2.071 . . . . 0.0 111.962 -178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.1 pp -112.05 14.66 20.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.739 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 77.8 p -62.87 104.78 0.58 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 5.7 m -88.3 104.31 16.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.239 -172.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.497 HG12 ' HB3' ' A' ' 131' ' ' LEU . 43.4 t -88.59 115.3 28.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.405 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -88.07 120.98 29.94 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.435 0.636 . . . . 0.0 111.198 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.829 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 26.9 ttt -76.61 103.7 6.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.55 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 5.1 m-20 -92.9 142.56 27.17 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.512 -178.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.1 tt -114.59 110.64 20.11 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 . . . . . 0 C--N 1.32 -0.716 0 CA-C-O 121.103 0.477 . . . . 0.0 111.196 -175.786 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo . . . . . 0 N--CA 1.448 -1.187 0 CA-C-O 120.876 0.282 . . . . 0.0 111.742 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.536 HD21 ' O ' ' A' ' 148' ' ' GLY . 23.2 tp -124.81 113.59 18.11 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.456 0.646 . . . . 0.0 110.019 176.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.2 t -93.63 111.7 23.43 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.808 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.4 pt -115.25 162.21 13.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.9 0.381 . . . . 0.0 110.716 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.479 HD11 ' HB3' ' A' ' 100' ' ' SER . 47.3 tp -110.79 104.03 12.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.116 0.484 . . . . 0.0 110.511 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.538 HG22 ' HB ' ' A' ' 155' ' ' VAL . 96.1 t -100.69 115.8 42.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.789 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -104.39 154.45 19.84 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.953 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 . . . . . 0 C--N 1.316 -0.873 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 175.564 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.161 0.505 . . . . 0.0 111.803 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.479 ' HB3' HD11 ' A' ' 92' ' ' LEU . 3.4 m -112.28 131.11 55.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.971 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.0 t -124.93 130.31 52.12 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.961 0.41 . . . . 0.0 110.131 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.5 m -92.11 107.19 19.03 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.282 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.471 ' CE1' ' HB ' ' A' ' 93' ' ' VAL . 32.8 m-85 -94.65 132.59 39.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.273 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -104.19 99.9 9.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.343 0.592 . . . . 0.0 109.621 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.418 HG11 HD13 ' A' ' 114' ' ' LEU . 34.8 m -115.33 -179.78 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.819 -174.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -119.15 151.39 38.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.952 175.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.64 -13.42 62.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.234 -175.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.9 m -74.86 -13.89 60.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.203 0.525 . . . . 0.0 110.844 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -85.12 144.3 28.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.734 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.4 p -94.23 175.6 6.64 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.6 t -55.23 -41.31 60.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.9 -42.91 90.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.903 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -69.67 -24.61 63.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.857 -172.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.584 HD22 HD11 ' A' ' 144' ' ' LEU . 57.3 tp -88.23 -43.41 11.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.981 0.42 . . . . 0.0 110.054 172.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -60.67 -42.44 97.04 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.662 -177.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -58.6 -35.21 72.07 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.274 0.359 . . . . 0.0 111.107 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -63.59 -48.3 77.93 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.446 0.641 . . . . 0.0 109.541 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.488 HG11 ' SD ' ' A' ' 157' ' ' MET . 45.0 t -61.81 -41.17 89.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.596 176.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.646 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 50.9 m -59.82 -21.43 60.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.431 177.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.99 -37.15 16.54 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.419 -0.895 . . . . 0.0 112.256 175.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 80.8 mt -92.11 -66.26 0.94 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.214 0.531 . . . . 0.0 112.068 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -100.49 8.27 43.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.945 -175.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.646 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -53.83 7.5 0.01 OUTLIER Glycine 0 CA--C 1.522 0.492 0 N-CA-C 117.547 1.779 . . . . 0.0 117.547 -170.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.404 HG12 HD12 ' A' ' 128' ' ' LEU . 58.4 t -29.87 94.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.07 0.948 . . . . 0.0 112.376 176.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.487 ' HB3' ' HG ' ' A' ' 128' ' ' LEU . 52.3 tt0 48.63 109.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 O-C-N 124.063 0.852 . . . . 0.0 111.314 -171.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -54.59 -19.07 5.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.02 -175.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.47 ' O ' ' HD3' ' A' ' 160' ' ' ARG . 0.7 OUTLIER -95.53 -6.53 40.29 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -177.753 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.487 ' HG ' ' HB3' ' A' ' 125' ' ' GLN . 66.4 mt -82.11 -26.65 33.39 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.174 0.443 . . . . 0.0 111.066 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.418 ' CE1' ' HA2' ' A' ' 123' ' ' GLY . 16.1 p90 -120.1 125.44 48.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.352 0.596 . . . . 0.0 111.046 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.433 ' HE1' ' HB3' ' A' ' 137' ' ' PRO . 21.6 t-105 -132.62 130.11 39.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.844 175.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 131' ' ' LEU . 2.6 pt? -106.08 138.16 42.76 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.966 0.412 . . . . 0.0 110.399 -173.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.632 HG22 ' HA ' ' A' ' 137' ' ' PRO . 49.6 p -134.76 146.25 49.2 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.865 -175.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.563 ' HB3' HD21 ' A' ' 138' ' ' LEU . 32.7 t80 -108.18 139.28 43.09 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.475 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 29.2 tt0 72.19 -29.4 0.2 Allowed 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.727 0.642 . . . . 0.0 111.766 174.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 133' ' ' PHE . . . 130.13 6.19 4.03 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -173.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -117.12 147.69 40.81 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-O 120.509 0.195 . . . . 0.0 110.538 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.632 ' HA ' HG22 ' A' ' 132' ' ' THR . 93.0 Cg_endo -74.87 142.78 28.71 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.187 1.925 . . . . 0.0 110.661 172.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.563 HD21 ' HB3' ' A' ' 133' ' ' PHE . 33.0 mt -95.51 141.1 29.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.623 -170.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.526 ' OE2' ' HB3' ' A' ' 141' ' ' GLN . 33.0 tt0 -86.31 132.3 34.01 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.51 -28.27 61.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.736 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.526 ' HB3' ' OE2' ' A' ' 139' ' ' GLU . 22.6 tm0? -59.29 -44.17 92.52 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.1 mt -74.59 139.84 74.73 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.089 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.76 154.18 73.95 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.505 2.137 . . . . 0.0 112.32 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.584 HD11 HD22 ' A' ' 114' ' ' LEU . 5.7 tt -58.92 -37.05 75.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.234 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.55 -20.46 56.0 Favored Glycine 0 C--O 1.227 -0.282 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.845 -178.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -67.42 -31.15 71.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.268 0.556 . . . . 0.0 110.108 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.472 ' CD1' HD22 ' A' ' 138' ' ' LEU . 16.2 m-85 -100.21 -29.67 12.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.068 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.536 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -94.62 5.78 70.24 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.489 -175.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -49.9 -21.59 1.22 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.532 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 55.8 mttp -86.91 120.7 71.75 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 172.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -59.12 -0.79 0.67 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.959 2.439 . . . . 0.0 112.746 174.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.414 ' H ' ' C ' ' A' ' 150' ' ' LYS . 1.9 pp -128.61 17.51 6.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.712 176.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.532 ' OG ' ' HB2' ' A' ' 150' ' ' LYS . 14.2 m -52.02 108.12 0.26 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.883 0.373 . . . . 0.0 110.69 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.6 m -80.99 90.71 5.98 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.278 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.538 ' HB ' HG22 ' A' ' 93' ' ' VAL . 45.3 t -91.23 114.47 28.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.347 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -90.25 109.6 20.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.366 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.488 ' SD ' HG11 ' A' ' 118' ' ' VAL . 59.4 ttp -77.17 92.89 3.85 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -87.37 114.53 24.06 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.088 -170.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.85 125.24 26.15 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 165.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.47 ' HD3' ' O ' ' A' ' 127' ' ' ASP . 84.0 mtp180 . . . . . 0 C--N 1.32 -0.714 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -170.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 N--CA 1.452 -0.97 0 CA-C-O 121.163 0.401 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.546 HD21 ' O ' ' A' ' 148' ' ' GLY . 63.3 tp -91.28 100.73 13.48 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.596 ' HB3' HG22 ' A' ' 102' ' ' THR . 47.3 m -83.87 111.88 19.62 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.557 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 39.2 pt -102.03 151.81 5.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.982 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.539 HD11 ' HB2' ' A' ' 100' ' ' SER . 18.0 tp -101.02 105.18 16.36 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.107 0.479 . . . . 0.0 110.874 -174.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.488 HG22 ' HB ' ' A' ' 155' ' ' VAL . 58.9 t -104.72 126.8 59.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.056 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.528 ' HG2' ' HA ' ' A' ' 100' ' ' SER . 20.0 mtp180 -109.67 128.63 55.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.649 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.56 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.12 177.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.535 ' N ' HD22 ' A' ' 95' ' ' ASN . 41.6 ttm180 . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.984 0.421 . . . . 0.0 111.064 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.539 ' HB2' HD11 ' A' ' 92' ' ' LEU . 3.0 p -87.9 100.35 12.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.387 176.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 m -101.61 119.99 39.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.432 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.596 HG22 ' HB3' ' A' ' 90' ' ' SER . 0.2 OUTLIER -82.13 103.78 11.99 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.478 -179.145 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -94.38 127.88 40.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.194 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -88.0 131.14 34.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.634 0.73 . . . . 0.0 110.963 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 29.7 m -147.85 -178.42 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.257 -177.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 106' ' ' ARG . 2.5 mmt180 -140.51 166.71 23.97 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 174.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 107' ' ' LEU . 5.1 mp -78.14 -5.6 52.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.026 0.441 . . . . 0.0 110.155 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.73 -3.23 56.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.775 -176.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.61 178.32 4.33 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.804 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 p -110.22 167.92 9.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.981 0.42 . . . . 0.0 112.091 -174.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.9 t -58.69 -30.92 43.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.64 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.0 -43.21 60.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.917 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.44 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 24.7 t60 -74.44 -14.56 60.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.723 0.297 . . . . 0.0 111.321 -174.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.792 ' HB2' HD11 ' A' ' 144' ' ' LEU . 59.0 tp -87.63 -48.02 8.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.449 0.642 . . . . 0.0 109.274 174.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -59.34 -43.07 92.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.68 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.42 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 63.6 tt0 -63.41 -31.52 72.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.321 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 53.7 mt-30 -63.78 -44.28 93.85 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.106 0.479 . . . . 0.0 109.865 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.5 t -66.16 -45.19 90.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.93 175.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' A' ' 116' ' ' GLN . 67.5 m -66.63 -8.0 24.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.775 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -100.3 -36.44 4.11 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.94 177.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.7 mt -94.84 -44.32 7.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.513 0.673 . . . . 0.0 110.942 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 124' ' ' VAL . 10.0 tp10 -100.12 11.11 40.14 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.234 -178.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -29.18 7.31 0.0 OUTLIER Glycine 0 N--CA 1.488 2.118 0 N-CA-C 121.104 3.202 . . . . 0.0 121.104 -172.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 122' ' ' GLU . 17.6 t -46.65 164.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 119.758 1.779 . . . . 0.0 109.798 167.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 128' ' ' LEU . 76.1 mt-30 -35.24 118.58 0.46 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.542 0.687 . . . . 0.0 111.95 -176.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -58.11 -29.56 65.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.828 -167.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -100.47 14.43 31.25 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.441 ' CD1' ' HB2' ' A' ' 125' ' ' GLN . 59.9 mt -91.14 -16.63 27.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.903 0.382 . . . . 0.0 110.788 174.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -121.75 145.76 47.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.537 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.442 ' HE1' ' HB3' ' A' ' 137' ' ' PRO . 7.2 t-105 -147.68 129.6 15.32 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 173.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.553 ' HB3' ' HA ' ' A' ' 157' ' ' MET . 1.1 pt? -111.48 134.5 53.02 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.065 0.46 . . . . 0.0 110.698 -173.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.612 HG22 ' HA ' ' A' ' 137' ' ' PRO . 46.2 p -135.29 131.52 36.61 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.823 -177.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . 14.8 t80 -70.89 -65.38 0.74 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.306 0.574 . . . . 0.0 111.078 179.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -92.77 1.43 57.28 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.232 -173.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.21 -10.13 69.7 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -164.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.498 ' HD2' ' HE1' ' A' ' 147' ' ' TYR . 17.3 ttmm -81.59 127.62 72.39 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 113.908 -1.146 . . . . 0.0 108.446 175.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.612 ' HA ' HG22 ' A' ' 132' ' ' THR . 82.1 Cg_endo -73.63 131.76 16.45 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.123 1.882 . . . . 0.0 111.862 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.4 mt -77.29 119.34 20.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.604 -174.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -97.74 134.43 40.92 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.486 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.15 -17.22 64.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.384 0.612 . . . . 0.0 111.03 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -58.14 -27.32 63.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.308 172.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 56.6 mt -109.72 145.24 31.57 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.661 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.26 155.69 51.37 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.583 2.189 . . . . 0.0 110.866 173.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.792 HD11 ' HB2' ' A' ' 114' ' ' LEU . 22.6 mt -64.7 -20.34 66.27 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -176.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -54.56 -31.63 52.54 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.79 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -58.77 -38.7 79.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.97 0.414 . . . . 0.0 110.989 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.498 ' HE1' ' HD2' ' A' ' 136' ' ' LYS . 13.8 m-85 -100.66 -32.31 10.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.272 0.558 . . . . 0.0 111.024 -177.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.546 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -97.7 7.05 63.05 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.39 -0.823 . . . . 0.0 113.986 -171.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -44.86 -23.62 0.15 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 62.7 mttp -104.47 134.46 19.67 Favored Pre-proline 0 C--N 1.329 -0.325 0 O-C-N 122.217 -0.302 . . . . 0.0 110.608 175.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 19.9 Cg_exo -67.16 4.89 1.0 Allowed 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.967 2.445 . . . . 0.0 112.586 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -127.6 11.63 6.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.441 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 55.9 m -57.61 107.77 0.48 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.944 0.402 . . . . 0.0 110.15 177.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.5 m -85.64 102.72 13.82 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.973 -176.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 133' ' ' PHE . 40.7 t -92.75 121.85 43.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.541 177.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -92.8 118.55 31.22 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.217 0.532 . . . . 0.0 110.856 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.56 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 40.4 ttm -79.81 93.13 5.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.181 176.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 51.5 m-80 -79.91 123.2 27.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.331 0.586 . . . . 0.0 111.519 -172.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 70.2 mt -105.39 95.56 5.91 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.368 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 . . . . . 0 C--N 1.325 -0.499 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.984 -177.026 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo . . . . . 0 N--CA 1.455 -0.788 0 N-CA-C 109.316 -1.071 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.576 ' HB3' HG23 ' A' ' 105' ' ' VAL . 14.0 tp -150.83 138.63 19.86 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.514 173.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.6 t -125.67 109.72 12.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.535 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 32.2 pt -116.12 134.72 58.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.945 0.402 . . . . 0.0 110.765 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' A' ' 100' ' ' SER . 58.4 tp -94.46 105.84 17.81 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.038 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 69.1 t -88.53 104.56 14.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.469 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -93.16 114.46 26.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.673 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.559 HD22 ' N ' ' A' ' 95' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--N 1.318 -0.767 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.224 176.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? . . . . . 0 N--CA 1.454 -0.266 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.459 ' HB3' HD11 ' A' ' 92' ' ' LEU . 8.8 m -93.38 96.53 9.99 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.801 0.334 . . . . 0.0 110.109 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.2 p -108.31 119.33 39.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.952 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.1 m -82.11 120.17 24.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.344 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -110.72 136.03 50.41 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -91.01 123.83 34.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.656 0.741 . . . . 0.0 109.679 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' ' 89' ' ' LEU . 16.0 m -135.78 -178.97 2.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.257 -175.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -127.1 157.0 40.83 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.16 -30.38 64.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 110.324 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -78.83 50.33 0.99 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.835 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -139.88 155.82 47.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.659 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.1 p -86.28 152.29 22.89 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.623 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 59.4 t -63.09 -23.79 34.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.004 0.431 . . . . 0.0 109.848 176.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.528 ' CA ' ' HB2' ' A' ' 140' ' ' ASP . . . -57.07 -44.09 82.74 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.81 174.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.509 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 13.0 m-70 -65.32 -32.96 74.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.269 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.472 HD22 HD11 ' A' ' 144' ' ' LEU . 56.4 tp -71.13 -48.0 54.67 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 174.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -54.94 -47.36 74.55 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.897 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.478 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 78.5 mt-30 -63.8 -34.31 77.63 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -176.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 89.4 mt-30 -66.43 -47.06 74.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.336 0.589 . . . . 0.0 109.729 176.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.99 -34.89 65.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.633 174.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.908 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 60.8 m -79.26 -1.33 36.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.399 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -88.81 -37.0 7.52 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.788 168.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.0 mt -86.5 -64.39 1.16 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.02 0.438 . . . . 0.0 111.508 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 124' ' ' VAL . 17.1 mm-40 -99.63 8.93 43.98 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.649 0.78 . . . . 0.0 110.069 -175.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.908 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -44.48 9.12 0.0 OUTLIER Glycine 0 CA--C 1.526 0.723 0 N-CA-C 120.032 2.773 . . . . 0.0 120.032 -170.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' A' ' 122' ' ' GLU . 13.0 t -58.45 75.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 119.517 1.658 . . . . 0.0 112.222 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 123' ' ' GLY . 76.7 mt-30 63.7 121.28 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.504 1.121 . . . . 0.0 113.399 175.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -73.53 54.81 0.47 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 122.412 1.101 . . . . 0.0 109.406 173.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.51 ' O ' ' HD2' ' A' ' 160' ' ' ARG . 19.0 t70 -146.4 -37.69 0.24 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.48 -1.237 . . . . 0.0 108.711 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.7 mt -80.87 -20.02 43.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.604 175.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -135.74 148.28 48.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.652 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.933 ' HZ3' ' HA ' ' A' ' 160' ' ' ARG . 1.2 p90 -155.32 152.52 29.28 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 170.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.798 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 6.7 mp -109.01 141.78 40.65 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.549 -173.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.8 p -122.41 131.37 53.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.83 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.564 ' HB3' HD21 ' A' ' 138' ' ' LEU . 10.9 t80 -100.79 -62.22 1.27 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.166 0.508 . . . . 0.0 110.768 174.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -95.87 27.85 3.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.914 -174.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.4 4.02 90.32 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.596 -174.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -127.05 149.54 69.62 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -62.46 148.52 93.18 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.803 2.335 . . . . 0.0 112.182 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.564 HD21 ' HB3' ' A' ' 133' ' ' PHE . 43.3 mt -96.92 112.94 24.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.443 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -61.76 130.65 46.8 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 173.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.623 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.7 p-10 -77.46 -18.52 57.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.49 -176.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.65 -36.73 73.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.867 0.365 . . . . 0.0 110.602 177.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.418 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 93.2 mt -78.54 158.17 76.44 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.402 -174.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.67 ' HG2' ' HG2' ' A' ' 146' ' ' GLU . 44.4 Cg_endo -69.23 146.71 64.34 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.648 2.232 . . . . 0.0 112.58 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.472 HD11 HD22 ' A' ' 114' ' ' LEU . 22.7 tp -72.12 -37.34 69.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.604 -174.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -57.4 -25.23 54.47 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.396 -0.431 . . . . 0.0 113.716 -176.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.67 ' HG2' ' HG2' ' A' ' 143' ' ' PRO . 24.4 mm-40 -65.78 -29.69 70.22 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.468 -0.43 . . . . 0.0 111.483 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -100.53 -38.47 8.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.171 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.44 ' O ' HD11 ' A' ' 89' ' ' LEU . . . -98.59 6.21 60.73 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-O 119.412 -0.66 . . . . 0.0 113.912 -172.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.5 pt? -37.21 -38.2 0.2 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -175.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.461 ' C ' ' H ' ' A' ' 152' ' ' LEU . 38.7 ttpt -90.76 125.95 57.49 Favored Pre-proline 0 C--N 1.322 -0.605 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.349 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.09 27.35 0.22 Allowed 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.356 2.704 . . . . 0.0 112.653 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.461 ' H ' ' C ' ' A' ' 150' ' ' LYS . 0.2 OUTLIER -140.83 14.83 2.3 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.718 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 31.9 p -75.92 131.74 39.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.443 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 23.6 m -95.09 110.43 22.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.737 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 41.0 t -92.7 109.52 21.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -85.26 120.32 26.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.843 0.354 . . . . 0.0 111.065 -176.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.798 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 27.4 ttt -85.19 103.87 14.55 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -102.65 123.44 46.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.513 -172.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.9 147.1 45.65 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.933 ' HA ' ' HZ3' ' A' ' 130' ' ' TRP . 60.6 ttt180 . . . . . 0 C--N 1.324 -0.513 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -170.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo . . . . . 0 N--CA 1.459 -0.541 0 CA-C-O 120.783 0.243 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.497 HD22 ' CD2' ' A' ' 107' ' ' LEU . 52.3 tp -109.34 103.44 12.37 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.432 ' OG ' HG22 ' A' ' 102' ' ' THR . 7.3 t -96.16 98.48 10.36 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.105 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.464 HG23 ' HG ' ' A' ' 89' ' ' LEU . 33.3 pt -95.5 159.99 2.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.41 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 33.8 tp -99.99 119.09 37.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.839 0.352 . . . . 0.0 110.877 -177.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 68.9 t -110.13 114.2 46.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.86 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 34.0 ttt-85 -110.08 137.98 47.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.703 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.541 ' ND2' ' HB2' ' A' ' 99' ' ' ARG . 56.7 p30 . . . . . 0 C--N 1.329 -0.292 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.871 175.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.541 ' HB2' ' ND2' ' A' ' 95' ' ' ASN . 4.6 mmp_? . . . . . 0 CA--C 1.518 -0.261 0 CA-C-O 121.115 0.483 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 5.2 m -118.71 100.09 7.19 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.503 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.9 t -101.27 136.62 40.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.86 0.362 . . . . 0.0 110.382 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.432 HG22 ' OG ' ' A' ' 90' ' ' SER . 0.6 OUTLIER -91.68 109.33 20.64 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.603 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 90' ' ' SER . 44.7 m-85 -95.86 120.15 35.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.021 0.439 . . . . 0.0 111.71 -174.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -79.69 100.39 7.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.663 176.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.415 ' C ' ' HD2' ' A' ' 106' ' ' ARG . 35.1 m -123.81 -179.86 2.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.023 0.439 . . . . 0.0 110.975 -177.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.502 ' N ' ' HD2' ' A' ' 106' ' ' ARG . 4.6 mpt_? -123.33 157.2 33.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.497 ' CD2' HD22 ' A' ' 89' ' ' LEU . 23.8 mt -62.03 -29.18 70.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.723 0.297 . . . . 0.0 111.364 -176.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.0 m -74.93 -7.89 54.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.695 -175.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -80.29 125.27 29.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.795 0.331 . . . . 0.0 110.912 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 21.2 p -73.96 157.86 35.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.759 172.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.611 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 60.3 t -59.03 -29.37 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.08 0.467 . . . . 0.0 109.963 177.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -58.71 -38.33 78.06 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.35 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -64.92 -46.33 82.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.708 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.456 HD23 HD11 ' A' ' 131' ' ' LEU . 34.0 tp -64.11 -40.68 96.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.319 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -52.85 -48.84 66.75 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.849 175.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.537 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 11.6 mm-40 -69.03 -28.94 67.02 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -66.98 -48.68 67.74 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.504 0.668 . . . . 0.0 109.452 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 114' ' ' LEU . 42.8 t -64.11 -33.6 63.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.495 175.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.737 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 67.9 m -67.68 -17.4 64.57 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.196 175.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.76 -37.09 27.25 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.559 175.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.9 mt -93.36 -64.98 1.03 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.958 0.409 . . . . 0.0 112.04 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 124' ' ' VAL . 64.6 mm-40 -98.06 9.61 42.42 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.349 0.659 . . . . 0.0 111.367 -174.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.737 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -45.11 7.3 0.01 OUTLIER Glycine 0 N--CA 1.473 1.131 0 N-CA-C 118.583 2.193 . . . . 0.0 118.583 -173.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.464 ' N ' ' O ' ' A' ' 122' ' ' GLU . 57.9 t -50.57 88.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 118.532 1.166 . . . . 0.0 111.019 171.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 49.04 105.8 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.824 0.703 . . . . 0.0 111.794 -175.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.562 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 3.4 p-10 -69.65 5.93 1.28 Allowed 'General case' 0 C--N 1.328 -0.364 0 O-C-N 121.92 -0.488 . . . . 0.0 110.618 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -77.54 -35.61 53.09 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.719 169.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.2 mt -73.78 -21.05 60.3 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.275 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.562 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 52.6 p90 -132.13 120.39 22.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.632 0.73 . . . . 0.0 111.403 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -134.12 131.97 39.35 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 170.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.727 HD23 ' H ' ' A' ' 131' ' ' LEU . 2.2 pt? -104.19 130.62 51.95 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.265 0.555 . . . . 0.0 111.273 -171.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.663 HG22 ' HA ' ' A' ' 137' ' ' PRO . 68.3 p -118.09 138.2 52.41 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.707 -174.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -84.23 132.14 34.68 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.179 175.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 63.87 8.08 3.64 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.959 175.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.04 -2.18 63.6 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.037 -177.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.487 ' O ' ' HB ' ' A' ' 132' ' ' THR . 78.4 mttt -102.02 132.83 21.12 Favored Pre-proline 0 C--N 1.327 -0.396 0 C-N-CA 122.321 0.248 . . . . 0.0 110.479 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.663 ' HA ' HG22 ' A' ' 132' ' ' THR . 19.5 Cg_exo -65.26 127.99 19.47 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.883 2.388 . . . . 0.0 112.936 -175.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 75.6 mt -98.45 164.58 12.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.427 178.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.465 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 32.8 mt-10 -105.99 141.13 37.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.75 175.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.611 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.8 p-10 -64.33 -18.53 64.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.216 0.532 . . . . 0.0 110.263 176.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -72.28 -16.87 61.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.285 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.465 ' HG ' ' HB2' ' A' ' 139' ' ' GLU . 87.4 mt -100.84 148.57 35.23 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.625 -173.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 2.8 Cg_exo -76.94 149.57 29.19 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.102 2.535 . . . . 0.0 112.159 175.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.441 HD11 ' HB2' ' A' ' 114' ' ' LEU . 60.8 mt -73.65 -29.24 62.22 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.401 -176.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.422 ' CA ' HD22 ' A' ' 107' ' ' LEU . . . -54.3 -37.97 60.91 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.308 -0.472 . . . . 0.0 114.131 -173.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -64.55 -32.04 73.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.904 0.383 . . . . 0.0 111.334 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -100.63 -24.31 14.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.21 0.529 . . . . 0.0 111.238 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.438 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -100.4 6.24 57.62 Favored Glycine 0 C--O 1.224 -0.511 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.108 -175.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -39.58 -35.92 0.35 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 98.4 mttt -100.31 129.65 27.59 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 50.9 Cg_exo -57.42 -24.93 63.49 Favored 'Trans proline' 0 N--CA 1.473 0.314 0 C-N-CA 122.834 2.356 . . . . 0.0 112.54 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.425 ' H ' ' HG ' ' A' ' 152' ' ' LEU . 2.3 pp -87.71 -1.28 57.86 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.496 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.3 t -68.89 120.68 15.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.5 m -98.01 119.05 35.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.323 0.582 . . . . 0.0 111.978 -172.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 29.2 t -96.11 119.16 43.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -88.95 117.78 28.21 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.803 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.507 ' HE2' HD21 ' A' ' 159' ' ' LEU . 20.7 ttt -77.56 91.47 3.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.19 176.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -75.46 109.88 9.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.0 -173.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.507 HD21 ' HE2' ' A' ' 157' ' ' MET . 99.6 mt -88.2 113.69 24.07 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.712 176.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 . . . . . 0 C--N 1.325 -0.495 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.603 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo . . . . . 0 N--CA 1.454 -0.844 0 N-CA-C 110.531 -0.603 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.578 HD21 ' O ' ' A' ' 148' ' ' GLY . 45.7 tp -78.9 89.26 4.7 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.939 -174.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.525 ' HB3' HG22 ' A' ' 102' ' ' THR . 19.7 m -84.91 93.63 8.58 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.617 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.2 pt -90.21 165.07 2.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.501 HD11 ' HB2' ' A' ' 100' ' ' SER . 21.5 tp -108.69 107.02 17.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.196 0.522 . . . . 0.0 110.916 -175.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.74 107.41 19.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.365 176.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.554 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 16.5 ttm180 -84.33 105.0 14.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -175.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.546 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 50.8 t-20 . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 115.493 -0.776 . . . . 0.0 108.973 175.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.423 ' CB ' ' HB3' ' A' ' 95' ' ' ASN . 13.3 mmt180 . . . . . 0 C--O 1.229 -0.012 0 CA-C-O 121.176 0.513 . . . . 0.0 111.478 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.544 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 32.6 p -79.65 92.05 5.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.116 0.484 . . . . 0.0 109.862 176.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.4 m -86.38 123.42 31.6 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.894 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.525 HG22 ' HB3' ' A' ' 90' ' ' SER . 8.7 m -90.2 102.54 15.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.124 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -95.89 136.32 36.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.51 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -79.49 103.65 9.55 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 173.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 21.9 m -107.97 166.28 4.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -138.33 154.17 48.98 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.405 HD22 ' CA ' ' A' ' 145' ' ' GLY . 16.3 mt -60.31 -33.46 72.4 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -169.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.6 m -80.56 -7.78 59.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.371 0.605 . . . . 0.0 111.187 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -86.96 122.26 30.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 39.1 p -79.18 165.99 22.69 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.82 0.343 . . . . 0.0 111.322 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.664 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 46.6 t -64.37 -27.84 43.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.21 177.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.481 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -59.62 -45.02 93.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.15 0.5 . . . . 0.0 110.252 174.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.44 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 50.9 m80 -63.42 -37.04 85.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.382 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.626 ' HB2' HD11 ' A' ' 144' ' ' LEU . 55.5 tp -65.25 -47.14 77.79 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.672 ' HD2' ' HB2' ' A' ' 126' ' ' ASP . 5.2 tppp? -54.1 -49.26 69.5 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.966 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.794 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 34.9 tt0 -70.26 -32.56 70.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.796 -174.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 92.4 mt-30 -63.67 -39.6 94.74 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 114' ' ' LEU . 67.2 t -71.63 -38.06 65.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.895 176.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.794 ' OG ' ' HA ' ' A' ' 116' ' ' GLN . 92.0 p -72.71 -5.0 34.68 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.005 0.431 . . . . 0.0 110.555 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -94.76 -59.46 1.13 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.372 173.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.4 mp -77.33 -45.24 26.77 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.328 0.585 . . . . 0.0 111.405 -177.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 124' ' ' VAL . 8.7 mm-40 -96.8 9.6 41.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.431 -176.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -28.82 6.54 0.0 OUTLIER Glycine 0 N--CA 1.485 1.911 0 N-CA-C 121.956 3.542 . . . . 0.0 121.956 -165.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.559 ' N ' ' O ' ' A' ' 122' ' ' GLU . 48.1 t -52.15 144.95 2.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 119.852 1.826 . . . . 0.0 108.53 168.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -49.03 135.93 15.26 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.097 0.475 . . . . 0.0 112.03 -170.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.672 ' HB2' ' HD2' ' A' ' 115' ' ' LYS . 7.2 p-10 -74.4 9.55 1.66 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.514 -171.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.67 -21.86 40.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.169 0.509 . . . . 0.0 110.125 173.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.468 HD12 HG12 ' A' ' 124' ' ' VAL . 83.0 mt -91.49 -45.93 8.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.007 -171.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.573 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 34.5 p90 -83.49 102.23 11.96 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.161 0.982 . . . . 0.0 110.848 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.609 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 25.4 t90 -100.81 93.22 5.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.493 -1.231 . . . . 0.0 109.414 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.52 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 8.6 mp -79.45 115.52 19.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.199 0.523 . . . . 0.0 111.762 -173.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 25.6 p -121.33 119.23 31.57 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.75 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.535 ' HB2' HG22 ' A' ' 155' ' ' VAL . 6.7 t80 -82.06 -74.39 0.34 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.886 0.374 . . . . 0.0 110.614 177.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.66 36.45 1.38 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.377 0.608 . . . . 0.0 109.64 -175.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.95 -36.42 3.85 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.869 -177.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -91.81 144.47 29.41 Favored Pre-proline 0 C--O 1.237 0.447 0 CA-C-O 120.581 0.229 . . . . 0.0 111.037 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -76.83 137.11 17.48 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.873 2.382 . . . . 0.0 111.541 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 71.2 mt -77.81 133.92 38.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.732 -177.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.505 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 44.2 mt-10 -76.12 139.46 41.33 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.664 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 6.6 p-10 -66.92 -24.77 66.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 0.0 111.894 -173.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -76.09 -14.63 60.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.108 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.505 ' HG ' ' HB2' ' A' ' 139' ' ' GLU . 87.5 mt -86.17 146.13 42.01 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.03 -175.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 142' ' ' LEU . 2.7 Cg_exo -76.74 140.37 20.81 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.142 2.562 . . . . 0.0 111.656 175.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.626 HD11 ' HB2' ' A' ' 114' ' ' LEU . 74.8 mt -67.73 -26.38 66.11 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -175.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.405 ' CA ' HD22 ' A' ' 107' ' ' LEU . . . -56.05 -35.02 62.95 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.85 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -50.35 -56.53 10.96 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -101.25 -13.14 18.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.455 -173.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.578 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -100.2 3.46 56.82 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.932 -177.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -46.73 -31.4 2.93 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.107 0.479 . . . . 0.0 111.744 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -92.63 117.35 67.56 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 174.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -58.01 -18.59 36.48 Favored 'Trans proline' 0 N--CA 1.476 0.443 0 C-N-CA 122.66 2.24 . . . . 0.0 112.911 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 84.9 mt -94.18 7.02 46.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.788 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 29.5 t -59.78 107.39 0.6 Allowed 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 23.6 m -94.97 100.23 12.11 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.28 -174.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.535 HG22 ' HB2' ' A' ' 133' ' ' PHE . 42.3 t -87.1 115.5 27.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.5 176.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.554 ' CE2' ' HD2' ' A' ' 94' ' ' ARG . 74.0 m-85 -79.28 117.97 20.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.904 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.546 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 52.6 ttm -80.47 83.4 6.29 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 174.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.609 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 1.9 m-20 -73.0 98.88 2.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.797 -174.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 91.6 mt -75.24 103.78 5.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.03 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.457 179.791 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 N--CA 1.451 -0.998 0 CA-C-O 121.052 0.355 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.596 HD21 ' O ' ' A' ' 148' ' ' GLY . 61.9 tp -112.4 111.45 22.31 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.585 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.4 t -85.72 114.61 22.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.666 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.4 pt -109.19 163.09 6.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.93 176.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.494 HD11 ' HB2' ' A' ' 100' ' ' SER . 27.0 tp -115.33 110.71 19.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.025 0.44 . . . . 0.0 110.724 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.8 t -104.68 109.21 26.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.284 0.564 . . . . 0.0 110.583 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 94' ' ' ARG . 16.3 ttt180 -92.61 116.93 29.44 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.385 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.515 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 30.4 p-10 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 121.777 0.799 . . . . 0.0 111.517 -174.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 94' ' ' ARG . 32.2 ttt180 . . . . . 0 N--CA 1.456 -0.174 0 CA-C-O 121.222 0.534 . . . . 0.0 111.743 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.494 ' HB2' HD11 ' A' ' 92' ' ' LEU . 12.6 p -88.31 92.07 9.03 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 171.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.2 m -83.32 124.66 30.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.697 -173.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.2 m -91.58 113.43 25.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.93 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -115.05 132.82 56.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.885 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -107.15 97.5 7.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.259 0.552 . . . . 0.0 111.1 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.9 m -104.15 -179.5 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.54 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.599 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 33.2 ttm180 -110.46 125.06 52.88 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 174.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.525 ' HB2' ' HA3' ' A' ' 145' ' ' GLY . 1.4 pp -62.88 -6.59 3.92 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -173.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 m -86.76 0.72 54.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.726 0.298 . . . . 0.0 110.926 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.599 ' HG2' ' O ' ' A' ' 106' ' ' ARG . 2.5 pt20 -92.66 158.86 15.72 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.0 m -87.43 154.29 20.77 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 30.3 t -58.18 -25.68 27.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.094 0.474 . . . . 0.0 110.844 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.56 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -60.84 -34.32 74.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.215 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.567 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 17.1 t-80 -72.34 -46.77 54.08 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.471 ' HA ' ' NE2' ' A' ' 117' ' ' GLN . 59.5 tp -47.83 -45.97 30.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.063 173.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.515 ' HE2' ' HB2' ' A' ' 126' ' ' ASP . 48.5 tttt -61.13 -41.9 97.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.627 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 18.1 tm0? -67.02 -39.72 87.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.985 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.567 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 18.6 mt-30 -57.15 -46.23 82.92 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.35 0.595 . . . . 0.0 109.867 176.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 63.8 t -65.49 -36.36 77.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.899 175.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.455 ' C ' ' HA2' ' A' ' 123' ' ' GLY . 62.4 m -67.88 -8.2 34.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.259 177.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -98.69 -61.93 0.87 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.63 173.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 88.7 mt -71.09 -41.4 70.69 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.494 0.664 . . . . 0.0 111.335 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 124' ' ' VAL . 6.0 mm-40 -100.06 11.07 40.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.814 -177.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.455 ' HA2' ' C ' ' A' ' 119' ' ' SER . . . -27.87 7.3 0.0 OUTLIER Glycine 0 N--CA 1.488 2.117 0 N-CA-C 122.334 3.694 . . . . 0.0 122.334 -157.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' A' ' 122' ' ' GLU . 44.3 t -51.57 141.71 4.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 119.928 1.864 . . . . 0.0 108.576 165.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -45.6 137.99 4.81 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -173.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.753 ' HA ' ' CE2' ' A' ' 129' ' ' PHE . 4.1 p-10 -63.77 -22.95 67.16 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.363 -172.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -73.82 -21.79 60.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.296 0.57 . . . . 0.0 110.657 178.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.505 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 93.4 mt -83.24 -17.25 43.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.837 -174.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.753 ' CE2' ' HA ' ' A' ' 126' ' ' ASP . 38.7 p90 -112.36 124.26 52.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.974 0.892 . . . . 0.0 111.45 175.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.706 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 49.9 t90 -112.68 92.55 4.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.688 177.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.707 HD23 ' H ' ' A' ' 131' ' ' LEU . 2.6 pt? -97.2 144.01 27.44 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.004 -177.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.36 150.23 36.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.249 0.547 . . . . 0.0 111.393 -178.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.532 ' HB2' HG22 ' A' ' 155' ' ' VAL . 5.1 t80 -112.69 -58.52 2.14 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.911 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.34 -20.26 23.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.501 -175.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 136.87 -19.69 3.48 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -171.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -102.25 149.41 36.6 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 114.334 -0.933 . . . . 0.0 109.202 174.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 131' ' ' LEU . 59.0 Cg_endo -72.02 0.35 7.34 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.699 2.266 . . . . 0.0 112.312 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.4 mt 69.61 115.83 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 O-C-N 123.931 0.769 . . . . 0.0 110.03 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.692 ' HB2' ' CD2' ' A' ' 142' ' ' LEU . 7.3 mm-40 -72.04 137.9 47.5 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.457 -177.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.566 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 5.7 p-10 -77.46 33.49 0.16 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.392 -176.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -118.63 -21.89 7.72 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.228 0.537 . . . . 0.0 109.789 -178.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.692 ' CD2' ' HB2' ' A' ' 139' ' ' GLU . 0.6 OUTLIER -95.95 153.97 39.08 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.261 -173.253 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.01 136.6 53.28 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.402 2.068 . . . . 0.0 110.999 173.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.424 ' O ' HD23 ' A' ' 144' ' ' LEU . 6.9 tt -60.78 -32.39 71.71 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.258 -176.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.525 ' HA3' ' HB2' ' A' ' 107' ' ' LEU . . . -60.42 -28.21 66.93 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 116.094 -0.503 . . . . 0.0 113.33 -178.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -61.67 -37.3 83.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.937 0.399 . . . . 0.0 110.814 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -100.77 -32.74 10.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.756 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.596 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -98.99 5.83 59.71 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.742 -172.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.5 pt? -45.2 -29.93 1.07 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.442 ' C ' ' H ' ' A' ' 152' ' ' LEU . 48.7 tttp -79.73 121.16 82.09 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 21.4 Cg_exo -67.25 12.86 0.17 Allowed 'Trans proline' 0 N--CA 1.476 0.457 0 C-N-CA 123.088 2.525 . . . . 0.0 112.789 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.442 ' H ' ' C ' ' A' ' 150' ' ' LYS . 26.5 tp -137.5 20.28 2.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.409 0.624 . . . . 0.0 109.417 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.0 p -67.37 118.77 11.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.142 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.7 m -97.19 111.06 23.46 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.999 -175.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 133' ' ' PHE . 39.9 t -100.86 129.29 52.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.609 177.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 131' ' ' LEU . 94.7 m-85 -95.07 110.21 22.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.822 0.344 . . . . 0.0 110.818 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.515 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 23.6 ttt -82.18 97.38 8.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.854 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.706 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 50.7 m-80 -90.6 136.2 33.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.323 -178.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 90.3 mt -104.54 81.6 1.81 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.488 -0.189 . . . . 0.0 110.488 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 128' ' ' LEU . 1.9 mmp_? . . . . . 0 N--CA 1.466 0.369 0 O-C-N 123.792 0.682 . . . . 0.0 111.306 -176.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo . . . . . 0 C--O 1.237 0.464 0 CA-C-O 121.166 0.403 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.587 HD21 ' O ' ' A' ' 148' ' ' GLY . 31.7 tp -105.69 116.36 31.82 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.246 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.428 ' HB3' ' OG1' ' A' ' 102' ' ' THR . 16.0 m -94.57 107.23 19.22 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.469 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 102' ' ' THR . 35.4 pt -99.06 160.93 3.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 154' ' ' THR . 36.7 tp -106.19 116.07 31.3 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.762 -176.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.1 t -104.37 121.49 56.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.461 ' HD2' ' CE1' ' A' ' 156' ' ' PHE . 18.4 ttm180 -106.54 107.01 17.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.188 -177.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.581 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 40.4 m-20 . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.52 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.5 ' NE ' ' HA ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 120.425 0.155 . . . . 0.0 111.132 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.3 m -94.15 86.15 4.88 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.4 t -104.8 129.96 52.99 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.109 -176.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 10.8 t -76.92 143.58 39.45 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 173.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -121.37 133.03 55.09 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.293 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -83.19 108.07 16.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.931 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.88 -179.18 3.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.491 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -121.47 178.84 4.65 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 173.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.61 -32.18 19.43 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.2 m -89.51 64.67 6.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.308 0.575 . . . . 0.0 110.74 -178.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -163.72 163.54 24.12 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.181 173.374 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 32.6 p -96.94 162.18 13.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.803 0.335 . . . . 0.0 111.332 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 45.3 t -57.51 -21.39 15.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.843 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.599 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -50.49 -46.33 56.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.557 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -81.57 -0.83 44.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.513 -175.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.581 ' HB2' HD11 ' A' ' 144' ' ' LEU . 43.7 tp -100.34 -47.33 4.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.437 0.637 . . . . 0.0 109.721 172.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -63.2 -27.33 69.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.628 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.882 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 22.4 tm0? -78.11 -23.26 47.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.521 177.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -68.56 -43.87 75.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.3 -43.73 98.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.872 174.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.882 ' OG ' ' HA ' ' A' ' 116' ' ' GLN . 7.9 p -76.38 -1.74 28.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.776 0.322 . . . . 0.0 111.435 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -88.35 -36.31 8.21 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.779 172.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 mp -99.94 -58.46 1.91 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.446 0.641 . . . . 0.0 111.197 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 124' ' ' VAL . 4.0 mm-40 -91.28 9.22 32.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.919 -177.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.851 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -49.26 7.72 0.01 OUTLIER Glycine 0 N--CA 1.469 0.851 0 N-CA-C 117.788 1.875 . . . . 0.0 117.788 -173.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.454 ' O ' HD22 ' A' ' 128' ' ' LEU . 94.6 t -47.26 86.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 CA-C-N 117.965 0.883 . . . . 0.0 111.742 172.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.41 ' O ' HD22 ' A' ' 128' ' ' LEU . 93.9 mt-30 59.29 119.26 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.61 0.719 . . . . 0.0 112.59 -178.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -78.85 57.01 2.02 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -147.63 -43.47 0.17 Allowed 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.435 -175.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.577 HD23 ' N ' ' A' ' 129' ' ' PHE . 0.9 OUTLIER -72.15 -22.58 61.29 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -169.642 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.577 ' N ' HD23 ' A' ' 128' ' ' LEU . 37.9 p90 -105.1 147.77 27.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.221 0.534 . . . . 0.0 111.313 -176.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.534 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 39.2 t90 -141.1 98.07 3.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.969 -175.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.547 ' HB3' ' HA ' ' A' ' 157' ' ' MET . 2.5 pp -99.13 138.55 36.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.152 0.501 . . . . 0.0 111.322 -174.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 38.8 p -136.2 150.98 49.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.098 -174.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.402 ' CD2' ' HB3' ' A' ' 147' ' ' TYR . 30.4 t80 -116.43 -70.37 0.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.026 0.441 . . . . 0.0 110.8 175.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -87.43 30.95 0.76 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.444 0.64 . . . . 0.0 110.469 -173.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.17 -3.53 71.24 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -172.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -115.54 143.67 30.98 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 115.036 -0.582 . . . . 0.0 109.476 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.55 137.79 51.92 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.267 1.978 . . . . 0.0 111.06 173.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.457 ' HB3' HG21 ' A' ' 111' ' ' VAL . 87.2 mt -81.7 106.77 13.9 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.059 0.457 . . . . 0.0 110.483 -178.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.552 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 42.7 mt-10 -71.96 141.76 49.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.935 177.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.599 ' HB2' ' HB2' ' A' ' 112' ' ' ALA . 4.1 p-10 -73.03 -5.78 41.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.97 0.414 . . . . 0.0 111.15 -177.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -83.49 -15.72 48.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.485 173.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.552 ' HG ' ' HB2' ' A' ' 139' ' ' GLU . 82.8 mt -91.32 144.29 29.54 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.037 -176.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 109' ' ' GLN . 6.3 Cg_exo -79.88 138.98 13.52 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.154 2.569 . . . . 0.0 111.612 174.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.581 HD11 ' HB2' ' A' ' 114' ' ' LEU . 33.6 mt -68.83 -40.2 79.57 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -177.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.26 -30.2 31.67 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.166 -0.54 . . . . 0.0 113.923 -175.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -66.25 -32.94 74.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.927 0.394 . . . . 0.0 110.899 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.402 ' HB3' ' CD2' ' A' ' 133' ' ' PHE . 89.0 m-85 -101.06 -32.23 10.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.36 0.6 . . . . 0.0 110.899 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.587 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -97.06 6.54 64.06 Favored Glycine 0 C--O 1.223 -0.531 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.809 -170.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.407 ' HG ' ' HG3' ' A' ' 150' ' ' LYS . 2.6 pt? -44.82 -24.54 0.22 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.498 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 67.7 mttt -102.23 131.0 23.08 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.497 177.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 12.8 Cg_exo -69.93 9.63 0.6 Allowed 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.197 2.598 . . . . 0.0 112.449 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.9 pp -119.93 0.0 10.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.586 178.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.6 m -61.83 110.87 1.66 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.895 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 29.3 m -95.6 114.38 26.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.03 -176.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.51 118.63 37.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.13 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.461 ' CE1' ' HD2' ' A' ' 94' ' ' ARG . 80.5 m-85 -90.57 113.96 26.08 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.942 0.401 . . . . 0.0 110.869 -177.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.581 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 2.0 tmt? -88.19 97.7 11.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.3 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.534 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 92.2 m-20 -97.49 176.93 5.69 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.646 -173.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.476 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 96.0 mt -120.33 133.27 55.48 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.918 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 159' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.943 0 O-C-N 124.132 0.895 . . . . 0.0 112.389 -174.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.432 ' C ' ' HD3' ' A' ' 88' ' ' PRO . 4.6 p-10 . . . . . 0 N--CA 1.461 0.124 0 CA-C-O 120.635 0.255 . . . . 0.0 111.585 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.698 ' HB2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -118.55 75.62 12.68 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.432 ' HD3' ' C ' ' A' ' 86' ' ' ASP . 8.7 Cg_endo -88.16 110.75 0.66 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.006 2.471 . . . . 0.0 111.644 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.613 HD23 HD11 ' A' ' 107' ' ' LEU . 0.2 OUTLIER -96.19 123.27 39.75 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.316 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -95.33 101.87 13.63 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.438 HG23 HD12 ' A' ' 89' ' ' LEU . 46.7 pt -108.33 164.08 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.105 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 154' ' ' THR . 32.2 tp -108.87 120.96 44.05 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.273 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 90.4 t -116.95 117.39 55.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.003 0.43 . . . . 0.0 110.173 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.563 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 23.2 ttt180 -96.61 133.14 41.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.632 -177.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -76.44 91.85 3.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.705 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.2 p30 42.27 -76.39 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.244 1.418 . . . . 0.0 114.301 -174.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -123.39 -15.29 7.2 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 122.039 -0.413 . . . . 0.0 110.775 -176.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -84.55 -124.66 1.23 Allowed Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.989 -0.55 . . . . 0.0 113.761 -170.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -79.93 143.64 34.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.254 0.55 . . . . 0.0 111.501 -173.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 15.0 m -95.02 102.06 13.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.414 173.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.8 m -95.45 136.41 35.86 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.042 0.448 . . . . 0.0 110.691 -176.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.3 m -85.97 124.78 32.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.073 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.516 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 43.5 m-85 -111.07 145.71 38.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.974 0.416 . . . . 0.0 111.376 -176.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -95.15 95.86 8.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.45 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.4 m -109.37 -179.79 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.842 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.433 ' HB3' ' OE1' ' A' ' 87' ' ' GLU . 20.1 mtm180 -138.78 166.11 25.25 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.698 HD13 ' HB2' ' A' ' 87' ' ' GLU . 6.9 mp -80.44 -23.4 40.32 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.7 p -76.31 -16.91 59.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.107 174.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -85.07 138.29 32.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.091 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.717 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 38.7 p -88.1 163.71 16.09 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 175.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.615 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 3.4 t -64.14 -27.31 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.274 0.559 . . . . 0.0 109.788 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.15 -37.83 88.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.742 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -70.86 -33.99 71.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.574 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.423 HD22 HD11 ' A' ' 144' ' ' LEU . 65.7 tp -61.3 -46.07 91.85 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 173.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -59.36 -39.97 84.96 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.186 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -66.96 -32.19 73.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.306 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -62.03 -51.22 68.89 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.97 0.89 . . . . 0.0 109.134 174.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.4 t -62.3 -32.03 53.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.848 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.648 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 49.9 m -65.12 -27.58 68.84 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.807 0.337 . . . . 0.0 111.082 177.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.01 -35.02 54.64 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.679 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 75.4 mt -93.46 -67.53 0.85 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.408 0.623 . . . . 0.0 112.001 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 124' ' ' VAL . 8.1 tp10 -100.47 9.9 41.94 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.788 0.835 . . . . 0.0 110.847 -172.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.648 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -44.57 7.68 0.01 OUTLIER Glycine 0 CA--C 1.532 1.139 0 N-CA-C 118.555 2.182 . . . . 0.0 118.555 -174.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 122' ' ' GLU . 59.1 t -48.26 91.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 118.428 1.114 . . . . 0.0 111.678 173.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 53.51 104.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.836 0.71 . . . . 0.0 111.698 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.653 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 4.5 p-10 -69.29 11.05 0.25 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.241 -173.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -117.62 -5.48 11.16 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 174.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 128' ' ' LEU . 44.6 mt -93.26 -31.06 14.86 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 171.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.653 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 25.0 p90 -110.14 135.05 51.54 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 172.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.471 ' HE1' ' HB3' ' A' ' 137' ' ' PRO . 4.2 t-105 -155.79 135.78 12.84 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.957 0.408 . . . . 0.0 109.937 -176.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.639 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 6.4 mp -104.67 131.79 51.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.06 0.457 . . . . 0.0 110.703 -174.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.828 HG22 ' HA ' ' A' ' 137' ' ' PRO . 19.9 p -135.22 140.59 45.4 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.681 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.697 ' CD2' ' HG3' ' A' ' 134' ' ' GLU . 6.1 t80 -106.04 -82.89 0.53 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.831 -175.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.697 ' HG3' ' CD2' ' A' ' 133' ' ' PHE . 98.6 mt-10 -77.97 25.73 0.21 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.755 0.312 . . . . 0.0 111.798 -173.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.25 -7.35 78.33 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -175.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -112.79 154.89 44.7 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.828 ' HA ' HG22 ' A' ' 132' ' ' THR . 85.9 Cg_endo -76.2 -5.78 16.58 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.851 2.367 . . . . 0.0 111.972 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 86.9 mt 62.1 176.29 0.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.053 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -104.19 101.79 11.52 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.615 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 9.9 p-10 -71.84 -9.28 58.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.938 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -68.79 -29.77 68.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.227 170.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 87.2 mt -97.28 160.83 27.99 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.876 -175.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.717 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 8.7 Cg_exo -72.09 153.71 57.36 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.76 2.306 . . . . 0.0 112.059 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.423 HD11 HD22 ' A' ' 114' ' ' LEU . 7.4 mt -70.92 -18.5 62.66 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.762 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.572 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -53.19 -44.02 63.85 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.675 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -63.96 -37.49 87.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -101.21 -37.1 8.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.037 0.446 . . . . 0.0 111.963 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.87 6.4 58.56 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.475 -170.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.572 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.0 pt? -47.18 -26.33 1.12 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.648 0.379 . . . . 0.0 112.014 175.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 53.6 mtmt -81.32 118.66 73.2 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.551 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 21.0 Cg_exo -66.1 -10.47 27.32 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.81 2.34 . . . . 0.0 111.412 177.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 82.9 mt -99.76 1.74 43.5 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.166 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.0 t -66.33 101.98 0.8 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.316 0.579 . . . . 0.0 109.85 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 18.0 m -90.84 92.18 8.68 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.873 -177.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 44.9 t -77.85 125.32 37.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.367 178.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -92.85 116.54 29.13 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.976 0.417 . . . . 0.0 110.604 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.639 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 1.1 tmt? -72.8 104.98 4.16 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -103.17 154.25 19.5 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.296 -173.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.5 mt -116.66 134.54 54.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.112 173.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 . . . . . 0 C--N 1.321 -0.671 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.72 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.401 ' OD2' ' HD2' ' A' ' 106' ' ' ARG . 28.6 t70 . . . . . 0 CA--C 1.518 -0.277 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -126.47 162.74 44.82 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.103 -174.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.75 111.01 0.61 Allowed 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.641 2.227 . . . . 0.0 111.794 176.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.479 HD21 ' O ' ' A' ' 148' ' ' GLY . 66.4 tp -106.71 109.09 20.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.983 -176.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.5 m -80.63 102.26 9.72 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.958 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.5 pt -101.83 146.11 10.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.132 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 44.2 tp -98.85 110.99 23.51 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.621 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.55 HG22 ' HB ' ' A' ' 155' ' ' VAL . 96.7 t -107.22 117.59 53.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.008 0.432 . . . . 0.0 110.359 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 26.3 ttt180 -85.64 101.25 12.56 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 176.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.486 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 0.7 OUTLIER -87.95 -176.71 5.56 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.992 0.901 . . . . 0.0 112.638 -173.684 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -70.68 175.7 4.73 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 113.728 -1.578 . . . . 0.0 108.534 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.4 mttp 64.07 15.66 9.42 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 123.633 0.773 . . . . 0.0 111.486 -172.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 59.33 67.47 2.16 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.616 -0.72 . . . . 0.0 114.086 174.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -157.55 141.39 15.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.107 0.454 . . . . 0.0 110.614 176.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 45.7 m -101.25 103.38 14.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.889 0.376 . . . . 0.0 110.135 177.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 m -99.22 138.36 36.43 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.647 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.4 m -90.04 115.65 27.47 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -101.0 136.27 41.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.917 0.389 . . . . 0.0 110.844 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -93.0 106.39 18.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.348 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.53 -179.54 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.225 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.401 ' HD2' ' OD2' ' A' ' 86' ' ' ASP . 58.5 mtm-85 -124.86 158.14 34.2 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 174.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.5 mp -67.1 -35.71 80.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.029 -176.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -89.87 14.65 11.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.276 0.56 . . . . 0.0 110.882 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -92.96 131.07 38.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.972 0.415 . . . . 0.0 110.004 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.634 ' HB ' ' OD1' ' A' ' 140' ' ' ASP . 3.2 p -74.03 159.21 33.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.646 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 83.3 t -63.87 -32.18 56.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.407 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.42 -41.85 73.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.79 176.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -65.18 -28.34 69.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.039 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.597 ' HB2' HD11 ' A' ' 144' ' ' LEU . 63.3 tp -82.25 -46.97 12.99 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 175.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -58.28 -46.55 85.85 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.571 -176.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -65.28 -30.81 71.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -70.21 -43.62 70.3 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.546 0.689 . . . . 0.0 109.466 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.35 -35.19 60.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.298 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.813 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 41.1 m -69.25 -18.64 63.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.942 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.68 -39.12 41.37 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.53 174.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.7 mp -95.04 -64.98 1.01 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.981 0.42 . . . . 0.0 111.852 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 124' ' ' VAL . 21.9 mm-40 -95.12 8.86 41.65 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 123.724 0.81 . . . . 0.0 111.035 -173.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.813 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -45.7 8.91 0.01 OUTLIER Glycine 0 N--CA 1.471 1.031 0 N-CA-C 119.028 2.371 . . . . 0.0 119.028 -173.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 122' ' ' GLU . 31.8 t -51.78 81.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 118.758 1.279 . . . . 0.0 112.575 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.432 ' HB2' HD12 ' A' ' 128' ' ' LEU . 23.7 mp0 60.8 118.03 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.226 1.011 . . . . 0.0 113.455 172.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -53.32 -28.78 30.2 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.293 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -76.07 -24.67 55.11 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.469 -176.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.441 HD12 HG12 ' A' ' 124' ' ' VAL . 92.2 mt -89.26 -36.41 15.62 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -174.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -113.35 140.88 47.67 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.861 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -153.47 154.68 34.85 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 172.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.593 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 6.4 mp -114.65 149.56 36.5 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.838 -175.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 66.6 p -126.0 144.65 50.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.826 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.486 ' C ' ' H ' ' A' ' 135' ' ' GLY . 73.0 t80 -129.23 140.12 51.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 168.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 69.78 -43.93 0.54 Allowed 'General case' 0 CA--C 1.536 0.416 0 O-C-N 123.833 0.708 . . . . 0.0 110.426 -176.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 133' ' ' PHE . . . 156.01 -18.8 0.48 Allowed Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -176.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -91.61 146.99 34.24 Favored Pre-proline 0 C--O 1.236 0.356 0 CA-C-N 115.315 -0.443 . . . . 0.0 109.94 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.27 147.61 66.37 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.541 2.16 . . . . 0.0 111.345 175.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 70.8 mt -70.59 108.15 4.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.789 0.328 . . . . 0.0 111.006 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -92.44 130.08 38.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.601 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.634 ' OD1' ' HB ' ' A' ' 110' ' ' THR . 36.5 t70 -72.45 -6.67 45.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.534 -175.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -74.12 -14.11 60.92 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.487 0.66 . . . . 0.0 109.904 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.469 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 88.5 mt -120.16 131.71 24.33 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.95 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 142' ' ' LEU . 28.0 Cg_exo -62.46 148.94 92.52 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.673 2.249 . . . . 0.0 112.004 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.597 HD11 ' HB2' ' A' ' 114' ' ' LEU . 83.2 mt -59.88 -25.39 65.05 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -176.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -61.16 -27.35 67.26 Favored Glycine 0 C--O 1.226 -0.396 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.505 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -72.32 -21.09 61.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.875 0.369 . . . . 0.0 111.184 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -100.3 -45.14 5.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.312 0.577 . . . . 0.0 110.606 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.479 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -100.16 6.67 58.21 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-O 119.227 -0.763 . . . . 0.0 113.973 -171.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.474 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.3 pt? -34.38 -41.32 0.11 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 88.4 tttt -91.23 119.88 68.61 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.533 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 17.4 Cg_exo -66.13 81.38 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.117 2.544 . . . . 0.0 112.199 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 151' ' ' PRO . 7.3 tt 167.75 -26.56 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.787 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.3 m -45.55 125.45 5.83 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.376 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 23.9 m -97.72 120.6 38.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.303 -175.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.55 ' HB ' HG22 ' A' ' 93' ' ' VAL . 61.7 t -99.96 133.04 44.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.338 176.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -103.82 124.81 49.6 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.079 0.466 . . . . 0.0 111.045 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.593 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 25.2 ttt -81.75 131.06 35.25 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 175.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -120.51 145.21 47.52 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.109 -175.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 50.9 mt -125.16 137.73 54.15 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 160' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.607 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 177.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 . . . . . 0 CA--C 1.517 -0.316 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 27.8 mm-40 -88.08 137.4 31.3 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.756 -172.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 24.0 Cg_exo -64.95 95.47 0.24 Allowed 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.71 2.273 . . . . 0.0 111.659 175.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.464 ' HG ' HG23 ' A' ' 91' ' ' ILE . 58.0 tp -85.3 107.51 17.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.233 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.447 ' HB3' HG22 ' A' ' 102' ' ' THR . 24.3 m -87.33 102.68 14.75 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.624 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.464 HG23 ' HG ' ' A' ' 89' ' ' LEU . 36.8 pt -102.84 157.79 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.023 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 154' ' ' THR . 37.4 tp -103.51 102.99 12.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.131 0.491 . . . . 0.0 110.922 -176.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.537 HG22 ' HB ' ' A' ' 155' ' ' VAL . 58.8 t -107.46 123.78 62.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.987 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -89.55 135.04 33.83 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.125 0.488 . . . . 0.0 110.2 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.407 HD21 ' HB2' ' A' ' 99' ' ' ARG . 4.1 p30 -99.28 170.18 8.84 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.915 -176.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -69.03 -19.21 64.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.713 -175.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -79.17 2.4 21.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.914 0.388 . . . . 0.0 111.16 177.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.38 -9.65 69.39 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.145 -0.55 . . . . 0.0 113.272 171.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.407 ' HB2' HD21 ' A' ' 95' ' ' ASN . 33.5 mtp180 -83.93 160.61 21.04 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.131 0.491 . . . . 0.0 111.417 -176.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.1 m -113.54 106.97 15.18 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.15 176.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.8 m -106.16 130.62 54.01 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.213 0.53 . . . . 0.0 111.004 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.447 HG22 ' HB3' ' A' ' 90' ' ' SER . 23.5 m -86.54 105.04 16.55 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.451 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.484 ' CD2' ' HB ' ' A' ' 93' ' ' VAL . 87.4 m-85 -91.27 134.23 34.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.744 -177.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -89.48 95.63 10.36 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.42 HG11 HD13 ' A' ' 114' ' ' LEU . 31.6 m -109.44 163.67 6.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.595 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.579 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 0.7 OUTLIER -110.98 146.97 35.72 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.154 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.511 HD23 ' HA3' ' A' ' 145' ' ' GLY . 6.7 mp -60.74 -35.41 76.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.719 -172.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.8 p -98.73 9.48 43.27 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -172.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.579 ' HG2' ' O ' ' A' ' 106' ' ' ARG . 10.0 pt20 -81.07 -8.93 59.87 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.653 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.6 p 64.19 159.11 0.09 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.066 1.346 . . . . 0.0 111.346 -175.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.581 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 48.4 t -63.85 -21.02 27.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.052 0.454 . . . . 0.0 109.979 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.57 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -58.21 -41.53 84.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.869 176.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -69.74 -36.51 75.9 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 120.745 0.307 . . . . 0.0 110.325 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.42 HD13 HG11 ' A' ' 105' ' ' VAL . 62.3 tp -66.92 -43.61 82.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.891 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -65.82 -28.18 68.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.349 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.513 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 35.0 tt0 -76.01 -34.77 59.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.588 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -60.21 -48.71 80.6 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.797 0.808 . . . . 0.0 108.909 171.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.46 -40.66 84.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.032 174.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.846 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 25.2 p -66.07 -14.75 62.27 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.843 0.354 . . . . 0.0 111.08 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.17 -44.03 8.34 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.656 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.3 mt -91.15 -59.9 2.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.044 0.45 . . . . 0.0 112.197 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 124' ' ' VAL . 4.4 tp10 -100.38 9.42 42.67 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 123.524 0.73 . . . . 0.0 110.396 -174.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.846 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -45.71 7.95 0.01 OUTLIER Glycine 0 N--CA 1.473 1.108 0 N-CA-C 118.69 2.236 . . . . 0.0 118.69 -172.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 122' ' ' GLU . 40.6 t -49.46 85.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 118.167 0.984 . . . . 0.0 112.276 174.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.409 ' HB2' HD12 ' A' ' 128' ' ' LEU . 2.3 mp0 56.29 106.81 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.586 0.754 . . . . 0.0 112.241 176.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -51.26 -24.17 4.21 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.746 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -81.51 -20.71 39.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.01 -175.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.461 HD12 HG12 ' A' ' 124' ' ' VAL . 96.7 mt -81.46 -14.84 56.58 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -175.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.417 ' HB3' HD23 ' A' ' 159' ' ' LEU . 54.4 p90 -133.82 151.11 51.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.451 0.643 . . . . 0.0 111.816 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.414 ' HD1' ' HB3' ' A' ' 137' ' ' PRO . 0.8 OUTLIER -149.25 157.07 43.04 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 172.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.651 HD12 HG11 ' A' ' 155' ' ' VAL . 1.3 pt? -123.57 135.85 54.21 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.727 -172.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 41.3 p -116.19 131.7 56.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.845 -178.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.553 ' CE2' ' HB2' ' A' ' 134' ' ' GLU . 8.4 t80 -94.16 -89.67 0.22 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.523 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.553 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 10.8 tt0 -98.42 25.44 6.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.561 0.696 . . . . 0.0 110.385 -170.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 133.25 -37.43 2.0 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.75 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 54.3 mmtt -117.18 156.21 48.85 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 120.54 0.209 . . . . 0.0 110.917 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 132' ' ' THR . 48.2 Cg_endo -69.25 152.99 71.94 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.121 2.547 . . . . 0.0 112.79 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.463 ' HB3' HG21 ' A' ' 111' ' ' VAL . 85.9 mt -94.6 121.72 36.45 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.767 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -84.81 146.09 27.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.589 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.581 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 6.7 p-10 -61.22 -22.05 64.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.54 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -73.42 -15.78 61.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.176 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 77.1 mt -102.14 140.17 20.93 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 121.121 0.486 . . . . 0.0 111.516 -172.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 142' ' ' LEU . 12.7 Cg_exo -71.23 144.1 45.53 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.983 2.456 . . . . 0.0 111.08 173.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.643 HD12 ' H ' ' A' ' 144' ' ' LEU . 4.1 mp -71.54 -33.9 69.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.998 -174.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.511 ' HA3' HD23 ' A' ' 107' ' ' LEU . . . -59.63 -30.29 68.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.286 -0.483 . . . . 0.0 113.686 -172.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.65 -41.26 94.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.049 0.452 . . . . 0.0 111.029 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -101.55 -30.2 11.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.529 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.445 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -98.97 6.73 60.24 Favored Glycine 0 C--O 1.227 -0.299 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.625 -172.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -41.09 -31.22 0.18 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -92.71 126.54 51.47 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.295 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -68.15 6.38 0.88 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.958 2.439 . . . . 0.0 112.922 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 97.7 mt -112.24 7.41 19.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.05 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.4 p -62.39 117.94 6.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.943 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 15.0 m -101.51 106.66 17.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.408 -175.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.651 HG11 HD12 ' A' ' 131' ' ' LEU . 25.6 t -99.33 140.09 19.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.427 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -109.81 118.3 36.13 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.434 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 2.1 ttm -81.37 106.49 13.37 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -98.82 135.03 40.87 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.741 -172.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.417 HD23 ' HB3' ' A' ' 129' ' ' PHE . 49.1 mt -102.88 -167.68 1.42 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.638 173.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 . . . . . 0 N--CA 1.466 0.369 0 CA-C-O 121.85 0.833 . . . . 0.0 111.754 174.482 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 . . . . . 0 N--CA 1.467 0.4 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -75.47 116.48 55.23 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -82.49 84.53 1.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.309 2.006 . . . . 0.0 110.863 174.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.9 tp -84.21 110.66 18.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.333 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.7 m -88.64 112.91 23.64 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.061 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.5 pt -107.08 134.75 47.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.529 HD11 ' HB3' ' A' ' 100' ' ' SER . 30.2 tp -93.1 101.37 13.67 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.593 -174.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.9 t -84.7 99.8 7.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -97.39 93.93 6.77 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.703 -174.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.593 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 6.1 p30 -79.16 136.37 37.09 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.408 -177.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 27.2 t-20 67.98 -77.32 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.24 -171.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 96' ' ' ASN . 17.2 ptpt 168.68 -23.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.98 0.912 . . . . 0.0 109.771 174.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -81.21 -38.6 14.64 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.0 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -93.67 106.76 18.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.986 0.422 . . . . 0.0 111.651 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.529 ' HB3' HD11 ' A' ' 92' ' ' LEU . 18.6 m -96.5 109.04 21.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.867 174.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.2 m -111.89 112.69 24.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.108 0.48 . . . . 0.0 110.638 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.4 m -76.66 121.92 23.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.515 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -111.81 132.13 54.88 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.96 0.41 . . . . 0.0 110.553 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -81.98 130.4 35.06 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.734 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.2 m -146.36 -179.96 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.765 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 39.7 mtm-85 -138.35 169.96 16.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.175 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.9 mp -73.03 -10.47 59.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.779 0.323 . . . . 0.0 111.43 -175.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 m -85.73 0.46 52.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.221 0.534 . . . . 0.0 110.669 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.489 ' HB3' HD12 ' A' ' 144' ' ' LEU . 13.3 mm100 -86.58 136.46 33.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.089 0.471 . . . . 0.0 111.521 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.5 p -94.7 166.83 11.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.231 175.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 64.2 t -60.39 -40.61 84.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.088 0.471 . . . . 0.0 109.731 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.418 ' O ' ' HG3' ' A' ' 116' ' ' GLN . . . -53.74 -48.35 69.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.898 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.457 ' HB3' ' NE2' ' A' ' 109' ' ' GLN . 3.6 m170 -63.71 -25.77 68.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.835 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.769 ' HB2' HD11 ' A' ' 144' ' ' LEU . 63.7 tp -83.48 -43.18 16.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.915 0.388 . . . . 0.0 110.181 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -60.15 -37.98 81.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.545 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 112' ' ' ALA . 55.5 mt-30 -64.93 -38.19 90.14 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 122.955 0.159 . . . . 0.0 111.41 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -63.37 -50.09 71.3 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.12 0.486 . . . . 0.0 109.786 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.4 t -57.34 -44.29 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.753 174.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.727 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 66.6 m -62.25 -22.2 65.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.086 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.61 -39.53 21.22 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.28 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -94.74 -64.9 1.02 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.1 0.476 . . . . 0.0 111.828 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -100.41 8.55 43.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.135 -174.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.727 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -55.81 7.26 0.01 OUTLIER Glycine 0 CA--C 1.521 0.466 0 N-CA-C 116.481 1.353 . . . . 0.0 116.481 -172.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 64.4 t -41.82 92.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 123.552 0.741 . . . . 0.0 111.777 173.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 52.97 106.23 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 O-C-N 123.858 0.724 . . . . 0.0 111.744 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.629 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 9.2 p-10 -69.11 1.9 3.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.439 0.638 . . . . 0.0 110.403 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -75.53 -33.63 60.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.676 169.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 93.5 mt -79.34 -33.37 43.12 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.323 -173.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.629 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 52.2 p90 -105.78 121.4 43.97 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.658 -0.817 . . . . 0.0 112.045 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.552 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 37.2 t90 -132.29 104.22 6.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.369 176.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.721 HD23 ' H ' ' A' ' 131' ' ' LEU . 2.4 pt? -96.77 140.69 30.97 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.496 0.665 . . . . 0.0 112.046 -170.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 76.8 p -128.05 144.97 51.13 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.067 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -109.02 -72.0 0.74 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.645 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.615 ' HB3' ' HG2' ' A' ' 136' ' ' LYS . 24.2 tt0 -92.29 32.61 1.16 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.535 -171.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.9 11.53 85.12 Favored Glycine 0 CA--C 1.509 -0.343 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -169.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.615 ' HG2' ' HB3' ' A' ' 134' ' ' GLU . 0.5 OUTLIER -134.2 149.56 71.72 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 114.474 -0.863 . . . . 0.0 109.328 -178.379 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.78 150.59 78.98 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.175 1.917 . . . . 0.0 111.115 173.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 76.1 mt -74.21 109.28 7.58 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.82 122.17 26.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.741 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.4 53.06 1.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.191 0.995 . . . . 0.0 110.569 -176.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.77 ' HG3' ' HG ' ' A' ' 142' ' ' LEU . 8.5 pt20 -129.97 -7.95 4.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.823 175.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.77 ' HG ' ' HG3' ' A' ' 141' ' ' GLN . 81.2 mt -127.22 157.01 73.76 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.781 -175.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.68 145.5 25.96 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.1 1.866 . . . . 0.0 111.789 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.769 HD11 ' HB2' ' A' ' 114' ' ' LEU . 79.6 mt -62.2 -23.01 66.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.468 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -57.67 -34.87 71.41 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.326 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -77.47 -24.09 50.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.233 0.517 . . . . 0.0 110.988 -176.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -91.11 -39.0 12.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.302 0.573 . . . . 0.0 110.629 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.05 6.37 59.9 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.655 -172.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -41.41 -32.18 0.3 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.462 ' HG2' ' H ' ' A' ' 152' ' ' LEU . 24.7 ttmm -83.18 114.98 56.62 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 173.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 16.8 Cg_exo -68.52 20.58 0.14 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.566 2.844 . . . . 0.0 113.427 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.462 ' H ' ' HG2' ' A' ' 150' ' ' LYS . 54.3 mt -146.93 19.73 1.27 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.588 177.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.8 p -64.97 127.27 30.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.752 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.3 m -94.59 100.72 12.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.904 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.4 t -92.6 111.49 24.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -79.13 102.35 8.41 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.042 -175.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.593 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 22.8 ttt -76.44 90.91 3.28 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.552 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 11.2 m120 -74.5 131.03 40.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.391 -173.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 76.6 mt -96.92 114.66 26.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.144 0.497 . . . . 0.0 110.164 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.785 -176.879 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.5 t70 . . . . . 0 CA--C 1.515 -0.377 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 64.75 81.18 0.22 Allowed Pre-proline 0 N--CA 1.455 -0.21 0 CA-C-N 113.191 -1.822 . . . . 0.0 112.836 169.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.92 132.52 15.63 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.682 2.254 . . . . 0.0 111.047 169.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.643 HD21 ' O ' ' A' ' 148' ' ' GLY . 55.1 tp -92.22 155.82 17.73 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 6.5 t -131.61 130.7 42.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.885 0.374 . . . . 0.0 110.013 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.465 HD12 HG21 ' A' ' 155' ' ' VAL . 35.4 pt -127.88 150.71 33.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.847 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.45 HD11 ' HB2' ' A' ' 100' ' ' SER . 50.6 tp -93.24 113.7 25.97 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.0 0.428 . . . . 0.0 110.762 -177.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 63.6 t -98.62 113.47 33.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.742 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -110.73 114.98 28.76 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.763 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.421 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 29.3 p30 -94.68 136.43 35.0 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.287 -178.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 17.52 -80.83 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.7 OUTLIER -139.13 8.92 2.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.928 0.394 . . . . 0.0 111.134 -165.926 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -122.03 -78.49 0.47 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.366 -1.397 . . . . 0.0 114.772 -170.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -111.29 136.65 50.08 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.261 0.553 . . . . 0.0 112.455 -164.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.45 ' HB2' HD11 ' A' ' 92' ' ' LEU . 12.7 p -115.86 106.51 13.91 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 167.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.0 t -118.24 133.01 56.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.993 0.425 . . . . 0.0 110.74 -175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.72 100.69 13.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.119 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 90' ' ' SER . 84.5 m-85 -90.66 166.04 13.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.834 0.349 . . . . 0.0 111.093 -176.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -103.97 128.98 51.52 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.374 0.606 . . . . 0.0 110.906 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.2 m -139.56 -179.44 2.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.713 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.47 ' HB2' ' HG2' ' A' ' 109' ' ' GLN . 67.8 mtp85 -132.13 164.42 26.33 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 174.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 107' ' ' LEU . 6.7 mp -82.23 -39.14 23.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.016 0.436 . . . . 0.0 110.135 176.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.1 m -92.12 66.15 4.85 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.292 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.47 ' HG2' ' HB2' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -156.43 157.99 36.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.789 174.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.523 ' HB ' ' O ' ' A' ' 140' ' ' ASP . 14.8 p -88.58 144.92 26.01 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.651 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 47.2 t -56.73 -19.25 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 120.925 0.393 . . . . 0.0 111.224 -177.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -55.81 -34.64 65.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.947 0.403 . . . . 0.0 110.713 173.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -74.23 -15.62 60.99 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.204 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.714 HD22 HD11 ' A' ' 144' ' ' LEU . 65.3 tp -92.46 -53.24 4.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.033 0.444 . . . . 0.0 110.028 174.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -61.44 -40.02 92.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.53 -173.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -69.1 -31.8 70.77 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.478 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -68.27 -44.81 74.72 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.87 -35.67 61.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.548 173.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.769 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 62.3 m -72.49 -14.96 61.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.451 178.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.76 -39.36 21.16 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.438 175.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.1 mp -94.85 -64.39 1.07 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.132 0.491 . . . . 0.0 111.8 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -96.81 8.3 44.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.62 -173.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.769 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -54.35 7.66 0.01 OUTLIER Glycine 0 CA--C 1.522 0.531 0 N-CA-C 118.02 1.968 . . . . 0.0 118.02 -169.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.471 HG12 HD12 ' A' ' 128' ' ' LEU . 57.7 t -43.23 93.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 118.122 0.961 . . . . 0.0 112.316 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 57.37 109.11 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.605 0.762 . . . . 0.0 111.753 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.466 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 39.1 t70 -60.22 -6.67 1.54 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.639 -176.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -96.48 -19.29 19.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.666 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.471 HD12 HG12 ' A' ' 124' ' ' VAL . 64.9 mt -79.04 -39.78 33.07 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.716 -176.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.466 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 29.6 p90 -96.59 94.71 7.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.948 0.88 . . . . 0.0 111.447 -177.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.665 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 34.1 t90 -90.12 87.6 6.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.29 176.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.604 HD23 ' H ' ' A' ' 131' ' ' LEU . 2.7 pt? -88.0 139.7 30.24 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.212 0.53 . . . . 0.0 110.652 -176.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.02 159.69 44.39 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.15 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.478 ' CD2' ' HB2' ' A' ' 134' ' ' GLU . 13.5 t80 -102.71 -74.51 0.63 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.934 -175.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.478 ' HB2' ' CD2' ' A' ' 133' ' ' PHE . 7.8 tp10 -98.49 21.26 11.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.176 0.512 . . . . 0.0 110.702 -171.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.36 9.17 62.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.512 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.495 ' HD3' ' O ' ' A' ' 137' ' ' PRO . 14.4 tmtt? -122.56 122.37 27.31 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.495 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 27.2 Cg_exo -58.91 152.75 55.66 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.785 2.324 . . . . 0.0 112.296 -176.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 44.8 mt -103.29 97.08 7.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.242 -174.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.42 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 2.6 mp0 -63.73 134.4 55.26 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 173.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.651 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 5.6 p-10 -65.54 -22.41 66.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.085 -174.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -81.89 -10.39 59.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.838 0.351 . . . . 0.0 111.202 -177.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.42 ' HG ' ' HB2' ' A' ' 139' ' ' GLU . 79.6 mt -90.55 157.06 44.88 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.977 -176.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 109' ' ' GLN . 3.0 Cg_exo -75.23 128.73 11.53 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.978 2.452 . . . . 0.0 111.686 177.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.714 HD11 HD22 ' A' ' 114' ' ' LEU . 5.1 tt -62.53 -36.72 83.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.33 -177.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -52.11 -28.91 27.24 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 114.392 0.517 . . . . 0.0 114.392 -176.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -61.63 -38.07 86.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.159 0.504 . . . . 0.0 110.481 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -100.71 -33.11 10.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.157 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.643 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -96.86 6.18 64.34 Favored Glycine 0 C--O 1.223 -0.593 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.761 -172.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.7 pt? -46.79 -25.98 0.86 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.463 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 66.6 mttm -96.84 133.89 23.79 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 17.1 Cg_exo -67.87 2.57 2.46 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.93 2.42 . . . . 0.0 111.878 176.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -124.58 11.34 8.54 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.046 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 46.7 m -60.52 110.22 1.22 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.926 0.393 . . . . 0.0 110.276 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 19.8 m -84.32 101.33 11.87 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.453 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.465 HG21 HD12 ' A' ' 91' ' ' ILE . 56.4 t -87.63 115.08 27.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.62 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -87.95 103.18 15.44 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.321 0.582 . . . . 0.0 110.745 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.421 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 26.4 ttt -77.17 87.19 3.63 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.842 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.665 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 23.3 m-80 -77.71 88.09 3.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.417 -174.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.63 94.1 3.16 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 172.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.889 -171.679 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.527 ' OD1' ' HD3' ' A' ' 106' ' ' ARG . 31.0 t70 . . . . . 0 CA--C 1.518 -0.258 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 53.67 73.84 0.86 Allowed Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.865 174.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -93.43 137.02 1.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 123.049 2.499 . . . . 0.0 112.783 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 148' ' ' GLY . 0.2 OUTLIER -97.98 125.75 43.07 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.031 177.617 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -89.11 99.18 12.22 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.008 0.433 . . . . 0.0 110.193 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 45.8 pt -101.6 163.72 3.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.218 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.541 HD11 ' HB3' ' A' ' 100' ' ' SER . 23.8 tp -119.2 111.27 18.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.778 0.323 . . . . 0.0 110.587 -178.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.421 HG22 ' HB ' ' A' ' 155' ' ' VAL . 61.7 t -110.38 112.55 41.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -90.24 125.2 35.4 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.929 0.395 . . . . 0.0 110.861 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.496 ' HA ' ' SD ' ' A' ' 157' ' ' MET . 12.2 m-20 -67.0 150.5 49.17 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -61.16 106.01 0.56 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.665 0.269 . . . . 0.0 110.592 -176.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt 61.32 21.0 11.58 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.28 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.74 -145.62 9.58 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.081 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 99' ' ' ARG . 14.8 ptt180 -89.72 160.62 16.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.144 0.497 . . . . 0.0 111.226 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.541 ' HB3' HD11 ' A' ' 92' ' ' LEU . 12.4 m -81.95 106.87 14.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.851 175.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.0 m -85.66 103.74 14.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.153 0.501 . . . . 0.0 110.488 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.5 m -77.39 115.51 17.22 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.991 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -107.09 131.76 53.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.059 0.457 . . . . 0.0 111.79 -175.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -95.24 103.11 14.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.488 -0.778 . . . . 0.0 108.915 173.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.526 HG11 HD13 ' A' ' 114' ' ' LEU . 33.1 m -129.3 137.61 56.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.896 0.379 . . . . 0.0 111.151 -175.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.527 ' HD3' ' OD1' ' A' ' 86' ' ' ASP . 22.1 mtm180 -83.06 149.83 26.69 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.864 0.364 . . . . 0.0 110.44 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 107' ' ' LEU . 6.6 mp -69.09 -18.47 63.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.957 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.3 m -80.59 1.03 31.39 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.367 0.604 . . . . 0.0 110.763 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -92.97 152.57 19.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.483 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 p -90.36 157.46 17.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.888 172.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.618 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 59.2 t -58.94 -30.88 44.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.034 0.445 . . . . 0.0 110.865 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.551 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -55.21 -39.51 69.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.397 177.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.583 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 5.9 t60 -65.65 -37.19 85.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.134 -178.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.526 HD13 HG11 ' A' ' 105' ' ' VAL . 50.8 tp -67.69 -50.49 57.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.666 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -63.09 -38.75 92.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.093 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 7.2 tp60 -66.7 -29.17 69.09 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.089 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.583 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 93.8 mt-30 -63.47 -49.66 72.76 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 172.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.1 t -59.58 -49.2 84.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.811 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.878 ' HA ' ' HA3' ' A' ' 123' ' ' GLY . 67.4 m -59.51 -20.26 54.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.762 178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -79.31 -36.49 26.97 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.105 176.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 82.7 mt -96.74 -69.15 0.77 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.03 0.443 . . . . 0.0 112.098 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -97.13 7.11 47.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.358 0.599 . . . . 0.0 110.014 -176.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.878 ' HA3' ' HA ' ' A' ' 119' ' ' SER . . . -62.25 7.18 0.22 Allowed Glycine 0 C--O 1.226 -0.374 0 N-CA-C 116.334 1.294 . . . . 0.0 116.334 -170.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.414 HG12 HD12 ' A' ' 128' ' ' LEU . 59.3 t -31.08 93.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.911 0.884 . . . . 0.0 112.648 177.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 53.31 111.78 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 O-C-N 123.913 0.758 . . . . 0.0 112.545 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -63.32 -4.31 2.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.716 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -88.05 -24.68 23.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.041 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.414 HD12 HG12 ' A' ' 124' ' ' VAL . 93.7 mt -85.58 -42.35 14.44 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.542 0.21 . . . . 0.0 111.32 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.587 ' CE1' ' HA2' ' A' ' 123' ' ' GLY . 11.5 p90 -114.83 152.57 31.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.017 0.437 . . . . 0.0 110.477 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.727 ' CD1' ' HG3' ' A' ' 137' ' ' PRO . 1.0 OUTLIER -162.13 135.68 6.32 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 169.082 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.601 HD13 HG11 ' A' ' 155' ' ' VAL . 2.1 pp -98.22 144.79 27.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.309 0.576 . . . . 0.0 111.691 -173.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 25.7 p -120.09 152.05 38.15 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.721 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.517 ' HB3' HD21 ' A' ' 138' ' ' LEU . 14.7 t80 -137.11 -60.43 0.68 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.995 0.426 . . . . 0.0 110.796 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.439 ' C ' ' H ' ' A' ' 136' ' ' LYS . 1.8 tm-20 -81.79 35.62 0.42 Allowed 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.69 -29.58 2.96 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -170.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.492 ' HB2' ' HD2' ' A' ' 137' ' ' PRO . 22.7 pttp -118.05 173.68 3.12 Favored Pre-proline 0 N--CA 1.446 -0.66 0 CA-C-N 115.026 -0.587 . . . . 0.0 109.838 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.727 ' HG3' ' CD1' ' A' ' 130' ' ' TRP . 24.7 Cg_exo -62.38 171.73 5.08 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.376 2.051 . . . . 0.0 111.899 175.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.527 ' HB2' HG11 ' A' ' 111' ' ' VAL . 93.5 mt -101.92 146.06 28.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.44 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -74.3 112.3 10.33 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.618 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.9 p-10 -60.97 -26.79 67.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.819 -174.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -77.72 -19.67 54.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.382 -175.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 61.5 mt -93.2 156.25 40.34 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.732 0.301 . . . . 0.0 110.966 -174.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.05 136.14 54.91 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.896 2.397 . . . . 0.0 112.236 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.507 HD11 HD22 ' A' ' 114' ' ' LEU . 3.0 tt -63.74 -35.78 81.71 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.831 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -59.04 -23.9 57.74 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.835 -0.62 . . . . 0.0 113.162 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -69.07 -30.74 69.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.002 0.401 . . . . 0.0 110.597 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -100.17 -29.24 12.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.147 0.499 . . . . 0.0 110.922 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.448 ' O ' ' HG ' ' A' ' 89' ' ' LEU . . . -100.27 5.58 57.52 Favored Glycine 0 C--O 1.219 -0.809 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.591 -174.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.405 HD23 ' N ' ' A' ' 149' ' ' LEU . 2.3 pt? -46.03 -32.61 2.91 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 22.7 tptm -97.41 116.68 65.92 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 17.4 Cg_exo -66.02 79.69 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.169 2.579 . . . . 0.0 111.806 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 49.2 tp 172.87 -25.06 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.105 -173.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.6 t -46.05 117.45 1.53 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.721 175.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 24.0 m -110.32 120.41 42.35 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.113 -175.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.601 HG11 HD13 ' A' ' 131' ' ' LEU . 42.7 t -98.19 135.9 31.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.614 177.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -111.98 124.82 53.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.811 0.339 . . . . 0.0 110.815 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.496 ' SD ' ' HA ' ' A' ' 95' ' ' ASN . 63.1 mtt -75.42 126.59 31.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.729 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -105.26 152.17 23.21 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.137 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 79.5 mt -115.77 144.91 43.31 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.413 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 160' ' ' ARG . 26.2 ttt180 . . . . . 0 C--N 1.321 -0.65 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.351 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 . . . . . 0 CA--C 1.521 -0.165 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 33.94 66.5 1.32 Allowed Pre-proline 0 N--CA 1.472 0.673 0 C-N-CA 124.446 1.098 . . . . 0.0 113.816 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.52 149.12 11.44 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.899 1.732 . . . . 0.0 111.915 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.537 HD21 ' O ' ' A' ' 148' ' ' GLY . 45.5 tp -110.67 123.63 50.38 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.873 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.6 m -90.55 99.66 12.65 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.008 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.4 pt -100.61 145.54 10.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' A' ' 100' ' ' SER . 23.9 tp -106.21 106.0 16.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.044 0.45 . . . . 0.0 110.256 -176.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 61.0 t -99.86 128.56 51.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.036 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.59 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 81.6 mtt180 -100.4 123.12 44.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.18 0.514 . . . . 0.0 110.875 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -67.73 169.66 9.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.963 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.556 ' HB3' HD12 ' A' ' 159' ' ' LEU . 19.8 p-10 -52.05 -44.38 64.24 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.618 -177.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -75.97 -38.01 57.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.751 0.31 . . . . 0.0 111.411 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 133.13 44.86 0.13 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.747 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 94' ' ' ARG . 11.6 ttm180 -104.02 123.87 48.0 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 175.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.484 ' HB3' HD11 ' A' ' 92' ' ' LEU . 43.8 m -89.49 94.21 9.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.947 0.403 . . . . 0.0 110.155 177.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.8 m -98.95 127.93 44.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.625 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.8 m -88.42 109.39 19.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.554 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -93.86 121.24 35.1 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -86.43 101.84 13.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.815 0.817 . . . . 0.0 109.854 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.469 HG21 HD13 ' A' ' 144' ' ' LEU . 26.2 m -111.9 -177.94 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.623 -177.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.525 ' HG2' ' H ' ' A' ' 108' ' ' THR . 41.8 ttm180 -133.35 153.68 51.38 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.516 ' CD2' HD22 ' A' ' 89' ' ' LEU . 14.3 mt -75.68 -9.11 58.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.023 0.44 . . . . 0.0 110.571 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.525 ' H ' ' HG2' ' A' ' 106' ' ' ARG . 0.2 OUTLIER -91.44 5.2 50.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.313 -177.393 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -122.69 161.73 23.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.824 0.345 . . . . 0.0 110.464 177.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 32.6 p -89.93 167.56 12.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.821 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.637 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 60.4 t -59.82 -31.38 47.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.057 174.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.54 ' HB2' ' HB3' ' A' ' 140' ' ' ASP . . . -57.47 -35.18 69.83 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.028 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -68.49 -17.71 64.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.153 0.502 . . . . 0.0 110.591 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.563 HD22 HD11 ' A' ' 144' ' ' LEU . 48.1 tp -100.12 -48.18 4.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.197 0.523 . . . . 0.0 110.468 176.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.2 tttm -63.19 -41.52 99.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.181 -177.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.791 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 63.5 tt0 -79.69 -17.97 52.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.062 0.458 . . . . 0.0 110.438 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -67.7 -52.79 33.61 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 51.7 t -64.59 -42.35 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.314 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . 1.049 ' HA ' ' HA3' ' A' ' 123' ' ' GLY . 93.9 p -62.98 -32.13 73.41 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.965 0.412 . . . . 0.0 110.62 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.92 -29.3 70.96 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.862 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 78.7 mt -91.61 -77.02 0.43 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.688 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -103.26 -15.84 15.86 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 1.049 ' HA3' ' HA ' ' A' ' 119' ' ' SER . . . -42.35 -54.92 4.57 Favored Glycine 0 C--O 1.229 -0.201 0 N-CA-C 115.426 0.93 . . . . 0.0 115.426 -165.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.401 HG12 HD12 ' A' ' 128' ' ' LEU . 84.1 t 60.07 82.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.962 0.411 . . . . 0.0 110.443 -172.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.468 ' C ' ' H ' ' A' ' 127' ' ' ASP . 93.5 mt-30 58.56 112.08 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.135 -175.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.608 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 8.0 p-10 -72.69 19.34 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.059 0.457 . . . . 0.0 111.496 -176.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 125' ' ' GLN . 29.5 t70 -108.11 -25.08 11.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.278 175.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.401 HD12 HG12 ' A' ' 124' ' ' VAL . 97.9 mt -75.96 -11.54 59.98 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.091 0.472 . . . . 0.0 110.742 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.608 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 31.2 p90 -142.85 148.48 37.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.131 178.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.453 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 1.3 p90 -150.08 156.34 41.47 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.867 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 7.1 mp -112.64 149.53 32.7 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.567 -176.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.491 HG22 ' HA ' ' A' ' 137' ' ' PRO . 47.4 p -131.75 154.4 49.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.961 -178.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -139.23 130.62 26.97 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.301 171.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 70.66 -0.94 2.75 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 123.725 0.641 . . . . 0.0 111.037 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 111.59 -4.32 27.83 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.808 -174.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 137' ' ' PRO . 35.5 mtmm -106.6 134.85 19.64 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.627 0.251 . . . . 0.0 110.616 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.491 ' HA ' HG22 ' A' ' 132' ' ' THR . 7.6 Cg_exo -72.5 147.62 46.55 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.651 2.234 . . . . 0.0 111.266 174.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 37.7 mt -86.49 111.32 20.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.335 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -80.33 126.17 30.83 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.637 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 0.0 OUTLIER -61.18 -25.17 66.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.038 0.447 . . . . 0.0 111.036 -177.583 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 141' ' ' GLN . 11.6 pt20 -78.54 -0.43 29.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.3 -175.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.2 mt -120.76 151.69 54.87 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.666 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 41.1 Cg_endo -67.47 143.79 64.59 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.736 2.291 . . . . 0.0 111.568 176.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.563 HD11 HD22 ' A' ' 114' ' ' LEU . 0.5 OUTLIER -65.9 -27.3 68.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.746 -174.413 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.64 -28.15 56.04 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.127 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -58.32 -39.29 79.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.996 0.426 . . . . 0.0 110.954 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -100.07 -38.56 8.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.166 0.507 . . . . 0.0 111.081 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.537 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -96.06 6.54 66.62 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-O 119.223 -0.765 . . . . 0.0 114.255 -170.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -39.59 -31.73 0.11 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.469 ' C ' ' H ' ' A' ' 152' ' ' LEU . 34.6 ttpt -96.5 124.8 49.65 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 122.286 -0.259 . . . . 0.0 110.359 175.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 20.0 Cg_exo -67.92 24.3 0.13 Allowed 'Trans proline' 0 N--CA 1.477 0.547 0 C-N-CA 123.69 2.927 . . . . 0.0 113.301 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.469 ' H ' ' C ' ' A' ' 150' ' ' LYS . 34.8 tp -133.64 6.19 3.74 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.4 p -60.47 119.67 8.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.654 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.3 m -92.52 99.49 12.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.78 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 49.1 t -92.34 132.61 36.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.715 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -103.3 130.16 50.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.674 0.273 . . . . 0.0 110.746 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.867 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 26.2 ttt -85.01 97.97 10.13 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 176.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 39.2 m-80 -82.37 90.59 6.7 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.168 -173.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.556 HD12 ' HB3' ' A' ' 96' ' ' ASN . 43.6 mt -84.13 84.88 7.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.162 174.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 160' ' ' ARG . 5.1 mpt_? . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.215 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.603 ' O ' ' HD3' ' A' ' 88' ' ' PRO . 8.0 m-20 . . . . . 0 CA--C 1.519 -0.219 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -94.05 103.91 11.87 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.987 0.423 . . . . 0.0 111.638 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.603 ' HD3' ' O ' ' A' ' 86' ' ' ASP . 57.9 Cg_endo -99.54 74.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.464 2.776 . . . . 0.0 111.657 176.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.471 ' HG ' HG23 ' A' ' 91' ' ' ILE . 52.9 tp -70.72 102.65 2.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.192 0.52 . . . . 0.0 110.527 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.8 m -95.58 95.49 8.41 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.832 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.471 HG23 ' HG ' ' A' ' 89' ' ' LEU . 28.8 pt -102.92 156.83 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.412 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.7 tp -96.38 108.01 20.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.063 0.458 . . . . 0.0 110.599 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.511 ' HB ' ' CD1' ' A' ' 103' ' ' TYR . 57.8 t -100.34 118.06 46.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.925 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.551 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 22.6 ttt85 -104.85 108.62 20.21 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.476 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.573 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 3.9 p-10 -90.43 111.33 22.54 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.96 0.886 . . . . 0.0 111.687 -176.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.557 ' HB2' HD12 ' A' ' 159' ' ' LEU . 53.4 t30 69.62 -86.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 113.824 -1.535 . . . . 0.0 112.692 177.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -129.6 -72.25 0.59 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -172.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -106.48 25.72 22.2 Favored Glycine 0 N--CA 1.455 -0.095 0 C-N-CA 120.205 -0.998 . . . . 0.0 113.872 -166.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -132.85 95.74 3.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.288 0.565 . . . . 0.0 111.555 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 2.7 p -107.53 107.81 18.82 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.798 172.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.8 t -116.63 138.16 51.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.351 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.9 m -76.39 116.75 17.37 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.511 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 43.6 m-85 -104.37 148.46 26.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.978 0.418 . . . . 0.0 111.168 -177.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -102.31 110.3 22.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.016 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.4 -179.91 3.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.999 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.621 ' HB2' ' HG3' ' A' ' 109' ' ' GLN . 83.8 mtm180 -128.39 159.87 34.02 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.733 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 mp -81.27 -27.45 35.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.054 0.454 . . . . 0.0 110.13 -176.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.6 m -84.81 10.17 12.22 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.538 0.685 . . . . 0.0 110.861 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.621 ' HG3' ' HB2' ' A' ' 106' ' ' ARG . 28.3 mt-30 -95.05 143.24 26.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.641 172.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 24.9 p -79.64 156.65 27.53 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 170.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.614 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 99.3 t -59.39 -26.83 35.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.842 0.353 . . . . 0.0 110.391 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -58.1 -33.49 69.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.634 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -70.75 -43.11 69.53 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.473 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.605 ' HB2' HD11 ' A' ' 144' ' ' LEU . 64.6 tp -69.72 -37.27 76.47 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 112' ' ' ALA . 21.8 tptp -49.73 -51.43 38.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.82 176.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -65.19 -33.61 76.41 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.093 0.245 . . . . 0.0 111.642 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.47 -43.43 85.48 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.056 0.455 . . . . 0.0 110.177 174.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 114' ' ' LEU . 99.4 t -61.42 -42.6 94.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.648 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 53.8 m -60.69 -21.05 62.44 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.401 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -85.47 -27.21 33.43 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.669 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.7 mt -99.97 -66.49 0.9 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.133 0.492 . . . . 0.0 112.065 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -100.48 8.06 43.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.655 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.648 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -54.45 7.7 0.01 OUTLIER Glycine 0 CA--C 1.523 0.567 0 N-CA-C 117.186 1.634 . . . . 0.0 117.186 -172.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.1 t -31.02 95.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.852 0.861 . . . . 0.0 112.3 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 52.03 103.7 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 O-C-N 123.939 0.775 . . . . 0.0 110.855 -174.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.513 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 32.0 t70 -56.91 -13.05 2.31 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.74 -170.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -99.85 -16.21 18.13 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 60.6 mt -80.71 -13.79 58.69 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 121.964 -0.46 . . . . 0.0 112.026 -175.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.651 ' HB3' HD23 ' A' ' 159' ' ' LEU . 44.5 p90 -123.58 151.18 43.21 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.306 0.574 . . . . 0.0 111.934 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 4.0 p90 -149.38 158.13 43.91 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 172.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.74 ' HG ' ' HG2' ' A' ' 157' ' ' MET . 5.5 mp -105.64 135.54 46.86 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.165 -173.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 21.0 p -123.66 123.63 40.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.121 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -97.11 -69.65 0.75 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.914 0.387 . . . . 0.0 110.293 172.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -69.86 -31.63 69.57 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.724 0.773 . . . . 0.0 110.312 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 139.4 -24.57 2.78 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -169.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 137' ' ' PRO . 52.8 mtpt -84.99 151.68 57.78 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 114.478 -0.861 . . . . 0.0 109.911 172.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 21.3 Cg_exo -66.86 133.32 31.01 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.825 2.35 . . . . 0.0 111.914 176.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 37.8 mt -67.35 120.79 14.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.052 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -73.95 120.98 20.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.385 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.614 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.1 p-10 -68.19 -16.14 63.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.283 0.563 . . . . 0.0 110.428 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -84.03 -4.08 58.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.459 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 70.0 mt -112.52 158.29 37.77 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.194 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.61 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 57.6 Cg_endo -72.45 148.15 47.84 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.605 2.203 . . . . 0.0 112.864 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.605 HD11 ' HB2' ' A' ' 114' ' ' LEU . 20.5 mt -66.09 -37.17 85.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.196 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -59.66 -23.91 59.15 Favored Glycine 0 C--O 1.226 -0.396 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.788 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.507 ' HB2' ' HG2' ' A' ' 143' ' ' PRO . 2.5 tt0 -69.74 -29.58 66.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.885 0.374 . . . . 0.0 110.478 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -100.92 -38.97 7.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.292 0.568 . . . . 0.0 110.831 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.445 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -98.13 7.33 62.29 Favored Glycine 0 C--O 1.227 -0.342 0 CA-C-N 115.497 -0.774 . . . . 0.0 113.859 -169.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.5 pt? -38.9 -36.09 0.25 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -103.62 133.79 20.09 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.65 -7.42 9.04 Favored 'Trans proline' 0 N--CA 1.474 0.354 0 C-N-CA 122.889 2.393 . . . . 0.0 112.422 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 92.5 mt -94.57 -0.64 54.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.984 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 62.6 m -65.14 105.08 1.0 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.037 0.446 . . . . 0.0 110.09 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.1 m -82.25 101.32 10.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.142 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.442 ' HB ' HG22 ' A' ' 93' ' ' VAL . 49.1 t -81.91 106.24 12.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.074 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -83.12 103.06 12.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.164 0.506 . . . . 0.0 110.087 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.74 ' HG2' ' HG ' ' A' ' 131' ' ' LEU . 7.6 tmm? -78.79 112.37 15.86 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.04 113.26 24.93 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -168.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.651 HD23 ' HB3' ' A' ' 129' ' ' PHE . 54.8 mt -92.84 81.38 4.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.318 174.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 110.897 -178.098 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 CA--C 1.513 -0.451 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 62.91 78.63 0.28 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 114.151 -1.386 . . . . 0.0 112.269 175.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -81.64 91.77 1.06 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.403 2.069 . . . . 0.0 110.102 170.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.41 ' CD1' ' HA ' ' A' ' 151' ' ' PRO . 0.1 OUTLIER -75.63 114.65 14.45 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.314 -173.382 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.6 t -82.37 95.44 7.64 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.9 pt -95.35 154.43 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.429 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 154' ' ' THR . 37.3 tp -106.72 114.39 28.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.941 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.3 t -109.37 118.83 57.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.039 0.447 . . . . 0.0 109.896 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 -90.29 132.74 35.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.241 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -62.96 -17.49 62.05 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.966 -175.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 157' ' ' MET . 3.2 p30 -169.44 -59.61 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -169.08 -33.25 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.911 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -78.09 -76.42 0.9 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.753 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 36.4 ttt-85 -69.67 134.3 48.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.89 0.376 . . . . 0.0 110.769 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.447 ' HB3' HD11 ' A' ' 92' ' ' LEU . 14.8 m -118.64 121.94 41.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.873 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.7 t -114.73 126.0 54.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.136 0.493 . . . . 0.0 109.903 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.8 m -90.14 134.48 34.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.981 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -132.64 139.2 47.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.516 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -99.58 107.38 19.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.957 0.408 . . . . 0.0 110.769 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.503 HG11 HD13 ' A' ' 114' ' ' LEU . 21.0 m -125.82 147.55 30.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.105 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -93.75 156.77 16.5 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.52 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.677 ' HG ' ' HA3' ' A' ' 145' ' ' GLY . 8.7 mp -65.44 -13.52 58.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.007 -175.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.2 t -88.58 3.72 49.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.831 0.348 . . . . 0.0 111.36 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -93.26 148.32 22.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.134 0.493 . . . . 0.0 111.02 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.1 p -85.14 159.96 20.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.977 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.545 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 55.8 t -62.17 -33.2 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.209 0.528 . . . . 0.0 109.87 175.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.524 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -64.43 -34.11 77.42 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.832 178.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.47 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 1.5 t60 -67.8 -41.85 82.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.962 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.738 HD22 HD11 ' A' ' 144' ' ' LEU . 62.2 tp -62.17 -45.75 92.02 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.111 173.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -55.13 -37.82 67.41 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.014 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -68.64 -35.39 77.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.758 0.314 . . . . 0.0 110.968 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 18.5 mt-30 -66.76 -45.45 78.49 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.485 0.66 . . . . 0.0 109.336 175.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.3 t -61.06 -36.76 74.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.613 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.829 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 72.5 m -66.82 -16.64 64.42 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.032 176.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.7 -35.75 35.15 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.654 174.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.7 mp -96.18 -71.55 0.67 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 124' ' ' VAL . 28.4 mm-40 -93.92 8.85 39.77 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.125 0.57 . . . . 0.0 111.109 -173.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.829 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -51.07 7.9 0.01 OUTLIER Glycine 0 N--CA 1.471 1.016 0 N-CA-C 118.09 1.996 . . . . 0.0 118.09 -170.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.417 ' N ' ' O ' ' A' ' 122' ' ' GLU . 28.1 t -54.73 82.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 118.154 0.977 . . . . 0.0 112.267 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.16 113.18 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.228 1.011 . . . . 0.0 112.348 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.537 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 1.8 p-10 -58.42 -12.89 4.31 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -173.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -72.75 -29.36 63.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.8 0.333 . . . . 0.0 110.414 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.9 mt -80.19 -39.5 29.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.903 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.537 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 25.8 p90 -109.67 105.04 14.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.946 0.879 . . . . 0.0 110.889 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.405 ' HE1' ' HG3' ' A' ' 137' ' ' PRO . 1.6 t90 -119.7 110.97 17.45 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.587 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.4 pp -92.41 152.19 19.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.075 0.464 . . . . 0.0 111.751 -172.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 13.8 p -140.71 154.82 46.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.121 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.444 ' CD2' ' HG3' ' A' ' 134' ' ' GLU . 10.3 t80 -125.0 -67.21 0.92 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.746 0.308 . . . . 0.0 110.863 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.444 ' HG3' ' CD2' ' A' ' 133' ' ' PHE . 46.3 mt-10 -77.85 3.54 14.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.08 0.467 . . . . 0.0 110.557 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.56 -24.19 27.95 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -168.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -92.99 158.21 37.88 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 114.873 -0.664 . . . . 0.0 109.551 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.405 ' HG3' ' HE1' ' A' ' 130' ' ' TRP . 3.5 Cg_exo -76.63 -2.42 12.64 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.075 2.517 . . . . 0.0 112.051 178.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 58.8 mt 70.67 -171.14 0.16 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.416 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -139.82 132.97 29.68 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.545 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.0 p-10 -70.47 -21.31 62.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.765 -174.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -65.15 -30.5 71.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.033 0.444 . . . . 0.0 110.871 177.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 72.5 mt -87.4 143.61 34.52 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.643 -176.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 142' ' ' LEU . 20.5 Cg_exo -64.05 131.8 32.0 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.642 2.228 . . . . 0.0 111.772 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.738 HD11 HD22 ' A' ' 114' ' ' LEU . 4.1 tt -55.27 -35.47 65.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.336 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.677 ' HA3' ' HG ' ' A' ' 107' ' ' LEU . . . -58.83 -23.37 56.06 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.638 -177.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -66.01 -31.24 72.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.221 0.51 . . . . 0.0 110.49 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -100.06 -29.11 12.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.151 0.5 . . . . 0.0 110.809 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.401 ' O ' ' HG ' ' A' ' 89' ' ' LEU . . . -100.09 5.73 57.89 Favored Glycine 0 C--O 1.222 -0.646 0 CA-C-N 115.652 -0.704 . . . . 0.0 113.937 -172.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.402 ' N ' HD23 ' A' ' 149' ' ' LEU . 2.5 pt? -46.28 -30.47 2.05 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -176.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.843 ' HD3' ' HD2' ' A' ' 151' ' ' PRO . 17.3 tppt? -89.21 119.73 69.75 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.843 ' HD2' ' HD3' ' A' ' 150' ' ' LYS . 48.6 Cg_endo -71.06 61.52 2.46 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.527 2.818 . . . . 0.0 112.165 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.4 tp -179.9 -26.79 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.307 -172.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.6 t -45.9 130.46 9.63 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.439 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 33.6 m -110.97 128.32 55.8 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.864 -173.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.8 t -99.1 138.57 23.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.027 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -110.1 117.0 32.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.964 0.411 . . . . 0.0 111.304 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.48 ' O ' ' HA ' ' A' ' 96' ' ' ASN . 73.5 mtp -80.2 99.03 7.6 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.864 174.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -79.36 96.04 5.89 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.396 0.617 . . . . 0.0 110.442 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.35 106.1 4.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.707 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 70.9 ttp85 . . . . . 0 C--N 1.322 -0.595 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.125 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.9 t70 . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 8.0 mt-10 -95.12 110.2 48.86 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.414 -170.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 4.4 Cg_exo -80.94 -172.61 1.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.69 2.927 . . . . 0.0 112.225 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.48 HD21 ' O ' ' A' ' 148' ' ' GLY . 65.7 tp -174.07 104.0 0.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.924 -175.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.8 m -85.33 105.96 16.37 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.005 0.431 . . . . 0.0 110.855 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 28.2 pt -106.8 145.47 14.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.162 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 14.5 tp -99.86 112.75 24.99 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 64.4 t -94.23 121.04 44.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.307 0.575 . . . . 0.0 111.44 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.405 ' HD3' ' HD1' ' A' ' 156' ' ' PHE . 21.4 ttt180 -85.17 118.55 24.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 175.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.556 ' ND2' ' HA ' ' A' ' 99' ' ' ARG . 4.1 p30 -135.63 -156.19 0.7 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.348 -167.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -93.33 -51.01 5.19 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -68.38 -76.01 0.1 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.781 0.324 . . . . 0.0 110.962 -171.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -123.26 106.05 0.97 Allowed Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 174.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.699 ' HD3' ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -78.25 59.65 2.33 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -162.563 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.9 p -169.16 59.58 0.05 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.52 0.676 . . . . 0.0 109.349 172.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.2 m -80.39 104.64 11.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.098 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 m -75.49 90.57 2.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.002 0.429 . . . . 0.0 110.094 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -82.87 117.35 22.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.907 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -86.28 101.14 12.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 173.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.4 m -121.04 -179.66 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.416 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -125.36 145.44 50.04 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.01 -12.11 52.77 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.981 -173.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.3 t -85.05 7.61 20.86 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.083 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -94.97 148.48 22.27 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.264 0.554 . . . . 0.0 111.806 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.64 ' HB ' ' OD1' ' A' ' 140' ' ' ASP . 9.4 p -82.02 166.86 19.43 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.188 170.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.09 -34.67 70.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.359 0.6 . . . . 0.0 109.688 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.53 -41.34 89.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.029 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -66.95 -15.49 63.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.937 0.399 . . . . 0.0 110.559 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.644 ' HB2' HD11 ' A' ' 144' ' ' LEU . 61.4 tp -91.89 -54.87 3.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.488 176.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -75.67 -10.01 59.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -172.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.859 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 63.7 tt0 -81.63 -31.86 32.19 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.048 0.451 . . . . 0.0 110.154 173.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -65.34 -35.78 82.04 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 172.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.23 -43.45 88.25 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.247 173.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.859 ' OG ' ' HA ' ' A' ' 116' ' ' GLN . 2.3 p -74.18 2.33 9.29 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.947 0.403 . . . . 0.0 111.69 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -92.42 -47.62 3.22 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.874 168.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.8 mt -86.71 -44.31 11.91 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.553 0.692 . . . . 0.0 111.267 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 124' ' ' VAL . 4.9 tp10 -98.29 10.55 40.42 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.227 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -29.35 6.62 0.0 OUTLIER Glycine 0 N--CA 1.486 2.003 0 N-CA-C 121.141 3.217 . . . . 0.0 121.141 -174.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' A' ' 122' ' ' GLU . 8.3 t -50.3 161.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 119.548 1.674 . . . . 0.0 109.407 169.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -42.54 136.99 2.27 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.339 0.59 . . . . 0.0 112.485 -175.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.643 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 28.2 t70 -61.01 -23.94 65.78 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.339 -172.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -89.42 -1.69 58.14 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.843 0.354 . . . . 0.0 110.873 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.499 HD12 HG12 ' A' ' 124' ' ' VAL . 74.6 mt -97.28 -28.02 14.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.64 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.643 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 42.5 p90 -103.55 113.84 27.65 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.076 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.403 ' HB3' ' O ' ' A' ' 158' ' ' ASN . 9.7 t90 -112.07 155.47 23.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.618 -176.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 5.5 mp -137.81 154.11 49.58 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.5 p -150.56 144.68 25.46 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.828 0.346 . . . . 0.0 111.2 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.543 ' CD2' ' HG2' ' A' ' 134' ' ' GLU . 14.8 t80 -135.31 -66.73 0.56 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.337 171.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.543 ' HG2' ' CD2' ' A' ' 133' ' ' PHE . 8.5 mm-40 -80.5 26.08 0.39 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.678 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.33 -9.35 67.47 Favored Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -173.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -124.38 162.81 40.04 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 131' ' ' LEU . 5.4 Cg_exo -74.92 4.07 5.02 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.179 2.586 . . . . 0.0 113.072 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 74.6 mt 73.8 142.22 0.07 Allowed 'General case' 0 N--CA 1.464 0.229 0 O-C-N 124.045 0.84 . . . . 0.0 110.996 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -85.52 124.18 31.79 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.35 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.64 ' OD1' ' HB ' ' A' ' 110' ' ' THR . 29.8 t70 -65.61 -22.14 66.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.343 0.592 . . . . 0.0 110.365 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -60.04 -26.91 66.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.504 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 87.8 mt -103.56 144.91 29.62 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.589 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 142' ' ' LEU . 14.4 Cg_exo -69.47 147.23 64.28 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.64 2.226 . . . . 0.0 112.027 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.644 HD11 ' HB2' ' A' ' 114' ' ' LEU . 76.6 mt -57.32 -33.19 67.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.659 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -56.23 -27.7 53.06 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.255 -0.498 . . . . 0.0 113.302 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.17 -43.92 83.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.097 0.475 . . . . 0.0 110.304 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -100.73 -28.53 12.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.811 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.48 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -96.41 5.76 65.24 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.517 -174.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.5 pt? -47.83 -27.7 2.21 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -91.13 110.23 40.88 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.462 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 16.9 Cg_exo -67.2 81.02 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.854 2.37 . . . . 0.0 111.913 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 151' ' ' PRO . 6.3 mt 162.86 -19.62 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.801 1.24 . . . . 0.0 109.683 -175.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.8 t -52.72 127.11 22.09 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.182 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.8 m -96.46 118.27 32.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.323 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.9 t -86.22 118.48 32.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.419 176.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.405 ' HD1' ' HD3' ' A' ' 94' ' ' ARG . 96.1 m-85 -88.79 99.25 12.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.045 0.45 . . . . 0.0 110.751 -177.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 24.6 ttt -80.08 98.66 7.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.303 0.573 . . . . 0.0 109.52 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 130' ' ' TRP . 4.6 m-20 -89.87 91.44 8.61 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.885 -177.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.4 tt -67.46 118.66 11.09 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 . . . . . 0 C--N 1.322 -0.595 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.653 -176.914 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 N--CA 1.463 0.184 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 59.29 70.69 1.06 Allowed Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.857 174.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -79.22 118.13 3.94 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.425 2.083 . . . . 0.0 112.23 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.554 HD11 ' HA ' ' A' ' 151' ' ' PRO . 29.1 tp -106.25 111.4 23.98 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.148 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.0 t -91.19 86.68 6.25 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.92 0.39 . . . . 0.0 110.301 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.5 pt -91.23 169.19 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.861 -176.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.517 HD11 ' HB2' ' A' ' 100' ' ' SER . 42.7 tp -108.54 106.12 16.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.042 0.448 . . . . 0.0 110.585 -177.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.0 t -97.69 116.0 39.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.5 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.56 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 71.6 mtp180 -96.99 157.86 15.7 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.013 0.435 . . . . 0.0 111.099 -177.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -77.18 -175.23 3.54 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.121 174.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -71.77 84.79 0.92 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.187 0.518 . . . . 0.0 109.852 177.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.446 ' HE2' ' HB3' ' A' ' 97' ' ' LYS . 32.0 mtpt 61.01 22.87 13.08 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.611 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -116.42 -118.57 3.06 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.512 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 42.4 mtp-105 -70.26 -179.84 2.14 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.343 0.592 . . . . 0.0 111.796 -177.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 20.5 p -144.79 120.67 10.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.249 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.2 t -115.37 128.58 56.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.173 0.511 . . . . 0.0 110.196 -177.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.1 m -87.54 107.86 18.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.475 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -101.05 141.62 33.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.059 0.457 . . . . 0.0 111.901 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -83.85 102.37 12.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.243 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.6 m -114.66 -179.86 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 176.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.61 ' HB2' ' HG3' ' A' ' 109' ' ' GLN . 77.0 mtt85 -140.84 146.61 37.79 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.83 -31.16 72.26 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.267 0.354 . . . . 0.0 111.404 -173.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 m -75.97 -19.23 58.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.151 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.61 ' HG3' ' HB2' ' A' ' 106' ' ' ARG . 25.2 mt-30 -74.22 133.06 42.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.652 0.263 . . . . 0.0 110.39 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.799 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 23.2 p -71.3 159.26 34.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.302 174.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.634 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 59.2 t -60.59 -28.7 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.0 0.429 . . . . 0.0 110.462 177.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.94 -35.43 74.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.104 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.442 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 31.1 m80 -66.61 -42.89 86.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.446 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.852 ' HB2' HD11 ' A' ' 144' ' ' LEU . 60.6 tp -62.26 -44.98 95.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.46 175.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -62.01 -32.26 72.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.728 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 47.1 mt-30 -81.03 -21.09 40.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 0.0 111.59 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 51.8 mt-30 -73.58 -47.78 37.88 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 170.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 81.1 t -61.07 -40.65 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.085 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.946 ' HA ' ' HA3' ' A' ' 123' ' ' GLY . 91.6 p -65.5 -34.18 77.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.916 0.388 . . . . 0.0 110.406 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.29 -27.49 72.49 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.207 175.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 37.3 mt -98.72 -76.29 0.54 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 111.77 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.414 ' C ' ' H ' ' A' ' 124' ' ' VAL . 6.1 tp10 -102.21 8.18 40.63 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.228 0.611 . . . . 0.0 111.621 -174.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.946 ' HA3' ' HA ' ' A' ' 119' ' ' SER . . . -53.36 7.37 0.01 OUTLIER Glycine 0 CA--C 1.525 0.715 0 N-CA-C 117.213 1.645 . . . . 0.0 117.213 -172.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.414 ' H ' ' C ' ' A' ' 122' ' ' GLU . 87.1 t -38.02 97.39 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 123.623 0.769 . . . . 0.0 112.414 175.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.414 ' C ' ' H ' ' A' ' 127' ' ' ASP . 57.3 mt-30 48.08 102.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 O-C-N 124.087 0.867 . . . . 0.0 112.263 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.518 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 12.1 p-10 -71.67 17.87 0.08 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -174.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 125' ' ' GLN . 16.3 t70 -100.24 -21.54 15.45 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 171.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.0 mt -82.2 -16.41 49.77 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.914 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.518 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 25.8 p90 -143.32 159.9 41.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.666 0.269 . . . . 0.0 111.015 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -163.44 155.51 17.67 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.523 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 6.9 mp -106.81 146.95 30.29 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.44 -174.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 13.3 p -138.75 143.17 38.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.145 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.44 ' CD2' ' HB2' ' A' ' 134' ' ' GLU . 20.9 t80 -111.49 -74.62 0.63 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.131 0.491 . . . . 0.0 110.962 176.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.44 ' HB2' ' CD2' ' A' ' 133' ' ' PHE . 28.7 tt0 -93.51 14.55 18.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.41 0.624 . . . . 0.0 110.091 -173.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 102.51 -19.02 49.39 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 -169.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 137' ' ' PRO . 59.7 mttp -73.89 134.95 77.73 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 115.036 -0.582 . . . . 0.0 109.681 174.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 3.3 Cg_exo -77.31 4.66 5.69 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.994 2.463 . . . . 0.0 111.454 175.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 39.8 mt 69.98 -176.39 0.2 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.725 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.483 ' OE2' ' HG ' ' A' ' 142' ' ' LEU . 36.4 tt0 -145.33 121.1 10.55 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 174.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.634 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 1.2 p-10 -63.8 -22.08 66.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.35 0.595 . . . . 0.0 110.674 -175.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -74.69 -27.29 60.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.351 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.483 ' HG ' ' OE2' ' A' ' 139' ' ' GLU . 68.1 mt -94.15 157.05 38.31 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.837 0.351 . . . . 0.0 111.324 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.799 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 10.1 Cg_exo -72.67 151.42 52.11 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.071 2.514 . . . . 0.0 112.566 177.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.852 HD11 ' HB2' ' A' ' 114' ' ' LEU . 43.3 mt -66.67 -32.78 74.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.58 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.541 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -53.83 -34.88 51.88 Favored Glycine 0 C--N 1.332 0.326 0 O-C-N 123.314 0.384 . . . . 0.0 113.133 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -61.0 -33.11 72.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.871 0.367 . . . . 0.0 111.544 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -101.09 -42.07 6.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.723 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -100.13 6.95 58.39 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-O 119.358 -0.69 . . . . 0.0 114.349 -168.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.541 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.6 pt? -43.45 -29.0 0.4 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -175.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.635 ' HB3' ' HB3' ' A' ' 153' ' ' SER . 40.6 tptt -67.82 125.09 90.89 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.554 ' HA ' HD11 ' A' ' 89' ' ' LEU . 52.9 Cg_exo -56.13 -19.24 26.19 Favored 'Trans proline' 0 N--CA 1.478 0.604 0 C-N-CA 123.45 2.767 . . . . 0.0 114.09 -173.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.447 HD23 ' N ' ' A' ' 152' ' ' LEU . 1.5 pt? -132.8 34.21 3.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.228 0.537 . . . . 0.0 109.815 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.635 ' HB3' ' HB3' ' A' ' 150' ' ' LYS . 34.7 p -60.69 139.42 57.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.48 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.7 m -100.86 101.88 12.81 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.013 0.435 . . . . 0.0 111.11 -176.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.3 t -94.56 132.26 39.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -103.1 120.54 40.86 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.0 0.428 . . . . 0.0 111.027 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.523 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 1.7 tmt? -83.5 103.27 12.71 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -98.19 145.16 26.89 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.293 -172.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 95.3 mt -102.39 156.9 17.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.644 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 160' ' ' ARG . 7.4 tpt180 . . . . . 0 C--N 1.326 -0.42 0 O-C-N 123.94 0.775 . . . . 0.0 112.371 -174.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.628 ' O ' ' HD3' ' A' ' 88' ' ' PRO . 6.7 p-10 . . . . . 0 CA--C 1.523 -0.09 0 CA-C-O 120.792 0.329 . . . . 0.0 110.493 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.633 ' O ' ' HG2' ' A' ' 106' ' ' ARG . 1.8 pm0 -107.52 90.57 6.13 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 121.202 0.525 . . . . 0.0 111.262 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.628 ' HD3' ' O ' ' A' ' 86' ' ' ASP . 4.7 Cg_exo -79.38 100.84 1.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.509 2.139 . . . . 0.0 111.485 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.3 tp -114.11 100.51 8.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.087 0.47 . . . . 0.0 110.003 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.5 t -92.84 107.31 19.12 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.617 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 102' ' ' THR . 43.7 pt -105.03 151.8 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.279 -178.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 100' ' ' SER . 19.8 tp -95.84 112.29 24.06 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.203 0.525 . . . . 0.0 111.751 -172.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.7 124.09 62.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.684 175.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -99.44 121.61 41.37 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -62.43 -21.59 65.53 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.522 0.514 . . . . 0.0 112.238 -172.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -173.76 -66.58 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -163.32 11.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.992 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -129.8 -68.14 0.11 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.041 -1.076 . . . . 0.0 111.956 -177.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -69.39 116.79 10.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.211 0.529 . . . . 0.0 111.159 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.528 ' HB2' HD11 ' A' ' 92' ' ' LEU . 15.4 p -103.98 84.02 2.19 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.712 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.1 m -94.96 118.12 31.27 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.58 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 14.9 t -88.49 113.29 23.93 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.59 0.71 . . . . 0.0 109.643 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -90.15 132.02 35.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.622 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -80.59 99.93 8.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.263 0.554 . . . . 0.0 109.937 177.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 29.7 m -113.3 179.24 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.53 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.633 ' HG2' ' O ' ' A' ' 87' ' ' GLU . 80.9 mtt85 -139.13 146.62 40.86 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -177.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.449 HD12 ' H ' ' A' ' 107' ' ' LEU . 5.4 mp -69.83 -31.85 69.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.36 -172.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 33.8 m -63.43 -28.07 69.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.337 0.589 . . . . 0.0 110.246 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.547 ' NE2' HD12 ' A' ' 144' ' ' LEU . 4.1 tt0 -79.2 141.01 37.54 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.518 -177.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.855 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 39.0 p -82.8 167.37 18.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.563 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.61 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 54.1 t -64.85 -23.59 33.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.1 176.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.24 -37.44 67.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.946 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.587 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 7.4 t-160 -66.07 -41.54 90.61 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.79 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.719 ' HB2' HD11 ' A' ' 144' ' ' LEU . 46.7 tp -65.4 -42.84 92.14 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -51.46 -50.36 59.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.403 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.763 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 77.9 mt-30 -75.85 -26.92 57.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.183 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.587 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 54.8 mt-30 -64.24 -50.2 68.94 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 174.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.2 t -63.49 -43.42 98.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.065 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.927 ' HA ' ' HA3' ' A' ' 123' ' ' GLY . 60.6 p -66.15 -23.66 66.52 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.89 0.376 . . . . 0.0 111.153 -176.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.34 -43.0 32.87 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.926 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.9 mt -85.66 -72.66 0.48 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.132 0.492 . . . . 0.0 111.55 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -100.36 6.8 44.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.503 -174.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.927 ' HA3' ' HA ' ' A' ' 119' ' ' SER . . . -63.74 6.92 0.51 Allowed Glycine 0 C--O 1.227 -0.29 0 CA-C-O 118.996 -0.891 . . . . 0.0 115.314 -172.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.504 HG12 HD12 ' A' ' 128' ' ' LEU . 63.6 t -35.24 92.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 123.934 0.894 . . . . 0.0 112.124 175.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 47.51 106.08 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 O-C-N 124.003 0.814 . . . . 0.0 111.046 -171.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.625 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 6.8 p-10 -61.9 -0.94 0.54 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -170.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -100.89 -7.12 23.79 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 176.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.504 HD12 HG12 ' A' ' 124' ' ' VAL . 85.9 mt -83.77 -12.44 55.7 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-O 120.88 0.371 . . . . 0.0 110.684 177.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.625 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 51.9 p90 -128.76 147.24 50.76 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 173.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.645 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 36.9 t90 -133.96 90.12 2.66 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.54 0.686 . . . . 0.0 110.029 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 131' ' ' LEU . 2.6 pt? -90.16 149.54 22.39 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.6 t -160.9 163.53 31.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.353 0.597 . . . . 0.0 111.15 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.433 ' HB3' HD21 ' A' ' 138' ' ' LEU . 6.9 t80 -142.3 -54.56 0.43 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.95 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -88.0 6.65 34.95 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.117 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.62 -22.56 39.94 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 -171.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.443 ' C ' ' H ' ' A' ' 138' ' ' LEU . 61.9 mttp -101.48 152.47 38.02 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 131' ' ' LEU . 62.3 Cg_endo -73.32 22.44 0.33 Allowed 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.653 2.235 . . . . 0.0 112.759 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.572 ' HB3' HG11 ' A' ' 111' ' ' VAL . 42.5 mt 68.36 117.13 0.03 OUTLIER 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.899 0.88 . . . . 0.0 110.981 -178.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -83.23 121.92 27.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.094 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.61 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 2.5 p-10 -69.78 -18.07 63.46 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.179 -174.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -70.0 -24.71 63.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.508 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.4 mt -95.19 156.93 37.23 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.708 -176.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.855 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 71.7 Cg_endo -77.17 153.77 32.13 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.631 2.22 . . . . 0.0 111.764 176.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.719 HD11 ' HB2' ' A' ' 114' ' ' LEU . 10.7 mt -71.25 -22.62 61.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.534 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -58.22 -30.99 64.98 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.55 177.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -66.53 -35.61 80.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.19 0.519 . . . . 0.0 110.856 -177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -95.53 -40.73 9.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.318 0.58 . . . . 0.0 111.081 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -97.54 6.76 63.2 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.232 -0.895 . . . . 0.0 114.156 -168.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -42.06 -32.49 0.46 Allowed 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 117.494 0.647 . . . . 0.0 112.55 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -90.93 123.7 64.04 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 173.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.62 -9.46 18.42 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.752 2.301 . . . . 0.0 112.31 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.8 pp -105.26 8.55 33.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.076 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 33.6 p -63.49 118.17 7.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.092 0.473 . . . . 0.0 109.976 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 9.9 m -98.93 106.11 18.34 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.966 -177.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 53.9 t -86.71 120.83 36.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.35 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.21 108.41 20.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.122 0.487 . . . . 0.0 110.752 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.53 ' HA ' ' CB ' ' A' ' 131' ' ' LEU . 27.5 ttt -85.37 100.89 12.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.564 176.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.645 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 43.1 m-80 -86.27 135.49 33.53 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.683 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 67.1 mt -97.78 20.58 11.79 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.176 0.512 . . . . 0.0 110.731 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 160' ' ' ARG . 8.1 tpt180 . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.5 t70 . . . . . 0 N--CA 1.469 0.492 0 CA-C-O 121.397 0.618 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 11.6 tp10 -116.84 107.97 45.33 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.652 -177.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 1.7 Cg_endo -82.48 114.14 2.38 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.207 2.605 . . . . 0.0 111.184 175.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.447 HD22 HD21 ' A' ' 107' ' ' LEU . 46.5 tp -78.08 114.97 17.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.271 0.558 . . . . 0.0 111.121 -174.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.8 p -94.35 98.63 11.03 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.591 176.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.2 pt -91.02 174.04 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.449 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' A' ' 100' ' ' SER . 1.3 tm? -118.6 112.93 20.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.878 0.371 . . . . 0.0 110.357 -176.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.8 t -103.16 127.35 57.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.887 175.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -98.58 108.53 21.25 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.586 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 36.0 p30 -84.79 174.34 9.95 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.535 -175.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.477 ' OD1' ' HB2' ' A' ' 159' ' ' LEU . 9.8 m-80 -62.02 -24.19 66.91 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.155 0.503 . . . . 0.0 111.226 -175.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -90.39 8.19 34.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.922 -171.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.98 9.62 86.03 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 116.014 -0.539 . . . . 0.0 113.139 174.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -92.3 138.72 31.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.967 0.413 . . . . 0.0 111.034 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.491 ' HB3' HD11 ' A' ' 92' ' ' LEU . 17.6 m -90.2 94.36 9.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.426 175.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.2 p -90.1 111.16 22.2 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.995 0.426 . . . . 0.0 110.612 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.7 m -78.66 114.26 17.43 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.283 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -99.99 120.36 39.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.011 0.434 . . . . 0.0 111.348 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -85.01 103.2 13.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.501 176.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.41 176.36 9.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.205 0.526 . . . . 0.0 111.579 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -115.24 156.61 25.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.785 174.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.509 HD22 ' HA2' ' A' ' 145' ' ' GLY . 80.4 mt -65.88 -29.37 69.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.978 0.418 . . . . 0.0 111.112 -177.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 p -97.53 21.94 9.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.359 -175.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.533 ' HB3' ' HB3' ' A' ' 113' ' ' HIS . 13.4 mt-30 -77.47 -30.2 53.05 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.108 176.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 m 72.91 157.78 0.19 Allowed 'General case' 0 C--O 1.236 0.388 0 O-C-N 123.899 0.75 . . . . 0.0 109.965 -175.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.2 t -54.71 -38.81 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 0.0 110.578 -178.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -47.63 -48.06 28.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.657 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.533 ' HB3' ' HB3' ' A' ' 109' ' ' GLN . 13.2 t-80 -77.69 -7.92 57.17 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.42 -172.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 54.1 tp -100.44 -51.04 3.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.068 0.461 . . . . 0.0 110.347 175.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.424 ' HE2' ' CZ ' ' A' ' 129' ' ' PHE . 3.3 tmtp? -59.02 -48.1 82.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.411 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.587 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 19.7 mm-40 -69.36 -18.28 63.77 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -174.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -70.67 -48.93 52.29 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.2 t -62.52 -36.74 76.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.224 175.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.737 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 55.3 m -62.05 -25.84 67.91 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.17 175.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.07 -35.46 53.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.843 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.7 mt -92.39 -71.89 0.62 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.909 0.385 . . . . 0.0 111.984 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 124' ' ' VAL . 48.0 mt-10 -99.98 9.3 43.13 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.855 0.462 . . . . 0.0 110.797 -174.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.737 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -46.93 7.79 0.01 OUTLIER Glycine 0 N--CA 1.47 0.901 0 N-CA-C 118.719 2.248 . . . . 0.0 118.719 -172.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 122' ' ' GLU . 80.7 t -37.75 100.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 118.446 1.123 . . . . 0.0 112.024 173.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.517 ' HB3' ' HG ' ' A' ' 128' ' ' LEU . 4.0 mm-40 55.81 106.18 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.122 0 O-C-N 123.916 0.76 . . . . 0.0 112.653 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -52.84 -24.54 9.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.023 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.27 -5.83 39.32 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -173.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.517 ' HG ' ' HB3' ' A' ' 125' ' ' GLN . 74.3 mt -89.37 -52.42 5.05 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.984 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.5 ' CE1' ' HA2' ' A' ' 123' ' ' GLY . 13.7 p90 -94.98 126.61 40.43 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.405 0.621 . . . . 0.0 110.155 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.638 ' HZ2' ' H ' ' A' ' 138' ' ' LEU . 9.4 t-105 -144.79 133.58 22.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.278 -178.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.829 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 4.9 mp -105.43 139.34 40.2 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.102 -174.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.581 HG22 ' HA ' ' A' ' 137' ' ' PRO . 45.8 p -132.91 140.7 48.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.31 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.519 ' CD2' ' HG3' ' A' ' 134' ' ' GLU . 11.1 t80 -87.83 -69.94 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.598 0.237 . . . . 0.0 111.462 -178.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.519 ' HG3' ' CD2' ' A' ' 133' ' ' PHE . 37.5 mt-10 -74.7 12.58 0.79 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.01 -177.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.41 2.94 89.86 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -166.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -112.87 147.93 38.26 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 114.867 -0.666 . . . . 0.0 109.574 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.581 ' HA ' HG22 ' A' ' 132' ' ' THR . 59.3 Cg_endo -69.71 146.03 59.27 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.468 2.112 . . . . 0.0 111.916 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.638 ' H ' ' HZ2' ' A' ' 130' ' ' TRP . 70.5 mt -105.05 149.15 26.05 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.78 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.85 144.19 43.91 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -65.49 -25.0 67.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.079 0.466 . . . . 0.0 110.625 -177.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -64.57 -21.85 66.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.856 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 69.4 mt -96.18 131.54 28.54 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.268 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.593 ' HG2' ' HB2' ' A' ' 146' ' ' GLU . 29.2 Cg_endo -63.09 131.27 31.84 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.356 2.037 . . . . 0.0 111.592 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.444 ' HA ' ' CE1' ' A' ' 147' ' ' TYR . 6.9 tt -57.51 -35.94 70.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.577 -175.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.509 ' HA2' HD22 ' A' ' 107' ' ' LEU . . . -66.38 -24.84 72.39 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.04 -0.6 . . . . 0.0 113.723 -178.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.593 ' HB2' ' HG2' ' A' ' 143' ' ' PRO . 35.7 tt0 -61.59 -41.86 98.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.122 0.461 . . . . 0.0 111.231 -175.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.444 ' CE1' ' HA ' ' A' ' 144' ' ' LEU . 0.9 OUTLIER -100.62 -32.59 10.68 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.682 178.526 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -92.22 5.62 78.23 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 121.127 -0.559 . . . . 0.0 114.13 -172.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.509 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.4 pt? -53.33 -24.29 11.54 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -76.34 132.02 73.84 Favored Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.248 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.28 -14.77 44.06 Favored 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.407 2.071 . . . . 0.0 111.962 -178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.1 pp -112.05 14.66 20.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.739 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 77.8 p -62.87 104.78 0.58 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 5.7 m -88.3 104.31 16.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.239 -172.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.497 HG12 ' HB3' ' A' ' 131' ' ' LEU . 43.4 t -88.59 115.3 28.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.405 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -88.07 120.98 29.94 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.435 0.636 . . . . 0.0 111.198 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.829 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 26.9 ttt -76.61 103.7 6.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.55 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 5.1 m-20 -92.9 142.56 27.17 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.512 -178.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.477 ' HB2' ' OD1' ' A' ' 96' ' ' ASN . 2.1 tt -114.59 110.64 20.11 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 . . . . . 0 C--N 1.32 -0.716 0 CA-C-O 121.103 0.477 . . . . 0.0 111.196 -175.786 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.56 ' O ' ' HD3' ' A' ' 88' ' ' PRO . 11.6 p-10 . . . . . 0 N--CA 1.46 0.059 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -111.84 84.83 5.76 Favored Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.44 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.56 ' HD3' ' O ' ' A' ' 86' ' ' ASP . 74.7 Cg_endo -99.09 168.98 0.54 Allowed 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 123.273 2.649 . . . . 0.0 111.742 173.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.536 HD21 ' O ' ' A' ' 148' ' ' GLY . 23.2 tp -124.81 113.59 18.11 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.456 0.646 . . . . 0.0 110.019 176.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.2 t -93.63 111.7 23.43 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.808 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.4 pt -115.25 162.21 13.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.9 0.381 . . . . 0.0 110.716 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.479 HD11 ' HB3' ' A' ' 100' ' ' SER . 47.3 tp -110.79 104.03 12.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.116 0.484 . . . . 0.0 110.511 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.538 HG22 ' HB ' ' A' ' 155' ' ' VAL . 96.1 t -100.69 115.8 42.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.789 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -104.39 154.45 19.84 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.953 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.411 HD21 ' HB2' ' A' ' 99' ' ' ARG . 4.3 p30 -104.52 165.8 10.82 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 175.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -70.1 -5.18 25.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.791 -175.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.423 ' NZ ' ' HB3' ' A' ' 97' ' ' LYS . 4.9 mtpm? -89.69 -14.53 34.56 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.823 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.99 -28.09 6.23 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.398 175.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.411 ' HB2' HD21 ' A' ' 95' ' ' ASN . 19.4 mmt180 -69.73 142.27 53.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.161 0.505 . . . . 0.0 111.803 -175.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.479 ' HB3' HD11 ' A' ' 92' ' ' LEU . 3.4 m -112.28 131.11 55.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.971 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.0 t -124.93 130.31 52.12 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.961 0.41 . . . . 0.0 110.131 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.5 m -92.11 107.19 19.03 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.282 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.471 ' CE1' ' HB ' ' A' ' 93' ' ' VAL . 32.8 m-85 -94.65 132.59 39.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.273 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -104.19 99.9 9.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.343 0.592 . . . . 0.0 109.621 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.418 HG11 HD13 ' A' ' 114' ' ' LEU . 34.8 m -115.33 -179.78 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.819 -174.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -119.15 151.39 38.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.952 175.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.64 -13.42 62.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.234 -175.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.9 m -74.86 -13.89 60.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.203 0.525 . . . . 0.0 110.844 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -85.12 144.3 28.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.734 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.4 p -94.23 175.6 6.64 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.6 t -55.23 -41.31 60.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.9 -42.91 90.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.903 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -69.67 -24.61 63.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.857 -172.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.584 HD22 HD11 ' A' ' 144' ' ' LEU . 57.3 tp -88.23 -43.41 11.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.981 0.42 . . . . 0.0 110.054 172.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -60.67 -42.44 97.04 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.662 -177.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -58.6 -35.21 72.07 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.274 0.359 . . . . 0.0 111.107 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -63.59 -48.3 77.93 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.446 0.641 . . . . 0.0 109.541 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.488 HG11 ' SD ' ' A' ' 157' ' ' MET . 45.0 t -61.81 -41.17 89.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.596 176.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.646 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 50.9 m -59.82 -21.43 60.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.431 177.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.99 -37.15 16.54 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.419 -0.895 . . . . 0.0 112.256 175.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 80.8 mt -92.11 -66.26 0.94 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.214 0.531 . . . . 0.0 112.068 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -100.49 8.27 43.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.945 -175.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.646 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -53.83 7.5 0.01 OUTLIER Glycine 0 CA--C 1.522 0.492 0 N-CA-C 117.547 1.779 . . . . 0.0 117.547 -170.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.404 HG12 HD12 ' A' ' 128' ' ' LEU . 58.4 t -29.87 94.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.07 0.948 . . . . 0.0 112.376 176.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.487 ' HB3' ' HG ' ' A' ' 128' ' ' LEU . 52.3 tt0 48.63 109.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 O-C-N 124.063 0.852 . . . . 0.0 111.314 -171.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -54.59 -19.07 5.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.02 -175.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.47 ' O ' ' HD3' ' A' ' 160' ' ' ARG . 0.7 OUTLIER -95.53 -6.53 40.29 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -177.753 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.487 ' HG ' ' HB3' ' A' ' 125' ' ' GLN . 66.4 mt -82.11 -26.65 33.39 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.174 0.443 . . . . 0.0 111.066 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.418 ' CE1' ' HA2' ' A' ' 123' ' ' GLY . 16.1 p90 -120.1 125.44 48.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.352 0.596 . . . . 0.0 111.046 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.433 ' HE1' ' HB3' ' A' ' 137' ' ' PRO . 21.6 t-105 -132.62 130.11 39.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.844 175.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 131' ' ' LEU . 2.6 pt? -106.08 138.16 42.76 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.966 0.412 . . . . 0.0 110.399 -173.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.632 HG22 ' HA ' ' A' ' 137' ' ' PRO . 49.6 p -134.76 146.25 49.2 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.865 -175.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.563 ' HB3' HD21 ' A' ' 138' ' ' LEU . 32.7 t80 -108.18 139.28 43.09 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.475 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 29.2 tt0 72.19 -29.4 0.2 Allowed 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.727 0.642 . . . . 0.0 111.766 174.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 133' ' ' PHE . . . 130.13 6.19 4.03 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -173.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -117.12 147.69 40.81 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-O 120.509 0.195 . . . . 0.0 110.538 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.632 ' HA ' HG22 ' A' ' 132' ' ' THR . 93.0 Cg_endo -74.87 142.78 28.71 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.187 1.925 . . . . 0.0 110.661 172.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.563 HD21 ' HB3' ' A' ' 133' ' ' PHE . 33.0 mt -95.51 141.1 29.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.623 -170.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.526 ' OE2' ' HB3' ' A' ' 141' ' ' GLN . 33.0 tt0 -86.31 132.3 34.01 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.51 -28.27 61.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.736 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.526 ' HB3' ' OE2' ' A' ' 139' ' ' GLU . 22.6 tm0? -59.29 -44.17 92.52 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.1 mt -74.59 139.84 74.73 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.089 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.76 154.18 73.95 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.505 2.137 . . . . 0.0 112.32 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.584 HD11 HD22 ' A' ' 114' ' ' LEU . 5.7 tt -58.92 -37.05 75.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.234 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.55 -20.46 56.0 Favored Glycine 0 C--O 1.227 -0.282 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.845 -178.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -67.42 -31.15 71.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.268 0.556 . . . . 0.0 110.108 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.472 ' CD1' HD22 ' A' ' 138' ' ' LEU . 16.2 m-85 -100.21 -29.67 12.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.068 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.536 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -94.62 5.78 70.24 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.489 -175.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -49.9 -21.59 1.22 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.532 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 55.8 mttp -86.91 120.7 71.75 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 172.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -59.12 -0.79 0.67 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.959 2.439 . . . . 0.0 112.746 174.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.414 ' H ' ' C ' ' A' ' 150' ' ' LYS . 1.9 pp -128.61 17.51 6.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.712 176.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.532 ' OG ' ' HB2' ' A' ' 150' ' ' LYS . 14.2 m -52.02 108.12 0.26 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.883 0.373 . . . . 0.0 110.69 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.6 m -80.99 90.71 5.98 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.278 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.538 ' HB ' HG22 ' A' ' 93' ' ' VAL . 45.3 t -91.23 114.47 28.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.347 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -90.25 109.6 20.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.366 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.488 ' SD ' HG11 ' A' ' 118' ' ' VAL . 59.4 ttp -77.17 92.89 3.85 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -87.37 114.53 24.06 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.088 -170.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.85 125.24 26.15 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 165.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.47 ' HD3' ' O ' ' A' ' 127' ' ' ASP . 84.0 mtp180 . . . . . 0 C--N 1.32 -0.714 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -170.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 C--O 1.233 0.201 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 65.3 81.04 0.22 Allowed Pre-proline 0 C--O 1.234 0.274 0 CA-C-O 121.105 0.479 . . . . 0.0 110.274 -176.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.28 158.28 12.98 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.069 2.513 . . . . 0.0 112.491 -178.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.546 HD21 ' O ' ' A' ' 148' ' ' GLY . 63.3 tp -91.28 100.73 13.48 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.596 ' HB3' HG22 ' A' ' 102' ' ' THR . 47.3 m -83.87 111.88 19.62 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.557 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 39.2 pt -102.03 151.81 5.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.982 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.539 HD11 ' HB2' ' A' ' 100' ' ' SER . 18.0 tp -101.02 105.18 16.36 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.107 0.479 . . . . 0.0 110.874 -174.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.488 HG22 ' HB ' ' A' ' 155' ' ' VAL . 58.9 t -104.72 126.8 59.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.056 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.528 ' HG2' ' HA ' ' A' ' 100' ' ' SER . 20.0 mtp180 -109.67 128.63 55.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.649 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.56 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 6.0 p30 -72.99 105.88 4.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.12 177.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 53.0 t30 64.52 -77.16 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.396 -174.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -158.8 5.23 0.1 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.105 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -91.0 -83.04 1.42 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.304 -0.951 . . . . 0.0 113.776 -167.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -93.3 129.23 39.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.984 0.421 . . . . 0.0 111.064 -172.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.539 ' HB2' HD11 ' A' ' 92' ' ' LEU . 3.0 p -87.9 100.35 12.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.387 176.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 m -101.61 119.99 39.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.432 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.596 HG22 ' HB3' ' A' ' 90' ' ' SER . 0.2 OUTLIER -82.13 103.78 11.99 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.478 -179.145 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -94.38 127.88 40.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.194 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -88.0 131.14 34.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.634 0.73 . . . . 0.0 110.963 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 29.7 m -147.85 -178.42 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.257 -177.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 106' ' ' ARG . 2.5 mmt180 -140.51 166.71 23.97 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 174.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 107' ' ' LEU . 5.1 mp -78.14 -5.6 52.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.026 0.441 . . . . 0.0 110.155 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.73 -3.23 56.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.775 -176.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.61 178.32 4.33 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.804 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 p -110.22 167.92 9.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.981 0.42 . . . . 0.0 112.091 -174.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.9 t -58.69 -30.92 43.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.64 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.0 -43.21 60.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.917 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.44 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 24.7 t60 -74.44 -14.56 60.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.723 0.297 . . . . 0.0 111.321 -174.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.792 ' HB2' HD11 ' A' ' 144' ' ' LEU . 59.0 tp -87.63 -48.02 8.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.449 0.642 . . . . 0.0 109.274 174.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -59.34 -43.07 92.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.68 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.42 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 63.6 tt0 -63.41 -31.52 72.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.321 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 53.7 mt-30 -63.78 -44.28 93.85 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.106 0.479 . . . . 0.0 109.865 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.5 t -66.16 -45.19 90.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.93 175.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' A' ' 116' ' ' GLN . 67.5 m -66.63 -8.0 24.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.775 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -100.3 -36.44 4.11 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.94 177.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.7 mt -94.84 -44.32 7.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.513 0.673 . . . . 0.0 110.942 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 124' ' ' VAL . 10.0 tp10 -100.12 11.11 40.14 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.234 -178.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -29.18 7.31 0.0 OUTLIER Glycine 0 N--CA 1.488 2.118 0 N-CA-C 121.104 3.202 . . . . 0.0 121.104 -172.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 122' ' ' GLU . 17.6 t -46.65 164.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 119.758 1.779 . . . . 0.0 109.798 167.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 128' ' ' LEU . 76.1 mt-30 -35.24 118.58 0.46 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.542 0.687 . . . . 0.0 111.95 -176.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -58.11 -29.56 65.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.828 -167.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -100.47 14.43 31.25 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.441 ' CD1' ' HB2' ' A' ' 125' ' ' GLN . 59.9 mt -91.14 -16.63 27.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.903 0.382 . . . . 0.0 110.788 174.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -121.75 145.76 47.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.537 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.442 ' HE1' ' HB3' ' A' ' 137' ' ' PRO . 7.2 t-105 -147.68 129.6 15.32 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 173.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.553 ' HB3' ' HA ' ' A' ' 157' ' ' MET . 1.1 pt? -111.48 134.5 53.02 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.065 0.46 . . . . 0.0 110.698 -173.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.612 HG22 ' HA ' ' A' ' 137' ' ' PRO . 46.2 p -135.29 131.52 36.61 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.823 -177.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . 14.8 t80 -70.89 -65.38 0.74 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.306 0.574 . . . . 0.0 111.078 179.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -92.77 1.43 57.28 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.232 -173.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.21 -10.13 69.7 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -164.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.498 ' HD2' ' HE1' ' A' ' 147' ' ' TYR . 17.3 ttmm -81.59 127.62 72.39 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 113.908 -1.146 . . . . 0.0 108.446 175.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.612 ' HA ' HG22 ' A' ' 132' ' ' THR . 82.1 Cg_endo -73.63 131.76 16.45 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.123 1.882 . . . . 0.0 111.862 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.4 mt -77.29 119.34 20.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.604 -174.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -97.74 134.43 40.92 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.486 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.15 -17.22 64.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.384 0.612 . . . . 0.0 111.03 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -58.14 -27.32 63.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.308 172.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 56.6 mt -109.72 145.24 31.57 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.661 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.26 155.69 51.37 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.583 2.189 . . . . 0.0 110.866 173.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.792 HD11 ' HB2' ' A' ' 114' ' ' LEU . 22.6 mt -64.7 -20.34 66.27 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -176.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -54.56 -31.63 52.54 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.79 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -58.77 -38.7 79.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.97 0.414 . . . . 0.0 110.989 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.498 ' HE1' ' HD2' ' A' ' 136' ' ' LYS . 13.8 m-85 -100.66 -32.31 10.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.272 0.558 . . . . 0.0 111.024 -177.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.546 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -97.7 7.05 63.05 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.39 -0.823 . . . . 0.0 113.986 -171.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -44.86 -23.62 0.15 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 62.7 mttp -104.47 134.46 19.67 Favored Pre-proline 0 C--N 1.329 -0.325 0 O-C-N 122.217 -0.302 . . . . 0.0 110.608 175.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 19.9 Cg_exo -67.16 4.89 1.0 Allowed 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.967 2.445 . . . . 0.0 112.586 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -127.6 11.63 6.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.441 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 55.9 m -57.61 107.77 0.48 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.944 0.402 . . . . 0.0 110.15 177.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.5 m -85.64 102.72 13.82 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.973 -176.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 133' ' ' PHE . 40.7 t -92.75 121.85 43.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.541 177.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -92.8 118.55 31.22 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.217 0.532 . . . . 0.0 110.856 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.56 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 40.4 ttm -79.81 93.13 5.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.181 176.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 51.5 m-80 -79.91 123.2 27.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.331 0.586 . . . . 0.0 111.519 -172.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 70.2 mt -105.39 95.56 5.91 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.368 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 . . . . . 0 C--N 1.325 -0.499 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.984 -177.026 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 C--O 1.234 0.267 0 CA-C-O 120.887 0.375 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -156.78 108.94 1.97 Allowed Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.853 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -82.37 -147.6 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.478 2.118 . . . . 0.0 109.316 166.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.576 ' HB3' HG23 ' A' ' 105' ' ' VAL . 14.0 tp -150.83 138.63 19.86 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.514 173.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.6 t -125.67 109.72 12.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.535 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 32.2 pt -116.12 134.72 58.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.945 0.402 . . . . 0.0 110.765 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' A' ' 100' ' ' SER . 58.4 tp -94.46 105.84 17.81 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.038 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 69.1 t -88.53 104.56 14.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.469 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -93.16 114.46 26.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.673 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.559 HD22 ' N ' ' A' ' 95' ' ' ASN . 0.7 OUTLIER -78.54 142.15 37.58 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.224 176.226 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.47 HD21 HD12 ' A' ' 159' ' ' LEU . 3.8 p-10 -62.56 -23.01 66.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.981 0.42 . . . . 0.0 110.491 178.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -84.92 15.25 4.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.112 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.75 55.91 3.25 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.991 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -141.67 96.51 2.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.997 0.399 . . . . 0.0 110.13 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.459 ' HB3' HD11 ' A' ' 92' ' ' LEU . 8.8 m -93.38 96.53 9.99 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.801 0.334 . . . . 0.0 110.109 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.2 p -108.31 119.33 39.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.952 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.1 m -82.11 120.17 24.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.344 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -110.72 136.03 50.41 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -91.01 123.83 34.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.656 0.741 . . . . 0.0 109.679 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' ' 89' ' ' LEU . 16.0 m -135.78 -178.97 2.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.257 -175.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -127.1 157.0 40.83 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.16 -30.38 64.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 110.324 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -78.83 50.33 0.99 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.835 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -139.88 155.82 47.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.659 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.1 p -86.28 152.29 22.89 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.623 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 59.4 t -63.09 -23.79 34.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.004 0.431 . . . . 0.0 109.848 176.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.528 ' CA ' ' HB2' ' A' ' 140' ' ' ASP . . . -57.07 -44.09 82.74 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.81 174.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.509 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 13.0 m-70 -65.32 -32.96 74.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.269 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.472 HD22 HD11 ' A' ' 144' ' ' LEU . 56.4 tp -71.13 -48.0 54.67 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 174.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -54.94 -47.36 74.55 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.897 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.478 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 78.5 mt-30 -63.8 -34.31 77.63 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -176.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 89.4 mt-30 -66.43 -47.06 74.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.336 0.589 . . . . 0.0 109.729 176.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.99 -34.89 65.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.633 174.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.908 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 60.8 m -79.26 -1.33 36.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.399 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -88.81 -37.0 7.52 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.788 168.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.0 mt -86.5 -64.39 1.16 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.02 0.438 . . . . 0.0 111.508 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 124' ' ' VAL . 17.1 mm-40 -99.63 8.93 43.98 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.649 0.78 . . . . 0.0 110.069 -175.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.908 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -44.48 9.12 0.0 OUTLIER Glycine 0 CA--C 1.526 0.723 0 N-CA-C 120.032 2.773 . . . . 0.0 120.032 -170.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' A' ' 122' ' ' GLU . 13.0 t -58.45 75.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 119.517 1.658 . . . . 0.0 112.222 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 123' ' ' GLY . 76.7 mt-30 63.7 121.28 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.504 1.121 . . . . 0.0 113.399 175.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -73.53 54.81 0.47 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 122.412 1.101 . . . . 0.0 109.406 173.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.51 ' O ' ' HD2' ' A' ' 160' ' ' ARG . 19.0 t70 -146.4 -37.69 0.24 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.48 -1.237 . . . . 0.0 108.711 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.7 mt -80.87 -20.02 43.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.604 175.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -135.74 148.28 48.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.652 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.933 ' HZ3' ' HA ' ' A' ' 160' ' ' ARG . 1.2 p90 -155.32 152.52 29.28 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 170.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.798 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 6.7 mp -109.01 141.78 40.65 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.549 -173.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.8 p -122.41 131.37 53.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.83 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.564 ' HB3' HD21 ' A' ' 138' ' ' LEU . 10.9 t80 -100.79 -62.22 1.27 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.166 0.508 . . . . 0.0 110.768 174.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -95.87 27.85 3.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.914 -174.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.4 4.02 90.32 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.596 -174.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -127.05 149.54 69.62 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -62.46 148.52 93.18 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.803 2.335 . . . . 0.0 112.182 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.564 HD21 ' HB3' ' A' ' 133' ' ' PHE . 43.3 mt -96.92 112.94 24.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.443 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -61.76 130.65 46.8 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 173.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.623 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.7 p-10 -77.46 -18.52 57.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.49 -176.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.65 -36.73 73.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.867 0.365 . . . . 0.0 110.602 177.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.418 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 93.2 mt -78.54 158.17 76.44 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.402 -174.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.67 ' HG2' ' HG2' ' A' ' 146' ' ' GLU . 44.4 Cg_endo -69.23 146.71 64.34 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.648 2.232 . . . . 0.0 112.58 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.472 HD11 HD22 ' A' ' 114' ' ' LEU . 22.7 tp -72.12 -37.34 69.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.604 -174.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -57.4 -25.23 54.47 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.396 -0.431 . . . . 0.0 113.716 -176.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.67 ' HG2' ' HG2' ' A' ' 143' ' ' PRO . 24.4 mm-40 -65.78 -29.69 70.22 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.468 -0.43 . . . . 0.0 111.483 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -100.53 -38.47 8.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.171 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.44 ' O ' HD11 ' A' ' 89' ' ' LEU . . . -98.59 6.21 60.73 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-O 119.412 -0.66 . . . . 0.0 113.912 -172.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.5 pt? -37.21 -38.2 0.2 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -175.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.461 ' C ' ' H ' ' A' ' 152' ' ' LEU . 38.7 ttpt -90.76 125.95 57.49 Favored Pre-proline 0 C--N 1.322 -0.605 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.349 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.09 27.35 0.22 Allowed 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.356 2.704 . . . . 0.0 112.653 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.461 ' H ' ' C ' ' A' ' 150' ' ' LYS . 0.2 OUTLIER -140.83 14.83 2.3 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.718 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 31.9 p -75.92 131.74 39.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.443 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 23.6 m -95.09 110.43 22.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.737 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 41.0 t -92.7 109.52 21.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -85.26 120.32 26.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.843 0.354 . . . . 0.0 111.065 -176.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.798 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 27.4 ttt -85.19 103.87 14.55 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -102.65 123.44 46.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.513 -172.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.47 HD12 HD21 ' A' ' 96' ' ' ASN . 88.5 mt -72.9 147.1 45.65 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.933 ' HA ' ' HZ3' ' A' ' 130' ' ' TRP . 60.6 ttt180 . . . . . 0 C--N 1.324 -0.513 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -170.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.7 p30 . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -103.93 107.65 57.47 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 178.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.03 131.83 10.16 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.197 2.598 . . . . 0.0 111.9 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.497 HD22 ' CD2' ' A' ' 107' ' ' LEU . 52.3 tp -109.34 103.44 12.37 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.432 ' OG ' HG22 ' A' ' 102' ' ' THR . 7.3 t -96.16 98.48 10.36 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.105 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.464 HG23 ' HG ' ' A' ' 89' ' ' LEU . 33.3 pt -95.5 159.99 2.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.41 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 33.8 tp -99.99 119.09 37.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.839 0.352 . . . . 0.0 110.877 -177.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 68.9 t -110.13 114.2 46.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.86 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 34.0 ttt-85 -110.08 137.98 47.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.703 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.541 ' ND2' ' HB2' ' A' ' 99' ' ' ARG . 56.7 p30 -79.84 -160.08 0.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.871 175.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -64.25 -32.27 73.79 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -174.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -160.08 105.13 1.53 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.96 0.41 . . . . 0.0 111.482 -176.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.21 -62.09 0.33 Allowed Glycine 0 C--N 1.318 -0.437 0 C-N-CA 120.67 -0.776 . . . . 0.0 114.443 164.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.541 ' HB2' ' ND2' ' A' ' 95' ' ' ASN . 4.6 mmp_? -69.56 105.8 2.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.115 0.483 . . . . 0.0 110.884 -172.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 5.2 m -118.71 100.09 7.19 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.503 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.9 t -101.27 136.62 40.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.86 0.362 . . . . 0.0 110.382 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.432 HG22 ' OG ' ' A' ' 90' ' ' SER . 0.6 OUTLIER -91.68 109.33 20.64 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.603 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 90' ' ' SER . 44.7 m-85 -95.86 120.15 35.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.021 0.439 . . . . 0.0 111.71 -174.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -79.69 100.39 7.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.663 176.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.415 ' C ' ' HD2' ' A' ' 106' ' ' ARG . 35.1 m -123.81 -179.86 2.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.023 0.439 . . . . 0.0 110.975 -177.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.502 ' N ' ' HD2' ' A' ' 106' ' ' ARG . 4.6 mpt_? -123.33 157.2 33.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.497 ' CD2' HD22 ' A' ' 89' ' ' LEU . 23.8 mt -62.03 -29.18 70.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.723 0.297 . . . . 0.0 111.364 -176.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.0 m -74.93 -7.89 54.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.695 -175.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -80.29 125.27 29.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.795 0.331 . . . . 0.0 110.912 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 21.2 p -73.96 157.86 35.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.759 172.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.611 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 60.3 t -59.03 -29.37 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.08 0.467 . . . . 0.0 109.963 177.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -58.71 -38.33 78.06 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.35 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -64.92 -46.33 82.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.708 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.456 HD23 HD11 ' A' ' 131' ' ' LEU . 34.0 tp -64.11 -40.68 96.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.319 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -52.85 -48.84 66.75 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.849 175.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.537 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 11.6 mm-40 -69.03 -28.94 67.02 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -66.98 -48.68 67.74 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.504 0.668 . . . . 0.0 109.452 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 114' ' ' LEU . 42.8 t -64.11 -33.6 63.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.495 175.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.737 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 67.9 m -67.68 -17.4 64.57 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.196 175.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.76 -37.09 27.25 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.559 175.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.9 mt -93.36 -64.98 1.03 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.958 0.409 . . . . 0.0 112.04 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 124' ' ' VAL . 64.6 mm-40 -98.06 9.61 42.42 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.349 0.659 . . . . 0.0 111.367 -174.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.737 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -45.11 7.3 0.01 OUTLIER Glycine 0 N--CA 1.473 1.131 0 N-CA-C 118.583 2.193 . . . . 0.0 118.583 -173.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.464 ' N ' ' O ' ' A' ' 122' ' ' GLU . 57.9 t -50.57 88.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 118.532 1.166 . . . . 0.0 111.019 171.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 49.04 105.8 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.824 0.703 . . . . 0.0 111.794 -175.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.562 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 3.4 p-10 -69.65 5.93 1.28 Allowed 'General case' 0 C--N 1.328 -0.364 0 O-C-N 121.92 -0.488 . . . . 0.0 110.618 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -77.54 -35.61 53.09 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.719 169.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.2 mt -73.78 -21.05 60.3 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.275 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.562 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 52.6 p90 -132.13 120.39 22.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.632 0.73 . . . . 0.0 111.403 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -134.12 131.97 39.35 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 170.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.727 HD23 ' H ' ' A' ' 131' ' ' LEU . 2.2 pt? -104.19 130.62 51.95 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.265 0.555 . . . . 0.0 111.273 -171.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.663 HG22 ' HA ' ' A' ' 137' ' ' PRO . 68.3 p -118.09 138.2 52.41 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.707 -174.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -84.23 132.14 34.68 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.179 175.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 63.87 8.08 3.64 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.959 175.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.04 -2.18 63.6 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.037 -177.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.487 ' O ' ' HB ' ' A' ' 132' ' ' THR . 78.4 mttt -102.02 132.83 21.12 Favored Pre-proline 0 C--N 1.327 -0.396 0 C-N-CA 122.321 0.248 . . . . 0.0 110.479 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.663 ' HA ' HG22 ' A' ' 132' ' ' THR . 19.5 Cg_exo -65.26 127.99 19.47 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.883 2.388 . . . . 0.0 112.936 -175.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 75.6 mt -98.45 164.58 12.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.427 178.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.465 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 32.8 mt-10 -105.99 141.13 37.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.75 175.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.611 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.8 p-10 -64.33 -18.53 64.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.216 0.532 . . . . 0.0 110.263 176.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -72.28 -16.87 61.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.285 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.465 ' HG ' ' HB2' ' A' ' 139' ' ' GLU . 87.4 mt -100.84 148.57 35.23 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.625 -173.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 2.8 Cg_exo -76.94 149.57 29.19 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.102 2.535 . . . . 0.0 112.159 175.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.441 HD11 ' HB2' ' A' ' 114' ' ' LEU . 60.8 mt -73.65 -29.24 62.22 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.401 -176.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.422 ' CA ' HD22 ' A' ' 107' ' ' LEU . . . -54.3 -37.97 60.91 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.308 -0.472 . . . . 0.0 114.131 -173.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -64.55 -32.04 73.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.904 0.383 . . . . 0.0 111.334 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -100.63 -24.31 14.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.21 0.529 . . . . 0.0 111.238 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.438 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -100.4 6.24 57.62 Favored Glycine 0 C--O 1.224 -0.511 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.108 -175.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -39.58 -35.92 0.35 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 98.4 mttt -100.31 129.65 27.59 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 50.9 Cg_exo -57.42 -24.93 63.49 Favored 'Trans proline' 0 N--CA 1.473 0.314 0 C-N-CA 122.834 2.356 . . . . 0.0 112.54 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.425 ' H ' ' HG ' ' A' ' 152' ' ' LEU . 2.3 pp -87.71 -1.28 57.86 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.496 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.3 t -68.89 120.68 15.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.5 m -98.01 119.05 35.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.323 0.582 . . . . 0.0 111.978 -172.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 29.2 t -96.11 119.16 43.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -88.95 117.78 28.21 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.803 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.507 ' HE2' HD21 ' A' ' 159' ' ' LEU . 20.7 ttt -77.56 91.47 3.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.19 176.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -75.46 109.88 9.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.0 -173.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.507 HD21 ' HE2' ' A' ' 157' ' ' MET . 99.6 mt -88.2 113.69 24.07 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.712 176.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 . . . . . 0 C--N 1.325 -0.495 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.603 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 CA--C 1.52 -0.19 0 CA-C-O 121.096 0.474 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.422 ' O ' ' HG2' ' A' ' 106' ' ' ARG . 50.4 mm-40 -119.4 91.88 44.94 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.898 176.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -77.67 70.56 6.87 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.675 2.25 . . . . 0.0 110.531 175.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.578 HD21 ' O ' ' A' ' 148' ' ' GLY . 45.7 tp -78.9 89.26 4.7 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.939 -174.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.525 ' HB3' HG22 ' A' ' 102' ' ' THR . 19.7 m -84.91 93.63 8.58 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.617 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.2 pt -90.21 165.07 2.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.501 HD11 ' HB2' ' A' ' 100' ' ' SER . 21.5 tp -108.69 107.02 17.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.196 0.522 . . . . 0.0 110.916 -175.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.74 107.41 19.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.365 176.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.554 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 16.5 ttm180 -84.33 105.0 14.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -175.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.546 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 50.8 t-20 -78.92 106.46 10.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.493 -0.776 . . . . 0.0 108.973 175.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 68.06 -84.07 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.086 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -146.8 -65.98 0.28 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.642 0.258 . . . . 0.0 111.606 -177.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -84.48 -25.17 44.0 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.986 -174.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.423 ' CB ' ' HB3' ' A' ' 95' ' ' ASN . 13.3 mmt180 -80.44 64.44 5.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.176 0.513 . . . . 0.0 111.478 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.544 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 32.6 p -79.65 92.05 5.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.116 0.484 . . . . 0.0 109.862 176.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.4 m -86.38 123.42 31.6 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.894 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.525 HG22 ' HB3' ' A' ' 90' ' ' SER . 8.7 m -90.2 102.54 15.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.124 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -95.89 136.32 36.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.51 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -79.49 103.65 9.55 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 173.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 21.9 m -107.97 166.28 4.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 87' ' ' GLU . 56.0 mtt180 -138.33 154.17 48.98 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.405 HD22 ' CA ' ' A' ' 145' ' ' GLY . 16.3 mt -60.31 -33.46 72.4 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -169.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.6 m -80.56 -7.78 59.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.371 0.605 . . . . 0.0 111.187 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -86.96 122.26 30.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 39.1 p -79.18 165.99 22.69 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.82 0.343 . . . . 0.0 111.322 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.664 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 46.6 t -64.37 -27.84 43.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.21 177.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.481 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -59.62 -45.02 93.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.15 0.5 . . . . 0.0 110.252 174.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.44 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 50.9 m80 -63.42 -37.04 85.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.382 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.626 ' HB2' HD11 ' A' ' 144' ' ' LEU . 55.5 tp -65.25 -47.14 77.79 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.672 ' HD2' ' HB2' ' A' ' 126' ' ' ASP . 5.2 tppp? -54.1 -49.26 69.5 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.966 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.794 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 34.9 tt0 -70.26 -32.56 70.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.796 -174.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 92.4 mt-30 -63.67 -39.6 94.74 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 114' ' ' LEU . 67.2 t -71.63 -38.06 65.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.895 176.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.794 ' OG ' ' HA ' ' A' ' 116' ' ' GLN . 92.0 p -72.71 -5.0 34.68 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.005 0.431 . . . . 0.0 110.555 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -94.76 -59.46 1.13 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.372 173.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.4 mp -77.33 -45.24 26.77 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.328 0.585 . . . . 0.0 111.405 -177.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 124' ' ' VAL . 8.7 mm-40 -96.8 9.6 41.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.431 -176.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -28.82 6.54 0.0 OUTLIER Glycine 0 N--CA 1.485 1.911 0 N-CA-C 121.956 3.542 . . . . 0.0 121.956 -165.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.559 ' N ' ' O ' ' A' ' 122' ' ' GLU . 48.1 t -52.15 144.95 2.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 119.852 1.826 . . . . 0.0 108.53 168.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -49.03 135.93 15.26 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.097 0.475 . . . . 0.0 112.03 -170.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.672 ' HB2' ' HD2' ' A' ' 115' ' ' LYS . 7.2 p-10 -74.4 9.55 1.66 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.514 -171.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.67 -21.86 40.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.169 0.509 . . . . 0.0 110.125 173.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.468 HD12 HG12 ' A' ' 124' ' ' VAL . 83.0 mt -91.49 -45.93 8.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.007 -171.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.573 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 34.5 p90 -83.49 102.23 11.96 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.161 0.982 . . . . 0.0 110.848 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.609 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 25.4 t90 -100.81 93.22 5.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.493 -1.231 . . . . 0.0 109.414 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.52 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 8.6 mp -79.45 115.52 19.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.199 0.523 . . . . 0.0 111.762 -173.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 25.6 p -121.33 119.23 31.57 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.75 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.535 ' HB2' HG22 ' A' ' 155' ' ' VAL . 6.7 t80 -82.06 -74.39 0.34 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.886 0.374 . . . . 0.0 110.614 177.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.66 36.45 1.38 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.377 0.608 . . . . 0.0 109.64 -175.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.95 -36.42 3.85 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.869 -177.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -91.81 144.47 29.41 Favored Pre-proline 0 C--O 1.237 0.447 0 CA-C-O 120.581 0.229 . . . . 0.0 111.037 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -76.83 137.11 17.48 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.873 2.382 . . . . 0.0 111.541 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 71.2 mt -77.81 133.92 38.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.732 -177.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.505 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 44.2 mt-10 -76.12 139.46 41.33 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.664 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 6.6 p-10 -66.92 -24.77 66.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 0.0 111.894 -173.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -76.09 -14.63 60.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.108 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.505 ' HG ' ' HB2' ' A' ' 139' ' ' GLU . 87.5 mt -86.17 146.13 42.01 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.03 -175.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 142' ' ' LEU . 2.7 Cg_exo -76.74 140.37 20.81 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.142 2.562 . . . . 0.0 111.656 175.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.626 HD11 ' HB2' ' A' ' 114' ' ' LEU . 74.8 mt -67.73 -26.38 66.11 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -175.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.405 ' CA ' HD22 ' A' ' 107' ' ' LEU . . . -56.05 -35.02 62.95 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.85 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -50.35 -56.53 10.96 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -101.25 -13.14 18.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.455 -173.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.578 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -100.2 3.46 56.82 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.932 -177.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -46.73 -31.4 2.93 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.107 0.479 . . . . 0.0 111.744 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -92.63 117.35 67.56 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 174.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -58.01 -18.59 36.48 Favored 'Trans proline' 0 N--CA 1.476 0.443 0 C-N-CA 122.66 2.24 . . . . 0.0 112.911 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 84.9 mt -94.18 7.02 46.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.788 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 29.5 t -59.78 107.39 0.6 Allowed 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 23.6 m -94.97 100.23 12.11 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.28 -174.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.535 HG22 ' HB2' ' A' ' 133' ' ' PHE . 42.3 t -87.1 115.5 27.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.5 176.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.554 ' CE2' ' HD2' ' A' ' 94' ' ' ARG . 74.0 m-85 -79.28 117.97 20.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.904 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.546 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 52.6 ttm -80.47 83.4 6.29 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 174.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.609 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 1.9 m-20 -73.0 98.88 2.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.797 -174.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 91.6 mt -75.24 103.78 5.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.03 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.457 179.791 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.7 t70 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 121.618 0.723 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -65.38 120.75 70.42 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.303 -176.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -86.7 161.24 9.23 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.584 2.189 . . . . 0.0 111.983 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.596 HD21 ' O ' ' A' ' 148' ' ' GLY . 61.9 tp -112.4 111.45 22.31 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.585 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.4 t -85.72 114.61 22.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.666 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.4 pt -109.19 163.09 6.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.93 176.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.494 HD11 ' HB2' ' A' ' 100' ' ' SER . 27.0 tp -115.33 110.71 19.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.025 0.44 . . . . 0.0 110.724 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.8 t -104.68 109.21 26.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.284 0.564 . . . . 0.0 110.583 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 94' ' ' ARG . 16.3 ttt180 -92.61 116.93 29.44 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.385 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.515 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 30.4 p-10 -82.07 100.73 9.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.777 0.799 . . . . 0.0 111.517 -174.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.444 ' OD1' ' HG2' ' A' ' 97' ' ' LYS . 10.7 t-20 65.11 -75.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.547 176.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.444 ' HG2' ' OD1' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -154.37 21.81 0.48 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -175.073 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -128.81 -93.96 0.76 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.638 -1.268 . . . . 0.0 114.109 -174.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 94' ' ' ARG . 32.2 ttt180 -84.53 131.98 34.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.222 0.534 . . . . 0.0 111.743 -167.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.494 ' HB2' HD11 ' A' ' 92' ' ' LEU . 12.6 p -88.31 92.07 9.03 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 171.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.2 m -83.32 124.66 30.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.697 -173.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.2 m -91.58 113.43 25.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.93 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -115.05 132.82 56.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.885 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -107.15 97.5 7.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.259 0.552 . . . . 0.0 111.1 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.9 m -104.15 -179.5 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.54 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.599 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 33.2 ttm180 -110.46 125.06 52.88 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 174.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.525 ' HB2' ' HA3' ' A' ' 145' ' ' GLY . 1.4 pp -62.88 -6.59 3.92 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -173.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 m -86.76 0.72 54.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.726 0.298 . . . . 0.0 110.926 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.599 ' HG2' ' O ' ' A' ' 106' ' ' ARG . 2.5 pt20 -92.66 158.86 15.72 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.0 m -87.43 154.29 20.77 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 30.3 t -58.18 -25.68 27.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.094 0.474 . . . . 0.0 110.844 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.56 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -60.84 -34.32 74.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.215 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.567 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 17.1 t-80 -72.34 -46.77 54.08 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.471 ' HA ' ' NE2' ' A' ' 117' ' ' GLN . 59.5 tp -47.83 -45.97 30.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.063 173.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.515 ' HE2' ' HB2' ' A' ' 126' ' ' ASP . 48.5 tttt -61.13 -41.9 97.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.627 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 18.1 tm0? -67.02 -39.72 87.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.985 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.567 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 18.6 mt-30 -57.15 -46.23 82.92 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.35 0.595 . . . . 0.0 109.867 176.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 63.8 t -65.49 -36.36 77.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.899 175.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.455 ' C ' ' HA2' ' A' ' 123' ' ' GLY . 62.4 m -67.88 -8.2 34.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.259 177.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -98.69 -61.93 0.87 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.63 173.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 88.7 mt -71.09 -41.4 70.69 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.494 0.664 . . . . 0.0 111.335 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 124' ' ' VAL . 6.0 mm-40 -100.06 11.07 40.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.814 -177.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.455 ' HA2' ' C ' ' A' ' 119' ' ' SER . . . -27.87 7.3 0.0 OUTLIER Glycine 0 N--CA 1.488 2.117 0 N-CA-C 122.334 3.694 . . . . 0.0 122.334 -157.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' A' ' 122' ' ' GLU . 44.3 t -51.57 141.71 4.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 119.928 1.864 . . . . 0.0 108.576 165.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -45.6 137.99 4.81 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -173.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.753 ' HA ' ' CE2' ' A' ' 129' ' ' PHE . 4.1 p-10 -63.77 -22.95 67.16 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.363 -172.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -73.82 -21.79 60.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.296 0.57 . . . . 0.0 110.657 178.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.505 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 93.4 mt -83.24 -17.25 43.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.837 -174.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.753 ' CE2' ' HA ' ' A' ' 126' ' ' ASP . 38.7 p90 -112.36 124.26 52.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.974 0.892 . . . . 0.0 111.45 175.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.706 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 49.9 t90 -112.68 92.55 4.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.688 177.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.707 HD23 ' H ' ' A' ' 131' ' ' LEU . 2.6 pt? -97.2 144.01 27.44 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.004 -177.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.36 150.23 36.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.249 0.547 . . . . 0.0 111.393 -178.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.532 ' HB2' HG22 ' A' ' 155' ' ' VAL . 5.1 t80 -112.69 -58.52 2.14 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.911 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.34 -20.26 23.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.501 -175.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 136.87 -19.69 3.48 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -171.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -102.25 149.41 36.6 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 114.334 -0.933 . . . . 0.0 109.202 174.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 131' ' ' LEU . 59.0 Cg_endo -72.02 0.35 7.34 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.699 2.266 . . . . 0.0 112.312 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.4 mt 69.61 115.83 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 O-C-N 123.931 0.769 . . . . 0.0 110.03 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.692 ' HB2' ' CD2' ' A' ' 142' ' ' LEU . 7.3 mm-40 -72.04 137.9 47.5 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.457 -177.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.566 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 5.7 p-10 -77.46 33.49 0.16 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.392 -176.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -118.63 -21.89 7.72 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.228 0.537 . . . . 0.0 109.789 -178.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.692 ' CD2' ' HB2' ' A' ' 139' ' ' GLU . 0.6 OUTLIER -95.95 153.97 39.08 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.261 -173.253 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.01 136.6 53.28 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.402 2.068 . . . . 0.0 110.999 173.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.424 ' O ' HD23 ' A' ' 144' ' ' LEU . 6.9 tt -60.78 -32.39 71.71 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.258 -176.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.525 ' HA3' ' HB2' ' A' ' 107' ' ' LEU . . . -60.42 -28.21 66.93 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 116.094 -0.503 . . . . 0.0 113.33 -178.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -61.67 -37.3 83.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.937 0.399 . . . . 0.0 110.814 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -100.77 -32.74 10.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.756 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.596 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -98.99 5.83 59.71 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.742 -172.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.5 pt? -45.2 -29.93 1.07 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.442 ' C ' ' H ' ' A' ' 152' ' ' LEU . 48.7 tttp -79.73 121.16 82.09 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 21.4 Cg_exo -67.25 12.86 0.17 Allowed 'Trans proline' 0 N--CA 1.476 0.457 0 C-N-CA 123.088 2.525 . . . . 0.0 112.789 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.442 ' H ' ' C ' ' A' ' 150' ' ' LYS . 26.5 tp -137.5 20.28 2.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.409 0.624 . . . . 0.0 109.417 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.0 p -67.37 118.77 11.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.142 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.7 m -97.19 111.06 23.46 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.999 -175.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 133' ' ' PHE . 39.9 t -100.86 129.29 52.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.609 177.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 131' ' ' LEU . 94.7 m-85 -95.07 110.21 22.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.822 0.344 . . . . 0.0 110.818 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.515 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 23.6 ttt -82.18 97.38 8.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.854 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.706 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 50.7 m-80 -90.6 136.2 33.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.323 -178.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 90.3 mt -104.54 81.6 1.81 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.488 -0.189 . . . . 0.0 110.488 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 128' ' ' LEU . 1.9 mmp_? . . . . . 0 N--CA 1.466 0.369 0 O-C-N 123.792 0.682 . . . . 0.0 111.306 -176.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 CA--C 1.516 -0.332 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -92.24 134.69 27.97 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.189 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.03 124.74 13.99 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 122.487 2.125 . . . . 0.0 111.713 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.587 HD21 ' O ' ' A' ' 148' ' ' GLY . 31.7 tp -105.69 116.36 31.82 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.246 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.428 ' HB3' ' OG1' ' A' ' 102' ' ' THR . 16.0 m -94.57 107.23 19.22 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.469 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 102' ' ' THR . 35.4 pt -99.06 160.93 3.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 154' ' ' THR . 36.7 tp -106.19 116.07 31.3 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.762 -176.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.1 t -104.37 121.49 56.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.461 ' HD2' ' CE1' ' A' ' 156' ' ' PHE . 18.4 ttm180 -106.54 107.01 17.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.188 -177.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.581 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 40.4 m-20 -81.67 148.85 28.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.52 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -56.64 -23.97 45.11 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.482 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -73.51 5.33 3.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.475 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.98 51.31 4.8 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.453 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.5 ' NE ' ' HA ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -137.95 103.34 4.95 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.132 -176.848 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.3 m -94.15 86.15 4.88 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.4 t -104.8 129.96 52.99 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.109 -176.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 10.8 t -76.92 143.58 39.45 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 173.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -121.37 133.03 55.09 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.293 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -83.19 108.07 16.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.931 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.88 -179.18 3.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.491 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -121.47 178.84 4.65 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 173.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.61 -32.18 19.43 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.2 m -89.51 64.67 6.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.308 0.575 . . . . 0.0 110.74 -178.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -163.72 163.54 24.12 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.181 173.374 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 32.6 p -96.94 162.18 13.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.803 0.335 . . . . 0.0 111.332 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 45.3 t -57.51 -21.39 15.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.843 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.599 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -50.49 -46.33 56.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.557 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -81.57 -0.83 44.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.513 -175.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.581 ' HB2' HD11 ' A' ' 144' ' ' LEU . 43.7 tp -100.34 -47.33 4.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.437 0.637 . . . . 0.0 109.721 172.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -63.2 -27.33 69.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.628 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.882 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 22.4 tm0? -78.11 -23.26 47.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.521 177.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -68.56 -43.87 75.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.3 -43.73 98.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.872 174.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.882 ' OG ' ' HA ' ' A' ' 116' ' ' GLN . 7.9 p -76.38 -1.74 28.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.776 0.322 . . . . 0.0 111.435 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -88.35 -36.31 8.21 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.779 172.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 mp -99.94 -58.46 1.91 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.446 0.641 . . . . 0.0 111.197 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 124' ' ' VAL . 4.0 mm-40 -91.28 9.22 32.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.919 -177.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.851 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -49.26 7.72 0.01 OUTLIER Glycine 0 N--CA 1.469 0.851 0 N-CA-C 117.788 1.875 . . . . 0.0 117.788 -173.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.454 ' O ' HD22 ' A' ' 128' ' ' LEU . 94.6 t -47.26 86.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 CA-C-N 117.965 0.883 . . . . 0.0 111.742 172.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.41 ' O ' HD22 ' A' ' 128' ' ' LEU . 93.9 mt-30 59.29 119.26 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.61 0.719 . . . . 0.0 112.59 -178.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -78.85 57.01 2.02 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -147.63 -43.47 0.17 Allowed 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.435 -175.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.577 HD23 ' N ' ' A' ' 129' ' ' PHE . 0.9 OUTLIER -72.15 -22.58 61.29 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -169.642 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.577 ' N ' HD23 ' A' ' 128' ' ' LEU . 37.9 p90 -105.1 147.77 27.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.221 0.534 . . . . 0.0 111.313 -176.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.534 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 39.2 t90 -141.1 98.07 3.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.969 -175.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.547 ' HB3' ' HA ' ' A' ' 157' ' ' MET . 2.5 pp -99.13 138.55 36.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.152 0.501 . . . . 0.0 111.322 -174.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 38.8 p -136.2 150.98 49.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.098 -174.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.402 ' CD2' ' HB3' ' A' ' 147' ' ' TYR . 30.4 t80 -116.43 -70.37 0.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.026 0.441 . . . . 0.0 110.8 175.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -87.43 30.95 0.76 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.444 0.64 . . . . 0.0 110.469 -173.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.17 -3.53 71.24 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -172.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -115.54 143.67 30.98 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 115.036 -0.582 . . . . 0.0 109.476 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.55 137.79 51.92 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.267 1.978 . . . . 0.0 111.06 173.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.457 ' HB3' HG21 ' A' ' 111' ' ' VAL . 87.2 mt -81.7 106.77 13.9 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.059 0.457 . . . . 0.0 110.483 -178.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.552 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 42.7 mt-10 -71.96 141.76 49.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.935 177.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.599 ' HB2' ' HB2' ' A' ' 112' ' ' ALA . 4.1 p-10 -73.03 -5.78 41.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.97 0.414 . . . . 0.0 111.15 -177.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -83.49 -15.72 48.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.485 173.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.552 ' HG ' ' HB2' ' A' ' 139' ' ' GLU . 82.8 mt -91.32 144.29 29.54 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.037 -176.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 109' ' ' GLN . 6.3 Cg_exo -79.88 138.98 13.52 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.154 2.569 . . . . 0.0 111.612 174.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.581 HD11 ' HB2' ' A' ' 114' ' ' LEU . 33.6 mt -68.83 -40.2 79.57 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -177.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.26 -30.2 31.67 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.166 -0.54 . . . . 0.0 113.923 -175.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -66.25 -32.94 74.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.927 0.394 . . . . 0.0 110.899 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.402 ' HB3' ' CD2' ' A' ' 133' ' ' PHE . 89.0 m-85 -101.06 -32.23 10.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.36 0.6 . . . . 0.0 110.899 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.587 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -97.06 6.54 64.06 Favored Glycine 0 C--O 1.223 -0.531 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.809 -170.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.407 ' HG ' ' HG3' ' A' ' 150' ' ' LYS . 2.6 pt? -44.82 -24.54 0.22 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.498 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 67.7 mttt -102.23 131.0 23.08 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.497 177.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 12.8 Cg_exo -69.93 9.63 0.6 Allowed 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.197 2.598 . . . . 0.0 112.449 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.9 pp -119.93 0.0 10.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.586 178.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.6 m -61.83 110.87 1.66 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.895 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 29.3 m -95.6 114.38 26.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.03 -176.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.51 118.63 37.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.13 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.461 ' CE1' ' HD2' ' A' ' 94' ' ' ARG . 80.5 m-85 -90.57 113.96 26.08 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.942 0.401 . . . . 0.0 110.869 -177.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.581 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 2.0 tmt? -88.19 97.7 11.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.3 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.534 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 92.2 m-20 -97.49 176.93 5.69 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.646 -173.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.476 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 96.0 mt -120.33 133.27 55.48 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.918 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 159' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.943 0 O-C-N 124.132 0.895 . . . . 0.0 112.389 -174.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo . . . . . 0 N--CA 1.452 -0.949 0 CA-C-O 121.01 0.337 . . . . 0.0 111.644 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.613 HD23 HD11 ' A' ' 107' ' ' LEU . 0.2 OUTLIER -96.19 123.27 39.75 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.316 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -95.33 101.87 13.63 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.438 HG23 HD12 ' A' ' 89' ' ' LEU . 46.7 pt -108.33 164.08 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.105 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 154' ' ' THR . 32.2 tp -108.87 120.96 44.05 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.273 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 90.4 t -116.95 117.39 55.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.003 0.43 . . . . 0.0 110.173 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.563 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 23.2 ttt180 -96.61 133.14 41.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.632 -177.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.705 178.371 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 . . . . . 0 C--O 1.234 0.239 0 CA-C-O 121.254 0.55 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 15.0 m -95.02 102.06 13.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.414 173.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.8 m -95.45 136.41 35.86 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.042 0.448 . . . . 0.0 110.691 -176.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.3 m -85.97 124.78 32.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.073 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.516 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 43.5 m-85 -111.07 145.71 38.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.974 0.416 . . . . 0.0 111.376 -176.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -95.15 95.86 8.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.45 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.4 m -109.37 -179.79 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.842 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.1 mtm180 -138.78 166.11 25.25 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.613 HD11 HD23 ' A' ' 89' ' ' LEU . 6.9 mp -80.44 -23.4 40.32 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.7 p -76.31 -16.91 59.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.107 174.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -85.07 138.29 32.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.091 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.717 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 38.7 p -88.1 163.71 16.09 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 175.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.615 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 3.4 t -64.14 -27.31 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.274 0.559 . . . . 0.0 109.788 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.15 -37.83 88.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.742 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -70.86 -33.99 71.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.574 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.423 HD22 HD11 ' A' ' 144' ' ' LEU . 65.7 tp -61.3 -46.07 91.85 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 173.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -59.36 -39.97 84.96 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.186 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -66.96 -32.19 73.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.306 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -62.03 -51.22 68.89 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.97 0.89 . . . . 0.0 109.134 174.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.4 t -62.3 -32.03 53.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.848 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.648 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 49.9 m -65.12 -27.58 68.84 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.807 0.337 . . . . 0.0 111.082 177.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.01 -35.02 54.64 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.679 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 75.4 mt -93.46 -67.53 0.85 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.408 0.623 . . . . 0.0 112.001 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 124' ' ' VAL . 8.1 tp10 -100.47 9.9 41.94 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.788 0.835 . . . . 0.0 110.847 -172.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.648 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -44.57 7.68 0.01 OUTLIER Glycine 0 CA--C 1.532 1.139 0 N-CA-C 118.555 2.182 . . . . 0.0 118.555 -174.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 122' ' ' GLU . 59.1 t -48.26 91.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 118.428 1.114 . . . . 0.0 111.678 173.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 53.51 104.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.836 0.71 . . . . 0.0 111.698 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.653 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 4.5 p-10 -69.29 11.05 0.25 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.241 -173.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -117.62 -5.48 11.16 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 174.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 128' ' ' LEU . 44.6 mt -93.26 -31.06 14.86 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 171.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.653 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 25.0 p90 -110.14 135.05 51.54 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 172.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.471 ' HE1' ' HB3' ' A' ' 137' ' ' PRO . 4.2 t-105 -155.79 135.78 12.84 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.957 0.408 . . . . 0.0 109.937 -176.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.639 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 6.4 mp -104.67 131.79 51.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.06 0.457 . . . . 0.0 110.703 -174.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.828 HG22 ' HA ' ' A' ' 137' ' ' PRO . 19.9 p -135.22 140.59 45.4 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.681 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.697 ' CD2' ' HG3' ' A' ' 134' ' ' GLU . 6.1 t80 -106.04 -82.89 0.53 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.831 -175.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.697 ' HG3' ' CD2' ' A' ' 133' ' ' PHE . 98.6 mt-10 -77.97 25.73 0.21 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.755 0.312 . . . . 0.0 111.798 -173.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.25 -7.35 78.33 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -175.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -112.79 154.89 44.7 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.828 ' HA ' HG22 ' A' ' 132' ' ' THR . 85.9 Cg_endo -76.2 -5.78 16.58 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.851 2.367 . . . . 0.0 111.972 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 86.9 mt 62.1 176.29 0.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.053 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -104.19 101.79 11.52 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.615 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 9.9 p-10 -71.84 -9.28 58.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.938 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -68.79 -29.77 68.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.227 170.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 87.2 mt -97.28 160.83 27.99 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.876 -175.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.717 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 8.7 Cg_exo -72.09 153.71 57.36 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.76 2.306 . . . . 0.0 112.059 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.423 HD11 HD22 ' A' ' 114' ' ' LEU . 7.4 mt -70.92 -18.5 62.66 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.762 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.572 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -53.19 -44.02 63.85 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.675 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -63.96 -37.49 87.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -101.21 -37.1 8.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.037 0.446 . . . . 0.0 111.963 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.87 6.4 58.56 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.475 -170.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.572 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.0 pt? -47.18 -26.33 1.12 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.648 0.379 . . . . 0.0 112.014 175.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 53.6 mtmt -81.32 118.66 73.2 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.551 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 21.0 Cg_exo -66.1 -10.47 27.32 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.81 2.34 . . . . 0.0 111.412 177.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 82.9 mt -99.76 1.74 43.5 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.166 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.0 t -66.33 101.98 0.8 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.316 0.579 . . . . 0.0 109.85 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 18.0 m -90.84 92.18 8.68 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.873 -177.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 44.9 t -77.85 125.32 37.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.367 178.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -92.85 116.54 29.13 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.976 0.417 . . . . 0.0 110.604 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.639 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 1.1 tmt? -72.8 104.98 4.16 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -103.17 154.25 19.5 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.296 -173.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.5 mt -116.66 134.54 54.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.112 173.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 . . . . . 0 C--N 1.321 -0.671 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.72 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 C--O 1.236 0.384 0 CA-C-O 121.397 0.499 . . . . 0.0 111.794 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.479 HD21 ' O ' ' A' ' 148' ' ' GLY . 66.4 tp -106.71 109.09 20.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.983 -176.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.5 m -80.63 102.26 9.72 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.958 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.5 pt -101.83 146.11 10.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.132 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 44.2 tp -98.85 110.99 23.51 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.621 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.55 HG22 ' HB ' ' A' ' 155' ' ' VAL . 96.7 t -107.22 117.59 53.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.008 0.432 . . . . 0.0 110.359 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 26.3 ttt180 -85.64 101.25 12.56 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 176.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.486 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 0.7 OUTLIER . . . . . 0 CA--C 1.507 -0.678 0 CA-C-O 121.992 0.901 . . . . 0.0 112.638 -173.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.765 0.317 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 45.7 m -101.25 103.38 14.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.889 0.376 . . . . 0.0 110.135 177.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 m -99.22 138.36 36.43 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.647 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.4 m -90.04 115.65 27.47 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -101.0 136.27 41.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.917 0.389 . . . . 0.0 110.844 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -93.0 106.39 18.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.348 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.53 -179.54 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.225 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 58.5 mtm-85 -124.86 158.14 34.2 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.5 mp -67.1 -35.71 80.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.029 -176.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -89.87 14.65 11.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.276 0.56 . . . . 0.0 110.882 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -92.96 131.07 38.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.972 0.415 . . . . 0.0 110.004 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.634 ' HB ' ' OD1' ' A' ' 140' ' ' ASP . 3.2 p -74.03 159.21 33.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.646 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 83.3 t -63.87 -32.18 56.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.407 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.42 -41.85 73.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.79 176.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -65.18 -28.34 69.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.039 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.597 ' HB2' HD11 ' A' ' 144' ' ' LEU . 63.3 tp -82.25 -46.97 12.99 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 175.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -58.28 -46.55 85.85 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.571 -176.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -65.28 -30.81 71.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -70.21 -43.62 70.3 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.546 0.689 . . . . 0.0 109.466 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.35 -35.19 60.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.298 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.813 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 41.1 m -69.25 -18.64 63.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.942 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.68 -39.12 41.37 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.53 174.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.7 mp -95.04 -64.98 1.01 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.981 0.42 . . . . 0.0 111.852 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 124' ' ' VAL . 21.9 mm-40 -95.12 8.86 41.65 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 123.724 0.81 . . . . 0.0 111.035 -173.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.813 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -45.7 8.91 0.01 OUTLIER Glycine 0 N--CA 1.471 1.031 0 N-CA-C 119.028 2.371 . . . . 0.0 119.028 -173.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 122' ' ' GLU . 31.8 t -51.78 81.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 118.758 1.279 . . . . 0.0 112.575 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.432 ' HB2' HD12 ' A' ' 128' ' ' LEU . 23.7 mp0 60.8 118.03 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.226 1.011 . . . . 0.0 113.455 172.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -53.32 -28.78 30.2 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.293 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -76.07 -24.67 55.11 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.469 -176.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.441 HD12 HG12 ' A' ' 124' ' ' VAL . 92.2 mt -89.26 -36.41 15.62 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -174.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -113.35 140.88 47.67 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.861 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -153.47 154.68 34.85 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 172.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.593 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 6.4 mp -114.65 149.56 36.5 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.838 -175.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 66.6 p -126.0 144.65 50.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.826 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.486 ' C ' ' H ' ' A' ' 135' ' ' GLY . 73.0 t80 -129.23 140.12 51.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 168.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 69.78 -43.93 0.54 Allowed 'General case' 0 CA--C 1.536 0.416 0 O-C-N 123.833 0.708 . . . . 0.0 110.426 -176.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 133' ' ' PHE . . . 156.01 -18.8 0.48 Allowed Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -176.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -91.61 146.99 34.24 Favored Pre-proline 0 C--O 1.236 0.356 0 CA-C-N 115.315 -0.443 . . . . 0.0 109.94 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.27 147.61 66.37 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.541 2.16 . . . . 0.0 111.345 175.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 70.8 mt -70.59 108.15 4.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.789 0.328 . . . . 0.0 111.006 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -92.44 130.08 38.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.601 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.634 ' OD1' ' HB ' ' A' ' 110' ' ' THR . 36.5 t70 -72.45 -6.67 45.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.534 -175.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -74.12 -14.11 60.92 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.487 0.66 . . . . 0.0 109.904 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.469 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 88.5 mt -120.16 131.71 24.33 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.95 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 142' ' ' LEU . 28.0 Cg_exo -62.46 148.94 92.52 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.673 2.249 . . . . 0.0 112.004 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.597 HD11 ' HB2' ' A' ' 114' ' ' LEU . 83.2 mt -59.88 -25.39 65.05 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -176.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -61.16 -27.35 67.26 Favored Glycine 0 C--O 1.226 -0.396 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.505 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -72.32 -21.09 61.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.875 0.369 . . . . 0.0 111.184 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -100.3 -45.14 5.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.312 0.577 . . . . 0.0 110.606 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.479 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -100.16 6.67 58.21 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-O 119.227 -0.763 . . . . 0.0 113.973 -171.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.474 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.3 pt? -34.38 -41.32 0.11 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 88.4 tttt -91.23 119.88 68.61 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.533 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 17.4 Cg_exo -66.13 81.38 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.117 2.544 . . . . 0.0 112.199 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 151' ' ' PRO . 7.3 tt 167.75 -26.56 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.787 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.3 m -45.55 125.45 5.83 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.376 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 23.9 m -97.72 120.6 38.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.303 -175.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.55 ' HB ' HG22 ' A' ' 93' ' ' VAL . 61.7 t -99.96 133.04 44.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.338 176.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -103.82 124.81 49.6 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.079 0.466 . . . . 0.0 111.045 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.593 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 25.2 ttt -81.75 131.06 35.25 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 175.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -120.51 145.21 47.52 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.109 -175.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 50.9 mt -125.16 137.73 54.15 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 160' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.607 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 177.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo . . . . . 0 N--CA 1.461 -0.415 0 CA-C-O 121.085 0.369 . . . . 0.0 111.659 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.464 ' HG ' HG23 ' A' ' 91' ' ' ILE . 58.0 tp -85.3 107.51 17.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.233 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.447 ' HB3' HG22 ' A' ' 102' ' ' THR . 24.3 m -87.33 102.68 14.75 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.624 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.464 HG23 ' HG ' ' A' ' 89' ' ' LEU . 36.8 pt -102.84 157.79 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.023 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 154' ' ' THR . 37.4 tp -103.51 102.99 12.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.131 0.491 . . . . 0.0 110.922 -176.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.537 HG22 ' HB ' ' A' ' 155' ' ' VAL . 58.8 t -107.46 123.78 62.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.987 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -89.55 135.04 33.83 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.125 0.488 . . . . 0.0 110.2 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.407 HD21 ' HB2' ' A' ' 99' ' ' ARG . 4.1 p30 . . . . . 0 C--N 1.313 -1.0 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.915 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.407 ' HB2' HD21 ' A' ' 95' ' ' ASN . 33.5 mtp180 . . . . . 0 N--CA 1.454 -0.255 0 CA-C-O 121.131 0.491 . . . . 0.0 111.417 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.1 m -113.54 106.97 15.18 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.15 176.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.8 m -106.16 130.62 54.01 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.213 0.53 . . . . 0.0 111.004 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.447 HG22 ' HB3' ' A' ' 90' ' ' SER . 23.5 m -86.54 105.04 16.55 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.451 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.484 ' CD2' ' HB ' ' A' ' 93' ' ' VAL . 87.4 m-85 -91.27 134.23 34.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.744 -177.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -89.48 95.63 10.36 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.42 HG11 HD13 ' A' ' 114' ' ' LEU . 31.6 m -109.44 163.67 6.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.595 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.579 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 0.7 OUTLIER -110.98 146.97 35.72 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.154 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.511 HD23 ' HA3' ' A' ' 145' ' ' GLY . 6.7 mp -60.74 -35.41 76.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.719 -172.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.8 p -98.73 9.48 43.27 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -172.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.579 ' HG2' ' O ' ' A' ' 106' ' ' ARG . 10.0 pt20 -81.07 -8.93 59.87 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.653 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.6 p 64.19 159.11 0.09 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.066 1.346 . . . . 0.0 111.346 -175.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.581 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 48.4 t -63.85 -21.02 27.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.052 0.454 . . . . 0.0 109.979 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.57 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -58.21 -41.53 84.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.869 176.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -69.74 -36.51 75.9 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 120.745 0.307 . . . . 0.0 110.325 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.42 HD13 HG11 ' A' ' 105' ' ' VAL . 62.3 tp -66.92 -43.61 82.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.891 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -65.82 -28.18 68.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.349 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.513 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 35.0 tt0 -76.01 -34.77 59.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.588 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -60.21 -48.71 80.6 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.797 0.808 . . . . 0.0 108.909 171.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.46 -40.66 84.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.032 174.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.846 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 25.2 p -66.07 -14.75 62.27 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.843 0.354 . . . . 0.0 111.08 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.17 -44.03 8.34 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.656 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.3 mt -91.15 -59.9 2.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.044 0.45 . . . . 0.0 112.197 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 124' ' ' VAL . 4.4 tp10 -100.38 9.42 42.67 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 123.524 0.73 . . . . 0.0 110.396 -174.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.846 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -45.71 7.95 0.01 OUTLIER Glycine 0 N--CA 1.473 1.108 0 N-CA-C 118.69 2.236 . . . . 0.0 118.69 -172.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 122' ' ' GLU . 40.6 t -49.46 85.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 118.167 0.984 . . . . 0.0 112.276 174.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.409 ' HB2' HD12 ' A' ' 128' ' ' LEU . 2.3 mp0 56.29 106.81 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.586 0.754 . . . . 0.0 112.241 176.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -51.26 -24.17 4.21 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.746 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -81.51 -20.71 39.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.01 -175.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.461 HD12 HG12 ' A' ' 124' ' ' VAL . 96.7 mt -81.46 -14.84 56.58 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -175.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.417 ' HB3' HD23 ' A' ' 159' ' ' LEU . 54.4 p90 -133.82 151.11 51.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.451 0.643 . . . . 0.0 111.816 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.414 ' HD1' ' HB3' ' A' ' 137' ' ' PRO . 0.8 OUTLIER -149.25 157.07 43.04 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 172.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.651 HD12 HG11 ' A' ' 155' ' ' VAL . 1.3 pt? -123.57 135.85 54.21 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.727 -172.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 41.3 p -116.19 131.7 56.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.845 -178.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.553 ' CE2' ' HB2' ' A' ' 134' ' ' GLU . 8.4 t80 -94.16 -89.67 0.22 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.523 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.553 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 10.8 tt0 -98.42 25.44 6.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.561 0.696 . . . . 0.0 110.385 -170.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 133.25 -37.43 2.0 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.75 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 54.3 mmtt -117.18 156.21 48.85 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 120.54 0.209 . . . . 0.0 110.917 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 132' ' ' THR . 48.2 Cg_endo -69.25 152.99 71.94 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.121 2.547 . . . . 0.0 112.79 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.463 ' HB3' HG21 ' A' ' 111' ' ' VAL . 85.9 mt -94.6 121.72 36.45 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.767 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -84.81 146.09 27.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.589 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.581 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 6.7 p-10 -61.22 -22.05 64.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.54 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -73.42 -15.78 61.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.176 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 77.1 mt -102.14 140.17 20.93 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 121.121 0.486 . . . . 0.0 111.516 -172.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 142' ' ' LEU . 12.7 Cg_exo -71.23 144.1 45.53 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.983 2.456 . . . . 0.0 111.08 173.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.643 HD12 ' H ' ' A' ' 144' ' ' LEU . 4.1 mp -71.54 -33.9 69.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.998 -174.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.511 ' HA3' HD23 ' A' ' 107' ' ' LEU . . . -59.63 -30.29 68.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.286 -0.483 . . . . 0.0 113.686 -172.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.65 -41.26 94.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.049 0.452 . . . . 0.0 111.029 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -101.55 -30.2 11.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.529 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.445 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -98.97 6.73 60.24 Favored Glycine 0 C--O 1.227 -0.299 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.625 -172.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -41.09 -31.22 0.18 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -92.71 126.54 51.47 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.295 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -68.15 6.38 0.88 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.958 2.439 . . . . 0.0 112.922 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 97.7 mt -112.24 7.41 19.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.05 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.4 p -62.39 117.94 6.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.943 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 15.0 m -101.51 106.66 17.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.408 -175.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.651 HG11 HD12 ' A' ' 131' ' ' LEU . 25.6 t -99.33 140.09 19.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.427 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -109.81 118.3 36.13 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.434 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 2.1 ttm -81.37 106.49 13.37 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -98.82 135.03 40.87 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.741 -172.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.417 HD23 ' HB3' ' A' ' 129' ' ' PHE . 49.1 mt -102.88 -167.68 1.42 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.638 173.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 . . . . . 0 N--CA 1.466 0.369 0 CA-C-O 121.85 0.833 . . . . 0.0 111.754 174.482 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.454 -0.798 0 N-CA-C 110.863 -0.476 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.9 tp -84.21 110.66 18.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.333 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.7 m -88.64 112.91 23.64 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.061 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.5 pt -107.08 134.75 47.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.529 HD11 ' HB3' ' A' ' 100' ' ' SER . 30.2 tp -93.1 101.37 13.67 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.593 -174.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.9 t -84.7 99.8 7.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -97.39 93.93 6.77 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.703 -174.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.593 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 6.1 p30 . . . . . 0 C--O 1.237 0.422 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.408 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 . . . . . 0 CA--C 1.521 -0.135 0 CA-C-O 120.986 0.422 . . . . 0.0 111.651 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.529 ' HB3' HD11 ' A' ' 92' ' ' LEU . 18.6 m -96.5 109.04 21.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.867 174.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.2 m -111.89 112.69 24.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.108 0.48 . . . . 0.0 110.638 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.4 m -76.66 121.92 23.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.515 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -111.81 132.13 54.88 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.96 0.41 . . . . 0.0 110.553 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -81.98 130.4 35.06 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.734 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.2 m -146.36 -179.96 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.765 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 39.7 mtm-85 -138.35 169.96 16.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.175 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.9 mp -73.03 -10.47 59.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.779 0.323 . . . . 0.0 111.43 -175.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 m -85.73 0.46 52.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.221 0.534 . . . . 0.0 110.669 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.489 ' HB3' HD12 ' A' ' 144' ' ' LEU . 13.3 mm100 -86.58 136.46 33.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.089 0.471 . . . . 0.0 111.521 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.5 p -94.7 166.83 11.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.231 175.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 64.2 t -60.39 -40.61 84.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.088 0.471 . . . . 0.0 109.731 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.418 ' O ' ' HG3' ' A' ' 116' ' ' GLN . . . -53.74 -48.35 69.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.898 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.457 ' HB3' ' NE2' ' A' ' 109' ' ' GLN . 3.6 m170 -63.71 -25.77 68.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.835 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.769 ' HB2' HD11 ' A' ' 144' ' ' LEU . 63.7 tp -83.48 -43.18 16.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.915 0.388 . . . . 0.0 110.181 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -60.15 -37.98 81.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.545 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 112' ' ' ALA . 55.5 mt-30 -64.93 -38.19 90.14 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 122.955 0.159 . . . . 0.0 111.41 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -63.37 -50.09 71.3 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.12 0.486 . . . . 0.0 109.786 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.4 t -57.34 -44.29 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.753 174.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.727 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 66.6 m -62.25 -22.2 65.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.086 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.61 -39.53 21.22 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.28 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -94.74 -64.9 1.02 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.1 0.476 . . . . 0.0 111.828 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -100.41 8.55 43.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.135 -174.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.727 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -55.81 7.26 0.01 OUTLIER Glycine 0 CA--C 1.521 0.466 0 N-CA-C 116.481 1.353 . . . . 0.0 116.481 -172.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 64.4 t -41.82 92.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 123.552 0.741 . . . . 0.0 111.777 173.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.809 ' HA ' HE21 ' A' ' 125' ' ' GLN . 0.0 OUTLIER 52.97 106.23 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 O-C-N 123.858 0.724 . . . . 0.0 111.744 -178.176 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.629 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 9.2 p-10 -69.11 1.9 3.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.439 0.638 . . . . 0.0 110.403 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -75.53 -33.63 60.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.676 169.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 93.5 mt -79.34 -33.37 43.12 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.323 -173.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.629 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 52.2 p90 -105.78 121.4 43.97 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.658 -0.817 . . . . 0.0 112.045 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.552 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 37.2 t90 -132.29 104.22 6.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.369 176.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.721 HD23 ' H ' ' A' ' 131' ' ' LEU . 2.4 pt? -96.77 140.69 30.97 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.496 0.665 . . . . 0.0 112.046 -170.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 76.8 p -128.05 144.97 51.13 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.067 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -109.02 -72.0 0.74 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.645 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.615 ' HB3' ' HG2' ' A' ' 136' ' ' LYS . 24.2 tt0 -92.29 32.61 1.16 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.535 -171.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.9 11.53 85.12 Favored Glycine 0 CA--C 1.509 -0.343 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -169.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.615 ' HG2' ' HB3' ' A' ' 134' ' ' GLU . 0.5 OUTLIER -134.2 149.56 71.72 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 114.474 -0.863 . . . . 0.0 109.328 -178.379 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.78 150.59 78.98 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.175 1.917 . . . . 0.0 111.115 173.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 76.1 mt -74.21 109.28 7.58 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.82 122.17 26.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.741 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.4 53.06 1.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.191 0.995 . . . . 0.0 110.569 -176.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.77 ' HG3' ' HG ' ' A' ' 142' ' ' LEU . 3.6 pt20 -129.97 -7.95 4.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.823 175.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.77 ' HG ' ' HG3' ' A' ' 141' ' ' GLN . 81.2 mt -127.22 157.01 73.76 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.781 -175.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.68 145.5 25.96 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.1 1.866 . . . . 0.0 111.789 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.769 HD11 ' HB2' ' A' ' 114' ' ' LEU . 79.6 mt -62.2 -23.01 66.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.468 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -57.67 -34.87 71.41 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.326 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -77.47 -24.09 50.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.233 0.517 . . . . 0.0 110.988 -176.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -91.11 -39.0 12.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.302 0.573 . . . . 0.0 110.629 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.05 6.37 59.9 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.655 -172.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -41.41 -32.18 0.3 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.462 ' HG2' ' H ' ' A' ' 152' ' ' LEU . 24.7 ttmm -83.18 114.98 56.62 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 173.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 16.8 Cg_exo -68.52 20.58 0.14 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.566 2.844 . . . . 0.0 113.427 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.462 ' H ' ' HG2' ' A' ' 150' ' ' LYS . 54.3 mt -146.93 19.73 1.27 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.588 177.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.8 p -64.97 127.27 30.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.752 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.3 m -94.59 100.72 12.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.904 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.4 t -92.6 111.49 24.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -79.13 102.35 8.41 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.042 -175.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.593 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 22.8 ttt -76.44 90.91 3.28 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.552 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 11.2 m120 -74.5 131.03 40.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.391 -173.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 76.6 mt -96.92 114.66 26.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.144 0.497 . . . . 0.0 110.164 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.785 -176.879 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo . . . . . 0 N--CA 1.454 -0.808 0 N-CA-C 111.047 -0.405 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.643 HD21 ' O ' ' A' ' 148' ' ' GLY . 55.1 tp -92.22 155.82 17.73 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 6.5 t -131.61 130.7 42.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.885 0.374 . . . . 0.0 110.013 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.465 HD12 HG21 ' A' ' 155' ' ' VAL . 35.4 pt -127.88 150.71 33.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.847 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.45 HD11 ' HB2' ' A' ' 100' ' ' SER . 50.6 tp -93.24 113.7 25.97 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.0 0.428 . . . . 0.0 110.762 -177.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 63.6 t -98.62 113.47 33.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.742 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -110.73 114.98 28.76 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.763 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.421 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 29.3 p30 . . . . . 0 C--N 1.325 -0.476 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.287 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 121.261 0.553 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.45 ' HB2' HD11 ' A' ' 92' ' ' LEU . 12.7 p -115.86 106.51 13.91 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 167.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.0 t -118.24 133.01 56.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.993 0.425 . . . . 0.0 110.74 -175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.72 100.69 13.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.119 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 90' ' ' SER . 84.5 m-85 -90.66 166.04 13.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.834 0.349 . . . . 0.0 111.093 -176.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -103.97 128.98 51.52 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.374 0.606 . . . . 0.0 110.906 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.2 m -139.56 -179.44 2.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.713 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.47 ' HB2' ' HG2' ' A' ' 109' ' ' GLN . 67.8 mtp85 -132.13 164.42 26.33 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 174.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 107' ' ' LEU . 6.7 mp -82.23 -39.14 23.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.016 0.436 . . . . 0.0 110.135 176.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.1 m -92.12 66.15 4.85 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.292 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.47 ' HG2' ' HB2' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -156.43 157.99 36.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.789 174.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.523 ' HB ' ' O ' ' A' ' 140' ' ' ASP . 14.8 p -88.58 144.92 26.01 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.651 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 47.2 t -56.73 -19.25 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 120.925 0.393 . . . . 0.0 111.224 -177.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -55.81 -34.64 65.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.947 0.403 . . . . 0.0 110.713 173.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -74.23 -15.62 60.99 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.204 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.714 HD22 HD11 ' A' ' 144' ' ' LEU . 65.3 tp -92.46 -53.24 4.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.033 0.444 . . . . 0.0 110.028 174.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -61.44 -40.02 92.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.53 -173.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -69.1 -31.8 70.77 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.478 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -68.27 -44.81 74.72 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.87 -35.67 61.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.548 173.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.769 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 62.3 m -72.49 -14.96 61.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.451 178.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.76 -39.36 21.16 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.438 175.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.1 mp -94.85 -64.39 1.07 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.132 0.491 . . . . 0.0 111.8 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -96.81 8.3 44.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.62 -173.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.769 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -54.35 7.66 0.01 OUTLIER Glycine 0 CA--C 1.522 0.531 0 N-CA-C 118.02 1.968 . . . . 0.0 118.02 -169.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.471 HG12 HD12 ' A' ' 128' ' ' LEU . 57.7 t -43.23 93.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 118.122 0.961 . . . . 0.0 112.316 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 57.37 109.11 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.605 0.762 . . . . 0.0 111.753 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.466 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 39.1 t70 -60.22 -6.67 1.54 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.639 -176.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -96.48 -19.29 19.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.666 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.471 HD12 HG12 ' A' ' 124' ' ' VAL . 64.9 mt -79.04 -39.78 33.07 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.716 -176.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.466 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 29.6 p90 -96.59 94.71 7.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.948 0.88 . . . . 0.0 111.447 -177.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.665 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 34.1 t90 -90.12 87.6 6.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.29 176.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.604 HD23 ' H ' ' A' ' 131' ' ' LEU . 2.7 pt? -88.0 139.7 30.24 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.212 0.53 . . . . 0.0 110.652 -176.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.02 159.69 44.39 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.15 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.478 ' CD2' ' HB2' ' A' ' 134' ' ' GLU . 13.5 t80 -102.71 -74.51 0.63 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.934 -175.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.478 ' HB2' ' CD2' ' A' ' 133' ' ' PHE . 7.8 tp10 -98.49 21.26 11.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.176 0.512 . . . . 0.0 110.702 -171.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.36 9.17 62.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.512 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.495 ' HD3' ' O ' ' A' ' 137' ' ' PRO . 14.4 tmtt? -122.56 122.37 27.31 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.495 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 27.2 Cg_exo -58.91 152.75 55.66 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.785 2.324 . . . . 0.0 112.296 -176.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 44.8 mt -103.29 97.08 7.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.242 -174.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.42 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 2.6 mp0 -63.73 134.4 55.26 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 173.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.651 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 5.6 p-10 -65.54 -22.41 66.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.085 -174.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -81.89 -10.39 59.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.838 0.351 . . . . 0.0 111.202 -177.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.42 ' HG ' ' HB2' ' A' ' 139' ' ' GLU . 79.6 mt -90.55 157.06 44.88 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.977 -176.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 109' ' ' GLN . 3.0 Cg_exo -75.23 128.73 11.53 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.978 2.452 . . . . 0.0 111.686 177.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.714 HD11 HD22 ' A' ' 114' ' ' LEU . 5.1 tt -62.53 -36.72 83.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.33 -177.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -52.11 -28.91 27.24 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 114.392 0.517 . . . . 0.0 114.392 -176.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -61.63 -38.07 86.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.159 0.504 . . . . 0.0 110.481 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -100.71 -33.11 10.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.157 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.643 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -96.86 6.18 64.34 Favored Glycine 0 C--O 1.223 -0.593 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.761 -172.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.7 pt? -46.79 -25.98 0.86 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.463 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 66.6 mttm -96.84 133.89 23.79 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 17.1 Cg_exo -67.87 2.57 2.46 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.93 2.42 . . . . 0.0 111.878 176.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -124.58 11.34 8.54 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.046 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 46.7 m -60.52 110.22 1.22 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.926 0.393 . . . . 0.0 110.276 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 19.8 m -84.32 101.33 11.87 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.453 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.465 HG21 HD12 ' A' ' 91' ' ' ILE . 56.4 t -87.63 115.08 27.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.62 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -87.95 103.18 15.44 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.321 0.582 . . . . 0.0 110.745 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.421 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 26.4 ttt -77.17 87.19 3.63 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.842 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.665 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 23.3 m-80 -77.71 88.09 3.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.417 -174.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.63 94.1 3.16 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 172.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.889 -171.679 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 N--CA 1.447 -1.25 0 CA-C-O 121.379 0.491 . . . . 0.0 112.783 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 148' ' ' GLY . 0.2 OUTLIER -97.98 125.75 43.07 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.031 177.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -89.11 99.18 12.22 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.008 0.433 . . . . 0.0 110.193 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 45.8 pt -101.6 163.72 3.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.218 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.541 HD11 ' HB3' ' A' ' 100' ' ' SER . 23.8 tp -119.2 111.27 18.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.778 0.323 . . . . 0.0 110.587 -178.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.421 HG22 ' HB ' ' A' ' 155' ' ' VAL . 61.7 t -110.38 112.55 41.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -90.24 125.2 35.4 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.929 0.395 . . . . 0.0 110.861 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.496 ' HA ' ' SD ' ' A' ' 157' ' ' MET . 12.2 m-20 . . . . . 0 C--N 1.325 -0.459 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 99' ' ' ARG . 14.8 ptt180 . . . . . 0 C--O 1.234 0.275 0 CA-C-O 121.144 0.497 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.541 ' HB3' HD11 ' A' ' 92' ' ' LEU . 12.4 m -81.95 106.87 14.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.851 175.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.0 m -85.66 103.74 14.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.153 0.501 . . . . 0.0 110.488 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.5 m -77.39 115.51 17.22 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.991 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -107.09 131.76 53.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.059 0.457 . . . . 0.0 111.79 -175.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -95.24 103.11 14.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.488 -0.778 . . . . 0.0 108.915 173.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.526 HG11 HD13 ' A' ' 114' ' ' LEU . 33.1 m -129.3 137.61 56.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.896 0.379 . . . . 0.0 111.151 -175.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.451 HH11 ' HD3' ' A' ' 106' ' ' ARG . 22.1 mtm180 -83.06 149.83 26.69 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.864 0.364 . . . . 0.0 110.44 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 107' ' ' LEU . 6.6 mp -69.09 -18.47 63.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.957 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.3 m -80.59 1.03 31.39 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.367 0.604 . . . . 0.0 110.763 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -92.97 152.57 19.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.483 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 p -90.36 157.46 17.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.888 172.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.618 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 59.2 t -58.94 -30.88 44.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.034 0.445 . . . . 0.0 110.865 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.551 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -55.21 -39.51 69.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.397 177.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.583 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 5.9 t60 -65.65 -37.19 85.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.134 -178.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.526 HD13 HG11 ' A' ' 105' ' ' VAL . 50.8 tp -67.69 -50.49 57.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.666 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -63.09 -38.75 92.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.093 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.927 ' HA ' HE21 ' A' ' 116' ' ' GLN . 0.0 OUTLIER -66.7 -29.17 69.09 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.089 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.583 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 26.5 mt-30 -63.47 -49.66 72.76 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 172.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.1 t -59.58 -49.2 84.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.811 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.878 ' HA ' ' HA3' ' A' ' 123' ' ' GLY . 67.4 m -59.51 -20.26 54.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.762 178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -79.31 -36.49 26.97 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.105 176.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 82.7 mt -96.74 -69.15 0.77 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.03 0.443 . . . . 0.0 112.098 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -97.13 7.11 47.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.358 0.599 . . . . 0.0 110.014 -176.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.878 ' HA3' ' HA ' ' A' ' 119' ' ' SER . . . -62.25 7.18 0.22 Allowed Glycine 0 C--O 1.226 -0.374 0 N-CA-C 116.334 1.294 . . . . 0.0 116.334 -170.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.414 HG12 HD12 ' A' ' 128' ' ' LEU . 59.3 t -31.08 93.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.911 0.884 . . . . 0.0 112.648 177.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.414 ' HB3' HE21 ' A' ' 125' ' ' GLN . 21.6 mt-30 53.31 111.78 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 O-C-N 123.913 0.758 . . . . 0.0 112.545 -176.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -63.32 -4.31 2.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.716 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -88.05 -24.68 23.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.041 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.414 HD12 HG12 ' A' ' 124' ' ' VAL . 93.7 mt -85.58 -42.35 14.44 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.542 0.21 . . . . 0.0 111.32 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.587 ' CE1' ' HA2' ' A' ' 123' ' ' GLY . 11.5 p90 -114.83 152.57 31.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.017 0.437 . . . . 0.0 110.477 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.727 ' CD1' ' HG3' ' A' ' 137' ' ' PRO . 1.0 OUTLIER -162.13 135.68 6.32 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 169.082 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.601 HD13 HG11 ' A' ' 155' ' ' VAL . 2.1 pp -98.22 144.79 27.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.309 0.576 . . . . 0.0 111.691 -173.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 25.7 p -120.09 152.05 38.15 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.721 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.517 ' HB3' HD21 ' A' ' 138' ' ' LEU . 14.7 t80 -137.11 -60.43 0.68 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.995 0.426 . . . . 0.0 110.796 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.439 ' C ' ' H ' ' A' ' 136' ' ' LYS . 1.8 tm-20 -81.79 35.62 0.42 Allowed 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.69 -29.58 2.96 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -170.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.492 ' HB2' ' HD2' ' A' ' 137' ' ' PRO . 22.7 pttp -118.05 173.68 3.12 Favored Pre-proline 0 N--CA 1.446 -0.66 0 CA-C-N 115.026 -0.587 . . . . 0.0 109.838 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.727 ' HG3' ' CD1' ' A' ' 130' ' ' TRP . 24.7 Cg_exo -62.38 171.73 5.08 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.376 2.051 . . . . 0.0 111.899 175.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.527 ' HB2' HG11 ' A' ' 111' ' ' VAL . 93.5 mt -101.92 146.06 28.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.44 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -74.3 112.3 10.33 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.618 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.9 p-10 -60.97 -26.79 67.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.819 -174.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -77.72 -19.67 54.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.382 -175.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 61.5 mt -93.2 156.25 40.34 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.732 0.301 . . . . 0.0 110.966 -174.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.05 136.14 54.91 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.896 2.397 . . . . 0.0 112.236 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.507 HD11 HD22 ' A' ' 114' ' ' LEU . 3.0 tt -63.74 -35.78 81.71 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.831 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -59.04 -23.9 57.74 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.835 -0.62 . . . . 0.0 113.162 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -69.07 -30.74 69.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.002 0.401 . . . . 0.0 110.597 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -100.17 -29.24 12.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.147 0.499 . . . . 0.0 110.922 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.448 ' O ' ' HG ' ' A' ' 89' ' ' LEU . . . -100.27 5.58 57.52 Favored Glycine 0 C--O 1.219 -0.809 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.591 -174.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.405 HD23 ' N ' ' A' ' 149' ' ' LEU . 2.3 pt? -46.03 -32.61 2.91 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 22.7 tptm -97.41 116.68 65.92 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 17.4 Cg_exo -66.02 79.69 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.169 2.579 . . . . 0.0 111.806 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 49.2 tp 172.87 -25.06 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.105 -173.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.6 t -46.05 117.45 1.53 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.721 175.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 24.0 m -110.32 120.41 42.35 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.113 -175.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.601 HG11 HD13 ' A' ' 131' ' ' LEU . 42.7 t -98.19 135.9 31.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.614 177.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -111.98 124.82 53.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.811 0.339 . . . . 0.0 110.815 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.496 ' SD ' ' HA ' ' A' ' 95' ' ' ASN . 63.1 mtt -75.42 126.59 31.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.729 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -105.26 152.17 23.21 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.137 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 79.5 mt -115.77 144.91 43.31 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.413 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 160' ' ' ARG . 26.2 ttt180 . . . . . 0 C--N 1.321 -0.65 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.351 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo . . . . . 0 N--CA 1.454 -0.824 0 CA-C-O 121.187 0.411 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.537 HD21 ' O ' ' A' ' 148' ' ' GLY . 45.5 tp -110.67 123.63 50.38 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.873 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.6 m -90.55 99.66 12.65 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.008 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.4 pt -100.61 145.54 10.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' A' ' 100' ' ' SER . 23.9 tp -106.21 106.0 16.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.044 0.45 . . . . 0.0 110.256 -176.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 61.0 t -99.86 128.56 51.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.036 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.59 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 81.6 mtt180 -100.4 123.12 44.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.18 0.514 . . . . 0.0 110.875 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.963 178.682 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 94' ' ' ARG . 11.6 ttm180 . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.484 ' HB3' HD11 ' A' ' 92' ' ' LEU . 43.8 m -89.49 94.21 9.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.947 0.403 . . . . 0.0 110.155 177.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.8 m -98.95 127.93 44.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.625 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.8 m -88.42 109.39 19.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.554 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -93.86 121.24 35.1 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -86.43 101.84 13.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.815 0.817 . . . . 0.0 109.854 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.469 HG21 HD13 ' A' ' 144' ' ' LEU . 26.2 m -111.9 -177.94 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.623 -177.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.525 ' HG2' ' H ' ' A' ' 108' ' ' THR . 41.8 ttm180 -133.35 153.68 51.38 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.516 ' CD2' HD22 ' A' ' 89' ' ' LEU . 14.3 mt -75.68 -9.11 58.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.023 0.44 . . . . 0.0 110.571 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.525 ' H ' ' HG2' ' A' ' 106' ' ' ARG . 0.2 OUTLIER -91.44 5.2 50.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.313 -177.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -122.69 161.73 23.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.824 0.345 . . . . 0.0 110.464 177.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 32.6 p -89.93 167.56 12.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.821 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.637 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 60.4 t -59.82 -31.38 47.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.057 174.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.54 ' HB2' ' HB3' ' A' ' 140' ' ' ASP . . . -57.47 -35.18 69.83 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.028 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -68.49 -17.71 64.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.153 0.502 . . . . 0.0 110.591 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.563 HD22 HD11 ' A' ' 144' ' ' LEU . 48.1 tp -100.12 -48.18 4.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.197 0.523 . . . . 0.0 110.468 176.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.2 tttm -63.19 -41.52 99.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.181 -177.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.791 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 63.5 tt0 -79.69 -17.97 52.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.062 0.458 . . . . 0.0 110.438 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -67.7 -52.79 33.61 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 51.7 t -64.59 -42.35 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.314 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 1.049 ' HA ' ' HA3' ' A' ' 123' ' ' GLY . 93.9 p -62.98 -32.13 73.41 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.965 0.412 . . . . 0.0 110.62 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.92 -29.3 70.96 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.862 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 78.7 mt -91.61 -77.02 0.43 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.688 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -103.26 -15.84 15.86 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 1.049 ' HA3' ' HA ' ' A' ' 119' ' ' SER . . . -42.35 -54.92 4.57 Favored Glycine 0 C--O 1.229 -0.201 0 N-CA-C 115.426 0.93 . . . . 0.0 115.426 -165.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.401 HG12 HD12 ' A' ' 128' ' ' LEU . 84.1 t 60.07 82.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.962 0.411 . . . . 0.0 110.443 -172.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.468 ' C ' ' H ' ' A' ' 127' ' ' ASP . 27.6 mt-30 58.56 112.08 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.135 -175.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.608 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 8.0 p-10 -72.69 19.34 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.059 0.457 . . . . 0.0 111.496 -176.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 125' ' ' GLN . 29.5 t70 -108.11 -25.08 11.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.278 175.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.401 HD12 HG12 ' A' ' 124' ' ' VAL . 97.9 mt -75.96 -11.54 59.98 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.091 0.472 . . . . 0.0 110.742 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.608 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 31.2 p90 -142.85 148.48 37.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.131 178.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.453 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 1.3 p90 -150.08 156.34 41.47 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.867 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 7.1 mp -112.64 149.53 32.7 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.567 -176.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.491 HG22 ' HA ' ' A' ' 137' ' ' PRO . 47.4 p -131.75 154.4 49.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.961 -178.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -139.23 130.62 26.97 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.301 171.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 70.66 -0.94 2.75 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 123.725 0.641 . . . . 0.0 111.037 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 111.59 -4.32 27.83 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.808 -174.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 137' ' ' PRO . 35.5 mtmm -106.6 134.85 19.64 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.627 0.251 . . . . 0.0 110.616 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.491 ' HA ' HG22 ' A' ' 132' ' ' THR . 7.6 Cg_exo -72.5 147.62 46.55 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.651 2.234 . . . . 0.0 111.266 174.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 37.7 mt -86.49 111.32 20.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.335 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -80.33 126.17 30.83 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.637 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 0.0 OUTLIER -61.18 -25.17 66.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.038 0.447 . . . . 0.0 111.036 -177.583 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 141' ' ' GLN . 11.6 pt20 -78.54 -0.43 29.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.3 -175.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.2 mt -120.76 151.69 54.87 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.666 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 41.1 Cg_endo -67.47 143.79 64.59 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.736 2.291 . . . . 0.0 111.568 176.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.563 HD11 HD22 ' A' ' 114' ' ' LEU . 0.5 OUTLIER -65.9 -27.3 68.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.746 -174.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.64 -28.15 56.04 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.127 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -58.32 -39.29 79.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.996 0.426 . . . . 0.0 110.954 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -100.07 -38.56 8.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.166 0.507 . . . . 0.0 111.081 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.537 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -96.06 6.54 66.62 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-O 119.223 -0.765 . . . . 0.0 114.255 -170.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -39.59 -31.73 0.11 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.469 ' C ' ' H ' ' A' ' 152' ' ' LEU . 34.6 ttpt -96.5 124.8 49.65 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 122.286 -0.259 . . . . 0.0 110.359 175.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 20.0 Cg_exo -67.92 24.3 0.13 Allowed 'Trans proline' 0 N--CA 1.477 0.547 0 C-N-CA 123.69 2.927 . . . . 0.0 113.301 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.469 ' H ' ' C ' ' A' ' 150' ' ' LYS . 34.8 tp -133.64 6.19 3.74 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.4 p -60.47 119.67 8.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.654 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.3 m -92.52 99.49 12.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.78 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 49.1 t -92.34 132.61 36.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.715 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -103.3 130.16 50.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.674 0.273 . . . . 0.0 110.746 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.867 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 26.2 ttt -85.01 97.97 10.13 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 176.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 39.2 m-80 -82.37 90.59 6.7 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.168 -173.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' A' ' 129' ' ' PHE . 43.6 mt -84.13 84.88 7.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.162 174.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 160' ' ' ARG . 5.1 mpt_? . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.215 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 N--CA 1.449 -1.142 0 CA-C-O 120.956 0.315 . . . . 0.0 111.657 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.471 ' HG ' HG23 ' A' ' 91' ' ' ILE . 52.9 tp -70.72 102.65 2.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.192 0.52 . . . . 0.0 110.527 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.8 m -95.58 95.49 8.41 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.832 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.471 HG23 ' HG ' ' A' ' 89' ' ' LEU . 28.8 pt -102.92 156.83 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.412 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.7 tp -96.38 108.01 20.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.063 0.458 . . . . 0.0 110.599 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.511 ' HB ' ' CD1' ' A' ' 103' ' ' TYR . 57.8 t -100.34 118.06 46.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.925 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.551 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 22.6 ttt85 -104.85 108.62 20.21 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.476 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.573 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 3.9 p-10 . . . . . 0 C--N 1.323 -0.584 0 CA-C-O 121.96 0.886 . . . . 0.0 111.687 -176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 . . . . . 0 N--CA 1.451 -0.379 0 CA-C-O 121.288 0.565 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 2.7 p -107.53 107.81 18.82 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.798 172.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.8 t -116.63 138.16 51.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.351 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.9 m -76.39 116.75 17.37 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.511 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 43.6 m-85 -104.37 148.46 26.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.978 0.418 . . . . 0.0 111.168 -177.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -102.31 110.3 22.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.016 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.4 -179.91 3.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.999 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.621 ' HB2' ' HG3' ' A' ' 109' ' ' GLN . 83.8 mtm180 -128.39 159.87 34.02 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.733 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 mp -81.27 -27.45 35.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.054 0.454 . . . . 0.0 110.13 -176.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.6 m -84.81 10.17 12.22 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.538 0.685 . . . . 0.0 110.861 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.621 ' HG3' ' HB2' ' A' ' 106' ' ' ARG . 28.3 mt-30 -95.05 143.24 26.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.641 172.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 24.9 p -79.64 156.65 27.53 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 170.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.614 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 99.3 t -59.39 -26.83 35.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.842 0.353 . . . . 0.0 110.391 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -58.1 -33.49 69.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.634 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -70.75 -43.11 69.53 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.473 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.605 ' HB2' HD11 ' A' ' 144' ' ' LEU . 64.6 tp -69.72 -37.27 76.47 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 112' ' ' ALA . 21.8 tptp -49.73 -51.43 38.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.82 176.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -65.19 -33.61 76.41 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.093 0.245 . . . . 0.0 111.642 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.47 -43.43 85.48 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.056 0.455 . . . . 0.0 110.177 174.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 114' ' ' LEU . 99.4 t -61.42 -42.6 94.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.648 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 53.8 m -60.69 -21.05 62.44 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.401 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -85.47 -27.21 33.43 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.669 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.7 mt -99.97 -66.49 0.9 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.133 0.492 . . . . 0.0 112.065 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -100.48 8.06 43.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.655 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.648 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -54.45 7.7 0.01 OUTLIER Glycine 0 CA--C 1.523 0.567 0 N-CA-C 117.186 1.634 . . . . 0.0 117.186 -172.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.1 t -31.02 95.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.852 0.861 . . . . 0.0 112.3 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 52.03 103.7 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 O-C-N 123.939 0.775 . . . . 0.0 110.855 -174.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.513 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 32.0 t70 -56.91 -13.05 2.31 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.74 -170.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -99.85 -16.21 18.13 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 60.6 mt -80.71 -13.79 58.69 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 121.964 -0.46 . . . . 0.0 112.026 -175.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.651 ' HB3' HD23 ' A' ' 159' ' ' LEU . 44.5 p90 -123.58 151.18 43.21 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.306 0.574 . . . . 0.0 111.934 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 4.0 p90 -149.38 158.13 43.91 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 172.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.74 ' HG ' ' HG2' ' A' ' 157' ' ' MET . 5.5 mp -105.64 135.54 46.86 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.165 -173.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 21.0 p -123.66 123.63 40.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.121 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -97.11 -69.65 0.75 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.914 0.387 . . . . 0.0 110.293 172.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -69.86 -31.63 69.57 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.724 0.773 . . . . 0.0 110.312 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 139.4 -24.57 2.78 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -169.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 137' ' ' PRO . 52.8 mtpt -84.99 151.68 57.78 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 114.478 -0.861 . . . . 0.0 109.911 172.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 21.3 Cg_exo -66.86 133.32 31.01 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.825 2.35 . . . . 0.0 111.914 176.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 37.8 mt -67.35 120.79 14.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.052 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -73.95 120.98 20.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.385 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.614 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.1 p-10 -68.19 -16.14 63.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.283 0.563 . . . . 0.0 110.428 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -84.03 -4.08 58.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.459 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 70.0 mt -112.52 158.29 37.77 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.194 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.61 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 57.6 Cg_endo -72.45 148.15 47.84 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.605 2.203 . . . . 0.0 112.864 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.605 HD11 ' HB2' ' A' ' 114' ' ' LEU . 20.5 mt -66.09 -37.17 85.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.196 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -59.66 -23.91 59.15 Favored Glycine 0 C--O 1.226 -0.396 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.788 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.507 ' HB2' ' HG2' ' A' ' 143' ' ' PRO . 2.5 tt0 -69.74 -29.58 66.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.885 0.374 . . . . 0.0 110.478 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -100.92 -38.97 7.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.292 0.568 . . . . 0.0 110.831 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.445 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -98.13 7.33 62.29 Favored Glycine 0 C--O 1.227 -0.342 0 CA-C-N 115.497 -0.774 . . . . 0.0 113.859 -169.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.5 pt? -38.9 -36.09 0.25 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -103.62 133.79 20.09 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.65 -7.42 9.04 Favored 'Trans proline' 0 N--CA 1.474 0.354 0 C-N-CA 122.889 2.393 . . . . 0.0 112.422 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 92.5 mt -94.57 -0.64 54.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.984 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 62.6 m -65.14 105.08 1.0 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.037 0.446 . . . . 0.0 110.09 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.1 m -82.25 101.32 10.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.142 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.442 ' HB ' HG22 ' A' ' 93' ' ' VAL . 49.1 t -81.91 106.24 12.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.074 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -83.12 103.06 12.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.164 0.506 . . . . 0.0 110.087 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.74 ' HG2' ' HG ' ' A' ' 131' ' ' LEU . 7.6 tmm? -78.79 112.37 15.86 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.04 113.26 24.93 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -168.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.651 HD23 ' HB3' ' A' ' 129' ' ' PHE . 54.8 mt -92.84 81.38 4.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.318 174.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 110.897 -178.098 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 N--CA 1.449 -1.094 0 N-CA-C 110.102 -0.768 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.41 ' CD1' ' HA ' ' A' ' 151' ' ' PRO . 0.1 OUTLIER -75.63 114.65 14.45 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.314 -173.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.6 t -82.37 95.44 7.64 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.9 pt -95.35 154.43 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.429 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 154' ' ' THR . 37.3 tp -106.72 114.39 28.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.941 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.3 t -109.37 118.83 57.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.039 0.447 . . . . 0.0 109.896 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 -90.29 132.74 35.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.241 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.465 0.32 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.966 -175.224 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 36.4 ttt-85 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.89 0.376 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.447 ' HB3' HD11 ' A' ' 92' ' ' LEU . 14.8 m -118.64 121.94 41.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.873 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.7 t -114.73 126.0 54.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.136 0.493 . . . . 0.0 109.903 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.8 m -90.14 134.48 34.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.981 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -132.64 139.2 47.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.516 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -99.58 107.38 19.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.957 0.408 . . . . 0.0 110.769 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.503 HG11 HD13 ' A' ' 114' ' ' LEU . 21.0 m -125.82 147.55 30.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.105 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -93.75 156.77 16.5 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.52 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.677 ' HG ' ' HA3' ' A' ' 145' ' ' GLY . 8.7 mp -65.44 -13.52 58.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.007 -175.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.2 t -88.58 3.72 49.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.831 0.348 . . . . 0.0 111.36 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -93.26 148.32 22.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.134 0.493 . . . . 0.0 111.02 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.1 p -85.14 159.96 20.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.977 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.545 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 55.8 t -62.17 -33.2 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.209 0.528 . . . . 0.0 109.87 175.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.524 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -64.43 -34.11 77.42 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.832 178.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.47 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 1.5 t60 -67.8 -41.85 82.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.962 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.738 HD22 HD11 ' A' ' 144' ' ' LEU . 62.2 tp -62.17 -45.75 92.02 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.111 173.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -55.13 -37.82 67.41 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.014 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -68.64 -35.39 77.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.758 0.314 . . . . 0.0 110.968 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 18.5 mt-30 -66.76 -45.45 78.49 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.485 0.66 . . . . 0.0 109.336 175.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.3 t -61.06 -36.76 74.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.613 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.829 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 72.5 m -66.82 -16.64 64.42 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.032 176.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.7 -35.75 35.15 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.654 174.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.7 mp -96.18 -71.55 0.67 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 124' ' ' VAL . 28.4 mm-40 -93.92 8.85 39.77 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.125 0.57 . . . . 0.0 111.109 -173.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.829 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -51.07 7.9 0.01 OUTLIER Glycine 0 N--CA 1.471 1.016 0 N-CA-C 118.09 1.996 . . . . 0.0 118.09 -170.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.417 ' N ' ' O ' ' A' ' 122' ' ' GLU . 28.1 t -54.73 82.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 118.154 0.977 . . . . 0.0 112.267 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.16 113.18 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.228 1.011 . . . . 0.0 112.348 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.537 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 1.8 p-10 -58.42 -12.89 4.31 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -173.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -72.75 -29.36 63.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.8 0.333 . . . . 0.0 110.414 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.9 mt -80.19 -39.5 29.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.903 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.537 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 25.8 p90 -109.67 105.04 14.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.946 0.879 . . . . 0.0 110.889 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.405 ' HE1' ' HG3' ' A' ' 137' ' ' PRO . 1.6 t90 -119.7 110.97 17.45 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.587 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.4 pp -92.41 152.19 19.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.075 0.464 . . . . 0.0 111.751 -172.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 13.8 p -140.71 154.82 46.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.121 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.444 ' CD2' ' HG3' ' A' ' 134' ' ' GLU . 10.3 t80 -125.0 -67.21 0.92 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.746 0.308 . . . . 0.0 110.863 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.444 ' HG3' ' CD2' ' A' ' 133' ' ' PHE . 46.3 mt-10 -77.85 3.54 14.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.08 0.467 . . . . 0.0 110.557 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.56 -24.19 27.95 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -168.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -92.99 158.21 37.88 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 114.873 -0.664 . . . . 0.0 109.551 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.405 ' HG3' ' HE1' ' A' ' 130' ' ' TRP . 3.5 Cg_exo -76.63 -2.42 12.64 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.075 2.517 . . . . 0.0 112.051 178.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 58.8 mt 70.67 -171.14 0.16 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.416 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -139.82 132.97 29.68 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.545 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.0 p-10 -70.47 -21.31 62.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.765 -174.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -65.15 -30.5 71.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.033 0.444 . . . . 0.0 110.871 177.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 72.5 mt -87.4 143.61 34.52 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.643 -176.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 142' ' ' LEU . 20.5 Cg_exo -64.05 131.8 32.0 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.642 2.228 . . . . 0.0 111.772 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.738 HD11 HD22 ' A' ' 114' ' ' LEU . 4.1 tt -55.27 -35.47 65.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.336 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.677 ' HA3' ' HG ' ' A' ' 107' ' ' LEU . . . -58.83 -23.37 56.06 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.638 -177.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -66.01 -31.24 72.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.221 0.51 . . . . 0.0 110.49 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -100.06 -29.11 12.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.151 0.5 . . . . 0.0 110.809 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.401 ' O ' ' HG ' ' A' ' 89' ' ' LEU . . . -100.09 5.73 57.89 Favored Glycine 0 C--O 1.222 -0.646 0 CA-C-N 115.652 -0.704 . . . . 0.0 113.937 -172.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.402 ' N ' HD23 ' A' ' 149' ' ' LEU . 2.5 pt? -46.28 -30.47 2.05 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -176.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.843 ' HD3' ' HD2' ' A' ' 151' ' ' PRO . 17.3 tppt? -89.21 119.73 69.75 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.843 ' HD2' ' HD3' ' A' ' 150' ' ' LYS . 48.6 Cg_endo -71.06 61.52 2.46 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.527 2.818 . . . . 0.0 112.165 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.4 tp -179.9 -26.79 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.307 -172.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.6 t -45.9 130.46 9.63 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.439 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 33.6 m -110.97 128.32 55.8 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.864 -173.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.8 t -99.1 138.57 23.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.027 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -110.1 117.0 32.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.964 0.411 . . . . 0.0 111.304 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 73.5 mtp -80.2 99.03 7.6 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.864 174.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -79.36 96.04 5.89 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.396 0.617 . . . . 0.0 110.442 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.35 106.1 4.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.707 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 70.9 ttp85 . . . . . 0 C--N 1.322 -0.595 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.125 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo . . . . . 0 N--CA 1.458 -0.597 0 CA-C-O 120.87 0.279 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.48 HD21 ' O ' ' A' ' 148' ' ' GLY . 65.7 tp -174.07 104.0 0.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.924 -175.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.8 m -85.33 105.96 16.37 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.005 0.431 . . . . 0.0 110.855 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 28.2 pt -106.8 145.47 14.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.162 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 14.5 tp -99.86 112.75 24.99 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 64.4 t -94.23 121.04 44.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.307 0.575 . . . . 0.0 111.44 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.405 ' HD3' ' HD1' ' A' ' 156' ' ' PHE . 21.4 ttt180 -85.17 118.55 24.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 175.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.556 ' ND2' ' HA ' ' A' ' 99' ' ' ARG . 4.1 p30 . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.348 -167.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.556 ' HA ' ' ND2' ' A' ' 95' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.184 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.9 p -169.16 59.58 0.05 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.52 0.676 . . . . 0.0 109.349 172.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.2 m -80.39 104.64 11.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.098 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 m -75.49 90.57 2.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.002 0.429 . . . . 0.0 110.094 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -82.87 117.35 22.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.907 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -86.28 101.14 12.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 173.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.4 m -121.04 -179.66 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.416 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -125.36 145.44 50.04 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.01 -12.11 52.77 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.981 -173.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.3 t -85.05 7.61 20.86 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.083 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -94.97 148.48 22.27 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.264 0.554 . . . . 0.0 111.806 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.64 ' HB ' ' OD1' ' A' ' 140' ' ' ASP . 9.4 p -82.02 166.86 19.43 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.188 170.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.09 -34.67 70.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.359 0.6 . . . . 0.0 109.688 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.53 -41.34 89.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.029 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -66.95 -15.49 63.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.937 0.399 . . . . 0.0 110.559 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.644 ' HB2' HD11 ' A' ' 144' ' ' LEU . 61.4 tp -91.89 -54.87 3.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.488 176.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -75.67 -10.01 59.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -172.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.859 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 10.4 tt0 -81.63 -31.86 32.19 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.048 0.451 . . . . 0.0 110.154 173.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -65.34 -35.78 82.04 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 172.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.23 -43.45 88.25 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.247 173.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.859 ' OG ' ' HA ' ' A' ' 116' ' ' GLN . 2.3 p -74.18 2.33 9.29 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.947 0.403 . . . . 0.0 111.69 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -92.42 -47.62 3.22 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.874 168.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.8 mt -86.71 -44.31 11.91 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.553 0.692 . . . . 0.0 111.267 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 124' ' ' VAL . 4.9 tp10 -98.29 10.55 40.42 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.227 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -29.35 6.62 0.0 OUTLIER Glycine 0 N--CA 1.486 2.003 0 N-CA-C 121.141 3.217 . . . . 0.0 121.141 -174.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' A' ' 122' ' ' GLU . 8.3 t -50.3 161.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 119.548 1.674 . . . . 0.0 109.407 169.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -42.54 136.99 2.27 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.339 0.59 . . . . 0.0 112.485 -175.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.643 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 28.2 t70 -61.01 -23.94 65.78 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.339 -172.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -89.42 -1.69 58.14 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.843 0.354 . . . . 0.0 110.873 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.499 HD12 HG12 ' A' ' 124' ' ' VAL . 74.6 mt -97.28 -28.02 14.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.64 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.643 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 42.5 p90 -103.55 113.84 27.65 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.076 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.403 ' HB3' ' O ' ' A' ' 158' ' ' ASN . 9.7 t90 -112.07 155.47 23.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.618 -176.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 5.5 mp -137.81 154.11 49.58 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.5 p -150.56 144.68 25.46 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.828 0.346 . . . . 0.0 111.2 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.543 ' CD2' ' HG2' ' A' ' 134' ' ' GLU . 14.8 t80 -135.31 -66.73 0.56 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.337 171.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.543 ' HG2' ' CD2' ' A' ' 133' ' ' PHE . 8.5 mm-40 -80.5 26.08 0.39 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.678 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.33 -9.35 67.47 Favored Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -173.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -124.38 162.81 40.04 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 131' ' ' LEU . 5.4 Cg_exo -74.92 4.07 5.02 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.179 2.586 . . . . 0.0 113.072 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 74.6 mt 73.8 142.22 0.07 Allowed 'General case' 0 N--CA 1.464 0.229 0 O-C-N 124.045 0.84 . . . . 0.0 110.996 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -85.52 124.18 31.79 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.35 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.64 ' OD1' ' HB ' ' A' ' 110' ' ' THR . 29.8 t70 -65.61 -22.14 66.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.343 0.592 . . . . 0.0 110.365 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -60.04 -26.91 66.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.504 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 87.8 mt -103.56 144.91 29.62 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.589 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 142' ' ' LEU . 14.4 Cg_exo -69.47 147.23 64.28 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.64 2.226 . . . . 0.0 112.027 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.644 HD11 ' HB2' ' A' ' 114' ' ' LEU . 76.6 mt -57.32 -33.19 67.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.659 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -56.23 -27.7 53.06 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.255 -0.498 . . . . 0.0 113.302 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.17 -43.92 83.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.097 0.475 . . . . 0.0 110.304 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -100.73 -28.53 12.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.811 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.48 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -96.41 5.76 65.24 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.517 -174.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.5 pt? -47.83 -27.7 2.21 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -91.13 110.23 40.88 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.462 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 16.9 Cg_exo -67.2 81.02 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.854 2.37 . . . . 0.0 111.913 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 151' ' ' PRO . 6.3 mt 162.86 -19.62 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.801 1.24 . . . . 0.0 109.683 -175.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.8 t -52.72 127.11 22.09 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.182 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.8 m -96.46 118.27 32.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.323 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.9 t -86.22 118.48 32.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.419 176.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.405 ' HD1' ' HD3' ' A' ' 94' ' ' ARG . 96.1 m-85 -88.79 99.25 12.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.045 0.45 . . . . 0.0 110.751 -177.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 24.6 ttt -80.08 98.66 7.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.303 0.573 . . . . 0.0 109.52 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 130' ' ' TRP . 0.9 OUTLIER -89.87 91.44 8.61 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.885 -177.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.4 tt -67.46 118.66 11.09 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 . . . . . 0 C--N 1.322 -0.595 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.653 -176.914 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo . . . . . 0 N--CA 1.454 -0.813 0 CA-C-O 121.423 0.509 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.554 HD11 ' HA ' ' A' ' 151' ' ' PRO . 29.1 tp -106.25 111.4 23.98 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.148 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.0 t -91.19 86.68 6.25 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.92 0.39 . . . . 0.0 110.301 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.5 pt -91.23 169.19 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.861 -176.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.517 HD11 ' HB2' ' A' ' 100' ' ' SER . 42.7 tp -108.54 106.12 16.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.042 0.448 . . . . 0.0 110.585 -177.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.0 t -97.69 116.0 39.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.5 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.56 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 71.6 mtp180 -96.99 157.86 15.7 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.013 0.435 . . . . 0.0 111.099 -177.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 C--N 1.321 -0.658 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.121 174.566 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 42.4 mtp-105 . . . . . 0 C--O 1.235 0.295 0 CA-C-O 121.343 0.592 . . . . 0.0 111.796 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 20.5 p -144.79 120.67 10.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.249 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.2 t -115.37 128.58 56.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.173 0.511 . . . . 0.0 110.196 -177.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.1 m -87.54 107.86 18.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.475 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -101.05 141.62 33.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.059 0.457 . . . . 0.0 111.901 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -83.85 102.37 12.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.243 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.6 m -114.66 -179.86 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 176.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.61 ' HB2' ' HG3' ' A' ' 109' ' ' GLN . 77.0 mtt85 -140.84 146.61 37.79 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.83 -31.16 72.26 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.267 0.354 . . . . 0.0 111.404 -173.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 m -75.97 -19.23 58.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.151 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.61 ' HG3' ' HB2' ' A' ' 106' ' ' ARG . 25.2 mt-30 -74.22 133.06 42.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.652 0.263 . . . . 0.0 110.39 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.799 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 23.2 p -71.3 159.26 34.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.302 174.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.634 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 59.2 t -60.59 -28.7 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.0 0.429 . . . . 0.0 110.462 177.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.94 -35.43 74.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.104 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.442 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 31.1 m80 -66.61 -42.89 86.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.446 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.852 ' HB2' HD11 ' A' ' 144' ' ' LEU . 60.6 tp -62.26 -44.98 95.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.46 175.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -62.01 -32.26 72.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.728 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 47.1 mt-30 -81.03 -21.09 40.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 0.0 111.59 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 46.5 mt-30 -73.58 -47.78 37.88 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 170.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 81.1 t -61.07 -40.65 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.085 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.946 ' HA ' ' HA3' ' A' ' 123' ' ' GLY . 91.6 p -65.5 -34.18 77.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.916 0.388 . . . . 0.0 110.406 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.29 -27.49 72.49 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.207 175.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 37.3 mt -98.72 -76.29 0.54 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 111.77 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.414 ' C ' ' H ' ' A' ' 124' ' ' VAL . 6.1 tp10 -102.21 8.18 40.63 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.228 0.611 . . . . 0.0 111.621 -174.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.946 ' HA3' ' HA ' ' A' ' 119' ' ' SER . . . -53.36 7.37 0.01 OUTLIER Glycine 0 CA--C 1.525 0.715 0 N-CA-C 117.213 1.645 . . . . 0.0 117.213 -172.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.414 ' H ' ' C ' ' A' ' 122' ' ' GLU . 87.1 t -38.02 97.39 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 123.623 0.769 . . . . 0.0 112.414 175.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.447 HE21 ' HB3' ' A' ' 125' ' ' GLN . 13.0 mt-30 48.08 102.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 O-C-N 124.087 0.867 . . . . 0.0 112.263 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.518 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 12.1 p-10 -71.67 17.87 0.08 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -174.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 125' ' ' GLN . 16.3 t70 -100.24 -21.54 15.45 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 171.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.0 mt -82.2 -16.41 49.77 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.914 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.518 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 25.8 p90 -143.32 159.9 41.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.666 0.269 . . . . 0.0 111.015 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -163.44 155.51 17.67 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.523 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 6.9 mp -106.81 146.95 30.29 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.44 -174.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 13.3 p -138.75 143.17 38.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.145 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.44 ' CD2' ' HB2' ' A' ' 134' ' ' GLU . 20.9 t80 -111.49 -74.62 0.63 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.131 0.491 . . . . 0.0 110.962 176.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.44 ' HB2' ' CD2' ' A' ' 133' ' ' PHE . 28.7 tt0 -93.51 14.55 18.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.41 0.624 . . . . 0.0 110.091 -173.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 102.51 -19.02 49.39 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 -169.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 137' ' ' PRO . 59.7 mttp -73.89 134.95 77.73 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 115.036 -0.582 . . . . 0.0 109.681 174.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 3.3 Cg_exo -77.31 4.66 5.69 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.994 2.463 . . . . 0.0 111.454 175.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 39.8 mt 69.98 -176.39 0.2 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.725 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.483 ' OE2' ' HG ' ' A' ' 142' ' ' LEU . 36.4 tt0 -145.33 121.1 10.55 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 174.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.634 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 1.2 p-10 -63.8 -22.08 66.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.35 0.595 . . . . 0.0 110.674 -175.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -74.69 -27.29 60.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.351 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.483 ' HG ' ' OE2' ' A' ' 139' ' ' GLU . 68.1 mt -94.15 157.05 38.31 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.837 0.351 . . . . 0.0 111.324 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.799 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 10.1 Cg_exo -72.67 151.42 52.11 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.071 2.514 . . . . 0.0 112.566 177.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.852 HD11 ' HB2' ' A' ' 114' ' ' LEU . 43.3 mt -66.67 -32.78 74.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.58 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.541 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -53.83 -34.88 51.88 Favored Glycine 0 C--N 1.332 0.326 0 O-C-N 123.314 0.384 . . . . 0.0 113.133 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -61.0 -33.11 72.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.871 0.367 . . . . 0.0 111.544 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -101.09 -42.07 6.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.723 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -100.13 6.95 58.39 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-O 119.358 -0.69 . . . . 0.0 114.349 -168.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.541 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.6 pt? -43.45 -29.0 0.4 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -175.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.635 ' HB3' ' HB3' ' A' ' 153' ' ' SER . 40.6 tptt -67.82 125.09 90.89 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.554 ' HA ' HD11 ' A' ' 89' ' ' LEU . 52.9 Cg_exo -56.13 -19.24 26.19 Favored 'Trans proline' 0 N--CA 1.478 0.604 0 C-N-CA 123.45 2.767 . . . . 0.0 114.09 -173.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.447 HD23 ' N ' ' A' ' 152' ' ' LEU . 1.5 pt? -132.8 34.21 3.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.228 0.537 . . . . 0.0 109.815 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.635 ' HB3' ' HB3' ' A' ' 150' ' ' LYS . 34.7 p -60.69 139.42 57.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.48 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.7 m -100.86 101.88 12.81 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.013 0.435 . . . . 0.0 111.11 -176.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.3 t -94.56 132.26 39.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -103.1 120.54 40.86 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.0 0.428 . . . . 0.0 111.027 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.523 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 1.7 tmt? -83.5 103.27 12.71 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -98.19 145.16 26.89 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.293 -172.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 95.3 mt -102.39 156.9 17.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.644 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 160' ' ' ARG . 7.4 tpt180 . . . . . 0 C--N 1.326 -0.42 0 O-C-N 123.94 0.775 . . . . 0.0 112.371 -174.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo . . . . . 0 N--CA 1.456 -0.693 0 CA-C-O 120.782 0.243 . . . . 0.0 111.485 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.3 tp -114.11 100.51 8.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.087 0.47 . . . . 0.0 110.003 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.5 t -92.84 107.31 19.12 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.617 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 102' ' ' THR . 43.7 pt -105.03 151.8 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.279 -178.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 100' ' ' SER . 19.8 tp -95.84 112.29 24.06 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.203 0.525 . . . . 0.0 111.751 -172.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.7 124.09 62.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.684 175.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -99.44 121.61 41.37 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 . . . . . 0 N--CA 1.469 0.48 0 O-C-N 123.522 0.514 . . . . 0.0 112.238 -172.283 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 . . . . . 0 CA--C 1.516 -0.357 0 CA-C-O 121.211 0.529 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.528 ' HB2' HD11 ' A' ' 92' ' ' LEU . 15.4 p -103.98 84.02 2.19 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.712 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.1 m -94.96 118.12 31.27 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.58 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 14.9 t -88.49 113.29 23.93 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.59 0.71 . . . . 0.0 109.643 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -90.15 132.02 35.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.622 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -80.59 99.93 8.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.263 0.554 . . . . 0.0 109.937 177.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 29.7 m -113.3 179.24 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.53 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -139.13 146.62 40.86 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -177.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.449 HD12 ' H ' ' A' ' 107' ' ' LEU . 5.4 mp -69.83 -31.85 69.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.36 -172.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 33.8 m -63.43 -28.07 69.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.337 0.589 . . . . 0.0 110.246 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.547 ' NE2' HD12 ' A' ' 144' ' ' LEU . 4.1 tt0 -79.2 141.01 37.54 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.518 -177.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.855 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 39.0 p -82.8 167.37 18.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.563 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.61 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 54.1 t -64.85 -23.59 33.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.1 176.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.24 -37.44 67.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.946 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.587 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 7.4 t-160 -66.07 -41.54 90.61 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.79 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.719 ' HB2' HD11 ' A' ' 144' ' ' LEU . 46.7 tp -65.4 -42.84 92.14 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -51.46 -50.36 59.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.403 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.763 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 77.9 mt-30 -75.85 -26.92 57.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.183 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.587 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 48.7 mt-30 -64.24 -50.2 68.94 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 174.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.2 t -63.49 -43.42 98.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.065 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.927 ' HA ' ' HA3' ' A' ' 123' ' ' GLY . 60.6 p -66.15 -23.66 66.52 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.89 0.376 . . . . 0.0 111.153 -176.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.34 -43.0 32.87 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.926 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.9 mt -85.66 -72.66 0.48 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.132 0.492 . . . . 0.0 111.55 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -100.36 6.8 44.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.503 -174.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.927 ' HA3' ' HA ' ' A' ' 119' ' ' SER . . . -63.74 6.92 0.51 Allowed Glycine 0 C--O 1.227 -0.29 0 CA-C-O 118.996 -0.891 . . . . 0.0 115.314 -172.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.504 HG12 HD12 ' A' ' 128' ' ' LEU . 63.6 t -35.24 92.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 123.934 0.894 . . . . 0.0 112.124 175.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 47.51 106.08 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 O-C-N 124.003 0.814 . . . . 0.0 111.046 -171.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.625 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 6.8 p-10 -61.9 -0.94 0.54 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -170.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -100.89 -7.12 23.79 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 176.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.504 HD12 HG12 ' A' ' 124' ' ' VAL . 85.9 mt -83.77 -12.44 55.7 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-O 120.88 0.371 . . . . 0.0 110.684 177.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.625 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 51.9 p90 -128.76 147.24 50.76 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 173.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.645 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 36.9 t90 -133.96 90.12 2.66 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.54 0.686 . . . . 0.0 110.029 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 131' ' ' LEU . 2.6 pt? -90.16 149.54 22.39 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.6 t -160.9 163.53 31.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.353 0.597 . . . . 0.0 111.15 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.433 ' HB3' HD21 ' A' ' 138' ' ' LEU . 6.9 t80 -142.3 -54.56 0.43 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.95 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -88.0 6.65 34.95 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.117 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.62 -22.56 39.94 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 -171.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.443 ' C ' ' H ' ' A' ' 138' ' ' LEU . 61.9 mttp -101.48 152.47 38.02 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 131' ' ' LEU . 62.3 Cg_endo -73.32 22.44 0.33 Allowed 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.653 2.235 . . . . 0.0 112.759 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.572 ' HB3' HG11 ' A' ' 111' ' ' VAL . 42.5 mt 68.36 117.13 0.03 OUTLIER 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.899 0.88 . . . . 0.0 110.981 -178.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -83.23 121.92 27.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.094 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.61 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 2.5 p-10 -69.78 -18.07 63.46 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.179 -174.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -70.0 -24.71 63.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.508 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.4 mt -95.19 156.93 37.23 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.708 -176.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.855 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 71.7 Cg_endo -77.17 153.77 32.13 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.631 2.22 . . . . 0.0 111.764 176.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.719 HD11 ' HB2' ' A' ' 114' ' ' LEU . 10.7 mt -71.25 -22.62 61.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.534 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -58.22 -30.99 64.98 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.55 177.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -66.53 -35.61 80.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.19 0.519 . . . . 0.0 110.856 -177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -95.53 -40.73 9.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.318 0.58 . . . . 0.0 111.081 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -97.54 6.76 63.2 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.232 -0.895 . . . . 0.0 114.156 -168.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -42.06 -32.49 0.46 Allowed 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 117.494 0.647 . . . . 0.0 112.55 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -90.93 123.7 64.04 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 173.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.62 -9.46 18.42 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.752 2.301 . . . . 0.0 112.31 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.8 pp -105.26 8.55 33.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.076 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 33.6 p -63.49 118.17 7.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.092 0.473 . . . . 0.0 109.976 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 9.9 m -98.93 106.11 18.34 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.966 -177.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 53.9 t -86.71 120.83 36.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.35 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.21 108.41 20.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.122 0.487 . . . . 0.0 110.752 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.53 ' HA ' ' CB ' ' A' ' 131' ' ' LEU . 27.5 ttt -85.37 100.89 12.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.564 176.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.645 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 43.1 m-80 -86.27 135.49 33.53 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.683 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 67.1 mt -97.78 20.58 11.79 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.176 0.512 . . . . 0.0 110.731 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 160' ' ' ARG . 8.1 tpt180 . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.457 -0.675 0 N-CA-C 111.184 -0.352 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.447 HD22 HD21 ' A' ' 107' ' ' LEU . 46.5 tp -78.08 114.97 17.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.271 0.558 . . . . 0.0 111.121 -174.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.8 p -94.35 98.63 11.03 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.591 176.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.2 pt -91.02 174.04 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.449 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' A' ' 100' ' ' SER . 1.3 tm? -118.6 112.93 20.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.878 0.371 . . . . 0.0 110.357 -176.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.8 t -103.16 127.35 57.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.887 175.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -98.58 108.53 21.25 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.586 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 36.0 p30 . . . . . 0 C--N 1.323 -0.569 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.535 -175.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 . . . . . 0 C--O 1.236 0.358 0 CA-C-O 120.967 0.413 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.491 ' HB3' HD11 ' A' ' 92' ' ' LEU . 17.6 m -90.2 94.36 9.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.426 175.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.2 p -90.1 111.16 22.2 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.995 0.426 . . . . 0.0 110.612 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.7 m -78.66 114.26 17.43 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.283 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -99.99 120.36 39.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.011 0.434 . . . . 0.0 111.348 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -85.01 103.2 13.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.501 176.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.41 176.36 9.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.205 0.526 . . . . 0.0 111.579 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -115.24 156.61 25.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.785 174.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.509 HD22 ' HA2' ' A' ' 145' ' ' GLY . 80.4 mt -65.88 -29.37 69.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.978 0.418 . . . . 0.0 111.112 -177.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 p -97.53 21.94 9.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.359 -175.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.533 ' HB3' ' HB3' ' A' ' 113' ' ' HIS . 13.4 mt-30 -77.47 -30.2 53.05 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.108 176.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 m 72.91 157.78 0.19 Allowed 'General case' 0 C--O 1.236 0.388 0 O-C-N 123.899 0.75 . . . . 0.0 109.965 -175.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.2 t -54.71 -38.81 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 0.0 110.578 -178.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -47.63 -48.06 28.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.657 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.533 ' HB3' ' HB3' ' A' ' 109' ' ' GLN . 13.2 t-80 -77.69 -7.92 57.17 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.42 -172.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 54.1 tp -100.44 -51.04 3.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.068 0.461 . . . . 0.0 110.347 175.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.424 ' HE2' ' CZ ' ' A' ' 129' ' ' PHE . 3.3 tmtp? -59.02 -48.1 82.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.411 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.587 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 19.7 mm-40 -69.36 -18.28 63.77 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -174.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -70.67 -48.93 52.29 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.2 t -62.52 -36.74 76.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.224 175.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.737 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 55.3 m -62.05 -25.84 67.91 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.17 175.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.07 -35.46 53.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.843 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.7 mt -92.39 -71.89 0.62 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.909 0.385 . . . . 0.0 111.984 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 124' ' ' VAL . 48.0 mt-10 -99.98 9.3 43.13 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.855 0.462 . . . . 0.0 110.797 -174.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.737 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -46.93 7.79 0.01 OUTLIER Glycine 0 N--CA 1.47 0.901 0 N-CA-C 118.719 2.248 . . . . 0.0 118.719 -172.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 122' ' ' GLU . 80.7 t -37.75 100.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 118.446 1.123 . . . . 0.0 112.024 173.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.517 ' HB3' ' HG ' ' A' ' 128' ' ' LEU . 4.0 mm-40 55.81 106.18 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.122 0 O-C-N 123.916 0.76 . . . . 0.0 112.653 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -52.84 -24.54 9.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.023 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.27 -5.83 39.32 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -173.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.517 ' HG ' ' HB3' ' A' ' 125' ' ' GLN . 74.3 mt -89.37 -52.42 5.05 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.984 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.5 ' CE1' ' HA2' ' A' ' 123' ' ' GLY . 13.7 p90 -94.98 126.61 40.43 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.405 0.621 . . . . 0.0 110.155 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.638 ' HZ2' ' H ' ' A' ' 138' ' ' LEU . 9.4 t-105 -144.79 133.58 22.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.278 -178.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.829 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 4.9 mp -105.43 139.34 40.2 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.102 -174.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.581 HG22 ' HA ' ' A' ' 137' ' ' PRO . 45.8 p -132.91 140.7 48.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.31 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.519 ' CD2' ' HG3' ' A' ' 134' ' ' GLU . 11.1 t80 -87.83 -69.94 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.598 0.237 . . . . 0.0 111.462 -178.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.519 ' HG3' ' CD2' ' A' ' 133' ' ' PHE . 37.5 mt-10 -74.7 12.58 0.79 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.01 -177.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.41 2.94 89.86 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -166.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -112.87 147.93 38.26 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 114.867 -0.666 . . . . 0.0 109.574 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.581 ' HA ' HG22 ' A' ' 132' ' ' THR . 59.3 Cg_endo -69.71 146.03 59.27 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.468 2.112 . . . . 0.0 111.916 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.638 ' H ' ' HZ2' ' A' ' 130' ' ' TRP . 70.5 mt -105.05 149.15 26.05 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.78 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.85 144.19 43.91 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -65.49 -25.0 67.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.079 0.466 . . . . 0.0 110.625 -177.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -64.57 -21.85 66.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.856 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 69.4 mt -96.18 131.54 28.54 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.268 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.593 ' HG2' ' HB2' ' A' ' 146' ' ' GLU . 29.2 Cg_endo -63.09 131.27 31.84 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.356 2.037 . . . . 0.0 111.592 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.444 ' HA ' ' CE1' ' A' ' 147' ' ' TYR . 6.9 tt -57.51 -35.94 70.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.577 -175.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.509 ' HA2' HD22 ' A' ' 107' ' ' LEU . . . -66.38 -24.84 72.39 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.04 -0.6 . . . . 0.0 113.723 -178.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.593 ' HB2' ' HG2' ' A' ' 143' ' ' PRO . 35.7 tt0 -61.59 -41.86 98.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.122 0.461 . . . . 0.0 111.231 -175.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.444 ' CE1' ' HA ' ' A' ' 144' ' ' LEU . 0.9 OUTLIER -100.62 -32.59 10.68 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.682 178.526 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -92.22 5.62 78.23 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 121.127 -0.559 . . . . 0.0 114.13 -172.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.509 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.4 pt? -53.33 -24.29 11.54 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -76.34 132.02 73.84 Favored Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.248 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.28 -14.77 44.06 Favored 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.407 2.071 . . . . 0.0 111.962 -178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.1 pp -112.05 14.66 20.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.739 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 77.8 p -62.87 104.78 0.58 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 5.7 m -88.3 104.31 16.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.239 -172.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.497 HG12 ' HB3' ' A' ' 131' ' ' LEU . 43.4 t -88.59 115.3 28.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.405 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -88.07 120.98 29.94 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.435 0.636 . . . . 0.0 111.198 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.829 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 26.9 ttt -76.61 103.7 6.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.55 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 0.9 OUTLIER -92.9 142.56 27.17 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.512 -178.052 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.1 tt -114.59 110.64 20.11 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 . . . . . 0 C--N 1.32 -0.716 0 CA-C-O 121.103 0.477 . . . . 0.0 111.196 -175.786 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo . . . . . 0 N--CA 1.448 -1.187 0 CA-C-O 120.876 0.282 . . . . 0.0 111.742 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.536 HD21 ' O ' ' A' ' 148' ' ' GLY . 23.2 tp -124.81 113.59 18.11 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.456 0.646 . . . . 0.0 110.019 176.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.2 t -93.63 111.7 23.43 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.808 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.4 pt -115.25 162.21 13.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.9 0.381 . . . . 0.0 110.716 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.479 HD11 ' HB3' ' A' ' 100' ' ' SER . 47.3 tp -110.79 104.03 12.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.116 0.484 . . . . 0.0 110.511 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.538 HG22 ' HB ' ' A' ' 155' ' ' VAL . 96.1 t -100.69 115.8 42.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.789 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -104.39 154.45 19.84 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.953 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.411 HD21 ' HB2' ' A' ' 99' ' ' ARG . 4.3 p30 . . . . . 0 C--N 1.316 -0.873 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 175.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.411 ' HB2' HD21 ' A' ' 95' ' ' ASN . 19.4 mmt180 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.161 0.505 . . . . 0.0 111.803 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.479 ' HB3' HD11 ' A' ' 92' ' ' LEU . 3.4 m -112.28 131.11 55.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.971 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.0 t -124.93 130.31 52.12 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.961 0.41 . . . . 0.0 110.131 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.5 m -92.11 107.19 19.03 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.282 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.471 ' CE1' ' HB ' ' A' ' 93' ' ' VAL . 32.8 m-85 -94.65 132.59 39.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.273 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -104.19 99.9 9.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.343 0.592 . . . . 0.0 109.621 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.418 HG11 HD13 ' A' ' 114' ' ' LEU . 34.8 m -115.33 -179.78 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.819 -174.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -119.15 151.39 38.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.952 175.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.64 -13.42 62.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.234 -175.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.9 m -74.86 -13.89 60.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.203 0.525 . . . . 0.0 110.844 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -85.12 144.3 28.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.734 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.4 p -94.23 175.6 6.64 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.6 t -55.23 -41.31 60.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.9 -42.91 90.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.903 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -69.67 -24.61 63.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.857 -172.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.584 HD22 HD11 ' A' ' 144' ' ' LEU . 57.3 tp -88.23 -43.41 11.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.981 0.42 . . . . 0.0 110.054 172.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -60.67 -42.44 97.04 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.662 -177.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -58.6 -35.21 72.07 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.274 0.359 . . . . 0.0 111.107 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -63.59 -48.3 77.93 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.446 0.641 . . . . 0.0 109.541 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.488 HG11 ' SD ' ' A' ' 157' ' ' MET . 45.0 t -61.81 -41.17 89.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.596 176.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.646 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 50.9 m -59.82 -21.43 60.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.431 177.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.99 -37.15 16.54 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.419 -0.895 . . . . 0.0 112.256 175.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 80.8 mt -92.11 -66.26 0.94 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.214 0.531 . . . . 0.0 112.068 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -100.49 8.27 43.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.945 -175.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.646 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -53.83 7.5 0.01 OUTLIER Glycine 0 CA--C 1.522 0.492 0 N-CA-C 117.547 1.779 . . . . 0.0 117.547 -170.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.404 HG12 HD12 ' A' ' 128' ' ' LEU . 58.4 t -29.87 94.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.07 0.948 . . . . 0.0 112.376 176.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.487 ' HB3' ' HG ' ' A' ' 128' ' ' LEU . 8.9 tt0 48.63 109.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 O-C-N 124.063 0.852 . . . . 0.0 111.314 -171.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -54.59 -19.07 5.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.02 -175.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.47 ' O ' ' HD3' ' A' ' 160' ' ' ARG . 0.7 OUTLIER -95.53 -6.53 40.29 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -177.753 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.487 ' HG ' ' HB3' ' A' ' 125' ' ' GLN . 66.4 mt -82.11 -26.65 33.39 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.174 0.443 . . . . 0.0 111.066 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.418 ' CE1' ' HA2' ' A' ' 123' ' ' GLY . 16.1 p90 -120.1 125.44 48.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.352 0.596 . . . . 0.0 111.046 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.433 ' HE1' ' HB3' ' A' ' 137' ' ' PRO . 21.6 t-105 -132.62 130.11 39.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.844 175.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 131' ' ' LEU . 2.6 pt? -106.08 138.16 42.76 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.966 0.412 . . . . 0.0 110.399 -173.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.632 HG22 ' HA ' ' A' ' 137' ' ' PRO . 49.6 p -134.76 146.25 49.2 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.865 -175.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.563 ' HB3' HD21 ' A' ' 138' ' ' LEU . 32.7 t80 -108.18 139.28 43.09 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.475 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 29.2 tt0 72.19 -29.4 0.2 Allowed 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.727 0.642 . . . . 0.0 111.766 174.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 133' ' ' PHE . . . 130.13 6.19 4.03 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -173.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -117.12 147.69 40.81 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-O 120.509 0.195 . . . . 0.0 110.538 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.632 ' HA ' HG22 ' A' ' 132' ' ' THR . 93.0 Cg_endo -74.87 142.78 28.71 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.187 1.925 . . . . 0.0 110.661 172.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.563 HD21 ' HB3' ' A' ' 133' ' ' PHE . 33.0 mt -95.51 141.1 29.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.623 -170.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.526 ' OE2' ' HB3' ' A' ' 141' ' ' GLN . 33.0 tt0 -86.31 132.3 34.01 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.51 -28.27 61.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.736 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.526 ' HB3' ' OE2' ' A' ' 139' ' ' GLU . 1.1 tm0? -59.29 -44.17 92.52 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.1 mt -74.59 139.84 74.73 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.089 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.76 154.18 73.95 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.505 2.137 . . . . 0.0 112.32 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.584 HD11 HD22 ' A' ' 114' ' ' LEU . 5.7 tt -58.92 -37.05 75.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.234 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.55 -20.46 56.0 Favored Glycine 0 C--O 1.227 -0.282 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.845 -178.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -67.42 -31.15 71.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.268 0.556 . . . . 0.0 110.108 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.472 ' CD1' HD22 ' A' ' 138' ' ' LEU . 16.2 m-85 -100.21 -29.67 12.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.068 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.536 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -94.62 5.78 70.24 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.489 -175.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -49.9 -21.59 1.22 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.532 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 55.8 mttp -86.91 120.7 71.75 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 172.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -59.12 -0.79 0.67 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.959 2.439 . . . . 0.0 112.746 174.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.414 ' H ' ' C ' ' A' ' 150' ' ' LYS . 1.9 pp -128.61 17.51 6.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.712 176.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.532 ' OG ' ' HB2' ' A' ' 150' ' ' LYS . 14.2 m -52.02 108.12 0.26 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.883 0.373 . . . . 0.0 110.69 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.6 m -80.99 90.71 5.98 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.278 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.538 ' HB ' HG22 ' A' ' 93' ' ' VAL . 45.3 t -91.23 114.47 28.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.347 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -90.25 109.6 20.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.366 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.488 ' SD ' HG11 ' A' ' 118' ' ' VAL . 59.4 ttp -77.17 92.89 3.85 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -87.37 114.53 24.06 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.088 -170.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.85 125.24 26.15 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 165.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.47 ' HD3' ' O ' ' A' ' 127' ' ' ASP . 84.0 mtp180 . . . . . 0 C--N 1.32 -0.714 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -170.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 N--CA 1.452 -0.97 0 CA-C-O 121.163 0.401 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.546 HD21 ' O ' ' A' ' 148' ' ' GLY . 63.3 tp -91.28 100.73 13.48 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.596 ' HB3' HG22 ' A' ' 102' ' ' THR . 47.3 m -83.87 111.88 19.62 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.557 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 39.2 pt -102.03 151.81 5.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.982 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.539 HD11 ' HB2' ' A' ' 100' ' ' SER . 18.0 tp -101.02 105.18 16.36 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.107 0.479 . . . . 0.0 110.874 -174.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.488 HG22 ' HB ' ' A' ' 155' ' ' VAL . 58.9 t -104.72 126.8 59.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.056 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.528 ' HG2' ' HA ' ' A' ' 100' ' ' SER . 20.0 mtp180 -109.67 128.63 55.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.649 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.56 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 6.0 p30 . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.12 177.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 . . . . . 0 N--CA 1.452 -0.363 0 CA-C-O 120.984 0.421 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.539 ' HB2' HD11 ' A' ' 92' ' ' LEU . 3.0 p -87.9 100.35 12.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.387 176.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 m -101.61 119.99 39.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.432 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.596 HG22 ' HB3' ' A' ' 90' ' ' SER . 0.2 OUTLIER -82.13 103.78 11.99 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.478 -179.145 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -94.38 127.88 40.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.194 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -88.0 131.14 34.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.634 0.73 . . . . 0.0 110.963 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 29.7 m -147.85 -178.42 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.257 -177.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 106' ' ' ARG . 2.5 mmt180 -140.51 166.71 23.97 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 174.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 107' ' ' LEU . 5.1 mp -78.14 -5.6 52.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.026 0.441 . . . . 0.0 110.155 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.73 -3.23 56.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.775 -176.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.61 178.32 4.33 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.804 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 p -110.22 167.92 9.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.981 0.42 . . . . 0.0 112.091 -174.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.9 t -58.69 -30.92 43.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.64 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.0 -43.21 60.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.917 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.44 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 24.7 t60 -74.44 -14.56 60.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.723 0.297 . . . . 0.0 111.321 -174.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.792 ' HB2' HD11 ' A' ' 144' ' ' LEU . 59.0 tp -87.63 -48.02 8.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.449 0.642 . . . . 0.0 109.274 174.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -59.34 -43.07 92.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.68 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.42 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 63.6 tt0 -63.41 -31.52 72.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.321 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 47.7 mt-30 -63.78 -44.28 93.85 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.106 0.479 . . . . 0.0 109.865 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.5 t -66.16 -45.19 90.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.93 175.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' A' ' 116' ' ' GLN . 67.5 m -66.63 -8.0 24.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.775 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -100.3 -36.44 4.11 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.94 177.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.7 mt -94.84 -44.32 7.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.513 0.673 . . . . 0.0 110.942 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 124' ' ' VAL . 10.0 tp10 -100.12 11.11 40.14 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.234 -178.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -29.18 7.31 0.0 OUTLIER Glycine 0 N--CA 1.488 2.118 0 N-CA-C 121.104 3.202 . . . . 0.0 121.104 -172.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 122' ' ' GLU . 17.6 t -46.65 164.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 119.758 1.779 . . . . 0.0 109.798 167.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 128' ' ' LEU . 76.1 mt-30 -35.24 118.58 0.46 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.542 0.687 . . . . 0.0 111.95 -176.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -58.11 -29.56 65.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.828 -167.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -100.47 14.43 31.25 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.441 ' CD1' ' HB2' ' A' ' 125' ' ' GLN . 59.9 mt -91.14 -16.63 27.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.903 0.382 . . . . 0.0 110.788 174.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -121.75 145.76 47.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.537 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.442 ' HE1' ' HB3' ' A' ' 137' ' ' PRO . 7.2 t-105 -147.68 129.6 15.32 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 173.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.553 ' HB3' ' HA ' ' A' ' 157' ' ' MET . 1.1 pt? -111.48 134.5 53.02 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.065 0.46 . . . . 0.0 110.698 -173.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.612 HG22 ' HA ' ' A' ' 137' ' ' PRO . 46.2 p -135.29 131.52 36.61 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.823 -177.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . 14.8 t80 -70.89 -65.38 0.74 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.306 0.574 . . . . 0.0 111.078 179.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -92.77 1.43 57.28 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.232 -173.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.21 -10.13 69.7 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -164.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.498 ' HD2' ' HE1' ' A' ' 147' ' ' TYR . 17.3 ttmm -81.59 127.62 72.39 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 113.908 -1.146 . . . . 0.0 108.446 175.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.612 ' HA ' HG22 ' A' ' 132' ' ' THR . 82.1 Cg_endo -73.63 131.76 16.45 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.123 1.882 . . . . 0.0 111.862 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.4 mt -77.29 119.34 20.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.604 -174.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -97.74 134.43 40.92 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.486 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.15 -17.22 64.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.384 0.612 . . . . 0.0 111.03 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -58.14 -27.32 63.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.308 172.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 56.6 mt -109.72 145.24 31.57 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.661 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.26 155.69 51.37 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.583 2.189 . . . . 0.0 110.866 173.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.792 HD11 ' HB2' ' A' ' 114' ' ' LEU . 22.6 mt -64.7 -20.34 66.27 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -176.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -54.56 -31.63 52.54 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.79 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -58.77 -38.7 79.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.97 0.414 . . . . 0.0 110.989 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.498 ' HE1' ' HD2' ' A' ' 136' ' ' LYS . 13.8 m-85 -100.66 -32.31 10.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.272 0.558 . . . . 0.0 111.024 -177.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.546 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -97.7 7.05 63.05 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.39 -0.823 . . . . 0.0 113.986 -171.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -44.86 -23.62 0.15 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 62.7 mttp -104.47 134.46 19.67 Favored Pre-proline 0 C--N 1.329 -0.325 0 O-C-N 122.217 -0.302 . . . . 0.0 110.608 175.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 19.9 Cg_exo -67.16 4.89 1.0 Allowed 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.967 2.445 . . . . 0.0 112.586 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -127.6 11.63 6.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.441 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 55.9 m -57.61 107.77 0.48 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.944 0.402 . . . . 0.0 110.15 177.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.5 m -85.64 102.72 13.82 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.973 -176.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 133' ' ' PHE . 40.7 t -92.75 121.85 43.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.541 177.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -92.8 118.55 31.22 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.217 0.532 . . . . 0.0 110.856 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.56 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 40.4 ttm -79.81 93.13 5.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.181 176.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 51.5 m-80 -79.91 123.2 27.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.331 0.586 . . . . 0.0 111.519 -172.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 70.2 mt -105.39 95.56 5.91 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.368 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 . . . . . 0 C--N 1.325 -0.499 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.984 -177.026 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo . . . . . 0 N--CA 1.455 -0.788 0 N-CA-C 109.316 -1.071 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.576 ' HB3' HG23 ' A' ' 105' ' ' VAL . 14.0 tp -150.83 138.63 19.86 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.514 173.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.6 t -125.67 109.72 12.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.535 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 32.2 pt -116.12 134.72 58.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.945 0.402 . . . . 0.0 110.765 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' A' ' 100' ' ' SER . 58.4 tp -94.46 105.84 17.81 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.038 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 69.1 t -88.53 104.56 14.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.469 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -93.16 114.46 26.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.673 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.559 HD22 ' N ' ' A' ' 95' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--N 1.318 -0.767 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.224 176.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? . . . . . 0 N--CA 1.454 -0.266 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.459 ' HB3' HD11 ' A' ' 92' ' ' LEU . 8.8 m -93.38 96.53 9.99 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.801 0.334 . . . . 0.0 110.109 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.2 p -108.31 119.33 39.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.952 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.1 m -82.11 120.17 24.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.344 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -110.72 136.03 50.41 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -91.01 123.83 34.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.656 0.741 . . . . 0.0 109.679 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' ' 89' ' ' LEU . 16.0 m -135.78 -178.97 2.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.257 -175.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -127.1 157.0 40.83 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.16 -30.38 64.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 110.324 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -78.83 50.33 0.99 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.835 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -139.88 155.82 47.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.659 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.1 p -86.28 152.29 22.89 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.623 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 59.4 t -63.09 -23.79 34.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.004 0.431 . . . . 0.0 109.848 176.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.528 ' CA ' ' HB2' ' A' ' 140' ' ' ASP . . . -57.07 -44.09 82.74 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.81 174.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.509 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 13.0 m-70 -65.32 -32.96 74.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.269 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.472 HD22 HD11 ' A' ' 144' ' ' LEU . 56.4 tp -71.13 -48.0 54.67 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 174.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -54.94 -47.36 74.55 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.897 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.478 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 29.0 mt-30 -63.8 -34.31 77.63 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -176.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 25.3 mt-30 -66.43 -47.06 74.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.336 0.589 . . . . 0.0 109.729 176.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.99 -34.89 65.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.633 174.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.908 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 60.8 m -79.26 -1.33 36.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.399 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -88.81 -37.0 7.52 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.788 168.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.0 mt -86.5 -64.39 1.16 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.02 0.438 . . . . 0.0 111.508 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 124' ' ' VAL . 17.1 mm-40 -99.63 8.93 43.98 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.649 0.78 . . . . 0.0 110.069 -175.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.908 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -44.48 9.12 0.0 OUTLIER Glycine 0 CA--C 1.526 0.723 0 N-CA-C 120.032 2.773 . . . . 0.0 120.032 -170.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' A' ' 122' ' ' GLU . 13.0 t -58.45 75.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 119.517 1.658 . . . . 0.0 112.222 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 123' ' ' GLY . 24.5 mt-30 63.7 121.28 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.504 1.121 . . . . 0.0 113.399 175.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -73.53 54.81 0.47 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 122.412 1.101 . . . . 0.0 109.406 173.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.51 ' O ' ' HD2' ' A' ' 160' ' ' ARG . 19.0 t70 -146.4 -37.69 0.24 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.48 -1.237 . . . . 0.0 108.711 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.7 mt -80.87 -20.02 43.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.604 175.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -135.74 148.28 48.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.652 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.933 ' HZ3' ' HA ' ' A' ' 160' ' ' ARG . 1.2 p90 -155.32 152.52 29.28 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 170.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.798 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 6.7 mp -109.01 141.78 40.65 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.549 -173.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.8 p -122.41 131.37 53.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.83 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.564 ' HB3' HD21 ' A' ' 138' ' ' LEU . 10.9 t80 -100.79 -62.22 1.27 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.166 0.508 . . . . 0.0 110.768 174.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -95.87 27.85 3.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.914 -174.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.4 4.02 90.32 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.596 -174.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -127.05 149.54 69.62 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -62.46 148.52 93.18 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.803 2.335 . . . . 0.0 112.182 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.564 HD21 ' HB3' ' A' ' 133' ' ' PHE . 43.3 mt -96.92 112.94 24.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.443 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -61.76 130.65 46.8 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 173.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.623 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.7 p-10 -77.46 -18.52 57.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.49 -176.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.65 -36.73 73.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.867 0.365 . . . . 0.0 110.602 177.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.418 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 93.2 mt -78.54 158.17 76.44 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.402 -174.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.67 ' HG2' ' HG2' ' A' ' 146' ' ' GLU . 44.4 Cg_endo -69.23 146.71 64.34 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.648 2.232 . . . . 0.0 112.58 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.472 HD11 HD22 ' A' ' 114' ' ' LEU . 22.7 tp -72.12 -37.34 69.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.604 -174.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -57.4 -25.23 54.47 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.396 -0.431 . . . . 0.0 113.716 -176.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.67 ' HG2' ' HG2' ' A' ' 143' ' ' PRO . 24.4 mm-40 -65.78 -29.69 70.22 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.468 -0.43 . . . . 0.0 111.483 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -100.53 -38.47 8.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.171 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.44 ' O ' HD11 ' A' ' 89' ' ' LEU . . . -98.59 6.21 60.73 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-O 119.412 -0.66 . . . . 0.0 113.912 -172.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.5 pt? -37.21 -38.2 0.2 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -175.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.461 ' C ' ' H ' ' A' ' 152' ' ' LEU . 38.7 ttpt -90.76 125.95 57.49 Favored Pre-proline 0 C--N 1.322 -0.605 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.349 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.09 27.35 0.22 Allowed 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.356 2.704 . . . . 0.0 112.653 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.461 ' H ' ' C ' ' A' ' 150' ' ' LYS . 0.2 OUTLIER -140.83 14.83 2.3 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.718 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 31.9 p -75.92 131.74 39.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.443 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 23.6 m -95.09 110.43 22.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.737 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 41.0 t -92.7 109.52 21.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -85.26 120.32 26.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.843 0.354 . . . . 0.0 111.065 -176.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.798 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 27.4 ttt -85.19 103.87 14.55 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.65 123.44 46.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.513 -172.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.9 147.1 45.65 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.933 ' HA ' ' HZ3' ' A' ' 130' ' ' TRP . 60.6 ttt180 . . . . . 0 C--N 1.324 -0.513 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -170.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo . . . . . 0 N--CA 1.459 -0.541 0 CA-C-O 120.783 0.243 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.497 HD22 ' CD2' ' A' ' 107' ' ' LEU . 52.3 tp -109.34 103.44 12.37 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.432 ' OG ' HG22 ' A' ' 102' ' ' THR . 7.3 t -96.16 98.48 10.36 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.105 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.464 HG23 ' HG ' ' A' ' 89' ' ' LEU . 33.3 pt -95.5 159.99 2.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.41 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 33.8 tp -99.99 119.09 37.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.839 0.352 . . . . 0.0 110.877 -177.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 68.9 t -110.13 114.2 46.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.86 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 34.0 ttt-85 -110.08 137.98 47.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.703 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.541 ' ND2' ' HB2' ' A' ' 99' ' ' ARG . 56.7 p30 . . . . . 0 C--N 1.329 -0.292 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.871 175.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.541 ' HB2' ' ND2' ' A' ' 95' ' ' ASN . 4.6 mmp_? . . . . . 0 CA--C 1.518 -0.261 0 CA-C-O 121.115 0.483 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 5.2 m -118.71 100.09 7.19 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.503 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.9 t -101.27 136.62 40.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.86 0.362 . . . . 0.0 110.382 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.432 HG22 ' OG ' ' A' ' 90' ' ' SER . 0.6 OUTLIER -91.68 109.33 20.64 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.603 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 90' ' ' SER . 44.7 m-85 -95.86 120.15 35.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.021 0.439 . . . . 0.0 111.71 -174.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -79.69 100.39 7.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.663 176.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.415 ' C ' ' HD2' ' A' ' 106' ' ' ARG . 35.1 m -123.81 -179.86 2.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.023 0.439 . . . . 0.0 110.975 -177.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.502 ' N ' ' HD2' ' A' ' 106' ' ' ARG . 4.6 mpt_? -123.33 157.2 33.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.497 ' CD2' HD22 ' A' ' 89' ' ' LEU . 23.8 mt -62.03 -29.18 70.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.723 0.297 . . . . 0.0 111.364 -176.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.0 m -74.93 -7.89 54.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.695 -175.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -80.29 125.27 29.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.795 0.331 . . . . 0.0 110.912 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 21.2 p -73.96 157.86 35.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.759 172.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.611 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 60.3 t -59.03 -29.37 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.08 0.467 . . . . 0.0 109.963 177.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -58.71 -38.33 78.06 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.35 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -64.92 -46.33 82.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.708 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.456 HD23 HD11 ' A' ' 131' ' ' LEU . 34.0 tp -64.11 -40.68 96.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.319 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -52.85 -48.84 66.75 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.849 175.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.537 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 11.6 mm-40 -69.03 -28.94 67.02 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -66.98 -48.68 67.74 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.504 0.668 . . . . 0.0 109.452 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 114' ' ' LEU . 42.8 t -64.11 -33.6 63.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.495 175.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.737 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 67.9 m -67.68 -17.4 64.57 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.196 175.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.76 -37.09 27.25 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.559 175.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.9 mt -93.36 -64.98 1.03 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.958 0.409 . . . . 0.0 112.04 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 124' ' ' VAL . 64.6 mm-40 -98.06 9.61 42.42 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.349 0.659 . . . . 0.0 111.367 -174.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.737 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -45.11 7.3 0.01 OUTLIER Glycine 0 N--CA 1.473 1.131 0 N-CA-C 118.583 2.193 . . . . 0.0 118.583 -173.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.464 ' N ' ' O ' ' A' ' 122' ' ' GLU . 57.9 t -50.57 88.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 118.532 1.166 . . . . 0.0 111.019 171.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 49.04 105.8 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.824 0.703 . . . . 0.0 111.794 -175.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.562 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 3.4 p-10 -69.65 5.93 1.28 Allowed 'General case' 0 C--N 1.328 -0.364 0 O-C-N 121.92 -0.488 . . . . 0.0 110.618 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -77.54 -35.61 53.09 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.719 169.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.2 mt -73.78 -21.05 60.3 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.275 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.562 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 52.6 p90 -132.13 120.39 22.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.632 0.73 . . . . 0.0 111.403 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -134.12 131.97 39.35 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 170.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.727 HD23 ' H ' ' A' ' 131' ' ' LEU . 2.2 pt? -104.19 130.62 51.95 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.265 0.555 . . . . 0.0 111.273 -171.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.663 HG22 ' HA ' ' A' ' 137' ' ' PRO . 68.3 p -118.09 138.2 52.41 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.707 -174.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -84.23 132.14 34.68 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.179 175.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 63.87 8.08 3.64 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.959 175.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.04 -2.18 63.6 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.037 -177.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.487 ' O ' ' HB ' ' A' ' 132' ' ' THR . 78.4 mttt -102.02 132.83 21.12 Favored Pre-proline 0 C--N 1.327 -0.396 0 C-N-CA 122.321 0.248 . . . . 0.0 110.479 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.663 ' HA ' HG22 ' A' ' 132' ' ' THR . 19.5 Cg_exo -65.26 127.99 19.47 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.883 2.388 . . . . 0.0 112.936 -175.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 75.6 mt -98.45 164.58 12.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.427 178.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.465 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 32.8 mt-10 -105.99 141.13 37.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.75 175.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.611 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.8 p-10 -64.33 -18.53 64.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.216 0.532 . . . . 0.0 110.263 176.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -72.28 -16.87 61.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.285 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.465 ' HG ' ' HB2' ' A' ' 139' ' ' GLU . 87.4 mt -100.84 148.57 35.23 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.625 -173.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 2.8 Cg_exo -76.94 149.57 29.19 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.102 2.535 . . . . 0.0 112.159 175.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.441 HD11 ' HB2' ' A' ' 114' ' ' LEU . 60.8 mt -73.65 -29.24 62.22 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.401 -176.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.422 ' CA ' HD22 ' A' ' 107' ' ' LEU . . . -54.3 -37.97 60.91 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.308 -0.472 . . . . 0.0 114.131 -173.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -64.55 -32.04 73.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.904 0.383 . . . . 0.0 111.334 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -100.63 -24.31 14.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.21 0.529 . . . . 0.0 111.238 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.438 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -100.4 6.24 57.62 Favored Glycine 0 C--O 1.224 -0.511 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.108 -175.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -39.58 -35.92 0.35 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 98.4 mttt -100.31 129.65 27.59 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 50.9 Cg_exo -57.42 -24.93 63.49 Favored 'Trans proline' 0 N--CA 1.473 0.314 0 C-N-CA 122.834 2.356 . . . . 0.0 112.54 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.425 ' H ' ' HG ' ' A' ' 152' ' ' LEU . 2.3 pp -87.71 -1.28 57.86 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.496 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.3 t -68.89 120.68 15.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.5 m -98.01 119.05 35.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.323 0.582 . . . . 0.0 111.978 -172.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 29.2 t -96.11 119.16 43.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -88.95 117.78 28.21 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.803 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.507 ' HE2' HD21 ' A' ' 159' ' ' LEU . 20.7 ttt -77.56 91.47 3.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.19 176.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -75.46 109.88 9.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.0 -173.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.507 HD21 ' HE2' ' A' ' 157' ' ' MET . 99.6 mt -88.2 113.69 24.07 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.712 176.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 . . . . . 0 C--N 1.325 -0.495 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.603 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo . . . . . 0 N--CA 1.454 -0.844 0 N-CA-C 110.531 -0.603 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.578 HD21 ' O ' ' A' ' 148' ' ' GLY . 45.7 tp -78.9 89.26 4.7 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.939 -174.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.525 ' HB3' HG22 ' A' ' 102' ' ' THR . 19.7 m -84.91 93.63 8.58 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.617 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.2 pt -90.21 165.07 2.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.501 HD11 ' HB2' ' A' ' 100' ' ' SER . 21.5 tp -108.69 107.02 17.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.196 0.522 . . . . 0.0 110.916 -175.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.74 107.41 19.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.365 176.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.554 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 16.5 ttm180 -84.33 105.0 14.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -175.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.546 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 50.8 t-20 . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 115.493 -0.776 . . . . 0.0 108.973 175.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.423 ' CB ' ' HB3' ' A' ' 95' ' ' ASN . 13.3 mmt180 . . . . . 0 C--O 1.229 -0.012 0 CA-C-O 121.176 0.513 . . . . 0.0 111.478 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.544 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 32.6 p -79.65 92.05 5.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.116 0.484 . . . . 0.0 109.862 176.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.4 m -86.38 123.42 31.6 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.894 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.525 HG22 ' HB3' ' A' ' 90' ' ' SER . 8.7 m -90.2 102.54 15.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.124 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -95.89 136.32 36.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.51 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -79.49 103.65 9.55 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 173.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 21.9 m -107.97 166.28 4.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -138.33 154.17 48.98 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.405 HD22 ' CA ' ' A' ' 145' ' ' GLY . 16.3 mt -60.31 -33.46 72.4 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -169.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.6 m -80.56 -7.78 59.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.371 0.605 . . . . 0.0 111.187 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -86.96 122.26 30.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 39.1 p -79.18 165.99 22.69 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.82 0.343 . . . . 0.0 111.322 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.664 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 46.6 t -64.37 -27.84 43.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.21 177.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.481 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -59.62 -45.02 93.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.15 0.5 . . . . 0.0 110.252 174.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.44 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 50.9 m80 -63.42 -37.04 85.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.382 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.626 ' HB2' HD11 ' A' ' 144' ' ' LEU . 55.5 tp -65.25 -47.14 77.79 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.672 ' HD2' ' HB2' ' A' ' 126' ' ' ASP . 5.2 tppp? -54.1 -49.26 69.5 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.966 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.794 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 34.9 tt0 -70.26 -32.56 70.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.796 -174.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 27.6 mt-30 -63.67 -39.6 94.74 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 114' ' ' LEU . 67.2 t -71.63 -38.06 65.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.895 176.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.794 ' OG ' ' HA ' ' A' ' 116' ' ' GLN . 92.0 p -72.71 -5.0 34.68 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.005 0.431 . . . . 0.0 110.555 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -94.76 -59.46 1.13 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.372 173.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.4 mp -77.33 -45.24 26.77 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.328 0.585 . . . . 0.0 111.405 -177.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 124' ' ' VAL . 8.7 mm-40 -96.8 9.6 41.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.431 -176.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -28.82 6.54 0.0 OUTLIER Glycine 0 N--CA 1.485 1.911 0 N-CA-C 121.956 3.542 . . . . 0.0 121.956 -165.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.559 ' N ' ' O ' ' A' ' 122' ' ' GLU . 48.1 t -52.15 144.95 2.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 119.852 1.826 . . . . 0.0 108.53 168.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -49.03 135.93 15.26 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.097 0.475 . . . . 0.0 112.03 -170.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.672 ' HB2' ' HD2' ' A' ' 115' ' ' LYS . 7.2 p-10 -74.4 9.55 1.66 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.514 -171.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.67 -21.86 40.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.169 0.509 . . . . 0.0 110.125 173.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.468 HD12 HG12 ' A' ' 124' ' ' VAL . 83.0 mt -91.49 -45.93 8.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.007 -171.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.573 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 34.5 p90 -83.49 102.23 11.96 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.161 0.982 . . . . 0.0 110.848 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.609 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 25.4 t90 -100.81 93.22 5.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.493 -1.231 . . . . 0.0 109.414 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.52 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 8.6 mp -79.45 115.52 19.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.199 0.523 . . . . 0.0 111.762 -173.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 25.6 p -121.33 119.23 31.57 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.75 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.535 ' HB2' HG22 ' A' ' 155' ' ' VAL . 6.7 t80 -82.06 -74.39 0.34 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.886 0.374 . . . . 0.0 110.614 177.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.66 36.45 1.38 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.377 0.608 . . . . 0.0 109.64 -175.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.95 -36.42 3.85 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.869 -177.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -91.81 144.47 29.41 Favored Pre-proline 0 C--O 1.237 0.447 0 CA-C-O 120.581 0.229 . . . . 0.0 111.037 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -76.83 137.11 17.48 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.873 2.382 . . . . 0.0 111.541 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 71.2 mt -77.81 133.92 38.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.732 -177.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.505 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 44.2 mt-10 -76.12 139.46 41.33 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.664 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 6.6 p-10 -66.92 -24.77 66.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 0.0 111.894 -173.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -76.09 -14.63 60.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.108 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.505 ' HG ' ' HB2' ' A' ' 139' ' ' GLU . 87.5 mt -86.17 146.13 42.01 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.03 -175.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 142' ' ' LEU . 2.7 Cg_exo -76.74 140.37 20.81 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.142 2.562 . . . . 0.0 111.656 175.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.626 HD11 ' HB2' ' A' ' 114' ' ' LEU . 74.8 mt -67.73 -26.38 66.11 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -175.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.405 ' CA ' HD22 ' A' ' 107' ' ' LEU . . . -56.05 -35.02 62.95 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.85 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -50.35 -56.53 10.96 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -101.25 -13.14 18.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.455 -173.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.578 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -100.2 3.46 56.82 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.932 -177.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -46.73 -31.4 2.93 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.107 0.479 . . . . 0.0 111.744 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -92.63 117.35 67.56 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 174.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -58.01 -18.59 36.48 Favored 'Trans proline' 0 N--CA 1.476 0.443 0 C-N-CA 122.66 2.24 . . . . 0.0 112.911 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 84.9 mt -94.18 7.02 46.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.788 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 29.5 t -59.78 107.39 0.6 Allowed 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 23.6 m -94.97 100.23 12.11 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.28 -174.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.535 HG22 ' HB2' ' A' ' 133' ' ' PHE . 42.3 t -87.1 115.5 27.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.5 176.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.554 ' CE2' ' HD2' ' A' ' 94' ' ' ARG . 74.0 m-85 -79.28 117.97 20.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.904 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.546 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 52.6 ttm -80.47 83.4 6.29 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 174.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.609 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 1.9 m-20 -73.0 98.88 2.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.797 -174.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 91.6 mt -75.24 103.78 5.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.03 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.457 179.791 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 N--CA 1.451 -0.998 0 CA-C-O 121.052 0.355 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.596 HD21 ' O ' ' A' ' 148' ' ' GLY . 61.9 tp -112.4 111.45 22.31 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.585 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.4 t -85.72 114.61 22.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.666 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.4 pt -109.19 163.09 6.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.93 176.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.494 HD11 ' HB2' ' A' ' 100' ' ' SER . 27.0 tp -115.33 110.71 19.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.025 0.44 . . . . 0.0 110.724 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.8 t -104.68 109.21 26.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.284 0.564 . . . . 0.0 110.583 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 94' ' ' ARG . 16.3 ttt180 -92.61 116.93 29.44 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.385 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.515 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 30.4 p-10 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 121.777 0.799 . . . . 0.0 111.517 -174.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 94' ' ' ARG . 32.2 ttt180 . . . . . 0 N--CA 1.456 -0.174 0 CA-C-O 121.222 0.534 . . . . 0.0 111.743 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.494 ' HB2' HD11 ' A' ' 92' ' ' LEU . 12.6 p -88.31 92.07 9.03 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 171.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.2 m -83.32 124.66 30.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.697 -173.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.2 m -91.58 113.43 25.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.93 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -115.05 132.82 56.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.885 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -107.15 97.5 7.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.259 0.552 . . . . 0.0 111.1 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.9 m -104.15 -179.5 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.54 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.599 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 33.2 ttm180 -110.46 125.06 52.88 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 174.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.525 ' HB2' ' HA3' ' A' ' 145' ' ' GLY . 1.4 pp -62.88 -6.59 3.92 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -173.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 m -86.76 0.72 54.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.726 0.298 . . . . 0.0 110.926 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.599 ' HG2' ' O ' ' A' ' 106' ' ' ARG . 2.5 pt20 -92.66 158.86 15.72 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.0 m -87.43 154.29 20.77 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 30.3 t -58.18 -25.68 27.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.094 0.474 . . . . 0.0 110.844 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.56 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -60.84 -34.32 74.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.215 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.567 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 17.1 t-80 -72.34 -46.77 54.08 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.471 ' HA ' ' NE2' ' A' ' 117' ' ' GLN . 59.5 tp -47.83 -45.97 30.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.063 173.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.515 ' HE2' ' HB2' ' A' ' 126' ' ' ASP . 48.5 tttt -61.13 -41.9 97.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.627 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 18.1 tm0? -67.02 -39.72 87.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.985 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.567 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 18.6 mt-30 -57.15 -46.23 82.92 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.35 0.595 . . . . 0.0 109.867 176.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 63.8 t -65.49 -36.36 77.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.899 175.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.455 ' C ' ' HA2' ' A' ' 123' ' ' GLY . 62.4 m -67.88 -8.2 34.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.259 177.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -98.69 -61.93 0.87 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.63 173.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 88.7 mt -71.09 -41.4 70.69 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.494 0.664 . . . . 0.0 111.335 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 124' ' ' VAL . 6.0 mm-40 -100.06 11.07 40.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.814 -177.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.455 ' HA2' ' C ' ' A' ' 119' ' ' SER . . . -27.87 7.3 0.0 OUTLIER Glycine 0 N--CA 1.488 2.117 0 N-CA-C 122.334 3.694 . . . . 0.0 122.334 -157.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' A' ' 122' ' ' GLU . 44.3 t -51.57 141.71 4.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 119.928 1.864 . . . . 0.0 108.576 165.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -45.6 137.99 4.81 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -173.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.753 ' HA ' ' CE2' ' A' ' 129' ' ' PHE . 4.1 p-10 -63.77 -22.95 67.16 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.363 -172.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -73.82 -21.79 60.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.296 0.57 . . . . 0.0 110.657 178.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.505 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 93.4 mt -83.24 -17.25 43.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.837 -174.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.753 ' CE2' ' HA ' ' A' ' 126' ' ' ASP . 38.7 p90 -112.36 124.26 52.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.974 0.892 . . . . 0.0 111.45 175.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.706 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 49.9 t90 -112.68 92.55 4.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.688 177.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.707 HD23 ' H ' ' A' ' 131' ' ' LEU . 2.6 pt? -97.2 144.01 27.44 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.004 -177.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.36 150.23 36.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.249 0.547 . . . . 0.0 111.393 -178.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.532 ' HB2' HG22 ' A' ' 155' ' ' VAL . 5.1 t80 -112.69 -58.52 2.14 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.911 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.34 -20.26 23.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.501 -175.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 136.87 -19.69 3.48 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -171.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -102.25 149.41 36.6 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 114.334 -0.933 . . . . 0.0 109.202 174.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 131' ' ' LEU . 59.0 Cg_endo -72.02 0.35 7.34 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.699 2.266 . . . . 0.0 112.312 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.4 mt 69.61 115.83 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 O-C-N 123.931 0.769 . . . . 0.0 110.03 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.692 ' HB2' ' CD2' ' A' ' 142' ' ' LEU . 7.3 mm-40 -72.04 137.9 47.5 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.457 -177.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.566 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 5.7 p-10 -77.46 33.49 0.16 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.392 -176.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -118.63 -21.89 7.72 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.228 0.537 . . . . 0.0 109.789 -178.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.692 ' CD2' ' HB2' ' A' ' 139' ' ' GLU . 0.6 OUTLIER -95.95 153.97 39.08 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.261 -173.253 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.01 136.6 53.28 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.402 2.068 . . . . 0.0 110.999 173.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.424 ' O ' HD23 ' A' ' 144' ' ' LEU . 6.9 tt -60.78 -32.39 71.71 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.258 -176.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.525 ' HA3' ' HB2' ' A' ' 107' ' ' LEU . . . -60.42 -28.21 66.93 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 116.094 -0.503 . . . . 0.0 113.33 -178.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -61.67 -37.3 83.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.937 0.399 . . . . 0.0 110.814 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -100.77 -32.74 10.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.756 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.596 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -98.99 5.83 59.71 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.742 -172.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.5 pt? -45.2 -29.93 1.07 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.442 ' C ' ' H ' ' A' ' 152' ' ' LEU . 48.7 tttp -79.73 121.16 82.09 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 21.4 Cg_exo -67.25 12.86 0.17 Allowed 'Trans proline' 0 N--CA 1.476 0.457 0 C-N-CA 123.088 2.525 . . . . 0.0 112.789 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.442 ' H ' ' C ' ' A' ' 150' ' ' LYS . 26.5 tp -137.5 20.28 2.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.409 0.624 . . . . 0.0 109.417 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.0 p -67.37 118.77 11.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.142 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.7 m -97.19 111.06 23.46 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.999 -175.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 133' ' ' PHE . 39.9 t -100.86 129.29 52.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.609 177.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 131' ' ' LEU . 94.7 m-85 -95.07 110.21 22.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.822 0.344 . . . . 0.0 110.818 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.515 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 23.6 ttt -82.18 97.38 8.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.854 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.706 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 50.7 m-80 -90.6 136.2 33.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.323 -178.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 90.3 mt -104.54 81.6 1.81 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.488 -0.189 . . . . 0.0 110.488 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 128' ' ' LEU . 1.9 mmp_? . . . . . 0 N--CA 1.466 0.369 0 O-C-N 123.792 0.682 . . . . 0.0 111.306 -176.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo . . . . . 0 C--O 1.237 0.464 0 CA-C-O 121.166 0.403 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.587 HD21 ' O ' ' A' ' 148' ' ' GLY . 31.7 tp -105.69 116.36 31.82 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.246 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.428 ' HB3' ' OG1' ' A' ' 102' ' ' THR . 16.0 m -94.57 107.23 19.22 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.469 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 102' ' ' THR . 35.4 pt -99.06 160.93 3.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 154' ' ' THR . 36.7 tp -106.19 116.07 31.3 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.762 -176.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.1 t -104.37 121.49 56.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.461 ' HD2' ' CE1' ' A' ' 156' ' ' PHE . 18.4 ttm180 -106.54 107.01 17.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.188 -177.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.581 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 40.4 m-20 . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.52 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.5 ' NE ' ' HA ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 120.425 0.155 . . . . 0.0 111.132 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.3 m -94.15 86.15 4.88 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.4 t -104.8 129.96 52.99 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.109 -176.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 10.8 t -76.92 143.58 39.45 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 173.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -121.37 133.03 55.09 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.293 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -83.19 108.07 16.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.931 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.88 -179.18 3.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.491 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -121.47 178.84 4.65 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 173.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.61 -32.18 19.43 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.2 m -89.51 64.67 6.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.308 0.575 . . . . 0.0 110.74 -178.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -163.72 163.54 24.12 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.181 173.374 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 32.6 p -96.94 162.18 13.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.803 0.335 . . . . 0.0 111.332 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 45.3 t -57.51 -21.39 15.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.843 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.599 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -50.49 -46.33 56.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.557 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -81.57 -0.83 44.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.513 -175.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.581 ' HB2' HD11 ' A' ' 144' ' ' LEU . 43.7 tp -100.34 -47.33 4.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.437 0.637 . . . . 0.0 109.721 172.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -63.2 -27.33 69.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.628 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.882 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 0.9 OUTLIER -78.11 -23.26 47.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.521 177.357 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -68.56 -43.87 75.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.3 -43.73 98.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.872 174.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.882 ' OG ' ' HA ' ' A' ' 116' ' ' GLN . 7.9 p -76.38 -1.74 28.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.776 0.322 . . . . 0.0 111.435 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -88.35 -36.31 8.21 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.779 172.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 mp -99.94 -58.46 1.91 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.446 0.641 . . . . 0.0 111.197 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 124' ' ' VAL . 4.0 mm-40 -91.28 9.22 32.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.919 -177.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.851 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -49.26 7.72 0.01 OUTLIER Glycine 0 N--CA 1.469 0.851 0 N-CA-C 117.788 1.875 . . . . 0.0 117.788 -173.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.454 ' O ' HD22 ' A' ' 128' ' ' LEU . 94.6 t -47.26 86.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 CA-C-N 117.965 0.883 . . . . 0.0 111.742 172.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.41 ' O ' HD22 ' A' ' 128' ' ' LEU . 93.9 mt-30 59.29 119.26 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.61 0.719 . . . . 0.0 112.59 -178.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -78.85 57.01 2.02 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -147.63 -43.47 0.17 Allowed 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.435 -175.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.577 HD23 ' N ' ' A' ' 129' ' ' PHE . 0.9 OUTLIER -72.15 -22.58 61.29 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -169.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.577 ' N ' HD23 ' A' ' 128' ' ' LEU . 37.9 p90 -105.1 147.77 27.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.221 0.534 . . . . 0.0 111.313 -176.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.534 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 39.2 t90 -141.1 98.07 3.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.969 -175.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.547 ' HB3' ' HA ' ' A' ' 157' ' ' MET . 2.5 pp -99.13 138.55 36.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.152 0.501 . . . . 0.0 111.322 -174.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 38.8 p -136.2 150.98 49.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.098 -174.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.402 ' CD2' ' HB3' ' A' ' 147' ' ' TYR . 30.4 t80 -116.43 -70.37 0.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.026 0.441 . . . . 0.0 110.8 175.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -87.43 30.95 0.76 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.444 0.64 . . . . 0.0 110.469 -173.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.17 -3.53 71.24 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -172.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -115.54 143.67 30.98 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 115.036 -0.582 . . . . 0.0 109.476 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.55 137.79 51.92 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.267 1.978 . . . . 0.0 111.06 173.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.457 ' HB3' HG21 ' A' ' 111' ' ' VAL . 87.2 mt -81.7 106.77 13.9 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.059 0.457 . . . . 0.0 110.483 -178.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.552 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 42.7 mt-10 -71.96 141.76 49.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.935 177.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.599 ' HB2' ' HB2' ' A' ' 112' ' ' ALA . 4.1 p-10 -73.03 -5.78 41.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.97 0.414 . . . . 0.0 111.15 -177.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -83.49 -15.72 48.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.485 173.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.552 ' HG ' ' HB2' ' A' ' 139' ' ' GLU . 82.8 mt -91.32 144.29 29.54 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.037 -176.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 109' ' ' GLN . 6.3 Cg_exo -79.88 138.98 13.52 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.154 2.569 . . . . 0.0 111.612 174.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.581 HD11 ' HB2' ' A' ' 114' ' ' LEU . 33.6 mt -68.83 -40.2 79.57 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -177.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.26 -30.2 31.67 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.166 -0.54 . . . . 0.0 113.923 -175.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -66.25 -32.94 74.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.927 0.394 . . . . 0.0 110.899 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.402 ' HB3' ' CD2' ' A' ' 133' ' ' PHE . 89.0 m-85 -101.06 -32.23 10.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.36 0.6 . . . . 0.0 110.899 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.587 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -97.06 6.54 64.06 Favored Glycine 0 C--O 1.223 -0.531 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.809 -170.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.407 ' HG ' ' HG3' ' A' ' 150' ' ' LYS . 2.6 pt? -44.82 -24.54 0.22 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.498 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 67.7 mttt -102.23 131.0 23.08 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.497 177.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 12.8 Cg_exo -69.93 9.63 0.6 Allowed 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.197 2.598 . . . . 0.0 112.449 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.9 pp -119.93 0.0 10.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.586 178.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.6 m -61.83 110.87 1.66 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.895 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 29.3 m -95.6 114.38 26.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.03 -176.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.51 118.63 37.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.13 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.461 ' CE1' ' HD2' ' A' ' 94' ' ' ARG . 80.5 m-85 -90.57 113.96 26.08 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.942 0.401 . . . . 0.0 110.869 -177.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.581 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 2.0 tmt? -88.19 97.7 11.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.3 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.534 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 92.2 m-20 -97.49 176.93 5.69 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.646 -173.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.476 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 96.0 mt -120.33 133.27 55.48 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.918 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 159' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.943 0 O-C-N 124.132 0.895 . . . . 0.0 112.389 -174.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.432 ' C ' ' HD3' ' A' ' 88' ' ' PRO . 4.6 p-10 . . . . . 0 N--CA 1.461 0.124 0 CA-C-O 120.635 0.255 . . . . 0.0 111.585 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.698 ' HB2' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -118.55 75.62 12.68 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.432 ' HD3' ' C ' ' A' ' 86' ' ' ASP . 8.7 Cg_endo -88.16 110.75 0.66 Allowed 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.006 2.471 . . . . 0.0 111.644 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.613 HD23 HD11 ' A' ' 107' ' ' LEU . 0.2 OUTLIER -96.19 123.27 39.75 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.316 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -95.33 101.87 13.63 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.438 HG23 HD12 ' A' ' 89' ' ' LEU . 46.7 pt -108.33 164.08 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.105 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 154' ' ' THR . 32.2 tp -108.87 120.96 44.05 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.273 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 90.4 t -116.95 117.39 55.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.003 0.43 . . . . 0.0 110.173 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.563 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 23.2 ttt180 -96.61 133.14 41.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.632 -177.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -76.44 91.85 3.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.705 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.2 p30 42.27 -76.39 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.244 1.418 . . . . 0.0 114.301 -174.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -123.39 -15.29 7.2 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 122.039 -0.413 . . . . 0.0 110.775 -176.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -84.55 -124.66 1.23 Allowed Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.989 -0.55 . . . . 0.0 113.761 -170.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -79.93 143.64 34.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.254 0.55 . . . . 0.0 111.501 -173.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 15.0 m -95.02 102.06 13.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.414 173.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.8 m -95.45 136.41 35.86 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.042 0.448 . . . . 0.0 110.691 -176.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.3 m -85.97 124.78 32.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.073 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.516 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 43.5 m-85 -111.07 145.71 38.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.974 0.416 . . . . 0.0 111.376 -176.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -95.15 95.86 8.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.45 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.4 m -109.37 -179.79 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.842 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.433 ' HB3' ' OE1' ' A' ' 87' ' ' GLU . 20.1 mtm180 -138.78 166.11 25.25 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.698 HD13 ' HB2' ' A' ' 87' ' ' GLU . 6.9 mp -80.44 -23.4 40.32 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.7 p -76.31 -16.91 59.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.107 174.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -85.07 138.29 32.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.091 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.717 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 38.7 p -88.1 163.71 16.09 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 175.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.615 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 3.4 t -64.14 -27.31 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.274 0.559 . . . . 0.0 109.788 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.15 -37.83 88.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.742 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -70.86 -33.99 71.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.574 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.423 HD22 HD11 ' A' ' 144' ' ' LEU . 65.7 tp -61.3 -46.07 91.85 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 173.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -59.36 -39.97 84.96 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.186 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -66.96 -32.19 73.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.306 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -62.03 -51.22 68.89 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.97 0.89 . . . . 0.0 109.134 174.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.4 t -62.3 -32.03 53.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.848 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.648 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 49.9 m -65.12 -27.58 68.84 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.807 0.337 . . . . 0.0 111.082 177.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.01 -35.02 54.64 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.679 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 75.4 mt -93.46 -67.53 0.85 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.408 0.623 . . . . 0.0 112.001 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 124' ' ' VAL . 8.1 tp10 -100.47 9.9 41.94 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.788 0.835 . . . . 0.0 110.847 -172.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.648 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -44.57 7.68 0.01 OUTLIER Glycine 0 CA--C 1.532 1.139 0 N-CA-C 118.555 2.182 . . . . 0.0 118.555 -174.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 122' ' ' GLU . 59.1 t -48.26 91.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 118.428 1.114 . . . . 0.0 111.678 173.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 53.51 104.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.836 0.71 . . . . 0.0 111.698 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.653 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 4.5 p-10 -69.29 11.05 0.25 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.241 -173.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -117.62 -5.48 11.16 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 174.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 128' ' ' LEU . 44.6 mt -93.26 -31.06 14.86 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 171.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.653 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 25.0 p90 -110.14 135.05 51.54 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 172.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.471 ' HE1' ' HB3' ' A' ' 137' ' ' PRO . 4.2 t-105 -155.79 135.78 12.84 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.957 0.408 . . . . 0.0 109.937 -176.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.639 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 6.4 mp -104.67 131.79 51.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.06 0.457 . . . . 0.0 110.703 -174.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.828 HG22 ' HA ' ' A' ' 137' ' ' PRO . 19.9 p -135.22 140.59 45.4 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.681 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.697 ' CD2' ' HG3' ' A' ' 134' ' ' GLU . 6.1 t80 -106.04 -82.89 0.53 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.831 -175.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.697 ' HG3' ' CD2' ' A' ' 133' ' ' PHE . 98.6 mt-10 -77.97 25.73 0.21 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.755 0.312 . . . . 0.0 111.798 -173.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.25 -7.35 78.33 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -175.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -112.79 154.89 44.7 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.828 ' HA ' HG22 ' A' ' 132' ' ' THR . 85.9 Cg_endo -76.2 -5.78 16.58 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.851 2.367 . . . . 0.0 111.972 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 86.9 mt 62.1 176.29 0.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.053 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -104.19 101.79 11.52 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.615 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 9.9 p-10 -71.84 -9.28 58.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.938 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -68.79 -29.77 68.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.227 170.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 87.2 mt -97.28 160.83 27.99 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.876 -175.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.717 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 8.7 Cg_exo -72.09 153.71 57.36 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.76 2.306 . . . . 0.0 112.059 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.423 HD11 HD22 ' A' ' 114' ' ' LEU . 7.4 mt -70.92 -18.5 62.66 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.762 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.572 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -53.19 -44.02 63.85 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.675 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -63.96 -37.49 87.61 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -101.21 -37.1 8.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.037 0.446 . . . . 0.0 111.963 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.87 6.4 58.56 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.475 -170.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.572 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.0 pt? -47.18 -26.33 1.12 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.648 0.379 . . . . 0.0 112.014 175.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 53.6 mtmt -81.32 118.66 73.2 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.551 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 21.0 Cg_exo -66.1 -10.47 27.32 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.81 2.34 . . . . 0.0 111.412 177.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 82.9 mt -99.76 1.74 43.5 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.166 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.0 t -66.33 101.98 0.8 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.316 0.579 . . . . 0.0 109.85 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 18.0 m -90.84 92.18 8.68 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.873 -177.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 44.9 t -77.85 125.32 37.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.367 178.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -92.85 116.54 29.13 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.976 0.417 . . . . 0.0 110.604 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.639 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 1.1 tmt? -72.8 104.98 4.16 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 175.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -103.17 154.25 19.5 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.296 -173.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.5 mt -116.66 134.54 54.69 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.112 173.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 . . . . . 0 C--N 1.321 -0.671 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 175.72 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.401 ' OD2' ' HD2' ' A' ' 106' ' ' ARG . 28.6 t70 . . . . . 0 CA--C 1.518 -0.277 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -126.47 162.74 44.82 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.103 -174.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.75 111.01 0.61 Allowed 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.641 2.227 . . . . 0.0 111.794 176.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.479 HD21 ' O ' ' A' ' 148' ' ' GLY . 66.4 tp -106.71 109.09 20.91 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.983 -176.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.5 m -80.63 102.26 9.72 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.958 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.5 pt -101.83 146.11 10.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.132 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 44.2 tp -98.85 110.99 23.51 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.621 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.55 HG22 ' HB ' ' A' ' 155' ' ' VAL . 96.7 t -107.22 117.59 53.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.008 0.432 . . . . 0.0 110.359 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 26.3 ttt180 -85.64 101.25 12.56 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 176.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.486 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 0.7 OUTLIER -87.95 -176.71 5.56 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.992 0.901 . . . . 0.0 112.638 -173.684 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -70.68 175.7 4.73 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 113.728 -1.578 . . . . 0.0 108.534 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.4 mttp 64.07 15.66 9.42 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 123.633 0.773 . . . . 0.0 111.486 -172.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 59.33 67.47 2.16 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.616 -0.72 . . . . 0.0 114.086 174.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -157.55 141.39 15.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.107 0.454 . . . . 0.0 110.614 176.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 45.7 m -101.25 103.38 14.38 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.889 0.376 . . . . 0.0 110.135 177.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 m -99.22 138.36 36.43 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.647 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.4 m -90.04 115.65 27.47 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -101.0 136.27 41.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.917 0.389 . . . . 0.0 110.844 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -93.0 106.39 18.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.348 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.53 -179.54 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.225 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.401 ' HD2' ' OD2' ' A' ' 86' ' ' ASP . 58.5 mtm-85 -124.86 158.14 34.2 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 174.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.5 mp -67.1 -35.71 80.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.029 -176.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -89.87 14.65 11.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.276 0.56 . . . . 0.0 110.882 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -92.96 131.07 38.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.972 0.415 . . . . 0.0 110.004 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.634 ' HB ' ' OD1' ' A' ' 140' ' ' ASP . 3.2 p -74.03 159.21 33.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.646 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 83.3 t -63.87 -32.18 56.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.407 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.42 -41.85 73.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.79 176.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -65.18 -28.34 69.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.039 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.597 ' HB2' HD11 ' A' ' 144' ' ' LEU . 63.3 tp -82.25 -46.97 12.99 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 175.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -58.28 -46.55 85.85 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.571 -176.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -65.28 -30.81 71.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -175.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -70.21 -43.62 70.3 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.546 0.689 . . . . 0.0 109.466 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.35 -35.19 60.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.298 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.813 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 41.1 m -69.25 -18.64 63.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.942 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.68 -39.12 41.37 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.53 174.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.7 mp -95.04 -64.98 1.01 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.981 0.42 . . . . 0.0 111.852 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 124' ' ' VAL . 21.9 mm-40 -95.12 8.86 41.65 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 123.724 0.81 . . . . 0.0 111.035 -173.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.813 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -45.7 8.91 0.01 OUTLIER Glycine 0 N--CA 1.471 1.031 0 N-CA-C 119.028 2.371 . . . . 0.0 119.028 -173.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 122' ' ' GLU . 31.8 t -51.78 81.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 118.758 1.279 . . . . 0.0 112.575 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.432 ' HB2' HD12 ' A' ' 128' ' ' LEU . 23.7 mp0 60.8 118.03 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.226 1.011 . . . . 0.0 113.455 172.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -53.32 -28.78 30.2 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.293 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -76.07 -24.67 55.11 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.469 -176.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.441 HD12 HG12 ' A' ' 124' ' ' VAL . 92.2 mt -89.26 -36.41 15.62 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -174.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -113.35 140.88 47.67 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.861 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -153.47 154.68 34.85 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 172.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.593 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 6.4 mp -114.65 149.56 36.5 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.838 -175.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 66.6 p -126.0 144.65 50.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.826 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.486 ' C ' ' H ' ' A' ' 135' ' ' GLY . 73.0 t80 -129.23 140.12 51.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 168.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 69.78 -43.93 0.54 Allowed 'General case' 0 CA--C 1.536 0.416 0 O-C-N 123.833 0.708 . . . . 0.0 110.426 -176.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 133' ' ' PHE . . . 156.01 -18.8 0.48 Allowed Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -176.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -91.61 146.99 34.24 Favored Pre-proline 0 C--O 1.236 0.356 0 CA-C-N 115.315 -0.443 . . . . 0.0 109.94 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.27 147.61 66.37 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.541 2.16 . . . . 0.0 111.345 175.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 70.8 mt -70.59 108.15 4.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.789 0.328 . . . . 0.0 111.006 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -92.44 130.08 38.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.601 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.634 ' OD1' ' HB ' ' A' ' 110' ' ' THR . 36.5 t70 -72.45 -6.67 45.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.534 -175.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -74.12 -14.11 60.92 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.487 0.66 . . . . 0.0 109.904 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.469 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 88.5 mt -120.16 131.71 24.33 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.95 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 142' ' ' LEU . 28.0 Cg_exo -62.46 148.94 92.52 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.673 2.249 . . . . 0.0 112.004 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.597 HD11 ' HB2' ' A' ' 114' ' ' LEU . 83.2 mt -59.88 -25.39 65.05 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -176.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -61.16 -27.35 67.26 Favored Glycine 0 C--O 1.226 -0.396 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.505 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -72.32 -21.09 61.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.875 0.369 . . . . 0.0 111.184 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -100.3 -45.14 5.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.312 0.577 . . . . 0.0 110.606 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.479 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -100.16 6.67 58.21 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-O 119.227 -0.763 . . . . 0.0 113.973 -171.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.474 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.3 pt? -34.38 -41.32 0.11 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -176.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 88.4 tttt -91.23 119.88 68.61 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.533 ' O ' ' HB2' ' A' ' 152' ' ' LEU . 17.4 Cg_exo -66.13 81.38 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.117 2.544 . . . . 0.0 112.199 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 151' ' ' PRO . 7.3 tt 167.75 -26.56 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.787 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.3 m -45.55 125.45 5.83 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.376 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 23.9 m -97.72 120.6 38.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.303 -175.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.55 ' HB ' HG22 ' A' ' 93' ' ' VAL . 61.7 t -99.96 133.04 44.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.338 176.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -103.82 124.81 49.6 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.079 0.466 . . . . 0.0 111.045 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.593 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 25.2 ttt -81.75 131.06 35.25 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 175.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -120.51 145.21 47.52 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.109 -175.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 50.9 mt -125.16 137.73 54.15 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 160' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.607 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 177.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 . . . . . 0 CA--C 1.517 -0.316 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 27.8 mm-40 -88.08 137.4 31.3 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.756 -172.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 24.0 Cg_exo -64.95 95.47 0.24 Allowed 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.71 2.273 . . . . 0.0 111.659 175.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.464 ' HG ' HG23 ' A' ' 91' ' ' ILE . 58.0 tp -85.3 107.51 17.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.233 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.447 ' HB3' HG22 ' A' ' 102' ' ' THR . 24.3 m -87.33 102.68 14.75 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.624 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.464 HG23 ' HG ' ' A' ' 89' ' ' LEU . 36.8 pt -102.84 157.79 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.023 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 154' ' ' THR . 37.4 tp -103.51 102.99 12.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.131 0.491 . . . . 0.0 110.922 -176.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.537 HG22 ' HB ' ' A' ' 155' ' ' VAL . 58.8 t -107.46 123.78 62.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.987 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -89.55 135.04 33.83 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.125 0.488 . . . . 0.0 110.2 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.407 HD21 ' HB2' ' A' ' 99' ' ' ARG . 4.1 p30 -99.28 170.18 8.84 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.915 -176.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -69.03 -19.21 64.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.713 -175.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -79.17 2.4 21.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.914 0.388 . . . . 0.0 111.16 177.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.38 -9.65 69.39 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.145 -0.55 . . . . 0.0 113.272 171.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.407 ' HB2' HD21 ' A' ' 95' ' ' ASN . 33.5 mtp180 -83.93 160.61 21.04 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.131 0.491 . . . . 0.0 111.417 -176.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.1 m -113.54 106.97 15.18 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.15 176.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.8 m -106.16 130.62 54.01 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.213 0.53 . . . . 0.0 111.004 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.447 HG22 ' HB3' ' A' ' 90' ' ' SER . 23.5 m -86.54 105.04 16.55 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.451 177.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.484 ' CD2' ' HB ' ' A' ' 93' ' ' VAL . 87.4 m-85 -91.27 134.23 34.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.744 -177.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -89.48 95.63 10.36 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.42 HG11 HD13 ' A' ' 114' ' ' LEU . 31.6 m -109.44 163.67 6.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.595 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.579 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 0.7 OUTLIER -110.98 146.97 35.72 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 173.154 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.511 HD23 ' HA3' ' A' ' 145' ' ' GLY . 6.7 mp -60.74 -35.41 76.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.719 -172.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 8.8 p -98.73 9.48 43.27 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -172.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.579 ' HG2' ' O ' ' A' ' 106' ' ' ARG . 10.0 pt20 -81.07 -8.93 59.87 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.653 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.6 p 64.19 159.11 0.09 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.066 1.346 . . . . 0.0 111.346 -175.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.581 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 48.4 t -63.85 -21.02 27.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.052 0.454 . . . . 0.0 109.979 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.57 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -58.21 -41.53 84.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.869 176.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -69.74 -36.51 75.9 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 120.745 0.307 . . . . 0.0 110.325 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.42 HD13 HG11 ' A' ' 105' ' ' VAL . 62.3 tp -66.92 -43.61 82.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.891 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -65.82 -28.18 68.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.349 178.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.513 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 35.0 tt0 -76.01 -34.77 59.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.588 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -60.21 -48.71 80.6 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.797 0.808 . . . . 0.0 108.909 171.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.46 -40.66 84.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.032 174.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.846 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 25.2 p -66.07 -14.75 62.27 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.843 0.354 . . . . 0.0 111.08 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.17 -44.03 8.34 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.656 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.3 mt -91.15 -59.9 2.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.044 0.45 . . . . 0.0 112.197 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 124' ' ' VAL . 4.4 tp10 -100.38 9.42 42.67 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 123.524 0.73 . . . . 0.0 110.396 -174.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.846 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -45.71 7.95 0.01 OUTLIER Glycine 0 N--CA 1.473 1.108 0 N-CA-C 118.69 2.236 . . . . 0.0 118.69 -172.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 122' ' ' GLU . 40.6 t -49.46 85.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 118.167 0.984 . . . . 0.0 112.276 174.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.409 ' HB2' HD12 ' A' ' 128' ' ' LEU . 2.3 mp0 56.29 106.81 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.586 0.754 . . . . 0.0 112.241 176.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -51.26 -24.17 4.21 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.746 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -81.51 -20.71 39.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.01 -175.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.461 HD12 HG12 ' A' ' 124' ' ' VAL . 96.7 mt -81.46 -14.84 56.58 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -175.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.417 ' HB3' HD23 ' A' ' 159' ' ' LEU . 54.4 p90 -133.82 151.11 51.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.451 0.643 . . . . 0.0 111.816 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.414 ' HD1' ' HB3' ' A' ' 137' ' ' PRO . 0.8 OUTLIER -149.25 157.07 43.04 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 172.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.651 HD12 HG11 ' A' ' 155' ' ' VAL . 1.3 pt? -123.57 135.85 54.21 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.727 -172.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 41.3 p -116.19 131.7 56.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.845 -178.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.553 ' CE2' ' HB2' ' A' ' 134' ' ' GLU . 8.4 t80 -94.16 -89.67 0.22 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.523 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.553 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 10.8 tt0 -98.42 25.44 6.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.561 0.696 . . . . 0.0 110.385 -170.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 133.25 -37.43 2.0 Allowed Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.75 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 54.3 mmtt -117.18 156.21 48.85 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 120.54 0.209 . . . . 0.0 110.917 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 132' ' ' THR . 48.2 Cg_endo -69.25 152.99 71.94 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.121 2.547 . . . . 0.0 112.79 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.463 ' HB3' HG21 ' A' ' 111' ' ' VAL . 85.9 mt -94.6 121.72 36.45 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.767 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -84.81 146.09 27.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.589 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.581 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 6.7 p-10 -61.22 -22.05 64.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.54 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -73.42 -15.78 61.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.176 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 77.1 mt -102.14 140.17 20.93 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 121.121 0.486 . . . . 0.0 111.516 -172.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 142' ' ' LEU . 12.7 Cg_exo -71.23 144.1 45.53 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.983 2.456 . . . . 0.0 111.08 173.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.643 HD12 ' H ' ' A' ' 144' ' ' LEU . 4.1 mp -71.54 -33.9 69.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.998 -174.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.511 ' HA3' HD23 ' A' ' 107' ' ' LEU . . . -59.63 -30.29 68.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.286 -0.483 . . . . 0.0 113.686 -172.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.65 -41.26 94.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.049 0.452 . . . . 0.0 111.029 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -101.55 -30.2 11.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.529 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.445 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -98.97 6.73 60.24 Favored Glycine 0 C--O 1.227 -0.299 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.625 -172.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -41.09 -31.22 0.18 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -92.71 126.54 51.47 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.295 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -68.15 6.38 0.88 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.958 2.439 . . . . 0.0 112.922 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 97.7 mt -112.24 7.41 19.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.05 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.4 p -62.39 117.94 6.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.943 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 15.0 m -101.51 106.66 17.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.408 -175.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.651 HG11 HD12 ' A' ' 131' ' ' LEU . 25.6 t -99.33 140.09 19.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.427 177.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -109.81 118.3 36.13 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.434 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 2.1 ttm -81.37 106.49 13.37 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -98.82 135.03 40.87 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.741 -172.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.417 HD23 ' HB3' ' A' ' 129' ' ' PHE . 49.1 mt -102.88 -167.68 1.42 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.638 173.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 . . . . . 0 N--CA 1.466 0.369 0 CA-C-O 121.85 0.833 . . . . 0.0 111.754 174.482 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 . . . . . 0 N--CA 1.467 0.4 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -75.47 116.48 55.23 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -82.49 84.53 1.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.309 2.006 . . . . 0.0 110.863 174.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.9 tp -84.21 110.66 18.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.333 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.7 m -88.64 112.91 23.64 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.061 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 36.5 pt -107.08 134.75 47.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.529 HD11 ' HB3' ' A' ' 100' ' ' SER . 30.2 tp -93.1 101.37 13.67 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.593 -174.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.9 t -84.7 99.8 7.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -97.39 93.93 6.77 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.703 -174.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.593 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 6.1 p30 -79.16 136.37 37.09 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.408 -177.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 97' ' ' LYS . 27.2 t-20 67.98 -77.32 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.24 -171.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 96' ' ' ASN . 17.2 ptpt 168.68 -23.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.98 0.912 . . . . 0.0 109.771 174.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -81.21 -38.6 14.64 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.563 -0.827 . . . . 0.0 113.0 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -93.67 106.76 18.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.986 0.422 . . . . 0.0 111.651 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.529 ' HB3' HD11 ' A' ' 92' ' ' LEU . 18.6 m -96.5 109.04 21.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.867 174.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.2 m -111.89 112.69 24.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.108 0.48 . . . . 0.0 110.638 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.4 m -76.66 121.92 23.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.515 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -111.81 132.13 54.88 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.96 0.41 . . . . 0.0 110.553 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -81.98 130.4 35.06 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.734 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.2 m -146.36 -179.96 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.765 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 39.7 mtm-85 -138.35 169.96 16.86 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.175 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.9 mp -73.03 -10.47 59.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.779 0.323 . . . . 0.0 111.43 -175.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 m -85.73 0.46 52.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.221 0.534 . . . . 0.0 110.669 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.489 ' HB3' HD12 ' A' ' 144' ' ' LEU . 13.3 mm100 -86.58 136.46 33.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.089 0.471 . . . . 0.0 111.521 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.5 p -94.7 166.83 11.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.231 175.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 64.2 t -60.39 -40.61 84.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.088 0.471 . . . . 0.0 109.731 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.418 ' O ' ' HG3' ' A' ' 116' ' ' GLN . . . -53.74 -48.35 69.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.898 173.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.457 ' HB3' ' NE2' ' A' ' 109' ' ' GLN . 3.6 m170 -63.71 -25.77 68.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.835 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.769 ' HB2' HD11 ' A' ' 144' ' ' LEU . 63.7 tp -83.48 -43.18 16.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.915 0.388 . . . . 0.0 110.181 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -60.15 -37.98 81.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.545 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 112' ' ' ALA . 55.5 mt-30 -64.93 -38.19 90.14 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 122.955 0.159 . . . . 0.0 111.41 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -63.37 -50.09 71.3 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.12 0.486 . . . . 0.0 109.786 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.4 t -57.34 -44.29 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.753 174.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.727 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 66.6 m -62.25 -22.2 65.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.086 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.61 -39.53 21.22 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.28 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -94.74 -64.9 1.02 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.1 0.476 . . . . 0.0 111.828 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -100.41 8.55 43.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.135 -174.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.727 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -55.81 7.26 0.01 OUTLIER Glycine 0 CA--C 1.521 0.466 0 N-CA-C 116.481 1.353 . . . . 0.0 116.481 -172.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 64.4 t -41.82 92.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 123.552 0.741 . . . . 0.0 111.777 173.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.809 ' HA ' HE21 ' A' ' 125' ' ' GLN . 0.0 OUTLIER 52.97 106.23 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 O-C-N 123.858 0.724 . . . . 0.0 111.744 -178.176 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.629 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 9.2 p-10 -69.11 1.9 3.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.439 0.638 . . . . 0.0 110.403 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -75.53 -33.63 60.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.676 169.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 93.5 mt -79.34 -33.37 43.12 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.323 -173.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.629 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 52.2 p90 -105.78 121.4 43.97 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.658 -0.817 . . . . 0.0 112.045 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.552 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 37.2 t90 -132.29 104.22 6.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.369 176.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.721 HD23 ' H ' ' A' ' 131' ' ' LEU . 2.4 pt? -96.77 140.69 30.97 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.496 0.665 . . . . 0.0 112.046 -170.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 76.8 p -128.05 144.97 51.13 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.067 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -109.02 -72.0 0.74 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.645 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.615 ' HB3' ' HG2' ' A' ' 136' ' ' LYS . 24.2 tt0 -92.29 32.61 1.16 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.535 -171.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.9 11.53 85.12 Favored Glycine 0 CA--C 1.509 -0.343 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -169.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.615 ' HG2' ' HB3' ' A' ' 134' ' ' GLU . 0.5 OUTLIER -134.2 149.56 71.72 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 114.474 -0.863 . . . . 0.0 109.328 -178.379 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.78 150.59 78.98 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.175 1.917 . . . . 0.0 111.115 173.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 76.1 mt -74.21 109.28 7.58 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.82 122.17 26.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.741 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.4 53.06 1.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 122.191 0.995 . . . . 0.0 110.569 -176.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.77 ' HG3' ' HG ' ' A' ' 142' ' ' LEU . 3.6 pt20 -129.97 -7.95 4.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.823 175.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.77 ' HG ' ' HG3' ' A' ' 141' ' ' GLN . 81.2 mt -127.22 157.01 73.76 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.781 -175.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.68 145.5 25.96 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.1 1.866 . . . . 0.0 111.789 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.769 HD11 ' HB2' ' A' ' 114' ' ' LEU . 79.6 mt -62.2 -23.01 66.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.468 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -57.67 -34.87 71.41 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.326 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -77.47 -24.09 50.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.233 0.517 . . . . 0.0 110.988 -176.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -91.11 -39.0 12.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.302 0.573 . . . . 0.0 110.629 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.05 6.37 59.9 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.655 -172.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -41.41 -32.18 0.3 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.462 ' HG2' ' H ' ' A' ' 152' ' ' LEU . 24.7 ttmm -83.18 114.98 56.62 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 173.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 16.8 Cg_exo -68.52 20.58 0.14 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.566 2.844 . . . . 0.0 113.427 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.462 ' H ' ' HG2' ' A' ' 150' ' ' LYS . 54.3 mt -146.93 19.73 1.27 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.588 177.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.8 p -64.97 127.27 30.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.752 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.3 m -94.59 100.72 12.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.904 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.4 t -92.6 111.49 24.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -79.13 102.35 8.41 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.042 -175.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.593 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 22.8 ttt -76.44 90.91 3.28 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.552 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 11.2 m120 -74.5 131.03 40.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.391 -173.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 76.6 mt -96.92 114.66 26.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.144 0.497 . . . . 0.0 110.164 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.785 -176.879 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.5 t70 . . . . . 0 CA--C 1.515 -0.377 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 64.75 81.18 0.22 Allowed Pre-proline 0 N--CA 1.455 -0.21 0 CA-C-N 113.191 -1.822 . . . . 0.0 112.836 169.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.92 132.52 15.63 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.682 2.254 . . . . 0.0 111.047 169.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.643 HD21 ' O ' ' A' ' 148' ' ' GLY . 55.1 tp -92.22 155.82 17.73 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 103' ' ' TYR . 6.5 t -131.61 130.7 42.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.885 0.374 . . . . 0.0 110.013 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.465 HD12 HG21 ' A' ' 155' ' ' VAL . 35.4 pt -127.88 150.71 33.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.847 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.45 HD11 ' HB2' ' A' ' 100' ' ' SER . 50.6 tp -93.24 113.7 25.97 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.0 0.428 . . . . 0.0 110.762 -177.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 63.6 t -98.62 113.47 33.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.742 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -110.73 114.98 28.76 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.763 -177.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.421 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 29.3 p30 -94.68 136.43 35.0 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.287 -178.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 17.52 -80.83 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 115.57 1.692 . . . . 0.0 115.57 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.7 OUTLIER -139.13 8.92 2.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.928 0.394 . . . . 0.0 111.134 -165.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -122.03 -78.49 0.47 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.366 -1.397 . . . . 0.0 114.772 -170.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -111.29 136.65 50.08 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.261 0.553 . . . . 0.0 112.455 -164.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.45 ' HB2' HD11 ' A' ' 92' ' ' LEU . 12.7 p -115.86 106.51 13.91 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 167.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.0 t -118.24 133.01 56.26 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.993 0.425 . . . . 0.0 110.74 -175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.72 100.69 13.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.119 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 90' ' ' SER . 84.5 m-85 -90.66 166.04 13.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.834 0.349 . . . . 0.0 111.093 -176.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -103.97 128.98 51.52 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.374 0.606 . . . . 0.0 110.906 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.2 m -139.56 -179.44 2.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.713 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.47 ' HB2' ' HG2' ' A' ' 109' ' ' GLN . 67.8 mtp85 -132.13 164.42 26.33 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 174.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 107' ' ' LEU . 6.7 mp -82.23 -39.14 23.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.016 0.436 . . . . 0.0 110.135 176.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.1 m -92.12 66.15 4.85 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.292 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.47 ' HG2' ' HB2' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -156.43 157.99 36.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.789 174.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.523 ' HB ' ' O ' ' A' ' 140' ' ' ASP . 14.8 p -88.58 144.92 26.01 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.651 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 47.2 t -56.73 -19.25 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 120.925 0.393 . . . . 0.0 111.224 -177.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -55.81 -34.64 65.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.947 0.403 . . . . 0.0 110.713 173.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -74.23 -15.62 60.99 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.204 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.714 HD22 HD11 ' A' ' 144' ' ' LEU . 65.3 tp -92.46 -53.24 4.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.033 0.444 . . . . 0.0 110.028 174.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -61.44 -40.02 92.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.53 -173.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -69.1 -31.8 70.77 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.073 -0.251 . . . . 0.0 111.478 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -68.27 -44.81 74.72 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.87 -35.67 61.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.548 173.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.769 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 62.3 m -72.49 -14.96 61.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.451 178.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.76 -39.36 21.16 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.438 175.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.1 mp -94.85 -64.39 1.07 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.132 0.491 . . . . 0.0 111.8 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -96.81 8.3 44.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.62 -173.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.769 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -54.35 7.66 0.01 OUTLIER Glycine 0 CA--C 1.522 0.531 0 N-CA-C 118.02 1.968 . . . . 0.0 118.02 -169.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.471 HG12 HD12 ' A' ' 128' ' ' LEU . 57.7 t -43.23 93.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 118.122 0.961 . . . . 0.0 112.316 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 57.37 109.11 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.605 0.762 . . . . 0.0 111.753 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.466 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 39.1 t70 -60.22 -6.67 1.54 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.639 -176.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -96.48 -19.29 19.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.666 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.471 HD12 HG12 ' A' ' 124' ' ' VAL . 64.9 mt -79.04 -39.78 33.07 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.716 -176.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.466 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 29.6 p90 -96.59 94.71 7.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.948 0.88 . . . . 0.0 111.447 -177.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.665 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 34.1 t90 -90.12 87.6 6.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.29 176.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.604 HD23 ' H ' ' A' ' 131' ' ' LEU . 2.7 pt? -88.0 139.7 30.24 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.212 0.53 . . . . 0.0 110.652 -176.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.02 159.69 44.39 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.15 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.478 ' CD2' ' HB2' ' A' ' 134' ' ' GLU . 13.5 t80 -102.71 -74.51 0.63 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.934 -175.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.478 ' HB2' ' CD2' ' A' ' 133' ' ' PHE . 7.8 tp10 -98.49 21.26 11.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.176 0.512 . . . . 0.0 110.702 -171.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.36 9.17 62.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.512 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.495 ' HD3' ' O ' ' A' ' 137' ' ' PRO . 14.4 tmtt? -122.56 122.37 27.31 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.495 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 27.2 Cg_exo -58.91 152.75 55.66 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.785 2.324 . . . . 0.0 112.296 -176.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 44.8 mt -103.29 97.08 7.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.242 -174.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.42 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 2.6 mp0 -63.73 134.4 55.26 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 173.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.651 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 5.6 p-10 -65.54 -22.41 66.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.085 -174.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -81.89 -10.39 59.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.838 0.351 . . . . 0.0 111.202 -177.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.42 ' HG ' ' HB2' ' A' ' 139' ' ' GLU . 79.6 mt -90.55 157.06 44.88 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.977 -176.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 109' ' ' GLN . 3.0 Cg_exo -75.23 128.73 11.53 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.978 2.452 . . . . 0.0 111.686 177.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.714 HD11 HD22 ' A' ' 114' ' ' LEU . 5.1 tt -62.53 -36.72 83.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.33 -177.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -52.11 -28.91 27.24 Favored Glycine 0 CA--C 1.519 0.288 0 N-CA-C 114.392 0.517 . . . . 0.0 114.392 -176.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -61.63 -38.07 86.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.159 0.504 . . . . 0.0 110.481 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -100.71 -33.11 10.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.157 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.643 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -96.86 6.18 64.34 Favored Glycine 0 C--O 1.223 -0.593 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.761 -172.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.7 pt? -46.79 -25.98 0.86 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.463 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 66.6 mttm -96.84 133.89 23.79 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 17.1 Cg_exo -67.87 2.57 2.46 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.93 2.42 . . . . 0.0 111.878 176.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -124.58 11.34 8.54 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.046 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 46.7 m -60.52 110.22 1.22 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.926 0.393 . . . . 0.0 110.276 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 19.8 m -84.32 101.33 11.87 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.453 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.465 HG21 HD12 ' A' ' 91' ' ' ILE . 56.4 t -87.63 115.08 27.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.62 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -87.95 103.18 15.44 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.321 0.582 . . . . 0.0 110.745 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.421 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 26.4 ttt -77.17 87.19 3.63 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.144 -0.935 . . . . 0.0 108.842 176.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.665 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 23.3 m-80 -77.71 88.09 3.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.417 -174.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.63 94.1 3.16 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 172.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.889 -171.679 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.527 ' OD1' ' HD3' ' A' ' 106' ' ' ARG . 31.0 t70 . . . . . 0 CA--C 1.518 -0.258 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 53.67 73.84 0.86 Allowed Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.865 174.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -93.43 137.02 1.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 123.049 2.499 . . . . 0.0 112.783 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 148' ' ' GLY . 0.2 OUTLIER -97.98 125.75 43.07 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.031 177.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -89.11 99.18 12.22 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.008 0.433 . . . . 0.0 110.193 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 45.8 pt -101.6 163.72 3.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.218 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.541 HD11 ' HB3' ' A' ' 100' ' ' SER . 23.8 tp -119.2 111.27 18.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.778 0.323 . . . . 0.0 110.587 -178.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.421 HG22 ' HB ' ' A' ' 155' ' ' VAL . 61.7 t -110.38 112.55 41.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -90.24 125.2 35.4 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.929 0.395 . . . . 0.0 110.861 -177.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.496 ' HA ' ' SD ' ' A' ' 157' ' ' MET . 12.2 m-20 -67.0 150.5 49.17 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -61.16 106.01 0.56 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.665 0.269 . . . . 0.0 110.592 -176.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt 61.32 21.0 11.58 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.28 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.74 -145.62 9.58 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.081 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 99' ' ' ARG . 14.8 ptt180 -89.72 160.62 16.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.144 0.497 . . . . 0.0 111.226 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.541 ' HB3' HD11 ' A' ' 92' ' ' LEU . 12.4 m -81.95 106.87 14.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.851 175.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.0 m -85.66 103.74 14.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.153 0.501 . . . . 0.0 110.488 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.5 m -77.39 115.51 17.22 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.991 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -107.09 131.76 53.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.059 0.457 . . . . 0.0 111.79 -175.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -95.24 103.11 14.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.488 -0.778 . . . . 0.0 108.915 173.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.526 HG11 HD13 ' A' ' 114' ' ' LEU . 33.1 m -129.3 137.61 56.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.896 0.379 . . . . 0.0 111.151 -175.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.527 ' HD3' ' OD1' ' A' ' 86' ' ' ASP . 22.1 mtm180 -83.06 149.83 26.69 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.864 0.364 . . . . 0.0 110.44 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 107' ' ' LEU . 6.6 mp -69.09 -18.47 63.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.957 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.3 m -80.59 1.03 31.39 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.367 0.604 . . . . 0.0 110.763 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -92.97 152.57 19.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.483 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 p -90.36 157.46 17.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.888 172.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.618 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 59.2 t -58.94 -30.88 44.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.034 0.445 . . . . 0.0 110.865 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.551 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -55.21 -39.51 69.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.397 177.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.583 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 5.9 t60 -65.65 -37.19 85.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.134 -178.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.526 HD13 HG11 ' A' ' 105' ' ' VAL . 50.8 tp -67.69 -50.49 57.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.666 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -63.09 -38.75 92.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.093 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.927 ' HA ' HE21 ' A' ' 116' ' ' GLN . 0.0 OUTLIER -66.7 -29.17 69.09 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.089 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.583 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 26.5 mt-30 -63.47 -49.66 72.76 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 172.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 58.1 t -59.58 -49.2 84.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.811 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.878 ' HA ' ' HA3' ' A' ' 123' ' ' GLY . 67.4 m -59.51 -20.26 54.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.762 178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -79.31 -36.49 26.97 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.105 176.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 82.7 mt -96.74 -69.15 0.77 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.03 0.443 . . . . 0.0 112.098 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -97.13 7.11 47.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.358 0.599 . . . . 0.0 110.014 -176.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.878 ' HA3' ' HA ' ' A' ' 119' ' ' SER . . . -62.25 7.18 0.22 Allowed Glycine 0 C--O 1.226 -0.374 0 N-CA-C 116.334 1.294 . . . . 0.0 116.334 -170.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.414 HG12 HD12 ' A' ' 128' ' ' LEU . 59.3 t -31.08 93.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 123.911 0.884 . . . . 0.0 112.648 177.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.414 ' HB3' HE21 ' A' ' 125' ' ' GLN . 21.6 mt-30 53.31 111.78 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 O-C-N 123.913 0.758 . . . . 0.0 112.545 -176.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -63.32 -4.31 2.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.716 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -88.05 -24.68 23.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.041 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.414 HD12 HG12 ' A' ' 124' ' ' VAL . 93.7 mt -85.58 -42.35 14.44 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.542 0.21 . . . . 0.0 111.32 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.587 ' CE1' ' HA2' ' A' ' 123' ' ' GLY . 11.5 p90 -114.83 152.57 31.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.017 0.437 . . . . 0.0 110.477 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.727 ' CD1' ' HG3' ' A' ' 137' ' ' PRO . 1.0 OUTLIER -162.13 135.68 6.32 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 169.082 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.601 HD13 HG11 ' A' ' 155' ' ' VAL . 2.1 pp -98.22 144.79 27.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.309 0.576 . . . . 0.0 111.691 -173.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 25.7 p -120.09 152.05 38.15 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.721 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.517 ' HB3' HD21 ' A' ' 138' ' ' LEU . 14.7 t80 -137.11 -60.43 0.68 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.995 0.426 . . . . 0.0 110.796 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.439 ' C ' ' H ' ' A' ' 136' ' ' LYS . 1.8 tm-20 -81.79 35.62 0.42 Allowed 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.69 -29.58 2.96 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -170.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.492 ' HB2' ' HD2' ' A' ' 137' ' ' PRO . 22.7 pttp -118.05 173.68 3.12 Favored Pre-proline 0 N--CA 1.446 -0.66 0 CA-C-N 115.026 -0.587 . . . . 0.0 109.838 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.727 ' HG3' ' CD1' ' A' ' 130' ' ' TRP . 24.7 Cg_exo -62.38 171.73 5.08 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.376 2.051 . . . . 0.0 111.899 175.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.527 ' HB2' HG11 ' A' ' 111' ' ' VAL . 93.5 mt -101.92 146.06 28.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.44 -178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -74.3 112.3 10.33 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.618 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.9 p-10 -60.97 -26.79 67.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.819 -174.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -77.72 -19.67 54.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.382 -175.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 61.5 mt -93.2 156.25 40.34 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.732 0.301 . . . . 0.0 110.966 -174.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.05 136.14 54.91 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.896 2.397 . . . . 0.0 112.236 177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.507 HD11 HD22 ' A' ' 114' ' ' LEU . 3.0 tt -63.74 -35.78 81.71 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.831 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -59.04 -23.9 57.74 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.835 -0.62 . . . . 0.0 113.162 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -69.07 -30.74 69.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.002 0.401 . . . . 0.0 110.597 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -100.17 -29.24 12.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.147 0.499 . . . . 0.0 110.922 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.448 ' O ' ' HG ' ' A' ' 89' ' ' LEU . . . -100.27 5.58 57.52 Favored Glycine 0 C--O 1.219 -0.809 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.591 -174.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.405 HD23 ' N ' ' A' ' 149' ' ' LEU . 2.3 pt? -46.03 -32.61 2.91 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 22.7 tptm -97.41 116.68 65.92 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 17.4 Cg_exo -66.02 79.69 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.169 2.579 . . . . 0.0 111.806 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 49.2 tp 172.87 -25.06 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.105 -173.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.6 t -46.05 117.45 1.53 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.721 175.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 24.0 m -110.32 120.41 42.35 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.113 -175.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.601 HG11 HD13 ' A' ' 131' ' ' LEU . 42.7 t -98.19 135.9 31.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.614 177.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -111.98 124.82 53.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.811 0.339 . . . . 0.0 110.815 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.496 ' SD ' ' HA ' ' A' ' 95' ' ' ASN . 63.1 mtt -75.42 126.59 31.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.729 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -105.26 152.17 23.21 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.137 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 79.5 mt -115.77 144.91 43.31 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.413 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 160' ' ' ARG . 26.2 ttt180 . . . . . 0 C--N 1.321 -0.65 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.351 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 . . . . . 0 CA--C 1.521 -0.165 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 33.94 66.5 1.32 Allowed Pre-proline 0 N--CA 1.472 0.673 0 C-N-CA 124.446 1.098 . . . . 0.0 113.816 178.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.52 149.12 11.44 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.899 1.732 . . . . 0.0 111.915 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.537 HD21 ' O ' ' A' ' 148' ' ' GLY . 45.5 tp -110.67 123.63 50.38 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.873 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.6 m -90.55 99.66 12.65 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.008 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.4 pt -100.61 145.54 10.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' A' ' 100' ' ' SER . 23.9 tp -106.21 106.0 16.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.044 0.45 . . . . 0.0 110.256 -176.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 61.0 t -99.86 128.56 51.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.036 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.59 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 81.6 mtt180 -100.4 123.12 44.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.18 0.514 . . . . 0.0 110.875 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -67.73 169.66 9.2 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.963 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.556 ' HB3' HD12 ' A' ' 159' ' ' LEU . 19.8 p-10 -52.05 -44.38 64.24 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.618 -177.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -75.97 -38.01 57.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.751 0.31 . . . . 0.0 111.411 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 133.13 44.86 0.13 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.747 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 94' ' ' ARG . 11.6 ttm180 -104.02 123.87 48.0 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 175.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.484 ' HB3' HD11 ' A' ' 92' ' ' LEU . 43.8 m -89.49 94.21 9.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.947 0.403 . . . . 0.0 110.155 177.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.8 m -98.95 127.93 44.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.625 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.8 m -88.42 109.39 19.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.554 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -93.86 121.24 35.1 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -86.43 101.84 13.51 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.815 0.817 . . . . 0.0 109.854 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.469 HG21 HD13 ' A' ' 144' ' ' LEU . 26.2 m -111.9 -177.94 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.623 -177.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.525 ' HG2' ' H ' ' A' ' 108' ' ' THR . 41.8 ttm180 -133.35 153.68 51.38 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.516 ' CD2' HD22 ' A' ' 89' ' ' LEU . 14.3 mt -75.68 -9.11 58.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.023 0.44 . . . . 0.0 110.571 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.525 ' H ' ' HG2' ' A' ' 106' ' ' ARG . 0.2 OUTLIER -91.44 5.2 50.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.313 -177.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -122.69 161.73 23.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.824 0.345 . . . . 0.0 110.464 177.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 32.6 p -89.93 167.56 12.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.821 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.637 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 60.4 t -59.82 -31.38 47.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.057 174.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.54 ' HB2' ' HB3' ' A' ' 140' ' ' ASP . . . -57.47 -35.18 69.83 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.028 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -68.49 -17.71 64.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.153 0.502 . . . . 0.0 110.591 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.563 HD22 HD11 ' A' ' 144' ' ' LEU . 48.1 tp -100.12 -48.18 4.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.197 0.523 . . . . 0.0 110.468 176.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.2 tttm -63.19 -41.52 99.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.181 -177.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.791 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 63.5 tt0 -79.69 -17.97 52.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.062 0.458 . . . . 0.0 110.438 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -67.7 -52.79 33.61 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 51.7 t -64.59 -42.35 94.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.314 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 1.049 ' HA ' ' HA3' ' A' ' 123' ' ' GLY . 93.9 p -62.98 -32.13 73.41 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.965 0.412 . . . . 0.0 110.62 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.92 -29.3 70.96 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.862 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 78.7 mt -91.61 -77.02 0.43 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.688 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -103.26 -15.84 15.86 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -176.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 1.049 ' HA3' ' HA ' ' A' ' 119' ' ' SER . . . -42.35 -54.92 4.57 Favored Glycine 0 C--O 1.229 -0.201 0 N-CA-C 115.426 0.93 . . . . 0.0 115.426 -165.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.401 HG12 HD12 ' A' ' 128' ' ' LEU . 84.1 t 60.07 82.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.962 0.411 . . . . 0.0 110.443 -172.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.468 ' C ' ' H ' ' A' ' 127' ' ' ASP . 27.6 mt-30 58.56 112.08 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.135 -175.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.608 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 8.0 p-10 -72.69 19.34 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.059 0.457 . . . . 0.0 111.496 -176.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 125' ' ' GLN . 29.5 t70 -108.11 -25.08 11.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.278 175.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.401 HD12 HG12 ' A' ' 124' ' ' VAL . 97.9 mt -75.96 -11.54 59.98 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.091 0.472 . . . . 0.0 110.742 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.608 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 31.2 p90 -142.85 148.48 37.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.131 178.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.453 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 1.3 p90 -150.08 156.34 41.47 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.867 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 7.1 mp -112.64 149.53 32.7 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.567 -176.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.491 HG22 ' HA ' ' A' ' 137' ' ' PRO . 47.4 p -131.75 154.4 49.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.961 -178.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -139.23 130.62 26.97 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.301 171.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 70.66 -0.94 2.75 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 123.725 0.641 . . . . 0.0 111.037 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 111.59 -4.32 27.83 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.808 -174.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 137' ' ' PRO . 35.5 mtmm -106.6 134.85 19.64 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 120.627 0.251 . . . . 0.0 110.616 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.491 ' HA ' HG22 ' A' ' 132' ' ' THR . 7.6 Cg_exo -72.5 147.62 46.55 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.651 2.234 . . . . 0.0 111.266 174.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 37.7 mt -86.49 111.32 20.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.335 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -80.33 126.17 30.83 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.637 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 0.0 OUTLIER -61.18 -25.17 66.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.038 0.447 . . . . 0.0 111.036 -177.583 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 141' ' ' GLN . 11.6 pt20 -78.54 -0.43 29.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.3 -175.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 97.2 mt -120.76 151.69 54.87 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.666 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 41.1 Cg_endo -67.47 143.79 64.59 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.736 2.291 . . . . 0.0 111.568 176.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.563 HD11 HD22 ' A' ' 114' ' ' LEU . 0.5 OUTLIER -65.9 -27.3 68.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.746 -174.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.64 -28.15 56.04 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.127 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -58.32 -39.29 79.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.996 0.426 . . . . 0.0 110.954 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -100.07 -38.56 8.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.166 0.507 . . . . 0.0 111.081 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.537 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -96.06 6.54 66.62 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-O 119.223 -0.765 . . . . 0.0 114.255 -170.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -39.59 -31.73 0.11 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.469 ' C ' ' H ' ' A' ' 152' ' ' LEU . 34.6 ttpt -96.5 124.8 49.65 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 122.286 -0.259 . . . . 0.0 110.359 175.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 20.0 Cg_exo -67.92 24.3 0.13 Allowed 'Trans proline' 0 N--CA 1.477 0.547 0 C-N-CA 123.69 2.927 . . . . 0.0 113.301 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.469 ' H ' ' C ' ' A' ' 150' ' ' LYS . 34.8 tp -133.64 6.19 3.74 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.4 p -60.47 119.67 8.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.654 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.3 m -92.52 99.49 12.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.78 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 49.1 t -92.34 132.61 36.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.715 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -103.3 130.16 50.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.674 0.273 . . . . 0.0 110.746 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.867 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 26.2 ttt -85.01 97.97 10.13 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 176.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 39.2 m-80 -82.37 90.59 6.7 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.168 -173.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.556 HD12 ' HB3' ' A' ' 96' ' ' ASN . 43.6 mt -84.13 84.88 7.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.162 174.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 160' ' ' ARG . 5.1 mpt_? . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.215 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.603 ' O ' ' HD3' ' A' ' 88' ' ' PRO . 8.0 m-20 . . . . . 0 CA--C 1.519 -0.219 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -94.05 103.91 11.87 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.987 0.423 . . . . 0.0 111.638 -176.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.603 ' HD3' ' O ' ' A' ' 86' ' ' ASP . 57.9 Cg_endo -99.54 74.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.464 2.776 . . . . 0.0 111.657 176.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.471 ' HG ' HG23 ' A' ' 91' ' ' ILE . 52.9 tp -70.72 102.65 2.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.192 0.52 . . . . 0.0 110.527 -176.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.8 m -95.58 95.49 8.41 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.832 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.471 HG23 ' HG ' ' A' ' 89' ' ' LEU . 28.8 pt -102.92 156.83 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.412 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.7 tp -96.38 108.01 20.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.063 0.458 . . . . 0.0 110.599 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.511 ' HB ' ' CD1' ' A' ' 103' ' ' TYR . 57.8 t -100.34 118.06 46.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.925 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.551 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 22.6 ttt85 -104.85 108.62 20.21 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.476 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.573 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 3.9 p-10 -90.43 111.33 22.54 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.96 0.886 . . . . 0.0 111.687 -176.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.557 ' HB2' HD12 ' A' ' 159' ' ' LEU . 53.4 t30 69.62 -86.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 113.824 -1.535 . . . . 0.0 112.692 177.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -129.6 -72.25 0.59 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -172.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -106.48 25.72 22.2 Favored Glycine 0 N--CA 1.455 -0.095 0 C-N-CA 120.205 -0.998 . . . . 0.0 113.872 -166.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -132.85 95.74 3.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.288 0.565 . . . . 0.0 111.555 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 2.7 p -107.53 107.81 18.82 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.798 172.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.8 t -116.63 138.16 51.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.351 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.9 m -76.39 116.75 17.37 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.511 ' CD1' ' HB ' ' A' ' 93' ' ' VAL . 43.6 m-85 -104.37 148.46 26.38 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.978 0.418 . . . . 0.0 111.168 -177.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -102.31 110.3 22.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.016 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.4 -179.91 3.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.999 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.621 ' HB2' ' HG3' ' A' ' 109' ' ' GLN . 83.8 mtm180 -128.39 159.87 34.02 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.733 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 mp -81.27 -27.45 35.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.054 0.454 . . . . 0.0 110.13 -176.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.6 m -84.81 10.17 12.22 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.538 0.685 . . . . 0.0 110.861 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.621 ' HG3' ' HB2' ' A' ' 106' ' ' ARG . 28.3 mt-30 -95.05 143.24 26.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.641 172.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 24.9 p -79.64 156.65 27.53 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 170.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.614 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 99.3 t -59.39 -26.83 35.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.842 0.353 . . . . 0.0 110.391 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -58.1 -33.49 69.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.634 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -70.75 -43.11 69.53 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.473 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.605 ' HB2' HD11 ' A' ' 144' ' ' LEU . 64.6 tp -69.72 -37.27 76.47 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 112' ' ' ALA . 21.8 tptp -49.73 -51.43 38.9 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.82 176.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -65.19 -33.61 76.41 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.093 0.245 . . . . 0.0 111.642 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -66.47 -43.43 85.48 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.056 0.455 . . . . 0.0 110.177 174.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 114' ' ' LEU . 99.4 t -61.42 -42.6 94.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.648 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 53.8 m -60.69 -21.05 62.44 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.401 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -85.47 -27.21 33.43 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.669 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.7 mt -99.97 -66.49 0.9 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.133 0.492 . . . . 0.0 112.065 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -100.48 8.06 43.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.655 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.648 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -54.45 7.7 0.01 OUTLIER Glycine 0 CA--C 1.523 0.567 0 N-CA-C 117.186 1.634 . . . . 0.0 117.186 -172.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.1 t -31.02 95.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.852 0.861 . . . . 0.0 112.3 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 52.03 103.7 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 O-C-N 123.939 0.775 . . . . 0.0 110.855 -174.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.513 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 32.0 t70 -56.91 -13.05 2.31 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.74 -170.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -99.85 -16.21 18.13 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 60.6 mt -80.71 -13.79 58.69 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 121.964 -0.46 . . . . 0.0 112.026 -175.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.651 ' HB3' HD23 ' A' ' 159' ' ' LEU . 44.5 p90 -123.58 151.18 43.21 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.306 0.574 . . . . 0.0 111.934 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 4.0 p90 -149.38 158.13 43.91 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 172.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.74 ' HG ' ' HG2' ' A' ' 157' ' ' MET . 5.5 mp -105.64 135.54 46.86 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.165 -173.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 21.0 p -123.66 123.63 40.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.121 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -97.11 -69.65 0.75 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.914 0.387 . . . . 0.0 110.293 172.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -69.86 -31.63 69.57 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.724 0.773 . . . . 0.0 110.312 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 139.4 -24.57 2.78 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -169.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 137' ' ' PRO . 52.8 mtpt -84.99 151.68 57.78 Favored Pre-proline 0 C--O 1.236 0.362 0 CA-C-N 114.478 -0.861 . . . . 0.0 109.911 172.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 21.3 Cg_exo -66.86 133.32 31.01 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.825 2.35 . . . . 0.0 111.914 176.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 37.8 mt -67.35 120.79 14.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.052 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -73.95 120.98 20.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.385 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.614 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.1 p-10 -68.19 -16.14 63.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.283 0.563 . . . . 0.0 110.428 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -84.03 -4.08 58.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.459 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 70.0 mt -112.52 158.29 37.77 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.194 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.61 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 57.6 Cg_endo -72.45 148.15 47.84 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.605 2.203 . . . . 0.0 112.864 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.605 HD11 ' HB2' ' A' ' 114' ' ' LEU . 20.5 mt -66.09 -37.17 85.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.196 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -59.66 -23.91 59.15 Favored Glycine 0 C--O 1.226 -0.396 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.788 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.507 ' HB2' ' HG2' ' A' ' 143' ' ' PRO . 2.5 tt0 -69.74 -29.58 66.99 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.885 0.374 . . . . 0.0 110.478 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -100.92 -38.97 7.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.292 0.568 . . . . 0.0 110.831 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.445 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -98.13 7.33 62.29 Favored Glycine 0 C--O 1.227 -0.342 0 CA-C-N 115.497 -0.774 . . . . 0.0 113.859 -169.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.5 pt? -38.9 -36.09 0.25 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -103.62 133.79 20.09 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.65 -7.42 9.04 Favored 'Trans proline' 0 N--CA 1.474 0.354 0 C-N-CA 122.889 2.393 . . . . 0.0 112.422 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 92.5 mt -94.57 -0.64 54.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.984 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 62.6 m -65.14 105.08 1.0 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.037 0.446 . . . . 0.0 110.09 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.1 m -82.25 101.32 10.43 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.142 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.442 ' HB ' HG22 ' A' ' 93' ' ' VAL . 49.1 t -81.91 106.24 12.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.074 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -83.12 103.06 12.26 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.164 0.506 . . . . 0.0 110.087 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.74 ' HG2' ' HG ' ' A' ' 131' ' ' LEU . 7.6 tmm? -78.79 112.37 15.86 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.04 113.26 24.93 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -168.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.651 HD23 ' HB3' ' A' ' 129' ' ' PHE . 54.8 mt -92.84 81.38 4.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.318 174.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 120.979 0.419 . . . . 0.0 110.897 -178.098 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 . . . . . 0 CA--C 1.513 -0.451 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 62.91 78.63 0.28 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 114.151 -1.386 . . . . 0.0 112.269 175.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -81.64 91.77 1.06 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.403 2.069 . . . . 0.0 110.102 170.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.41 ' CD1' ' HA ' ' A' ' 151' ' ' PRO . 0.1 OUTLIER -75.63 114.65 14.45 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.314 -173.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.6 t -82.37 95.44 7.64 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 46.9 pt -95.35 154.43 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.429 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 154' ' ' THR . 37.3 tp -106.72 114.39 28.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.941 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.3 t -109.37 118.83 57.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.039 0.447 . . . . 0.0 109.896 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 -90.29 132.74 35.38 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.241 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -62.96 -17.49 62.05 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.966 -175.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 157' ' ' MET . 3.2 p30 -169.44 -59.61 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -169.08 -33.25 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.911 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -78.09 -76.42 0.9 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.753 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 36.4 ttt-85 -69.67 134.3 48.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.89 0.376 . . . . 0.0 110.769 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.447 ' HB3' HD11 ' A' ' 92' ' ' LEU . 14.8 m -118.64 121.94 41.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.873 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.7 t -114.73 126.0 54.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.136 0.493 . . . . 0.0 109.903 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.8 m -90.14 134.48 34.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.981 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -132.64 139.2 47.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.516 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -99.58 107.38 19.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.957 0.408 . . . . 0.0 110.769 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.503 HG11 HD13 ' A' ' 114' ' ' LEU . 21.0 m -125.82 147.55 30.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.105 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -93.75 156.77 16.5 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.52 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.677 ' HG ' ' HA3' ' A' ' 145' ' ' GLY . 8.7 mp -65.44 -13.52 58.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.007 -175.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.2 t -88.58 3.72 49.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.831 0.348 . . . . 0.0 111.36 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -93.26 148.32 22.14 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.134 0.493 . . . . 0.0 111.02 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 47.1 p -85.14 159.96 20.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.977 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.545 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 55.8 t -62.17 -33.2 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.209 0.528 . . . . 0.0 109.87 175.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.524 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -64.43 -34.11 77.42 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.832 178.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.47 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 1.5 t60 -67.8 -41.85 82.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.962 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.738 HD22 HD11 ' A' ' 144' ' ' LEU . 62.2 tp -62.17 -45.75 92.02 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.111 173.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -55.13 -37.82 67.41 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.014 177.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -68.64 -35.39 77.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.758 0.314 . . . . 0.0 110.968 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 18.5 mt-30 -66.76 -45.45 78.49 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.485 0.66 . . . . 0.0 109.336 175.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.3 t -61.06 -36.76 74.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.613 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.829 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 72.5 m -66.82 -16.64 64.42 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.032 176.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.7 -35.75 35.15 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.654 174.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.7 mp -96.18 -71.55 0.67 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 124' ' ' VAL . 28.4 mm-40 -93.92 8.85 39.77 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.125 0.57 . . . . 0.0 111.109 -173.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.829 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -51.07 7.9 0.01 OUTLIER Glycine 0 N--CA 1.471 1.016 0 N-CA-C 118.09 1.996 . . . . 0.0 118.09 -170.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.417 ' N ' ' O ' ' A' ' 122' ' ' GLU . 28.1 t -54.73 82.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 118.154 0.977 . . . . 0.0 112.267 177.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.16 113.18 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.228 1.011 . . . . 0.0 112.348 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.537 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 1.8 p-10 -58.42 -12.89 4.31 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -173.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -72.75 -29.36 63.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.8 0.333 . . . . 0.0 110.414 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.9 mt -80.19 -39.5 29.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.903 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.537 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 25.8 p90 -109.67 105.04 14.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.946 0.879 . . . . 0.0 110.889 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.405 ' HE1' ' HG3' ' A' ' 137' ' ' PRO . 1.6 t90 -119.7 110.97 17.45 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.587 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.4 pp -92.41 152.19 19.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.075 0.464 . . . . 0.0 111.751 -172.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 13.8 p -140.71 154.82 46.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.121 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.444 ' CD2' ' HG3' ' A' ' 134' ' ' GLU . 10.3 t80 -125.0 -67.21 0.92 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.746 0.308 . . . . 0.0 110.863 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.444 ' HG3' ' CD2' ' A' ' 133' ' ' PHE . 46.3 mt-10 -77.85 3.54 14.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.08 0.467 . . . . 0.0 110.557 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.56 -24.19 27.95 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -168.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -92.99 158.21 37.88 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 114.873 -0.664 . . . . 0.0 109.551 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.405 ' HG3' ' HE1' ' A' ' 130' ' ' TRP . 3.5 Cg_exo -76.63 -2.42 12.64 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.075 2.517 . . . . 0.0 112.051 178.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 58.8 mt 70.67 -171.14 0.16 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.416 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -139.82 132.97 29.68 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.545 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.0 p-10 -70.47 -21.31 62.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.765 -174.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -65.15 -30.5 71.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.033 0.444 . . . . 0.0 110.871 177.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 72.5 mt -87.4 143.61 34.52 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.643 -176.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 142' ' ' LEU . 20.5 Cg_exo -64.05 131.8 32.0 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.642 2.228 . . . . 0.0 111.772 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.738 HD11 HD22 ' A' ' 114' ' ' LEU . 4.1 tt -55.27 -35.47 65.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.336 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.677 ' HA3' ' HG ' ' A' ' 107' ' ' LEU . . . -58.83 -23.37 56.06 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.638 -177.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -66.01 -31.24 72.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.221 0.51 . . . . 0.0 110.49 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -100.06 -29.11 12.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.151 0.5 . . . . 0.0 110.809 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.401 ' O ' ' HG ' ' A' ' 89' ' ' LEU . . . -100.09 5.73 57.89 Favored Glycine 0 C--O 1.222 -0.646 0 CA-C-N 115.652 -0.704 . . . . 0.0 113.937 -172.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.402 ' N ' HD23 ' A' ' 149' ' ' LEU . 2.5 pt? -46.28 -30.47 2.05 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -176.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.843 ' HD3' ' HD2' ' A' ' 151' ' ' PRO . 17.3 tppt? -89.21 119.73 69.75 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.843 ' HD2' ' HD3' ' A' ' 150' ' ' LYS . 48.6 Cg_endo -71.06 61.52 2.46 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.527 2.818 . . . . 0.0 112.165 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.4 tp -179.9 -26.79 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.307 -172.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.6 t -45.9 130.46 9.63 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.439 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 33.6 m -110.97 128.32 55.8 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.864 -173.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.8 t -99.1 138.57 23.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.027 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -110.1 117.0 32.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.964 0.411 . . . . 0.0 111.304 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.48 ' O ' ' HA ' ' A' ' 96' ' ' ASN . 73.5 mtp -80.2 99.03 7.6 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.864 174.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -79.36 96.04 5.89 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.396 0.617 . . . . 0.0 110.442 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.35 106.1 4.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.707 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 70.9 ttp85 . . . . . 0 C--N 1.322 -0.595 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.125 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.9 t70 . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 8.0 mt-10 -95.12 110.2 48.86 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.414 -170.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 4.4 Cg_exo -80.94 -172.61 1.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.69 2.927 . . . . 0.0 112.225 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.48 HD21 ' O ' ' A' ' 148' ' ' GLY . 65.7 tp -174.07 104.0 0.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.924 -175.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.8 m -85.33 105.96 16.37 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.005 0.431 . . . . 0.0 110.855 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 28.2 pt -106.8 145.47 14.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.162 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 14.5 tp -99.86 112.75 24.99 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 64.4 t -94.23 121.04 44.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.307 0.575 . . . . 0.0 111.44 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.405 ' HD3' ' HD1' ' A' ' 156' ' ' PHE . 21.4 ttt180 -85.17 118.55 24.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 175.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.556 ' ND2' ' HA ' ' A' ' 99' ' ' ARG . 4.1 p30 -135.63 -156.19 0.7 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.348 -167.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -93.33 -51.01 5.19 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -176.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -68.38 -76.01 0.1 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.781 0.324 . . . . 0.0 110.962 -171.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -123.26 106.05 0.97 Allowed Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 174.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.699 ' HD3' ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -78.25 59.65 2.33 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -162.563 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.9 p -169.16 59.58 0.05 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.52 0.676 . . . . 0.0 109.349 172.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.2 m -80.39 104.64 11.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.098 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 m -75.49 90.57 2.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.002 0.429 . . . . 0.0 110.094 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -82.87 117.35 22.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.907 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -86.28 101.14 12.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 173.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.4 m -121.04 -179.66 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.416 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -125.36 145.44 50.04 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.01 -12.11 52.77 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.981 -173.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.3 t -85.05 7.61 20.86 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.083 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -94.97 148.48 22.27 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.264 0.554 . . . . 0.0 111.806 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.64 ' HB ' ' OD1' ' A' ' 140' ' ' ASP . 9.4 p -82.02 166.86 19.43 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.188 170.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.09 -34.67 70.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.359 0.6 . . . . 0.0 109.688 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.53 -41.34 89.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.029 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -66.95 -15.49 63.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.937 0.399 . . . . 0.0 110.559 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.644 ' HB2' HD11 ' A' ' 144' ' ' LEU . 61.4 tp -91.89 -54.87 3.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.488 176.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -75.67 -10.01 59.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -172.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.859 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 10.4 tt0 -81.63 -31.86 32.19 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.048 0.451 . . . . 0.0 110.154 173.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -65.34 -35.78 82.04 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 172.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.23 -43.45 88.25 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.247 173.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.859 ' OG ' ' HA ' ' A' ' 116' ' ' GLN . 2.3 p -74.18 2.33 9.29 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.947 0.403 . . . . 0.0 111.69 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -92.42 -47.62 3.22 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.874 168.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.8 mt -86.71 -44.31 11.91 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.553 0.692 . . . . 0.0 111.267 -177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 124' ' ' VAL . 4.9 tp10 -98.29 10.55 40.42 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.227 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -29.35 6.62 0.0 OUTLIER Glycine 0 N--CA 1.486 2.003 0 N-CA-C 121.141 3.217 . . . . 0.0 121.141 -174.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' A' ' 122' ' ' GLU . 8.3 t -50.3 161.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 119.548 1.674 . . . . 0.0 109.407 169.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -42.54 136.99 2.27 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.339 0.59 . . . . 0.0 112.485 -175.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.643 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 28.2 t70 -61.01 -23.94 65.78 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.339 -172.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -89.42 -1.69 58.14 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.843 0.354 . . . . 0.0 110.873 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.499 HD12 HG12 ' A' ' 124' ' ' VAL . 74.6 mt -97.28 -28.02 14.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.64 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.643 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 42.5 p90 -103.55 113.84 27.65 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.076 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.403 ' HB3' ' O ' ' A' ' 158' ' ' ASN . 9.7 t90 -112.07 155.47 23.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.618 -176.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 137' ' ' PRO . 5.5 mp -137.81 154.11 49.58 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.5 p -150.56 144.68 25.46 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.828 0.346 . . . . 0.0 111.2 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.543 ' CD2' ' HG2' ' A' ' 134' ' ' GLU . 14.8 t80 -135.31 -66.73 0.56 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.337 171.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.543 ' HG2' ' CD2' ' A' ' 133' ' ' PHE . 8.5 mm-40 -80.5 26.08 0.39 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.678 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.33 -9.35 67.47 Favored Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -173.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -124.38 162.81 40.04 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 131' ' ' LEU . 5.4 Cg_exo -74.92 4.07 5.02 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.179 2.586 . . . . 0.0 113.072 -177.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 74.6 mt 73.8 142.22 0.07 Allowed 'General case' 0 N--CA 1.464 0.229 0 O-C-N 124.045 0.84 . . . . 0.0 110.996 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -85.52 124.18 31.79 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.35 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.64 ' OD1' ' HB ' ' A' ' 110' ' ' THR . 29.8 t70 -65.61 -22.14 66.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.343 0.592 . . . . 0.0 110.365 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -60.04 -26.91 66.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.504 176.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 87.8 mt -103.56 144.91 29.62 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.589 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 142' ' ' LEU . 14.4 Cg_exo -69.47 147.23 64.28 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.64 2.226 . . . . 0.0 112.027 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.644 HD11 ' HB2' ' A' ' 114' ' ' LEU . 76.6 mt -57.32 -33.19 67.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.659 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -56.23 -27.7 53.06 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.255 -0.498 . . . . 0.0 113.302 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.17 -43.92 83.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.097 0.475 . . . . 0.0 110.304 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -100.73 -28.53 12.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.811 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.48 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -96.41 5.76 65.24 Favored Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.517 -174.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.5 pt? -47.83 -27.7 2.21 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -91.13 110.23 40.88 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.462 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 16.9 Cg_exo -67.2 81.02 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.854 2.37 . . . . 0.0 111.913 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 151' ' ' PRO . 6.3 mt 162.86 -19.62 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.801 1.24 . . . . 0.0 109.683 -175.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.8 t -52.72 127.11 22.09 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.182 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.8 m -96.46 118.27 32.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.323 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.9 t -86.22 118.48 32.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.419 176.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.405 ' HD1' ' HD3' ' A' ' 94' ' ' ARG . 96.1 m-85 -88.79 99.25 12.22 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.045 0.45 . . . . 0.0 110.751 -177.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 24.6 ttt -80.08 98.66 7.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.303 0.573 . . . . 0.0 109.52 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 130' ' ' TRP . 0.9 OUTLIER -89.87 91.44 8.61 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.885 -177.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.4 tt -67.46 118.66 11.09 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 . . . . . 0 C--N 1.322 -0.595 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.653 -176.914 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 N--CA 1.463 0.184 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 59.29 70.69 1.06 Allowed Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.857 174.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -79.22 118.13 3.94 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.425 2.083 . . . . 0.0 112.23 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.554 HD11 ' HA ' ' A' ' 151' ' ' PRO . 29.1 tp -106.25 111.4 23.98 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.148 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.0 t -91.19 86.68 6.25 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.92 0.39 . . . . 0.0 110.301 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.5 pt -91.23 169.19 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.861 -176.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.517 HD11 ' HB2' ' A' ' 100' ' ' SER . 42.7 tp -108.54 106.12 16.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.042 0.448 . . . . 0.0 110.585 -177.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.0 t -97.69 116.0 39.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.5 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.56 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 71.6 mtp180 -96.99 157.86 15.7 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.013 0.435 . . . . 0.0 111.099 -177.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -77.18 -175.23 3.54 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.121 174.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -71.77 84.79 0.92 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.187 0.518 . . . . 0.0 109.852 177.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.446 ' HE2' ' HB3' ' A' ' 97' ' ' LYS . 32.0 mtpt 61.01 22.87 13.08 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.611 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -116.42 -118.57 3.06 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.512 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 42.4 mtp-105 -70.26 -179.84 2.14 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.343 0.592 . . . . 0.0 111.796 -177.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 20.5 p -144.79 120.67 10.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.249 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.2 t -115.37 128.58 56.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.173 0.511 . . . . 0.0 110.196 -177.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.1 m -87.54 107.86 18.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.475 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -101.05 141.62 33.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.059 0.457 . . . . 0.0 111.901 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -83.85 102.37 12.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.243 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.6 m -114.66 -179.86 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 176.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.61 ' HB2' ' HG3' ' A' ' 109' ' ' GLN . 77.0 mtt85 -140.84 146.61 37.79 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.83 -31.16 72.26 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.267 0.354 . . . . 0.0 111.404 -173.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 m -75.97 -19.23 58.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.151 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.61 ' HG3' ' HB2' ' A' ' 106' ' ' ARG . 25.2 mt-30 -74.22 133.06 42.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.652 0.263 . . . . 0.0 110.39 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.799 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 23.2 p -71.3 159.26 34.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.302 174.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.634 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 59.2 t -60.59 -28.7 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.0 0.429 . . . . 0.0 110.462 177.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.94 -35.43 74.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.104 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.442 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 31.1 m80 -66.61 -42.89 86.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.446 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.852 ' HB2' HD11 ' A' ' 144' ' ' LEU . 60.6 tp -62.26 -44.98 95.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.46 175.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -62.01 -32.26 72.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.728 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 47.1 mt-30 -81.03 -21.09 40.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 0.0 111.59 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 46.5 mt-30 -73.58 -47.78 37.88 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 170.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 81.1 t -61.07 -40.65 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.085 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.946 ' HA ' ' HA3' ' A' ' 123' ' ' GLY . 91.6 p -65.5 -34.18 77.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.916 0.388 . . . . 0.0 110.406 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.29 -27.49 72.49 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.207 175.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 37.3 mt -98.72 -76.29 0.54 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 111.77 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.414 ' C ' ' H ' ' A' ' 124' ' ' VAL . 6.1 tp10 -102.21 8.18 40.63 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.228 0.611 . . . . 0.0 111.621 -174.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.946 ' HA3' ' HA ' ' A' ' 119' ' ' SER . . . -53.36 7.37 0.01 OUTLIER Glycine 0 CA--C 1.525 0.715 0 N-CA-C 117.213 1.645 . . . . 0.0 117.213 -172.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.414 ' H ' ' C ' ' A' ' 122' ' ' GLU . 87.1 t -38.02 97.39 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 123.623 0.769 . . . . 0.0 112.414 175.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.447 HE21 ' HB3' ' A' ' 125' ' ' GLN . 13.0 mt-30 48.08 102.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 O-C-N 124.087 0.867 . . . . 0.0 112.263 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.518 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 12.1 p-10 -71.67 17.87 0.08 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -174.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 125' ' ' GLN . 16.3 t70 -100.24 -21.54 15.45 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 171.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.0 mt -82.2 -16.41 49.77 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.914 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.518 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 25.8 p90 -143.32 159.9 41.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.666 0.269 . . . . 0.0 111.015 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -163.44 155.51 17.67 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.523 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 6.9 mp -106.81 146.95 30.29 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.44 -174.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 13.3 p -138.75 143.17 38.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.145 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.44 ' CD2' ' HB2' ' A' ' 134' ' ' GLU . 20.9 t80 -111.49 -74.62 0.63 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.131 0.491 . . . . 0.0 110.962 176.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.44 ' HB2' ' CD2' ' A' ' 133' ' ' PHE . 28.7 tt0 -93.51 14.55 18.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.41 0.624 . . . . 0.0 110.091 -173.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 102.51 -19.02 49.39 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 -169.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 137' ' ' PRO . 59.7 mttp -73.89 134.95 77.73 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 115.036 -0.582 . . . . 0.0 109.681 174.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 136' ' ' LYS . 3.3 Cg_exo -77.31 4.66 5.69 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.994 2.463 . . . . 0.0 111.454 175.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 39.8 mt 69.98 -176.39 0.2 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.725 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.483 ' OE2' ' HG ' ' A' ' 142' ' ' LEU . 36.4 tt0 -145.33 121.1 10.55 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 174.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.634 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 1.2 p-10 -63.8 -22.08 66.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.35 0.595 . . . . 0.0 110.674 -175.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -74.69 -27.29 60.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.351 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.483 ' HG ' ' OE2' ' A' ' 139' ' ' GLU . 68.1 mt -94.15 157.05 38.31 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.837 0.351 . . . . 0.0 111.324 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.799 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 10.1 Cg_exo -72.67 151.42 52.11 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.071 2.514 . . . . 0.0 112.566 177.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.852 HD11 ' HB2' ' A' ' 114' ' ' LEU . 43.3 mt -66.67 -32.78 74.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.58 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.541 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -53.83 -34.88 51.88 Favored Glycine 0 C--N 1.332 0.326 0 O-C-N 123.314 0.384 . . . . 0.0 113.133 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -61.0 -33.11 72.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.871 0.367 . . . . 0.0 111.544 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -101.09 -42.07 6.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.723 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -100.13 6.95 58.39 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-O 119.358 -0.69 . . . . 0.0 114.349 -168.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.541 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.6 pt? -43.45 -29.0 0.4 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -175.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.635 ' HB3' ' HB3' ' A' ' 153' ' ' SER . 40.6 tptt -67.82 125.09 90.89 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.554 ' HA ' HD11 ' A' ' 89' ' ' LEU . 52.9 Cg_exo -56.13 -19.24 26.19 Favored 'Trans proline' 0 N--CA 1.478 0.604 0 C-N-CA 123.45 2.767 . . . . 0.0 114.09 -173.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.447 HD23 ' N ' ' A' ' 152' ' ' LEU . 1.5 pt? -132.8 34.21 3.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.228 0.537 . . . . 0.0 109.815 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.635 ' HB3' ' HB3' ' A' ' 150' ' ' LYS . 34.7 p -60.69 139.42 57.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.48 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.7 m -100.86 101.88 12.81 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.013 0.435 . . . . 0.0 111.11 -176.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.3 t -94.56 132.26 39.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -103.1 120.54 40.86 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.0 0.428 . . . . 0.0 111.027 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.523 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 1.7 tmt? -83.5 103.27 12.71 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -98.19 145.16 26.89 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.293 -172.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 95.3 mt -102.39 156.9 17.29 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.644 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 160' ' ' ARG . 7.4 tpt180 . . . . . 0 C--N 1.326 -0.42 0 O-C-N 123.94 0.775 . . . . 0.0 112.371 -174.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.628 ' O ' ' HD3' ' A' ' 88' ' ' PRO . 6.7 p-10 . . . . . 0 CA--C 1.523 -0.09 0 CA-C-O 120.792 0.329 . . . . 0.0 110.493 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.633 ' O ' ' HG2' ' A' ' 106' ' ' ARG . 1.8 pm0 -107.52 90.57 6.13 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 121.202 0.525 . . . . 0.0 111.262 -178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.628 ' HD3' ' O ' ' A' ' 86' ' ' ASP . 4.7 Cg_exo -79.38 100.84 1.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.509 2.139 . . . . 0.0 111.485 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.3 tp -114.11 100.51 8.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.087 0.47 . . . . 0.0 110.003 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.5 t -92.84 107.31 19.12 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.617 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 102' ' ' THR . 43.7 pt -105.03 151.8 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.279 -178.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 100' ' ' SER . 19.8 tp -95.84 112.29 24.06 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.203 0.525 . . . . 0.0 111.751 -172.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.7 124.09 62.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.684 175.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -99.44 121.61 41.37 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -62.43 -21.59 65.53 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.522 0.514 . . . . 0.0 112.238 -172.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -173.76 -66.58 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.8 pttt -163.32 11.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.992 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -129.8 -68.14 0.11 Allowed Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.041 -1.076 . . . . 0.0 111.956 -177.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -69.39 116.79 10.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.211 0.529 . . . . 0.0 111.159 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.528 ' HB2' HD11 ' A' ' 92' ' ' LEU . 15.4 p -103.98 84.02 2.19 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.712 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.1 m -94.96 118.12 31.27 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.58 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 14.9 t -88.49 113.29 23.93 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.59 0.71 . . . . 0.0 109.643 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -90.15 132.02 35.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.622 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -80.59 99.93 8.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.263 0.554 . . . . 0.0 109.937 177.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 29.7 m -113.3 179.24 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.53 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.633 ' HG2' ' O ' ' A' ' 87' ' ' GLU . 80.9 mtt85 -139.13 146.62 40.86 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -177.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.449 HD12 ' H ' ' A' ' 107' ' ' LEU . 5.4 mp -69.83 -31.85 69.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.36 -172.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 33.8 m -63.43 -28.07 69.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.337 0.589 . . . . 0.0 110.246 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.547 ' NE2' HD12 ' A' ' 144' ' ' LEU . 4.1 tt0 -79.2 141.01 37.54 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.518 -177.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.855 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 39.0 p -82.8 167.37 18.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.563 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.61 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 54.1 t -64.85 -23.59 33.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.1 176.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.24 -37.44 67.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.946 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.587 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 7.4 t-160 -66.07 -41.54 90.61 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.79 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.719 ' HB2' HD11 ' A' ' 144' ' ' LEU . 46.7 tp -65.4 -42.84 92.14 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.0 tptt -51.46 -50.36 59.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.403 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.763 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 77.9 mt-30 -75.85 -26.92 57.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.183 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.587 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 48.7 mt-30 -64.24 -50.2 68.94 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 174.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.2 t -63.49 -43.42 98.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.065 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.927 ' HA ' ' HA3' ' A' ' 123' ' ' GLY . 60.6 p -66.15 -23.66 66.52 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.89 0.376 . . . . 0.0 111.153 -176.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.34 -43.0 32.87 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.926 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.9 mt -85.66 -72.66 0.48 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.132 0.492 . . . . 0.0 111.55 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -100.36 6.8 44.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.503 -174.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.927 ' HA3' ' HA ' ' A' ' 119' ' ' SER . . . -63.74 6.92 0.51 Allowed Glycine 0 C--O 1.227 -0.29 0 CA-C-O 118.996 -0.891 . . . . 0.0 115.314 -172.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.504 HG12 HD12 ' A' ' 128' ' ' LEU . 63.6 t -35.24 92.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 123.934 0.894 . . . . 0.0 112.124 175.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 47.51 106.08 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 O-C-N 124.003 0.814 . . . . 0.0 111.046 -171.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.625 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 6.8 p-10 -61.9 -0.94 0.54 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -170.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -100.89 -7.12 23.79 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 176.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.504 HD12 HG12 ' A' ' 124' ' ' VAL . 85.9 mt -83.77 -12.44 55.7 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-O 120.88 0.371 . . . . 0.0 110.684 177.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.625 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 51.9 p90 -128.76 147.24 50.76 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 173.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.645 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 36.9 t90 -133.96 90.12 2.66 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.54 0.686 . . . . 0.0 110.029 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 131' ' ' LEU . 2.6 pt? -90.16 149.54 22.39 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.6 t -160.9 163.53 31.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.353 0.597 . . . . 0.0 111.15 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.433 ' HB3' HD21 ' A' ' 138' ' ' LEU . 6.9 t80 -142.3 -54.56 0.43 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.95 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -88.0 6.65 34.95 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.117 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.62 -22.56 39.94 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 -171.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.443 ' C ' ' H ' ' A' ' 138' ' ' LEU . 61.9 mttp -101.48 152.47 38.02 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 131' ' ' LEU . 62.3 Cg_endo -73.32 22.44 0.33 Allowed 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.653 2.235 . . . . 0.0 112.759 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.572 ' HB3' HG11 ' A' ' 111' ' ' VAL . 42.5 mt 68.36 117.13 0.03 OUTLIER 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.899 0.88 . . . . 0.0 110.981 -178.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -83.23 121.92 27.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.094 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.61 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 2.5 p-10 -69.78 -18.07 63.46 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.179 -174.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -70.0 -24.71 63.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.508 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.4 mt -95.19 156.93 37.23 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.708 -176.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.855 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 71.7 Cg_endo -77.17 153.77 32.13 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.631 2.22 . . . . 0.0 111.764 176.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.719 HD11 ' HB2' ' A' ' 114' ' ' LEU . 10.7 mt -71.25 -22.62 61.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.534 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -58.22 -30.99 64.98 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.55 177.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -66.53 -35.61 80.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.19 0.519 . . . . 0.0 110.856 -177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -95.53 -40.73 9.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.318 0.58 . . . . 0.0 111.081 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -97.54 6.76 63.2 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.232 -0.895 . . . . 0.0 114.156 -168.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -42.06 -32.49 0.46 Allowed 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 117.494 0.647 . . . . 0.0 112.55 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -90.93 123.7 64.04 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 173.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -63.62 -9.46 18.42 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.752 2.301 . . . . 0.0 112.31 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.8 pp -105.26 8.55 33.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.076 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 33.6 p -63.49 118.17 7.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.092 0.473 . . . . 0.0 109.976 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 9.9 m -98.93 106.11 18.34 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.966 -177.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 53.9 t -86.71 120.83 36.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.35 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.21 108.41 20.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.122 0.487 . . . . 0.0 110.752 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.53 ' HA ' ' CB ' ' A' ' 131' ' ' LEU . 27.5 ttt -85.37 100.89 12.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.564 176.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.645 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 43.1 m-80 -86.27 135.49 33.53 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.683 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 67.1 mt -97.78 20.58 11.79 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.176 0.512 . . . . 0.0 110.731 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 160' ' ' ARG . 8.1 tpt180 . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.5 t70 . . . . . 0 N--CA 1.469 0.492 0 CA-C-O 121.397 0.618 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 11.6 tp10 -116.84 107.97 45.33 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.652 -177.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 87' ' ' GLU . 1.7 Cg_endo -82.48 114.14 2.38 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.207 2.605 . . . . 0.0 111.184 175.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.447 HD22 HD21 ' A' ' 107' ' ' LEU . 46.5 tp -78.08 114.97 17.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.271 0.558 . . . . 0.0 111.121 -174.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.8 p -94.35 98.63 11.03 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.591 176.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.2 pt -91.02 174.04 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.449 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' A' ' 100' ' ' SER . 1.3 tm? -118.6 112.93 20.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.878 0.371 . . . . 0.0 110.357 -176.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.8 t -103.16 127.35 57.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.887 175.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -98.58 108.53 21.25 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.586 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 36.0 p30 -84.79 174.34 9.95 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.535 -175.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.477 ' OD1' ' HB2' ' A' ' 159' ' ' LEU . 9.8 m-80 -62.02 -24.19 66.91 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.155 0.503 . . . . 0.0 111.226 -175.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -90.39 8.19 34.84 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.922 -171.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.98 9.62 86.03 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 116.014 -0.539 . . . . 0.0 113.139 174.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -92.3 138.72 31.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.967 0.413 . . . . 0.0 111.034 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.491 ' HB3' HD11 ' A' ' 92' ' ' LEU . 17.6 m -90.2 94.36 9.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.426 175.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.2 p -90.1 111.16 22.2 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.995 0.426 . . . . 0.0 110.612 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.7 m -78.66 114.26 17.43 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.283 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -99.99 120.36 39.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.011 0.434 . . . . 0.0 111.348 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -85.01 103.2 13.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.501 176.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.41 176.36 9.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.205 0.526 . . . . 0.0 111.579 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -115.24 156.61 25.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.785 174.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.509 HD22 ' HA2' ' A' ' 145' ' ' GLY . 80.4 mt -65.88 -29.37 69.8 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.978 0.418 . . . . 0.0 111.112 -177.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 p -97.53 21.94 9.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.359 -175.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.533 ' HB3' ' HB3' ' A' ' 113' ' ' HIS . 13.4 mt-30 -77.47 -30.2 53.05 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.108 176.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 m 72.91 157.78 0.19 Allowed 'General case' 0 C--O 1.236 0.388 0 O-C-N 123.899 0.75 . . . . 0.0 109.965 -175.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.2 t -54.71 -38.81 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 0.0 110.578 -178.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -47.63 -48.06 28.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.657 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.533 ' HB3' ' HB3' ' A' ' 109' ' ' GLN . 13.2 t-80 -77.69 -7.92 57.17 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.42 -172.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 54.1 tp -100.44 -51.04 3.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.068 0.461 . . . . 0.0 110.347 175.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.424 ' HE2' ' CZ ' ' A' ' 129' ' ' PHE . 3.3 tmtp? -59.02 -48.1 82.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.411 -176.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.587 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 19.7 mm-40 -69.36 -18.28 63.77 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -174.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -70.67 -48.93 52.29 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.2 t -62.52 -36.74 76.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.224 175.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.737 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 55.3 m -62.05 -25.84 67.91 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.17 175.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.07 -35.46 53.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.843 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.7 mt -92.39 -71.89 0.62 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.909 0.385 . . . . 0.0 111.984 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 124' ' ' VAL . 48.0 mt-10 -99.98 9.3 43.13 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.855 0.462 . . . . 0.0 110.797 -174.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.737 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -46.93 7.79 0.01 OUTLIER Glycine 0 N--CA 1.47 0.901 0 N-CA-C 118.719 2.248 . . . . 0.0 118.719 -172.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 122' ' ' GLU . 80.7 t -37.75 100.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 118.446 1.123 . . . . 0.0 112.024 173.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.517 ' HB3' ' HG ' ' A' ' 128' ' ' LEU . 4.0 mm-40 55.81 106.18 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.122 0 O-C-N 123.916 0.76 . . . . 0.0 112.653 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -52.84 -24.54 9.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.023 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.27 -5.83 39.32 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -173.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.517 ' HG ' ' HB3' ' A' ' 125' ' ' GLN . 74.3 mt -89.37 -52.42 5.05 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.984 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.5 ' CE1' ' HA2' ' A' ' 123' ' ' GLY . 13.7 p90 -94.98 126.61 40.43 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.405 0.621 . . . . 0.0 110.155 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.638 ' HZ2' ' H ' ' A' ' 138' ' ' LEU . 9.4 t-105 -144.79 133.58 22.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.278 -178.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.829 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 4.9 mp -105.43 139.34 40.2 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.102 -174.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.581 HG22 ' HA ' ' A' ' 137' ' ' PRO . 45.8 p -132.91 140.7 48.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.31 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.519 ' CD2' ' HG3' ' A' ' 134' ' ' GLU . 11.1 t80 -87.83 -69.94 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.598 0.237 . . . . 0.0 111.462 -178.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.519 ' HG3' ' CD2' ' A' ' 133' ' ' PHE . 37.5 mt-10 -74.7 12.58 0.79 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.01 -177.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.41 2.94 89.86 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -166.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -112.87 147.93 38.26 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 114.867 -0.666 . . . . 0.0 109.574 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.581 ' HA ' HG22 ' A' ' 132' ' ' THR . 59.3 Cg_endo -69.71 146.03 59.27 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.468 2.112 . . . . 0.0 111.916 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.638 ' H ' ' HZ2' ' A' ' 130' ' ' TRP . 70.5 mt -105.05 149.15 26.05 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.78 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.85 144.19 43.91 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -65.49 -25.0 67.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.079 0.466 . . . . 0.0 110.625 -177.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -64.57 -21.85 66.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.856 176.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 69.4 mt -96.18 131.54 28.54 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.268 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.593 ' HG2' ' HB2' ' A' ' 146' ' ' GLU . 29.2 Cg_endo -63.09 131.27 31.84 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.356 2.037 . . . . 0.0 111.592 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.444 ' HA ' ' CE1' ' A' ' 147' ' ' TYR . 6.9 tt -57.51 -35.94 70.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.577 -175.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.509 ' HA2' HD22 ' A' ' 107' ' ' LEU . . . -66.38 -24.84 72.39 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.04 -0.6 . . . . 0.0 113.723 -178.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.593 ' HB2' ' HG2' ' A' ' 143' ' ' PRO . 35.7 tt0 -61.59 -41.86 98.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.122 0.461 . . . . 0.0 111.231 -175.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.444 ' CE1' ' HA ' ' A' ' 144' ' ' LEU . 0.9 OUTLIER -100.62 -32.59 10.68 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.682 178.526 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -92.22 5.62 78.23 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 121.127 -0.559 . . . . 0.0 114.13 -172.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.509 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.4 pt? -53.33 -24.29 11.54 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -76.34 132.02 73.84 Favored Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.248 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.28 -14.77 44.06 Favored 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.407 2.071 . . . . 0.0 111.962 -178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.1 pp -112.05 14.66 20.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.739 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 77.8 p -62.87 104.78 0.58 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 5.7 m -88.3 104.31 16.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.239 -172.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.497 HG12 ' HB3' ' A' ' 131' ' ' LEU . 43.4 t -88.59 115.3 28.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.405 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -88.07 120.98 29.94 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.435 0.636 . . . . 0.0 111.198 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.829 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 26.9 ttt -76.61 103.7 6.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.55 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 0.9 OUTLIER -92.9 142.56 27.17 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.512 -178.052 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.477 ' HB2' ' OD1' ' A' ' 96' ' ' ASN . 2.1 tt -114.59 110.64 20.11 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 . . . . . 0 C--N 1.32 -0.716 0 CA-C-O 121.103 0.477 . . . . 0.0 111.196 -175.786 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.56 ' O ' ' HD3' ' A' ' 88' ' ' PRO . 11.6 p-10 . . . . . 0 N--CA 1.46 0.059 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -111.84 84.83 5.76 Favored Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.44 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.56 ' HD3' ' O ' ' A' ' 86' ' ' ASP . 74.7 Cg_endo -99.09 168.98 0.54 Allowed 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 123.273 2.649 . . . . 0.0 111.742 173.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.536 HD21 ' O ' ' A' ' 148' ' ' GLY . 23.2 tp -124.81 113.59 18.11 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.456 0.646 . . . . 0.0 110.019 176.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.2 t -93.63 111.7 23.43 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.808 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 41.4 pt -115.25 162.21 13.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.9 0.381 . . . . 0.0 110.716 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.479 HD11 ' HB3' ' A' ' 100' ' ' SER . 47.3 tp -110.79 104.03 12.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.116 0.484 . . . . 0.0 110.511 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.538 HG22 ' HB ' ' A' ' 155' ' ' VAL . 96.1 t -100.69 115.8 42.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.789 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -104.39 154.45 19.84 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.953 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.411 HD21 ' HB2' ' A' ' 99' ' ' ARG . 4.3 p30 -104.52 165.8 10.82 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 175.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -70.1 -5.18 25.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.791 -175.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.423 ' NZ ' ' HB3' ' A' ' 97' ' ' LYS . 4.9 mtpm? -89.69 -14.53 34.56 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.823 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.99 -28.09 6.23 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.398 175.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.411 ' HB2' HD21 ' A' ' 95' ' ' ASN . 19.4 mmt180 -69.73 142.27 53.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.161 0.505 . . . . 0.0 111.803 -175.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.479 ' HB3' HD11 ' A' ' 92' ' ' LEU . 3.4 m -112.28 131.11 55.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.971 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.0 t -124.93 130.31 52.12 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.961 0.41 . . . . 0.0 110.131 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.5 m -92.11 107.19 19.03 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.282 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.471 ' CE1' ' HB ' ' A' ' 93' ' ' VAL . 32.8 m-85 -94.65 132.59 39.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.273 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -104.19 99.9 9.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.343 0.592 . . . . 0.0 109.621 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.418 HG11 HD13 ' A' ' 114' ' ' LEU . 34.8 m -115.33 -179.78 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.819 -174.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -119.15 151.39 38.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.952 175.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.64 -13.42 62.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.234 -175.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.9 m -74.86 -13.89 60.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.203 0.525 . . . . 0.0 110.844 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -85.12 144.3 28.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.734 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.4 p -94.23 175.6 6.64 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.6 t -55.23 -41.31 60.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.9 -42.91 90.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.903 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -69.67 -24.61 63.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.857 -172.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.584 HD22 HD11 ' A' ' 144' ' ' LEU . 57.3 tp -88.23 -43.41 11.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.981 0.42 . . . . 0.0 110.054 172.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -60.67 -42.44 97.04 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.662 -177.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -58.6 -35.21 72.07 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.274 0.359 . . . . 0.0 111.107 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -63.59 -48.3 77.93 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.446 0.641 . . . . 0.0 109.541 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.488 HG11 ' SD ' ' A' ' 157' ' ' MET . 45.0 t -61.81 -41.17 89.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.596 176.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.646 ' HA ' ' CA ' ' A' ' 123' ' ' GLY . 50.9 m -59.82 -21.43 60.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.431 177.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -81.99 -37.15 16.54 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.419 -0.895 . . . . 0.0 112.256 175.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 80.8 mt -92.11 -66.26 0.94 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.214 0.531 . . . . 0.0 112.068 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -100.49 8.27 43.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.945 -175.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.646 ' CA ' ' HA ' ' A' ' 119' ' ' SER . . . -53.83 7.5 0.01 OUTLIER Glycine 0 CA--C 1.522 0.492 0 N-CA-C 117.547 1.779 . . . . 0.0 117.547 -170.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.404 HG12 HD12 ' A' ' 128' ' ' LEU . 58.4 t -29.87 94.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.07 0.948 . . . . 0.0 112.376 176.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.487 ' HB3' ' HG ' ' A' ' 128' ' ' LEU . 8.9 tt0 48.63 109.23 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 O-C-N 124.063 0.852 . . . . 0.0 111.314 -171.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -54.59 -19.07 5.25 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.02 -175.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.47 ' O ' ' HD3' ' A' ' 160' ' ' ARG . 0.7 OUTLIER -95.53 -6.53 40.29 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -177.753 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.487 ' HG ' ' HB3' ' A' ' 125' ' ' GLN . 66.4 mt -82.11 -26.65 33.39 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.174 0.443 . . . . 0.0 111.066 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.418 ' CE1' ' HA2' ' A' ' 123' ' ' GLY . 16.1 p90 -120.1 125.44 48.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.352 0.596 . . . . 0.0 111.046 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.433 ' HE1' ' HB3' ' A' ' 137' ' ' PRO . 21.6 t-105 -132.62 130.11 39.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.844 175.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 131' ' ' LEU . 2.6 pt? -106.08 138.16 42.76 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.966 0.412 . . . . 0.0 110.399 -173.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.632 HG22 ' HA ' ' A' ' 137' ' ' PRO . 49.6 p -134.76 146.25 49.2 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.865 -175.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.563 ' HB3' HD21 ' A' ' 138' ' ' LEU . 32.7 t80 -108.18 139.28 43.09 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.475 ' HB2' ' CE2' ' A' ' 133' ' ' PHE . 29.2 tt0 72.19 -29.4 0.2 Allowed 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.727 0.642 . . . . 0.0 111.766 174.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 133' ' ' PHE . . . 130.13 6.19 4.03 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -173.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -117.12 147.69 40.81 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-O 120.509 0.195 . . . . 0.0 110.538 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.632 ' HA ' HG22 ' A' ' 132' ' ' THR . 93.0 Cg_endo -74.87 142.78 28.71 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.187 1.925 . . . . 0.0 110.661 172.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.563 HD21 ' HB3' ' A' ' 133' ' ' PHE . 33.0 mt -95.51 141.1 29.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.623 -170.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.526 ' OE2' ' HB3' ' A' ' 141' ' ' GLN . 33.0 tt0 -86.31 132.3 34.01 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 174.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -73.51 -28.27 61.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.736 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.526 ' HB3' ' OE2' ' A' ' 139' ' ' GLU . 1.1 tm0? -59.29 -44.17 92.52 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.1 mt -74.59 139.84 74.73 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.089 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.76 154.18 73.95 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.505 2.137 . . . . 0.0 112.32 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.584 HD11 HD22 ' A' ' 114' ' ' LEU . 5.7 tt -58.92 -37.05 75.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.234 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.55 -20.46 56.0 Favored Glycine 0 C--O 1.227 -0.282 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.845 -178.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -67.42 -31.15 71.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.268 0.556 . . . . 0.0 110.108 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.472 ' CD1' HD22 ' A' ' 138' ' ' LEU . 16.2 m-85 -100.21 -29.67 12.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.068 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.536 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -94.62 5.78 70.24 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.489 -175.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -49.9 -21.59 1.22 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.532 ' HB2' ' OG ' ' A' ' 153' ' ' SER . 55.8 mttp -86.91 120.7 71.75 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 172.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -59.12 -0.79 0.67 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.959 2.439 . . . . 0.0 112.746 174.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.414 ' H ' ' C ' ' A' ' 150' ' ' LYS . 1.9 pp -128.61 17.51 6.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.712 176.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.532 ' OG ' ' HB2' ' A' ' 150' ' ' LYS . 14.2 m -52.02 108.12 0.26 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.883 0.373 . . . . 0.0 110.69 178.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.6 m -80.99 90.71 5.98 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.278 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.538 ' HB ' HG22 ' A' ' 93' ' ' VAL . 45.3 t -91.23 114.47 28.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.347 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -90.25 109.6 20.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.366 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.488 ' SD ' HG11 ' A' ' 118' ' ' VAL . 59.4 ttp -77.17 92.89 3.85 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -87.37 114.53 24.06 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.088 -170.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.85 125.24 26.15 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 165.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.47 ' HD3' ' O ' ' A' ' 127' ' ' ASP . 84.0 mtp180 . . . . . 0 C--N 1.32 -0.714 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -170.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 C--O 1.233 0.201 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 65.3 81.04 0.22 Allowed Pre-proline 0 C--O 1.234 0.274 0 CA-C-O 121.105 0.479 . . . . 0.0 110.274 -176.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.28 158.28 12.98 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.069 2.513 . . . . 0.0 112.491 -178.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.546 HD21 ' O ' ' A' ' 148' ' ' GLY . 63.3 tp -91.28 100.73 13.48 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.596 ' HB3' HG22 ' A' ' 102' ' ' THR . 47.3 m -83.87 111.88 19.62 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.557 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 39.2 pt -102.03 151.81 5.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.982 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.539 HD11 ' HB2' ' A' ' 100' ' ' SER . 18.0 tp -101.02 105.18 16.36 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.107 0.479 . . . . 0.0 110.874 -174.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.488 HG22 ' HB ' ' A' ' 155' ' ' VAL . 58.9 t -104.72 126.8 59.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.056 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.528 ' HG2' ' HA ' ' A' ' 100' ' ' SER . 20.0 mtp180 -109.67 128.63 55.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.649 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.56 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 6.0 p30 -72.99 105.88 4.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.12 177.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 64.52 -77.16 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.396 -174.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -158.8 5.23 0.1 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.105 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -91.0 -83.04 1.42 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.304 -0.951 . . . . 0.0 113.776 -167.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -93.3 129.23 39.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.984 0.421 . . . . 0.0 111.064 -172.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.539 ' HB2' HD11 ' A' ' 92' ' ' LEU . 3.0 p -87.9 100.35 12.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.387 176.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 m -101.61 119.99 39.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.432 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.596 HG22 ' HB3' ' A' ' 90' ' ' SER . 0.2 OUTLIER -82.13 103.78 11.99 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.478 -179.145 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -94.38 127.88 40.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.194 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -88.0 131.14 34.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.634 0.73 . . . . 0.0 110.963 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 29.7 m -147.85 -178.42 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.257 -177.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 106' ' ' ARG . 2.5 mmt180 -140.51 166.71 23.97 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 174.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 107' ' ' LEU . 5.1 mp -78.14 -5.6 52.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.026 0.441 . . . . 0.0 110.155 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.73 -3.23 56.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.775 -176.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.61 178.32 4.33 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.804 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 p -110.22 167.92 9.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.981 0.42 . . . . 0.0 112.091 -174.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.9 t -58.69 -30.92 43.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.64 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.0 -43.21 60.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.917 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.44 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 24.7 t60 -74.44 -14.56 60.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.723 0.297 . . . . 0.0 111.321 -174.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.792 ' HB2' HD11 ' A' ' 144' ' ' LEU . 59.0 tp -87.63 -48.02 8.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.449 0.642 . . . . 0.0 109.274 174.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -59.34 -43.07 92.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.68 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.42 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 63.6 tt0 -63.41 -31.52 72.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.321 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 47.7 mt-30 -63.78 -44.28 93.85 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.106 0.479 . . . . 0.0 109.865 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.5 t -66.16 -45.19 90.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.93 175.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' A' ' 116' ' ' GLN . 67.5 m -66.63 -8.0 24.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.775 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -100.3 -36.44 4.11 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.94 177.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.7 mt -94.84 -44.32 7.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.513 0.673 . . . . 0.0 110.942 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 124' ' ' VAL . 10.0 tp10 -100.12 11.11 40.14 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.234 -178.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -29.18 7.31 0.0 OUTLIER Glycine 0 N--CA 1.488 2.118 0 N-CA-C 121.104 3.202 . . . . 0.0 121.104 -172.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 122' ' ' GLU . 17.6 t -46.65 164.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 119.758 1.779 . . . . 0.0 109.798 167.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 128' ' ' LEU . 76.1 mt-30 -35.24 118.58 0.46 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.542 0.687 . . . . 0.0 111.95 -176.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -58.11 -29.56 65.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.828 -167.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -100.47 14.43 31.25 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.441 ' CD1' ' HB2' ' A' ' 125' ' ' GLN . 59.9 mt -91.14 -16.63 27.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.903 0.382 . . . . 0.0 110.788 174.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -121.75 145.76 47.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.537 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.442 ' HE1' ' HB3' ' A' ' 137' ' ' PRO . 7.2 t-105 -147.68 129.6 15.32 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 173.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.553 ' HB3' ' HA ' ' A' ' 157' ' ' MET . 1.1 pt? -111.48 134.5 53.02 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.065 0.46 . . . . 0.0 110.698 -173.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.612 HG22 ' HA ' ' A' ' 137' ' ' PRO . 46.2 p -135.29 131.52 36.61 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.823 -177.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . 14.8 t80 -70.89 -65.38 0.74 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.306 0.574 . . . . 0.0 111.078 179.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -92.77 1.43 57.28 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.232 -173.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.21 -10.13 69.7 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -164.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.498 ' HD2' ' HE1' ' A' ' 147' ' ' TYR . 17.3 ttmm -81.59 127.62 72.39 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 113.908 -1.146 . . . . 0.0 108.446 175.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.612 ' HA ' HG22 ' A' ' 132' ' ' THR . 82.1 Cg_endo -73.63 131.76 16.45 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.123 1.882 . . . . 0.0 111.862 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.4 mt -77.29 119.34 20.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.604 -174.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -97.74 134.43 40.92 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.486 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.15 -17.22 64.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.384 0.612 . . . . 0.0 111.03 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -58.14 -27.32 63.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.308 172.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 56.6 mt -109.72 145.24 31.57 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.661 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.26 155.69 51.37 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.583 2.189 . . . . 0.0 110.866 173.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.792 HD11 ' HB2' ' A' ' 114' ' ' LEU . 22.6 mt -64.7 -20.34 66.27 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -176.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -54.56 -31.63 52.54 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.79 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -58.77 -38.7 79.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.97 0.414 . . . . 0.0 110.989 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.498 ' HE1' ' HD2' ' A' ' 136' ' ' LYS . 13.8 m-85 -100.66 -32.31 10.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.272 0.558 . . . . 0.0 111.024 -177.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.546 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -97.7 7.05 63.05 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.39 -0.823 . . . . 0.0 113.986 -171.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -44.86 -23.62 0.15 Allowed 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 62.7 mttp -104.47 134.46 19.67 Favored Pre-proline 0 C--N 1.329 -0.325 0 O-C-N 122.217 -0.302 . . . . 0.0 110.608 175.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 19.9 Cg_exo -67.16 4.89 1.0 Allowed 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.967 2.445 . . . . 0.0 112.586 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -127.6 11.63 6.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.441 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 55.9 m -57.61 107.77 0.48 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.944 0.402 . . . . 0.0 110.15 177.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.5 m -85.64 102.72 13.82 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.973 -176.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 133' ' ' PHE . 40.7 t -92.75 121.85 43.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.541 177.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -92.8 118.55 31.22 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.217 0.532 . . . . 0.0 110.856 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.56 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 40.4 ttm -79.81 93.13 5.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.181 176.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 51.5 m-80 -79.91 123.2 27.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.331 0.586 . . . . 0.0 111.519 -172.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 70.2 mt -105.39 95.56 5.91 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.368 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 . . . . . 0 C--N 1.325 -0.499 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.984 -177.026 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 C--O 1.234 0.267 0 CA-C-O 120.887 0.375 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -156.78 108.94 1.97 Allowed Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.853 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -82.37 -147.6 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.478 2.118 . . . . 0.0 109.316 166.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.576 ' HB3' HG23 ' A' ' 105' ' ' VAL . 14.0 tp -150.83 138.63 19.86 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.514 173.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.6 t -125.67 109.72 12.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.535 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 32.2 pt -116.12 134.72 58.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.945 0.402 . . . . 0.0 110.765 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' A' ' 100' ' ' SER . 58.4 tp -94.46 105.84 17.81 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.038 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 69.1 t -88.53 104.56 14.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.469 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -93.16 114.46 26.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.673 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.559 HD22 ' N ' ' A' ' 95' ' ' ASN . 0.7 OUTLIER -78.54 142.15 37.58 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.224 176.226 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.47 HD21 HD12 ' A' ' 159' ' ' LEU . 3.8 p-10 -62.56 -23.01 66.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.981 0.42 . . . . 0.0 110.491 178.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -84.92 15.25 4.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.112 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.75 55.91 3.25 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.991 175.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -141.67 96.51 2.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.997 0.399 . . . . 0.0 110.13 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.459 ' HB3' HD11 ' A' ' 92' ' ' LEU . 8.8 m -93.38 96.53 9.99 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.801 0.334 . . . . 0.0 110.109 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.2 p -108.31 119.33 39.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.952 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.1 m -82.11 120.17 24.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.344 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -110.72 136.03 50.41 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -91.01 123.83 34.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.656 0.741 . . . . 0.0 109.679 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' ' 89' ' ' LEU . 16.0 m -135.78 -178.97 2.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.257 -175.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -127.1 157.0 40.83 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.16 -30.38 64.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 110.324 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -78.83 50.33 0.99 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.835 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -139.88 155.82 47.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.659 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.1 p -86.28 152.29 22.89 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.623 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 59.4 t -63.09 -23.79 34.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.004 0.431 . . . . 0.0 109.848 176.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.528 ' CA ' ' HB2' ' A' ' 140' ' ' ASP . . . -57.07 -44.09 82.74 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.81 174.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.509 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 13.0 m-70 -65.32 -32.96 74.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.269 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.472 HD22 HD11 ' A' ' 144' ' ' LEU . 56.4 tp -71.13 -48.0 54.67 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 174.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -54.94 -47.36 74.55 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.897 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.478 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 29.0 mt-30 -63.8 -34.31 77.63 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -176.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 25.3 mt-30 -66.43 -47.06 74.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.336 0.589 . . . . 0.0 109.729 176.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.99 -34.89 65.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.633 174.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.908 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 60.8 m -79.26 -1.33 36.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.399 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -88.81 -37.0 7.52 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.788 168.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.0 mt -86.5 -64.39 1.16 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.02 0.438 . . . . 0.0 111.508 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 124' ' ' VAL . 17.1 mm-40 -99.63 8.93 43.98 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.649 0.78 . . . . 0.0 110.069 -175.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.908 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -44.48 9.12 0.0 OUTLIER Glycine 0 CA--C 1.526 0.723 0 N-CA-C 120.032 2.773 . . . . 0.0 120.032 -170.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.452 ' N ' ' O ' ' A' ' 122' ' ' GLU . 13.0 t -58.45 75.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 119.517 1.658 . . . . 0.0 112.222 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 123' ' ' GLY . 24.5 mt-30 63.7 121.28 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.504 1.121 . . . . 0.0 113.399 175.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -73.53 54.81 0.47 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 122.412 1.101 . . . . 0.0 109.406 173.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.51 ' O ' ' HD2' ' A' ' 160' ' ' ARG . 19.0 t70 -146.4 -37.69 0.24 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.48 -1.237 . . . . 0.0 108.711 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.7 mt -80.87 -20.02 43.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.604 175.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -135.74 148.28 48.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.652 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.933 ' HZ3' ' HA ' ' A' ' 160' ' ' ARG . 1.2 p90 -155.32 152.52 29.28 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 170.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.798 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 6.7 mp -109.01 141.78 40.65 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.549 -173.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.8 p -122.41 131.37 53.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.83 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.564 ' HB3' HD21 ' A' ' 138' ' ' LEU . 10.9 t80 -100.79 -62.22 1.27 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.166 0.508 . . . . 0.0 110.768 174.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -95.87 27.85 3.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.914 -174.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.4 4.02 90.32 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.596 -174.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -127.05 149.54 69.62 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -62.46 148.52 93.18 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.803 2.335 . . . . 0.0 112.182 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.564 HD21 ' HB3' ' A' ' 133' ' ' PHE . 43.3 mt -96.92 112.94 24.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.443 -179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -61.76 130.65 46.8 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 173.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.623 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.7 p-10 -77.46 -18.52 57.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.49 -176.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.65 -36.73 73.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.867 0.365 . . . . 0.0 110.602 177.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.418 ' HB3' ' HD2' ' A' ' 143' ' ' PRO . 93.2 mt -78.54 158.17 76.44 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.402 -174.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.67 ' HG2' ' HG2' ' A' ' 146' ' ' GLU . 44.4 Cg_endo -69.23 146.71 64.34 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.648 2.232 . . . . 0.0 112.58 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.472 HD11 HD22 ' A' ' 114' ' ' LEU . 22.7 tp -72.12 -37.34 69.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.604 -174.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 149' ' ' LEU . . . -57.4 -25.23 54.47 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.396 -0.431 . . . . 0.0 113.716 -176.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.67 ' HG2' ' HG2' ' A' ' 143' ' ' PRO . 24.4 mm-40 -65.78 -29.69 70.22 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 122.468 -0.43 . . . . 0.0 111.483 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -100.53 -38.47 8.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.171 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.44 ' O ' HD11 ' A' ' 89' ' ' LEU . . . -98.59 6.21 60.73 Favored Glycine 0 C--O 1.224 -0.491 0 CA-C-O 119.412 -0.66 . . . . 0.0 113.912 -172.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.5 pt? -37.21 -38.2 0.2 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -175.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.461 ' C ' ' H ' ' A' ' 152' ' ' LEU . 38.7 ttpt -90.76 125.95 57.49 Favored Pre-proline 0 C--N 1.322 -0.605 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.349 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.09 27.35 0.22 Allowed 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 123.356 2.704 . . . . 0.0 112.653 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.461 ' H ' ' C ' ' A' ' 150' ' ' LYS . 0.2 OUTLIER -140.83 14.83 2.3 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.718 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 31.9 p -75.92 131.74 39.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.443 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 23.6 m -95.09 110.43 22.37 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.737 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 41.0 t -92.7 109.52 21.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -85.26 120.32 26.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.843 0.354 . . . . 0.0 111.065 -176.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.798 ' HA ' ' HG ' ' A' ' 131' ' ' LEU . 27.4 ttt -85.19 103.87 14.55 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 174.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.65 123.44 46.36 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.513 -172.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.47 HD12 HD21 ' A' ' 96' ' ' ASN . 88.5 mt -72.9 147.1 45.65 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 169.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.933 ' HA ' ' HZ3' ' A' ' 130' ' ' TRP . 60.6 ttt180 . . . . . 0 C--N 1.324 -0.513 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -170.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.7 p30 . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -103.93 107.65 57.47 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 178.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.03 131.83 10.16 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.197 2.598 . . . . 0.0 111.9 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.497 HD22 ' CD2' ' A' ' 107' ' ' LEU . 52.3 tp -109.34 103.44 12.37 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.432 ' OG ' HG22 ' A' ' 102' ' ' THR . 7.3 t -96.16 98.48 10.36 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.105 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.464 HG23 ' HG ' ' A' ' 89' ' ' LEU . 33.3 pt -95.5 159.99 2.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.41 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 33.8 tp -99.99 119.09 37.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.839 0.352 . . . . 0.0 110.877 -177.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 68.9 t -110.13 114.2 46.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.86 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 34.0 ttt-85 -110.08 137.98 47.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.703 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.541 ' ND2' ' HB2' ' A' ' 99' ' ' ARG . 56.7 p30 -79.84 -160.08 0.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.871 175.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -64.25 -32.27 73.79 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -174.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -160.08 105.13 1.53 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.96 0.41 . . . . 0.0 111.482 -176.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.21 -62.09 0.33 Allowed Glycine 0 C--N 1.318 -0.437 0 C-N-CA 120.67 -0.776 . . . . 0.0 114.443 164.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.541 ' HB2' ' ND2' ' A' ' 95' ' ' ASN . 4.6 mmp_? -69.56 105.8 2.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.115 0.483 . . . . 0.0 110.884 -172.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 5.2 m -118.71 100.09 7.19 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.503 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.9 t -101.27 136.62 40.82 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.86 0.362 . . . . 0.0 110.382 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.432 HG22 ' OG ' ' A' ' 90' ' ' SER . 0.6 OUTLIER -91.68 109.33 20.64 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.603 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 90' ' ' SER . 44.7 m-85 -95.86 120.15 35.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.021 0.439 . . . . 0.0 111.71 -174.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -79.69 100.39 7.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.663 176.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.415 ' C ' ' HD2' ' A' ' 106' ' ' ARG . 35.1 m -123.81 -179.86 2.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.023 0.439 . . . . 0.0 110.975 -177.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.502 ' N ' ' HD2' ' A' ' 106' ' ' ARG . 4.6 mpt_? -123.33 157.2 33.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.497 ' CD2' HD22 ' A' ' 89' ' ' LEU . 23.8 mt -62.03 -29.18 70.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.723 0.297 . . . . 0.0 111.364 -176.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.0 m -74.93 -7.89 54.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.695 -175.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -80.29 125.27 29.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.795 0.331 . . . . 0.0 110.912 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 21.2 p -73.96 157.86 35.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.759 172.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.611 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 60.3 t -59.03 -29.37 41.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.08 0.467 . . . . 0.0 109.963 177.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -58.71 -38.33 78.06 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.35 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -64.92 -46.33 82.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.708 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.456 HD23 HD11 ' A' ' 131' ' ' LEU . 34.0 tp -64.11 -40.68 96.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.319 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -52.85 -48.84 66.75 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.849 175.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.537 ' HA ' ' HB2' ' A' ' 119' ' ' SER . 11.6 mm-40 -69.03 -28.94 67.02 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -66.98 -48.68 67.74 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.504 0.668 . . . . 0.0 109.452 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 114' ' ' LEU . 42.8 t -64.11 -33.6 63.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.495 175.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.737 ' HA ' ' HA2' ' A' ' 123' ' ' GLY . 67.9 m -67.68 -17.4 64.57 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.196 175.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.76 -37.09 27.25 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.559 175.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.9 mt -93.36 -64.98 1.03 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.958 0.409 . . . . 0.0 112.04 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 124' ' ' VAL . 64.6 mm-40 -98.06 9.61 42.42 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.349 0.659 . . . . 0.0 111.367 -174.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.737 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -45.11 7.3 0.01 OUTLIER Glycine 0 N--CA 1.473 1.131 0 N-CA-C 118.583 2.193 . . . . 0.0 118.583 -173.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.464 ' N ' ' O ' ' A' ' 122' ' ' GLU . 57.9 t -50.57 88.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 118.532 1.166 . . . . 0.0 111.019 171.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 49.04 105.8 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.824 0.703 . . . . 0.0 111.794 -175.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.562 ' HA ' ' CE1' ' A' ' 129' ' ' PHE . 3.4 p-10 -69.65 5.93 1.28 Allowed 'General case' 0 C--N 1.328 -0.364 0 O-C-N 121.92 -0.488 . . . . 0.0 110.618 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -77.54 -35.61 53.09 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.719 169.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.2 mt -73.78 -21.05 60.3 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.275 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.562 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 52.6 p90 -132.13 120.39 22.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.632 0.73 . . . . 0.0 111.403 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -134.12 131.97 39.35 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 170.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.727 HD23 ' H ' ' A' ' 131' ' ' LEU . 2.2 pt? -104.19 130.62 51.95 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.265 0.555 . . . . 0.0 111.273 -171.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.663 HG22 ' HA ' ' A' ' 137' ' ' PRO . 68.3 p -118.09 138.2 52.41 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.707 -174.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -84.23 132.14 34.68 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.179 175.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 63.87 8.08 3.64 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.959 175.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.04 -2.18 63.6 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.037 -177.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.487 ' O ' ' HB ' ' A' ' 132' ' ' THR . 78.4 mttt -102.02 132.83 21.12 Favored Pre-proline 0 C--N 1.327 -0.396 0 C-N-CA 122.321 0.248 . . . . 0.0 110.479 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.663 ' HA ' HG22 ' A' ' 132' ' ' THR . 19.5 Cg_exo -65.26 127.99 19.47 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.883 2.388 . . . . 0.0 112.936 -175.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 75.6 mt -98.45 164.58 12.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.427 178.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.465 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 32.8 mt-10 -105.99 141.13 37.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.75 175.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.611 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 4.8 p-10 -64.33 -18.53 64.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.216 0.532 . . . . 0.0 110.263 176.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -72.28 -16.87 61.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.285 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.465 ' HG ' ' HB2' ' A' ' 139' ' ' GLU . 87.4 mt -100.84 148.57 35.23 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.625 -173.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 2.8 Cg_exo -76.94 149.57 29.19 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.102 2.535 . . . . 0.0 112.159 175.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.441 HD11 ' HB2' ' A' ' 114' ' ' LEU . 60.8 mt -73.65 -29.24 62.22 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.401 -176.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.422 ' CA ' HD22 ' A' ' 107' ' ' LEU . . . -54.3 -37.97 60.91 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.308 -0.472 . . . . 0.0 114.131 -173.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -64.55 -32.04 73.52 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.904 0.383 . . . . 0.0 111.334 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -100.63 -24.31 14.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.21 0.529 . . . . 0.0 111.238 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.438 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -100.4 6.24 57.62 Favored Glycine 0 C--O 1.224 -0.511 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.108 -175.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -39.58 -35.92 0.35 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 98.4 mttt -100.31 129.65 27.59 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 174.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 50.9 Cg_exo -57.42 -24.93 63.49 Favored 'Trans proline' 0 N--CA 1.473 0.314 0 C-N-CA 122.834 2.356 . . . . 0.0 112.54 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.425 ' H ' ' HG ' ' A' ' 152' ' ' LEU . 2.3 pp -87.71 -1.28 57.86 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.496 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.3 t -68.89 120.68 15.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.5 m -98.01 119.05 35.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.323 0.582 . . . . 0.0 111.978 -172.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 29.2 t -96.11 119.16 43.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -88.95 117.78 28.21 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.803 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.507 ' HE2' HD21 ' A' ' 159' ' ' LEU . 20.7 ttt -77.56 91.47 3.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.19 176.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -75.46 109.88 9.36 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.0 -173.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.507 HD21 ' HE2' ' A' ' 157' ' ' MET . 99.6 mt -88.2 113.69 24.07 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.712 176.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 . . . . . 0 C--N 1.325 -0.495 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.603 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 CA--C 1.52 -0.19 0 CA-C-O 121.096 0.474 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.422 ' O ' ' HG2' ' A' ' 106' ' ' ARG . 50.4 mm-40 -119.4 91.88 44.94 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.898 176.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -77.67 70.56 6.87 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.675 2.25 . . . . 0.0 110.531 175.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.578 HD21 ' O ' ' A' ' 148' ' ' GLY . 45.7 tp -78.9 89.26 4.7 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.939 -174.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.525 ' HB3' HG22 ' A' ' 102' ' ' THR . 19.7 m -84.91 93.63 8.58 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.617 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.2 pt -90.21 165.07 2.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.501 HD11 ' HB2' ' A' ' 100' ' ' SER . 21.5 tp -108.69 107.02 17.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.196 0.522 . . . . 0.0 110.916 -175.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.9 t -96.74 107.41 19.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.365 176.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.554 ' HD2' ' CE2' ' A' ' 156' ' ' PHE . 16.5 ttm180 -84.33 105.0 14.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -175.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.546 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 50.8 t-20 -78.92 106.46 10.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.493 -0.776 . . . . 0.0 108.973 175.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 68.06 -84.07 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.086 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -146.8 -65.98 0.28 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.642 0.258 . . . . 0.0 111.606 -177.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -84.48 -25.17 44.0 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.986 -174.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.423 ' CB ' ' HB3' ' A' ' 95' ' ' ASN . 13.3 mmt180 -80.44 64.44 5.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.176 0.513 . . . . 0.0 111.478 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.544 ' HA ' ' HA ' ' A' ' 94' ' ' ARG . 32.6 p -79.65 92.05 5.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.116 0.484 . . . . 0.0 109.862 176.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.4 m -86.38 123.42 31.6 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.894 -176.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.525 HG22 ' HB3' ' A' ' 90' ' ' SER . 8.7 m -90.2 102.54 15.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.124 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -95.89 136.32 36.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.51 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -79.49 103.65 9.55 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 173.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 21.9 m -107.97 166.28 4.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 87' ' ' GLU . 56.0 mtt180 -138.33 154.17 48.98 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.405 HD22 ' CA ' ' A' ' 145' ' ' GLY . 16.3 mt -60.31 -33.46 72.4 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -169.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.6 m -80.56 -7.78 59.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.371 0.605 . . . . 0.0 111.187 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -86.96 122.26 30.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 39.1 p -79.18 165.99 22.69 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.82 0.343 . . . . 0.0 111.322 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.664 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 46.6 t -64.37 -27.84 43.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.21 177.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.481 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -59.62 -45.02 93.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.15 0.5 . . . . 0.0 110.252 174.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.44 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 50.9 m80 -63.42 -37.04 85.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.382 178.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.626 ' HB2' HD11 ' A' ' 144' ' ' LEU . 55.5 tp -65.25 -47.14 77.79 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.672 ' HD2' ' HB2' ' A' ' 126' ' ' ASP . 5.2 tppp? -54.1 -49.26 69.5 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.966 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.794 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 34.9 tt0 -70.26 -32.56 70.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.796 -174.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 27.6 mt-30 -63.67 -39.6 94.74 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 114' ' ' LEU . 67.2 t -71.63 -38.06 65.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.895 176.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.794 ' OG ' ' HA ' ' A' ' 116' ' ' GLN . 92.0 p -72.71 -5.0 34.68 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.005 0.431 . . . . 0.0 110.555 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -94.76 -59.46 1.13 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.372 173.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.4 mp -77.33 -45.24 26.77 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.328 0.585 . . . . 0.0 111.405 -177.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 124' ' ' VAL . 8.7 mm-40 -96.8 9.6 41.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.431 -176.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -28.82 6.54 0.0 OUTLIER Glycine 0 N--CA 1.485 1.911 0 N-CA-C 121.956 3.542 . . . . 0.0 121.956 -165.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.559 ' N ' ' O ' ' A' ' 122' ' ' GLU . 48.1 t -52.15 144.95 2.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 119.852 1.826 . . . . 0.0 108.53 168.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -49.03 135.93 15.26 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.097 0.475 . . . . 0.0 112.03 -170.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.672 ' HB2' ' HD2' ' A' ' 115' ' ' LYS . 7.2 p-10 -74.4 9.55 1.66 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.514 -171.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.67 -21.86 40.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.169 0.509 . . . . 0.0 110.125 173.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.468 HD12 HG12 ' A' ' 124' ' ' VAL . 83.0 mt -91.49 -45.93 8.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.007 -171.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.573 ' CE1' ' HA ' ' A' ' 126' ' ' ASP . 34.5 p90 -83.49 102.23 11.96 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.161 0.982 . . . . 0.0 110.848 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.609 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 25.4 t90 -100.81 93.22 5.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.493 -1.231 . . . . 0.0 109.414 -176.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.52 ' HG ' ' HA ' ' A' ' 157' ' ' MET . 8.6 mp -79.45 115.52 19.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.199 0.523 . . . . 0.0 111.762 -173.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 25.6 p -121.33 119.23 31.57 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.75 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.535 ' HB2' HG22 ' A' ' 155' ' ' VAL . 6.7 t80 -82.06 -74.39 0.34 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.886 0.374 . . . . 0.0 110.614 177.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.66 36.45 1.38 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.377 0.608 . . . . 0.0 109.64 -175.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.95 -36.42 3.85 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.869 -177.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -91.81 144.47 29.41 Favored Pre-proline 0 C--O 1.237 0.447 0 CA-C-O 120.581 0.229 . . . . 0.0 111.037 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -76.83 137.11 17.48 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.873 2.382 . . . . 0.0 111.541 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 71.2 mt -77.81 133.92 38.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.732 -177.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.505 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 44.2 mt-10 -76.12 139.46 41.33 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.664 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 6.6 p-10 -66.92 -24.77 66.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 0.0 111.894 -173.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -76.09 -14.63 60.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.108 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.505 ' HG ' ' HB2' ' A' ' 139' ' ' GLU . 87.5 mt -86.17 146.13 42.01 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.03 -175.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 142' ' ' LEU . 2.7 Cg_exo -76.74 140.37 20.81 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.142 2.562 . . . . 0.0 111.656 175.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.626 HD11 ' HB2' ' A' ' 114' ' ' LEU . 74.8 mt -67.73 -26.38 66.11 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -175.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.405 ' CA ' HD22 ' A' ' 107' ' ' LEU . . . -56.05 -35.02 62.95 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.85 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -50.35 -56.53 10.96 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -101.25 -13.14 18.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.455 -173.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.578 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -100.2 3.46 56.82 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.932 -177.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -46.73 -31.4 2.93 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.107 0.479 . . . . 0.0 111.744 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -92.63 117.35 67.56 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 174.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -58.01 -18.59 36.48 Favored 'Trans proline' 0 N--CA 1.476 0.443 0 C-N-CA 122.66 2.24 . . . . 0.0 112.911 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 84.9 mt -94.18 7.02 46.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.788 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 29.5 t -59.78 107.39 0.6 Allowed 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 23.6 m -94.97 100.23 12.11 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.28 -174.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.535 HG22 ' HB2' ' A' ' 133' ' ' PHE . 42.3 t -87.1 115.5 27.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.5 176.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.554 ' CE2' ' HD2' ' A' ' 94' ' ' ARG . 74.0 m-85 -79.28 117.97 20.77 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.904 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.546 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 52.6 ttm -80.47 83.4 6.29 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 174.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.609 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 1.9 m-20 -73.0 98.88 2.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.797 -174.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 91.6 mt -75.24 103.78 5.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.03 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.457 179.791 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.7 t70 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 121.618 0.723 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -65.38 120.75 70.42 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.303 -176.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -86.7 161.24 9.23 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.584 2.189 . . . . 0.0 111.983 174.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.596 HD21 ' O ' ' A' ' 148' ' ' GLY . 61.9 tp -112.4 111.45 22.31 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.585 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.4 t -85.72 114.61 22.82 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.666 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 34.4 pt -109.19 163.09 6.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.93 176.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.494 HD11 ' HB2' ' A' ' 100' ' ' SER . 27.0 tp -115.33 110.71 19.79 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.025 0.44 . . . . 0.0 110.724 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.8 t -104.68 109.21 26.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.284 0.564 . . . . 0.0 110.583 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 94' ' ' ARG . 16.3 ttt180 -92.61 116.93 29.44 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.385 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.515 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 30.4 p-10 -82.07 100.73 9.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.777 0.799 . . . . 0.0 111.517 -174.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.444 ' OD1' ' HG2' ' A' ' 97' ' ' LYS . 10.7 t-20 65.11 -75.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.547 176.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.444 ' HG2' ' OD1' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -154.37 21.81 0.48 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -175.073 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -128.81 -93.96 0.76 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.638 -1.268 . . . . 0.0 114.109 -174.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 94' ' ' ARG . 32.2 ttt180 -84.53 131.98 34.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.222 0.534 . . . . 0.0 111.743 -167.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.494 ' HB2' HD11 ' A' ' 92' ' ' LEU . 12.6 p -88.31 92.07 9.03 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 171.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.2 m -83.32 124.66 30.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.697 -173.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.2 m -91.58 113.43 25.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.93 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -115.05 132.82 56.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.885 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -107.15 97.5 7.26 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.259 0.552 . . . . 0.0 111.1 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.9 m -104.15 -179.5 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.54 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.599 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 33.2 ttm180 -110.46 125.06 52.88 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 174.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.525 ' HB2' ' HA3' ' A' ' 145' ' ' GLY . 1.4 pp -62.88 -6.59 3.92 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -173.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 m -86.76 0.72 54.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.726 0.298 . . . . 0.0 110.926 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.599 ' HG2' ' O ' ' A' ' 106' ' ' ARG . 2.5 pt20 -92.66 158.86 15.72 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 178.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.0 m -87.43 154.29 20.77 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 30.3 t -58.18 -25.68 27.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.094 0.474 . . . . 0.0 110.844 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.56 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -60.84 -34.32 74.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.215 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.567 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 17.1 t-80 -72.34 -46.77 54.08 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.962 -0.385 . . . . 0.0 109.962 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.471 ' HA ' ' NE2' ' A' ' 117' ' ' GLN . 59.5 tp -47.83 -45.97 30.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.063 173.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.515 ' HE2' ' HB2' ' A' ' 126' ' ' ASP . 48.5 tttt -61.13 -41.9 97.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.627 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 18.1 tm0? -67.02 -39.72 87.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.985 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.567 ' HG3' ' O ' ' A' ' 113' ' ' HIS . 18.6 mt-30 -57.15 -46.23 82.92 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.35 0.595 . . . . 0.0 109.867 176.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 63.8 t -65.49 -36.36 77.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.899 175.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.455 ' C ' ' HA2' ' A' ' 123' ' ' GLY . 62.4 m -67.88 -8.2 34.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.259 177.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -98.69 -61.93 0.87 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.63 173.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 88.7 mt -71.09 -41.4 70.69 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.494 0.664 . . . . 0.0 111.335 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 124' ' ' VAL . 6.0 mm-40 -100.06 11.07 40.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.814 -177.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.455 ' HA2' ' C ' ' A' ' 119' ' ' SER . . . -27.87 7.3 0.0 OUTLIER Glycine 0 N--CA 1.488 2.117 0 N-CA-C 122.334 3.694 . . . . 0.0 122.334 -157.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' A' ' 122' ' ' GLU . 44.3 t -51.57 141.71 4.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 119.928 1.864 . . . . 0.0 108.576 165.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -45.6 137.99 4.81 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -173.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.753 ' HA ' ' CE2' ' A' ' 129' ' ' PHE . 4.1 p-10 -63.77 -22.95 67.16 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.363 -172.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -73.82 -21.79 60.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.296 0.57 . . . . 0.0 110.657 178.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.505 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 93.4 mt -83.24 -17.25 43.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.837 -174.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.753 ' CE2' ' HA ' ' A' ' 126' ' ' ASP . 38.7 p90 -112.36 124.26 52.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.974 0.892 . . . . 0.0 111.45 175.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.706 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 49.9 t90 -112.68 92.55 4.06 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.688 177.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.707 HD23 ' H ' ' A' ' 131' ' ' LEU . 2.6 pt? -97.2 144.01 27.44 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.004 -177.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.36 150.23 36.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.249 0.547 . . . . 0.0 111.393 -178.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.532 ' HB2' HG22 ' A' ' 155' ' ' VAL . 5.1 t80 -112.69 -58.52 2.14 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.911 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.34 -20.26 23.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.501 -175.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 136.87 -19.69 3.48 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -171.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -102.25 149.41 36.6 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 114.334 -0.933 . . . . 0.0 109.202 174.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 131' ' ' LEU . 59.0 Cg_endo -72.02 0.35 7.34 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.699 2.266 . . . . 0.0 112.312 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 48.4 mt 69.61 115.83 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 O-C-N 123.931 0.769 . . . . 0.0 110.03 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.692 ' HB2' ' CD2' ' A' ' 142' ' ' LEU . 7.3 mm-40 -72.04 137.9 47.5 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.457 -177.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.566 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 5.7 p-10 -77.46 33.49 0.16 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.392 -176.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -118.63 -21.89 7.72 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.228 0.537 . . . . 0.0 109.789 -178.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.692 ' CD2' ' HB2' ' A' ' 139' ' ' GLU . 0.6 OUTLIER -95.95 153.97 39.08 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.261 -173.253 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -64.01 136.6 53.28 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.402 2.068 . . . . 0.0 110.999 173.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.424 ' O ' HD23 ' A' ' 144' ' ' LEU . 6.9 tt -60.78 -32.39 71.71 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.258 -176.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.525 ' HA3' ' HB2' ' A' ' 107' ' ' LEU . . . -60.42 -28.21 66.93 Favored Glycine 0 C--O 1.225 -0.416 0 CA-C-N 116.094 -0.503 . . . . 0.0 113.33 -178.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -61.67 -37.3 83.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.937 0.399 . . . . 0.0 110.814 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -100.77 -32.74 10.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.756 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.596 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -98.99 5.83 59.71 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.742 -172.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 145' ' ' GLY . 2.5 pt? -45.2 -29.93 1.07 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.442 ' C ' ' H ' ' A' ' 152' ' ' LEU . 48.7 tttp -79.73 121.16 82.09 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 21.4 Cg_exo -67.25 12.86 0.17 Allowed 'Trans proline' 0 N--CA 1.476 0.457 0 C-N-CA 123.088 2.525 . . . . 0.0 112.789 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.442 ' H ' ' C ' ' A' ' 150' ' ' LYS . 26.5 tp -137.5 20.28 2.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.409 0.624 . . . . 0.0 109.417 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.0 p -67.37 118.77 11.17 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.142 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 20.7 m -97.19 111.06 23.46 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.999 -175.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 133' ' ' PHE . 39.9 t -100.86 129.29 52.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.609 177.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.428 ' O ' ' HA ' ' A' ' 131' ' ' LEU . 94.7 m-85 -95.07 110.21 22.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.822 0.344 . . . . 0.0 110.818 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.515 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 23.6 ttt -82.18 97.38 8.2 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.854 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.706 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 50.7 m-80 -90.6 136.2 33.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.323 -178.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 90.3 mt -104.54 81.6 1.81 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.488 -0.189 . . . . 0.0 110.488 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 128' ' ' LEU . 1.9 mmp_? . . . . . 0 N--CA 1.466 0.369 0 O-C-N 123.792 0.682 . . . . 0.0 111.306 -176.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 CA--C 1.516 -0.332 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -92.24 134.69 27.97 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.189 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.03 124.74 13.99 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 122.487 2.125 . . . . 0.0 111.713 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.587 HD21 ' O ' ' A' ' 148' ' ' GLY . 31.7 tp -105.69 116.36 31.82 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.246 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.428 ' HB3' ' OG1' ' A' ' 102' ' ' THR . 16.0 m -94.57 107.23 19.22 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.469 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 102' ' ' THR . 35.4 pt -99.06 160.93 3.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 154' ' ' THR . 36.7 tp -106.19 116.07 31.3 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.762 -176.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.1 t -104.37 121.49 56.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.461 ' HD2' ' CE1' ' A' ' 156' ' ' PHE . 18.4 ttm180 -106.54 107.01 17.8 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.188 -177.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.581 ' HA ' ' HB3' ' A' ' 157' ' ' MET . 40.4 m-20 -81.67 148.85 28.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.52 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -56.64 -23.97 45.11 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.482 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -73.51 5.33 3.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.475 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.98 51.31 4.8 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.453 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.5 ' NE ' ' HA ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -137.95 103.34 4.95 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.132 -176.848 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.3 m -94.15 86.15 4.88 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.4 t -104.8 129.96 52.99 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.109 -176.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 91' ' ' ILE . 10.8 t -76.92 143.58 39.45 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 173.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -121.37 133.03 55.09 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.293 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -83.19 108.07 16.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.931 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.88 -179.18 3.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.491 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -121.47 178.84 4.65 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 173.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.61 -32.18 19.43 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 176.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.2 m -89.51 64.67 6.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.308 0.575 . . . . 0.0 110.74 -178.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -163.72 163.54 24.12 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.181 173.374 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 32.6 p -96.94 162.18 13.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.803 0.335 . . . . 0.0 111.332 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 140' ' ' ASP . 45.3 t -57.51 -21.39 15.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.843 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.599 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . . . -50.49 -46.33 56.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.557 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -81.57 -0.83 44.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.513 -175.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.581 ' HB2' HD11 ' A' ' 144' ' ' LEU . 43.7 tp -100.34 -47.33 4.96 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.437 0.637 . . . . 0.0 109.721 172.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -63.2 -27.33 69.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.628 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.882 ' HA ' ' OG ' ' A' ' 119' ' ' SER . 0.9 OUTLIER -78.11 -23.26 47.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.521 177.357 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -68.56 -43.87 75.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.3 -43.73 98.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.872 174.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.882 ' OG ' ' HA ' ' A' ' 116' ' ' GLN . 7.9 p -76.38 -1.74 28.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.776 0.322 . . . . 0.0 111.435 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -88.35 -36.31 8.21 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.779 172.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 mp -99.94 -58.46 1.91 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.446 0.641 . . . . 0.0 111.197 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 124' ' ' VAL . 4.0 mm-40 -91.28 9.22 32.29 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.919 -177.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.851 ' HA2' ' HA ' ' A' ' 119' ' ' SER . . . -49.26 7.72 0.01 OUTLIER Glycine 0 N--CA 1.469 0.851 0 N-CA-C 117.788 1.875 . . . . 0.0 117.788 -173.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.454 ' O ' HD22 ' A' ' 128' ' ' LEU . 94.6 t -47.26 86.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 CA-C-N 117.965 0.883 . . . . 0.0 111.742 172.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.41 ' O ' HD22 ' A' ' 128' ' ' LEU . 93.9 mt-30 59.29 119.26 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.61 0.719 . . . . 0.0 112.59 -178.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -78.85 57.01 2.02 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -147.63 -43.47 0.17 Allowed 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.435 -175.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.577 HD23 ' N ' ' A' ' 129' ' ' PHE . 0.9 OUTLIER -72.15 -22.58 61.29 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -169.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.577 ' N ' HD23 ' A' ' 128' ' ' LEU . 37.9 p90 -105.1 147.77 27.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.221 0.534 . . . . 0.0 111.313 -176.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.534 ' O ' ' HB2' ' A' ' 158' ' ' ASN . 39.2 t90 -141.1 98.07 3.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.969 -175.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.547 ' HB3' ' HA ' ' A' ' 157' ' ' MET . 2.5 pp -99.13 138.55 36.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.152 0.501 . . . . 0.0 111.322 -174.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 38.8 p -136.2 150.98 49.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.098 -174.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.402 ' CD2' ' HB3' ' A' ' 147' ' ' TYR . 30.4 t80 -116.43 -70.37 0.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.026 0.441 . . . . 0.0 110.8 175.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -87.43 30.95 0.76 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.444 0.64 . . . . 0.0 110.469 -173.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 80.17 -3.53 71.24 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -172.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -115.54 143.67 30.98 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 115.036 -0.582 . . . . 0.0 109.476 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.55 137.79 51.92 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.267 1.978 . . . . 0.0 111.06 173.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.457 ' HB3' HG21 ' A' ' 111' ' ' VAL . 87.2 mt -81.7 106.77 13.9 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.059 0.457 . . . . 0.0 110.483 -178.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.552 ' HB2' ' HG ' ' A' ' 142' ' ' LEU . 42.7 mt-10 -71.96 141.76 49.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.935 177.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.599 ' HB2' ' HB2' ' A' ' 112' ' ' ALA . 4.1 p-10 -73.03 -5.78 41.13 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.97 0.414 . . . . 0.0 111.15 -177.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -83.49 -15.72 48.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.485 173.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.552 ' HG ' ' HB2' ' A' ' 139' ' ' GLU . 82.8 mt -91.32 144.29 29.54 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.037 -176.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 109' ' ' GLN . 6.3 Cg_exo -79.88 138.98 13.52 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.154 2.569 . . . . 0.0 111.612 174.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.581 HD11 ' HB2' ' A' ' 114' ' ' LEU . 33.6 mt -68.83 -40.2 79.57 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -177.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -52.26 -30.2 31.67 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.166 -0.54 . . . . 0.0 113.923 -175.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -66.25 -32.94 74.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.927 0.394 . . . . 0.0 110.899 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.402 ' HB3' ' CD2' ' A' ' 133' ' ' PHE . 89.0 m-85 -101.06 -32.23 10.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.36 0.6 . . . . 0.0 110.899 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.587 ' O ' HD21 ' A' ' 89' ' ' LEU . . . -97.06 6.54 64.06 Favored Glycine 0 C--O 1.223 -0.531 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.809 -170.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.407 ' HG ' ' HG3' ' A' ' 150' ' ' LYS . 2.6 pt? -44.82 -24.54 0.22 Allowed 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.498 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 67.7 mttt -102.23 131.0 23.08 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.497 177.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 150' ' ' LYS . 12.8 Cg_exo -69.93 9.63 0.6 Allowed 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.197 2.598 . . . . 0.0 112.449 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.9 pp -119.93 0.0 10.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.586 178.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.6 m -61.83 110.87 1.66 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.895 176.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 29.3 m -95.6 114.38 26.13 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.03 -176.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.6 t -91.51 118.63 37.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.13 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.461 ' CE1' ' HD2' ' A' ' 94' ' ' ARG . 80.5 m-85 -90.57 113.96 26.08 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.942 0.401 . . . . 0.0 110.869 -177.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.581 ' HB3' ' HA ' ' A' ' 95' ' ' ASN . 2.0 tmt? -88.19 97.7 11.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.3 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.534 ' HB2' ' O ' ' A' ' 130' ' ' TRP . 92.2 m-20 -97.49 176.93 5.69 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.646 -173.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.476 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 96.0 mt -120.33 133.27 55.48 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.918 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 159' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.943 0 O-C-N 124.132 0.895 . . . . 0.0 112.389 -174.978 . . . . . . . . 2 2 . 1 stop_ save_